ECR 2016 Final Programme PDF

FINAL PROGRAMME
TIMETABLE
08:30 09:00 09:30 10:00 10:30 11:00 11:30 12:00 12:15 13:00 13:30 14:00
New Horizons Session E³ - ECR Academy E³ - The Beauty of Basic Knowledge

NH 1 E³ 221 E³ 24A, E³ 25A
Wednesday, March 2
E³ - ECR Academy
E³ 121 Scientific Sessions (200) Clinical Trials in Radiology 1
E³ - ECR Master Class Satellite Symposium Satellite Symposia
E³ 126 SY 1a SY 1b, SY 2, SY 3, SY 4
Refresher Courses (100)
EuroSafe Imaging Session 1
1 2
New Horizons Session E³ - ECR Academies Wilhelm Conrad Röntgen
NH 5 E³ 621, E³ 622 Honorary Lecture
Professional Challenges Session Andrea G. Rockall; UK
PC 5 Joint Course: ESR and RSNA
Thursday, March 3
Special Focus Session MC 628 E³ - The Beauty of Basic Knowledge

SF 5 E³ 24B, E³ 25B
Scientific Sessions (600)
State of the Art Symposium Clinical Trials in Radiology 2
SA 5 E³ - Rising Stars Programme
E³ - ECR Academies Basic Session 2 Satellite Symposia
E³ 522, E³ 521, E³ 519 SY 5, SY 6, SY 7, SY 8, SY 9, SY 10,
E³ - ECR Master Class SY 11, SY 12
E³ 526 RTF Quiz
5 6
Joint Course: ESR and RSNA
MC 528
E³ - Rising Stars Programme
Basic Session 1
Professional Challenges Sessions ESR meets the Nordic Countries Josef Lissner
PC 9a, PC 9b Honorary Lecture
Special Focus Sessions E³ - ECR Academies Valérie Vilgrain; FR
SF 9a, SF 9b, SF 9c E³ 1022, E³ 1021
E³ - The Beauty of Basic Knowledge
Friday, March 4
E³ - ECR Academies Scientific Sessions (1000)

E³ 922, E³ 921, E³ 920, E³ 919 E³ 24C, E³ 25C
EFOMP Workshop EF 2 MIR @ ECR Session MIR 1
E³ - Rising Stars Programme Satellite Symposia
EFOMP Workshop EF 1 Student Session 4 SY 13, SY 14, SY 15, SY 16, SY 17, SY 18,
E³ - Rising Stars Programme SY 19, SY 20
Student Session 3
9 10
Special Focus Sessions ESR meets Japan Sven-Ivar Seldinger
SF 13a, SF 13b, SF 13c, SF 13d Honorary Lecture
E³ - ECR Academies E³ - ECR Academy Staffan Holmin; SE
E³ 1421
Saturday, March 5
E³ 1321, E³ 1318
E³ - European Diploma Prep Session E³ - European Diploma Prep Session E³ - The Beauty of Basic Knowledge
E³ 1323 E³ 1423 E³ 24D, E³ 25D
Refresher Course
Refresher Courses (1300) RC 1405 Junior Image Interpretation Quiz
ESR Patient Advisory Group ESR-PAG 1 Scientific Sessions (1400) EIBIR Session 3
E³ - Rising Stars Programme ESR Patient Advisory Group ESR-PAG 2 Satellite Symposia
Basic Session 4 SY 26, SY 27, SY 28, SY 29, SY 30
13 14
RTF Highlighted Lectures
Basic Session 5
Special Focus Sessions ESR meets Colombia E³ - The Beauty of Basic Knowledge
SF 17a, SF 17b E³ 24E, E³ 25E
Professional Challenges Session Professional Challenges Session
PC 17 PC 18 E³ - Rising Stars Programme
Sunday, March 6
State of the Art Symposium E³ - ECR Master Class Case-Based Diagnosis Training
SA 17 E³ 1826
E³ - ECR Academy E³ - European Diploma Prep Session
E³ 1721 E³ 1823
E³ - ECR Master Classes Scientific Sessions (1800)
E³ 1726a, E³ 1726b, E³ 1726c, E³ 1726d
17 18
EIBIR Session 4
Joint Session: ESR and ESHI
Basic Session 6
The Voice of EPOS • in the EPOS™ Arena

Wednesday – Saturday: hourly between 09:00 and 17:00 • Sunday: hourly between 09:00 and 13:00
2 ECR 2016 | Final Programme www.myESR.org

TIMETABLE
14:00 14:30 15:00 15:30 16:00 16:30 17:00 17:30 17:45 18:00 18:30 19:00
Scientific Sessions (300) New Horizons Session Opening Ceremony

NH 4
Wednesday, March 2
Satellite Symposium E³ - ECR Academy Presentation of Honorary Members:
SY 1c E³ 419 Ronald L. Arenson; US
E³ - ECR Master Classes Hassen A. Gharbi; TN
E³ 426a, E³ 426b Qiyong Guo; CN
Pros & Cons Session
PS 427
3 4
Satellite Symposium
SY 1d
E³ - ECR Academies Professional Challenges Sessions

E³ 721, E³ 722 PC 8a, PC 8b
Special Focus Sessions
Scientific Sessions (700) SF 8a, SF 8b, SF 8c, SF 8d
Thursday, March 3
EIBIR Session 1 Multidisciplinary Session
MS 8
ESOR Session E³ - ECR Academies
Joint Course: ESR and RSNA E³ 822, E³ 821, E³ 819
MC 728 Refresher Courses (800)
E³ - Rising Stars Programme Joint Session:
Student Session 1 American College of Radiology Session
7 8
ESR Working Group on Ultrasound
Joint Course: ESR and RSNA
MC 828
Student Session 2
EFRS meets Sweden Professional Challenges Sessions

PC 12a, PC 12b
Image Interpretation Quiz E³ - ECR Academies
MIR @ ECR Session MIR 2 E³ 1221, E³ 1220, E³ 1218
Friday, March 4
E³ - ECR Master Classes
EIBIR Session 2 E³ 1226a, E³ 1226b, E³ 1226c
Joint Session: ESR and ESMRMB Refresher Courses (1200)
Satellite Symposia MIR @ ECR Session MIR 3
SY 21, SY 22, SY 23, SY 24, SY 25
11 12
Joint Session: ESR and EANM
EDiR talk
Basic Session 3
Special Focus Session Special Focus Session

SF 15 SF 16
State of the Art Symposium Multidisciplinary Sessions
Saturday, March 5
SA 15 MS 16a, MS 16b
E³ - ECR Academies E³ - ECR Academies
E³ 1521, E³ 1520, E³ 1518 E³ 1621, E³ 1620, E³ 1618
E³ - ECR Master Class E³ - ECR Master Class
E³ 1526 E³ 1626
E³ - European Diploma Prep Session E³ - European Diploma Prep Session
E³ 1523 E³ 1623
Refresher Courses (1500) Refresher Courses (1600)
15 16
Joint Session: ESR and ERS EuroSafe Imaging Session 4
Joint Session: ESR and ESTRO
Student Final Session Joint Session:
ESR, EFSUMB and ESPR
E³ - European Diploma Prep Session

E³ 1923
Scientific Sessions (1900)
Sunday, March 6

Case-Based Diagnosis Training
19
www.myESR.org Final Programme | ECR 2016 3
28TH EUROPEAN CONGRESS OF RADIOLOGY
CONGRESS VENUE CONGRESS LANGUAGE

Austria Center Vienna English
Bruno Kreisky Platz 1
1220 Vienna, Austria
ONSITE OPENING HOURS

Registration Technical Exhibition
Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00 EXPO Halls and EXPO Foyer D
Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . 07:00–18:00 Thursday, March 3 to Saturday, March 5. . . 10:00–17:00
Thursday, March 3 to Saturday, March 5. . . 07:30–18:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
First Level (Gallery)
Preview Centre Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . 14:00–17:00
Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00 Thursday, March 3 to Saturday, March 5. . . 10:00–17:00
Wednesday, March 2 to Saturday, March 5. . . 07:30–18:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 10:00–16:00
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
Travel Service
EPOS™ – Scientific Exhibition Tuesday, March 1 . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00
Wednesday, March 2 to Saturday, March 5. . 08:00–18:00 Wednesday, March 2 to Saturday, March 5. . . 07:30–18:00
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 08:00–15:30 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 07:30–15:00
Press Office & Business Centre

Wednesday, March 2 to Sunday, March 6. . 08:00–18:00
SESSIONS IN JOINT SPONSORSHIP WITH
CIRSE Cardiovascular and Interventional Radiological Society of Europe

EFOMP European Federation of Organisations for Medical Physics
EFRS European Federation of Radiographer Societies
ESCR European Society of Cardiac Radiology
ESER European Society of Emergency Radiology
ESGAR European Society of Gastrointestinal and Abdominal Radiology
ESHNR European Society of Head and Neck Radiology
ESMOFIR European Society of Molecular and Functional Imaging in Radiology
ESNR European Society of Neuroradiology
ESOI European Society of Oncologic Imaging
ESPR European Society of Paediatric Radiology
ESSR European Society of Musculoskeletal Radiology
ESTI European Society of Thoracic Imaging
ESUR European Society of Urogenital Radiology
EUSOBI European Society of Breast Imaging
EuSoMII European Society of Medical Imaging Informatics

General Information
INFORMATION FROM A–Z
TABLE OF
CONTENTS
Forewords Scientific Programme

by the ESR President. . . . . . . . . . . . . . . . . . . . . . . . . . 6 ESR/EFRS meets Sessions. . . . . . . . . . . . . . . . . . . 81
by the ECR 2016 Congress President. . . . . . . . . . . . 8 New Horizons Sessions. . . . . . . . . . . . . . . . . . . . . . . 83
State of the Art Symposia . . . . . . . . . . . . . . . . . . . . 85
General Information Special Focus Sessions . . . . . . . . . . . . . . . . . . . . . . 87
Information from A to Z . . . . . . . . . . . . . . . . . . . . . . 12 Professional Challenges Sessions . . . . . . . . . . . . . 91
CME at ECR 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Multidisciplinary Sessions. . . . . . . . . . . . . . . . . . . . . 95
Headline Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 European Excellence in Education (E3) . . . . . . . . 97
(Junior) Image Interpretation Quizzes. . . . . . . . . . 27 Rising Stars Programme. . . . . . . . . . . . . . . . . . . 99
EPOS™ – Scientific Exhibition . . . . . . . . . . . . . . . . . 28 European Diploma Prep Sessions. . . . . . . . . . . 105
Green Meeting. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 The Beauty of Basic Knowledge . . . . . . . . . . 107
Free Publications. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 ECR Academies . . . . . . . . . . . . . . . . . . . . . . . . . 109
ECR 2016 welcomes its industry partners. . . . . . 33 ECR Master Classes . . . . . . . . . . . . . . . . . . . . . . . 115
ESR Journals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 Mini Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
Underground Map . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Pros & Cons Session . . . . . . . . . . . . . . . . . . . . . . . . 121
The Voice of EPOS. . . . . . . . . . . . . . . . . . . . . . . . . 123
Floor Plans. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Refresher Courses / Scientific Sessions. . . . . . . 143
Abdominal and Gastrointestinal. . . . . . . . . . . 144
ESR Dignitaries Breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
Honorary Member Ronald L. Arenson. . . . . . . . . 50 Cardiac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
Honorary Member Hassen A. Gharbi . . . . . . . . . . . 51 Chest. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
Honorary Member Qiyong Guo. . . . . . . . . . . . . . . . 52 Computer Applications. . . . . . . . . . . . . . . . . . . . 150
Gold Medallist Gabriel P. Krestin. . . . . . . . . . . . . . . 53 Molecular Imaging . . . . . . . . . . . . . . . . . . . . . . . 150
Gold Medallist Claude Manelfe. . . . . . . . . . . . . . . . 54 Genitourinary. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
Gold Medallist Peter Vock. . . . . . . . . . . . . . . . . . . . 55 Head and Neck . . . . . . . . . . . . . . . . . . . . . . . . . . 152
Honorary Lecturer Staffan Holmin . . . . . . . . . . . . . 56 Interventional Radiology. . . . . . . . . . . . . . . . . . 153
Honorary Lecturer Andrea G. Rockall . . . . . . . . . . 57 Musculoskeletal. . . . . . . . . . . . . . . . . . . . . . . . . . 155
Honorary Lecturer Valérie Vilgrain. . . . . . . . . . . . . 58 Neuro. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156
Paediatric. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
Committees Physics in Radiology . . . . . . . . . . . . . . . . . . . . . 159
ESR Executive Council . . . . . . . . . . . . . . . . . . . . . . 60 Radiographers. . . . . . . . . . . . . . . . . . . . . . . . . . . 160
Congress Committee. . . . . . . . . . . . . . . . . . . . . . . . . 61 Vascular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
Programme Planning Committee . . . . . . . . . . . . . . 61 Oncologic Imaging . . . . . . . . . . . . . . . . . . . . . . . 163
Scientific Subcommittees. . . . . . . . . . . . . . . . . . . . . 62 Emergency Radiology. . . . . . . . . . . . . . . . . . . . . 164
Topic Coordinators . . . . . . . . . . . . . . . . . . . . . . . . . . 65 Joint Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165
Programme Overviews Industry Programme

Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . . 68 Satellite Symposia. . . . . . . . . . . . . . . . . . . . . . . . . . 177
Thursday, March 3 . . . . . . . . . . . . . . . . . . . . . . . . . . 70 Industry Workshops. . . . . . . . . . . . . . . . . . . . . . . . . 181
Friday, March 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
Saturday, March 5 . . . . . . . . . . . . . . . . . . . . . . . . . . 74
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76

Forewords
FOREWORD BY THE ESR PRESIDENT
DEAR COLLEAGUES,
It gives me great pleasure to welcome you to the European ties together various previous endeavours in the field of
Congress of Radiology (ECR) 2016. As president of the imaging biomarkers and personalised imaging, including
European Society of Radiology (ESR), it is very satisfying close collaboration with the ESR-EORTC and QIBA™.
to see the culmination of all the hard work and dedication
that has gone into preparing this event, which is always the On a similar note, I am pleased to say that the ESR has
biggest highlight of the society’s year. recently signed a memorandum of understanding with the
Biobanking and BioMolecular resources Research Infra-
The ECR is so much more than a scientific meeting; beyond structure – European Research Infrastructure Consortium
the regular programme that forms its basis, there are an (BBMRI-ERIC) with the aim of raising the profile of imaging
ever-increasing number of special sessions and side events biobanks and ultimately establishing a European imaging
that tie in with the ESR’s ongoing activities. More and more, biobank infrastructure. Endeavours such as this and the
the ECR is becoming not only a marker of the current state EIBALL are vital groundwork for ensuring we can make the
of our discipline, via its scientific content, but also a reflec- most of future developments in medical imaging.
tion of the ESR’s progress, as so many of the achievements
from throughout the prior twelve months are represented The EuroSafe Imaging campaign, the ESR’s own initia-
here in one way or another. Naturally, this congress is not tive to promote quality and safety in medical imaging, will
just where we, as individuals, come to discover the latest also be well represented at the congress. The campaign is
in our field; it is also where we, as a society, celebrate and continually growing in scope and this year that is clearly
look back on the steps we have taken over the last year. reflected in the ECR programme, with not only four ded-
icated EuroSafe Imaging sessions, but six other sessions
Some of our proudest recent moments have come in the and workshops centred on various subjects. One of those
field of research. In particular, the European Institute for topics is clinical decision support (CDS), a major issue on
Biomedical Imaging Research (EIBIR), of which the ESR the ESR’s agenda over the last year, during which we have
is the majority owner, saw remarkable success in 2015. Four launched a CDS platform (the ESR iGuide), as well as our
Horizon 2020 projects benefiting from EIBIR’s proposal own basis patient safety standards and the ESR Clinical
preparation services and expertise had grant agreements Audit Tool. Such services are an important part of the ESR’s
signed, meaning EIBIR is now involved in 25% of all projects strategy going forward, as part of a larger commitment to
funded under the imaging-specific call. Considering the suc- providing professional support for the radiological family.
cess rate for Horizon 2020 proposals has been generally low,
this is a real credit to the expertise we have at our disposal The provision of qualifications is yet another form of sup-
in this arena. This success story will form part of one of port we offer to radiologists, and one of the most notable
the four EIBIR sessions at this congress, and EIBIR will also non-programme aspects of recent ECRs is the hosting
feature in an additional session introducing the European of examinations for the European Diploma in Radiology
Imaging Biomarkers Alliance (EIBALL), a new body that (EDiR). This will be the sixth ECR at which an EDiR exam

Forewords
FOREWORD BY THE ESR PRESIDENT
has been held and this year it will serve as a platform for the
introduction of a change in format. The European Board of
Radiology (EBR) has been actively reviewing the examina-
tion process with the aim of making sure the exam remains
as accurate a test of candidates’ ability as possible. The
result of this is that a new ‘skills examination’ will be tested
at ECR 2016, developed from what used to be known as the Prof. Luis Donoso Bach is Director of the
oral part of the exam. I would like to wish everyone taking Diagnostic Imaging Department of the Hospital
the exam, which will include the EDiR’s 1000th candidate, Clínic of the University of Barcelona, Spain.
the very best of luck! He is also the Executive Director of the UDIAT
Diagnostic Centre at the Health Corporation
Another educational service that is fundamentally tied in Parc Taulí.
with the ECR is the Electronic Poster Online System, better
known to most of us as EPOS™. The online database serves
as a learning resource all year round, but the posters it programme will match the recent standard and see just as
contains are of course all submitted for the congress. This broad a range of the radiological family joining us in Vienna.
year, EPOS has a new side to it, as submitters have been
able to apply to present their posters in person, under the Finally, I would like to express my thanks to Prof. Katrine
heading The Voice of EPOS. I hope many of you will take the Riklund for masterminding a fantastic programme for ECR
oportunity to attend these presentations, which will bring 2016, along with all members of the Congress Programme
a valuable new dimension to the usual EPOS experience. Planning Committee, the Chairs and members of the Sci-
entific Subcommittees, the Subspecialty Societies and, of
One of the outcomes of this expansion of EPOS may very course, the wonderful team at the ESR office. I hope each
well be that some submitters who may usually stay at home one of you will enjoy the experience, and the amazing city
during the ECR might make their first trip to Vienna, and of Vienna, to the very fullest.
this of course would be a wonderful bonus. By adding more
and more flavours to our congress, we hope to cater for
every taste in the radiological spectrum. One of the largest
growing areas of the ECR in that respect is the programme
for radiographers. We are delighted that the numbers of
radiographers and radiological technicians visiting the con-
gress have been consistently high over recent years, thanks Luis Donoso Bach
largely to the close involvement of the European Federation ESR President
of Radiographer Societies. I am positive that this year’s

Forewords
FOREWORD BY THE ECR PRESIDENT
DEAR FRIENDS,
DEAR COLLEAGUES,
during last year’s ECR. Even if we are in a transition period,

with an increased use of digital communication and online
participation, a huge number of people still take part on-site
in Vienna, and I hope you will continue to do so. Another
good example of our progress is that, even as time is passing
by, we are getting younger. Between 2008 and 2015 the
average age of attendees has fallen from 47 to 42 years.
At ECR 2016 you will have the chance to find out a lot about
interesting medical imaging in the ‘ESR meets’ sessions,
such as breast radiology in the Nordic countries, state-of-
the-art radiology in Japan, and the transition from practice
to reality in Colombia. You are all invited to these sessions;
they are not intended exclusively for attendees from the
presenting countries, but for everyone else to discover
Prof. Katrine Riklund is a radiologist who is also something new. Radiology will also meet nuclear medicine
licensed in nuclear medicine at Umeå University in a session on hybrid imaging and during ECR 2016 you
Hospital, Sweden. She is deputy head of the can also witness the launch of the new European Society
for Hybrid Medical Imaging (ESHI) by visiting the ESHI
department of radiation sciences and director of
booth in the entrance hall, where you can pick plenty of
the medical school at Umeå University.
information about the new society.
For ECR 2016, the new format introduced to the educational

I am very proud and greatly honoured to welcome you to programme last year will remain, which means you will find
the European Congress of Radiology (ECR) 2016. During sessions with the right level of complexity wherever you
the last 20 years I have seen the congress evolve and grow, are in your professional development. To guide you, the
and every year I love being at this wonderful event. The sessions are marked with the knowledge level they are
first impression when arriving in the entrance hall is always intended for. Also this year, candidates will once again be
fabulous and the feeling of being welcome is always strong sitting examinations for the European Diploma in Radiology
for me, and I hope all of you will feel the same. To meet you (EDiR) during the congress. Interest in the EDiR has been
all in the entrance hall, in lecture rooms, and in the technical increasing every year and I am pleased to say this particular
exhibition, strengthens my confidence of the importance examination was fully booked a long time in advance.
of keeping face-to-face meetings. The number of friends
and colleagues attending the ECR has increased year by This year’s poster shows you a combination of the phe-
year and we ended up with more than 25,000 attendees nomena we have up north, close to the Arctic Circle; the

Forewords
FOREWORD BY THE ECR PRESIDENT
northern lights and the midnight sun, but something is radiology beyond our comfort zones, just because our field
wrong. They do not show up simultaneously, not even at is so amazing!
Kebnekajse, which is the mountain on the poster. So the
poster is a hybrid of both summer and winter, and hybrid is This ECR is the result of almost one and a half years of work
a theme that is repeated throughout ECR 2016. These phe- from hundreds of people who have contributed to creat-
nomena are mixed with small objects symbolising people, ing this wonderful congress, and I am so thankful to have
or molecules, or whatever you would like them to be, and the opportunity to be part of this enormous preparation
if you look at the movies you can see them all moving, in team. The enthusiasm and devotion of all collaborators is
some way connected to each other. The ECR 2015 theme the basis for creating a congress which delivers both the
‘radiology without borders’ is more relevant than ever for basics and the front line in imaging. I would like to offer my
most of us and I hope we still can meet at ECR 2016 with- most sincere thanks to the fantastic efforts of the Congress
out borders even if the situation in Europe has changed Programme Planning Committee, the Chairs and members
dramatically during recent months. The ECR is one of the of the Scientific Subcommittees, the Subspecialty Societies
greatest radiological events in the world, with participants and, of course, the dedicated and professional support of
from more than 120 countries, which means you will meet ESR office staff. Progression demands change and, when
friends and colleagues from almost every part of the world. ECR 2016 comes to a close, I will be the last ‘ECR Congress
President’. In the coming year we are moving forward with
ECR 2016 will keep up the good reputation of a programme a re-organisation of the European Society of Radiology
woven from high quality teaching and scientific sessions, (ESR) leadership structure, and the ECR will become the
as well as posters. A new feature this year is the Voice of responsibility of the new combined ESR/ECR President.
EPOS, which consists of poster sessions with short oral
presentations in the EPOSTM area. Interest in this new idea Finally, I would like to warmly welcome you to ECR 2016,
has been great, leading to an all-time high in EPOS abstract and hope you enjoy the congress, meet friends, make new
submissions, with 2,989 abstracts submitted. The Voice of contacts in your network, and take the opportunity to enjoy
EPOS sessions will be held not only in organ-based topic the social events of the congress and also of Vienna.
groups, but also in several different languages, adding a
useful new dimension to the congress.
I am also happy to announce that submission of Clinical

Trials in Radiology abstracts has increased substantially
compared to last year, so I also encourage you to come
and listen to the presentations based on these ongoing Katrine Riklund
trials. I know that sessions with basic radiology are very ECR 2016 Congress President
much appreciated, but I have a wish that, this year, all of
us will challenge ourselves by taking some time to explore

PROUDLY PRESENTS
JUAN DIEGO FLÓREZ
AN EXCLUSIVE
PERFORMANCE AT THE
ECR 2016
OPENING CEREMONY
© Juan Diego Flórez 2014
WEDNESDAY, MARCH 2
17:45–19:00, ROOM A
GENERAL
INFORMATION
General Information
ARTS & CULTURE BOOKSTORE

Delegates are encouraged to visit the Arts & Culture Desk This year, for the third time, the ECR is offering delegates an
in the entrance hall for information on Vienna’s cultural outstanding service. The Viennese bookstore Buchkontor
events such as exclusive opera performances, delightful will open a special ECR bookstore in the entrance hall of
concerts, and the fascinating exhibitions in Vienna’s most the congress venue. Browse through a wide range of books,
important and remarkable museums. Pick up your personal from guidebooks on Vienna’s best sights to cookbooks full
Arts & Culture Brochure at this counter to find descriptions of delicious Austrian recipes. For the more discerning reader,
of all cultural places. there will also be a range of Austrian literature so you can
take some of the country’s history and culture home with
BADGES you. The Buchkontor staff look forward to welcoming you
For organisational and security reasons, badges must be and helping you find that page-turner.
worn at the congress venue. Access to the different areas will Buchkontor’s ECR Bookstore, entrance hall.
only be granted upon presentation of an appropriate badge.
BROADCAST ZONES
Lost or Forgotten Badges The ECR features specific Broadcast Zones, where you can
In the case of loss, a replacement badge will only be provided listen to sessions and view the corresponding presentation
on full payment of the applicable onsite registration fee. material in a relaxed atmosphere when the actual lecture
Forgotten badges will be replaced against a deposit of the rooms are overcrowded. Broadcast Zones are located
full onsite fee. In the Austria Center Vienna next to Room B and C
(2nd level), Rooms O and N (1st level), and Room K (lower
BOOK OF ABSTRACTS level)
In keeping with the ESR’s commitment to environmental In the M Building next to Rooms M4 and M5
sustainability, and due to demand from its members, the See Floor Plans on pages 40–48.
Book of Abstracts is only available online.
All abstracts can be accessed at www.i3-journal.org/articles. BUSINESS CENTRE
You can also create your own personal Book of Abstracts with The Press Office & Business Centre, located on the entrance
the help of the popular ECR Interactive Programme Planner level, offers copy facilities for a small charge.
on our new platform ECR Online (ecronline.myESR.org). Opening hours:
Abstracts of EPOS™ presentations no longer appear in the Wednesday, March 2 to Sunday, March 6. . . . 08:00–18:00
Book of Abstracts. Each full EPOS™ presentation can instead
be cited by a Digital Object Identifier (DOI), which appears CAFÉS & RESTAURANTS
with the presentation at www.myESR.org/epos. If you are looking for an ideal meeting point, or if you just
want to take a short break, try one of the various foyer cafés
and restaurants. They are situated throughout the whole
congress venue and on all levels of the building, offering a
variety of tasty hot and cold snacks.
Please see the ‘coffee-cup’ signs on the Floor Plans on pages
40–48 of this programme to locate the various foyer cafés.
CASE-BASED DIAGNOSIS TRAINING

Please refer to the E3 – Rising Stars Programme and see
pages 99–104.

General Information
CASES OF THE DAY CLINICAL TRIALS IN RADIOLOGY

From Wednesday to Saturday, five Cases of the Day cover- For the second time, at ECR 2016, Clinical Trials in Radiol-
ing different sections of radiology are shown on computer ogy (CTiR) sessions are taking place. The CTiR sessions are
stations in the EPOS™ classroom on the 1 level. Participants
st
comprised of presentations on recent trials which are very
are invited to submit their diagnoses. The winners will be likely to have an impact on clinical practice.
announced on the ESR website. Session places are allocated on a first-come, first-served
We would like to acknowledge the contribution of the fol- basis. Please refer to page 167 for the programme of the
lowing authors to the Cases of the Day: sessions.
Wednesday: CME ACCREDITATION SYSTEM

Case 1: M.-A. Weber; Germany The ESR is happy to provide you with a fully digital CME
Case 2: S. Liddy, O. Buckley; Ireland acquisition system for ECR 2016. Please note that we no
Case 3: S. Hanquinet, M. Laurent; Switzerland longer provide printed CME stickers.
Case 4: J. Avsenik, K. Surlan Popovič; Slovenia Evaluation and CME acquisition will be possible via
Case 5: V. Di Paola, R. Pozzi Mucelli; Italy
» The official ECR app, ECR 2016, available via the App Store
Thursday: (iOS) and Google play (Android)
Case 1: G.M. Magnano, M.B. Damasio; Italy » More than 130 laptops in the ECR Online & EPOS Lounge
Case 2: G. Chassagnon, M.-P. Revel; France located on the 1st level
Case 3: Ž. Snoj, J. Regvat, V. Salapura; Slovenia » The registration counters on the entrance level from Friday,
Case 4: F. Iafrate, M. Santoni, C. Cavallini, S. Pontone; Italy March 4, 13:00 onwards
Case 5: E. Loney; United Kingdom » The CME & evaluation terminals located on the 1st level
Friday: Please note that evaluation of the sessions is only possible

Case 1: A. Alcalá-Galiano; Spain March 2–7, 2016.
Case 2: L. Oleaga Zufiría; Spain
Case 3: R. Woitek, T.H. Helbich, H. Ringl, C.J. Herold; Austria CME credits will only be awarded if
Case 4: I. Shrainer, I. Arkhipova, V. Sinitsyn, E. Zorin, N. » You are logged into https://eval.webges.com/ecr2016
Ermakov; Russian Federation with your username (last name) and Personal ID (printed
Case 5: M. Claudon; France on your badge)
» You have fully completed the electronic questionnaire
Saturday: for each session
Case 1: A.C. Tsili, G.V. Mouka, A.A. Ntorkou, D. Giannakis, S.
Stavrou, M.I. Argyropoulou; Greece See pages 22–23.
Case 2: J.A. Gonzalez-Nieto, J. Vizuete del Rio; Spain
Case 3: J. Babar, S. Karia; United Kingdom COAT CHECK
Case 4: P. Martín, A. Ramos, E. Salvador; Spain
The coat check services are located on the entrance level, in
Case 5: E. Vachev, G. Kirova, V. Traykov, E. Ruskova, B. Penev,
Foyers E and F, as well as on the lower level next to Room D1.
G. Kuninski; Bulgaria
COMMUNICATION AREAS
CHURCHES AND RELIGIOUS COMMUNITIES IN VIENNA
If you are looking for the perfect place to meet and talk with
Vienna is a multi-denominational, multi-cultural city. We
friends or just to relax and browse through ECR Today, ECR
will be pleased to provide you with information on local
2016 offers areas perfectly equipped for communication and
religious communities and places of worship at the Travel
recreation; the ESR Welcome Lounge right in the middle
Service Desk.
of the entrance hall, and the Rising Stars & RTF Lounge
on the lower level, which welcomes all students, residents
and trainees.

General Information
CONFIRMATION OF PAYMENT AND ATTENDANCE ECR 2016 SMARTPHONE APP

Congress-related confirmation will be available during and The ECR 2016 App gives iPhone, iPad and Android users a
after the congress from the ESR website (www.myESR.org) new way to experience the congress. The app is packed with
via the MyUserArea (login with your last name and your features, including general congress information, scientific
Personal ID as printed on your badge). and educational programme details, top news stories from
ECR Today, full abstracts, and even floor plans of the Austria
CONGRESS LANGUAGE Center. Please make sure you have Bluetooth enabled, as
English the app supports iBeacons™ technology. You can download
the ECR 2016 App from iTunes/Google Play.
CONGRESS VENUE
EFOMP (European Federation of Organisations for Medical
Austria Center Vienna Physics) WORKSHOP
Bruno Kreisky Platz 1
This workshop is the 18th in the series of EFOMP Workshops
1220 Vienna, Austria
on new technology in diagnostic radiology. This year’s work-
Phone: (+43 1) 533 40 64–0
shop is entitled ‘Radiation protection for the female patient
To reach the ACV by public transport from the city centre
and female medical staff’. It has been organised by EFOMP
(Stephansplatz) take the U1 underground line (red line,
in collaboration with the ESR to address the current and
direction Leopoldau). Get off at Kaisermühlen/Vienna Inter-
future technological requirements for radiology imaging
national Centre and take the exit marked Donau-City-Straße.
equipment (please refer to page 169).
Travelling time: approximately eight minutes.
‘EFRS MEETS’ SESSION

‘ECR ONLINE’ (PREVIOUSLY ‘ECR LIVE’)
After the enormous success at previous ECRs, which
After last year’s success, the ESR is once again providing
reflected the good relations between the ESR and the
a live streaming service for ECR 2016, under its new name
European Federation of Radiographer Societies (EFRS),
ECR Online, in an effort to bring the ECR to everyone. All
the EFRS is again hosting a dedicated session. ‘EFRS meets
ECR sessions are being broadcast live via the ESR website,
Sweden’ underlines the essential role of radiographers in
with Facebook and Twitter options integrated into the web
medical imaging. Please refer to page 82 for the programme
interface to provide a fully interactive experience.
of the session.
ECR Online is kindly supported by Bayer HealthCare and
GE Healthcare.
EIBIR BOOTH
Link: ecronline.myESR.org
Visit the EIBIR Booth in the entrance hall for the most recent
ECR ONLINE & EPOS™ LOUNGE news on the European Institute for Biomedical Imaging
Research and to celebrate ten years of EIBIR.
The ECR Online & EPOS™ Lounge has 130 computer termi-
nals where delegates can watch ECR sessions either live or
EMERGENCY INFORMATION/FIRST AID
on demand. Enjoy the Lounge’s relaxing atmosphere while
you catch up with the congress sessions. For fire, medical or police assistance, please contact ACV
Information or the nearest available ECR or ACV staff mem-
ECR TODAY ber. A medical specialist trained in emergency medicine will

be present for the duration of the congress.
ECR Today, the popular daily newspaper of the congress,
See Red Cross sign on the Floor Plan page 41.
is published from Wednesday to Sunday and distributed in
the entrance hall of the congress venue and in the entrance
area of the Technical Exhibition. In addition, all issues are
available online at www.myESR.org

General Information
EPOS™ – SCIENTIFIC EXHIBITION EUROPEAN EXCELLENCE IN EDUCATION (E3)

The ECR 2016 electronic scientific exhibition is open The E3 programme emphasises the importance of lifelong
Wednesday to Saturday from 08:00 to 18:00, and Sunday learning. It covers the entire range of educational issues,
from 08:00 to 15:30. EPOS™ can be accessed via the 130 from undergraduate medical education to subspecialised
workstations in the ECR Online & EPOS™ Lounge, which is continuing professional development. For the second time
located on the 1st level. at ECR 2016, the E3 programme is structured according to
Make sure to attend the new The Voice of EPOS sessions, the different levels defined by the ESR European Training
where the authors of the best posters will present those in Curriculum for Radiology.
moderated poster sessions. The E3 programme consists of the following five branches,
See pages 28–29. which reflect the different levels of education in radiology,
as well as the different stages of an individual’s professional
‘ESR MEETS’ SESSIONS career:
The purpose of ‘ESR meets’ is to forge closer ties between Rising Stars Programme, European Diploma Prep Sessions,
the ESR and its guest societies. The guest nations of this The Beauty of Basic Knowledge, ECR Academies, ECR
year’s ECR are the Colombia, Japan and the Nordic Coun- Master Classes.
tries, as a tribute to the home of ECR Congress President
Katrine Riklund from Sweden. There are dedicated ses- The Rising Stars Programme is designed especially for res-
sions for the radiological communities of these nations to idents, students, radiographers and trainee radiographers.
demonstrate the excellence of radiology in their countries. It consists of Basic Sessions, Student Sessions, Case-Based
Places at these sessions are allocated on a first-come, first- Diagnosis Training, and the Radiology Trainees Forum Pro-
served basis. Please refer to pages 81–82 for the programme gramme including the RTF Highlighted Lectures and the
of the sessions. RTF Quiz.
ESR WELCOME LOUNGE The European Diploma Prep Sessions aim to prepare pro-
spective candidates for the European Diploma in Radiology
Visit the ESR Welcome Lounge in the entrance hall! Whether
(EDiR).
you are looking for an ideal meeting point or just want to
They are also suitable for residents who want an overview
take a short break – the ESR Welcome Lounge will suit your
of the various topics relevant to imaging and for those
needs. Free wireless LAN is provided for your convenience.
preparing for their national board examinations.
Watch out for artistic performances from the ‘ESR meets’
The content of the programme reflects Level I European
countries during the lunch breaks.
Training Curriculum for Radiology (ETC) learning objectives
across a two-year cycle. The sessions are held in close
EUROPEAN BOARD OF RADIOLOGY (EBR)
cooperation with the European Board of Radiology (EBR).
Visit the EBR Booth in the entrance hall to learn all about
Each of the six sessions is led by three lecturers and mod-
the European Diploma in Radiology (EDiR), how to apply,
erated by one chairman.
and where and when the next exams will take place.
www.myEBR.org
The Beauty of Basic Knowledge programmes focus on
knowledge essential to the daily practice of radiology. The
EUROPEAN DIPLOMA IN RADIOLOGY (EDIR)
format of these sessions reflects the tradition of conven-
An examination for the European Diploma in Radiology tional teaching sessions, in which experienced teachers
is being held at ECR 2016. The electronic-based written share their insights into a topic of particular relevance with
examination takes place on Tuesday, March 1, in the ECR a group of attendees.
Online & EPOS™ Lounge on the 1st level, whereas the case- Each Beauty of Basic Knowledge session consists of a
based oral examinations take place Wednesday, March 2 in 45-minute lecture or two 25-minute lectures held by one or
various rooms on the entrance level in the M Building (see two speakers plus 10–15 minutes for discussion. The teaching
Floor Plan M Building on page 46). format is usually case-based with some interaction with
Success in the examination certifies a standard of radi- the attendees. The content of the sessions is mostly tied to
ological knowledge deemed appropriate by the ESR for the Level I and Level II European Training Curriculum (ETC)
independent practise in general radiology. learning objectives. The Beauty of Basic Knowledge sessions
www.myEBR.org are suited to residents and board-certified radiologists who

General Information
want to refresh their knowledge in basic topics of imaging EUROSAFE IMAGING

and image-guided therapy. EuroSafe Imaging is the ESR’s latest initiative in radiation
The programmes will be concluded with a self-assessment protection. It aims to promote the safe and appropriate
test, published on the platform ‘ESR Education on Demand’. use of medical imaging in Europe and around the world.
ECR delegates can access the platform and the self-assess- Please view the EuroSafe Imaging Poster Exhibition on a
ment tests through the work stations in the ECR Online & dedicated screen in the ECR Online & EPOS™ Lounge on
EPOS™ Lounge (1st level). the 1st level, with submissions from all over Europe. And
stop by the EuroSafe Imaging Booth in the entrance hall
The ECR Academies consist of a series of four to six ses- to learn all about this important initiative.
sions relevant to a particular area of radiology. This may be
a classic organ-based field or a technically oriented area EXPO HALLS & EXPO FOYER D
of another field related to radiology, such as management.
Opening hours:
Each ECR Academy spans several days, in which the differ-
Thursday, March 3 to Saturday, March 5. . . . . . 10:00–17:00
ent facets of the area in question are covered by experts in
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00
the field. An ECR Academy is a coherent course in which
the different sessions complement one another in order to
Visit the additional technical exhibition area on the 1st level
reflect the entirety of the field.
of the congress venue:
The ECR Academies are particularly suited to general radi-
ologists or radiologists with a subspecialisation.
Opening hours:
All programmes (apart from Interactive Teaching Sessions)
Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00
will be concluded with a self-assessment test, published on
the platform ‘ESR Education on Demand’. ECR delegates can
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–16:00
access the platform and the self-assessment tests through
the work stations in the ECR Online & EPOS™ Lounge
FREE PUBLICATIONS
(1st level).
The ESR again presents the ‘Free Publications’ Booth on the
1st level, integrated into the ECR Online & EPOS™ Lounge.
The ECR Master Classes focus on continuous professional
Pick up free copies of radiology journals and magazines
development and lifelong learning. The classes are designed
(see page 31).
for subspecialised radiologists seeking cutting-edge infor-
mation in their particular fields of interest. They are held by
FUTURE MEETINGS DESK
experts in the field and reflect state-of-the-art knowledge,
as well as emerging trends. This area – located in the ECR Online & EPOS™ Lounge on the
The ECR Master Classes are offered in cooperation with 1stlevel – offers you an overview of future meetings in the
each of the following subspecialty societies: field of radiology and related disciplines, from all over the
CIRSE (one on vascular and one on interventional radiology), world. Feel free to contribute flyers and posters to promote
ESCR, ESER, ESGAR, ESHNR, ESMOFIR, ESNR, ESOI, ESPR, your own meetings and courses.
ESSR, ESTI, ESUR, EUSOBI.
HEADLINE SESSIONS
‘EUROPEAN RADIOLOGY’ For details on the Honorary Lectures by Staffan Holmin,
European Radiology is Europe’s number one journal in gen- Andrea G. Rockall and Valérie Vilgrain see page 25.
eral radiology. And it celebrates its 25 anniversary this year!
th
See page 35. ‘INSIGHTS INTO IMAGING’

Insights into Imaging is the ESR’s online journal for educa-
EUROPEAN SCHOOL OF RADIOLOGY (ESOR) BOOTH tion and guidelines. It is open access and PubMed indexed.
Visit the ESOR Booth in the entrance hall for the latest news See page 35.
on the European School of Radiology. In addition, there is
an ESOR Info Desk in the Rising Stars & RTF Lounge.

General Information
INDUSTRY WORKSHOPS MEETING ROOMS

At ECR 2016 there are various Industry Workshops sched- Meeting rooms at ECR 2016 are to be found here:
uled, organised by Bayer HealthCare, Fujifilm Europe, GE
Healthcare, Hologic, Mammotome and Toshiba Medical In the Austria Center Vienna
Systems. Please note that Industry Workshops are no longer 1st level: Meeting Rooms 1.85, 1.86
CME-accredited. 2nd level: Meeting Rooms 2.11, 2.12, 2.34, 2.41, 2.42, 2.44,
See separate booklet for details. 2.95
3 level:
rd
Meeting Room 3.32
INTERACTIVE PROGRAMME PLANNER
The ESR is again proud to present this popular interactive In the adjoining M Building
tool for ECR 2016. The IPP provides a convenient way to (only available from Wednesday, March 2, to Saturday,
explore and customise the congress programme online, in March 5)
both traditional browser and mobile device versions. Entrance level: Meeting Rooms M6, M7, M8, M10, M21, M22,
Featuring various search and browse functions for sessions M23, M24, M25, M26, M27, M29, M30, M32,
as well as posters, the IPP also includes a ‘basket’ option, M33, M34.
which enables users to collate items from the programme
to create their own personal calendar and even print a You will find them marked on the Floor Plans (see pages
personalised Book of Abstracts. The IPP is integrated into 40–48).
the new platform ECR Online. Please contact the Info Service Desk at the entrance to
Link: ecronline.myESR.org the M Building for onsite booking of meeting rooms; from
Saturday onwards please contact the Meeting Room Service
(JUNIOR) IMAGE INTERPRETATION QUIZ Desk at the right end of the registration desks.
The Image Interpretation Quizzes are two traditional high-

MEMBERSHIP
lights of every ECR. This year’s themes are ‘Imaging with
the Stars’ and ‘Millennials showdown: the next generation For membership application and renewal, please go to the
of radiology’ (see page 27). membership desk in the entrance hall.
LIABILITY MINI COURSE
The ESR and the Austria Center Vienna are free from all ECR 2016 features again the joint course of the ESR and
liabilities that may arise from the delegates’ and presenters’ RSNA (Radiological Society of North America), which will
participation in ECR 2016 and its activities. this year focus again on ‘Emergency Radiology’.
The sessions will be interactive with electronic voting/self
LOST & FOUND assessment.
Places for all courses are allocated on a first-come, first-
Lost and found articles may be picked up or handed in at
served basis. Please refer to pages 119–120 for the course’s
the ACV Information Desk located in the entrance area.
programme.
MEDITATION & PRAYER ZONE

MIR @ ECR
The Meditation & Prayer Zone is located on the lower level
After last year’s success, the ESR Subcommittee on
next to Room K. You will find it marked on the Floor Plan.
Management in Radiology has again organised special
sessions at the ECR on communication and improving
quality and safety, taking place on Friday, March 4, 12:15–
17:30 in Room D2.
See pages 169–171.

General Information
MULTIDISCIPLINARY SESSIONS PREVIEW CENTRE

The concept of these sessions is to promote a multidisci- Speakers are reminded to check in at the cSlide Preview
plinary approach to detection and treatment, integrating Centre’s welcome desk at least three hours prior to their
radiologists and other clinicians to share their expertise. scheduled presentation, even if they have already uploaded
The topics that are covered this year are: pancreatic cancer, their presentation prior to the conference. Three speaker
uterine myomas and sports injuries. registration workstations will be at the speakers’ disposal,
Please refer to pages 95–96 for the programme of the and an additional workstation for last-minute changes and
sessions. uploads is available.
Onsite presentation upload procedure:
NEW HORIZONS SESSIONS » Check in at the cSlide Preview Centre Welcome Desk to
The aim of the New Horizons Sessions is to provide prac- receive your login details and the title of your presentation
titioners with an overview of the new developments in a »
Log into an available computer and upload your
specific area of practice e.g. specialty, technique, or disease. presentation
These developments may become routine within a few years, » Presentations can be checked in presenter mode and
or may indicate a new direction for research and clinical edited onsite
application. There are three New Horizons Sessions at ECR
2016, entitled ‘New frontiers in imaging of vascular wall The Preview Centre is located on the 1st level, next to the
and plaque’, ‘Big data: why should radiologists care?’ and ECR Online & EPOS™ Lounge.
‘Imaging beyond morphology’. Session places are allocated Opening hours:
on a first-come, first-served basis. Please refer to pages Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00
83–84 for the programme of the sessions. Wednesday, March 2 to Saturday, March 5. . . . 07:30–18:00
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
OPENING CEREMONY
Please note that only digital material will be accepted for
The ECR 2016 Opening Ceremony will take place Wednes-
oral presentations. Presenters may submit their presentation
day, March 2, 17:45–19:00 in Room A. ESR Honorary Mem-
material, with their login details, prior to the congress. All
bership will be awarded to Ronald L. Arenson, Hassen A.
material must be in English and be provided on CD-ROM,
Gharbi and Qiyong Guo. See page 10.
DVD or USB devices. All presentations will be transferred
to the session rooms electronically.
PRESS
The material remains the property of the speakers.
The ECR 2016 Opening Press Conference takes place on
Wednesday, March 2, at 09:30 at the Austria Center Vienna,
PROFESSIONAL CHALLENGES SESSIONS
Room 1.85, 1st level. For press accreditation, please contact
These sessions are intended to communicate and exchange
the Press Office & Business Centre on the entrance level.
issues on radiological training and education, research net-
To obtain a press badge, you must present an international
working, radiological management and professional devel-
press ID or a confirmation letter from the relevant medium.
opments. This year’s topics are ‘Personalised radiology: myth
Delegates and exhibitors may display their press kits in
or reality?’, ‘Clinical decision support (CDS)’, ‘An introduc-
the Press Office & Business Centre. There are also several
tion to European Imaging Biomarkers Alliance (EIBALL)’,
publicly available computer terminals as well as workspace
‘Biobanks meet imaging’, ‘Radiology ten years from now:
and plug points for you to work with your personal laptop.
where will it be?’, ‘Comprehensive cardiothoracic radiology:
Opening hours:
the way to go?’, ‘How to become the undergraduate teacher
Wednesday, March 2 to Sunday, March 6. . . . 08:00–18:00
you always wanted to be’, ‘European variation in imaging:
focus on technology’ and ‘Monitoring safety and quality’.
Places are allocated on a first-come, first-served basis.
Please refer to pages 91–93 for the sessions’ programme.

General Information
PUBLIC TRANSPORT REFRESHER COURSES

Tickets for public transportation are available online at 73 Refresher Courses have been organised by the various
shop.wienerlinien.at or at any underground station. scientific subcommittees for ECR 2016. Based on the topic
Underground map; see page 37. of the session, some refresher courses are presented in
an ‘integrated’ format with an organised panel discussion,
PUBLISHERS ROW (1ST LEVEL) & similar to Special Focus Sessions.
PARTNER PUBLISHERS (ENTRANCE LEVEL) Places are allocated on a first-come, first-served basis.
Opening hours: Please refer to pages 143–164 for the programme of the
Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00 sessions.
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–16:00 REGISTRATION OPENING HOURS
Browse through a wide range of scientific publications Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00
displayed by the most important publishers in the field of Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . 07:00–18:00
medicine. Thursday, March 3. . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00
Friday, March 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00
RADIOLOGY TRAINEES FORUM (RTF) Saturday, March 5. . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00
The RTF promotes and coordinates the efforts of radiology Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
trainees at a European level in order to improve the progress
of radiology and related sciences. One of the RTF’s most RESTAURANT RESERVATIONS
important goals is to provide an equal level of radiological Our staff at the Dining & Shopping Desk in the entrance
knowledge and skills for radiology trainees all over Europe. hall will be pleased to recommend places to eat close to
Highlighted Lectures organised by the RTF will be given on your hotel or near a certain theatre, and will be happy to
Saturday, March 5, 10:30–12:00 in Room O (see page 159). reserve a table for you.
The RTF General Assembly takes place on Thursday, March
3, 09:00–10:30, in Meeting Room 2.95 (1st level). For more RISING STARS LOUNGE / RESIDENTS & STUDENTS LOUNGE
detailed information please visit the RTF Meeting Point in
The Rising Stars Lounge for residents and students is located
the Rising Stars & RTF Lounge on the lower level.
on the lower level. In the lounge you will find information on
Don’t miss the Meet & Greet Sessions with ESR President
the European School of Radiology, the European Diploma
Luis Donoso Bach (Thursday, March 3, 15:40–16:00) and
of Radiology and the Radiology Trainees Forum.
ECR 2016 Congress President Katrine Riklund (Thursday,
Don’t miss the Meet & Greet Sessions with ESR President
March 3, 16:00–16:20) in the Rising Stars & RTF Lounge.
Luis Donoso Bach (Thursday, March 3, 15:40–16:00) and
And join us at the RTF Quiz with Quizmaster José Cáceres on
ECR 2016 Congress President Katrine Riklund (Thursday,
Thursday, March 3, 12:30–13:30 in Room Z.
March 3, 16:00–16:20).
RECORDING / PHOTOGRAPHY
RISING STARS PROGRAMME
Video or audio recording of presentations is not allowed
The E³ – Rising Stars Programme is part of the E³ – European
without the speaker’s/exhibitor’s and ECR’s prior permission.
Excellence in Education programme. See pages 99–104.
Flash photography is not permitted during presentations.
Interviews must take place outside the lecture room. For
SATELLITE SYMPOSIA
queries, please contact the ESR Press Office.
Industrial Satellite Symposia are presented by international
companies. Please note that Satellite Symposia are no longer
CME-accredited. Places are allocated on a first-come, first-
served basis.
See separate booklet for details.

General Information
SCIENTIFIC PRESENTATION AWARDS SOCIETY BOOTHS

The authors of the best scientific papers and scientific/ More than 50 national and international radiological soci-
educational exhibits will be presented with a certificate and eties present their meetings and societies in the society
given free ECR 2017 registration. booths area, which is located on the entrance level, next to
Scientific Papers: The award will be assigned to the best the registration desks and the coat checks.
paper presentation of each topic based on the evaluation by
session moderators and subcommittee members. Selection SPECIAL ASSISTANCE
criteria comprise quality of presentation, scientific content Delegates with special needs may park on the lower level
and overall impression of the performance. with direct elevator access to the ACV. All lecture rooms
The award winners will be informed after the congress and are accessible by wheelchair.
will be published on the ESR website.
Scientific/educational exhibits: See page 29 (Scientific SPECIAL FOCUS SESSIONS
Exhibition Awards).
Special Focus Sessions deal with a topic at the cutting edge
of development and clinical application. The topics of these
SCIENTIFIC SESSIONS
sessions are presented so as to promote debate and to give
Accepted papers for oral presentation are presented in the an in-depth analysis. The chairman introduces each aspect
Scientific Sessions. of the topic and the panellists then discuss their different
Places are allocated on a first-come, first-served basis. perspectives and opinions. The audience is also given the
Please refer to pages 143–164 for the programme of the opportunity to discuss their ideas with the lecturers. Places
sessions. are allocated on a first-come, first-served basis. Please refer
to pages 87–90 for the programme of the sessions.
SECURITY / SAFETY
The safety of all congress attendees is of utmost importance STATE OF THE ART SYMPOSIA
to the European Society of Radiology. The Austria Center These sessions are intended to inform the audience about
Vienna and the ESR have taken security precautions to the ‘real state of the art’ of a given subject. Each of the lectur-
ensure the maximum possible safety for all ECR participants. ers is an expert on the topic as a whole or on some specific
Please inform our staff, especially our room attendants, aspect of the topic, which will be the subject of the respec-
immediately if security problems occur. tive session. The presentations are followed by a discussion
The ESR reserves the right to check your identification upon conducted by the panellists, led by the chairman. Places are
admission to the congress centre and/or inside the building. allocated on a first-come, first-served basis. Please refer to
You may be asked at any time to present adequate proof of page 85–86 for the programme of the sessions.
identity by showing your passport, driver’s licence, national
or military identification, or student ID, all with photograph STUDENTS’ SESSIONS
and signature.
At ECR 2016, students have again the chance to present
their own abstracts in front of a huge audience. The sub-
SMOKING
mitters of the best 32 abstracts have been invited to Vienna
Smoking is not permitted inside the Austria Center Vienna. to present their work in dedicated sessions.
The ECR is a non-smoking congress. Outside the building, See page 102–103.
we kindly ask you to use the ashtrays provided. Please note
that smoking is prohibited in front of the main entrance. TAXI
There is a taxi stand outside the main entrance.
SOCIAL MEDIA
The official congress hashtag for Twitter and Instagram is
#ECR2016.

General Information
TECHNICAL EXHIBITION
Opening hours:
Expo Halls & Expo Foyer D
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00

Opening hours:
Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–16:00
Detailed information on the Technical Exhibition can be

found in the ‘Industry Programme & On-Show Guide’.
TRAVEL SERVICE
The ESR and ECR are proud to offer their delegates services
that should facilitate their travel arrangements and make
their stay in Vienna as pleasant as possible. The ESR’s Travel
Service Desk is located in the entrance hall of the Austria
Center Vienna. Next to it you can find the ECR’s official
travel agency Mondial.
Opening hours:
Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00
Wednesday, March 2 to Saturday, March 5. . . . 07:30–18:00
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–15:00
WIRELESS LAN
Free wireless LAN access is available throughout the con-
gress venue and all lecture rooms. The name of the public
WiFi is ‘ECR’.

General Information
CME AT ECR 2016
GENERAL INFORMATION CME ACQUISITION PROCEDURE

Each ECR delegate has access to confirmation of all activi- The ESR is happy to provide you with a fully digital CME
ties attended (CME confirmation and record of attendance). acquisition system for ECR 2016. Please note that we no
The event has been accredited by the UEMS/EACCME and longer provide printed CME stickers. Not only will we save
it is possible to claim a maximum of 28 CME points for tons of paper and become an even greener and more sus-
attendance of scientific sessions at the ECR. Please note tainable meeting, but the system provides a lot more flex-
that this number may differ from the maximum number of ibility to delegates in regard to evaluating sessions and
credits your national jurisdiction approves for your contin- obtaining CME credits. At ECR 2016, you will have several
uous medical education. opportunities to complete the electronic questionnaires
for each session.
The Österreichische Ärztekammer (Austrian Medical Cham-
Evaluation and CME acquisition will be possible via
ber) has granted a maximum of 40 DFP (Diplom-Fortbil-
» The official ECR app, ECR 2016, available via the App Store
dungs-Programm der Österreichischen Akademie der Ärzte)
(iOS) and Google play (Android)
credits for ECR 2016.
» More than 130 laptops in the ECR Online & EPOS Lounge
USA located on the first level
Following the agreement on the mutual recognition of » The registration counters on the entrance level from Friday,
credits between the AMA (American Medical Association) March 4, 13:00 onwards
and the UEMS-EACCME, American physicians attending an » The CME & Evaluation terminals located on the first level
event in Europe will have their credits converted to AMA
Please note that evaluation of the sessions is only possible
PRA Category 1 in the USA.
March 2–7, 2016.
Worldwide
CME points claimed at the ECR are accepted by the majority CME credits will only be awarded if
of national CME authorities worldwide, which have manda- » You are logged into https://eval.webges.com/ecr2016 with
tory CME for their physicians. Please consult your national your username and PID (printed on your badge)
jurisdiction for the maximum number of CME points they » You have fully completed the electronic questionnaire
will approve following your attendance at ECR 2016. for each session
The combined participation and evaluation questionnaire is
of great value to the organising committee when selecting
topics for future ECRs. Evaluation forms differ depending
on the type of scientific event.

General Information
CME AT ECR 2016
GUIDANCE CME CONFIRMATION

Confirmation of participation in the scientific programme Every participant will be able to view and print their own
may be obtained as follows: personal record of attendance via the internet in the MyUs-
erArea on the condition that the above procedures have
Scientific Sessions
been carried out.
1. Attend the session.
2. Log in to https://eval.webges.com/ecr2016 or use the ECR This service will be available from two weeks after
2016 app to evaluate the session. the congress via the MyUserArea on the ESR website
3. Fill out this form completely during or after the session. (www.myESR.org).
Please note that your Personal ID, which is printed on your

If you do not have a smartphone, tablet or laptop with
badge, is required for login.
you, please visit one of the locations mentioned above and
The printout of your record should be submitted to your
evaluate the session(s) you visited on one of the CME &
national jurisdiction (usually responsible for accredita-
Evaluation terminals there.
tion) for approval of your CME points. Please note that the
Scientific Exhibition record of attendance will be issued only to the participant.
1. Enter EPOS™ (Electronic Presentation Online System) on It will not be supplied to any accreditation agency or other
one of the 130 laptops in the ECR Online & EPOS™ Lounge organisation.
and view posters.
Although participants may partially attend multiple con-
2. Log in to https://eval.webges.com/ecr2016 or use the ECR
current sessions, the total number of hours printed at the
2016 app to evaluate the session.
end of the list limits the credit to the equivalent of a single
3. Fill out this form completely after visiting the electronic
session during that time slot.
scientific exhibition.
A maximum of 3 hours of attendance at the scientific For further information, please contact ECR CME Support at
exhibition will be listed if the participant has completed cme@myESR.org.
and submitted the online evaluation form.

HEADLINE SESSIONS
24
OPENING CEREMONY
Wednesday, March 2, 17:45–19:00, Room A
Luis Donoso Bach; Barcelona/ES

ESR President
Katrine Riklund; Umeå/SE

ECR 2016 Congress President
Presentation of Honorary Membership

Ronald L. Arenson; San Francisco, CA/US
Hassen A. Gharbi; Tunis/TN
Qiyong Guo; Shenyang/CN
WILHELM CONRAD RÖNTGEN

HONORARY LECTURE (HL 1)
Imaging the invisible killer:
towards personalisation of ovarian cancer care
Thursday, March 3, 12:15–12:45, Room A

Andrea G. Rockall; London/UK
JOSEF LISSNER
Liver imaging: where do we stand now?
Friday, March 4, 12:15–12:45, Room A
Valérie Vilgrain; Clichy/FR
SVEN-IVAR SELDINGER
Imaging and micronavigation: time to redraw the map?
Saturday, March 5, 12:15–12:45, Room A
Staffan Holmin; Stockholm/SE
IMAGE INTERPRETATION QUIZ

Imaging with the stars
Friday, March 4, 14:00–15:30, Room A

Moderator: A.G. Rockall; London/UK
JUNIOR IMAGE INTERPRETATION QUIZ

Millennials showdown: the next generation of radiology
Saturday, March 5, 12:55–13:55, Room A

Moderator: F. Arnberg; Stockholm/SE
25
General Information
10 YEARS OF EIBIR
€63,000,000
research funding
secured with EIBIR support
VISIT OUR BOOTH IN THE MAIN ENTRANCE HALL

www.eibir.org

General Information
(JUNIOR) IMAGE INTERPRETATION QUIZZES
The Image Interpretation sessions, two traditional highlights of every ECR, provide
both education and entertainment. Two panels of distinguished radiologists will share
their knowledge and diagnosis strategies with you.
The slogan for this year’s ‘senior’ quiz is ‘Imaging with the stars’. Radiologists will
challenge each other in an enjoyable and exciting competition where they will face
some tricky cases.
In the ‘junior’ quiz, with its theme ‘Millennials showdown: the next generation of
radiology’, the panellists will compete with each other in teams. While solving a variety
of cases, the moderator will guarantee a scientifically challenging and entertaining
session.
Both quizzes will be interactive with the use of an electronic voting system via one’s
own device (smartphone, tablet or laptop) at no costs.
4
March Friday, March 4, 14:00–15:30, Room A
5
March Saturday, March 5, 12:55–13:55, Room A
Image Interpretation Quiz (IIQ) Junior Image Interpretation Quiz (JIIQ)
Imaging with the stars Millennials showdown:
the next generation of radiology
Moderator: A.G. Rockall; London/UK
» Team 1: Moderator: F. Arnberg; Stockholm/SE
N. Grenier; Bordeaux/FR » Team 1:
M. Vernooij; Rotterdam/NL C. Toxopeus; Amsterdam/NL
M. Gardarsdottir; Reykjavik/IS A. Gupta; London/UK
S.A. Taylor; London/UK » Team 2:
» Team 2: F.G. Meinel; Munich/DE
I. Thomassin-Naggara; Paris/FR D. Penha; Lisbon/PT
H.R. Jäger; London/UK » Team 3:
A.R. Larici; Rome/IT J.A. Prat-Matifoll; Barcelona/ES
T.K. Helmberger; Munich/DE O. Urbán; Szeged/HU
» Team 4:
B. Fejér; Budapest/HU
S. Belkacem; Monaco/MC

General Information
EPOS™ – SCIENTIFIC EXHIBITION
OPENING HOURS WHAT’S AVAILABLE IN THE ECR ONLINE & EPOSTM LOUNGE?
Wednesday, March 2 to Saturday, March 5. . . 08:00–18:00 » Over 2,000 new scientific and educational exhibits and
Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 08:00–15:30 scientific paper presentations
» The new feature ‘The Voice of EPOS’ with 350 oral poster
The staff of the EPOS™ Service Desk will be glad to assist presentations
you during these times. » Access to ECR Online and ECR on Demand
» 20 new Cases-of-the-Day (five new cases each day)
LOCATION » eLearning including self assessment modules on ECR
ECR Online & EPOS™ Lounge, 1 level st 2016 courses
» EURORAD – Europe’s largest radiological case database
ESR THANKS ALL REVIEWERS

We cordially thank the members of the Scientific Exhibition Committee (see p.
XX) and the EPOS™ Reviewers who reviewed abstracts and graded electronic
posters in the past months, establishing the basis for presenting the awards.
(in alphabetical order) C Cem Calli; Izmir/TR Birgitta Hansson; Stockholm/SE

A Jose Acosta Batlle; Madrid/ES Fabrizio Calliada; Pavia/IT Johannes Heverhagen; Bern/CH
Emel Ada; Izmir/TR Davide Caramella; Pisa/IT Jérome Hodel; Paris/FR
Helen C. Addley; Cambridge/UK Nelson M.G. Caserta; Campinas/BR Philip Hodnett; Dooradoyle/IE
Angel Alberich-Bayarri; Valencia/ES Francesca Coppola; Bologna/IT
Efthymia Alexopoulou; Athens/GR I Anna Maria Ierardi; Marsala/IT
Hatem Alkadhi; Zurich/CH D John Damilakis; Iraklion/GR
Maria Chiara Ambrosetti; Verona/IT Adelard I. B. De Backer; Ghent/BE J Alan Jackson; Manchester/UK
Takatoshi Aoki; Kitakyushu/JP Pim De Graaf; Amsterdam/NL Jarl A. Jakobsen; Oslo/NO
Paraskevi Argyropoulou; Albert de Roos; Leiden/NL Laura Jimenez-Juan; Toronto, ON/CA
Alexandroupolis/GR Savas Deftereos; Alexandroupolis/GR
Irina Arkhipova; Moscow/RU Stefan Delorme; Heidelberg/DE K Nektarios Kalyvas; Athens/GR
Loukas G. Astrakas; Ioannina/GR Aikaterini Kanavaki; Geneva/CH
E Olle Ekberg; Malmö/SE Panagiotis Kapetas; Vienna/AT
B Mojisola Balogun; Birmingham/UK Georgios Kapsas; Alexandroupolis/GR
Nuria Bargalló Alabart; Barcelona/ES F Eduardo F.C. Fleury; Sao Paulo/BR Ara Kassarjian; Majadahonda, Madrid/ES
Irene Bargellini; Pisa/IT Anastasia Fotiadou; Huntingdon/UK Caroline Keyzer; Brussels/BE
Antonio Barile; L’Aquila/IT Ferdinand Frauscher; Innsbruck/AT Daniela Kienzl-Palma; Vienna/AT
Tommaso V. Bartolotta; Palermo/IT Susan Freeman; Cambridge/UK Friedrich Knollmann; Sacramento, CA/US
Antonio Basile; Catania/IT Paraskevi Kosta; Ioannina/GR
Gorka Bastarrika; Toronto, ON/CA G Matthew T.G. Gaskarth; Cambridge/UK Elmar Kotter; Freiburg/DE
Tobias Baumann; Freiburg/DE Jonn-Terje Geitung; Norbyhagen/NO Karl-Friedrich Kreitner; Mainz/DE
Radu Baz; Constanta/RO Abraham Ghiatas; Ekali-Athens/GR Miltiadis Krokidis; Cambridge/UK
Kunwar S.S. Bhatia; Hong Kong/CN Anastasia Glantzouni; Ioannina/GR
Vasiliki Bizimi; Athens/GR Sofia Gourtsoyianni; London/UK L Andrea Laghi; Latina/IT
Johan G. Blickman; Rochester, NY/US Ali Guermazi; Boston, MA/US Andrea Lakatos; Miskolc/HU
Einat Blumfield; New York, NY/US Marc Lemmerling; Beervelde/BE
Alessandro Bozzao; Rome/IT H Danisia Haba; Iasi/RO Eva Llopis; Alzira-Valencia/ES
Florian M. Buck; Langnau am Albis/CH Andreas Hansch; Jena/DE Roberto Llorens; Valencia/ES

General Information
EPOS™ – SCIENTIFIC EXHIBITION
SCIENTIFIC EXHIBITION AWARDS ATTENDANCE AND EVALUATION

A jury of European radiologists has judged all scientific and Confirmation of participation in the Scientific Exhibition
educational exhibits with regard to their scientific content, may be obtained as follows:
educational value, originality and visual impression. Taking 1. Enter EPOS™ (Electronic Presentation Online System) on
advantage of EPOS™, the rating was carried out online, one of the 132 laptops in the ECR Online & EPOS™ Lounge
prior to the congress, enabling a detailed and considered and view posters.
assessment. On this basis, the Scientific Exhibition Commit- 2. Log in to https://eval.webges.com/ecr2016 or use the ECR
tee has awarded the best posters with Magna Cum Laude, 2016 app to evaluate the session.
Cum Laude and Certificate of Merits. 3. Fill out this form completely after visiting the electronic
Awardees can pick up their certificates at the EPOS™ Service scientific exhibition.
Desk. Each of the Magna Cum Laude awardees will also be
granted free ECR 2017 registration.
Awarded posters are flagged in EPOS™ and will be published
on the ESR website and on myESR.org/epos
Elizabeth Loney; Darlington/UK Tadeusz J. Popiela; Krakow/PL T Denis Tack; Braine-L’Alleud/BE

Ioana Gabriela Lupescu; Bucharest/RO Panos K. Prassopoulos; Adele Taibbi; Palermo/IT
Alexandroupolis/GR Stephen Taylor; Mons/BE
M Andreas Mahnken; Marburg/DE Lorenzo Preda; Milan/IT Stuart A. Taylor; London/UK
Lorenzo Mannelli; New York, NY/US Davide Prezzi; London/UK Gail Thornbury; Belfast/UK
Celso Matos; Lisbon/PT Stefan Puig; Vienna/AT Michael Toepker; Vienna/AT
Josephine McHugo; Birmingham/UK Michael Torkzad; Milford/UK
Elena Mershina; Moscow/RU Q Emilio Quaia; Trieste/IT Ioannis A. Tsalafoutas; Athens/GR
Peter Mildenberger; Mainz/DE Dimitrios K. Tsetis; Iraklion/GR
Manabu Minami; Ibaraki/JP R Christopher Riedl; New York, NY/US Athina Tsili; Ioannina/GR
Saeed Mirsadraee; Edinburgh/UK Soraya Robinson; Vienna/AT
Penelope L. Moyle; Cambridge/UK Janeth Romero; Boston, MA/US U Sara Upponi; Cambridge/UK
Valdair F. Muglia; Ribeirao Preto/BR Alejandro Rovira-Canellas;
Barcelona/ES V Edwin J. Van Beek; Edinburgh/UK
N Stephanie Nougaret; St Clement Reinhard Rzanny; Jena/DE Will J.M. van der Putten; Galway/IE
de Riviere/FR Berit Verbist; Leiden/NL
S Roberto Sanz-Requena; Valencia/ES
O Amaka Offiah; Sheffield/UK Christoph Schaeffeler; Chur/CH W Matthew G. Wallis; Cambridge/UK
Anastasia Oikonomou; Toronto, ON/CA Martina Scharitzer; Vienna/AT Dag Wormanns; Berlin/DE
Yumiko Oishi Tanaka; Tsukuba/JP Karl Schürmann; Aachen/DE Klaus Wörtler; Munich/DE
Mihaela Onu; Bucharest/RO Teik Choon See; Cambridge/UK Ximena Wortsman; Santiago/CL
Nisha Sharma; Leeds/UK Petra Wunderlich; Radebeul/DE
P Leo Pallwein-Prettner; Linz/AT Ashley Shaw; Cambridge/UK
Miguel Palm; Maastricht/NL Martin J. Shelly; Dublin/IE X Vasilis Xydis; Ioannina/GR
Valeria Panebianco; Rome/IT Paul Sijens; Groningen/NL
Gerald Pärtan; Vienna/AT Gustavo N. Simao; Ribeirao Preto/BR Z Giulia Zamboni; Verona/IT
Annie Paterson; Belfast/UK Stephan Skornitzke; Heidelberg/DE Anastasia Zikou; Ioannina/GR
Luis J. Pina Insausti; Pamplona/ES Wolfram Stiller; Heidelberg/DE
Katja Pinker-Domenig; Vienna/AT Misa Sumi; Nagasaki/JP

WATCH MORE THAN 1,500 LECTURES ONLINE
LIVE OR ON DEMAND
Plan and personalise your ECR 2016 experience with the Interactive
Programme Planner
Free live video and social media stream
ONE PLATFORM FOR ALL

ecronline.myESR.org
POWERED BY
General Information
GREEN MEETING FREE PUBLICATIONS
Broaden your horizons with

Let’s keep our congress green Free Publications at ECR 2016
The ECR 2016 will be a green meeting designed to meet The Free Publications initiative will run for the 10th consec-
environmental sustainability criteria set by the ‘Federal utive year after attracting increasing levels of attention at
Ministry of Agriculture, Forestry, Environment and Water ECR 2015. The Free Publications booth will be located on
Management’ (Austria’s national eco-friendly certificate). the first level of the ACV within the Preview Area (next
to the EPOS™ Lounge). The booth will be richly stocked
We encourage our employees, partners and customers to with a galaxy of fascinating reading material from many of
adopt practices that promote awareness of environmental our associated organisations and publishing houses from
conservation and sustainable use and we endeavour to around the world, such as Globetech, Diagnostic Imaging
adhere to these principles throughout our entire enterprise. and European Hospital.
Here are some ways you can contribute to our goal of About 20 publishers will provide more than 30 different
becoming a green meeting: titles for this initiative, ranging from copies of the ESR’s
» If possible, please choose an environmentally friendly form flagship journals European Radiology and Insights into Imag-
of transport like public transport or car sharing ing, to issues from as far afield as South America. It is a
» Please follow your hotel’s eco-friendly advice (e.g. chang- rare chance to learn from so many diverse medical imaging
ing towels and bed sheets only when necessary) and communities from around the globe, so we encourage you
please switch off all lights and electronic devices when to make the very best of the opportunity.
leaving your hotel room
» Please choose drinks served in glass, food served on reus- We are of course grateful for the enthusiasm of our friends
able dishes and avoid cans, plastic bottles and products in the publishing industry for making the Free Publications
in disposable packaging initiative possible, and allowing us to provide ECR par-
» Please dispose of your waste (PET, glass, paper, residual ticipants with the chance to pick up some literature and
waste, metal) by using the separate bins in your hotel and broaden their medical imaging horizons.
at the congress venue.
» Please use online registration and non-printed media FREE PUBLICATIONS BOOTH:
instead of paper 1st level, within the ECR Online & EPOS™ Lounge.
» Please return your badge to the info point after the con-
gress has ended
We’re not saying it’ll be easy,

but we know that it’ll be worth it.
Thank you for your support!

General Information

General Information
ECR 2016 WELCOMES ITS INDUSTRY PARTNERS
The ESR welcomes its

Supporting Members
The ESR gives a warm welcome to all its existing and newly The companies contribute with their active involvement
joined supporting membership companies. to the success of the society and its congress with their
As the ECR puts a special focus on innovation and keeping continuous support for the cause of radiology in Europe.
up to date with recent developments in the field, a close
cooperation with the industry leaders is indispensable.
ESR Supporting Members:

4-STAR: 3-STAR:
Agfa HealthCare HealthCare Mindray
Bayer HealthCare TeraRecon
Bracco
Carestream Health
Esaote 2-STAR:
Fujifilm Europe Alpinion Medical Systems
GE Healthcare Paramed Medical Systems
Guerbet Shimadzu Europa
Hitachi Medical Systems Europe Swissray Medical
Philips Varian Medical Systems
Samsung Vinno Technology
Siemens Healthcare
Toshiba Medical Systems Europe

‘ESR MEETS’ COUNTRIES
Each year the ECR places a special focus on its ‘ESR meets’
countries – in 2016 namely the Nordic Countries (Denmark,
Finland, Iceland, Norway and Sweden), Japan and Colombia
– with particular emphasis on their scientific and techno-
logical developments. The ESR, industry companies and
the national societies work closely together to highlight
these countries.
Thank you for your involvement!

General Information
LET’S CELEBRATE
YEARS OF
Top radiologists read more than just images

www.european-radiology.org

General Information
JOURNALS
EUROPEAN RADIOLOGY INSIGHTS INTO IMAGING

European Radiology at your fingertips! The clearest insights … for all to see!
Carry Europe’s leading radiology journal with you wherever Insights into Imaging is the ESR journal for education and
you go – with the European Radiology App – download strategies in radiology. Besides excellent review articles,
the app from iTunes or via the QR code below. it publishes articles on professional issues, several official
documents and political statements.
This year marks the 25th anniversary of European Radiology,
the official journal of the ESR and official organ of numerous Insights into Imaging is an Open Access journal on the
subspecialty organisations. It acts as a flagship, publishing SpringerOpen platform – therefore all articles published are
original scientific papers in the radiological field with an freely available. As benefit for ESR members, ESR covers
Impact Factor of 4.014 for 2014. the Article Processing Charges for all its active members!
Full access to the online version of European Radiology is Links to the journals
included in the ESR membership fee. www.european-radiology.org
ESR members can also arrange subscriptions for the printed www.i3-journal.org
version at special rates in the MyUserArea (www.myESR.
org/MyUserArea under ‘MyJournals’).
Don’t miss another issue of the special cover illustrations
(on all printed issues in 2016), and subscribe to the printed
version now.

Underground Line (U-Bahn)
Commuter Train (S-Bahn)
City Airport Train
Urban Train (Lokalbahn)
www.myESR.org
Vienna International Busterminal
Customer Service Centre
(U3 Erdberg)
Infopoints
Ticket Sales ECR STOP:
A
C
Kaisermühlen /
V
Vienna Int. Centre
Park & Ride
Final Programme | ECR 2016

© Wiener Linien, August 2013
37
UNDERGROUND MAP
General Information
Floor Plans
– LEVEL BUILDING
FLOOR
PLANS

ACV
0 - ENTRANCE LEVEL
40
CONGRESS PHILIPS
OFFICE Scanning Suite
Floor Plans
CH
K1
E
EC T
C
CO CK
Room Room
CH OA
AT 2
22 - 30
E2 F1
31 - 34
56
-
Room Room
1-
52
5
35
21
-
-
TOSHIBA
12
44
Industry Workshop
E1 F2
Room 0.93
1
ESR MEETS
+5
6+
7
50
N RE
IO GIS
AT TR
TR AT M Building
IO
ECR 2016 | Final Programme

GIS N
RE
47
10 - 49 0 - ENTRANCE LEVEL
8-
re 45
sto +4
ok 6
Bo
ESR
WELCOME
sy
CM
LOUNGE
Ea
Ea
sy
CM
B
E S
MB
INTERNET
PR USIN
E
CORNER
uil
din
S O SS C
g
Ch
n
FF EN
ec
k-i
ICE TR
R
D
AN E
k-i
M29
ec
Exegis
n
xp
Info
o
W es a ’
Se hib trati
Ch
- E nd
Austrian
M1
MA rvic itors on
Airlines
Mondial M7 M8 M30
Travel Service M27
Arts & Culture M26
= SOCIETY BOOTHS
Restaurant M25
= CASH DISPENSER / ATM
Reservations M24
M6
M34 M33 M32
MAIN ENTRANCE MOBILE UNIT
M10 M21 M22 M23
TO / FROM UNDERGROUND EDiR EXAMINATION AREA

All Rooms on this level, with the exception of Room M1 and the EDiR Zone - are Meeting Rooms.
0 – ENTRANCE LEVEL ACV + M BUILDING
EXPO X4 EXPO X5
LOUNGE
AREA
www.myESR.org
Floor Plans
ACV 0 – ENTRANCE LEVEL ACV

0 - ENTRANCE LEVEL
CONGRESS PHILIPS
OFFICE Scanning Suite
CH
CO CK
K1
EC T
CH OA
E
AT 2
C
Room Room
22 - 30
E2 F1
31 - 34
56
Room Room
E1 F2
-
1-
52
TOSHIBA
35
21
5
-
-
44
12
Industry Workshop
Room 0.93
ESR MEETS
1
6+
+5
50
RE
7
N GI
TIO ST
RA RA
ST TIO
GI N
RE
47
10 -
8- 49
re 45
sto +4
Bo
ok 6
ESR
WELCOME
MB
CM
sy
LOUNGE
Ea
Ea
CM
sy
PR USIN
uil
B
ES ES
din
SO SC
g
FF EN
Ch
ICE TR
n
ec
AN E
MA rvic itorsion
k-i
Se hib trat
Exegis
k-i
D
W es a ’
ec
- E nd
n
xp
Ch
Info
Mondial
o
Austrian
Airlines
Travel Service
Arts & Culture
= SOCIETY BOOTHS
Restaurant
= CASH DISPENSER / ATM
Reservations
MAIN ENTRANCE MOBILE UNIT
TO / FROM UNDERGROUND
EXPO X4 EXPO X5
LOUNGE
AREA

Floor Plans
1 – FIRST LEVEL ACV ACV

1 - FIRST LEVEL
Meeting Room 1.85

EVALUATION & CME TERMINALS
BAYER
Industry Workshop Meeting Room 1.86
Room 1.61-62
Room Room
O N
EXPO GALLERY
MAMMOTOME
Industry Workshop
Room 1.98
Room
L8 Room
STUDIO 2016
HOLOGIC PREVIEW
Industry Workshop
Room L7 CENTRE
ECR ONLINE &

EPOSTM LOUNGE
FREE PUBLICATIONS &
FUTURE MEETINGS EPOSTM ARENA

Floor Plans
ACV 2 – SECOND LEVEL ACV

2 - SECOND LEVEL
ESUR
OERG Lounge ESGAR Lounge
2.83
BR
ON
OA
TZ
DC
Room Room
AS
B C
AS
DC
TZ
OA
ON
BR
E
Meeting Room 2.44 Meeting Room 2.95
Room 2.96
Rooms 2.41 + 2.42

A 2.97
2.98
Meeting Room 2.34
Meeting Room 2.11
Meeting Room 2.12

2.13
2.14
Room
Z
RESTAURANT 2.17

Floor Plans
3 – THIRD LEVEL ACV ACV

3 - THIRD LEVEL
OF
6
3.6
FIC
3–
ES
3.4
3.7
ES
7–
FIC
3.9
OF
7
OF +3.3
5
3.3
3.1
FIC 4
3
2–
ES
3.1
ES
FIC
PRESIDENTS’
OF
Meeting Room 3.32

OFFICE
Past Presidents Circle

Floor Plans
ACV -2 – LOWER LEVEL ACV

-2 - LOWER LEVEL
MEDITATION & PRAYER ZONE

HOLOGIC
Industry Workshop
Room -2.83 / -2.84
FUJIFILM GE
Industry Workshop Industry Workshop
Room -2.61-62 Room -2.85 / -2.86
RISING STARS
NT
BR ZON
Room Room & RTF LOUNGE
OA E
RA
G K
DC
AU
AS
ST
T
RE
CO
CKK 3 AT
CHEEC
H
T
CH
EC
COTA
C
A K 4
CO
Room
D1
EX TO
PO
X1
Room
D2
VIRTUAL
EXPO FOYER D SKYDIVE
TO EXPO
X1 - X3
EXPO X1
EXPO X2
EXPO X3

Floor Plans
0 – ENTRANCE LEVEL M BUILDING
M Building
0 - ENTRANCE LEVEL
INTERNET
AC CORNER
EN
TRVA M29
LE NCE
VE
L M1
M7 M8 M30
M27
M26
M25
M24
M6
M34 M33 M32
M10 M21 M22 M23
EDiR EXAMINATION AREA

All Rooms on this level, with the exception of Room M1 and the EDiR Zone - are Meeting Rooms.

Floor Plans
1 – FIRST LEVEL M BUILDING
M Building
1 - FIRST LEVEL
BROADCAST ZONE
M2
M4
M3

Floor Plans
2 – SECOND LEVEL M BUILDING
M Building
2 - SECOND LEVEL
BROADCAST ZONE
M5

General Information
ESR
DIGNITARIES

ESR Dignitaries
HONORARY MEMBERS
Ronald L. Arenson
San Francisco, CA/US
Honorary Member
His research interest is informatics in radiology. He has also

patented new techniques in interventional radiology. One of
his achievements was the development of a catheter that can
be steered in a magnetic field, enabling interventionists to
reach further into smaller blood vessels. In 2001, he and fellow
researchers filed a patent on the invention, which was selected
for presentation at a national fair on technology.
Although he now dedicates most of his time to being an admin-

istrator and mentor, he is still involved in the development of
novel information system applications.
Prof. Arenson has authored or co-authored more than 110

peer-reviewed scientific articles, four book chapters, three
books and numerous exhibits, abstracts and editorials. He has
also served on the editorial boards of several journals, including
Radiology and Journal of the American College of Radiology.
In recognition of his pioneering work in radiology
and commitment to the advancement of medical He has served on several committees of numerous medical soci-
imaging, Professor Ronald L. Arenson from eties and organisations, such as the American College of Medical
San Francisco, United States, will be awarded Informatics (ACMI), the Association of University Radiologists
Honorary Membership of the European Society (AUR), the Academy of Radiology Research (ARR) and the
of Radiology at ECR 2016. American College of Radiology (ACR). He was also a founding
member of the Radiology Information System Consortium, now
the Society for Imaging Informatics in Medicine (SIIM).
Ronald L. Arenson is the Alexander R. Margulis Distinguished
Professor and chair of the department of radiology and bio- Prof. Arenson holds fellowships in the ACR, ACMI and SIIM, and is
medical imaging at the University of California, San Francisco, past-president of the AUR, ARR and the Society of Chairmen of
where he has worked since 1992. He is the immediate past Academic Radiology Departments (SCARD). In addition he has
president of the Radiological Society of North America (RSNA). served on the United States’ National Advisory Council of the
National Institute of Biomedical Imaging and Bioengineering of
Prof. Arenson received his medical degree in 1970 from New York the National Institutes of Health, and the NIH Council of Councils.
Medical College in New York and completed his diagnostic radi- Prof. Arenson has received numerous honours throughout his
ology residency at Massachusetts General Hospital in Boston. long career, including the Alumni Medal of Honor from New York
Medical College in 2001 and a gold medal from AUR in 2013.
He began his academic career in 1976 at the University of
Pennsylvania, where he successively became associate chair- At ECR 2016, he will receive Honorary Membership of the
man of clinical services in radiology, director of administrative European Society of Radiology.
services, and interim vice provost for information systems and
computing for the campus.

ESR Dignitaries
HONORARY MEMBERS
Hassen A. Gharbi
Tunis/TN
Honorary Member
Hassen A. Gharbi is a professor of radiology and medical bio-

physics from Tunis, Tunisia. He was head of the department of
radiology at Tunis Children’s Hospital and head of the medical
biophysics department at Tunis Medical School. He is the imme-
diate past president of the World Federation for Ultrasound
in Medicine and Biology (WFUMB) and the African Society of
Radiology (ASR).
He obtained his medical degree in 1966 from Paris Medical

School, where he subsequently specialised in radiology, aero-
nautic medicine, medical informatics and medical biophysics.
He completed a PhD in optic physiology at the Orsay Science
Faculty in Paris, and two decades later graduated in Man-
agement of Radiation Accidents from Oak Ridge Associated
Universities, Tennessee, USA.
Prof. Gharbi worked as an assistant professor at the biophysics

department of Paris Medical School between 1966 and 1970,
In recognition of his contribution to the
before being appointed vice dean of Tunis Medical School in 1971. development of paediatric radiology in Africa
In 1970 he created the first paediatric radiology department in and his dedication to strengthening ties between
North Africa at Tunis Children’s Hospital, which he later headed. African and European radiologists, Professor
Hassen A. Gharbi from Tunis, Tunisia, will be
Prof. Gharbi is the founder and the first president of the Medi- awarded Honorary Membership of the European
terranean and African Society of Ultrasound (MASU) and also Society of Radiology at ECR 2016.
founded the Tunisian National Centre of Radiation Protection,
serving as its director between 1971 and 1989.
classification of the hydatid cyst appearance published in Radi-
Between 1975 and 1985 he was president of the Radiological ology in 1981 is still used around the world.
Tunisian Commission of the Ministry of Public Health, to which
he also acted as adviser on radiology, paediatric radiology, bio- He has authored or co-authored more than 20 books on pae-
medical engineering, radiation protection, training and hospital diatric radiology, and tropical and infectious diseases (hydatid
equipment planning. diseases), and has published more than 130 articles in national
He has served the World Health Organization as an expert in and international journals. He also sits on the editorial boards
radiology, radioprotection and paediatric radiology since 1993. of several international journals.
Prof. Gharbi is retired but is still involved in several teaching Prof. Gharbi has received many awards recognising his contri-
programmes, mainly to promote the good use of ultrasound butions to the promotion of radiology in developing countries,
in developing countries around the world. mainly in Africa.
His other main interest was imaging of hydatid diseases and At ECR 2016, he will receive Honorary Membership of the
the study of their epidemiology and treatment. His ultrasound European Society of Radiology.

ESR Dignitaries
HONORARY MEMBERS
Qiyong Guo
Shenyang/CN
Honorary Member
His research interests relate to abdominal imaging, especially of

the liver and biliary tract. He is also an interventional radiologist,
with particular interests in non-vascular interventional radiology
and tumour diagnosis and treatment, and has published more
than 150 papers.
His main activities are hospital management, diagnostic imaging

consultancy, and guidance for graduate and PHD students. He
has mentored more than 100 graduate students and PhD
doctors.
Prof. Guo is chief editor of the China Clinical Medical Imaging

Journal and Contemporary Hospital Management. He is also
in charge of more than ten projects at all levels of academic
research, including national natural science funds. He is chief
editor of three specialised textbooks including Interventional
Radiology and chief editor of several specialised monographs
In recognition of his contributions to the such as Practical Radiology.
advancement of abdominal imaging and his He is president of the Chinese Association of Radiologists and
efforts in strengthening ties between Asian chairman of medical imaging for the China Hospitals Associ-
and European radiologists, Professor Qiyong ation. He is also an executive member of the Asian Oceanian
Guo from Shenyang, China, will be awarded Society of Radiology (AOSR), and a former president of the
Honorary Membership of the European Society Chinese Society of Radiology and the Asian Society of Abdom-
of Radiology at ECR 2016. inal Radiology (ASAR).
In recognition of his work, he has been awarded numerous dis-

Qiyong Guo is a professor of radiology and chairman of the tinctions throughout his career, including honorary membership
radiology department at Shengjing Hospital, China Medical of the Russian Society of Radiology in 2009, the Japan Society
University (CMU). He is also president of Shengjing Hospital, of Radiology in 2011 and the German Society of Radiology in
vice president of CMU, and dean of the radiology faculty. 2013. Last but not least, he received the Gold Medal of ASAR
in 2015.
Prof. Guo graduated from CMU in 1983 and started working as a
radiologist in Shengjing Hospital. He finished his medical studies At ECR 2016, Prof. Guo will receive Honorary Membership of
in Japan, at Nara Medical University, where he specialised in the European Society of Radiology.
abdominal imaging and interventional radiology and majored
in liver research between 1988 and 1993. In 1993 he returned
to Shengjing Hospital, where he took on his current positions.

ESR Dignitaries
GOLD MEDALLISTS
Gabriel P. Krestin
Rotterdam/NL
Gold Medallist
Gabriel P. Krestin is full professor of radiology and chairman of

the Department of Radiology and Nuclear Medicine at Erasmus
MC, University Medical Centre Rotterdam, the Netherlands.
He graduated in medicine from the University of Cologne in

Germany, where he completed his residency in radiology in 1988.
After undertaking fellowship training in abdominal imaging and
MRI, Prof. Krestin completed a PhD on experimental and clinical
applications of fast gradient-echo MR imaging in the abdomen,
in 1990, at the same university.
He was subsequently appointed as a radiologist and head of

the MRI centre at Zürich University Hospital, Switzerland, where
he later became associate professor of radiology and head of
the clinical radiology service. He also served as acting chairman
of the diagnostic radiology department before he moved into
his present position in the Netherlands.
In recognition of his pioneering work in
He was a permanent visiting professor at Stanford University abdominal and molecular imaging, and
Medical School from 1998 to 2009, and the Couch-Kerley Trav- his commitment to the development and
eling Professor to the Royal College of Radiologists in the UK. harmonisation of radiology in Europe, Professor
Gabriel P. Krestin from Rotterdam, the
Prof. Krestin has authored more than 390 original articles and 90 Netherlands, will be awarded the Gold Medal of
book chapters, and is the editor of seven books, some of which the European Society of Radiology at ECR 2016.
have been translated into several languages. His main areas of
research are imaging of abdominal organs and cardio-vascu-
lar diseases, molecular imaging and population imaging. His
research has been supported by numerous grants from Euro- Prof. Krestin currently serves on the editorial and advisory
pean and national research organisations, charities and industry. boards of several international journals including MagMa, Inves-
tigative Radiology, and Abdominal Radiology, and has been a
Prof. Krestin has extensive experience in leadership, manage- member of the editorial boards of Radiology and European
ment and strategic planning. He is the founder of Management Radiology.
in Radiology (MIR) and founder and current Scientific Director
of the European Institute for Biomedical Imaging Research He has been awarded many distinctions for his work, including
(EIBIR). He is also a member of numerous scientific advisory the Albers Schönberg Medal of the German Society of Radiol-
boards for companies, European organisations, and universities. ogy and the Schinz Medal of the Swiss Society of Radiology.
Furthermore he has been awarded honorary membership of
Prof. Krestin recently served as president of the ESR and of the numerous national radiology societies and of the ESMRMB.
International Society for Strategic Studies in Radiology. He is
also the past president of the European Society for Magnetic At ECR 2016, he will receive the Gold Medal of the European
Resonance in Medicine and Biology. Society of Radiology.

ESR Dignitaries
GOLD MEDALLISTS
Claude Manelfe
Toulouse/FR
Gold Medallist
Prof. Manelfe is a founding member, former president and sec-

retary general of the French Society of Neuroradiology, as well
as a former president of the European Society of Neuroradi-
ology (1998 to 2000). He also served as Secretary General
and President of the International Society of Radiology from
2002 to 2008.
He was a visiting professor at the University of California, San

Francisco in 1981–1982, and at the University of British Columbia,
Vancouver in 1982.
He has published more than 235 publications in neurology,

neurosurgery, neuroradiology, and diagnostic and interventional
neuroradiology. Seventy of his articles have been devoted to MR,
mainly to the field of neuroimaging. He also served as Editor in
Chief of Neuroradiology from 1993 to 2004.
In recognition of his service to the discipline, He retired from his activities eight years ago but is still working
French neuroradiologist Professor Claude part time in a general hospital.
Manelfe from Toulouse, France, will be awarded
the Gold Medal of the European Society of Prof. Manelfe has been awarded many distinctions over his
Radiology at ECR 2016. long career, including the Gold Medal of Toulouse Faculty of
Medicine and the scientific prize of the European Society of
Neuroradiology for his medical thesis on vascular supply of the
Claude Manelfe is professor emeritus at Paul Sabatier University human spinal dura mater. He was also laureate of the Medical
in Toulouse, France. He was professor and chairman of diag- Research Foundation for his work on therapeutic endovascular
nostic radiology at Paul Sabatier University for thirty years, occlusions. His achievements have been recognised with various
and head of the diagnostic and therapeutic neuroradiology honours, including the Schinz medal of the Swiss Society of
department at Purpan University Hospital in Toulouse. Radiology, fellowship of the American College of Radiology,
and honorary membership of the American Society of Neuro-
In 1969, Prof. Manelfe received his medical degree from Toulouse radiology, the Radiological Society of North America, and the
University, where he subsequently completed fellowships in European Society of Neuroradiology.
neurology and radiology, and a specialisation in neuropsychiatry.
At ECR 2016, he will receive the Gold Medal of the European
His main interests were interventional neuroradiology and end- Society of Radiology.
ovascular occlusions at the beginning of the 1970s, and MRI and
imaging of the spine and spinal cord later.

ESR Dignitaries
GOLD MEDALLISTS
Peter Vock
Bern/CH
Gold Medallist
Peter Vock is professor emeritus at the University of Bern

and senior consultant radiologist at Bern University Hospital
(Inselspital) in Bern, Switzerland. He chaired the Institute of
Radiology of Bern University from 1989 to 2012.
In 1973 he obtained his medical degree from the University of

Bern, and subsequently did a residency in radiation oncology,
radiology and nuclear medicine at Inselspital, where he started
working as a radiologist after his board certification in 1980.
Before that, he also completed a residency in internal medicine
at Tiefenauspital in Bern. Between 1982 and 1983, he was a vis-
iting research associate in chest imaging at the department of
radiology, Duke University Medical Center, Durham, NC, USA.
Prof. Vock’s research interests focus on chest imaging, CT and

particularly radiation protection. He has dedicated much of his
work to radiation protection on an institutional, professional,
national and international level, serving as a member of the
In recognition of his lifelong commitment to the
Swiss Federal Commission of Radiation Protection for more than field of radiology, Professor Peter Vock from
twelve years and chairing the commission’s medical subcommit- Bern, Switzerland, will be awarded the Gold
tee for six years. He was also responsible for radiation protection Medal of the European Society of Radiology
within the Swiss Society of Radiology and currently serves as (ESR) at ECR 2016.
chairman of the ESR’s Radiation Protection Subcommittee.
Prof. Vock has also represented the ESR in different radiation

protection projects, such as the European Medical ALARA
Network (EMAN), Medical Radiation Protection Education and
Training (MEDRAPET) and European Diagnostic Reference
Levels for Paediatric Imaging (PiDRL).
Prof. Vock is Deputy Editor of European Radiology and a mem-

ber of the Steering Committee of the EuroSafe Imaging cam-
paign. He has been attending the ECR ever since its creation
in the early 1990s.
At ECR 2016, Prof. Vock will receive the Gold Medal of the
European Society of Radiology.

ESR Dignitaries
HONORARY LECTURERS
Staffan Holmin
Stockholm/SE
Honorary Lecturer
Prof. Holmin leads the research group in neuroradiology at

Karolinska Institutet, working on clinical and experimental
projects in stroke management and endovascular technique
development, and is responsible for the imaging research
facilities in the planning of the new Karolinska Hospital.
After graduating with a medical degree from Karolinska Insti-

tutet in 1995, Prof. Holmin obtained his doctoral degree in 1997
and his physician certification from the same institution in 1999.
In 2006 he did a post-doc and fellowship training at Bicêtre
Hospital in Paris, France, under the supervision of Professor
Pierre Lasjaunias.
In 2005 he passed the Swedish and European specialist neuro-

surgery examinations and two years later the Swedish specialist
neuroradiology examination.
In recognition of his significant expertise in Prof. Holmin is the main inventor of an endovascular device
the field of neurointervention and his great for transvasal passage (Extroducer), a project he developed
achievements in research, Professor Staffan together with Karolinska Institutet Innovations AB between
Holmin from Stockholm, Sweden, has been 2008 and 2014. The project resulted in granted patents in USA,
invited to give the Sven-Ivar Seldinger Honorary Japan and Europe.
Lecture ‘Imaging and micronavigation – time to He has been responsible for human and animal imaging facilities
redraw the map?’ at ECR 2016. in the research building of the New Karolinska Hospital since
March 2013. He is the Karolinska Institutet’s representative for
neuroradiology in the preparation for the New Karolinska Hospi-
Staffan Holmin is the Söderberg professor of clinical neuroim- tal. He is the principal investigator and co-principal investigator
aging at Karolinska Institutet. He is also a consultant in end- for a number of different national and international research
ovascular neurointervention and vice chairman of the neu- projects, and is currently developing additional new applications
roradiology department at Karolinska University Hospital in for endovascular techniques.
Stockholm, Sweden.
At ECR 2016, Prof. Holmin will present the Sven-Ivar Seldinger
Honorary Lecture, titled ‘Imaging and micronavigation – time
to redraw the map?’

ESR Dignitaries
HONORARY LECTURERS
Andrea G. Rockall
London/UK
Honorary Lecturer
Andrea G. Rockall is Consultant Radiologist at the Royal Mars-

den Hospital and Visiting Professor of Radiology at Imperial
College London, UK.
She graduated in neuroanatomy at King’s College London in

1987 and received her medical degree from King’s College
Hospital Medical School in 1990. She was awarded the Royal
College of Radiologists’ (RCR) Rohan Williams Medal, the gold
medal award for the FRCR examination, in 1997.
She chose radiology as a career because of the central role

imaging plays in the diagnostic pathway. After completing her
training in internal medicine, she started working as a registrar
in radiology at St. Mary’s Hospital and then as a senior registrar
in radiology at University College London Hospitals. In 2000,
she was appointed Senior Lecturer and Consultant Radiologist
at St. Bartholomew’s Hospital London, a position she held for
twelve years. During that time, she was appointed Honorary
In recognition of her major contributions to
Professor of Cancer Imaging at Bart’s Cancer Institute, Queen oncologic radiology and her dedication to
Mary University London, before taking up her current position. the advancement of the field in Europe and
beyond, Professor Andrea G. Rockall from
Prof. Rockall is currently chief investigator on three national mul- London, United Kingdom, has been invited to
ti-centre studies: the MAPPING study, which is evaluating diffusion give the Wilhelm Conrad Röntgen Honorary
weighted imaging, FDG and F-ethyl-choline PET/CT in nodal stag- Lecture ‘Imaging the invisible killer: towards
ing in cervix and endometrial cancer (funded by Cancer Research personalisation of ovarian cancer care’.
UK); the MALIBO study, which is developing machine learning in
whole body MRI for detection of metastatic disease (funded by
National Institute for Health Research – NIHR); and the MROC study, In addition, she serves on several committees, including the
which is evaluating multi-parametric MRI in determining treatment European Society of Gynaecologic Oncology’s quality standards
planning and staging of ovarian cancer (also funded by NIHR). in ovarian cancer surgery committee, the RSNA Programme
Committee and the ACR O-RADS steering committee. She has
Prof. Rockall has authored or co-authored more than 100 pub- also served as Chair of the ESR Statutes and Rules Subcommit-
lications in peer-reviewed journals, three books and numerous tee and as a member of the ESR Membership Subcommittee.
book chapters.
Prof. Rockall has received many distinctions for her work, includ-
She was president of the International Cancer Imaging Society ing the Outstanding Teacher Award from the International
for 2015 and is a council member of the British Gynaecologic Society for Magnetic Resonance in Medicine in 2014.
Cancer Society. She is also currently a member of the RCR
Steering Group for Cancer Imaging and Reporting, and she At ECR 2016, Prof. Rockall will present the Wilhelm Conrad
chairs the Female Pelvic Imaging Working Group for the Euro- Röntgen Honorary Lecture, titled ‘Imaging the invisible killer:
pean Society of Urogenital Radiology. towards personalisation of ovarian cancer care’.

ESR Dignitaries
HONORARY LECTURERS
Valérie Vilgrain
Clichy/FR
Honorary Lecturer
University Hospital, an institution well known for its expertise

and outstanding clinicians in abdominal diseases. She subspe-
cialised in the gastrointestinal tract, with a special focus on liver,
biliary and pancreatic diseases, an area that still fascinates her
to this day.
Her major research interests are diagnostic and interventional

imaging of the liver, pancreas and bile ducts, focusing on multi-
detector CT, MRI, contrast-enhanced ultrasound and functional
imaging.
In addition, Prof. Vilgrain is involved in several on-going research

projects, and she is the principal investigator of the SARAH trial,
which aims to compare SorAfenib, the reference treatment of
advanced hepatocellular carcinoma (HCC), against radioembo-
lisation. She is also involved in a combined academic/company
project on HCC, which aims to develop imaging solutions for
In recognition of her contribution to abdominal better patient management.
imaging and commitment to the advancement
of radiology, Professor Valérie Vilgrain from She has authored or co-authored 332 articles original articles,
Clichy, France, has been invited to give the Josef mainly on abdominal imaging, and co-edited 30 books on
Lissner Honorary Lecture, titled ‘Liver imaging: abdominal imaging.
where do we stand now?’ at ECR 2016. Prof. Vilgrain holds membership of many societies, including
the European Society of Radiology (ESR), the Radiological
Society of North America (RSNA) and the European Society
Valérie Vilgrain is chair of the radiology department at Beaujon of Gastrointestinal and Abdominal Radiology (ESGAR).
University Hospital in Clichy and full professor of radiology at
Paris Diderot University – Paris 7, France. She has served as vice-chairperson of the French Radiological
Society and chairperson of the Education Programme Com-
She obtained her medical degree from René Descartes Univer- mittee for the society’s annual meeting. She serves on several
sity in Paris in 1985. She then did a residency in internal medicine, committees for the European Congress of Radiology and chairs
neurology and radiology at Paris University. the RSNA Regional Committee for Europe.
Prof. Vilgrain chose to subspecialise in chest and abdominal At ECR 2016, Prof. Vilgrain will present the Josef Lissner Hon-
diseases, and completed a fellowship in radiology at Beaujon orary Lecture, titled ‘Liver imaging: where do we stand now?’

COMMITTEES

General Information
ESR EXECUTIVE COUNCIL
BOARD OF DIRECTORS
President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Luis Donoso Bach; Barcelona/ES
1st Vice-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Paul M. Parizel; Antwerp/BE
2nd Vice-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Bernd Hamm; Berlin/DE
Past President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lorenzo Bonomo; Rome/IT
COMMITTEE CHAIRS
Communication and External Affairs Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Boris Brkljačić; Zagreb/HR
ECR 2016 Congress Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Katrine Riklund; Umeå/SE
ECR 2017 Programme Planning Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Paul M. Parizel; Antwerp/BE
Education Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Laura Oleaga; Barcelona/ES
Finance and Internal Affairs Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Michael Fuchsjäger; Graz/AT
National Societies Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deniz Akata; Ankara/TR
Publications Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lorenzo E. Derchi; Genoa/IT
Quality; Safety and Standards Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Jane Adam; London/UK
Research Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hans-Ulrich Kauczor; Heidelberg/DE
Subspecialties and Allied Sciences Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Catherine M. Owens; London/UK
NON-VOTING
Director of the European School of Radiology (ESOR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nicholas Gourtsoyiannis; Athens/GR
Executive Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Peter Baierl; Vienna/AT

ECR 2016 Committees
CONGRESS COMMITTEE
Chairperson (Congress President) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Riklund; Umeå/SE

ESR President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Donoso Bach; Barcelona/ES
ESR 1st Vice-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.M. Parizel; Antwerp/BE
ESR Executive Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Baierl; Vienna/AT
Chairperson of the Finance and Internal Affairs Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.H. Fuchsjäger; Graz/AT
Chairperson of the Publications Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.E. Derchi; Genoa/IT
PROGRAMME PLANNING COMMITTEE
POSTGRADUATE EDUCATIONAL PROGRAMME E³ – RISING STARS PROGRAMME
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . H.-U. Kauczor; Heidelberg/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Szczerbo-Trojanowska; Lublin/PL

Members: . . . . . . . . . . . . . . . . . . . . . . . . . R.G.H. Beets-Tan; Maastricht/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Camps Herrero; Valencia/ES CASES OF THE DAY
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Dewey; Berlin/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Vilar; Valencia/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H.B. Eggesbø; Oslo/NO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.J. Grainger; Leeds/UK
EFOMP REPRESENTATIVE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Haliloglu; Ankara/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D.R. Kool; Nijmegen/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Torresin; Milan/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Malamateniou; London/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .R. Pozzi-Mucelli; Verona/IT ESMRMB REPRESENTATIVE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Puech; Lille/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E.R. Danielsen; Copenhagen/DK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D.K. Tsetis; Iraklion/GR
IMAGE INTERPRETATION QUIZ

SCIENTIFIC PAPERS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A.G. Rockall; London/UK
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Brkljačić; Zagreb/HR
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.E. Andersen; Odense/DK
JUNIOR IMAGE INTERPRETATION QUIZ
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Arkhipova; Moscow/RU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.-Y. Marcy; Ollioules/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .F. Arnberg; Stockholm/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A.C. Offiah; Sheffield/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.P. Parkar; Bergen/NO EVALUATION
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H.-P. Schlemmer; Heidelberg/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Zackrisson; Malmö/SE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.H. Fuchsjäger; Graz/AT
EPOS EDITOR ESR EDUCATION COMMITTEE CHAIRPERSON
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.I. Argyropoulou; Ioannina/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Oleaga Zufiría: Barcelona/ES
E³ – EUROPEAN EXCELLENCE IN EDUCATION E-LEARNING EDITORS

E³ – ECR ACADEMIES: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Maas; Amsterdam/NL
Modern imaging in Colorectal Cancer . L.K. Blomqvist; Stockholm/SE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S. Barter; Cambridge/UK
Neuroradiology: from Morphology to Function . P.M. Parizel; Antwerp/BE
Modern Cardiac Imaging . . . . . . . . . . . . . . . . . . V.E. Sinitsyn; Moscow/RU ESR QUALITY, SAFETY AND
Diagnostic Urogenital Radiology . . . . . . . . . . . . H.C. Thoeny; Berne/CH STANDARDS COMMITTEE CHAIRPERSON
Interactive Teaching Sessions . . . . . . . . . . . . . . . . M.G. Mack; Munich/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E.J. Adam; London/UK
ESR PUBLICATIONS COMMITTEE CHAIRPERSON
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.E. Derchi, Genoa/IT
ESR SUBSPECIALTIES AND

ALLIED SCIENCES COMMITTEE CHAIRPERSON
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Owens; London/UK

ECR 2016 Committees
SCIENTIFIC SUBCOMMITTEES
ABDOMINAL AND GASTROINTESTINAL CARDIAC

The ESR would like to thank ESGAR for their cooperation on this subcommittee The ESR would like to thank the ESCR for their cooperation on this subcommittee
Chairpersons: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.A. Bali; Brussels/BE Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . F. Cademartiri; Rotterdam/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Laghi; Latina/IT
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Croisille; Saint-Etienne/FR
Abdominal Viscera . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Donato; Coimbra/PT
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.R. Ayuso; Barcelona/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Kallifatidis; Thessaloniki/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Blachar; Tel Aviv/IL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G.I. Kirova-Nedialkova; Sofia/BG
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Hatzidakis; Iraklion/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Loewe; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.A. Jackson; Plymouth/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .K. Nikolaou; Tübingen/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Karcaaltincaba; Ankara/TR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.J. Perea; Barcelona/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.C. Lauenstein; Essen/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Roditi; Glasgow/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Lewin-Zeitoun; Villejuif/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.D. Rud; St. Petersburg/RU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Manfredi; Verona/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Stolzmann; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Maniatis; Aabenraa/DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Urbanczyk-Zawadzka; Krakow/PL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Phoa; Amsterdam/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.M.A. van Ooijen; Groningen/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Staunton; Cork/IE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J. Venancio; Lisbon/PT CHEST
The ESR would like to thank ESTI for their cooperation on this subcommittee
GI Tract
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.-P. Revel; Paris/FR
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S. Aasen; Oslo/NO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Cappendijk; ‘s Hertogenbosch/NL
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Bakon; Warsaw/PL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Hoeffel; Reims/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Buckley; Dublin/IE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Kölblinger; Ried im Innkreis/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Devaraj; London/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U. Korman; Istanbul/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Frauenfelder; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Laniado; Dresden/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Hartmann; Rotterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Maksimović; Belgrade/RS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Karabulut; Denizli/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Ramalho; Almada/PT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Mershina; Moscow/RU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J. Rimola; Barcelona/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Persson; Linköping/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Terraz; Geneva/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Regier; Hamburg/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.J.M. Tolan; Leeds/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Sverzellati; Parma/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Weninger; Arvika/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Tack; Baudour/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Vilar; Valencia/ES
BREAST
The ESR would like to thank EUSOBI for their cooperation on this subcommittee
COMPUTER APPLICATIONS
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . C.S. Balleyguier; Villejuif/FR The ESR would like to thank EuSoMII for their cooperation on this subcommittee
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Regge; Turin/IT

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Bernathova; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Borbely; Budapest/HU
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Bricault; Grenoble/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E.J. Cornford; Nottingham/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. de Bruijne; Rotterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E.M. Fallenberg; Berlin/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Kotter; Freiburg/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .K. Kinkel; Chêne-Bougeries/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Morozov; Moscow/RU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Panizza; Milan/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Pokieser; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.M. Pijnappel; Utrecht/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Salvador; Barcelona/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.J. Pina Insausti; Pamplona/ES

ECR 2016 Committees
MOLECULAR IMAGING INTERVENTIONAL RADIOLOGY

The ESR would like to thank ESMOFIR for their cooperation on this subcommittee The ESR would like to thank CIRSE for their cooperation on this subcommittee
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X. Montet; Geneva/CH Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Filippiadis; Athens/GR
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Cyran; Munich/DE Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L. Crocetti; Pisa/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. de Jong; Rotterdam/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Denys; Lausanne/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Fanti; Bologna/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Dimopoulou; Uppsala/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L. Fournier; Paris/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Georgiades; Nicosia/CY
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.H. Helbich; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.K. Helmberger; Munich/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . W. Jaschke; Innsbruck/AT
GENITOURINARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. McDermott; Cork/IE
The ESR would like to thank ESUR for their cooperation on this subcommittee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G.J. Munneke; London/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Pellerin; Paris/FR
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Forstner; Salzburg/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B. Peynircioglu; Ankara/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.A.A.J. van den Bosch; Utrecht/NL
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.D. Alt; Düsseldorf/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Wojtaszek; Warsaw/PL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. De Visschere; Ghent/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Donati; Zurich/CH
MUSCULOSKELETAL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.L. Lobo; Lisbon/PT
The ESR would like to thank the ESSR for their cooperation on this subcommittee
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Nicolau; Barcelona/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Nikolic; Novi Sad/RS Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Maas; Amsterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Rørvik; Bergen/NO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Rouvière; Lyon/FR Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Alcalá-Galiano; Madrid/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Studniarek; Gdansk/PL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Andreisek; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.R. Torkzad; Milford/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Barile; L’Aquila/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Tsili; Ioannina/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Cyteval; Montpellier/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Valentino; Udine/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E.E. Drakonaki; Iraklion/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I.-M. Noebauer-Huhmann; Vienna/AT
HEAD AND NECK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.P. Parkar; Bergen/NO
The ESR would like to thank the ESHNR for their cooperation on this subcommittee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Robinson; Leeds/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Shahabpour; Brussels/BE
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Kohler; Sion/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . V. Vasilevska Nikodinovska; Skopje/MK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Vieira; Porto/PT
Members: . . . . . . . . . . . . . . . . . . . . . . . . J. Frühwald-Pallamar; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.-A. Weber; Heidelberg/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D. Haba; Iasi/RO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Koltowska; Wroclaw/PL
NEURO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Lell; Erlangen/DE
The ESR would like to thank the ESNR for their cooperation on this subcommittee
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Lo Casto; Palermo/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Loney; Darlington/UK Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.A. Yousry; London/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Steens; Nijmegen/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.-A. Varoquaux; Marseille/FR Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Calli; Izmir/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Dörfler; Erlangen/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Due-TØnnessen; Oslo/NO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Gerevini; Milan/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.A. Lucic; Sremska Kamenica/RS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Pierot; Reims/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Ramos; Madrid/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B.F. Schuknecht; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Surlan Popovič; Ljubljana/SI
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L. van den Hauwe; Antwerp/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.P. Wattjes; Amsterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Zlatareva; Sofia/BG

ECR 2016 Committees
PAEDIATRIC VASCULAR
The ESR would like to thank the ESPR for their cooperation on this subcommittee The ESR would like to thank CIRSE for their cooperation on this subcommittee
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Raissaki; Iraklion/GR Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.P. Lawler; Dublin/IE
Members: . . . . . . . . . . . . . . . . .S. Franchi-Abella; Le Kremlin-Bicêtre/FR Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Brisbois; Liège/BE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Hanquinet; Geneva/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Burrel; Barcelona/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.D. Humphries; London/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Engelke; Göttingen/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Kljucevsek; Ljubljana/SI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.N.M. Lohle; Tilburg/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G.M. Magnano; Genoa/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Melchiorre; Milan/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .H.-J. Mentzel; Jena/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Pfammatter; Zurich/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.A.J. Nievelstein; Utrecht/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Uberoi; Oxford/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Sorantin; Graz/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Vilares Morgado; Porto/PT
PHYSICS IN RADIOLOGY ONCOLOGIC IMAGING

The ESR would like to thank EFOMP for their cooperation on this subcommittee The ESR would like to thank ESOI for their cooperation on this subcommittee
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Beyer; Vienna/AT Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V.J. Goh; London/UK
Member: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.J. Caruana; Msida/MT Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Coenegrachts; Bruges/BE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Damilakis; Iraklion/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.J. Fütterer; Nijmegen/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .V. Gershan; Skopje/MK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Johnston; Dublin/IE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Gilligan; Dublin/IE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I.G. Lupescu; Bucharest/RO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Kachelrieß; Heidelberg/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.K. Prassopoulos; Alexandroupoli/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.J. Lurie; Aberdeen/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.E. Sundin; Stockholm/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Trianni; Udine/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G. Zamboni; Verona/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Zanca; Leuven/BE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C.J. Zech; Basle/CH
RADIOGRAPHERS EMERGENCY RADIOLOGY

The ESR would like to thank the EFRS for their cooperation on this subcommittee The ESR would like to thank ESER for their cooperation on this subcommittee
Chairpersons: . . . . . . . . . . . . . . . . . . . I.M. Björkman-Burtscher; Lund/SE Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Alkadhi; Zurich/CH

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Malamateniou; London/UK
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J.M. Artigas; Zaragoza/ES
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Bezzina; Msida/MT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Basilico; Chieti/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.J. Foley; Dublin/IE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F.H. Berger; Amsterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Mekiš; Ljubljana/SI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.B. Dormagen; Oslo/NO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Precht; Odense/DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Eklof; Uppsala/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Santos; Coimbra/PT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Ilves; Tartu/EE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .V. Syrgiamiotis; Athens/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Schouman-Claeys; Paris/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Wirth; Munich/DE

ECR 2016 Committees
ECR 2016 TOPIC COORDINATORS
E³ – EUROPEAN EXCELLENCE IN EDUCATION MINI COURSE
E³ – Rising Stars Programme: Joint Course of ESR and RSNA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Szczerbo-Trojanowska; Lublin/PL (Radiological Society of North America):
Case-Based Diagnosis Training . . . . . . . . . . . . K.M. Friedrich; Vienna/AT Emergency Radiology
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Robinson; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U. Linsenmaier; Munich/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Palkó; Szeged/HU
E³ – European Diploma Prep Sessions: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Smits; Rotterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Ertl-Wagner; Munich/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.J. Zagoria; San Francisco, CA/US
E³ – The Beauty of Basic Knowledge: MULTIDISCIPLINARY SESSIONS

Breast Imaging . . . . . . . . . . . . . . . . . . . . . J. Camps Herrero; Valencia/ES
Sports injuries:
Chest Imaging . . . . . . . . . . . . . . . . . . . N. Howarth; Chêne-Bougeries/CH
diagnosis and management . . . . . . . . . . . . . . . . . . M. Padrón; Madrid/ES
Pancreatic cancer:
E³ – ECR Academies:
radiological diagnosis and treatment . . . L. Grenacher; Heidelberg/DE
Modern imaging in Colorectal Cancer . L.K. Blomqvist; Stockholm/SE
Uterine myomas:
Neuroradiology:
radiological diagnosis and treatment . . . . . . . . . A.-M. Belli; London/UK
from Morphology to Function . . . . . . . . . . . . . P.M. Parizel; Antwerp/BE
Modern Cardiac Imaging . . . . . . . . . . . . . . . . . . V.E. Sinitsyn; Moscow/RU
PROS AND CONS SESSION
Diagnostic Urogenital Radiology . . . . . . . . . . . . H.C. Thoeny; Berne/CH
Interactive Teaching Sessions . . . . . . . . . . . . . . . . M.G. Mack; Munich/DE Risks and benefits
of reporting incidental findings . . . . . . . . S. Weckbach; Heidelberg/DE
E³ – Master Classes:
Abdominal and Gastrointestinal CLINICAL TRIALS IN RADIOLOGY
(ESGAR) . . . . . . . . . . . . . . . . M.A. Bali; Brussels/BE, A. Laghi; Latina/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Dewey; Berlin/DE
Breast (EUSOBI) . . . . . . . . . . . . . . . . . . . . . . C.S. Balleyguier; Villejuif/FR
Cardiac (ESCR) . . . . . . . . . . . . . . . . . . . . . F. Cademartiri; Rotterdam/NL
Chest (ESTI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.-P. Revel; Paris/FR
Molecular Imaging (ESMOFIR) . . . . . . . . . . . . . . . X. Montet; Geneva/CH
Genitourinary (ESUR) . . . . . . . . . . . . . . . . . . . . R. Forstner; Salzburg/AT
Head and Neck (ESHNR) . . . . . . . . . . . . . . . . . . . . . . . R. Kohler; Sion/CH
Interventional Radiology (CIRSE) . . . . . . . . . . D. Filippiadis; Athens/GR
Musculoskeletal (ESSR) . . . . . . . . . . . . . . . . . . . M. Maas; Amsterdam/NL
Neuro (ESNR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.A. Yousry; London/UK
Paediatric (ESPR) . . . . . . . . . . . . . . . . . . . . . . . . . M. Raissaki; Iraklion/GR
Vascular (CIRSE) . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.P. Lawler; Dublin/IE
Oncologic Imaging (ESOI) . . . . . . . . . . . . . . . . . . . . V.J. Goh; London/UK
Emergency Radiology (ESER) . . . . . . . . . . . . . . . . H. Alkadhi; Zurich/CH

Programme Overviews
Title
PROGRAMME
OVERVIEWS

Programme Overviews Programme Overviews Programme Overviews
WEDNESDAY, MARCH 2 WEDNESDAY, MARCH 2 WEDNESDAY, MARCH 2

E1 E2 F1 F2 ECR Online M1
A B C Z O N Studio 2016 L8 L2 D1 D2 G K M2 M3 M4 M5
Room/ Entrance Entrance Entrance Entrance & EPOS™ Room/ Entrance Room/
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level Lower Level Lower Level Lower Level Lower Level 1st Level 1st Level 1st Level 2nd Level
Time (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
Level Level Level Level (ACV) (ACV) (ACV) (ACV)
Lounge Time Level (M Building) (M Building) (M Building) (M Building)
Time
(ACV) (ACV) (ACV) (ACV) (EPOS™ Arena) (M Building)
E³ 121 RC 101 NH 1 RC 105 EuroSafe RC 110 RC 102 RC 104 RC 113 RC 111 RC 107 RC 106 RC 109 RC 117 E³ 126
08:30- E³ - ECR GI Tract New Horizons Computer Imaging Musculo- Breast Chest Physics in Neuro Genitourinary 08:30- Molecular Interventional Emergency E³ - ECR 08:30-
09:00 Academies: Assessing Session Applications Session 1 skeletal Breast Pneumonia Radiology Toxic brain Pitfalls in 09:00 Imaging Radiology Radiology Master Class 09:00
Interactive inflammation New frontiers Daily use Low-dose The elbow: a ultrasound Single-dual- disorders gynaecologic Molecular Image fusion Abdominal Cardiac CT
Teaching and fibrosis in imaging of of mobile research comprehen- 2016 multi-energy oncologic imaging: for image- trauma: does and new
09:00- Session in Crohn’s vascular wall devices in in medical sive approach CT imaging: how 09:00- what can we guided it bleed, interventions 09:00-
Head
09:30 ‘and neck
disease and plaque radiology radiation to avoid them 09:30 quantify? interventions will it start 09:30
protection and minimise bleeding or
cancer after risks is something
09:30- treatment: 09:30- else leaking? 09:30-
what you
10:00 need to know 10:00 10:00
VoE 1
10:00- The Voice of 10:00- 10:00-
10:30 EPOS™ 10:30 10:30
Abdominal/GI
E³ 221 SS 201a SS 202 SS 206 SS 201b SS 203a SY 1a SS 215 SS 210 SS 211a SS 216a SS 213 SS 204 SS 209 SS 214 SS 207 SS 208 SS 212 SS 203b SS 216b SS 211b
10:30- E³ - ECR Abdominal Breast Molecular Gastro- Cardiac Joint Satellite Vascular Musculo- Neuro Oncologic Physics in Chest Interventional Radiogra- Genitourinary 10:30- Head and Paediatric Cardiac Oncologic Neuro 10:30-
11:00 Academies: Viscera Breast biopsy Imaging intestinal Cardio- Symposium* Vasculopathy: skeletal Paediatric and Imaging Radiology Pulmonary Radiology phers Technical 11:00 Neck Brain and The evolving Imaging Gadolinium 11:00
Interactive Pancreas and PET/CT Tract myopathies form and Trauma and epilepsy Hepatocellular CT imaging: vessels and Ablation Radiog- advances Orbits and neck role of cardiac Advanced deposition
Teaching bile ducts and MR in A guided tour (1) function inflammation cancer: char- effects of perfusion outside the raphers’ VoE 2 olfaction CT imaging and trauma
11:00- Session oncology through the GI acterisation, body size liver education: the The Voice of 11:00- methods (2) 11:00-
11:30 Unexpected tract response and and use of curriculum EPOS™ 11:30 11:30
findings recurrence iterative Breast
on brain MRI reconstruction
11:30- 11:30- 11:30-
12:00 12:00 12:00
VoE 3
12:00- The Voice of 12:00- 12:00-
12:30 SY 1b EPOS™ 12:30 12:30
Joint Satellite Italian
E³ 24A Symposium* E³ 25A CTiR 1
12:30- E³ - The Beauty
SY 2 SY 3 SY 4
E³ - The Beauty Clinical Trials 12:30- 12:30-
Satellite Satellite Satellite
13:00 of Basic of Basic in Radiology 13:00 13:00
Knowledge: Symposium* Symposium* Symposium*
Knowledge:
Breast Imaging Chest Imaging VoE 4
13:00- Breast Useful signs The Voice of 13:00- 13:00-
ultrasound: in chest
13:30 a primer radiology
EPOS™ 13:30 13:30
Cardiac
13:30- 13:30- 13:30-

14:00 14:00 14:00
SS 301a SS 302 SS 305 SS 301b SS 303a SY 1c SS 315 SS 310 SS 311a SS 316 SS 313 SS 304 SS 309 SS 314 SS 307 VoE 5 SS 308 SS 312 SS 303b SS 311b SS 311c
14:00- Abdominal Breast Computer Gastro- Cardiac Joint Satellite Vascular Musculo- Neuro Oncologic Physics in Chest Interventional Radiogra- Genitourinary The Voice of 14:00- Head and Paediatric Cardiac Neuro Neuro 14:00-
14:30 Viscera Breast Applications intestinal Cardio- Symposium* Peripheral skeletal Cerebral Imaging Radiology Lung MRI Radiology phers Prostate EPOS™ 14:30 Neck Thorax and CT perfusion Dementia Neurovascular 14:30
Liver metas- innovation, Developing Tract myopathies arteries: Ultrasound tumours (1) Dealing with Radiation risk Musculo- CT parame- cancer: French Salivary musculoskeletal interventions
tases: biomarkers tools for Colon (2) imaging and metastatic assessment skeletal ters: juggling targeted glands, neck, (1)
14:30- detection, clinical therapy disease and or struggling? biopsy and 14:30- parathyroid 14:30-
15:00 characteri- workflow awareness” beyond 15:00 15:00
sation and management
treatment VoE 6
15:00- response The Voice of 15:00- 15:00-
15:30 assessment EPOS™ 15:30 15:30
Arabic
15:30- 15:30- 15:30-

16:00 16:00 16:00
E³ 426a NH 4 RC 412 RC 408 SY 1d RC 410 EuroSafe RC 416 RC 402 RC 404 RC 413 E³ 419 E³ 426b VoE 7 RC 415 RC 403 RC 409 RC 417 PS 427
16:00- E³ - ECR Mas- New Horizons Paediatric Head and Joint Satellite Musculoskel- Imaging Oncologic Breast Chest Physics in E³ - ECR E³ - ECR The Voice of 16:00- Vascular Cardiac Interventional Emergency Pros & Cons 16:00-
16:30 ter Class Session Chest imaging Neck Symposium* etal Session 2 Imaging Radio- Pulmonary Radiology Academies: Master Class EPOS™ 16:30 Basic Imaging of Radiology Radiology Session 16:30
A tour around Big data: in paediatrics Head and Bone trauma EuroSafe Evaluating pathological embolism Artefacts Neuroradiol- MR-targeted Chest principles of cardiac valves: Basic ‘Special Risks and
cholangiopa- why should neck imaging: in the axial Imaging lymph node correlation: - persistent and pitfalls in ogy: focal therapies varicose vein new trends principles of patients’ benefits of
16:30- thies radiologists don’t sell your skeleton: Alliance & involvement: more controversies tomography from Mor- for prostate 16:30- diagnosis and percutaneous in the reporting 16:30-
17:00 care? ultrasound patterns of Campaign - an impossible important phology to cancer 17:00 endovascular tumour emergency incidental 17:00
yet! injury what is new? task? than you Function treatment ablation room: when findings
and how I de- thought Functional MRI and how to
17:00- scribe them of the brain 17:00- image them? 17:00-
opens new
17:30 horizons
17:30 17:30
17:45–19:00 Room A: Opening Ceremony / Presentation of Honorary Members Technical Exhibition: EXPO First Level (Gallery): 14:00–17:00
Registration: Tuesday, March 1: 12:00–18:00 / Wednesday, March 2: 07:00–18:00 * Not CME accredited EPOS™ – Scientific Exhibition: 08:00–18:00
68 ECR 2016 | Final Programme www.myESR.org www.myESR.org Final Programme | ECR 2016 69 www.myESR.org
THURSDAY, MARCH 3 THURSDAY, MARCH 3 THURSDAY, MARCH 3

TODAY’S
HIGHLIGHTS
Time
E³ 521 RC 501 SF 5 RC 512 RC 508 PC 5 NH 5 RC 510 SA 5 RC 516 RC 504 RC 513 E³ 519 E³ - Rising E³ 526 RC 503 RC 509 MC 528 E³ 522
08:30- E³ - ECR Abdominal Special Focus Paediatric Head and Professional New Horizons Musculo- State of Oncologic Chest Physics in E³ - ECR Stars 08:30- E³ - ECR Cardiac Interventional Joint Course E³ - ECR 08:30-
09:00 Academies: Viscera Session Imaging of Neck Challenges Session skeletal the Art Imaging HRCT - Radiology Academies: Programme 09:00 Master Class Novel ways Radiology of ESR Academies: 09:00
Wednesday, March 2
Interactive The many Taking foetus and Pathways Session Imaging Inflammatory Symposium A multidis- patterns How to Neuroradiol Basic 1: Perfusion to assess Imaging and and RSNA: Diagnostic
Teaching faces of imaging to the infant for tumour Personalised beyond arthritis: Abdominal ciplinary in chest assess and ogy: from Neuroradiology: VoE 8 imaging myocardial endovascular Emergency Urogenital
09:00- Session benign cloud spread radiology: morphology beyond the diffusion- approach radiology: communicate Morphology Brain The Voice of 09:00- tissue treatment of Radiology Radiology 09:00-
09:30 Integrating liver lesions myth or radiograph weighted to prostate back to basics examination to Function EPOS™ 09:30 pulmonary Abdominal Retroperi- 09:30
diagnostic reality? imaging cancer: can and beyond risks to Advanced Head and embolism emergencies toneum and
tools (DWI): an we make a patients and imaging tech- Neck adrenals
Room A OPENING CEREMONY 09:30- in breast update difference? referring niques in brain 09:30- 09:30-
17:45–19:00 Prof. Donoso & Prof. Riklund 10:00 imaging physicians? tumours 10:00 10:00
officially open ECR 2016
VoE 9
Presentation of Honorary Members 10:00- The Voice of 10:00- 10:00-
Musical Entertainment by 10:30 EPOS™ 10:30 10:30
Martin Grubinger Emergency
E³ 621 SS 601a SS 602a SS 605 SS 601b SS 603 SS 607a SS 615 SS 610a SS 611 SS 616 SS 617 SS 602b SS 609 SS 610b E³ - Rising SS 608 SS 607b SS 604 MC 628 E³ 622
10:30- E³ - ECR Abdominal Breast Computer Gastro- Cardiac Genitourinary Vascular Musculo- Neuro Oncologic Emergency Breast Interventional Musculo- Stars 10:30- Head and Genitourinary Chest Joint Course E³ - ECR 10:30-
Room O NH 1 New frontiers in imaging of 11:00 Academies: Viscera Breast Applications intestinal Evolving Female pelvis Optimising skeletal Cerebrovascu- Imaging Radiology Breast Radiology skeletal Programme 11:00 Neck New frontiers: Spectral CT, of ESR Academies: 11:00
Interactive Chronic liver MRI: new Image Tract techniques vascular Body compo- lar disease (1) Advanced Cardiothoracic ultrasound Non-vascular Cartilage Basic 2: Pre- and urolithiasis advanced CT and RSNA: Diagnostic
08:30–10:00 vascular wall and plaque Teaching disease and sequences processing Multi- imaging sition imaging emergencies techniques in assessment Head and post-operative and renal analysis and Emergency Urogenital
VoE 10
11:00- Session primary liver and techniques modality techniques methods (1) the abdomen neck imaging The Voice of 11:00- imaging in function emphysema Radiology Radiology 11:00-
11:30 Cardiac CT: tumours applications (1) imaging of EPOS™ 11:30 oncology Chest Kidney 11:30
Room L8 EuroSafe Imaging Session 1 from Crohn’s Genitourinary emergencies
08:30–10:00 Low-dose research in medical stenosis disease
11:30- assessment 11:30- 11:30-
radiation protection to risk
12:00 12:00 12:00
stratification
Room D2 CTiR 1 Clinical Trials in Radiology VoE 11

12:00- The Voice of 12:00- 12:00-
12:30–13:30
12:30 HL 1 EPOS™ 12:30 12:30
Headline Chinese
Session E³ 24B SY 5 SY 6 SY 7 SY 8 E³ 25B CTiR 2 SY 10 SY 9 SY 11 SY 12
Room C NH 4 Big data: why should radiologists care? 12:30- E³ - The Beauty
Satellite Satellite Satellite Satellite E³ - The Beauty Clinical Trials Satellite Satellite 12:30- Satellite Satellite 12:30-
16:00–17:30 of Basic of Basic
13:00 Knowledge: RTF Quiz Symposium* Symposium* Symposium* Symposium* Knowledge: in Radiology Symposium* Symposium* 13:00 Symposium* Symposium* 13:00
Breast Imaging Radiology Chest Imaging
Cracking the Trainees How to avoid VoE 12
Room M 5 PS 427 Risks and benefits of reporting 13:00- mystery of Forum misdiagnosis The Voice of 13:00- 13:00-
13:30 needles and on the chest 13:30 13:30
16:00–17:30 incidental findings gauges x-ray
EPOS™
Oncology
13:30- 13:30- 13:30-

Room E2 EuroSafe Imaging Session 2
14:00 14:00 14:00
16:00–17:30 EuroSafe Imaging Alliance &
Campaign - what is new? E³ 721 SS 701a SS 702 SS 715 SS 701b ESOR EIBIR E³ - Rising SS 710 SS 711 SS 716 SS 713 SS 704 SS 717 SS 714 SS 707 VoE 13 SS 708 SS 701c SS 703 MC 728 E³ 722
14:00- E³ - ECR Abdominal Breast Vascular Gastro- Session Session 1 Stars Musculo- Neuro Oncologic Physics in Chest Emergency Radiogra- Genitourinary The Voice of 14:00- Head and Abdominal Cardiac Joint Course E³ - ECR 14:00-
14:30 Academies: Viscera Breast MRI- Endovascular intestinal Advancing Joint VPH- Programme skeletal Cerebrovascu- Imaging Radiology Lung cancer Radiology phers Prostate EPOS™ 14:30 Neck Viscera Epidemiology, of ESR Academies: 14:30
Interactive Functional DWI (1) therapies: Tract clinical PRISM/ Student Muscles lar disease (2) Whole body Innovations in Trauma of Quality issues cancer: Nordic Temporal Advances in CT prognosis and and RSNA: Diagnostic
Teaching imaging of what’s new? Advanced practice: ASSURE Session 1: imaging radiology the brain and in ultrasound routine and bone trials Emergency Urogenital
14:30- Session liver and imaging of the role of Session - from Breast body and CT novel MRI 14:30- Radiology Radiology 14:30-
15:00 Cardiac spleen oesophagus education screening techniques 15:00 CNS Emergencies 15:00
imaging and stomach to therapy: emergencies
innovative VoE 14
15:00- breast care The Voice of 15:00- 15:00-
15:30 concepts EPOS™ 15:30 15:30
Russian
15:30- 15:30- 15:30-

16:00 16:00 16:00
E³ 821 RC 801 SF 8a ESR Working RC 808 PC 8a E³ - Rising RC 810 MS 8 PC 8b SF 8b SF 8c SF 8d E³ 819 VoE 15 RC 815 RC 803 RC 809 MC 828 E³ 822
16:00- ACR Session 16:00- 16:00-
E³ - ECR GI Tract Special Focus Group on Head and Professional Stars Musculo- Multidiscipli- Professional Special Focus Special Focus Special Focus E³ - ECR Delivering The Voice of Vascular Cardiac Interventional Joint Course E³ - ECR
16:30 Academies: CT Session Ultrasound Neck Challenges Programme skeletal nary Session Challenges Session Session Session Academies: higher value EPOS™ 16:30 Carotid artery Imaging of Radiology of ESR Academies: 16:30
Interactive colonography Common Minimising Paediatric: Session Student Sports injuries Pancreat- Session Assessing Imaging in CT radiation Neuroradiol care in radiol- Abdominal/GI disease: heart failure Current trends and RSNA: Diagnostic
Teaching today mistakes in the risk of how we do Clinical Session 2: to the knee: ic cancer: An myocardium obesity dose ogy: from ogy: how to so what’s in transarterial Emergency Urogenital
16:30- Session breast transmitting head and neck decision Neuro improving my radiological introduction at-risk with optimisation: Morphology make it work 16:30- new? chemoemboli- Radiology Radiology 16:30-
17:00 Evaluation of imaging infections imaging in support (CDS) report diagnosis and to European MRI are we doing to Function in clinical 17:00 sation (TACE) General Upper and 17:00
practice -
patients with through children treatment Imaging enough? Cerebral blood and radioem- principles: lower urinary
perspectives
lung ultrasound: Biomarker flow quantifi- from the bolisation for paediatric tract
17:00- emphysema is current Alliance cation American 17:00- HCC and ENT 17:00-
17:30 practice (EIBALL) College of 17:30 emergencies 17:30
sufficient? Radiology
Registration: 07:30–18:00 Technical Exhibition: EXPO First Level (Gallery): 10:00–17:00
EPOS™ – Scientific Exhibition: 08:00–18:00 * Not CME accredited Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00
FRIDAY, MARCH 4 FRIDAY, MARCH 4 FRIDAY, MARCH 4

TODAY’S
HIGHLIGHTS
Time
E³ 921 RC 901 RC 912 E³ 920 PC 9a E³ - Rising PC 9b SF 9c RC 916 SF 9a RC 904 RC 914 E³ 919 EF 1 RC 906 RC 915 SF 9b RC 917 E³ 922
08:30- E³ - ECR Abdominal Paediatric E³ - ECR Professional Stars Professional Special Focus Oncologic Special Focus Chest Radiogra- E³ - ECR EFOMP 08:30- Molecular Vascular Special Focus Emergency E³ - ECR 08:30-
09:00 Academies: Viscera Hepatobiliary Academies: Challenges Programme Challenges Session Imaging Session Low dose phers Academies: Workshop: 09:00 Imaging Fixing a leaky Session Radiology Academies: 09:00
Radiation
Thursday, March 3
Interactive Hepatocellular imaging Modern Car- Session Student Session Brain hy- Diffusion- Breast and no-dose State-of-the- Neuroradiol Preclinical EVAR Imaging in the Acute pain: Diagnostic
Protection for
Teaching tumours in children diac Imaging Biobanks Session 3: Radiology ten persignals weighted density: how chest imaging: art breast ogy: from VoE 16 imaging as a presence of your friend Urogenital
09:00- the female 09:00- 09:00-
Session How to meet imaging Abdominal years from after repeated imaging (DWI) not to be opportunities imaging Morphology patient and The Voice of driver for orthopaedic and enemy in Radiology
09:30 Diagnostic quantify the and Gastroin- now: where gadolinium in oncology: confused? and limitations to Function female medi- EPOS™ 09:30 translational hardware emergency Gynaecology 09:30
evaluation of haemodynam- testinal will it be? administra- how I do it Functional cal staff Head and research: how radiology
bone tumours ic significance tions imaging of the Breast imag- Neck I do it
Room A WILHELM CONRAD RÖNTGEN 09:30- ing modalities 09:30- 09:30-
of coronary spine
12:15–12:45 HONORARY LECTURE 10:00 stenosis and radiation 10:00 10:00
Imaging the invisible killer: towards dose
personalisation of ovarian cancer care VoE 17
Andrea G. Rockall; London/UK 10:00- The Voice of 10:00- 10:00-
10:30 EPOS™ 10:30 10:30
Interventional
Room L8 NH 5 Imaging beyond morphology E³ 1021 EM 1 SS 1002 SS 1015 SS 1001a SS 1003 SS 1011a E³ - Rising SS 1010a SS 1011b SS 1016 SS 1001b SS 1004 SS 1009 SS 1014 EF 2 SS 1008 SS 1012 SS 1006 SS 1010b E³ 1022
10:30- E³ - ECR ESR meets Breast Vascular Gastro- Cardiac Neuro Stars Musculo- Neuro Oncologic Abdominal Chest Interventional Radiogra- EFOMP 10:30- Head and Paediatric Molecular Musculo- E³ - ECR 10:30-
08:30–10:00 11:00 Academies: the Nordic Breast MRI- Thoracic intestinal CT of the Neurovascular Programme skeletal Cerebrovascu- Imaging Viscera Imaging Radiology phers Workshop: 11:00 Neck Abdominal Imaging skeletal Academies: 11:00
Interactive Countries DWI (2) and aorta: novel Tract coronary interventions Student Oncology lar disease (3) Prostate and Hepatocellular methods: Liver ablation High dose Radiation Maxillofacial and foetal Advanced Hip and Diagnostic
Teaching Mammogra- various MRI imaging and Rectal cancer: arteries (2) Session 4: renal tract carcinoma: something antidotes Protection for VoE 18 imaging imaging hybrid shoulder Urogenital
Room E2 SA 5 Abdominal diffusion-weighted 11:00- Session phy in Nordic applications interventions staging and Student cancers: evaluation of old, the female The Voice of 11:00- imaging in Radiology 11:00-
08:30–10:00 imaging (DWI): an update 11:30 Emergency countries: restaging Projects advanced therapeutic something patient EPOS™ 11:30 oncology Prostate 11:30
radiology I screening and detection response new and female Musculo-
new develop- methods medical staff skeletal
Studio 2016 PC 5 Personalised radiology: 11:30- ments Pregnancy 11:30- 11:30-
12:00 and lactation 12:00 12:00
08:30–10:00 myth or reality?
VoE 19
12:00- The Voice of 12:00- 12:00-
Room D2 CTiR 2 Clinical Trials in Radiology
12:30 HL 2 MIR @ ECR EPOS™ 12:30 12:30
12:30–13:30 Headline Session 1 Turkish
Session E³ 24C SY 13 SY 14 SY 15 SY 16 SY 17 E³ 25C Commu- SY 19 SY 18 SY 20
12:30- E³ - The Beauty Satellite Satellite Satellite Satellite Joint Satellite E³ - The Beauty nication in Satellite Satellite 12:30- Satellite 12:30-
Room Z RTF Quiz 13:00 of Basic Symposium* Symposium* Symposium* Symposium* Symposium* of Basic radiology Symposium* Symposium* 13:00 Symposium* 13:00
12:30–13:30 Knowledge: Knowledge:
Breast Imaging Chest Imaging VoE 20
13:00- Breast cancer Reporting The Voice of 13:00- 13:00-
staging: chest radiology
Studio 2016 PC 8a Clinical Decision Support (CDS) 13:30 made easy
EPOS™ 13:30 13:30
why and how Neuro
16:00–17:30
13:30- 13:30- 13:30-
14:00 14:00 14:00
Room F1 PC 8b An introduction to European Imaging
16:00–17:30 Biomarkers Alliance (EIBALL) IIQ EM 4 SY 21 SY 22 SY 23 EIBIR MIR @ ECR SY 24 VoE 21 SY 25 Joint Session
14:00- Image EFRS meets Satellite Satellite Satellite Session 2 Session 2 Satellite The Voice of 14:00- Satellite of the ESR 14:00-
14:30 Interpretation Sweden Symposium* Symposium* Symposium* MITIGATE: Improving Symposium* EPOS™ 14:30 Symposium* and ESMRMB 14:30
Room E2 MS 8 Pancreatic cancer: Quiz The What does quality and Spanish Cardiac MRI
16:00–17:30 radiological diagnosis and treatment Imaging with professional it take to safety
14:30- the stars role of perform in radiology 14:30- 14:30-
15:00 Swedish clinical trials in 15:00 15:00
radiographers interventional
Room O ESR Working Group on Ultrasound in medical radiology? VoE 22
Minimising the risk of transmitting
16:00–17:30 15:00- imaging The Voice of 15:00- 15:00-
infections through ultrasound: 15:30 EPOS™ 15:30 15:30
is current practice sufficient? Japanese
15:30- 15:30- 15:30-

16:00 16:00 16:00
E³ 1221 Joint Session E³ 1218 EDiR talk RC 1212 E³ 1220 RC 1207 EIBIR RC 1210 RC 1216 PC 12a RC 1204 MIR @ ECR RC 1211 E³ - Rising VoE 23 EuroSafe E³ 1226a E³ 1226b E³ 1226c PC 12b
16:00- E³ - ECR of the ESR E³ - ECR What you Paediatric E³ - ECR Genitourinary Session 3 Musculo- Oncologic Professional Chest Session 3 Neuro Stars The Voice of 16:00- Imaging E³ - ECR E³ - ECR E³ - ECR Professional 16:00-
16:30 Academies: and the Academies: should know Key issues Academies: MRI for Gateway to skeletal Imaging Challenges Occupational Improving Cerebrovascu- Programme EPOS™ 16:30 Session 3 Master Class Master Class Master Class Challenges 16:30
Interactive EANM Modern about the in paediatric Modern gynaecologic European Systemic New insights Session lung diseases: radiology lar disease Basic 3: Genitourinary Joint Session Interventional Expanding Whole body Session
Teaching Hybrid Imaging in EDiR imaging Cardiac imaging: how funding for disease: in bone Compre- the known departments Interventional of the ESR radiology for horizons in CT in trauma How to
16:30- Session imaging: Colorectal Imaging I do it research what to look tumour hensive and the less radiology: 16:30- and HERCA: deep venous paediatric patients become the 16:30-
17:00 Use of radiology Cancer Essentials projects for in the imaging cardiothoracic known tumour 17:00 the new EU- thrombosis imaging undergradu- 17:00
staging and and nuclear Rectal cancer: of modern musculoskele- radiology: the ablation BSS Directive (DVT): ready ate teacher
classification medicine update on imaging tal system way to go? - a step for prime you always
17:00- systems organ saving in cardiac 17:00- forward to time? wanted to be 17:00-
17:30 treatments diseases 17:30 patient safety 17:30
SATURDAY, MARCH 5 SATURDAY, MARCH 5 SATURDAY, MARCH 5

TODAY’S
HIGHLIGHTS
Time
E³ 1321 RC 1301 E³ 1318 SF 13a RC 1312 RC 1308 RC 1307 ESR-PAG 1 SF 13b SF 13c E³ 1323 RC 1302 SF 13d RC 1314 RC 1311 E³ - Rising
08:30- E³ - ECR Abdominal E³ - ECR Special Focus Paediatric Head and Genitourinary ESR Patient Special Focus Special Focus E³ - European Breast Special Focus Radiogra- Neuro Stars 08:30- 08:30-
09:00 Academies: Viscera Academies: Session Imaging Neck Lessons I Advisory Group Session Session Diploma Prep Tailoring Session phers Reporting the Programme 09:00 09:00
Friday, March 4
Interactive IgG4-related Modern MR/PET: role children with Pitfalls in learned from Patient-centred Cholangio- Non-alcoholic Session breast cancer Severe trauma Enhancing degenerative Basic 4:
Teaching disease: what Imaging in in oncology cancer interpretation mistakes in care in clinical carcinoma: fatty liver Cardiac and screening to patients: research in lumbar spine Musculo- VoE 24
09:00- Session is it and what Colorectal of kidney and radiology: do an update disease vascular risk level myths, radiography: a skeletal: The Voice of 09:00- 09:00-
09:30 MR imaging do I need to Cancer head and neck adrenal we really put (NAFLD) realities and change trauma EPOS™ 09:30 09:30
in sports know? Colon cancer: disease imaging our patients future of culture Neuro
medicine I staging and first?
Room A JOSEF LISSNER HONORARY LECTURE 09:30- restaging of 09:30- 09:30-
12:15–12:45 Liver imaging: where do we stand now? 10:00 local disease 10:00 10:00
Valérie Vilgrain; Clichy/FR
VoE 25
10:00- The Voice of 10:00- 10:00-
10:30 EPOS™ 10:30 10:30
Studio 2016 PC 9a Biobanks meet imaging Breast
08:30–10:00 E³ 1421 EM 2 SS 1402a SS 1406 TF 1 RC 1405 SS 1407 ESR-PAG 2 SS 1410 SS 1411a E³ 1423 SS 1401 SS 1404 SS 1409 SS 1414 E³ - Rising SS 1408 SS 1416 SS 1415 SS 1411b SS 1402b
10:30- E³ - ECR ESR meets Breast Molecular Radiology Computer Genitourinary ESR Patient Musculo- Neuro E³ - European Abdominal Chest Interventional Radiogra- Stars 10:30- Head and Oncologic Vascular Neuro Breast 10:30-
11:00 Academies: Japan Screening Imaging Trainees Applications Multi- Advisory Group skeletal Cerebrovascu- Diploma Prep Viscera Chest CT dose Radiology phers Programme 11:00 Neck Imaging Pulmonary Cerebral Contrast- 11:00
Room E1 PC 9b Radiology ten years from now: Interactive State-of-the- Advanced Forum Will the good parametric MR Mind the gap - Applications lar disease (4) Session Advances in reduction Intra-arterial Safety and Basic 5: Thyroid Pelvic and vasculature: tumours (2) spectral mam-
08:30–10:00 where will it be? Teaching art radiology experimental Highlighted old PACS of prostate data-sharing in CT and MR: Head and abdominal therapies in patient care Neuroradiology: VoE 26 nodules breast cancer new and mography and
11:00- Session imaging Lectures disappear? cancer: an for better something neck MRI the liver in medical spine The Voice of 11:00- improved MRI update in 11:00-
11:30 Skull base update patient old, some- imaging EPOS™ 11:30 background 11:30
lesions outcomes - thing new Paediatric parenchymal
Room B EM1 ESR meets the Nordic Countries
the key issues enhancement
10:30–12:00 Mammography in Nordic countries: 11:30- for patients and 11:30- 11:30-
screening and new developments 12:00 the radiology 12:00 12:00
community
VoE 27
Room B EM 5 EFRS meets Sweden (European 12:00- The Voice of 12:00- 12:00-
14:00–15:30 Federation of Radiographer Societies) 12:30 HL 3 EPOS™ 12:30 12:30
The professional role of Swedish Headline German
Session E³ 24D SY 26 SY 27 SY 28 SY 29 E³ 25D SY 30
radiographers in medical imaging 12:30- E³ - The Beauty
Satellite Satellite Satellite Satellite E³ - The Beauty Satellite 12:30- 12:30-
of Basic of Basic
13:00 Knowledge: Symposium* Symposium* Symposium* Symposium* Symposium* 13:00 13:00
Breast Imaging Knowledge:
Room A IIQ IMAGE INTERPRETATION QUIZ Ductal carci- Chest Imaging VoE 28
13:00- noma in situ Measurements 13:00- 13:00-
14:00–15:30 Imaging with the stars (DCIS): small The Voice of
13:30 in chest EPOS™ 13:30 13:30
tumour but big
problem radiology Musculo-
Room F2 PC 12a Comprehensive cardiothoracic EIBIR skeletal
13:30- Session 4 13:30- 13:30-
16:00–17:30 radiology: the way to go?
14:00 The VPH- 14:00 14:00
DARE@IT
E³ 1521 SF 15 E³ 1518 Project: deliv- E³ 1526 E³ 1520 Joint Session E³ - Rising RC 1510 SA 15 E³ 1523 RC 1502 RC 1504 RC 1514 RC 1511 RC 1513 VoE 29 SS 1503 SS 1501 SS 1515 SS 1511 SS 1502
Room M 5 PC 12b How to become the undergraduate 14:00- E³ - ECR Special Focus E³ - ECR ering a clinical E³ - ECR E³ - ECR of the ESR Stars Musculo- State of E³ - European Breast Chest Radiogra- Neuro Physics in The Voice of 14:00- Cardiac Abdominal Vascular Neuro Breast 14:00-
16:00–17:30 teacher you always wanted to be 14:30 Academies: Session Academies: decision sup- Master Class Academies: and ERS Programme skeletal the Art Diploma Prep Update on Mediastinal phers White spots in Radiology EPOS™ 14:30 Interventional Viscera New Multiple Breast 14:30
Interactive Head Modern port platform Fire and ice Modern Imaging Student Final Shoulder MRI: Symposium Session BI-RADS disease Innovative the brain IT tools for Korean applications Liver fibrosis: observations sclerosis density: an
Imaging in
Teaching and neck for earlier outside the Cardiac of airways: Session mastering Endovascular Gynaeco- revisited education in dose tracking imaging in visceral update
Colorectal
Room B Joint Session of the ESR and the 14:30- Session radiology: Cancer dementia liver Imaging what the technique and abdominal logical and medical and workflow 14:30- assessment imaging and 14:30-
16:00–17:30 EANM (European Association of 15:00 Genitourinary from Colorectal diagnosis Myocardial respirologist making my re- aneurysm obstetrics imaging optimisation 15:00 therapy 15:00
and gastro- symptoms to cancer: syn- charac- needs to know port relevant repair (EVAR):
Nuclear Medicine) intestinal diagnosis chronous and terisation: where do we VoE 30
Hybrid imaging: radiology and nuclear 15:00- radiology metachronous established stand now? The Voice of 15:00- 15:00-
medicine metastases modalities vs
15:30 EPOS™ 15:30 15:30
new ones Portuguese
15:30- 15:30- 15:30-

16:00 16:00 16:00
E³ 1621 RC 1601 E³ 1618 Joint Session Joint Session E³ 1620 MS 16a EuroSafe MS 16b SF 16 E³ 1623 RC 1602 E³ 1626 RC 1614 RC 1611 RC 1613 VoE 31
16:00- E³ - ECR Abdominal E³ - ECR of the ESR of the ESR, E³ - ECR Multidiscipli- Imaging Multidiscipli- Special Focus E³ - European Breast E³ - ECR Radiogra- Neuro Physics in The Voice of 16:00- 16:00-
16:30 Academies: Viscera Academies: and ESTRO EFSUMB and Academies: nary Session Session 4 nary Session Session Diploma Tomosyn- Master Class phers Update on Radiology EPOS™ 16:30 16:30
Interactive The spleen: Modern MRI and ESPR Modern Uterine You too can Sports injuries: Prostate MRI: Prep Session thesis: the Less common Safety issues endovascular MR: artefacts Interventional
Teaching the forgotten Imaging in MR/PET in Contrast Cardiac myomas: definitely do diagnosis increasing Interventional new mam- infiltrative in medical stroke and devices
16:30- Session organ Colorectal radiation enhanced Imaging radiological audits and need? mography lung diseases imaging treatment: 16:30- 16:30-
17:00 Emergency Cancer treatment ultrasound Cardiac diagnosis and management a medical 17:00 17:00
radiology II Rectal cancer: planning - (CEUS) in imaging: treatment breakthrough?
staging and challenges paediatrics to new
17:00- restaging local and horizons 17:00- 17:00-
17:30 disease opportunities 17:30 17:30
SUNDAY, MARCH 6 SUNDAY, MARCH 6 NOTES

TODAY’S
HIGHLIGHTS
E1 E2 F1 F2 ECR Online
A B C Z O N Studio 2016 L8 L2 D1 D2 G K
Room/ Entrance Entrance Entrance Entrance & EPOS™ Room/
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level 1st Level 1st Level 1st Level Lower Level Lower Level Lower Level Lower Level
Lounge Time
(ACV) (ACV) (ACV) (ACV) (EPOS™ Arena)
E³ 1721 RC 1701 Joint Session PC 17 E³ 1726a RC 1707 SA 17 SF 17a E³ 1726b E³ 1726c SF 17b RC 1714 E³ 1726d E³ - Rising
08:30- E³ - ECR Abdominal of the ESR Professional E³ - ECR Genitourinary State of Special Focus E³ - ECR E³ - ECR Special Focus Radiogra- E³ - ECR Stars 08:30-
09:00 Academies: Viscera and ESHI Challenges Master Class Prostate the Art Session Master Class Master Class Session phers Master Class Programme 09:00
Challenging
Saturday, March 5
Interactive Differential Medical hybrid Session Characterisa- imaging: how Symposium Neuro Personalised Actionable The magic Imaging in Basic 6:
Teaching diagnosis in imaging European tion of salivary I do it Emergency imaging in medicine questions for pulmonary of excellent dementia Thoracic VoE 32
09:00- breast imag- 09:00-
Session pancreatic variation in gland masses imaging of paediatrics in oncology: nodules: images emergencies The Voice of
ing in 2016:
09:30 MR imaging in imaging imaging: focus the pregnant what can breast density, should we rely EPOS™ 09:30
sports on technology patient imaging offer? how to solve on size only? Vascular
medicine II the non-mass
Room A SVEN-IVAR SELDINGER 09:30- enigma, new 09:30-
12:15–12:45 HONORARY LECTURE 10:00 developments 10:00
in breast MRI
Imaging and micronavigation:
VoE 33
time to redraw the map? 10:00- The Voice of 10:00-
Staffan Holmin; Stockholm/SE 10:30 EPOS™ 10:30
Oncology
E³ 1826 EM 3 SS 1802 SS 1805 PC 18 SS 1803 SS 1816 SS 1815 SS 1810 SS 1811 E³ 1823 SS 1813 SS 1804 SS 1809 SS 1814 SS 1807
Room B EM 3 ESR meets Japan 10:30- E³ - ECR ESR meets Breast Computer Professional Cardiac Oncologic Vascular Musculo- Neuro E³ - European Physics in Chest Interventional Radiogra- Genitourinary 10:30-
10:30–12:00 State-of-the-art radiology 11:00 Master Class Colombia Digital breast Applications Challenges MR (1) Imaging Abdominal skeletal Spine Diploma Prep Radiology COPD and Radiology phers Tumours of 11:00
MSK and From practice tomosyn- Image Session Gastrointes- aortic Ligaments, Session Practical infiltrative Peri- and Getting the the urinary
intervention to reality: thesis: an processing Monitoring tinal cancer: and other tendons and Paediatric radiation risk lung diseases postprocedur- radiation dose tract and VoE 34
11:00- how we do it update techniques (2) safety and prediction and aneurysms joints management al imaging as low as adrenals The Voice of 11:00-
Room A JIIQ JUNIOR IMAGE INTERPRETATION QUIZ
11:30 quality assessment possible EPOS™ 11:30
12:55–13:55 Millennials showdown: of therapeutic Cardiac
the next generation of radiology response
11:30- 11:30-
12:00 12:00
Room E2 SA 15 Endovascular abdominal aneurysm
14:00–15:30 repair (EVAR): where do we stand now? VoE 35
12:00- The Voice of 12:00-
12:30 EPOS™ 12:30
Chest
Studio 2016 Joint Session of the ESR and ERS E³ 24E E³ 25E
ESR General
14:00–15:30 (European Respiratory Society) 12:30- E³ - The Beauty Assembly
E³ - The Beauty 12:30-
of Basic of Basic
Imaging of airways: what the 13:00 Knowledge: Knowledge: 13:00
respirologist needs to know Breast Imaging Chest Imaging
High-risk CBDT Dose optimisa-
13:00- lesions: tion made easy 13:00-
E³ - Rising in computed
13:30 solving the 13:30
Studio 2016 MS 16a Uterine myomas: radiological dilemma
Stars tomography of
Programme the chest
16:00–17:30 diagnosis and treatment Case-Based
13:30- Diagnosis 13:30-
14:00 Training 14:00
Room E1 MS 16b Sports injuries: Part 1
16:00–17:30 diagnosis and management SS 1902a SS 1901a SS 1902b SS 1905 SS 1901b SS 1903 SS 1916 SS 1907 13:00–14:00 SS 1911 E³ 1923 SS 1913 SS 1904 SS 1909 SS 1914
14:00- Breast Abdominal Breast Computer Abdominal Cardiac Oncologic Genitourinary ––––– Neuro E³ - European Physics in Chest Interventional Radiogra- 14:00-
14:30 Multiparamet- Viscera Preoperative Applications Viscera MR (2) Imaging Imaging of the Cased-Based Movement Diploma Prep Radiology Computer- Radiology phers 14:30
Room Z Joint Session of the ESR and ESTRO ric breast MRI, Benign and imaging, Quality Abdominal Assessment reproductive Training disorders and Session Physics of based Endovascular How to im-
PET malignant neoadjuvant control and surgery: the and prediction Interlude
16:00–17:30 (European Society for Radiotherapy system neurode- Urogenital dual-energy quantification prove image
14:30- pancreatic chemother- safety issues added value of treatment 14:00–14:30 generative CT and breast and texture quality in 14:30-
and Oncology) –––––
15:00 diseases apy, imaging in radiology of radiology response diseases imaging analysis MRI and mam- 15:00
MRI and MR/PET in radiation of the axilla Case-Based mography
treatment planning – challenges and Diagnosis
opportunities 15:00- Training 15:00-
15:30 Part 2 15:30
14:30–15:30
Room O Joint Session of the ESR, EFSUMB
15:30- 15:30-
16:00–17:30 (European Federation of Societies for
16:00 16:00
Ultrasound in Medicine and Biology)
and ESPR (European Society of
Paediatric Radiology) 16:00- 16:00-
Contrast enhanced ultrasound (CEUS) 16:30 16:30
in paediatrics
16:30- 16:30-
17:00 17:00
17:00- 17:00-
17:30 17:30
EPOS™ – Scientific Exhibition: 08:00–15:30 Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–14:00
TODAY’S New eLearning Platform
HIGHLIGHTS
Sunday, March 6
Room E1 SA 17 Emergency imaging of the
08:30–10:00 pregnant patient
Room O PC 17 European variation in imaging:

08:30–10:00 focus on technology
Room F1 E3 1726b Personalised medicine in oncology:

08:30–10:00 what can imaging offer?
Room C Joint Session of the ESR and ESHI

08:30–10:00 (European Society for Hybrid Medical
Imaging)
Medical hybrid imaging
Room B EM 4 ESR meets Colombia

10:30–12:00 From practice to reality: how we do it
Room O PC 18 Monitoring safety and quality

10:30–12:00
Room E1 CBDT Case-Based Diagnosis Training

13:00–15:30 Special programme for residents and
general radiologists
EDUCATION ON DEMAND
learn.myESR.org
SCIENTIFIC
PROGRAMME
Please note that sessions are marked with a logo to indicate their
classification according to the European Training Curriculum.
First three years of training
Fourth and fifth years of training

(general radiologist standard)
Subspecialty training standard
ESR/EFRS meets Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81

New Horizons Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
State of the Art Symposia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
Special Focus Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
Professional Challenges Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Multidisciplinary Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
European Excellence in Education (E3) . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
Rising Stars Programme. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
European Diploma Prep Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
The Beauty of Basic Knowledge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
ECR Academies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
ECR Master Classes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
Mini Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
Pros & Cons Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
The Voice of EPOS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
Refresher Courses / Scientific Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . 143
79
80
ESR/EFRS MEETS
SESSIONS
Once again, the ESR will welcome a number of guest countries to the
ECR as part of the ‘ESR meets’ programme.
The national radiological societies of Colombia, Japan, and the Nordic

countries, will present their most recent scientific developments
in joint sessions with the ESR, and try to strengthen links between
professionals from different countries and disciplines. The European
Federation of Radiographer Societies (EFRS) will also host its own
‘meets’ session for radiographers, in conjunction with representatives
of the Swedish Society of Radiographers.
Both the ESR and the EFRS warmly welcome these societies and hope
to see ECR delegates attend the sessions in large numbers.
81
Programme by Session Type
ESR/EFRS MEETS SESSIONS
4
March Friday, March 4, 10:30–12:00, Room B
5
March Saturday, March 5, 10:30–12:00, Room B
ESR meets the Nordic Countries ESR meets Japan
EM 1 Mammography in Nordic countries: EM 2 State-of-the-art radiology
screening and new developments
Presiding: K. Riklund; Umea/SE
Presiding: K. Riklund; Umea/SE H. Honda; Fukuoka/JP
M. Gardarsdottir; Reykjavik/IS » Welcome by the ESR President
G. Hagen; Oslo/NO L. Donoso Bach; Barcelona/ES
K.R. Nielsen; Copenhagen/DK
» Introduction: Radiology today in Japan [A-570]
H. Ståhlbrandt; Eksjö/SE
H. Honda; Fukuoka/JP
R.L. Vanninen; Kuopio/FI
» State-of-the-art of neuroimaging [A-571]
» Welcome by the ESR President
S. Aoki; Tokyo/JP
L. Donoso Bach; Barcelona/ES
» Interlude: Radiologist’s intermission:
» Introduction [A-384]
refreshing photo-stream on our beautiful country (I)
[A-572]
» Mammography screening in Denmark: Y. Miki; Osaka/JP
implementation and results [A-385]
» Advanced liver imaging: improving treatment
I. Vejborg; Copenhagen/DK
decisions [A-573]
» Performing MRI preoperatively in all breast cancer T. Murakami; Osaka/JP
patients in Iceland: is it worthwhile? [A-386]
» Interlude: Radiologist’s intermission:
M. Gardarsdottir; Reykjavik/IS
refreshing photo-stream on our beautiful country (II)
» Breast density, risk for breast cancer and how to [A-574]
personalise screening: what are the future breast T. Taoka; Nagoya/JP
imaging modalities? [A-387]
» Diagnostic imaging of thymic tumours [A-575]
S. Zackrisson; Malmö/SE
N. Tomiyama; Osaka/JP
» Interval cancers in population-based screening
» Panel discussion: Always be a pioneer:
programmes [A-388]
state-of-the-art technologies from Japan
S.R. Hoff; Aalesund/NO
» New developments in MRI and MR image analysis of
breast cancer [A-389] 6
March Sunday, March 6, 10:30–12:00, Room B
J. Hakumäki; Kuopio/FI
ESR meets Colombia
EM 3 From practice to reality:
4
March Friday, March 4, 14:00–15:30, Room B how we do it
EFRS meets Sweden
Presiding: K. Riklund; Umea/SE
(European Federation of Radiographer Societies)
F.G. Lubinus; Bucaramanga/CO
EM 4 The professional role of Swedish
» Welcome by the ESR President
radiographers in medical imaging
Presiding: H
.H. Hjemly; Oslo/NO
F.G. Lubinus; Bucaramanga/CO
K. Hillergård; Jönköping/SE
» The law of radiology in Colombia:
» Introduction [A-405, A-406]
how we arrived to it [A-780]
H.H. Hjemly; Oslo/NO
R. Restrepo; Medellin/CO
K. Hillergård; Jönköping/SE
» Interlude: The history of radiology in Colombia
» The Swedish radiographer as a professional [A-407]
B.T. Andersson; Lund/SE » Percutaneous biopsies: how do I do it? [A-781]
F. Uriza; Bogota/CO
» Implementation of a caring approach within the
Swedish radiography programme [A-408] » Interlude: Colombia, magical realism
M. Lundén; Gothenburg/SE » Minor interventional procedures in tropical diseases
» Implementation of a research process and quality [A-782]
improvement within the Swedish radiography A. Morillo; Bogota/CO
programme [A-409] » Panel discussion: Minimally-invasive procedures: is
K. Fridell; Stockholm/SE there a place for the non-interventional radiologists?
» Cultural highlights [A-410]
G. Örnberg; Umeå/SE
» Panel discussion

NEW HORIZONS
SESSIONS
The New Horizons Sessions aim to provide practitioners with an

overview of the new developments in a specific area of practice,
whether it is a subspecialty, a particular technique, or certain diseases.
These developments may become routine within a few years, or may
indicate a new direction for research and clinical application.
Each session is 90 minutes long and features an introduction from a
chairman, followed by three or four brief presentations on different
aspects of the main subject, and concluded by a panel discussion that
will hopefully answer some critical questions.
83
NEW HORIZONS SESSIONS
2
March Wednesday, March 2, 08:30–10:00, Room O
3
March Thursday, March 3, 08:30–10:00, Room L8
NH 1 New frontiers in imaging of vascular NH 5 Imaging beyond morphology
wall and plaque
» Chairman’s introduction [A-149]
» Chairman’s introduction: How to use the tools? [A-007] O. Clément; Paris/FR
C. Loewe; Vienna/AT » MRI fingerprinting: the future? [A-150]
» Molecular imaging for MR [A-008] S. Trattnig; Vienna/AT
M.R. Makowski; Berlin/DE » Receptor-targeted multimodal imaging [A-151]
» New insights using nuclear and hybrid imaging [A-009] M. de Jong; Rotterdam/NL
J. Knuuti; Turku/FI » Radiomics [A-152]
» Ultrasound elastography: how useful can it be? [A-010] L.S. Fournier; Paris/FR
N. Liasis; Athens/GR » Panel discussion: Imaging biomarkers:
» New options with CT [A-011] a key role for radiologists in the future?
A. Persson; Linköping/SE
» Panel discussion: Predictive role of imaging in the
evolution of atherosclerosis: where do we stand?
2
March Wednesday, March 2, 16:00–17:30, Room C
NH 4 Big data: why should
radiologists care?

M. Dewey; Berlin/DE
» Big data: big science [A-066]
G. Zanetti; Pula/IT
» Big data: big business [A-067]
B.J. Hillman; Charlottesville, VA/US
» Big data: what’s in it for the patient? [A-068]
M.M. Hunink; Rotterdam/NL
» Panel discussion: How to make best use of big data?

STATE OF THE ART
SYMPOSIA
These sessions will inform the audience about the ‘real state of the art’
of a given subject. Each of the lecturers is an expert on the given topic
as a whole or on a specific aspect of the topic.
The 90-minute sessions are chaired by a moderator who will introduce

three to four speakers addressing various issues within wider subjects
such as anatomical regions, specific diseases, or particular techniques.
The presentations will be followed by a discussion conducted by the
panellists, led by the chairman.
85
STATE OF THE ART SYMPOSIA
3
March Thursday, March 3, 08:30–10:00, Room E2
6
March Sunday, March 6, 08:30–10:00, Room E1
SA 5 Abdominal diffusion-weighted imaging SA 17 Emergency imaging
(DWI): an update of the pregnant patient
» Chairman’s introduction [A-157] » Chairman’s introduction [A-743]

L. Martí-Bonmatí; Valencia/ES R. Basilico; Chieti/IT
» Technical advances: the many faces of DWI [A-158] » Polytrauma: US, CT or MR [A-744]
N. Papanikolaou; Iraklion/GR A. Palkó; Szeged/HU
» Biliary ducts and pancreas: main advantages in » Pulmonary embolism: CT or scintigraphy? [A-745]
clinical practice [A-159] M.-P. Revel; Paris/FR
C. Matos; Lisbon/PT » MRI and contrast media:
» Small bowel: main advantages in clinical practice what are the risks for the foetus? [A-746]
[A-160] M. Wozniak; Lublin/PL
S.A. Taylor; London/UK » Ionising radiation: when should we be concerned?
» Panel discussion: Should we do it qualitative or [A-747]
quantitatively? J. Damilakis; Iraklion/GR
» Panel discussion with sample cases presentation:
5
March Saturday, March 5, 14:00–15:30, Room E2
Emergency in pregnancy: what is best for the mother
and baby?
SA 15 Endovascular abdominal
aneurysm repair (EVAR):
where do we stand now?

T. Rand; Vienna/AT
» Endovascular versus open surgical repair:
what do we know so far? [A-632]
D.K. Tsetis; Iraklion/GR
» The role of imaging in preoperative
planning and follow-up [A-633]
F. Rengier; Heidelberg/DE
» Implantation techniques and long-term results
[A-634]
R. Uberoi; Oxford/UK
» Imaging and treatment of endoleaks [A-635]
M. Gschwendtner; Linz/AT
» Panel discussion: The key role of the radiologist
in endovascular abdominal aortic aneurysm repair

SPECIAL FOCUS
SESSIONS
The concept of a Special Focus Session is to deal with a topic at the

cutting edge of development and clinical application.
A traditional approach is inappropriate for such a session, which should
reflect the lecturers’ forthright personal views on a developing subject.
The topics of these sessions should be presented in such a
way as to promote debate and give an in-depth analysis.
The chairman will introduce each aspect of the topic and the panellists will
then discuss their different perspectives and opinions. The audience will
have the opportunity to discuss their ideas with the lecturers.
Session length: 90 minutes; three to four speakers.
87
SPECIAL FOCUS SESSIONS
3
March Thursday, March 3, 08:30–10:00, Room C
3
March Thursday, March 3, 16:00–17:30, Room D1
SF 5 Taking imaging to the cloud SF 8c Imaging in obesity

J. Reponen; Raahe/FI S. Lee; Manchester/UK
» How does it work? [A-135] » Epidemiology and current trends in obesity [A-279]
J. Fernandez-Bayó; Sabadell/ES N. Finer; London/UK
» What are the benefits? [A-136] » Fat quantification and advanced body composition
E.R. Ranschaert; ‘s-Hertogenbosch/NL assessment using MRI [A-280]
» What are the applications of cloud O. Dahlqvist Leinhard; Linkoping/SE
in radiology? [A-137] » Imaging of modern surgical procedures and
O. Ratib; Geneva/CH their complications [A-281]
» Panel discussion: Will cloud computing be the future M. Rengo; Latina/IT
of image storage? » Is there a role for bariatric embolisation
in the treatment of the obese patient? [A-282]
C. Weiss; Baltimore, MD/US
3
March Thursday, March 3, 16:00–17:30, Room C » Panel discussion: How best to manage obesity and
SF 8a Common mistakes its implications on the radiology department
in breast imaging
3
G. Forrai; Budapest/HU SF 8d CT radiation dose optimisation:
» Common mistakes in mammography [A-244] are we doing enough?
E.J. Cornford; Nottingham/UK
» Common mistakes in second-look ultrasound » Chairmen’s introduction [A-283, A-284]
after MRI [A-245] I.M. Björkman-Burtscher; Lund/SE
P.A.T. Baltzer; Vienna/AT C. Malamateniou; London/UK
» Common mistakes in breast MRI [A-246] » CT radiation dose optimisation: what has been
F. Pediconi; Rome/IT achieved so far? [A-285]
J. Santos; Coimbra/PT
» Panel discussion: How to avoid common mistakes
in breast imaging? » Dose reduction techniques in paediatric CT:
from A to Z [A-286]
E. Sorantin; Graz/AT
3
March Thursday, March 3, 16:00–17:30, Room F2 » Challenges and opportunities in CT dose
optimisation: what can we do in the future? [A-287]
SF 8b Assessing myocardium S.J. Foley; Dublin/IE
at-risk with MRI
» Panel discussion: What are the suggested priorities
and actions for CT dose optimisation?
» T2 imaging [A-275] 4
March Friday, March 4, 08:30–10:00, Room F2
M. Gutberlet; Leipzig/DE
SF 9a Breast density:
» Late gadolinium enhancement [A-276]
how not to be confused?
S. Kozerke; Zurich/CH
» Prognostic value of area-at-risk assessment by T2 and
late enhancement imaging [A-277]
E. Azavedo; Stockholm/SE
A. de Roos; Leiden/NL
» The mammographic dense breast [A-344]
» Panel discussion: How do we best assess at-risk
F.J. Gilbert; Cambridge/UK
myocardium and how do we best get the correct
information across? » The ultrasound dense breast [A-345]
L.J. Pina Insausti; Pamplona/ES
» The MRI dense breast [A-346]
P.A.T. Baltzer; Vienna/AT
» Panel discussion: How to overcome the dense breast
in screening?

4
March Friday, March 4, 08:30–10:00, Room M 3
5
March Saturday, March 5, 08:30–10:00, Room Z
SF 9b Imaging in the presence SF 13a MR/PET: role in oncology
of orthopaedic hardware
» Chairman’s introduction [A-371] G. Cook; London/UK
M. Zanetti; Zurich/CH » Principles and possibilities of MR/PET [A-515]
» Optimising CT for imaging metalwork [A-372] A. Kjaer; Copenhagen/DK
M.-A. Weber; Heidelberg/DE » MR/PET: imaging head and neck cancer [A-516]
» What problems do metalwork cause for MRI and how S. Bisdas; London/UK
can we solve them? [A-373] » MR/PET: imaging prostate cancer [A-517]
J.V. Dehem; Ypres/BE A.J. Beer; Ulm/DE
» Imaging prosthetic joint infection: traditionally » MR/PET: imaging of GI cancer [A-518]
problematic, but do we have the answers now? V.J. Goh; London/UK
[A-374]
» Panel discussion: Which clinical indications have enough
F. Kainberger; Vienna/AT
evidence for routine MR/PET rather than PET/CT?
» Panel discussion: What is the imaging modality
of choice after plain films in the presence of
orthopaedic hardware? 5
SF 13b Cholangiocarcinoma:
4
March Friday, March 4, 08:30–10:00, Room E2 an update
SF 9c Brain hypersignals after repeated
gadolinium administrations R. Manfredi; Verona/IT
» Classification of cholangiocellular carcinoma (CCC)
[A-536]
V. Runge; Berne/CH
C. Cantwell; Dublin/IE
» Chemistry of Gd chelates and fundamentals
» Imaging in mass-forming intrahepatic (IH) type [A-537]
in toxicity [A-335]
F. Caseiro-Alves; Coimbra/PT
S. Aime; Turin/IT
» Diagnostic assessment of periductal/infiltrating
» Recent literature review [A-336]
and intraductal-growing types:
A. Radbruch; Heidelberg/DE
the view of the diagnostic radiologist [A-538]
» Hypersignals in the brain: which clinical impact [A-337] R. Kloeckner; Mainz/DE
T. Yousry; London/UK
» Diagnostic assessment of periductal/infiltrating
» Recent FDA and EMA undertakings in the matter [A-338] and intraductal-growing types:
O. Clément; Paris/FR the view of the interventional radiologist [A-539]
» Panel discussion: Gadolinium injections: S. Terraz; Geneva/CH
should we change our practice? » Therapeutic role of interventional radiology
in unresectable patients [A-540]
G. Carrafiello; Varese/IT
» Panel discussion: Can we improve diagnosis and
treatment of cholangiocarcinoma?
5
SF 13c Non-alcoholic fatty liver disease
(NAFLD)
» Chairman’s introduction:
Defining the clinical problem [A-541]
C. Bartolozzi; Pisa/IT
» Imaging in diagnosing and quantifying liver fat [A-542]
V. Vilgrain; Clichy/FR
» Imaging in diagnosing and staging liver fibrosis [A-543]
L. Martí-Bonmatí; Valencia/ES
» Early detection of HCC [A-544]
T. Denecke; Berlin/DE
» Panel discussion: How to manage the surveillance
of the population at risk

5
March Saturday, March 5, 08:30–10:00, Room D1
6
SF 13d Severe trauma patients: SF 17a Neuro imaging in paediatrics
myths, realities and future
» Chairman’s introduction [A-552] A. Rossi; Genoa/IT
M. Stajgis; Poznan/PL » Imaging of metabolic disorders in children [A-749]
» ‘When time is gold’: whole-body CT in polytrauma B. Ertl-Wagner; Munich/DE
patients [A-553] » Imaging in paediatric epilepsy [A-750]
S. Wirth; Munich/DE T.A.G.M. Huisman; Baltimore, MD/US
» Where is the proper place for fast FAST (focused » Imaging headache in children [A-751]
assessment with sonography for trauma)? [A-554] E. Vázquez; Barcelona/ES
H. Alkadhi; Zurich/CH
» Panel discussion: Can we do without CT in paediatric
» Missed lesions in trauma patients: neuroimaging?
the Damocles’ sword [A-555]
R. Basilico; Chieti/IT
» Geriatric trauma: what is different? [A-556] 6
March Sunday, March 6, 08:30–10:00, Room D1
E. Dick; London/UK
SF 17b Actionable pulmonary nodules:
» Panel discussion: How is the role of the radiologist should we rely on size only?
changing in the management of trauma patients?
5
L. Bonomo; Rome/IT
» Limitations of nodule measurements [A-759]
SF 15 Head and neck radiology: A.R. Larici; Rome/IT
from symptoms to diagnosis » Shape and density: predictors of subtypes and
mutations in NSCLC? [A-760]
» Chairman’s introduction [A-608] O.L. Sedlaczek; Heidelberg/DE
B. Verbist; Leiden/NL
» Proliferation tracers and not only [A-761]
» Tinnitus [A-609] R. Boellaard; Amsterdam/NL
M.M. Lemmerling; Ghent/BE
» How necessary is clinical data? [A-762]
» Stuffy and runny nose [A-610] A.A. Bankier; Boston, MA/US
S. Colley; Birmingham/UK
» Panel discussion: How to define an actionable nodule
» Sore throat [A-611] in daily practice?
D. Farina; Brescia/IT
» Lumps of the infrahyoid neck [A-612]
M.G. Mack; Munich/DE
» Panel discussion: To what extent do symptoms guide
your imaging approach and interpretation?
5
SF 16 Prostate MRI: increasing need?

J.C. Vilanova; Girona/ES
» MRI before the first prostate biopsy:
has the time come? [A-695]
B. Hamm; Berlin/DE
» The role of prostate MRI in active surveillance [A-696]
A.R. Padhani; London/UK
» Is prostate MRI accurate enough for focal treatment
planning? [A-697]
V. Panebianco; Rome/IT
» Panel discussion: Does the use of MRI improve the
outcome in prostate cancer?

PROFESSIONAL
CHALLENGES
SESSIONS
The idea of these sessions is to communicate and exchange

information on professional issues related to radiology, such as training
and education, research networking, radiological management and
professional developments.
90-minute sessions; introduction by one or two chairmen; three to four

lecturers; panel discussion.
91
3
March Thursday, March 3, 08:30–10:00, Studio 2016
3
March Thursday, March 3, 16:00–17:30, Room F1
PC 5 Personalised radiology: PC 8b An introduction to European Imaging
myth or reality? Biomarkers Alliance (EIBALL)

C.J. Herold; Vienna/AT P.M. Parizel; Antwerp/BE
» Personalised imaging in practice: a myth? [A-145] » EIBALL and its mission [A-270]
F.J. Gilbert; Cambridge/UK S. Trattnig; Vienna/AT
» Personalised imaging and standardised protocols: » The potential role of EIBALL for EORTC
a contradiction? [A-146] multicentre trials [A-271]
S.O. Schönberg; Mannheim/DE Y. Liu; Brussels/BE
» En route to personalised imaging: the role of » The organisational role of EIBIR in EIBALL [A-272]
multidisciplinary conferences [A-147] V. Vilgrain; Clichy/FR
J.A. Verschakelen; Leuven/BE » Imaging biomarker development for EIBALL
» From personalised to precision imaging: by subspecialty societies [A-273]
impact on clinical practise [A-148] K. Nikolaou; Tübingen/DE
G.P. Krestin; Rotterdam/NL » Panel discussion:
» Panel discussion: How to enhance personalised What is the role of EIBALL now and in the future?
radiology in clinical routine
4 Friday, March 4, 08:30–10:00, Studio 2016

3
March
PC 9a Biobanks meet imaging

PC 8a Clinical decision support (CDS)
Moderators: E. Neri; Pisa/IT
» Chairman’s introduction [A-255] M. Pasterk; Graz/AT
L. Donoso Bach; Barcelona/ES » How does Biobanking and BioMolecular resource
» What is a clinical decision support system? Research Infrastructur - European Research
[A-256] Infrastructure Consortium (BBMRI-ERIC) work?
F. Sardanelli; San Donato Milanese/IT [A-324]
J.-E. Litton; Graz/AT
» Imaging referral guidelines in Europe [A-257]
M.G.M. Hunink; Rotterdam/NL » Patient rights: data overprotection? [A-325]
M.T. Mayrhofer; Graz/AT
» An effective clinical decision support system [A-258]
G. Boland; Boston, MA/US » What is the difference between a PACS and a clinical
bank of radiological images? [A-326]
» Cost-effectiveness of clinical decision support
A. van der Lugt; Rotterdam/NL
[A-259]
P. Mildenberger; Mainz/DE » Population-based cohort biobanks:
accessing large European prospective cohorts
» Panel discussion: Is CDS really adding value to
through the biobanking infrastructure BBMRI -
healthcare in addition to radiation safety?
large prospective cohorts (LPC) [A-327]
This session is part of the EuroSafe Imaging campaign. O. Törnwall; Graz/AT
» Population-based cohort: image banks [A-328]
F. Bamberg; Tübingen/DE
» What are ontologies? [A-329]
B. Gibaud; Rennes/FR

4
March Friday, March 4, 08:30–10:00, Room E1
6
March Sunday, March 6, 08:30–10:00, Room O
PC 9b Radiology ten years from now: PC 17 European variation in imaging:
where will it be? focus on technology

C.D. Becker; Geneva/CH G. Frija; Paris/FR
» Expanding radiology with new multidisciplinary » PACS and eHealth [A-732]
competencies [A-331] D. Caramella; Pisa/IT
J.A. Reekers; Amsterdam/NL » Reporting and communication [A-733]
» Potential synergies between radiology and pathology O. Ratib; Geneva/CH
[A-332] » Procedure codes and lexica in radiology for
R.H. Oyen; Leuven/BE supporting workflow improvements [A-734]
» The beauty of general radiology [A-333] P. Mildenberger; Mainz/DE
G.H. Mostbeck; Vienna/AT » Equipment and innovation [A-735]
» Panel discussion: What are the leadership challenges B. Brkljačić; Zagreb/HR
for the next decade? » Panel discussion:
What is the European vision on imaging technology?
4
PC 12a Comprehensive cardiothoracic
6
radiology: the way to go? PC 18 Monitoring safety and quality
» Chairman’s introduction: A perspective from both » Chairmen’s introduction [A-783, A-784]

worlds: cardiac and thoracic imaging [A-465] G. Frija; Paris/FR
E.J.R. van Beek; Edinburgh/UK A. Torresin; Milan/IT
» Challenges and opportunities [A-466] » Experience of total management of quality
A. de Roos; Leiden/NL and safety [A-785]
» Perspectives from thoracic imaging [A-467] L. Oleaga Zufiría; Barcelona/ES
M. Rémy-Jardin; Lille/FR » Dose monitoring systems in CT [A-786]
» Perspectives from cardiac imaging [A-468] D. Caramella; Pisa/IT
J. Bremerich; Basle/CH » Experience from a group of imaging centres [A-787]
» Panel discussion: How to best increase our impact on A. Palkó; Szeged/HU
this interdisciplinary field? » Dose monitoring systems in interventional
radiology [A-788]
A. England; Salford/UK
4 Friday, March 4, 16:00–17:30, Room M 5
March » Panel discussion: What are the bottlenecks in safety
PC 12b How to become the and quality management?
undergraduate teacher you This session is part of the EuroSafe Imaging campaign.
always wanted to be
» Chairmen’s introduction [A-499, A-500]

S.J. Golding; Oxford/UK
M. Maas; Amsterdam/NL
» The undergraduate curriculum: how to get the
balance right [A-501]
B. Ertl-Wagner; Munich/DE
» Teaching methods’ top tips: how you can capture and
maintain your students’ attention [A-502]
C. Nyhsen; Sunderland/UK
» Online resources: how to find the best case material
and tutorials for your medical students [A-503]
P. Pokieser; Vienna/AT
» Using social media for undergraduate education:
this generation’s communication [A-504]
N. Pyatigorskaya; Paris/FR
» Panel discussion: Teaching the undergraduate:
in what ways is this similar to teaching radiology to
other groups and in what ways does it differ?
= Interactive session with electronic voting/self assessment

Activities 2016
Visiting Schools
Visiting Seminars
ESOR Courses for EDiR
Scholarship Programmes
Fellowship Programmes
Visiting Professorship
Programmes
Online Courses
Tutorials
myESR.org/esor
Education in partnership
MULTIDISCIPLINARY
SESSIONS
The concept of these sessions is to promote a multidisciplinary

approach to detection and treatment, integrating radiologists and
other clinicians to share their expertise.
95
MULTIDISCIPLINARY SESSIONS
3
MS 8 Pancreatic cancer: radiological
diagnosis and treatment

L. Grenacher; Munich/DE
» Surgical oncological management [A-265]
J. Werner; Munich/DE
» Medical oncological management [A-266]
D. Jäger; Heidelberg/DE
» Radiology oncological management [A-267]
» Radiation oncological management [A-268]
F. Sterzing; Heidelberg/DE
» Multidisciplinary case presentation and discussion
5
March Saturday, March 5, 16:00–17:30, Studio 2016
MS 16a Uterine myomas: radiological

A.-M. Belli; London/UK
» Imaging of fibroids [A-682]
R. Das; London/UK
» Epidemiology, clinical presentation and non
radiological therapeutic options for the treatment
of fibroids [A-683]
I. Manyonda; London/UK
» Radiological treatments for fibroids [A-684]
» Multidisciplinary case discussion
5
MS 16b Sports injuries:
diagnosis and management

M. Padrón; Madrid/ES
» What does the radiologist offer? [A-690]
C. Faletti; Turin/IT
» How I face a sport injury:
the sport physician’s approach [A-691]
J.-M. Alonso; Doha/QA
» The physiotherapist’s view [A-692]
A. Zerolo; Madrid/ES
» The surgeon’s perspective [A-693]
M. Leyes; Madrid/ES
» Multidisciplinary case presentation and discussion:
Which practice help and which hinder the team
approach to managing the injured athlete?
How can we improve on this?

EUROPEAN
EXCELLENCE IN
EDUCATION (E³)
The E³ programme emphasises the importance of lifelong learning.
It covers the entire range of educational issues, from undergraduate

medical education to subspecialised continuing professional
development.
For the second time at ECR 2016, the E³ programme is structured

according to the different levels defined by the European Training
Curriculum for Radiology.
The E³ programme consists of the following five branches, which

reflect the different levels of education in radiology, as well as the
different stages of an individual’s professional career:
Rising Stars Programme

European Diploma Prep Sessions
The Beauty of Basic Knowledge
ECR Academies
ECR Master Classes
97
European Board of Radiology
Take the
European Diploma in Radiology
EDiR
YOUR PASSPORT
TO A BETTER CAREER
Next Exam:
July 1, 2016 (Barcelona, Spain)
First EDiR with the new examination structure!
www.myEBR.org
diploma@myEBR.org
E3
RISING STARS
PROGRAMME
The Rising Stars Programme is designed especially for residents,

students, radiographers and trainee radiographers.
It consists of Basic Sessions, Student Sessions,

Case-Based Diagnosis Training sessions, and the
Radiology Trainees Forum Programme including the
RTF Highlighted Lectures and the RTF Quiz.
99
ESR Learning Centre
Passeig de Gràcia, 86, planta 8
HOST YOUR COURSE,
08008 Barcelona
Spain
SEMINAR OR
WORKSHOP IN AN
www.esrlearningcentre.com
ESR LEARNING CENTRE
For more information including rates,
please contact learningcentre@myESR.org
ESR Learning Centre

Neutorgasse 9
1010 Vienna
Austria
www.esrlearningcentre.com
E3 – RISING STARS PROGRAMME
BASIC SESSIONS
Special sessions suitable for residents, students,
radiographers and radiographers-in-training
3
March Thursday, March 3, 08:30–10:00, Room K
5
March Saturday, March 5, 08:30–10:00, Room K
Basic Session 1: Basic Session 4:
Neuroradiology: brain Musculoskeletal: trauma
» White matter disorders [A-174] » Shoulder [A-562]

A. Rovira-Cañellas; Barcelona/ES M. Zanetti; Zurich/CH
» Tumours [A-175] » Knee [A-563]
J. Walecki; Warsaw/PL K. Verstraete; Ghent/BE
» Stroke [A-176] » Ankle [A-564]
E.T. Tali; Ankara/TR J. Kramer; Linz/AT
3
5
Head and neck imaging Neuroradiology: spine
» Orbit [A-202] » Anatomy and congenital disorders [A-593]

P.C. Maly Sundgren; Lund/SE A. Rossi; Genoa/IT
» Ear [A-203] » Tumours [A-594]
B. Verbist; Leiden/NL M.M. Thurnher; Vienna/AT
» Sinuses [A-204] » Degenerative disease of the spine [A-595]
R. Maroldi; Brescia/IT M. Sasiadek; Wroclaw/PL
4
March Friday, March 4, 16:00–17:30, Room K
6
March Sunday, March 6, 08:30–10:00, Room K
Interventional radiology: tumour ablation Thoracic emergencies
» Kidney [A-477] » Vascular [A-768]

K. Katsanos; London/UK R. Morgan; London/UK
» Liver [A-478] » Pulmonary [A-769]
L. Crocetti; Pisa/IT C.M. Schaefer-Prokop; Amersfoort/NL
» Bones [A-479] » Cardiac [A-770]
A. Gangi; Strasbourg/FR C. Loewe; Vienna/AT

STUDENT SESSIONS
Students will present their work
3
3
Student Session 1: Student Session 2:
Breast Neuro
» Magnetic resonance spectroscopy and its potential to » Altered brain activation in cortical-subcortical and
identify neoadjuvant chemotherapy non-responders pyramydal white matter stroke patients during hand
in triple negative breast cancer patients motion: functional MRI study
M.A. Chiorean; Cluj-Napoca/RO O. Omelchenko; Kyiv/UA
» What’s lurking in the corner? Extra-mammary » Diffusion tensor imaging as a potential biomarker
findings on breast MRI, frequency and relevance in prognosticating neurocognitive outcome in mild
R. Hayden; Dublin/IE traumatic brain injury: evidence of altered structural
» The challenge of breast imaging in young: connectivity
when to proceed to biopsy? V. Veeramuthu; Kuala Lumpur/MY
A. Hatw; Cairo/EG » Diagnostic accuracy of MR imaging techniques for
» Results of quality control of three digital breast treatment response assessment in patients with high
tomosynthesis systems in the clinical environment grade glioma: a systematic review and meta-analysis
A. Rodriguez Ruiz; Madrid/ES B.R.J. van Dijken; Winsum/NL
» Incidentally detected enhancing lesions found » Osseous pseudoprogression in vertebral bodies

in preoperative breast MRI: analysis of apparent treated with stereotactic radiosurgery
diffusion coefficient and T2 signal intensity C. Beaman; TX/US
significantly improves classification accuracy » CSF flow quantification by MRI: a diagnostic tool
O.H. Arponen; Kuopio/FI in normal pressure hydrocephalus
» Background parenchymal enhancement and breast J. Shanks; Uppsala/SE
density on preoperative breast MRI: correlation with » Alcohol consumption during adolescence
tumour characteristics and size estimation is associated with reduced volumes of anterior
M. Pizzato; Turin/IT cingulate cortex and insula
» Is a one-year follow-up an efficient method for better N. Heikkinen; Kuopio/FI
management of MRI BI-RADS® 3 lesions? » Cerebellum enlargement in 4-6-month-old infants
C. Ziadé; Bordeaux/FR at high familial risk of autism spectrum disorders
» Stereotactic vacuum-assisted breast biopsy: I. Pote; London/UK
comparison between 11- and 8-gauge needles » Do genetic effects really influence frequent anatomic
I. Ruggirello; Florence/IT variations of intra- and extracranial arteries?
B. Forgo; Budapest/HU

STUDENT SESSIONS
Students will present their work
4
March Friday, March 4, 08:30–10:00, Room L8
4
Student Session 3: Student Session 4:
Abdominal and Gastrointestinal Student Projects
» Abdominal tumours beyond the classical framework » Flipping our learning: a blended story about
A.S. Yancheva; Varna/BG alternative methods to improve study skills among
» Multiparametric magnetic resonance in the medical students
assessment of the normal pancreas T.I. Adam; Cluj-Napoca/RO
N. Gennaro; Perugia/IT » Sharing my passion for neuroradiology through
» Age dependence of spleen- and muscle-corrected a workshop for medical students interested in
hepatic signal enhancement on hepatobiliary phase neurosurgery
gadoxetate MRI S. Abu Arif; Cluj-Napoca/RO
S. Matoori; Zurich/CH » A new educational project in Radiology:
» Detection of appendicitis using 99mTc- the concept of cross-sectional knowledge
antigranulocyte antibodies F. Serpi; Milan/IT
J. Petrovic; Belgarde/RS » Involving medical students in the Breast Unit:
» Transarterial drug-eluting beads chemoembolization a university project aiming healthcare quality and
for patients with liver tumours, single center educational achievements
experience M. Morellá; Murcia/ES
R. Skumbiņš; Riga/LV » Beyond images: a radiology educational platform
» Diffusion-weighted MRI in rectal cancer: for medical students
apparent diffusion coefficient for discriminating M. Saftencu; Cluj-Napoca/RO
recurrence from scar-tissue » The H.E.A.R.T. Project: a students’ approach on
S. Grosu; Freiburg/DE providing support for personal and professional
» Measurement of interstitial volume to assess development of European medical students
abdominal organ amyloid burden using quantitative S. Curcean; Agnita/RO
equilibrium contrast enhanced CT » A review of thyroid sonographic features and
S. Sivarajan; London/UK international guidelines: ability to differentiate
» Measuring two target lesions: how representative benign and malignant nodules
are selected target lesions of all liver metastases? A. Weir; Limerick/IE
F.O. Hofmann; Munich/DE » Internship dissertation: comparative study
of integrative neural networks implemented
in modal and tonal auditory stimulation of brain with
functional MRI of activation and diffusion tensor
J.-B. Billaud; Villejuif/FR
5
March Saturday, March 5, 14:00–15:30, Room L8
Student Final Session
Programme to be announced

RADIOLOGY TRAINEES CASE-BASED DIAGNOSIS TRAINING

FORUM PROGRAMME Special programme for residents and general radiologists
3
March Thursday, March 3, 12:30–13:30, Room Z
6
RTF Quiz CBDT I Case-Based Diagnosis Training - Part I

Moderator: J. Cáceres; Barcelona/ES
Moderators: K.M. Friedrich; Vienna/AT
S. Robinson; Vienna/AT
5 Saturday, March 5, 10:30–12:00, Room O
March » Liver [A-796]
TF Highlighted Lectures
R L. Martí-Bonmatí; Valencia/ES
» Neuro [A-797]
Moderators: M. Basta-Nikolic; Novi Sad/RS D. Prayer; Vienna/AT
D. Berritto; Naples/IT
» Maxillofacial [A-798]
» Imaging of prostate cancer [A-576] S. Robinson; Vienna/AT
S. Stojanovic; Novi Sad/RS
» Musculoskeletal [A-799]
» Rectal cancer: tips for a better staging [A-577] F. Kainberger; Vienna/AT
L. Curvo-Semedo; Coimbra/PT
» Breast [A-800]
» Intestinal ischaemia: key points for the radiologist [A-578] M.H. Fuchsjäger; Graz/AT
R. Grassi; Naples/IT
6
Interlude: Know your calcifications!
[A-801, A-802]
W. Drahanowsky; Vienna/AT
6
CBDT II Case-Based Diagnosis Training - Part II

Moderators: K.M. Friedrich; Vienna/AT

» Head and neck [A-807]
C. Czerny; Vienna/AT
» Chest [A-808]
H. Prosch; Vienna/AT
» Spine [A-809]
K.M. Friedrich; Vienna/AT
» Gastrointestinal [A-810]
W. Schima; Vienna/AT
» Genitourinary [A-811]
M. Toepker; Vienna/AT

E3
EUROPEAN DIPLOMA
PREP SESSIONS
The European Diploma Prep Sessions aim to prepare prospective

candidates for the European Diploma in Radiology (EDiR).
They are also suitable for residents who want an overview of the
various topics relevant to imaging and for those preparing for their
national board examinations.
The content of the programme reflects Level I European Training

Curriculum (ETC) learning objectives across a two-year cycle. The
sessions are held in close cooperation with the European Board of
Radiology (EBR).
Each of the six sessions is led by three lecturers and moderated

by one chairman.
105
E3 – EUROPEAN DIPLOMA PREP SESSIONS
5
March Saturday, March 5, 08:30–10:00, Room F1
6
March Sunday, March 6, 10:30–12:00, Room F1
E³ 1323 Cardiac and vascular E³ 1823 Paediatric

R. Vliegenthart; Groningen/NL V. Donoghue; Dublin/IE
A. Cardiovascular imaging: the basics [A-546] A. Paediatric neuro imaging [A-790]
M. Gutberlet; Leipzig/DE M.I. Argyropoulou; Ioannina/GR
B. Cardiovascular imaging: valves, endocardium B. Paediatric chest imaging [A-791]
and aorta [A-547] C. Owens; London/UK
C. Loewe; Vienna/AT C. Paediatric abdominal imaging [A-792]
C. Cardiovascular imaging: myocardium and pericardium S.G.F. Robben; Maastricht/NL
[A-548]
J. Bogaert; Leuven/BE
6
5
E³ 1923 Urogenital
E³ 1423 Head and neck » Chairman’s introduction [A-803]

D. Akata; Ankara/TR
» Chairman’s introduction [A-589] A. Renal and adrenal imaging [A-804]
M.G. Mack; Munich/DE L.E. Derchi; Genoa/IT
A. Temporal bone and skull base [A-590] B. Imaging of the ureter and bladder [A-805]
A. Trojanowska; Lublin/PL J.-M. Correas; Paris/FR
B. Nose, paranasal sinuses and nasopharynx [A-591] C. Prostate imaging [A-806]
C. Czerny; Vienna/AT H.C. Thoeny; Berne/CH
C. Oral cavity, oro- and hypopharynx and larynx [A-592]
M. Becker; Geneva/CH
5
E³ 1523 Gynaecological and obstetrics

C.D. Alt; Düsseldorf/DE
A. Imaging of the uterus [A-637]
R.A. Kubik-Huch; Baden/CH
B. Disorders of the adnexa [A-638]
E. Sala; New York, NY/US
C. Fundamentals of foetal imaging [A-639]
D. Prayer; Vienna/AT
5
E³ 1623 Interventional

M. Szczerbo-Trojanowska; Lublin/PL
A. Basic principles of angiography and image-guided
interventions [A-699]
T.K. Helmberger; Munich/DE
B. Interventions of the hepatobiliary system [A-700]
J.I. Bilbao; Pamplona/ES
C. Vascular interventions [A-701]
J.A. Reekers; Amsterdam/NL

E3
THE BEAUTY OF
BASIC KNOWLEDGE
The Beauty of Basic Knowledge programmes focus on knowledge

essential to the daily practice of radiology. The format of these
sessions reflects the tradition of conventional teaching sessions,
in which experienced teachers share their insights into a topic of
particular relevance with a group of attendees.
A Beauty of Basic Knowledge session either consists of 45-minute

lectures held by one or two speakers (plus 10–15 minutes of discussion
per lecture), or two 25-minute lectures and a general discussion. The
teaching format is usually case-based, and features some interaction
with the attendees.
The content of the sessions is mostly tied to the Level I and Level II
European Training Curriculum (ETC) learning objectives. The Beauty of
Basic Knowledge sessions are suited to residents and board-certified
radiologists who want to refresh their knowledge of basic topics in
imaging and image-guided therapy.
107
E3 – THE BEAUTY OF BASIC KNOWLEDGE
BREAST IMAGING CHEST IMAGING

The programme will be concluded with a self-assessment test, The programme will be concluded with a self-assessment test,
published on ‘ESR Education on Demand’. published on ‘ESR Education on Demand’.
Moderator: J. Camps Herrero; Valencia/ES Moderator: N. Howarth; Chêne-Bougeries/CH
2
March Wednesday, March 2, 12:30–13:30, Room B
2
March Wednesday, March 2, 12:30–13:30, Room D1
E³ 24A Breast ultrasound: E³ 25A Useful signs in chest radiology
a primer [A-058]
A. Lung parenchyma [A-059]
A. Tardivon; Paris/FR G.R. Ferretti; Grenoble/FR
B. Mediastinum and chest wall [A-060]
3
March Thursday, March 3, 12:30–13:30, Room B
J. Cáceres; Barcelona/ES
E³ 24B Cracking the mystery of needles

and gauges [A-213]
3
E³ 25B How to avoid misdiagnosis
R.M. Pijnappel; Utrecht/NL
on the chest x-ray
4
A. Neoplastic lesions [A-214]
J. Vlahos; London/UK
E³ 24C Breast cancer staging: B. Non neoplastic lesions [A-215]
why and how [A-402] A.R. Larici; Rome/IT
K. Kinkel; Chêne-Bougeries/CH
4
March Friday, March 4, 12:30–13:30, Room D1
5
March Saturday, March 5, 12:30–13:30, Room B E³ 25C Reporting chest radiology
made easy
E³ 24D Ductal carcinoma in situ (DCIS):
small tumour but big problem
A. Interstitial lung disease: 5 golden rules [A-403]
[A-597]
S.R. Desai; London/UK
G. Forrai; Budapest/HU B. Pleural disease [A-404]
C. Beigelman; Lausanne/CH
6
March Sunday, March 6, 12:30–13:30, Room B 5
E³ 24E High-risk lesions:
solving the dilemma [A-793] E³ 25D Measurements
in chest radiology
A. Linda; Udine/IT
A. Heart and great vessels: how, why, when? [A-598]
G. Fassa-Ashrafpoor; Chêne-Bougeries/CH
B. Lung nodules: is volume better than size? [A-599]
M. Prokop; Nijmegen/NL
6
E³ 25E Dose optimisation made easy
in computed tomography
of the chest
A. Dose descriptors [A-794]

D. Tack; Baudour/BE
B. CT angiography and CT of lung disease [A-795]
X. Montet; Geneva/CH

E3
ECR ACADEMIES
The ECR Academies consist of a series of four to six sessions relevant

to a particular area of radiology. This may be a classic organ-based field
or a technically oriented area of another field related to radiology, such
as management. Each ECR Academy spans several days, in which the
different facets of the area in question are covered by experts in the field.
An ECR Academy is a coherent course in which the different sessions
complement one another in order to reflect the entirety of the field.
The ECR Academies are particularly suited to general radiologists or

radiologists with a subspecialisation.
109
E3 – ECR ACADEMIES
MODERN IMAGING NEURORADIOLOGY:

IN COLORECTAL CANCER FROM MORPHOLOGY TO FUNCTION
The programme will be concluded with a self-assessment test, The programme will be concluded with a self-assessment test,
published on ‘ESR Education on Demand’. published on ‘ESR Education on Demand’.
4
March Friday, March 4, 16:00–17:30, Room C
2
March Wednesday, March 2, 16:00–17:30, Room G
E³ 1218 Rectal cancer: update E³ 419 Functional MRI of the brain
on organ saving treatments opens new horizons
Moderator: L.K. Blomqvist; Stockholm/SE
T.A. Yousry; London/UK
A. The surgical perspective [A-431] A. No function without structure: challenges in diffusion
G.L. Beets; Amsterdam/NL MRI and fiber tractography for clinical research [A-107]
B. The oncological perspective [A-432] A. Leemans; Utrecht/NL
V. Valentini; Rome/IT B. Clinical utility of fMRI for pre-operative brain
C. The radiological perspective [A-433] mapping [A-108]
R.G.H. Beets-Tan; Amsterdam/NL H. Urbach; Freiburg/DE
C. Introduction to resting state fMRI and functional
connectomics [A-109]
5
March Saturday, March 5, 08:30–10:00, Room C L. Nyberg; Umea/SE
E³ 1318 Colon cancer: staging and

3 Thursday, March 3, 08:30–10:00, Room G
restaging of local disease March
E³ 519 Advanced imaging techniques

Moderator: P. Lefere; Roeselare/BE
in brain tumours
A. Computed tomography for staging [A-511]
E. Rollven; Stockholm/SE
P.C. Maly Sundgren; Lund/SE
B. Imaging for restaging after neoadjuvant A. Clinical utility of perfusion imaging for differentiating
treatment [A-512] brain tumours [A-178]
M. Maas; Maastricht/NL I.N. Pronin; Moscow/RU
C. Assessment of vasculature prior to laparoscopic B. Hybrid imaging with MRI/PET of brain tumours [A-179]
resection [A-513] N.L. Albert; Munich/DE
A. Laghi; Latina/IT C. Assessment of brain tumour perfusion and abnormal
vascular structure using arterial spin-labelling [A-180]
5
March Saturday, March 5, 14:00–15:30, Room C
P. Hales; London/UK
E³ 1518 Colorectal cancer: synchronous 3

March Thursday, March 3, 16:00–17:30, Room G
and metachronous metastases
E³ 819 Cerebral blood flow
Moderator: T.K. Helmberger; Munich/DE quantification
A. Clinical management: » Chairman’s introduction [A-291]
what needs to be improved? [A-613] T. van der Zijden; Edegem/BE
T. Holm; Stockholm/SE A. Functional imaging of cerebral perfusion [A-292]
B. Optimal diagnostic algorithm [A-614] A. Krainik; Grenoble/FR
A. Ba-Ssalamah; Vienna/AT B. Cerebral blood flow measurements with arterial
spin-labelling [A-293]
C. PET/CT vs MR/PET: which and when? [A-615]
X. Golay; London/UK
P. Veit-Haibach; Zurich/CH
C. Cerebrovascular reserve imaging and the
consequences of neurovascular uncoupling [A-294]
5
March Saturday, March 5, 16:00–17:30, Room C
D. Mikulis; Toronto, ON/CA
E³ 1618 Rectal cancer: staging and 4 Friday, March 4, 08:30–10:00, Room G

restaging local disease March
E³ 919 Functional imaging of the spine

Moderator: D.-M. Koh; Sutton/UK » Chairman’s introduction [A-359]
A. Transrectal ultrasonography [A-664] M. Muto; Naples/IT
J.E.R. Waage; Hillerød/DK A. Measuring CSF flow: technique and clinical usefulness
B. Emerging MR-techniques [A-665] [A-360]
D.M. Lambregts; Amsterdam/NL B. Ertl-Wagner; Munich/DE
C. Multiparametric assessment of treatment response B. Diffusion tensor imaging of the spinal cord in the
[A-666] assessment of intramedullary changes [A-361]
N. Papanikolaou; Iraklion/GR M. Sasiadek; Wroclaw/PL
C. Functional and quantitative MRI of symptomatic
stenoses of the lumbar spine [A-362]
K. Eberhardt; Werneck/DE

MODERN CARDIAC IMAGING
The programme will be concluded with a self-assessment test,

published on ‘ESR Education on Demand’.
4
March Friday, March 4, 08:30–10:00, Room N
5
March Saturday, March 5, 14:00–15:30, Room N
E³ 920 How to quantify the haemodynamic E³ 1520 Myocardial characterisation:
significance of coronary stenosis established modalities
vs new ones
Moderator: C. Loewe; Vienna/AT
A. CT-angiography: new tools (TAFE, TAG, CT-FFR) [A-321] Moderator: J. Bremerich; Basle/CH
G. Pontone; Milan/IT A. Hybrid systems in the assessment
B. Myocardial perfusion: what can be done of myocardial perfusion and viability [A-620]
with MR and CT [A-322] D.V. Ryzhkova; St. Petersburg/RU
R. Vliegenthart; Groningen/NL B. T1 and T2-mapping: new items in the radiology
C. New players on the field: toolbox [A-621]
SPECT/CT, PET/CT, MR/PET [A-323] P. Croisille; Saint-Etienne/FR
S.G. Nekolla; Munich/DE C. Cardiac spectroscopy: is it ready for clinical practice?
[A-622]
M. Beer; Ulm/DE
4
E³ 1220 Essentials of modern imaging 5 Saturday, March 5, 16:00–17:30, Room N
in cardiac diseases March
E³ 1620 Cardiac imaging:

Moderator: G.I. Kirova-Nedialkova; Sofia/BG to new horizons
A. Major challenges in diagnostic imaging of cardiac
diseases [A-447] Moderator: E. Mousseaux; Paris/FR
M. Oudkerk; Groningen/NL A. New approaches for coronary atherosclerotic plaque
B. Backbone of cardiac imaging: CT and MRI [A-448] characterisation [A-678]
M. Gutberlet; Leipzig/DE E.J.R. van Beek; Edinburgh/UK
C. Hybrid systems for cardiac applications: B. Imaging of microvascular disease [A-679]
essentials [A-449] R. Manka; Zurich/CH
J. Knuuti; Turku/FI C. Tracking of stem cells in cardiac repair:
role of MR and hybrid imaging [A-680]
L. Natale; Rome/IT

DIAGNOSTIC UROGENITAL RADIOLOGY
The programme will be concluded with a self-assessment test,

published on ‘ESR Education on Demand’.
3
March Thursday, March 3, 08:30–10:00, Room M 5
3
E³ 522 Retroperitoneum and adrenals E³ 822 Upper and lower urinary tract
Moderator: J. Venancio; Lisbon/PT Moderator: V. Logager; Copenhagen/DK

A. Anatomy and imaging techniques of the A. CTU and MRU of the upper urinary tract [A-309]
retroperitoneum [A-197] N.C. Cowan; Portsmouth/UK
F.M. Danza; Rome/IT B. Imaging of kidney and ureter [A-310]
B. Differential diagnoses of retroperitoneal masses M.A. Cova; Trieste/IT
[A-198] C. Imaging of bladder and urethra [A-311]
M.-F. Bellin; Le Kremlin-Bicêtre/FR J. Lopes Dias; Lisbon/PT
C. Differential diagnoses of adrenal lesions [A-199]
G. Heinz-Peer; St. Pölten/AT
4
3
E³ 922 Gynaecology
E³ 622 Kidney Moderator: T.M. Cunha; Lisbon/PT

A. MR imaging techniques and normal anatomy
Moderator: H.C. Thoeny; Berne/CH of the female pelvis [A-379]
A. Differential diagnoses of cystic renal masses [A-209] C.S. Balleyguier; Villejuif/FR
M. Claudon; Vandoeuvre-les-Nancy/FR B. Staging of cervical cancer [A-380]
B. Differential diagnoses of solid renal masses [A-210] R. Forstner; Salzburg/AT
R.H. Oyen; Leuven/BE C. Differential diagnoses of adnexal masses [A-381]
C. Acute and chronic renal infection [A-211] S. Swift; Leeds/UK
N. Grenier; Bordeaux/FR

3
March
E³ 1022 Prostate
E³ 722 Emergencies
Moderator: J.J. Fütterer; Nijmegen/NL
Moderator: M.M. Otero-García; Vigo/ES A. Ultrasound of the prostate [A-394]
A. Male pelvis emergencies [A-234] T. Fischer; Berlin/DE
M. Bertolotto; Trieste/IT B. Multiparametric MRI of the prostate [A-395]
B. Gynaecological emergencies [A-235] G.M. Villeirs; Ghent/BE
R.A. Kubik-Huch; Baden/CH C. Staging of prostate cancer [A-396]
C. Imaging of obstetric and puerperal emergencies A.R. Padhani; London/UK
[A-236]
M. Weston; Leeds/UK

INTERACTIVE TEACHING SESSIONS
2
March Wednesday, March 2, 08:30–10:00, Room A
3
March Thursday, March 3, 16:00–17:30, Room A
E³ 121 Head and neck cancer after treatment: E³ 821 Evaluation of patients
what you need to know with lung emphysema
A. Imaging after surgical treatment [A-001] A. Pretherapeutic evaluation of lung emphysema

M. Lell; Erlangen/DE [A-237]
B. Imaging after radiotherapy/chemotherapy [A-002] C.P. Heussel; Heidelberg/DE
G. Madani; London/UK B. Diagnostic work-up after treatment of lung
emphysema [A-238]
N. Sverzellati; Parma/IT
2
March Wednesday, March 2, 10:30–12:00, Room A
E³ 221 Unexpected findings 4
on brain MRI
E³ 921 Diagnostic evaluation
A. Large ventricles: normal or abnormal? [A-056] of bone tumours
S. Langner; Greifswald/DE
B. Incidental lesions on a brain MRI [A-057] A. Bone tumours: benign or malignant? [A-312]
E.T. Tali; Ankara/TR H.-J. van der Woude; Amsterdam/NL
B. Pseudotumours: mimic bone tumours [A-313]
F.M.H.M. Vanhoenacker; Antwerp/BE
3
E³ 521 Integrating diagnostic tools 4
in breast imaging
E³ 1021 Emergency radiology I
A. Multimodality breast imaging [A-128]
K. Kinkel; Chêne-Bougeries/CH A. Abdominal vascular emergencies [A-382]
A. Palkó; Szeged/HU
B. Multiparametric breast MRI [A-129]
J. Camps Herrero; Valencia/ES B. Chest trauma [A-383]
J.D. Dodd; Dublin/IE
3
March Thursday, March 3, 10:30–12:00, Room A 4
E³ 621 Cardiac CT: from stenosis assessment
to risk stratification E³ 1221 Use of staging and
classification systems
A. CT in stable chest pain [A-200]
R. Marano; Rome/IT A. RECIST 1.1 training [A-423]
A. Graser; Munich/DE
B. Cardiac CT in the emergency room [A-201]
G. Feuchtner; Innsbruck/AT B. Gastrointestinal-abdominal masses [A-424]
A. Ba-Ssalamah; Vienna/AT
3
E³ 721 Cardiac imaging
A. Patterns of delayed enhancement [A-216]

P. Hunold; Lübeck/DE
B. Cardiomyopathies: from diagnosis to prognosis
[A-217]
A. Jacquier; Marseille/FR

INTERACTIVE TEACHING SESSIONS
5
6
March Sunday, March 6, 08:30–10:00, Room A
E³ 1321 MR imaging in sports medicine I E³ 1721 MR imaging in sports
medicine II
A. Muscle injury in sports [A-505]
M.G. Mack; Munich/DE A. Sports injuries of the ankle [A-719]
B. Knee trauma [A-506] P. Robinson; Leeds/UK
M.O. De Maeseneer; Brussels/BE B. Shoulder injury [A-720]
M. Zanetti; Zurich/CH
5
E³ 1421 Skull base lesions
A. Imaging of the cavernous sinus and the anterior

skull base [A-568]
B. Imaging of the central skull base [A-569]
D.-A. Varoquaux; Marseille/FR
5
E³ 1521 Genitourinary and
gastrointestinal radiology
A. Prostate MRI using PI-RADS [A-606]

H.C. Thoeny; Berne/CH
B. New aspects of renal tumours [A-607]
5
E³ 1621 Emergency radiology II
A. Brain trauma [A-658]

M. Smits; Rotterdam/NL
B. Peripheral vascular injury [A-659]
J. Ferda; Plzen/CZ

E3
ECR MASTER
CLASSES
The ECR Master Classes focus on continuous professional development

and lifelong learning. The classes are designed for subspecialised
radiologists seeking cutting-edge information in their particular fields
of interest. They are held by experts in the field and reflect state-of-
the-art knowledge, as well as emerging trends.
ECR Master Classes are offered in cooperation

with each of the following subspecialty societies:
CIRSE (one on vascular and one on interventional radiology), ESCR,

ESER, ESGAR, ESHNR, ESMOFIR, ESNR, ESOI, ESPR, ESSR, ESTI,
ESUR, EUSOBI.
115
E3 – ECR MASTER CLASSES
2
March Wednesday, March 2, 08:30–10:00, Room M 5
3
Cardiac Molecular Imaging
E³ 126 Cardiac CT and new interventions E³ 526 Perfusion imaging

A. Jankauskas; Kaunas/LT X. Montet; Geneva/CH
A. CT before and after transcatheter aortic valve A. Perfusion imaging: how I do it - by CT and/or by MRI?
interventions (TAVI) [A-053] [A-182]
J.-N. Dacher; Rouen/FR C.C. Cyran; Munich/DE
B. CT before and after transcatheter mitral valve B. Liver perfusion [A-183]
interventions (TMVI) [A-054] V.J. Goh; London/UK
P. Blanke; Vancouver, BC/CA C. Lung perfusion [A-184]
C. CT before and after electrophysiology interventions M. Rémy-Jardin; Lille/FR
[A-055] D. Cerebral perfusion [A-185]
R. Salgado; Antwerp/BE H.R. Jäger; London/UK
» Discussion: » Panel discussion:
How can CT best facilitate cardiac interventions? The pros and cons of perfusion imaging
2 Wednesday, March 2, 16:00–17:30, Room B 4

March
Abdominal and Gastrointestinal Vascular
E³ 426a A tour around cholangiopathies E³ 1226a Interventional radiology for deep
venous thrombosis (DVT):
ready for prime time?
C. Matos; Lisbon/PT
A. Clinical scenarios [A-062] Moderator: J.I. Bilbao; Pamplona/ES
M. Arvanitaki; Brussels/BE A. Imaging of DVT [A-490]
B. Which imaging modalities? [A-063] P. Haage; Wuppertal/DE
J.M. Lee; Seoul/KR B. Declotting in the emergency room: why not? [A-491]
C. Treatment: which and when [A-064] R. de Graaf; Maastricht/NL
E. Jonas; Stockholm/SE C. Filter indications 2016: new oral anticoagulants
» Multidisciplinary panel discussion and other developments [A-492]
M.J. Lee; Dublin/IE
2 Wednesday, March 2, 16:00–17:30, Room K

March
Genitourinary March
E³ 426b MR-targeted focal therapies for Paediatric

prostate cancer E³ 1226b Expanding horizons in paediatric
imaging
» Chairman’s introduction:
the rationale for focal therapy [A-101] Moderator: S. Franchi-Abella; Le Kremlin-Bicêtre/FR
F. Cornud; Paris/FR A. Elastography in paediatrics [A-493]
A. The role of multiparametric MR in the planning phase M. Anooshiravani-Dumont; Geneva/CH
of focal therapy [A-102] B. Diffusion-weighted imaging: toy or solution? [A-494]
V. Panebianco; Rome/IT P.D. Humphries; London/UK
B. MR-targeted high intensity focused ultrasound [A-103] C. Contrast-enhanced ultrasound in children [A-495]
M.C. Roethke; Heidelberg/DE D. Kljucevsek; Ljubljana/SI
C. MR-guided cryoablation and focal laser therapy [A-104]
J.J. Fütterer; Nijmegen/NL
D. MR-targeted intensity-modulated radiotherapy with
focal boost [A-105]
V. Fonteyne; Gent/BE
» Panel discussion:
What are the challenges in providing focal treatment
in prostate cancer?

4
6
March Sunday, March 6, 08:30–10:00, Room N
Emergency Radiology Head and Neck
E³ 1226c Whole body CT in trauma patients E³ 1726a Characterisation of salivary
gland masses
Moderator: H. Alkadhi; Zurich/CH
A. Improving the triage: which patients should undergo Moderator: A. Trojanowska; Lublin/PL
whole-body CT (WBCT)? [A-496] A. Ultrasound [A-736]
D.R. Kool; Nijmegen/NL C.Z. Karaman; Aydin/TR
B. How can we improve our WBCT protocol? [A-497] B. CT, MR/PET and PET/CT [A-737]
B. Leidner; Ekerö/SE N.J.M. Freling; Amsterdam/NL
C. Optimising the value of radiologists in trauma care C. MRI diffusion and perfusion [A-738]
[A-498] S. Espinoza-Boireau; Paris/FR
K.H. Nieboer; Brussels/BE
6
5
March Saturday, March 5, 14:00–15:30, Room O
Oncologic Imaging
Interventional Radiology E³ 1726b Personalised medicine in oncology:
E³ 1526 Fire and ice outside the liver what can imaging offer?
» Chairman’s introduction [A-616] Moderator: R.G.H. Beets-Tan; Amsterdam/NL

M. Bezzi; Rome/IT A. Personalised medicine in oncology:
A. Lung ablation: update and level of evidence [A-617] hope or reality? [A-752]
W. Prevoo; Amsterdam/NL E.E. Voest; Amsterdam/NL
B. Renal ablation: update and level of evidence [A-618] B. Radiogenomics: can this assist personalised
C.M. Sommer; Heidelberg/DE medicine? [A-753]
C. Bone and soft tissues ablation: update and level V.J. Goh; London/UK
of evidence [A-619] C. Hybrid MRI/PET: the next step in personalised
A. Gangi; Strasbourg/FR cancer care? [A-754]
» Panel discussion: A. Kjaer; Copenhagen/DK
How to strengthen the role of ablation beyond the » Panel discussion:
liver in everyday clinical practice and how to prove Can imaging facilitate a personalised medicine
the value of what we do approach in oncology?
5
6
Chest Breast
E³ 1626 Less common infiltrative lung diseases E³ 1726c Challenging questions for breast
imaging in 2016: breast density,
Moderator: M. Regier; Hamburg/DE
how to solve the non-mass enigma,
A. Pleuroparenchymal fibro elastosis [A-705] new developments in breast MRI
A. Devaraj; London/UK
B. Alveolar proteinosis [A-706] Moderator: R.M. Mann; Nijmegen/NL
W.F.M. De Wever; Leuven/BE A. Breast density: what the breast radiologist
C. Lymphangioleiomyomatosis [A-707] needs to know [A-755]
A. Oikonomou; Toronto, ON/CA S.J. Vinnicombe; Dundee/UK
B. How can we manage the non-mass breast (enigma)
pattern? [A-756]
F. Pediconi; Rome/IT
C. New developments in breast MRI [A-757]
L. Umutlu; Essen/DE

6
March Sunday, March 6, 08:30–10:00, Room G
Neuro
E³ 1726d Imaging in dementia
Moderator: D. van Westen; Lund/SE

A. The neurochemistry of the Alzheimer’s continuum
[A-771]
S. Engelborghs; Antwerp/BE
B. MR contribution to diagnosis and differential
diagnosis [A-772]
F. Barkhof; London/UK, Amsterdam/NL
C. PET imaging in dementia [A-773]
K. Herholz; Manchester/UK
6
Musculoskeletal
E³ 1826 MSK and intervention

A. Gangi; Strasbourg/FR
A. How to biopsy soft tissue and bone tumours [A-775]
G.K.O. Åström; Uppsala/SE
B. Lower back pain: what can I do? [A-776]
D.J. Wilson; Oxford/UK
C. Injectables - steroids and platelet-rich plasma (PRP):
how and when? [A-777]
M.J.C.M. Rutten; ‘s-Hertogenbosch/NL
D. Painful solitary bone lesions:
what is the most appropriate approach? [A-778]
F. Arrigoni; L’Aquila/IT

MINI
COURSE
The Joint Course of the ESR and RSNA (Radiological Society of North
America) focuses on emergency radiology.
Please note that you can only take part in electronic voting via your
own device (smartphone, tablet, laptop) by connecting to the WiFi
network of the lecture room you are in. Once connected, you will be
automatically directed to the voting website. No app required.
119
MINI COURSE
JOINT COURSE OF THE ESR AND RSNA

(RADIOLOGICAL SOCIETY OF NORTH AMERICA):
EMERGENCY RADIOLOGY
3
3
MC 528 Abdominal emergencies MC 728 CNS emergencies
Moderators: A. Palkó; Szeged/HU Moderators: A. Palkó; Szeged/HU

R.J. Zagoria; San Francisco, CA/US R.J. Zagoria; San Francisco, CA/US
A. Abdominal injuries [A-193] A. CNS trauma and neurovascular injury [A-230]
A. Palkó; Szeged/HU H.A. Rowley; Madison, WI/US
B. The enemy within: non-traumatic abdominal B. CNS non-traumatic emergencies [A-231]
emergencies [A-194] M. Smits; Rotterdam/NL
R.J. Zagoria; San Francisco, CA/US C. Interactive case discussion [A-232, A-233]
C. Interactive case discussion [A-195, A-196] H.A. Rowley; Madison, WI/US
A. Palkó; Szeged/HU M. Smits; Rotterdam/NL
R.J. Zagoria; San Francisco, CA/US
3 Thursday, March 3, 16:00–17:30, Room M 4

3 Thursday, March 3, 10:30–12:00, Room M 4
March
March MC 828 General principles: paediatric
MC 628 Chest emergencies and ENT emergencies
Moderators: A. Palkó; Szeged/HU Moderators: A. Palkó; Szeged/HU
R.J. Zagoria; San Francisco, CA/US R.J. Zagoria; San Francisco, CA/US
A. Thoracic injuries [A-205] A. Imaging of polytrauma patients [A-306]
J.A. Soto; Boston, MA/US U. Linsenmaier; Munich/DE
B. Non-traumatic thoracic emergencies [A-206] B. Challenges of imaging paediatric abdominal
C.M. Schaefer-Prokop; Amersfoort/NL emergencies [A-307]
C. Interactive case discussion [A-207, A-208] C.J. Sivit; Cleveland, OH/US
J.A. Soto; Boston, MA/US C. Imaging in ENT emergencies [A-308]
C.M. Schaefer-Prokop; Amersfoort/NL D. Nunez; New Haven, CT/US

PROS & CONS
SESSION
The Pros & Cons Session will examine the controversial topic:
‘Risks and benefits of reporting incidental findings’
The session will be split into one interactive and
one non-interactive part.
2
PS 427 Risks and benefits of
reporting incidental findings
Moderator: S. Weckbach; Heidelberg/DE

Teaser: J. Sellors; London/UK
A. Good reasons to ignore incidental findings [A-124]
L. Berlin; Skokie, IL/US
B. Good reasons to report incidental findings [A-125]
» Questions and answers [A-126, A-127]
S. Weckbach; Heidelberg/DE
J. Sellors; London/UK
= Partly interactive session with electronic voting/self assessment

EPOS™
SCIENTIFIC EXHIBITION
More than 2,000 new scientific and educational exhibits
and scientific paper presentations
EURORAD
Learn from more than 5,500 case reports
EUROSAFE IMAGING POSTER EXHIBITION

The ESR’s latest initiative in radiation protection
with submissions from all over Europe
ECR ONLINE & EPOSTM LOUNGE

WEDNESDAY, MARCH 2 TO SATURDAY, MARCH 5: 08:00–18:00
SUNDAY, MARCH 6: 08:00–15:30
TRADEMARK OF
THE VOICE
OF EPOS
ECR 2016 proudly presents The Voice of EPOS, a unique opportunity

for a direct scientific exchange between poster authors and their
audience.
Located in the ECR Online & EPOS Lounge, the EPOS™ Arena will offer
a stage for the best posters submitted for ECR 2016, presented by
their authors in moderated poster sessions.
In addition to sessions comprising organ-based topics, there will be

foreign language sessions to provide a platform for an international
and multilingual scientific community.
All presentations will also be broadcast online via the ECR Online
streaming service.
Sessions will be held at the following times in the EPOS™ Arena.
123
THE VOICE OF EPOS
2
March Wednesday, March 2, 10:00–11:00
2
VoE 1 Abdominal/GI VoE 2 Breast
Moderator: M. Torkzad; Milford/UK Moderator: L.J. Pina Insausti; Pamplona/ES

» Assessment of kidney iron accumulation as a cause of » Descriptors of malignant non-mass enhancement of
renal dysfunction in patients with sickle cell disease breast MRI: their correlation to clinical prognostic
(SCD) using MRI- R2* relaxometry (C-0940) factors (C-0226)
S. Keller; Hamburg/DE Y. Machida; Chuo City, Tokyo/JP
» Educating medical students and junior doctors » Shear-wave elastography for the differential
through an ‘abdominopelvic imaging’ multimedia diagnosis of breast papillary lesions (C-0339)
radiology application (C-1122) W.K. Lee; Seoul/KR
C. Ní Leidhin; Dublin/IE » Quantitative shear wave elastography in the
» Characterisation of liver nodules with Gd-EOB- evaluation of breast cancer metastatic axillary lymph
DTPA-enhanced MRI and contrast-enhanced nodes (C-0494)
ultrasound (CEUS) in a transgenic mouse model of V.V. Kapustin; Moscow Oblast/RU
hepatocellular carcinoma (C-1187) » Radar imaging of breast lesions – a clinical evaluation
P. Marra; Milano/IT and comparison (C-0521)
» Transjugular intrahepatic portosystemic shunt (TIPS) M. Shere; Bristol/UK
– what radiologists should know (C-1508) » Dual-energy contrast enhanced spectral
E. Nagaya; Sao Paulo/BR mammography. One step beyond BI-RADS score, by
» Can magnetic resonance enterocolonography reflect adding the power of iodinated contrast media
the presence of partial mucosal healing in patients (C-0756)
with Crohn’s disease? (C-1853) C. Gkali; Athens/GR
Y. Kitazume; Tokyo/JP » Radiation-induced angiosarcoma of the breast –
» Contrast enhanced ultrasonography is safe in a 15-year retrospective review (C-1143)
paediatric patients: a 10-year retrospective study I.P. Alves; Funchal/PT
(C-2070) » Liponecrosis after autologous lipofilling: Which is the
A. Torres; Stockholm/SE best imaging modality for evaluating it? (C-1224)
» Abdominal wall lesions: a pictorial review (C-2181) A. Jarre; Valencia/ES
K. Nam; Seoul/KR » Invasive breast cancer in young Korean women
» MRI in the evaluation of pancreatic tumour treated under 35 years of age: clinical, radiological, and
with irreversible electroporation (IRE) (C-2196) histopathological characteristics (C-1591)
M. Studniarek; Gdansk/PL S. Lee; Seoul/KR
» Age dependence of spleen- and muscle-corrected » Prognostic importance of SWE on breast cancer:
hepatic signal enhancement on hepatobiliary phase lysyl oxidase gene study (C-2150)
gadoxetate MRI (C-2342) Y.K. Kayadibi; Istanbul/TR
S. Matoori; Salzburg/AT » Comparison of full-field digital mammography
» Acute gastro-intestinal bleeding (AGB), diagnostic (FFDM) with synthesised 2D mammography and
and interventional management: a preliminary digital breast tomosynthesis (DBT) in Chinese women
retrospective single centre experience (C-2372) (C-2332)
E. Puglielli; Teramo/IT H.Y.L. Sinn; Hong Kong/HK

THE VOICE OF EPOS
2
2
VoE 3 Italian VoE 4 Cardiac
Moderator: I. Bargellini; Pisa/IT Moderator: A. Alberich-Bayarri; Valencia/ES

» Accuracy of integrated imaging techniques in » Size of hypertrophic myocardium or myocardial
paediatric airway diseases (C-0729) fibrosis by LGE and cine in patients with hypertrophic
N. Stagnaro; Genova/IT cardiomyopathy: correlation with the New York Heart
» Role of interventional radiology in the treatment of Function Assessment (NYHA) (C-0037)
pancreatitis complications (C-1029) J. Zhao; Chongqing/CN
F. Corvino; Naples/IT » CT perfusion imaging of the myocardium vs. coronary
» MRI patterns of brain toxicity in children (C-1297) CT angiography for the assessment of hemodynamic
M.C. Rossi Espagnet; Rome/IT relevant coronary artery stenosis (C-0066)
A.S. Straeter; Munich/DE
» Clinical, functional and imaging results after one year
from intrarticular injection of platelet rich plasma » T1 mapping of the myocardium: what a resident
(PRP) versus hyaluronic acid (HA) in patients with needs to know (C-0385)
osteoarthritis of the knee (OA) (C-1699) F.M. Caballeros; Pamplona/ES
S. Quarchioni; Teramo/IT » The relationship between coronary artery stenosis
» Unexplained chronic cough (UCC) in children: can using non-invasive computed tomography coronary
chest computed tomography (CCT) help in making a angiography and invasive fractional flow reserve in
diagnosis? What about radiation exposure? (C-2027) patients with ischemic heart disease (C-0615)
M. Cellina; Milan/IT I. Anan; Tokyo/JP
» MR thermometry: ex-vivo model assessment using » Radiologic and clinicopathologic findings of

three fast T1-weighted sequences during laser eosinophilic heart diseases: assessment with cardiac
ablation procedures (C-2042) MRI and MDCT (C-1326)
F. Giurazza; Rome/IT J.Y. Yoo; Seoul/KR
» Role of STIR and T2-weighted TSE MR sequences for » Diagnostic, therapeutic and economic implications
recognising occult inflammatory breast cancer of FFRCT-adoption in the non-invasive assessment of
(C-2152) CAD: a retrospective study (C-1518)
M. Moschetta; Bari/IT K. De Smet; Oostduinkerke/BE
» Digital breast tomosynthesis-guided biopsy: » Everything you need to know about congenital
preliminary experience (C-2207) anomalies involving the coronary sinus on CT
F. Pipan; Udine/IT (C-1534)
A. Goienetxea Murgiondo; Donostia/ES
» A new MR follow-up algorithm for a proper
management of ‘small’ adrenal adenomas (AA) » Take a look at the heart: Role of cardiovascular CT
(C-2245) and MRI in cardioembolic stroke (C-1788)
R. Faletti; Turin/IT A. Ugarte; San Sebastian/ES
» The impact of alcohol intake on the presence of
coronary artery disease (C-2212)
D. Danicska; Budapest/HU
» Inferior insertion points delayed enhancement and
right ventricular dilation in patients with congenital
heart disease (C-2357)
P.M. Cannao; San Donato Milanese/IT

THE VOICE OF EPOS
2
2
VoE 5 French VoE 6 Arabic
Moderator: S. Nougaret; St. Clement de Riviere/FR Moderator: T. El-Diasty; Mansoura/EG

» Imaging of the complications of middle ear surgery: » Value of subtracted magnetic resonance images in
how do I keep my favourite surgeon away from jail? diagnosis of different non vascular lesions of the
(C-0658) body (C-0039)
A. Venkatasamy; Strasbourg/FR A.M. Abougabal; Alexandria/EG
» Selective arterial embolisation of renal tumour » Detection of uterine vascular malformations using
in a hybrid operating room at the same time as 4D-CT angiography: initial experience (C-0553)
laparoscopic partial nephrectomy: a new approach in A.M.H. El-Sharkawy; Tanta/EG
renal surgery (C-0905) » Imaging appearances of stromal fibrosis (C-1134)
L. Besnier; Angers/FR L. Nassar; Beirut/LB
» Updated prostate imaging reporting and data system » MRI defecography signs in obstructed defecation
(PI-RADS) 2.0 versus 1.0: detection accuracy of (C-1906)
prostate clinically significant and insignificant cancer M. A. Alkubeyyer; Riyadh/SA
(C-1203)
» Meningeal thickening in MRI: from signs to etiologies
S. Peslerbe; Angers/FR
(C-1979)
» Automatic detection of prostate cancer using A. Hssine; Soussa/TN
quantitative perfusion parameters in contrast-
» Endovascular treatment of distal basilar artery
enhanced ultrasound (C-1798)
aneurysms (C-2019)
M. Skendi; Paris/FR
M. Zaitoun; Zagazig/EG
» 320-row CT transcatheter aortic valve implantation
» Radiology reports evaluation by University of
planning using a single reduced contrast media bolus
Rochester Medical Center (URMC) emergency
injection: a prospective study on 50 patients
department (ED) (C-2102)
(C-2034)
W.A. Abdellatif; Zagazig/EG
M. Ohana; Strasbourg/FR
» Utility of intra-arterial cone beam CT angiography
» Assesment of comparative accuracies of ultrasound
in detection of intracranial micro-arteriovenous
and fluoroscopic steroid injections into the
malformations (C-2304)
subacromial bursa (C-2068)
A. Elmokadem; Mansoura/EG
S. Charlon; Paris/FR
» Image defined risk factors using MDCT: are they a
» Greater occipital nerve MR tractography: feasibility
good predictor of surgical outcomes in abdominal
and anatomical considerations (C-2088)
neuroblastoma regardless of the disease stage?
A. Kastler; Grenoble/FR
(C-0413)
» Post-traumatic neuroma after surgery of the carpal O. Kamal; Asyut/EG
tunnel: MRI study (C-2291)
» RENAL nephrometry score value in approach and
J.-L. Drapé; Paris/FR
outcomes of partial nephrectomy (C-1395)
» Radiation dose and acquisition time for CT H.S. Gaber; Mansoura/EG
transaortic valve implantation (TAVI) planning
examinations with new-generation 256 multi-detector
CT (MDCT) (C-2376)
L. Macron; Saint-Denis/FR
» Brain cysts (C-2385)
A. Krainik; Grenoble/FR

THE VOICE OF EPOS
2
3
March Thursday, March 3, 09:00–10:00
VoE 7 Chest VoE 8 Head and Neck
Moderator: M. Toepker; Vienna/AT Moderator: E. Ada; Izmir/TR

» Assessment of primary pulmonary malignancy: » A pilot feasibility study of 99mTc-EC-DG SPECT/
comparison of CT and MR imaging with radial 3D CT imaging in the treatment response evaluation in
T1-weighted gradient echo and radial 3D ultrashort patients with locally advanced head and neck cancer
TE sequences at 3.0 Tesla using a high-density coil (C-0200)
(C-0582) C.W. Westin; Chicago, IL/US
H. Lee; Wonju/KR » Salivary gland tumours: a pictorial review (C-0317)
» A type of future virtual 3D microscope and its 3D A.R. Ramírez; Madrid/ES
image printing to make realized magnified model of » “Necrotic lymphadenopathy” in the neck:
the peripheral lung, based on micro CT of the lung how many diagnostic keys do you have? (C-0411)
specimen (C-0716) J.S. Kim; Seoul/KR
H. Natori; Sapporo/JP
» Thyroid FNA guidelines; a comparison of the six
» CT lung subtraction for assessment of regional internationally recognised guidelines (C-0441)
pulmonary perfusion in patients with chronic A. Weir; Limerick/IE
thromboembolic pulmonary hypertension (C-0926)
» Usability of exposure dose reduction using volume
T. Kariyasu; Tokyo/JP
scan in the auditory-ossicle CT scan (C-0653)
» 80 kV low contrast volume CT pulmonary K. Nagamoto; Fukuoka/JP
angiography for the diagnosis of acute pulmonary
» Compliance of British thyroid ultrasound «U»
embolism: improving patient safety (C-1152)
guidelines - are we all speaking the “Unified”
J. Bell; Bradford/UK
thyroid language? (C-1158)
» MR imaging of mediastinal tumours (C-1156) S. Singh; Leeds/UK
A. Matos; Lisbon/PT
» Are we requesting PET-CT scans in line with current
» Lung sonography; a valuable contributor in the NICU guidance at the Edinburgh Cancer Centre in the
(C-1323) diagnostic work-up of head and neck cancers?
E. Manoli; Marousi/GR (C-1272)
» The use of hyperpolarised xenon (HP 129Xe-MRI) for A. Vibhakar; Edinburgh/UK
assessing collateral ventilation (C-1541) » Parathyroid glands: so small but yet so big (C-1520)
M. Chen; Oxford/UK M. Pérez Dávila; Madrid/ES
» MDCT signs of acute thoracic compartment » Retropharyngeal calcific tendinitis of the musculus
syndrome (TCS): a pictorial review (C-1757) longus colli tendon - a clinical mimicker (C-1744)
C. Liguori; Naples/IT E.C. Schubert; Munich/DE
» Individualised CTPA injection protocol optimises » Labyrinthine hemorrhage detected on magnetic
contrast use and increases arterial attenuation resonance image as a cause of sudden profound
(C-2235) sensorineural hearing loss (C-1837)
H.-J. Raatschen; Hannover/DE D.-W. Park; Guri-si/KR
» CT-guided needle biopsy of lung lesions: is there the
possibility of reducing the dose? (C-2317)
G. Coppola; Rome/IT

THE VOICE OF EPOS
3
3
VoE 9 Emergency VoE 10 Genitourinary
Moderator: S. Nougaret; St. Clement de Riviere/FR Moderator: N. Caserta; Campinas/BR

» Traumatic adrenal hematoma: clinical and imaging » Vesical artery embolization in hemorragic cystitis in
findings (C-0193) children, a case series of 3 patients (C-0380)
A.S. Kahraman; Malatya/TR D. Barnés Navarro; Montornés del Vallés/ES
» Magnetic resonance imaging evaluation of spinal cord » Multifocal renal solid tumours: radiological approach
injury with out radiographic abnormality (SCIWORA). (C-0781)
(C-0640) M.Á. Corral de la Calle; Ávila/ES
D. Rajgopal; Manglore/IN » Preliminary results of prostate artery embolisation as
» Major trauma CTs: how reliable are trainee final treatment in selected BPH patients (C-0888)
radiologists reports? (C-0822) F. Imani; Rotterdam/NL
E. Lagha; London/UK » Imaging findings of various uterine and extrauterine
» Radiologic patterns of hepatic injuries following leiomyomas with unusual appearance or location
cardiopulmonary resuscitation (C-0941) (C-0915)
A. Dixit; St. John’s/CA R. Dosho; Tokyo/JP
» Pearls and pitfalls in the diagnosis of ectopic » Postpartum period: uncommon emergent
pregnancy (C-1251) complications (C-0922)
S. Ramanathan; Doha/QA M. Certo; Santo Tirso/PT
» Brain attack: imaging of non traumatic neuro » Comparison of ADC of normal uterine zones between
emergencies, what radiologists should know (C-1563) postmenopausal and reproductive age women
R. Gautam; Manila/PH (C-1267)
» CT pulmonary angiography in pregnancy: to do or A. Tsili; Ioannina/GR
not to do? Role of minimally invasive CTPA (C-2058) » Technical pitfalls in prostate MRI - insights into
A. Lemos; Milan/IT eliminating artifacts in your prostate protocol
» Reliability and time effectivity of an assisted bone (C-1392)
reading software for the analysis of CT trauma cases M. Czarniecki; Warsaw/PL
(C-2280) » Differentiation of adrenal nodular hyperplasia and
S.M. Anton; Lübeck/DE lipid-poor adenoma by clinical manifestation and
» MDCT signs accuracy in detection of acute perforated advance virtual monoenergetic technique on CT
appendicitis (C-2354) (C-2047)
P. P. Saturnino; Naples/IT W. Shu xian; Zhengzhou/CN
» Diffusion magnetic resonance in cervical carcinoma:
the role of ADC in the evaluation of treatment
response (C-2114)
G.M. Barelli; Rome/IT
» Value of MRI features of acute adnexal torsion in
pregnant women (C-2216)
D. Kang; Dong-gu, Ulsan/KR

THE VOICE OF EPOS
3
3
VoE 11 Chinese VoE 12 Oncology
Moderator: V. Chong; Singapore/SG Moderator: O. Tanaka; Tsukuba/JP

» Resting-state functional magnetic resonance imaging » Increased incidence of pancreatic cancer in
study on amplitude of low-frequency fluctuate of hepatocellular carcinoma cohort (C-0038)
somatoform disorder (C-0137) W. Gonoi; Tokyo/JP
L. Wei; Chongqing/CN » A web-based and user friendly planning tool to
» Quantitative spectral CT evaluation of kidney predict outcome for percutaneous cryoablation of
tumours with the stretched-exponential nonlinear renal tumours including validation of the simulation
regression analysis model (C-0256) model (C-0451)
X. Yang; Shenyang/CN J.J. Futterer; Nijmegen/NL
» Safety and efficacy of high-dose adenosine stress » Dual energy CT quantification of lipiodol
cardiac MR (C-0718) deposition after transarterial chemoembolization in
Y.Y. Kwong; Hong Kong/CN patients with hepatocellular carcinoma (C-0608)
» The experimental study of diffusion kurtosis imaging Y. Yoshiyasu; Nagoya/JP
combined with dynamic contrast-enhanced magnetic » Y90-radioembolization of hypovascular liver lesions:
resonance imaging in the prediction of post- role of cone-beam CT (C-0698)
traumatic epilepsy (C-0971) A. Grigolini; Pisa/IT
W. Li; Shanghai/CN » Response assessment of response to treatment in the
» Differentiation of angiomyolipoma with minimal fat cancer patient: a tutorial for the radiologist (C-0755)
and common non-clear cell renal cell carcinoma on A. Nunziata; Ercolano/IT
MDCT (C-1104) » Dose modulation in low dose lung cancer screening:
X. Li; Tianjin/CN how low can we go? (C-0920)
» The combination of shear wave elastography and N. Verma; Gainesville, FL/US
contrast-enhanced ultrasound for diagnosing breast » Comparative analysis of multi-parametric positron
lesions: a mutiple logistic regression analysis (C-1371) emission tomography, diffusion weighted imaging
H. Wu; Chengdu/CN and diffusion tensor imaging values in lung
» Dynamic functional connectivity patterns of the adenocarcinoma patients (C-1249)
subgenual anterior cingulate cortex in patients S. Lucic; Sremska Kamenica, Novi Sad/RS
with refractory and nonrefractory major depressive » Low-dose computed tomography for lung cancer
disorders (C-2173) screening: comparison of performance between
B. Cheng; Chengdu/CN annual and biennial screen (C-1544)
» Cortico-striatal connectivity in drug-naive patients M. Silva; Parma/IT
with obsessive-compulsive disorder (C-2349) » Pre-treatment ADC histogram-analysis at whole body
X. Hu; Chengdu/CN diffusion-weighted MRI predicts disease free survival
in ovarian cancer (C-2122)
K.L.M. Michielsen; Leuven/BE
» Five year follow up of indeterminate pulmonary
nodules in osteosarcoma patients: how do they
behave? (C-2190)
M. Iqbal; Lahore/PK

THE VOICE OF EPOS
3
3
VoE 13 Nordic VoE 14 Russian
Moderator: M. Torkzad; Milford/UK Moderator: I. Arkhipova; Moscow/RU

» Assessment of effective dose in a series of CT of the » Assessment of dynamic pelvic floor MRI (MR-
knees, time to revise the guidelines? (C-0205) defecography) (C-0069)
J.M.E. Torsvik; Bergen/NO K.S. Petrov; Moscow/RU
» Magnetic resonance imaging of hyperacute tissue » Cervical spine MRI in Hirayama disease: practical
injury and regional cerebral blood flow in clinically aspects (C-0189)
relevant ischemic stroke model in the rat (C-0320) E.I. Kremneva; Moscow/RU
P. Little; Stockholm/SE » Ultrasound diagnostics simulators for students and
» Measuring mammographic density: comparing a fully residents: implementation experience (C-0239)
automated volumetric assessment versus European D. Venidiktova; Smolensk/RU
radiologists’ qualitative classification (C-0383) » Opposed phase (out-of-phase) imaging. Resident
H. Sartor; Malmö/SE guide (C-0472)
» MRI changes after the implantation of percutaneous T. Movsisyan; Moscow/RU
interspinous device Aperius in spinal stenosis - » Proton MR spectroscopy of ischemic rat brain:
a retrospective cohort study (C-0469) dynamic changes of metabolites in infarct zone in
W. Witwit; Gothenburg/SE deferent normalisations (C-0518)
» Dynamic contrast enhanced computed tomography: D. Namestnikova; Moscow/RU
effects of non rigid motion correction on image » Evaluation of the radiation-induced brain injury: MRI
quality and reproducibility (C-0564) follow-up study (C-0707)
K.R. Brow; Glostrup/DK Z. Savintseva; Saint-Petersburg/RU
» PGMI score of baseline mammograms before interval » Localization of Broca’s and Wernicke’s areas with
cancers in a population-based screening programme resting state fMRI (C-1673)
(C-0675) E. Pechenkova; Moscow/RU
R. Gullien; Oslo/NO
» The comparison between coronary CT angiography
» Emerging role of functional brain MRI in low-grade and intravascular ultrasound for assessment of
glioma surgery (C-0873) coronary plaque components in patients with acute
A. Friismose; Odense/DK coronary syndrome (C-1696)
» Protocol for evaluation of radiologist’s active role M. Shabanova; Moscow/RU
in the diagnostic assessment of patients with vague » Brain CT-perfusion: correlation between
symptoms suspected of serious illness that can be completeness of the circle of Willis and
cancer (C-1687) haemodynamic changes in cases of not-acute
N. Lapitskaya; Silkeborg/DK atherosclerotic occlusion of main brachiocephalic
» Semi-automatic quantification of exocrine pancreatic arteries (C-2366)
function by secretin-stimulated MRI in chronic A. Vishnevskaia; Moscow/RU
pancreatitis and healthy subjects (C-1921)
A. Madzak; Aalborg/DK
» The natural history of non-resected intraductal
papillary mucinous neoplasms (IPMN) of the
pancreas: a single institution experience (C-2387)
N. Kartalis; Stockholm/SE

THE VOICE OF EPOS
3
4
March Friday, March 4, 09:00–10:00
VoE 15 Abdominal/GI VoE 16 Head and Neck
Moderator: I. Arkhipova; Moscow/RU Moderator: K. Bhatia; Hong Kong/CN

» Radiofrequency ablation following transarterial » Correlation between sonographic features and
chemoembolization for patients with BCLC B, C stage nuclear morphometric parameters in parotid gland
hepatocellular carcinoma (C-0067) tumours (C-0079)
T. Jianfei; lishui/CN D. Obad Kovacevic; Zagreb/HR
» Peritoneal cavity anatomy in CT peritoneography: » Nodular (N) and non-nodular (non-N) configuration
a comprehensive description (C-0401) of subacute granulomatous thyroiditis (SAT):
J. Calvo Blanco; Oviedo/ES characteristics and interval change (IC) using follow-
» Part II - Video animation of anomalies of rotation of up (FU) ultrasonography (US) (C-0129)
gut (C-0580) Y.J. Lee; Busan/KR
M.D. Rahalkar; Pune/IN » Head and neck manifestation of aarcoidosis:
» The role of MRCP in a hospital with a 24/7 a pictorial review of findings at CT and MR (C-0253)
experienced ultrasound service: when is MRCP J. Rogers; Knoxville, TN/US
indispensable and when could it be avoided? » Ultrasound for the diagnosis of carotidynia (C-0261)
(C-0789) M.A. Abrahamy; Zerifin/IL
V. Moustakas; Rodos/GR » Differential diagnosis of non-traumatic lesions of the
» Imaging of ALPPS procedure: what the radiologist scalp: a pictorial review (C-0284)
should know (C-0818) R. Morcillo; Toledo/ES
M. Zerial; Udine/IT » Cystic fibrosis sinus score (CFSS) for the evaluation
» Reproducibility of relative liver enhancement of the paranasal sinuses complications of cystic
(C-0836) fibrosis using cone beam CT (C-2007)
K.A. Schelz; Kogarah/AU M.C. Firetto; Milan/IT
» Evaluation of the scan timing for CT during arterial » Thyroglossal duct cyst: imaging characteristics and
portography using two different bolus tracking clinical correlation (C-2132)
methods (C-0856) I.H. Lee; Daejeon/KR
A.Chiba; Sapporo, Hokkaido/JP » Evaluation of shear wave elastography with
» Primary solid tumours of the liver: a pictorial transverse and longitudinal scans: differentiation
review (C-1424) between benign and malignant thyroid nodules
P. Brown; Leeds/UK (C-2383)
» Linitis plastica of the rectum: an unusual type of Y.J. Choi; Seoul/KR
rectal cancer (C-1723)
D.M. Angulo; Palma de Mallorca/ES
» Predictive value of the target appearance on the
hepatobiliary phase of GD-EOB-DTPA MRI in the
patients of breast cancer hepatic metastasis: the first
step for the personalised radiology (C-2030)
H.J. Lee; Seoul/KR

THE VOICE OF EPOS
4
4
VoE 17 Interventional VoE 18 Musculoskeletal
Moderator: I. Bargellini; Pisa/IT Moderator: E. Llopis; Alzira-Valencia/ES

» Out of sight, out of mind? A three point plan to » Tarsal tunnel syndrome: evaluation on MRI (C-0022)
optimize IVC filter follow-up (C-0231) Y. Kobashi; Chiba/JP
C. C. Logan; Dublin/IE » Dynamic MRI scan in osteosarcoma and Ewing
» Liver regeneration: comparison of portal vein sarcoma (C-0295)
embolization versus radio-frequency-assisted liver O. M. Albtoush; Vienna/AT
partition with portal vein ligation (RALPP) (C-0471) » An optimal protocol for full-spine radiography
M. Tsakok; London/UK (C-0649)
» Minimally invasive treatment of osteoid osteoma C. Ernst; Brussels/BE
(OO): MR guided focused ultrasound surgery » Scaphoid imaging with digital tomosynthesis as
(MRgFUS) and radiofrequency thermal ablation (RFA) an adjunct to radiography: a single department’s
(C-0473) experience (C-1036)
F. Arrigoni; L’Aquila/IT B. Gibney; Dublin/IE
» The use of fluoroscopy and ultrasound guidance in » Anatomy and non-traumatic pathology of the atlanto-
placement of peritoneal dialysis catheter (C-0911) axial joint (C-1260)
A.M.K. Abdel Aal; Birmingham, AL/US G. Retnasingam; Leicester/UK
» Evaluation of sclerotherapy for the treatment of » The diagnostic challenge of groin pain in adults:
infected postoperative lymphocele (C-1013) review of imaging modalities and differential
S.H. Kang; Seongnam-si/KR diagnoses (C-1291)
» Key points of successful percutaneous ethanol A. Zaidi; Ariana/TN
sclerotherapy (PEST) procedure – long term results of » Radiographic signs predicting rotator cuff tears
PEST treatments in patients with symptomatic liver (C-1443)
and splenic cysts (C-1553) J.J. van der Reijden; Deventer/NL
A. Kollár; Budapest/HU
» MR imaging in the post-therapeutic/post-surgical
» Variant hepatic arterial anatomy and extra-hepatic follow-up of malignant musculoskeletal neoplasms:
arterial supply in hepatocellular carcinoma (HCC) pearls and pitfalls (C-1781)
and colorectal metastases: impact on transarterial N.S. Sideri; Chaidari/GR
chemoembolization (TACE) planning and technique
» Cyclops lesions do not worsen clinical outcome two
(C-1686)
years after anterior cruciate ligament surgery
S. Aquilina; Msida/MT
(C-2026)
» Correlation of peak skin dose with geometrical L. Facchetti; San Francisco, CA/US
and dosimetric parameters from interventional
» Radiation dose of lumbar spine CT: analysis and
procedures (C-1835)
comparison between different modes of acquisition
N. Fitousi; Leuven/BE
in two European imaging centers (C-2386)
» A new classification of stent graft-induced distal A. Papachristodoulou; Thessaloniki/GR
complications (SIDCs) after repair with stainless
steel-based device for aortic dissection (C-2062)
Y. Xue; Beijing/CN
» Checklist use in radiology: an Australia-wide cross-
sectional study (C-2209)
C. Mandel; Melbourne/AU

THE VOICE OF EPOS
4
4
VoE 19 Turkish VoE 20 Neuro
Moderator: C. Calli; Izmir/TR Moderator: E. Ada; Izmir/TR

» Value of dynamic MR imaging using the Ktrans » T2*-weighted perfusion MRI imaging biomarkers
technique for assessment of native kidneys in pre- obtained at the peritumoural area of high-grade
emptive renal transplantation (C-0033) gliomas relate to patients survival (C-0599)
R. Sade; Erzurum/TR L. Marti-Bonmati; Valencia/ES
» Evaluation of bone marrow via diffusion-weighted » Hypertrophic olivar degeneration: review of literature
imaging in adult patients with acute leukemia and presentation of a 7 case series (C-0728)
(C-0062) J.P. Martínez Barbero; Jaen/ES
A. Kocyigit; Denizli/TR » 3D arterial spin labelling: as a part of routine MRI
» The view from the mastoid fontanel of the neonatal brain protocols (C-0792)
brain (C-0974) M. R. Verma; Mumbai/IN
F.C. Sarioglu; Izmir/TR » High resolution MRI of the intracranial arterial wall:
» MRI findings in paediatric acquired brown syndrome utility and imaging findings in a variety of disease
with various etiological factors (C-0983) states (C-0878)
C.Z. Karaman; Aydin/TR S. Power; Toronto, ON/CA
» Decreased bilateral insula volume and widespread » Diffusion tensor imaging of spinal cord as an
white matter dysintegrity in schizophrenia (C-1033) emerging tool in neuroradiology (C-1049)
A. Onay; Istanbul/TR K. Agawane; Mumbai/IN
» Efficiency and utility of strain elastography in the » Gender related peculiarities of amygdala deactivation
diagnosis and staging of acute appendicitis in during movements (C-1342)
patients in paediatric age group (C-1103) O. Omelchenko; Kyiv/UA
H. Arslan; Van/TR » Middle cerebral artery anatomy: do you know yours?
» Extraarticular lateral ankle impingement (C-1282) (C-1360)
C. Cevikol; Antalya/TR D.P. Mitchell; Dublin/IE
» Evaluation of optic nerve head biomechanical » Ultra-high field MRI of the substantia nigra in patients
properties in pseudoexfoliation glaucoma with real- with atypical parkinsonisms (C-1366)
time ultrasound elastography (C-1412) D. Frosini; Pisa/IT
Ö. Ünal; Ankara/TR » Intrinsic brain abnormalities in drug-naive patients
» Rhabdomyosarcoma everywhere: differential with obsessive-compulsive disorder: a resting-state
diagnosis on imaging (C-1675) functional MRI study (C-2361)
A. Güneş; Ankara/TR X. Hu; Chengdu/CN
» Evaluation of iron accumulation in choroid plexus » Diffusion MR imaging using multi-band EPI in brain:
in patients with beta-thalassaemia major by using basics and its clinical application (C-0595)
susceptibility weighted imaging (SWI) (C-2254) M. Hori; Tokyo/JP
E. Üre; Istanbul/TR

THE VOICE OF EPOS
4
4
VoE 21 Spanish VoE 22 Japanese
Moderator: A. Alberich-Bayarri; Valencia/ES Moderator: Y.O. Tanaka; Tsukuba/JP

» Multi-task paradigm in functional magnetic resonance » Proposal of quantitative identification method of
imaging (fMRI) (C-0011) a small-type OSL dosimeter: conditions that the
A. Granados; Cali/CO dosimeter is not identified in the medical image
» Diagnostic errors: understanding the concepts (C-0010)
through spine examples (C-0444) K. Takegami; Tokushima/JP
R. Mirón Mombiela; Valencia/ES » Comparison of shear wave velocity measurement
» Prognostic value of early diffusion weighted using VTQ and VTIQ: phantom and cervical lymph
MRI in full-term newborns with hypoxic ischemic node studies (C-0290)
encephalopathy (C-0795) R. Kishimoto; Chiba/JP
E.-M. Heursen; Cádiz/ES » Evaluation of energy dependence of nanoDot
» Ultrasound of the lumbar spine: what should the optically stimulated luminescence (OSL) dosimeter
radiologist know to perform interventional spine using characteristic x-ray induced by medical x-ray
procedures? Technique, normal anatomy, and equipment (C-0338)
anatomic variant with radiologic correlation (C-1327) T. Okazaki; Tsukuba, Ibaraki/JP
M. Squarcia; Barcelona/ES » Imaging of pulmonary nontuberculous mycobacterial
» Imaging findings of paediatric intestinal, liver- infection: variations, sequential changes, and
intestinal, and multivisceral transplantation (C-1358) differential diagnoses (C-0584)
M. Parrón; Madrid/ES S. Noguchi; Tenri/JP
» Detection of bone metastases through diffusion- » Image quality evaluation of turbo-spin echo diffusion
weighted whole-body imaging with background body weighted image (TSE-DWI): a phantom study
signal suppression (DWIBS) (C-1601) (C-0631)
H. Barragán-Campos; Queretaro/MX T. Yoshida; Shizuoka/JP
» Retained surgical sponge in chest and abdomen: » Evaluation of myocardial fibrosis using T1 mapping
CT imaging appearance and complications (C-1614) in dilated cardiomyopathy (DCM) compared with
S. Ramirez; Medellin/CO endomyocardial biopsy (EMB) (C-0651)
Y. Morita; Suita, Osaka/JP
» Post-treatment imaging in primary and secondary
brain tumours: a diagnostic challenge (C-1672) » Consideration of reliability in the diagnosis of acute
D.D.J. De la Rosa Porras; Madrid/ES ischemic cerebrovascular disorders about MRI in iPad
air (C-1280)
» Aorto-caval space: a forgotten retroperitoneal space
H. Hattori; Toyoake/JP
(C-1925)
C. Varela Ubilla; Santiago/CL » Research and development of tumour response
observation system for dose-volume delivery guided
» MRI: the technique of choice in the study of
particle therapy (TROS-DGPT) (C-1362)
pleomorphic adenoma (C-2211)
T. Nishio; Hiroshima/JP
B. Brea Alvarez; Majadahonda/ES
» Development of activity pencil beam algorithm using
measured distribution data of positron emitter nuclei
generated by target nuclear fragmentation reaction
for innovative proton therapy (C-1364)
A. Nishio-Miyatake; Yokohama/JP
» A predictive factor of delayed neurological sequelae
following carbon monoxide intoxication (C-1695)
Y. Kubo; Tokyo/JP

THE VOICE OF EPOS
4
5
March Saturday, March 5, 09:00–10:00
VoE 23 Genitourinary VoE 24 Neuro
Moderator: V.F. Muglia; Ribeirao Preto/BR Moderator: Moderator: C. Calli; Izmir/TR

» Postsurgical complications of the urinary diversion » Incidence, risk factors and clinical significance
after radical cystectomy (C-0678) of contrast staining areas after mechanical
B. Garcia Martinez; Santander/ES thrombectomy in patients with acute ischaemic
» MRI of benign and malignant lesions of prostate stroke (C-1082)
(C-0964) M. Rusina; Trnava/SK
A. Bangaragiri; Singapore/SG » Grey-white matter ratio of the brain: a candidate
» Emergency imaging of acute abdomen of marker for the duration of the terminal phase based
gynecologic origin: spectrum of MDCT findings on post-mortem CT-scans (C-1141)
(C-1213) P.A.M. Hofman; Maastricht/NL
V.S. Teran Pareja; Madrid/ES » Extra-axial hyperdense lesions in head CT scan
» Benign mimics of gynecologic malignancies (C-1523) without contrast: systematic guide of differential
D. Ballah; San Francisco, CA/US diagnosis (C-1273)
A. Pacheco; Valencia/ES
» MRI findings of placental invasion without placental
previa (C-1594) » Stroke imaging – time is brain (C-1743)
S. Kitai; Tokyo/JP R. Rege; Mumbai/IN
» Contribution of magnetic resonance imaging of » Fiber tractography of the brachial plexus in patients
pelvic floor to de novo stress urinary incontinence with avulsion trauma (C-1851)
post vaginal delivery (C-2180) M. Amelin; Novosibirsk/RU
N. Li; Tianjin/CN » Understanding microstructure of the brain with
» Low dose multidetector CT for the initial detection of advanced diffusion tensor imaging and comparing
urolithiasis: a local clinical audit (C-2239) with pathological findings (C-1967)
Y.A.R.M. Selim; Nizwa/OM K. Sato; Tokyo/JP
» Radiologic percutaneous interventions for ureter » The outcome of fMRI language mapping is affected
disease (C-0966) by patient fatigue (C-2314)
H. Lee; Anyang/KR M. Kiss; Budapest/HU
» Prostate cancer: correlation of intravoxel incoherent » Comparison of quantitative susceptibility mapping at

motion MR parameters with Gleason score (C-0918) 1.5- and 3.0-Tesla (C-2355)
D.M. Yang; Seoul/KR O. Solyanik; Hanover/DE
» Neuroimaging of the sciatic nerve high division
causing Piriformis syndrome (C-2379)
S.A. Jengojan; Vienna/AT
» Stent-retriever thrombectomy of small caliber
intracranial vessels using pREset LITE - safety and
efficacy (C-2381)
W. Kurre; Stuttgart/DE

THE VOICE OF EPOS
5
5
VoE 25 Breast VoE 26 Paediatric
Moderator: E. Fleury; Sao Paulo/BR Moderator: M. Argyropoulou; Ioannina/GR

» Real-time elastography: impact of strain ratio on » Gastro-intestinal anomalies in infants with congenital
diagnostic performance of solid breast lesions diaphragmatic hernia: prenatal diagnosis and
(C-0731) postnatal complications (C-0372)
K. Bojanic; Osijek/HR K. Minkner; Neuchâtel/CH
» Importance of anatomopathological-imaging » Which serum biochemical markers could predict
correlations for the validation of a breast biopsy radiologic metabolic bone disease in preterm infants?
results (C-1182) (C-0890)
A. Jalaguier-Coudray; Marseille/FR J.W. Park; Daejeon/KR
» MRI in high cancer-risk patients with BIRADS-3 » CT and MRI imaging features of paediatric
lesions: is short-interval follow-up the answer? rhabdomyosarcomas (RMS) (C-1441)
(C-1211) L. A. Fowkes; London/UK
G. Bar On; Beer Yaakov/IL » Imaging evaluation of the thyroid gland in children:
» Health-related quality of life, anxiety and what radiologists should know (C-1616)
depression in women related to mammography in B.F. Corgosinho; São Paulo/BR
Greece (C-1325) » Assessment of the quality of portable x-ray
A. Zisakis; Athens/GR examinations at a level 3 neonatal intensive care unit
» The European Commission Initiative on Breast Cancer (NICU) (C-1769)
(ECIBC) and the development of the person-centered J. Deakin; London/UK
new European guidelines (C-1470) » The role of diffusion tensor imaging (DTI) in
A. Uluturk Tekin; Varese/IT developmental brain anomalies in pediatric age
» Reduction mammoplasty: what radiologists should group of Egyptian patients (C-2097)
know (C-1558) D.H.F.H. Haroun; Cairo/EG
S. Plaza Loma; Valladolid/ES » Patient size and radiation dose: a grid too far?
» Is there a place for dual-energy contrast enhanced (C-2129)
digital mammography in daily practice? (C-1746) J. Shur; London/UK
I. Garkalne; Merchtem/BE » Serial flow-sensitive 4D MRI in paediatric patients
» The accuracy of MRI in evaluating residual tumour with Marfan syndrome for early risk stratification of
size and complete response post neoadjuvant progressive aortic disease (C-2156)
chemotherapy in patients with non metastatic breast J. Geiger; Zurich/CH
cancer (C-1869)
H.A. Fleming; Cork/IE
» Can breast cancer biopsy influence sentinel lymph
node status? (C-2149)
R. Rella; Rome/IT
» Quantitative 1HMR spectroscopy as a predictive
biomarker of pathological complete response
during neoadjuvant chemotherapy for localy
advanced breast cancer: results from early response
assessement (C-2382)
S. Drisis; Brussels/BE

THE VOICE OF EPOS
5
5
VoE 27 German VoE 28 Musculoskeletal
Moderator: S. Delorme; Heidelberg/DE Moderator: A. Guermazi; Boston, MA/US

» A web-based and user friendly planning tool to » Referring physicians’ experiences of outsourcing
predict outcome for percutaneous microwave radiological examinations (C-0447)
ablation of liver tumours including validation of the P. Tavakol Olofsson; Stockholm/SE
simulation model (C-0241) » Fat suppression techniques for MR imaging of the
C. Schnedl; Graz/AT musculoskeletal system (C-0585)
» Flip-angle and compliance assessment of the median C. Tsiotsios; Haidari/GR
nerve as diagnostic tools in CTS? (C-0439) » Beyond ulcers and osteomyelitis: imaging of less
L. Gruber; Innsbruck/AT common musculoskeletal complications in diabetes
» Development of an analogue decision aid for (C-0775)
mammographic mass lesions based on a naive Bayes A. Rao; Bangalore/IN
network (C-0704) » Clinical evaluation of a new x-ray imaging system
M. Benndorf; Freiburg/DE based on Talbot-Lau interferometry: comparison of
» Radial volumetric interpolated breath-hold patients with RA to healthy volunteers (C-0953)
examination of the liver: clinical impact of self- J. Tanaka; Iruma-County/JP
gated 3D isotropic contrast-enhanced late-phase MR » Calcific tendonitis affecting the linea aspera: a case
imaging (C-1032) series and systematic narrative review (C-1310)
J. Weiß; Tübingen/DE S.B.L. Low; Norwich/UK
» MRI-derived regional biventricular function in » Diagnostic benefit of susceptibility weighted
patients with chronic thromboembolic pulmonary magnetic resonance imaging for the assessment of
hypertension (CTEPH) before and after pulmonary subacromial spur formation causing subacromial
endarterectomy (PEA) (C-1677) impingement syndrome (SAIS) (C-2039)
S. K. Maschke; Hanover/DE D. Nörenberg; Munich/DE
» Cloud-based teleoncology system for interactive » “Fat brook” of posteromedial popliteal fossa:
evaluation of new software tools through common pathologic correlation between cadaver and MR
web browsers and its application to multi-disciplinary imaging (C-2172)
treatment planning (C-1829) Y. Song; Seoul/KR
J. Woetzel; Bremen/DE
» Can we predict fracture in pathologic altered bone
» Breast cancer detection and tumour characteristics of the proximal femur using only plain radiographs?
differ in BRCA1 and BRCA2 mutation carriers (C-2131) (C-2194)
J. Knaudt; Mannheim/DE M. Simunovic; Zagreb/HR
» Flow velocity determination by magnetic » Low-energy laser therapy efficacy assessment by MRI
particle imaging: phantom validation and in vivo in patients with herniated intravertebral discs
measurements in a mouse model (C-2215) (C-2281)
M. Kaul; Hamburg/DE A. Tkachev; Volgograd/RU
» In vivo visualisation of tumour-mediated immune » Predicting poor outcome from simple ankle injuries
remodelling in premetastatic tissue - target-specific (C-2371)
imaging of S100A8/A9 reveals premetastatic niche S. Bullock; Oxford/UK
establishment (C-2334)
M. Eisenblatter; Münster/DE

THE VOICE OF EPOS
5
5
VoE 29 Korean VoE 30 Portuguese
Moderator: J.M. Goo; Seoul/KR Moderator: V.F. Muglia; Ribeirao Preto/BR

» Adenovirus pneumonia: thin-section CT findings in » CT role in distinguishing GIST from non-GIST
104 immunocompetent patients (C-0224) mesenchymal gastric tumours (C-0686)
C. Park; Daejeon/KR N. Almeida Costa; Porto/PT
» Abnormalities in intrahepatic periportal space: » Borderline breast lesions: Correlation between
multimodality imaging findings (C-0541) imaging, epidemiology and histology - 7 years of
J.Y. Oh; Busan/KR experience (C-1121)
» Guideline for repeat imaging studies: nationwide G.G.N. Mello; São Paulo/BR
result of pilot project for application of the guideline » Do not fall on your knees - recognizing common and
(C-0544) uncommon pitfalls that may simulate meniscal tears
S.E. Jung; Seoul/KR (C-1146)
» Role of CT in siting and post procedural following P. Musa Aguiar; São Paulo/BR
of central venous catheter: anatomical review and » Prognostic value of baseline MRI in glioblastoma
strategy for preventing complication (C-0952) multiforme patients: a survival analysis of
E.-J. Kang; Busan/KR morphological, volumetric and diffusion MRI
» Corrosive esophageal cancer: esophagographic and predictors (C-1179)
computed tomography (CT) findings (C-1154) D.J. Pereira; Coimbra/PT
S.Y. Noh; Seoul/KR » Breast fibromatosis: the great pretender (C-1238)
» Distinct pattern of recurrence of lung mucinous C. Salvador; Lisbon/PT
adenocarcinoma after surgical resection: implication » The role of ultrasonography with colour Doppler in
for postoperative surveillance strategy (C-1697) the acute scrotum (C-1509)
D.H. Lee; Daegu/KR A.L. Amado Costa; Lisbon/PT
» Ankle after Brostrom operation: MR imaging findings » The immediate effect of sildenafil on right ventricular
in individuals without lateral instability - a pilot study function in patients with heart failure measured by
(C-2171) cardiac magnetic resonance: a randomized controlled
J. Yi; Bucheon-si/KR trial (C-1586)
» Reproducibility and diagnostic performance of shear S.M. Borges; Salvador/BR
wave elastography in evaluating breast solid mass » Imaging findings after breast implant removal
(C-2176) (C-1888)
H.S. Shin; Seoul/KR E. Francolin; São Paulo/BR
» Fluoroscopic-guided artificial pneumoperitoneum » Radioprotection in paediatric CT examinations:
formation for the management of air leak after application of a dose reduction protocol (C-2363)
pulmonary resection (C-2299) B.P.M. Morgado; Vila Real de Santo António/PT
H.Y. Choi; Seoul/KR
» Evaluation of the antiperistaltic effect of intravenous
butylscopolamine in pediatric magnetic resonance
enterography (C-2368)
S. Jang; Seoul/KR

THE VOICE OF EPOS
5
6
March Sunday, March 6, 09:00–10:00
VoE 31 Interventional VoE 32 Vascular
Moderator: A. Basile; Catania/IT Moderator: I. Bargellini; Pisa/IT

» Evidence-based levels, guidelines and » Anomalies and normal variants of the intracranial
recommendations in interventional spine treatments arteries: proposed workflow for classification and
according to clinical diagnoses (C-0324) significance (C-0199)
H. Brat; Sion/CH A. Hakim; Bern/CH
» Percutaneous embolization in pelvic congestive » Anomalous pulmonary venous connection:
syndrome. Does it really improve symptoms? the journey from theory to practice (C-1245)
(C-0708) C. Schiau; Cluj-Napoca/RO
M.D. Ferrer-Puchol; Alzira/ES » All clogged up: spectrum of venous thrombosis in the
» Creating a larger zone of safety versus “livin’ on the abdomen and pelvis (C-1597)
edge”-a review of rare complications of microwave E. Zalaquett; Santiago/CL
ablation (C-0712) » MRI assessment of vascular age:
Y. Zhang; Valhalla, NY/US principles, techniques and applications (C-1909)
» Preoperative thrombus volume predicts sac M.N. Sicaja; Zagreb/HR
enlargement after EVAR (C-1419) » Isolated cortical vein thrombosis: a review of imaging
R. Müller-Wille; Regensburg/DE features and diagnostic pitfall (C-1975)
» Percutaneous transhepatic intraductal biopsy in K.H. Lee; Deajeon/KR
biliary stricture differentiation (C-2029) » Dual source dual energy CT: optimising performance
D. Frantsev; Moscow/RU of routine contrast enhanced chest CT for detection
» Comparison of lesion conspicuity between of pulmonary embolus (C-2054)
conventional ultrasonography and Sonazoid D. Caruso; Rome/IT
contrast enhanced ultrasonography as pretreatment » Distinguishing high-flow from low-flow vascular
evaluation for percutaneous radiofrequency ablation malformations using maximum intensity projection
of small hepatocellular carcinomas (C-2112) images in dynamic magnetic resonance angiography
J.W. Seo; Goyang/KR (C-2297)
» Safety and survival in the management of N.K. Majewska; Poznan/PL
complicated tunneled and non-tunneled catheters: a » Comparison imaging findings in patients with
comparison of over-the-wire catheter exchange and internal carotid artery dissection and vertebral artery
catheter removal and replacement (C-2120) dissection (C-2340)
Y. Yim; Seoul/KR M. Dreval; Moscow/RU
» Radiation exposure to interventional radiologists » Dynamic CT angiography in native kidneys using
during endovascular procedures (C-2124) a multiphase CT protocol - potential of significant
A.M.H. Sailer; Maastricht/NL reduction of contrast medium (C-2389)
» Transarterial embolisation of type II endoleaks after A. Helck; Munich/DE
EVAR with the use the embolic polymer Onyx
(C-2146)
M. Wojtaszek; Warsaw/PL

THE VOICE OF EPOS
6
6
VoE 33 Oncology VoE 34 Cardiac
Moderator: S. Delorme; Heidelberg/DE Moderator: E. Mershina; Moscow/RU

» Pain palliation in metastatic bone disease: » Syntax score in patients with high computed
interventional radiology is a “key player” among tomography coronary calcium score (C-0243)
equals (C-1299) M. Hegde; Bengaluru/IN
D.K. Filippiadis; Marousi, Athens/GR » Assessment of left ventricular dissipative energy loss
» PET/CT in diagnosis of synchronous and by vector flow mapping in end stage senal disease
metachronous tumours (C-1528) patients (C-0670)
D. Zlatareva; Sofia/BG Y. Zhong; Chengdu/CN
» Elastofibroma dorsi: diagnosis and follow-up (C-1640) » Feasibility of low-concentration iodinated contrast
M. Bartocci; Rome/IT medium with lower-tube-voltage dual-source
» The copycat - an illustrative review of benign entities CT aortography using iterative reconstruction:
that may mimic malignancy from head to toe (C-1719) comparison with automatic exposure control CT
C. Azzopardi; Birkirkara/MT aortography (C-0702)
D.M. Choo; Daejeon/KR
» Compare multiparametric 3TMRI to clinical
parameters to characterise single lesion of prostate » Vessel flexibility index as a potential new marker for
cancer, using three different scores: Likert scale, cardio-vascular disease - a pilot study (C-1535)
PIRADS v1 and v2 (C-2157) E. Nagy; Graz/AT
L. Zantedeschi; Verona/IT » Dynamic CT cardiac perfusion protocol at 70 kV:
» Diffusion weighted MRI; can it help in differentiation impact on radiation and contrast agent dose (C-2073)
of abdomino-pelvic lymphadenopathy; comparative N. Buls; Brussels/BE
study (C-2266) » Relation between left atrial appendage morphology
M. Essam; Cairo/EG and left atrial volume in patients with atrial
» Impact of structuring a computed tomography fibrillation (C-2082)
(CT) report on radiological practice and clinicians’ R. Faletti; Turin/IT
perception: a study on lymphoma patients (C-2271) » Rationale and design of the PERFECTION (C-2083)
R. Girometti; Udine/IT G. Pontone; Milan/IT
» Increased reproducibility of semiautomatic » Occult coronary artery disease in asymptomatic
3D-segmentation over 2D-measurements for patients: utility of coronary computed tomography
quantification of specific iodine uptake of hepatic angiography as a screening tool (C-2164)
colorectal metastases in dual-energy CT (C-2308) L. Patriarca; L’Aquila/IT
K.S. Winter; Munich/DE » Determination of scan delay time in coronary CT
» Increased abdominal visceral adiposity is associated angiography: utility of ECG gated bolus tracking
with unsuspected pulmonary embolism in technique (C-2221)
hospitalised patients with malignant digestive tract J. Chang; Seoul/KR
tumours (C-2325) » Peri-aortic fluid after surgery of the ascending aorta:
L. Lin; Guangzhou/CN range of normal findings on early postoperative CT
(C-2331)
S. Boccalini; Genova/IT

THE VOICE OF EPOS
6
VoE 35 Chest
Moderator: M. Toepker; Vienna/AT

» Value of expiratory chest x-rays in diagnosing
pneumothorax (C-0314)
M. Imran; Middlesborough/UK
» Mixed convolution kernel in thoracic computed
tomography images (C-0875)
J. Neubauer; Freiburg/DE
» Pulmonary imaging in ANCA-associated vasculitides
(C-1473)
M. Affes; Ariana/TN
» Complications of tuberculous mediastinal
lymphadenitis in HIV-positive patients: CT findings
(C-1525)
I. Sokolina; Moscow/RU
» A quantitative CT analysis in the evaluation of lymph
node involvement of pulmonary tuberculosis and
sarcoidosis (C-1721)
H. Choi; Seoul/KR
» A novel classification system for thoracic gallstones
(C-2155)
A.J.S. Lott; Tromso/NO
» Influence of computed tomography dose reduction
and iterative reconstruction on computer-aided
detection of pulmonary nodules (C-2186)
R. W. van Hamersvelt; Utrecht/NL
» Influence of arterial input function placement on CT
lung dynamic perfusion maps (C-2229)
N.S. Paul; Toronto, ON/CA
» Subclinical pulmonary tuberculosis and airway
obstruction: correlation of HRCT findings with
pulmonary function test and immunologic diagnostic
test of tuberculosis (C-2327)
D.H. Lee; Ansan/KR
» When fat is good news: lipoid pneumonia, an
overlooked differential diagnosis (C-2384)
A.L. Popirtac; Paris/FR

THE VOICE OF EPOS
myESR.org/RisingStars
facebook.com/ESRRisingStars
ECR STUDENT REGISTRATION FOR ONLY € 50

Students and radiographers-in-training under the age of 30, without any academic degree,
can register for just € 50.
SIX BASIC SESSIONS

Renowned professors from all over Europe give basic lectures.
STUDENT SESSIONS
The submitting authors of the best 32 abstracts have been invited to the ECR to present their work,
with their accommodation and travel expenses paid by the European Society of Radiology.

REFRESHER COURSES &
SCIENTIFIC SESSIONS
Refresher Courses, as the name suggests, aim to refresh knowledge, reviewing and
updating the more basic subjects for those who have not kept up to speed with certain
developments, or who just need a reminder – something of interest not only to young
radiologists but also experienced doctors.
The length of each course is 90 minutes (classic Refresher Course: three parts of
30 minutes each, including the introduction and time for discussion; integrated
Refresher Course: three parts of 23 minutes each, leaving enough time for the
introduction by the chairpersons and the panel discussion).
The course will be given by two or three lecturers and led by one or two moderator(s)
on a defined subject of clinical imaging, imaging technique, interventional radiology and
related subjects.
Accepted papers for oral presentation are presented in the Scientific Sessions. Places
are allocated on a first-come, first-served basis.
The authors of the best scientific papers will be presented with a certificate and given
free ECR 2017 registration.
The award will be assigned to the best paper presentation of each topic based on
the evaluation by session moderators and subcommittee members. Selection criteria
comprise quality of presentation, scientific content and overall impression of the
performance. The award winners will be informed after the congress and will be
published on the ESR website.
143
REFRESHER COURSES / SCIENTIFIC SESSIONS

Abdominal and Gastrointestinal
2
3
RC 101 Assessing inflammation and fibrosis RC 501 The many faces of
in Crohn’s disease benign liver lesions

A. Laghi; Latina/IT M. Karcaaltincaba; Ankara/TR
A. Is sonography (CEUS and elastography) A. Vascular [A-131]
the right tool? [A-004] F. Caseiro-Alves; Coimbra/PT
E. Quaia; Trieste/IT
B. Cystic-Biliary [A-132]
B. Is there space for MDCT (spectral imaging, G. Brancatelli; Palermo/IT
iodine map)? [A-005]
C. Hepatocellular [A-133]
J. Podgorska; Warsaw/PL
R.L. Baron; Chicago, IL/US
C. Will MRI (DWI and perfusion) solve the problem?
» Panel discussion: How do I manage an incidental and
[A-006]
potentially benign liver lesion?
S.A. Taylor; London/UK
» Panel discussion: How do I approach a case
in my routine clinical practice? 3
SS 601a Chronic liver disease and primary liver
2
tumours
[B-0408 – B-0417]
SS 201a Pancreas and bile ducts
[B-0001 – B-0011] Moderators: D.E. Malone; Dublin/IE
P. Rodríguez; Madrid/ES
Moderators: B.I. Choi; Seoul/KR
G. Zamboni; Verona/IT
3
March Thursday, March 3, 10:30–12:00, Room O
2
SS 601b Multimodality imaging of Crohn’s
disease
SS 201b A guided tour through the GI tract
[B-0441 – B-0451]
[B-0035– B-0044]
Moderators: S. Gourtsoyianni; London/UK
Moderators: K. Skrobisz-Balandowska; Gdansk/PL
C. Hoeffel; Reims/FR
B.E. Van Beers; Clichy/FR
2 3
SS 701a Functional imaging of liver and spleen
SS 301a Liver metastases: detection,
[B-0591 – B-0601]
characterisation and treatment
response assessment Moderators: P. Leander; Malmö/SE
[K-05, B-0206 – B-0215] A. Wibmer; Vienna/AT
Moderators: E. Kasatkina; Heidelberg/DE

A.M. Riddell; London/UK 3
March Thursday, March 3, 14:00–15:30, Room O
SS 701b Advanced imaging of the oesophagus
2
and stomach
[B-0623 – B-0633]
SS 301b Colon
[K-06, B-0238 – B-0247] Moderators: O. Ekberg; Malmö/SE
M.A. Mazzei; Siena/IT
Moderators: R. Maksimović; Belgrade/RS
T. Mang; Vienna/AT
3
SS 701c Advances in CT
[B-0729 – B-0739]
Moderators: E. Akchurina; Moscow/RU

H. Ringl; Vienna/AT
This session is part of the EuroSafe Imaging campaign.


Abdominal and Gastrointestinal
3
5
RC 801 CT colonography today SS 1401 Advances in abdominal MRI
[B-0974 – B-0984]
M. Hellström; Gothenburg/SE Moderators: K. Coenegrachts; Bruges/BE
A.J. van der Molen; Leiden/NL
A. How I perform it [A-240]
P. Lefere; Roeselare/BE
B. How I interpret it [A-241] 5
March Saturday, March 5, 14:00–15:30, Room M 2
T. Mang; Vienna/AT
SS 1501 Liver fibrosis: imaging assessment
C. Screening with CTC [A-242]
[B-1083 – B-1093]
D. Regge; Turin/IT
» Panel discussion: Challenging cases Moderators: F. Caseiro-Alves; Coimbra/PT
from clinical practice S.K. Venkatesh; Rochester, MN/US
4
5
RC 901 Hepatocellular tumours RC 1601 The spleen:
the forgotten organ
C. Bartolozzi; Pisa/IT » Chairman’s introduction [A-660]
A. The revised adenoma classification [A-315] L.H. Ros Mendoza; Zaragoza/ES
C.J. Zech; Basle/CH A. Acute and chronic splenic disease [A-661]
B. HCC staging: what is new in imaging and can predict G. Zamboni; Verona/IT
prognosis [A-316] B. The incidental splenic lesion [A-662]
C. Ayuso; Barcelona/ES M. Laniado; Dresden/DE
C. Equivocal nodules in cirrhotic patient: how to solve C. Malignant lesions [A-663]
the puzzle [A-317] S. Gourtsoyianni; London/UK
Y. Menu; Paris/FR
» Panel discussion: How to manage incidental findings
» Panel discussion: Impact of imaging on classification in clinical routine practice
and differentiation of hepatocellular lesions
6
4
March Friday, March 4, 10:30–12:00, Room O
RC 1701 Differential diagnosis
SS 1001a Rectal cancer: staging and restaging in pancreatic imaging
[K-20, B-0773 – B-0782]
Moderators: L. Curvo-Semedo; Coimbra/PT
B. Marincek; Cleveland, OH/US
A. Plumb; London/UK
A. Pancreatic cancer or pancreatitis [A-722]
R. Manfredi; Verona/IT
4
March Friday, March 4, 10:30–12:00, Room F2 B. Cystic tumours vs pseudocysts [A-723]
SS 1001b Hepatocellular carcinoma: M.A. Bali; Brussels/BE
evaluation of therapeutic response C. Incidental findings [A-724]
[B-0835 – B-0845] C. Stoupis; Männedorf/CH
» Panel discussion: How do we manage difficult cases
Moderators: D. Akata; Ankara/TR and incidental findings?
L. Crocetti; Pisa/IT
6
5
SS 1901a Benign and malignant pancreatic
RC 1301 IgG4-related disease: what is it and diseases [K-33, B-1263 – B-1272]
what do I need to know?
Moderators: J.M. Lee; Seoul/KR
» Chairman’s introduction [A-507] M. Spirovski; Sremska Kamenica/RS
S.A. Jackson; Plymouth/UK
A. Pancreatic manifestations [A-508] 6
R. Pozzi-Mucelli; Verona/IT
B. Hepatobiliary manifestations [A-509]
SS 1901b Abdominal surgery:
M. Ronot; Clichy/FR the added value of radiology
[B-1295 – B-1304]
C. Systemic manifestations [A-510]
G. Morana; Treviso/IT
Moderators: I. Dudás; Budapest/HU
» Panel discussion: Tips and tricks in clinical practice D. Vorwerk; Ingolstadt/DE


Breast
2
March Wednesday, March 2, 08:30–10:00, Room F2
3
RC 102 Breast ultrasound 2016 SS 702 Breast MRI-DWI (1)
[B-0602 – B-0612]
Moderator: A. Athanasiou; Athens/GR
A. Evidence for screening in dense breasts [A-024] Moderators: F. Pediconi; Rome/IT
V. Girardi; Brescia/IT F. Thibault; Paris/FR
B. Elastosonography: true advances or false hope? [A-025]
C.S. Balleyguier; Villejuif/FR 4
C. Nodal staging of breast cancer: still needed? [A-026]
F. Kilburn-Toppin; Cambridge/UK SS 1002 Breast MRI-DWI (2) and various MRI
applications
[B-0751 – B-0761]
2
Moderators: M. Di Matteo; Rome/IT
SS 202 Breast biopsy
S.H. Heywang-Köbrunner, Munich/DE
[B-0012 – B-0022]
Moderators: S. Allen; Sutton/UK 5

V. Girardi, Brescia/IT
RC 1302 Tailoring breast cancer screening
to risk level
2
Moderator: R.M. Pijnappel; Utrecht/NL
SS 302 Breast innovation, biomarkers
[B-0216 – B-0226] A. Calculating, using and improving individual risk
estimates [A-549]
Moderators: C.S. Balleyguier; Villejuif/FR S.W. Duffy; London/UK
M.H. Fuchsjäger; Graz/AT B. Intermediate risk: the grey zone [A-550]
S.H. Heywang-Köbrunner; Munich/DE
2
C. High risk: MRI alone? [A-551]
F. Sardanelli; San Donato Milanese/IT
RC 402 Radio-pathological correlation:
more important 5 Saturday, March 5, 10:30–12:00, Room C
than you thought March
SS 1402a Screening
» Chairman’s introduction [A-089] [B-0920 – B-0930]
Moderators: S. Perez Rodrigo; Madrid/ES
A. Pre-treatment planning [A-090]
C.K. Kuhl; Aachen/DE
B. Intra-operative specimen evaluation [A-091]
J. Camps Herrero; Valencia/ES 5
C. The breast radiologist sitting down with
the pathologist [A-092]
SS 1402b Contrast-spectral mammography and
T. Tot; Falun/SE MRI update in background parenchymal
» Panel discussion: How to enhance the interaction
enhancement
between radiologists and pathologists? [B-1061 – B-1071]
Moderators: M. Bernathova; Vienna/AT

3
L.J. Pina Insausti; Pamplona/ES
SS 602a Breast MRI: new sequences and

applications 5
[B-0419 – B-0429] RC 1502 Update on BI-RADS
Moderators: A. Sever; Maidstone/UK Moderator: G. Esen; Istanbul/TR
I. Thomassin-Naggara; Paris/FR
A. Mammography [A-640]
U. Bick; Berlin/DE
3
March Thursday, March 3, 10:30–12:00, Room D1 B. Ultrasound [A-641]
A. Evans; Dundee/UK
SS 602b Breast ultrasound
C. MRI [A-642]
[K-12, B-0526 – B-0535]
M.H. Fuchsjäger; Graz/AT
Moderators: B. Brkljačić; Zagreb/HR
A. Domingo; Tarragona/ES


Breast Cardiac
5
2
March Wednesday, March 2, 10:30–12:00, Room N
SS 1502 Breast density: an update SS 203a Cardiomyopathies (1)
[B-1116 – B-1126] [B-0045 – B-0055]
Moderators: I. Baglio, Verona/IT Moderators: F. Bamberg; Tübingen/DE

R. Schulz-Wendtland; Erlangen/DE R. Dore; Pavia/IT
5
2
RC 1602 Tomosynthesis: SS 203b The evolving role of cardiac CT
the new mammography [K-01, B-0174 – B-0183]
Moderator: D. Bernardi; Trento/IT Moderators: F. Cademartiri; Rotterdam/NL

A. Should we abandon 2D mammography? [A-702] G. Feuchtner; Innsbruck/AT
B. Clinical validation and results in the last 5 years: 2
where do we stand? [A-703]
P. Skaane; Oslo/NO SS 303a Cardiomyopathies (2)
C. The future of mammography: my predictions [A-704] [B-0248 – B-0258]
E.M. Fallenberg; Berlin/DE
Moderators: J. Broncano; Cordoba/ES
6
March Sunday, March 6, 10:30–12:00, Room C
SS 1802 Digital breast tomosynthesis: an update 2
[K-27, B-1127 – B-1136]
SS 303b CT perfusion
Moderators: T. Knogler; Vienna/AT [B-0376 – B-0386]
A. Selim; Cairo/EG
Moderators: R. Fischbach; Hamburg/DE
M. Francone; Rome/IT
6
SS 1902a Multiparametric breast MRI, PET 2
[K-34, B-1253 – B-1262]
RC 403 Imaging of cardiac valves:
Moderators: E.M. Fallenberg; Berlin/DE new trends
G. Forrai; Budapest/HU
Moderator: G. Roditi; Glasgow/UK
A. Echocardiography remains the reference technique
6
March Sunday, March 6, 14:00–15:30, Room C [A-113]
F. Knebel; Berlin/DE
SS 1902b Preoperative imaging, neoadjuvant
B. MRI is the best comprehensive approach [A-114]
chemotherapy, imaging of the axilla
M. Francone; Rome/IT
[B-1273 – B-1283]
C. Does CT have a role in diagnosing valvular disease?
Moderators: C. Dromain; Villejuif/FR [A-115]
P. Panizza; Milan/IT G. Feuchtner; Innsbruck/AT
3
RC 503 Novel ways to assess
myocardial tissue
Moderator: G. Bastarrika; Pamplona/ES

A. T1 mapping: technical considerations [A-186]
M.R. Makowski; Berlin/DE
B. T2 mapping: technical considerations [A-187]
C. Tessa; Lido di Camaiore/IT
C. Clinical use of T1 and T2 mapping [A-188]


Cardiac Chest
3
March Thursday, March 3, 10:30–12:00, Room N
2
SS 603 Evolving techniques RC 104 Pneumonia
[B-0452 – B-0462]
Moderators: A.J.B.S. Madureira; Porto/PT I.E. Tyurin; Moscow/RU
M. Meyer; Mannheim/DE
A. Community-acquired pneumonia [A-028]
I. Hartmann; Rotterdam/NL
3
B. Tuberculosis [A-029]
E. Castañer; Sabadell/ES
SS 703 Epidemiology, prognosis and trials C. Fungal pneumonia in immunocompromised hosts
[B-0740 – B-0750] [A-030]
J. Mayer; Heidelberg/DE
Moderators: C. Colantoni; Milan/IT
K. Gruszczynska; Katowice/PL » Panel discussion: What is the role of radiologists in
the diagnosis and management of lung infections?
3
March Thursday, March 3, 16:00–17:30, Room M 2 2
RC 803 Imaging of heart failure
SS 204 Pulmonary vessels and perfusion
C. Loewe; Vienna/AT
Moderators: E.E.J.G. Coche; Brussels/BE
A. Current ESC and AHA guidelines: how to choose J. Dinkel; Munich/DE
imaging techniques in heart failure patients? [A-299]
J.T. Ortiz-Pérez; Barcelona/ES
B. Differentiating the causes for heart failure: 2
is MRI the indisputable gold standard? [A-300]
SS 304 Lung MRI
T. Leiner; Utrecht/NL
[B-0312 – B-0322]
C. SPECT as an alternative imaging technique [A-301]
F. Caobelli; Hannover/DE Moderators: P. Ciet; Rotterdam/NL
» Panel discussion: What is the preferred W.F.M. De Wever; Leuven/BE
comprehensive imaging test in heart failure?
2 Wednesday, March 2, 16:00–17:30, Room D1

4 Friday, March 4, 10:30–12:00, Room N
March
March RC 404 Pulmonary embolism -
SS 1003 CT of the coronary arteries persistent controversies
[K-21, B-0783 – B-0792]
Moderators: D. Brisbois; Liège/BE M. Rémy-Jardin; Lille/FR
J.M. Kerl; Darmstadt/DE
A. Subsegmental PE, incidental PE: diagnosis and
management [A-094]
5
C.M. Schaefer-Prokop; Amersfoort/NL
B. CT not available, contraindicated, or inconclusive:
SS 1503 Interventional applications what to do? [A-095]
[B-1072 – B-1082] E.J.R. van Beek; Edinburgh/UK
C. Can we predict outcome from imaging? [A-096]
Moderators: D. Maintz; Cologne/DE
B. Ghaye; Brussels/BE
E. Pershina; Moscow/RU
» Panel discussion: How to optimise patient
management?
6
SS 1803 MR (1)
[B-1148 – B-1158]
Moderators: A. Jacquier; Marseille/FR

K. Pagonidis; Iraklion/GR
6
SS 1903 MR (2)
[B-1305 – B-1315]
Moderators: A. Esposito; Milan/IT

C. Herzog; Munich/DE


Chest
3
4
RC 504 HRCT - patterns in chest radiology: RC 1204 Occupational lung diseases:
back to basics and beyond the known and the less known

H. Prosch; Vienna/AT N. Karabulut; Denizli/TR
A. Secondary pulmonary lobule anatomy: A. Silicosis and coal workers’ pneumoconiosis [A-470]
essential to tackle with the nodular pattern [A-166] K. Marten-Engelke; Göttingen/DE
T. Frauenfelder; Zurich/CH B. Asbestos-related disease [A-471]
B. Linear and reticular pattern [A-167] S.J. Copley; London/UK
F. Molinari; Lille/FR C. Hypersensitivity pneumonitis [A-472]
C. Ground glass opacities (GGO) and consolidation P.-Y. Brillet; Bobigny/FR
[A-168] » Panel discussion: What are the key findings for
J. Vogel-Claussen; Hannover/DE diagnosing occupational lung diseases?
» Panel discussion: Is it always easy to detect
a pattern? Tips for success 5
SS 1404 Chest CT dose reduction
3
[K-25, B-0985 – B-0994]
SS 604 Spectral CT, advanced CT analysis and Moderators: T. Henzler; Mannheim/DE
emphysema D. Tack; Baudour/BE
[B-0580 – B-0590]
Moderators: F. Molinari; Lille/FR
M. Silva; Parma/IT
5
RC 1504 Mediastinal disease revisited
3
March Thursday, March 3, 14:00–15:30, Room D1 Moderator: A. Persson; Linköping/SE
SS 704 Lung cancer A. The crucial role of chest x-ray:
[K-16, B-0676 – B-0685] mediastinal lines and stripes [A-643]
E.E.J.G. Coche; Brussels/BE
Moderators: G. Aviram; Tel Aviv/IL B. Mediastinal masses: role of CT [A-644]
E. Jon; Vitoria/ES M. Occhipinti; Rome/IT
C. A new look at the mediastinum:
4
role of MRI and PET/CT [A-645]
F.L. Giesel; Heidelberg/DE
RC 904 Low dose and no-dose chest imaging:
opportunities and limitations
6
SS 1804 COPD and infiltrative lung diseases
Moderator: A.P. Parkar; Bergen/NO
[K-28, B-1211 – B-1220]
A. Low-dose CT [A-347]
O. Buckley; Dublin/IE Moderators: D. Kienzl-Palma; Vienna/AT
B. MRI [A-348] A. Oikonomou; Toronto, ON/CA
J. Dinkel; Munich/DE
C. US [A-349]
6
F. Gleeson; Oxford/UK SS 1904 Computer-based quantification and
texture analysis
4
[B-1358 – B-1368]
SS 1004 Imaging methods: Moderators: R. Cesar; Golnik/SI

something old, something new M. Regier; Hamburg/DE
[B-0846 – B-0856]
Moderators: E.J. Stern; Seattle, WA/US

M. Toepker; Vienna/AT


Computer Applications Molecular Imaging
2
2
RC 105 Daily use of mobile devices RC 106 Molecular imaging:
in radiology what can we quantify?
» Chairman’s introduction [A-012] Moderator: T.H. Helbich; Vienna/AT

O. Ratib; Geneva/CH A. Advanced MRI techniques [A-042]
A. What did mobile devices change in radiology C.A. Cuénod; Paris/FR
education? [A-013] B. Advanced PET imaging techniques [A-043]
E. Kotter; Freiburg/DE T. Beyer; Vienna/AT
B. Is it appropriate to read a study on a smartphone or a C. Clinical applications of quantitative hybrid imaging
tablet? [A-014] in oncology [A-044]
E. Neri; Pisa/IT L. Umutlu; Essen/DE
C. Security and ethical issues of mobile device
technology [A-015]
E.R. Ranschaert; ‘s-Hertogenbosch/NL 2
March Wednesday, March 2, 10:30–12:00, Room Z
» Panel discussion: Will mobile technology overcome SS 206 PET/CT and MR in oncology
stationary technology in radiology?
[B-0023 – B-0033]
2
March Wednesday, March 2, 14:00–15:30, Room Z Moderators: S. Chatziioannou; Athens/GR
SS 305 Developing tools for clinical workflow E. Lopci; Rozzano/IT
management
[B-0227 – B-0237]
4
Moderators: L. Faggioni; Pisa/IT
B. Gibaud; Rennes/FR RC 906 Preclinical imaging as a driver
for translational research:
3 Thursday, March 3, 10:30–12:00, Room Z
March how I do it
SS 605 Image processing techniques (1)
[B-0430 – B-0440] » Chairman’s introduction [A-363]
J. Hodler; Zurich/CH
Moderators: S. Bickelhaupt; Heidelberg/DE
M. de Bruijne; Rotterdam/NL A. Preclinical MR/PET imaging of cancer [A-364]
C. Kuntner-Hannes; Seibersdorf/AT
5
March Saturday, March 5, 10:30–12:00, Room N B. What about nano-technology? [A-365]
F.M.A. Kiessling; Aachen/DE
RC 1405 Will the good old
PACS disappear? C. View of the young researcher [A-366]
D. Berritto; Acerra/IT
» Chairman’s introduction [A-579] D. View of the radiographer [A-367]
D. Regge; Turin/IT R. Harris; London/UK
A. It’s time for PACS replacement: how-to guide, » Panel discussion: How to set-up an attractive
recommendations and pitfalls [A-580] programme
S. Morozov; Moscow/RU
B. Enterprise-based vendor-neutral archiving:
is this the future of PACS? [A-581] 4
J. Fernandez-Bayó; Sabadell/ES
SS 1006 Advanced hybrid imaging in oncology
C. Does PACS into the cloud means PACS evaporates? [A-582] [K-22, B-0899 – B-0908]
J. Schillebeeckx; Knokke/BE
» Panel discussion: How will increased interconnection Moderators: A.M. Herneth; Vienna/AT
affect radiologist’s day-to-day life? N.N.
6 Sunday, March 6, 10:30–12:00, Room Z

March
5 Saturday, March 5, 10:30–12:00, Room Z
SS 1805 Image processing techniques (2) March
[B-1137 – B-1147] SS 1406 Advanced experimental imaging

Moderators: A. Alberich-Bayarri; Valencia/ES [B-0931 – B-0941]
U. Bick; Berlin/DE
Moderators: S. Walker-Samuel; London/UK
6
March Sunday, March 6, 14:00–15:30, Room Z
B. Wängler; Mannheim/DE
SS 1905 Quality control and

safety issues in radiology
[K-35, B-1284 – B-1293]
Moderators: R. Salvador; Barcelona/ES
P.M.A. van Ooijen; Groningen/NL


Genitourinary
2
March Wednesday, March 2, 08:30–10:00, Room K
4
March Friday, March 4, 16:00–17:30, Studio 2016
RC 107 Pitfalls in gynaecologic oncologic RC 1207 MRI for gynaecologic imaging:
imaging: how to avoid them and how I do it
minimise risks
» Chairman’s introduction [A-035] C.D. Alt; Düsseldorf/DE
E. Sala; New York, NY/US A. Basics of patient preparation and T2W-imaging
A. Mistakes in assessment of cervical cancer [A-036] [A-451]
K. Downey; London/UK N.M. deSouza; Sutton/UK
B. Mistakes in assessment of endometrial cancer [A-037] B. Contrast agents [A-452]
T.M. Cunha; Lisbon/PT R.A. Kubik-Huch; Baden/CH
C. Mistakes in assessment of ovarian masses [A-038] C. Diffusion and ADC [A-453]
I. Thomassin-Naggara; Paris/FR E. Sala; New York, NY/US
» Panel discussion: How can we improve » Panel discussion: Multiparametric MRI of the female
interdisciplinary communication and avoid pelvis - should it replace tailored protocols?
misunderstanding in our reports?
5 Saturday, March 5, 08:30–10:00, Studio 2016

2
March
RC 1307 Lessons I learned from mistakes

SS 207 Technical advances in kidney and adrenal imaging
[B-0131 – B-0141]
Moderators: U.G. Mueller-Lisse; Munich/DE S.M. Dudea; Cluj-Napoca/RO
R. Turkay; Istanbul/TR
A. Renal cancer [A-526]
T. Bäuerle; Erlangen/DE
2
B. PET/CT in nephrourology [A-527]
SS 307 Prostate cancer: C. Common mistakes in tumour percutaneous
targeted biopsy and beyond radiofrequency ablation [A-528]
[B-0334 – B-0344] J.-M. Correas; Paris/FR
» Panel discussion: How to manage small lesions of the
Moderators: K. Downey; London/UK
kidneys incidentally detected in abdominal imaging
M. Meissnitzer; Salzburg/AT
3 5
SS 1407 Multi-parametric MR of prostate cancer:
SS 607a Female pelvis
an update
[K-13, B-0463 – B-0472]
[K-26, B-0942 – B-0951]
Moderators: O. Nikolic; Novi Sad/RS
K. Pyra; Lublin/PL Moderators: D. Junker; Innsbruck/AT
3
SS 607b New frontiers:
urolithiasis and renal function
[B-0569 – B-0579]
Moderators: M.-F. Bellin; Le Kremlin-Bicêtre/FR

J. Lopes Dias; Lisbon/PT
3
SS 707 Prostate cancer:
routine and novel MRI techniques
[B-0697 – B-0707]
Moderators: D. Bonekamp; Hirschberg/DE

N.C. Cowan; Portsmouth/UK


Genitourinary Head and Neck
6
March Sunday, March 6, 08:30–10:00, Studio 2016
2
RC 1707 Prostate imaging: how I do it SS 208 Orbits and olfaction
[K-02, B-0153 – B-0162]
H.-P. Schlemmer; Heidelberg/DE Moderators: L.S. Politi; Worcester, MA/US
T. Rodt; Hannover/DE
A. Detection and assessment of aggressiveness [A-740]
P. Puech; Lille/FR
B. Image-guided biopsy and staging [A-741]
2
J.J. Fütterer; Nijmegen/NL SS 308 Salivary glands, neck, parathyroid
C. Role of imaging in active surveillance and detection [B-0355 – B-0365]
of recurrence [A-742]
V. Logager; Copenhagen/DK Moderators: G. Conte; Milan/IT
» Panel discussion: Multiparametric MRI: what are the C. Czerny; Vienna/AT
challenges and strategies to solve these?
2
6
March Sunday, March 6, 10:30–12:00, Room K
RC 408 Head and neck imaging:
don’t sell your ultrasound yet!
SS 1807 Tumours of the urinary tract and
adrenals Moderator: D.-A. Varoquaux; Marseille/FR
[B-1232 – B-1242] A. Salivary gland imaging with ultrasound [A-072]
S. Colley; Birmingham/UK
Moderators: G. Heinz-Peer; St. Pölten/AT
B. Masses of the soft parts of the neck [A-073]
R. Huzjan Korunić; Zagreb/HR
C. Lymph nodes: differential diagnosis and
6
March Sunday, March 6, 14:00–15:30, Room L8
fine-needle aspiration [A-074]
R. Maroldi; Brescia/IT
SS 1907 Imaging of the reproductive system
[B-1326 – B-1335] 3
Moderators: G. Masselli; Rome/IT RC 508 Pathways for tumour spread
K.B. Puzakov; Moscow/RU
Moderator: R. Hermans; Leuven/BE
A. Pathways for oral cavity and oropharynx
tumour spread [A-141]
A. Borges; Lisbon/PT
B. Pathways for nasopharyngeal tumour spread
including perineural spread [A-142]
V. Chong; Singapore/SG
C. Pathway for laryngeal and hypopharyngeal
tumour spread [A-143]
R. Kohler; Sion/CH
3
SS 608 Pre- and post-operative imaging
in oncology
[B-0558 – B-0568]
Moderators: A. Borges; Lisbon/PT

S. Steens; Nijmegen/NL
3
SS 708 Temporal bone
[K-17, B-0719 – B-0728]
Moderators: S. Kösling; Halle a.d. Saale/DE

K. Markiet; Gdansk/PL


Head and Neck Interventional Radiology
3
2
RC 808 Paediatric: how we do head and neck RC 109 Image fusion for image-guided
imaging in children interventions
Moderator: N.J.M. Freling; Amsterdam/NL » Chairman’s introduction [A-045]

A. Temporal bone [A-252] A. Adam; London/UK
B. De Foer; Antwerp/BE A. Cone-beam CT in vascular and non-vascular
B. Oral, paranasal sinuses and orbit [A-253] interventional procedures [A-046]
M. Lell; Erlangen/DE T.F. Jakobs; Munich/DE
C. Cysts and lumps in the neck [A-254] B. US image fusion [A-047]
A. Ailianou; Geneva/CH G.H. Mostbeck; Vienna/AT
C. How can we improve targeting in image-guided
4
interventions: stereotaxis, robotics and advanced
techniques [A-048]
SS 1008 Maxillofacial imaging L.A. Solbiati; Rozzano/IT
[B-0877 – B-0887] » Panel discussion: Practical and economic issues in
using high-end guidance for interventional radiology
Moderators: N.I. Traykova; Plovdiv/BG
G. Widmann; Innsbruck/AT
2
5
SS 209 Ablation outside the liver
[B-0120 – B-0130]
RC 1308 Pitfalls in interpretation of head and
neck disease Moderators: G. Carrafiello; Varese/IT
M. Tsitskari; Athens/GR
Moderator: J. Frühwald-Pallamar; Vienna/AT
A. Anatomical variants without clinical consequence
[A-522]
2
F.A. Pameijer; Utrecht/NL SS 309 Musculoskeletal
B. Anatomical variants posing surgical risks [A-523] [B-0323 – B-0333]
C. Distinct head and neck disease or systemic disease? Moderators: A. Diamantopoulos; London/UK
[A-524] S. Marcia; Cagliari/IT
B.F. Schuknecht; Zurich/CH
2 Wednesday, March 2, 16:00–17:30, Room M 3
5
March
March Saturday, March 5, 10:30–12:00, Room M 1 RC 409 Basic principles of percutaneous

SS 1408 Thyroid nodules tumour ablation
[B-1017 – B-1027]
Moderators: K.S.S. Bhatia; Shatin/HK T. de Baère; Villejuif/FR
R.K. Lingam; London/UK A. Thermal ablation with RF [A-117]
F. Orsi; Milan/IT
B. Microwave ablation: what is the difference? [A-118]
P.L. Pereira; Heilbronn/DE
C. Cryoablation: ice can be better than heat [A-119]
D.J. Breen; Southampton/UK
D. Irreversible electroporation: principles, technique and
clinical applications [A-120]
A. Nilsson; Uppsala/SE
» Panel discussion: Selection of ablation modalities:
operator’s preference or evidence-based?


Interventional Radiology
3
4
RC 509 Imaging and endovascular treatment of SS 1009 Liver ablation
pulmonary embolism [B-0857 – B-0865]
» Chairman’s introduction [A-189] Moderators: T. Albrecht; Berlin/DE

B. Peynircioglu; Ankara/TR J. Garnon; Strasbourg/FR
A. Imaging algorithm for pulmonary embolism [A-190]

B. Ghaye; Brussels/BE 5
B. What is new in the recently published guidelines for
pulmonary embolism treatment? [A-191] SS 1409 Intra-arterial therapies in the liver
R. Uberoi; Oxford/UK [B-0995 – B-1005]
C. Updates on the endovascular treatment of massive
Moderators: R.F. Dondelinger; Liège/BE
and submassive pulmonary embolism [A-192]
C. Schmid-Tannwald; Munich/DE
S.C. Spiliopoulos; Patras/GR
» Panel discussion: Appropriate diagnosis and risk
stratification in the management of acute massive 6
and acute sub-massive pulmonary embolism
SS 1809 Peri- and postprocedural imaging
[B-1222 – B-1231]
3
Moderators: A. Bharadwaz; Aarhus/DK
SS 609 Non-vascular techniques in the A.D. Kelekis; Athens/GR
abdomen
[B-0536 – B-0546]
6
Moderators: O. Akhan; Ankara/TR
D. Kuhelj; Ljubljana/SI SS 1909 Endovascular
[K-36, B-1369 – B-1378]
3
Moderators: V. Bérczi; Budapest/HU
M. Krokidis; Cambridge/UK
RC 809 Current trends in transarterial
chemoembolisation (TACE) and
radioembolisation for HCC

A. Denys; Lausanne/CH
A. Imaging in therapy planning and follow-up [A-303]
B. TACE and TAE for HCC: new agents, new schedules,
new combinations [A-304]
K. Malagari; Athens/GR
C. Radioembolisation: critical appraisal of techniques
and guidelines for treatment [A-305]
J.I. Bilbao; Pamplona/ES
» Panel discussion: The intermediate HCC patient: how
can we stratify patients and allocate them to different
therapies?


Musculoskeletal
2
March Wednesday, March 2, 08:30–10:00, Room E1
3
RC 110 The elbow: RC 510 Inflammatory arthritis:
a comprehensive approach beyond the radiograph

A. Alcalá-Galiano; Madrid/ES M. Reijnierse; Leiden/NL
A. The tendons: anatomy, pathology and intervention A. Rheumatoid arthritis: what does MRI show and how
[A-021] do I do it? [A-154]
P. Peetrons; Brussels/BE I. Sudoł-Szopińska; Warsaw/PL
B. Ligament injury and instability: what to look for and B. The axial skeleton in spondyloarthritis: conventional
what to say [A-022] radiograph to MRI [A-155]
M.C. De Jonge; Amsterdam/NL R. Campbell; Liverpool/UK
C. Nerve entrapment at the elbow [A-023] C. Ultrasound in inflammatory arthritis:
L.M. Sconfienza; San Donato Milanese/IT what does it show and what does it mean? [A-156]
» Panel discussion: US, CT, conventional MR, high field A. Klauser; Innsbruck/AT
MR: what to choose when? » Panel discussion: How practical is it for radiologists
to support ultrasound and MRI for clinical
rheumatology? Is it something the rheumatologists
2
March Wednesday, March 2, 10:30–12:00, Room E1 should undertake themselves?
SS 210 Trauma and inflammation

[K-03, B-0067 – B-0076] 3
Moderators: R. Hemke; Amsterdam/NL SS 610a Body composition
I.-M. Noebauer-Huhmann; Vienna/AT [B-0484 – B-0494]
Moderators: G. Guglielmi; Andria/IT

2
A.S. Issever; Berlin/DE
SS 310 Ultrasound
[B-0270 – B-0280]
3
SS 610b Cartilage assessment
Moderators: P. Peetrons; Brussels/BE
[B-0547 – B-0557]
L.M. Sconfienza; San Donato Milanese/IT
Moderators: E.H.G. Oei; Rotterdam/NL
2
S. Trattnig; Vienna/AT
RC 410 Bone trauma in the axial skeleton: 3 Thursday, March 3, 14:00–15:30, Room E1
patterns of injury and how I March
describe them SS 710 Muscles

[B-0634 – B-0644]
Moderator: D. Spira; Heidelberg/DE
Moderators: J. Oudeman; Amsterdam/NL
A. Thoracic and lumbar spine [A-075]
V.N. Cassar-Pullicino; Oswestry/UK
B. Pelvis [A-076]
K. Verstraete; Ghent/BE 3
C. Acetabulum [A-077] RC 810 Sports injuries to the knee:
A. Kassarjian; Majadahonda/ES
improving my report

V. Vasilevska Nikodinovska; Skopje/MK
A. Reporting meniscal tears: pitfalls and how I
avoid them [A-261]
G. Andreisek; Zurich/CH
B. The collateral ligaments and posterolateral corner:
what are they, why do they matter and how do I
assess them? [A-262]
U. Aydingoz; Ankara/TR
C. Imaging the reconstructed ACL in athletes:
how to assess and what to report [A-263]
A.P. Parkar; Bergen/NO
» Panel discussion: How will the patient and clinician
be most helped by our report, and is there a role
for structured reporting?


Musculoskeletal Neuro
4
2
SS 1010a Oncology RC 111 Toxic brain disorders
[K-24, B-0804 – B-0812]
Moderator: P. Due-Tønnessen; Oslo/NO
Moderators: S. Boudabbous; Geneva/CH A. Alcohol-related changes in the brain [A-039]
K. Wörtler; Munich/DE M. Knauth; Goettingen/DE
B. Recreational drugs and occupational hazards [A-040]
4
L. Reneman; Amsterdam/NL
C. Treatment-induced effects on the brain parenchyma
SS 1010b Hip and shoulder [A-041]
[B-0909 – B-0918] J. Alvarez-Linera; Madrid/ES
Moderators: S.E. Anderson; Baden/CH

T. Geith; Munich/DE 2
SS 211a Paediatric and epilepsy
4
[B-0077 – B-0087]
RC 1210 Systemic disease: what to look for Moderators: N. Bargalló; Barcelona/ES
in the musculoskeletal system I. Koerte; Munich/DE
Moderator: A. Cotten; Lille/FR

A. Imaging the diabetic foot [A-458]
2
J. Kramer; Linz/AT SS 211b Gadolinium deposition and trauma
B. MSK manifestations of non-malignant [B-0195 – B-0205]
haematological disease [A-459]
A.H. Karantanas; Iraklion/GR Moderators: H. Hanelore; Cluj-Napoca/RO
C. MSK manifestations of renal disease [A-460] A. Rovira-Cañellas; Barcelona/ES
G. Guglielmi; Andria/IT
2
5
March Saturday, March 5, 10:30–12:00, Room E1 SS 311a Cerebral tumours (1)
SS 1410 Applications in CT and MR: something [K-07, B-0281 – B-0290]
old, something new Moderators: A. Falini; Milan/IT
[B-0952 – B-0962] F.P. Kuhn; Zurich/CH
Moderators: A. Cotten; Lille/FR

J. Fereirra, Lisbon/PT 2
SS 311b Dementia
5
March Saturday, March 5, 14:00–15:30, Room E1 [B-0387 – B-0397]
RC 1510 Shoulder MRI: mastering technique and Moderators: N. Pyatigorskaya; Paris/FR
making my report relevant M.A. van Buchem; Leiden/NL

M. Maas; Amsterdam/NL 2
A. The normal MRI: techniques and anatomy [A-628] SS 311c Neurovascular interventions (1)
E. Llopis; Valencia/ES [K-08, B-0398 – B-0407]
B. Rotator cuff tears: what are they and what
do they look like? [A-629] Moderators: A. Biondi; Besançon/FR
K.-F. Kreitner; Mainz/DE H.P. Schemuth; Essen/DE
C. Patterns of instability: what does the MRI show? [A-630]
A.J. Grainger; Leeds/UK 3
» Panel discussion: How are the indications for MR
arthography in the shoulder changing? SS 611 Cerebrovascular disease (1)
[K-14, B-0495 – B-0504]
6
Moderators: K.M. Thierfelder; Munich/DE
P. Vilela; Almada/PT
SS 1810 Ligaments, tendons and joints
[K-29, B-1180 – B-1189]
Moderators: A.H. Karantanas; Iraklion/GR

A. Sachs; Vienna/AT


Neuro
3
5
SS 711 Cerebrovascular disease (2) SS 1411b Cerebral tumours (2)
[B-0645 – B-0654] [B-1050 – B-1060]
Moderators: U. Lamot; Ljubljana/SI Moderators: J.H. Gillard; Cambridge/UK

Z. Merhemic; Sarajevo/BA S. Looby; Dublin/IE
4 Friday, March 4, 10:30–12:00, Studio 2016

5
March March Saturday, March 5, 14:00–15:30, Room G
SS 1011a Neurovascular interventions (2) RC 1511 White spots in the brain
[B-0793 – B-0803]
Moderator: E.T. Tali; Ankara/TR
Moderators: T. Kau; Klagenfurt/AT A. White spots and blots in the brain: what are they?
S. Haller; Geneva/CH [A-655]
4 Friday, March 4, 10:30–12:00, Room E2
B. How can I improve my reporting of T2-hyperintense
March lesions? [A-656]
SS 1011b Cerebrovascular disease (3) A. Rovira-Cañellas; Barcelona/ES
[B-0813 – B-0823] C. Is there a need for quantitative reporting of white
matter lesions? [A-657]
Moderators: M. Buruian; Targu-Mures/RO F. Barkhof; London/UK, Amsterdam/NL
T. Rostovtseva; St. Petersburg/RU
5
4
March Friday, March 4, 16:00–17:30, Room G SS 1511 Multiple sclerosis
RC 1211 Cerebrovascular disease [B-1105 – B-1115]
Moderator: M. Vernooij; Rotterdam/NL Moderators: K.-O. Løvblad; Geneva/CH

R. Woitek; Vienna/AT
A. Vascular distribution territories: arterial and venous
[A-480]
A. Dörfler; Erlangen/DE
5
March Saturday, March 5, 16:00–17:30, Room G
B. Detecting microhaemorrhages: why are they RC 1611 Update on endovascular stroke treatment:
important? What are they? Should we use GRE T2* or a medical breakthrough?
SWI or both? [A-481]
H.R. Jäger; London/UK Moderator: S. Rohde; Dortmund/DE
C. Cerebral perfusion studies in cerebrovascular disease: A. A critical appraisal of the current literature [A-716]
techniques, indications and applications [A-482] W. van Zwam; Maastricht/NL
P.M. Parizel; Antwerp/BE
B. Which techniques can we use to reopen an occluded
cerebral blood vessel? [A-717]
5
T. van der Zijden; Edegem/BE
C. Endovascular stroke treatment: ethical and
RC 1311 Reporting the degenerative economical concerns [A-718]
lumbar spine K.-O. Løvblad; Geneva/CH
Moderator: D. Zlatareva; Sofia/BG 6

A. Disc nomenclature: how I make my report [A-565]
J. Rankine; Leeds/UK SS 1811 Spine
B. Don’t forget the facet joints and posterior elements [K-30, B-1190 – B-1199]
[A-566]
L. van den Hauwe; Antwerp/BE Moderators: S. Morozova; Moscow/RU
J. Van Goethem; Antwerp/BE
C. What to say and not to say in your report [A-567]
M.M. Thurnher; Vienna/AT
6
5 SS 1911 Movement disorders and
March Saturday, March 5, 10:30–12:00, Room E2 neurodegenerative diseases
SS 1411a Cerebrovascular disease (4) [B-1337 – B-1347]
[B-0963 – B-0973]
Moderators: L. Haider; Vienna/AT
Moderators: D. Bos; Rotterdam/NL S. Lehéricy; Paris/FR
C. Calli; Izmir/TR


Paediatric
2
4
SS 212 Brain and neck SS 1012 Abdominal and foetal imaging
[B-0163 – B-0173] [B-0888 – B-0898]
Moderators: P. Gulino; Florence/IT Moderators: G. Kasprian; Vienna/AT

D. Prayer; Vienna/AT G. Papaioannou; Athens/GR
2
4
SS 312 Thorax and musculoskeletal RC 1212 Key issues in paediatric
[K-09, B-0366 – B-0375] imaging
Moderators: C. Balassy; Vienna/AT » Chairman’s introduction [A-443]

Z. Yazici; Bursa/TR J. Portelli; Msida/MT
A. Key issues in the x-ray department [A-444]
2
B. Dose reduction and image quality in paediatric CT
RC 412 Chest imaging in paediatrics [A-445]
R.A.J. Nievelstein; Utrecht/NL
Moderator: W. Hirsch; Leipzig/DE
C. Patient compliance and motion-free protocols
A. Congenital anomalies of the chest [A-069] in general paediatric MRI [A-446]
M. Haliloglu; Ankara/TR G.K. Schneider; Homburg a.d. Saar/DE
B. Lung infection and its complications [A-070] » Panel discussion: What are the essentials in education
M.L. Lobo; Lisbon/PT and training for paediatric imaging?
C. Imaging interstitial lung disease in children:
update 2016 [A-071]
M.P. García-Peña; Barcelona/ES 5
RC 1312 Imaging children with cancer
3
March Thursday, March 3, 08:30–10:00, Room O Moderator: P. Tomà; Rome/IT
RC 512 Imaging of foetus and infant A. Imaging of abdominal masses at diagnosis:
clues for benignity vs malignancy [A-519]
Moderator: A.M. Taylor; London/UK A.M.J.B. Smets; Amsterdam/NL
A. Foetal neuro imaging [A-138] B. From whole body MRI to MR/PET [A-520]
A. Rossi; Genoa/IT J. Schäfer; Tübingen/DE
B. Foetal body imaging [A-139] C. Imaging of complications of therapy [A-521]
F.E. Avni; Lille/FR K. McHugh; London/UK
C. Neonatal urinary tract imaging [A-140]
M. Riccabona; Graz/AT
4
RC 912 Hepatobiliary imaging
in children
Moderator: M. Raissaki; Iraklion/GR

A. Imaging of liver masses [A-318]
H. Woodley; Leeds/UK
B. Imaging of biliary disorders [A-319]
S.G.F. Robben; Maastricht/NL
C. Intervention in the hepatobiliary system [A-320]
S. Franchi-Abella; Le Kremlin-Bicêtre/FR


Physics in Radiology
2
3
RC 113 Single-dual-multi-energy CT RC 513 How to assess and communicate
examination risks to patients and
» Chairman’s introduction [A-031] referring physicians?
J. Damilakis; Iraklion/GR
A. Basics of diagnostic dual energy CT [A-032] » Chairman’s introduction [A-169]
T. Klinder; Hamburg/DE A. Torresin; Milan/IT
B. Photon counting detector technology for A. Radiation risk: a patient’s perspective [A-170]
diagnostic CT [A-033] E. Briers; Hasselt/BE
M. Danielsson; Stockholm/SE B. Radiation risks for patients and staff [A-171]
C. Do we really need multi-energy CT? [A-034] P. Gilligan; Dublin/IE
S.T. Schindera; Basle/CH C. Risk in MRI [A-172]
» Panel discussion: How many energies do R. Peeters; Leuven/BE
we need in CT? D. Communicating risks to patients and the public [A-173]
N. Leitgeb; Graz/AT
2
» Panel discussion: How real are the risks and how do
we communicate them?
SS 213 CT imaging: effects of body size and
use of iterative reconstruction
[K-04, B-0099 – B-0108]
3
Moderators: B.M. Gramer; Munich/DE
A. Jahnen; Esch-sur-Alzette/LU SS 713 Innovations in radiology
[B-0665 – B-0675]
2
March Wednesday, March 2, 14:00–15:30, Room F2 Moderators: Y. Bouchareb; London/UK
R. Raupach; Forchheim/DE
SS 313 Radiation risk assessment
and awareness
[K-10, B-0302 – B-0311] 5
Moderators: N. Buls; Brussels/BE RC 1513 IT tools for dose tracking
O. Ciraj-Bjelac; Belgrade/RS and workflow optimisation
A. Trianni; Udine/IT
2
A. Digital Imaging and Communications in Medicine
(DICOM) standard and Integrating the Healthcare
RC 413 Artefacts and pitfalls Enterprise (IHE) [A-652]
in tomography D. Peck; Detroit, MI/US
B. Patient dose index tracking: a must have? [A-653]
» Chairman’s introduction [A-097] F. Zanca; Leuven/BE
V. Tsapaki; Athens/GR
C. Optimising technique using patient dose index
A. CT [A-098] tracking software: tips and tricks [A-654]
M. Kachelrieß; Heidelberg/DE R.W.R. Loose; Nürnberg/DE
B. PET/CT [A-099] » Panel discussion: Dose index tracking in clinical
T. Beyer; Vienna/AT practice
C. MR/PET [A-100]
H.H. Quick; Essen/DE
» Panel discussion: Imagine imaging without artefacts:
dos and don’ts in your clinical practice


Physics in Radiology Radiographers
5
2
RC 1613 MR: artefacts and devices SS 214 Radiographers’ education:
the curriculum
M. Tosetti; Pisa/IT
A. Image artefacts in MRI and their mitigation [A-713] Moderators: P.H. Hogg; Manchester/UK
D.J. Lurie; Aberdeen/UK Y. Menu; Paris/FR
B. Imaging around metal implants: artefact reduction

in MRI [A-714] 2
C. McGrath; Belfast/IE
C. Artefacts in perfusion and diffusion MRI [A-715] SS 314 CT parameters:
I. Tsougos; Larissa/GR juggling or struggling?
» Panel discussion: Clinically applicable tools/ [K-11, B-0345 – B-0354]
strategies to minimising/avoiding MR imaging
artefacts Moderators: E. Agadakos; Athens/GR

6
SS 1813 Practical radiation 3
risk management March Thursday, March 3, 14:00–15:30, Room G
[B-1200 – B-1210] SS 714 Quality issues in ultrasound and CT
[B-0708 – B-0718]
Moderators: M. Koutalonis; Colchester/UK
R.W.R. Loose; Nürnberg/DE Moderators: C. Beardmore; London/UK
K. Lang; Malmö/SE
6 4
RC 914 State-of-the-art breast imaging
SS 1913 Physics of dual-energy CT and
breast imaging
[B-1348 – B-1357] V. Syrgiamiotis; Athens/GR
Moderators: H. de las Heras Gala; Zorneding/DE
I.A. Tsalafoutas; Athens/GR A. Current status of digital mammography [A-352]
C.E. Mercer; Manchester/UK
B. Developments in digital mammography [A-353]
C. Reis; Lisbon/PT
C. Breast MRI and the future [A-354]
G. Podobnik; Ljubljana/SI
» Panel discussion: The role of multimodality
imaging in breast imaging
4
March Friday, March 4, 10:30–12:00, Room G
SS 1014 High dose antidotes
[B-0866 – B-0876]
Moderators: I. Arkhipova; Moscow/RU

S. Brandão; Porto/PT


Radiographers
5
5
RC 1314 Enhancing research in radiography: RC 1614 Safety issues in medical imaging
a change of culture
Moderators: C. Leidecker; Forchheim/DE
J. Santos; Coimbra/PT
I.M. Björkman-Burtscher; Lund/SE A. Safeguarding patients and staff in MRI [A-708]
J. McNulty; Dublin/IE T. Owman; Lund/SE
A. Radiography research updates: new collaborations B. Safety aspects in an interventional
and initiatives in Europe [A-559] radiology setting? [A-709]
J. McNulty; Dublin/IE D. Catania; Milan/IT
B. FoRRM: a Formal Radiography Research Mentorship C. An introduction to mammography safety:
scheme as an instrument for change [A-560] what can be done? [A-710]
C. Malamateniou; London/UK D. O’Leary; Hertfordshire/UK
C. Translating research evidence into clinical practice D. Safety in CT: dose minimisation and beyond [A-711]
[A-561] R. Booij; Rotterdam/NL
G. Paulo; Coimbra/PT
» Panel discussion: Research: the key to advancing the
profession of radiography?
6
5
RC 1714 The magic of excellent images
SS 1414 Safety and patient care in medical » Chairmen’s introduction [A-763, A-764]
imaging N. Mekiš; Ljubljana/SI
[B-1006 – B-1016] A.P. Parkar; Bergen/NO
A. Image quality optimisation in MRI:
Moderators: A. Henner; Oulu/FI
a radiographer’s perspective [A-765]
D. Miletić; Rijeka/HR
M. Kiss; Miskolc/HU
B. Fine tuning of image quality in computed
5
tomography, the role of the radiographer [A-766]
D. Pekarovic; Ljubljana/SI
RC 1514 Innovative education in medical C. X-ray radiography: tips and tricks for high quality
imaging imaging on the frontline [A-767]
E. Constantarogianni; Athens/GR
» Chairmen’s introduction [A-646, A-647] » Panel discussion: The importance of excellent images
P. Bezzina; Msida/MT for advancing the quality of healthcare
M. Bachmann Nielsen; Copenhagen/DK
A. Is there a role for smartphones and tablets in medical
imaging education? [A-648] 6
F. Girard; Pont de Roide/FR
SS 1814 Getting the radiation dose
B. Using simulators as an innovative teaching tool
as low as possible
in medical imaging [A-649]
P. Cosson; Teeside/UK [K-31, B-1243 – B-1252]
C. Beyond eye candy: developing effective interactive Moderators: H. Ståhlbrandt; Eksjö/SE
animations to enhance MRI learning [A-650] F. Zarb; Msida/MT
D. Koumarianos; Athens/GR
» Panel discussion: What is the value of innovation
in advancing clinical practice and education in
radiography? 6
SS 1914 How to improve image quality in MRI
and mammography
[B-1379 – B-1389]
Moderators: B. Bougias; Ioannina/GR

E. Szabó; Szeged/HU


Vascular
2
March Wednesday, March 2, 10:30–12:00, Room L8
4
SS 215 Vasculopathy: form and function RC 915 Fixing a leaky EVAR
[B-0056 – B-0066]
Moderator: R. Morgan; London/UK
Moderators: M. Reiter; Vienna/AT A. The role of US: Doppler, 3D US, CEUS [A-368]
A. van der Lugt; Rotterdam/NL P. Ricci; Rome/IT
B. 2D and 3D CTA: current concepts [A-369]
2
A. Bücker; Homburg a.d. Saar/DE
C. Endovascular management [A-370]
SS 315 Peripheral arteries: imaging and R. Uberoi; Oxford/UK
therapy
[B-0259 – B-0269]
4
March Friday, March 4, 10:30–12:00, Room Z
Moderators: M. de Bucourt; Berlin/DE
SS 1015 Thoracic aorta: novel imaging and
J.T. Ortiz-Pérez; Barcelona/ES
interventions
[B-0762 – B-0772]
2
March Wednesday, March 2, 16:00–17:30, Room M 1 Moderators: A. Contegiacomo; Rome/IT
RC 415 Basic principles of varicose H. Hoppe; Berne/CH
vein diagnosis and
endovascular treatment
5
Moderator: D. Karnabatidis; Patras/GR
SS 1415 Pulmonary vasculature:
A. Diagnostic cross-sectional imaging [A-110] new and improved
H. Hoppe; Berne/CH
[B-1039 – B-1049]
B. Saphenous vein ablation [A-111]
M. Akesson; Höllviken/SE Moderators: K. Nikolaou; Tübingen/DE
C. Ultrasound guided sclerotherapy [A-112] M. Prokop; Nijmegen/NL
P.F. Sousa; Ermesinde/PT
5 Saturday, March 5, 14:00–15:30, Room M 3

3
March
SS 1515 New observations in visceral imaging

SS 615 Optimising vascular imaging techniques and therapy
[B-0473 – B-0483] [B-1094 – B-1104]
Moderators: A.L.J. Bojanovic; Nis/RS Moderators: J.I. Bilbao; Pamplona/ES

T. Rand; Vienna/AT K. Katsanos; London/UK
3
March Thursday, March 3, 14:00–15:30, Room Z
6
March Sunday, March 6, 10:30–12:00, Room L8
SS 715 Endovascular therapies: what’s new? SS 1815 Abdominal aortic and other aneurysms
[K-18, B-0613 – B-0622] [K-32, B-1170 – B-1179]
Moderators: F. Fanelli; Rome/IT Moderators: I. Bargellini; Pisa/IT

D.K. Tsetis; Iraklion/GR E. Brountzos; Athens/GR
3
RC 815 Carotid artery disease:
so what’s new?
Moderator: T. Jargiello; Lublin/PL

A. The diagnostic assessment of carotid arteries [A-295]
R. Iezzi; Rome/IT
B. Carotid stenting vs endarterectomy:
is the jury back yet? [A-296]
S. MacDonald; Newcastle upon Tyne/UK
C. Carotid interventions in the setting of acute CVA
[A-297]
S. Sencer; Istanbul/TR


Oncologic Imaging
2
3
SS 216a Hepatocellular cancer: characterisation, SS 616 Advanced imaging methods (1)
response and recurrence [B-0505 – B-0515]
[B-0088 – B-0098]
Moderators: V. Panebianco; Rome/IT
Moderators: M.A. Bali; Brussels/BE B.M. Schaarschmidt; Düsseldorf/DE
A. Fohlen; Caen/FR
3 Thursday, March 3, 14:00–15:30, Room F1

2
March
SS 716 Whole body imaging

SS 216b Advanced imaging methods (2) [K-19, B-0655 – B-0664]
[B-0184 – B-0194]
Moderators: J. Sosna; Jerusalem/IL
Moderators: C. Ayuso; Barcelona/ES T.D. Westwood; Manchester/UK
O.V. Kucheruk; Moscow/RU
4 Friday, March 4, 08:30–10:00, Room F1

2
March
RC 916 Diffusion-weighted imaging (DWI)

SS 316 Dealing with metastatic disease in oncology: how I do it
[B-0291 – B-0301]
Moderators: D.M. Lambregts; Amsterdam/NL D.-M. Koh; Sutton/UK
A. Sohaib; London/UK
A. DWI: how to optimise protocols [A-340]
N. Papanikolaou; Iraklion/GR
2
B. DWI in abdominal oncology:
ready for clinical practice? [A-341]
RC 416 Evaluating lymph node involvement: D.M. Lambregts; Amsterdam/NL
an impossible task? C. DWI: whole body imaging [A-342]
V. Vandecaveye; Leuven/BE
» Chairman’s introduction [A-085] » Panel discussion: How to optimise DWI for clinical
D.-M. Koh; Sutton/UK practice?
A. The current criteria for nodal involvement MRI/CTI
[A-086]
W. Schima; Vienna/AT 4
B. Advanced MRI techniques: what do they contribute? SS 1016 Prostate and renal tract cancers:
[A-087]
advanced detection methods
[B-0824 – B-0834]
C. PET and other nuclear medicine techniques [A-088]
T. Barwick; London/UK Moderators: J. Rørvik; Bergen/NO
» Panel discussion: Will imaging ever make diagnostic W. Sommer; Munich/DE
biopsy unnecessary?

3 Thursday, March 3, 08:30–10:00, Room F1
March
March RC 1216 New insights in bone
RC 516 A multidisciplinary approach tumour imaging
to prostate cancer:
can we make a difference? » Chairman’s introduction [A-461]
D. Vanel; Bologna/IT
» Chairman’s introduction [A-161] A. New insights in treatment-associated changes
B. Hamm; Berlin/DE in patients with bone tumours [A-462]
A. The urologist: evidence-based clinical decision C.R. Krestan; Vienna/AT
making [A-162] B. New insights in staging and restaging
B.A. Hadaschik; Heidelberg/DE musculoskeletal tumours [A-463]
B. The radiologist: evidence-based use of J.L. Bloem; Leiden/NL
multiparametric MRI [A-163] C. New insights in imaging for multiple myeloma
H.-P. Schlemmer; Heidelberg/DE [A-464]
C. The interventional radiologist [A-164] G. Sommer; Basle/CH
C. Catalano; Rome/IT » Panel discussion: The future of bone tumour imaging
» Panel discussion: Prostate cancer: evidence-based
multidisciplinary approach to imaging and treatment


Oncologic Imaging Emergency Radiology
5
2
SS 1416 Pelvic and breast cancer RC 117 Abdominal trauma:
[B-1028 – B-1038] does it bleed, will it start bleeding or
is something else leaking?
Moderators: O. Abeyakoon; Cambridge/UK
B.D. Klumpp; Tübingen/DE Moderator: S. Wirth; Munich/DE
A. Liver and spleen [A-049]
6
March Sunday, March 6, 10:30–12:00, Studio 2016
M. Scaglione; Castel Volturno/IT
B. Pancreas, bowel and mesentery [A-050]
SS 1816 Gastrointestinal cancer: prediction and M.A. Patak; Zurich/CH
assessment of therapeutic response C. Urogenital tract [A-051]
[B-1160 – B-1169] R.H. Oyen; Leuven/BE
Moderators: S. Battisti; Rome/IT

L.K. Blomqvist; Stockholm/SE 2
RC 417 ‘Special patients’
6
March Sunday, March 6, 14:00–15:30, Studio 2016 in the emergency room:
when and how to image them?
SS 1916 Assessment and prediction of
treatment response Moderator: U. Linsenmaier; Munich/DE
[K-37, B-1316 – B-1325]
A. Children [A-121]
V. Miele; Rome/IT
Moderators: L.S. Fournier; Paris/FR
A. Gogbashian; Middlesex/UK B. Pregnant patients [A-122]
C. Elderly patients [A-123]
K. Katulska; Poznan/PL
3
SS 617 Cardiothoracic emergencies
[K-15, B-0516 – B-0525]
Moderators: F. Carbonetti; Rome/IT

J.B. Dormagen; Oslo/NO
3
SS 717 Trauma of the brain and body
[B-0686 – B-0695]
Moderators: J.M. Artigas; Zaragoza/ES

F. Mrakic Sposta; Milan/IT
4
RC 917 Acute pain: your friend and enemy
in emergency radiology
» Chairman’s introduction: patients with acute pain -

management and therapeutic pathways [A-375]
J. Walecki; Warsaw/PL
A. Head [A-376]
B. Chest [A-377]
C.N. De Cecco; Charleston, SC/US
C. Abdomen [A-378]
R. Basilico; Chieti/IT
» Panel discussion: Where does radiology fit
in the pathway?

JOINT
SESSIONS
165
JOINT SESSIONS
INVEST
IN THE YOUTH
THIRTEEN YEARS OF INVESTING IN RADIOLOGY’S
NEXT GENERATION
Free registration for the ECR and hotel

accommodation voucher
For more than 4,500 young radiologists and

radiographers from all around the world since 2003
All funded by
The aim of the programme is to give radiologists-in-training under 35 or

radiographers-in-training who are 30 or younger the chance to participate in the
166 ECR 2016 | Final Programme
annual meeting of the ESR. www.myESR.org
JOINT SESSIONS
2
2
EuroSafe Imaging Session 1 EuroSafe Imaging Session 2
Low-dose research in medical EuroSafe Imaging Alliance & Campaign -
radiation protection what is new?
Moderator: L. Rainford; Dublin/IE Moderator: G. Frija; Paris/FR

» Developing a strategic research agenda for » An overview of the EuroSafe Imaging
medical radiation protection: a chance for achievements over the past year [A-078]
advancing research in radiology [A-016] G. Frija; Paris/FR
W. Stiller; Heidelberg/DE » Update on the concept of Diagnostic
» Do iodinated contrast media enhance DNA damage Reference Levels [A-079]
after exposure to ionising radiation? [A-017] P. Vock; Spiegel/CH
G. Frija; Paris/FR » Establishing European Diagnostic Reference Levels
» Dose reduction in modern digital plain-radiography for paediatric imaging: an update on the EC tender
on the basis of indication-specific, standardised project PiDRL [A-080]
quality criteria [A-018] J. Damilakis; Iraklion/GR
D. Spira; Heidelberg/DE » The European paediatric imaging project [A-081]
» Paediatric imaging: are risks of ionising radiation C. Owens; London/UK
exposure established? [A-019] » The EuroSafe Imaging dose management project
H. Ducou le Pointe; Paris/FR [A-082]
This session is part of the EuroSafe Imaging campaign. D. Caramella; Pisa/IT
» AFROSAFE Imaging Alliance and Campaign [A-083]
M.G. Kawooya; Kampala/UG
2
March Wednesday, March 2, 12:30–13:30; Room D2 » Image Wisely and Image Gently: an overview [A-084]
Clinical Trials in Radiology (CTiR) 1 D. Frush; Durham, NC/US
» Panel discussion
Moderators: R.L. Arenson; San Francisco, CA/US Chair: J. Griebel; Neuherberg/DE (HERCA, BfS)
M. Dewey; Berlin/DE Panellists:
» The Swedish CArdioPulmonary BioImage Study M. Perez; Geneva/CH (WHO)
(SCAPIS): objectives and design D. Paez; Vienna/AT (IAEA)
G. Bergström; Gothenburg/SE G. Simeonov; Luxembourg/LU (EC)
Discussant: G. Krombach; Giessen/DE N. Denjoy; Brussels/BE (COCIR)
G. Paulo; Coimbra/PT (EFRS)
» NSsaFe study: observational study on the incidence
of nephrogenic systemic fibrosis in renal impaired This session is part of the EuroSafe Imaging campaign.
patients following gadoteric acid administration
A. Gottschalk; Frankfurt a. Main/DE
Discussant: G. Heinz-Peer; St. Pölten/AT 3
» Computed tomography angiography vs Agatston
Clinical Trials in Radiology (CTiR) 2
score for diagnosis of coronary artery disease:
results from the international Collaborative Meta- Moderators: R.L. Arenson; San Francisco, CA/US
Analysis of Cardiac CT (COME-CCT) M. Dewey; Berlin/DE
V. Wieske; Berlin/DE
» MR-targeted vs TRUS-guided prostate biopsy
Discussant: L. Saba; Cagliari/IT
in patients with high PSA values:
» Efficient use of medical imaging in Belgium: a randomized controlled trial
where does it go wrong in prescribing imaging D. Regge; Candiolo/IT
studies for the lumbar spine and abdomen? Discussant: P. Asbach; Berlin/DE
A national multicentric study
» The multicentre DISCHARGE trial pilot study:
N. Stichelbaut; Ghent/BE
Image quality and protocol adherence results
Discussant: F.J. Gilbert; Cambridge/UK
G. De Rubeis; Rome/IT
Discussant: R. Vliegenthart; Groningen/NL
» Dynamic stress perfusion CT for detection
of inducible myocardial ischemia:
rationale and design of the SPECIFIC-trial
Discussant: S. Kajander; Turku/FI
» The impact of breast MRI on surgical planning and
reoperation rate: first results from the MIPA study
G. Di Leo; San Donato Milanese/IT
Discussant: E.M. Fallenberg; Berlin/DE

JOINT SESSIONS
3
3
EIBIR Session 1 ACR Session (American College of Radiology)
(European Institute for Biomedical Imaging Delivering higher value care in radiology:
Research) how to make it work in clinical practice –
Joint VPH-PRISM/ASSURE Session - perspectives from the American College
from screening to therapy: of Radiology
innovative breast care concepts
Chairpersons: B. Allen, Jr.; Birmingham, AL/US
Moderator: H.K. Hahn; Bremen/DE H.-U. Kauczor; Heidelberg/DE
» Introduction: challenges and innovative approaches » Awareness to accountability: coping with the
in image-based breast care [A-224] mandates for documenting higher-value care [A-288]
H.K. Hahn; Bremen/DE B. Allen, Jr.; Birmingham, AL/US
» Density patterns, breast cancer risk and masking » Radiologists’ role in delivering higher-value care
in screening mammograms [A-225] through population health management [A-289]
C. van Gils; Utrecht/NL W.T. Thorwarth; Reston, VA/US
» Novel ultrasound and MRI technologies for breast » Involving patients in their radiological care:
cancer screening [A-226] radiologist visibility, personalised care and improving
N. Karssemeijer; Nijmegen/NL outcomes [A-290]
D.C. Kushner; Norfolk, VA/US
» Breast cancer risk and masking risk-based
stratification protocols: key drivers of » Questions and answers
cost-effectiveness [A-227]
E. Gray; Manchester/UK
3 Thursday, March 3, 16:00–17:30, Room O
» Histopathology images: the new kid on the block March
of clinical multimodality imaging [A-228] ESR Working Group on Ultrasound

J. van der Laak; Nijmegen/NL Minimising the risk of transmitting
» Quantitative treatment planning, response prediction, infections through ultrasound:
and monitoring [A-229] is current practice sufficient?
K. Pinker-Domenig; New York, NY/US
3
L.E. Derchi; Genoa/IT
» Why is it important to consider infection control
ESOR Session issues in ultrasound? Low- vs high-risk examinations
(European School of Radiology) [A-248]
Advancing clinical practice: C. Nyhsen; Sunderland/UK
role of education » Current accepted practice of ultrasound probe
decontamination in endocarvitary and interventional
Moderators: L. Donoso Bach; Barcelona/ES radiology [A-249, A-250]
N. Gourtsoyiannis; Athens/GR N. Grenier; Bordeaux/FR
» Introduction [A-218] M. Claudon; Vandoeuvre-les-Nancy/FR
L. Donoso Bach; Barcelona/ES » Why current practice may not be safe: main risks of
» ESOR in action 2016 [A-219] infection transmission and published evidence
N. Gourtsoyiannis; Athens/GR [A-251]
H. Humphreys; Dublin/IE
» Role of remodelling in delivering of learning [A-220]
P.R. Ros; Cleveland, OH/US » Panel discussion: Safer practice vs considerable cost
implications: are changes needed and feasible?
» Role of referral guidelines and clinical decision
support systems [A-221]
» MDTs and patient outcomes [A-222]
R.H. Reznek; London/UK
» Role of research and innovation: essential ingredients
for our professional advancement [A-223]
H. Hricak; New York, NY/US
Awards
During the session, scholars and fellows will be
awarded certificates for successfully completing
the 2015 ESOR Scholarship and Fellowship Programmes.

JOINT SESSIONS
4
March Friday, March 4, 08:30–10:00, Room K
4
EFOMP Workshop: MIR @ ECR Session (Management in Radiology)
Radiation protection for the female patient and MIR 1 Communication in radiology
female medical staff
Moderators: B. Hamm; Berlin/DE
(European Federation of
Organisations for Medical Physics)
A. Communication and conflict resolution in radiology:
EF 1 Breast imaging modalities and
how to recruit and retain the best team [A-398]
radiation dose P.R. Ros; Cleveland; OH/US
Moderators: J. Damilakis; Iraklion/GR B. Impact of structured reporting on communication
T. Beyer; Vienna/AT with referring physicians [A-399]
D.P. dos Santos; Mainz/DE
J. Damilakis; Iraklion/GR C. Informed consent in the radiology department:
when and how? [A-400]
» Breast CT: technology and patient dose
L.H.R. Mendoza; Zaragoza/ES
[A-356]
I. Sechopoulos; Nijmegen/NL D. Patients’ expectations in communication
with radiologists [A-401]
» Digital mammography for screening and diagnosis
E. Briers; Hasselt/BE
of breast cancer: breast doses and radiogenic risks
[A-357] » Discussion
O. Morrish; Cambridge/UK
Management in Radiology is a subcommittee
» Digital breast tomosynthesis: physical principles and
of the ESR Professional Organisation Committee.
radiation dose levels [A-358]
G. Gennaro; Padua/IT Those involved in the field of healthcare are experiencing
a time of increasing pressure, stress and change. The de-
This session is part of the EuroSafe Imaging campaign. mand for efficiency and effectiveness in all business and
administrative matters is constantly growing. MIR addresses
current challenges and provides a forum for education and
4
March Friday, March 4, 10:30–12:00, Room K the exchange of ideas and concepts.
EFOMP Workshop:
Radiation protection for the female patient 4
and female medical staff
(European Federation of Joint Session of the ESR and ESMRMB
Organisations for Medical Physics) (European Society for Magnetic
EF 2 Pregnancy and lactation Resonance in Medicine and Biology)
Cardiac MRI
Moderators: P. Sharp; Aberdeen/UK
V. Tsapaki; Athens/GR Moderators: E.R. Danielsen; Copenhagen/DK
J. Bremerich; Basle/CH
P. Sharp; Aberdeen/UK » Overview of cardiac MR methods [A-420]
» Radiation protection of pregnant and
lactating patients in nuclear medicine » Clinical use of MR in congenital cardiac disease [A-421]
[A-391] V. Muthurangu; London/UK
S. Mattsson; Malmö/SE » Clinical use of MR in acquired cardiac disease [A-422]
» Dose management of pregnant patients in x-ray T. Leiner; Utrecht/NL
imaging [A-392]
» Occupational radiation protection: protecting
pregnant or potentially pregnant workers in
interventional radiology [A-393]

JOINT SESSIONS
4
4
EIBIR Session 2 EuroSafe Imaging Session 3
(European Institute for Biomedical Imaging Joint Session of the ESR and HERCA
Research) (Heads of the European Radiological protection
MITIGATE: What does it take to perform clinical Competent Authorities):
trials in interventional radiology? the new EU-BSS Directive -
a step forward to patient safety
S.O. Schönberg; Mannheim/DE » Chairmen’s introduction [A-483, A-484]
W.R. Jaschke; Innsbruck/AT G. Frija; Paris/FR
» Overview on clinical trials in interventional radiology S. Ebdon-Jackson; Didcot/UK
in Europe [A-413] » Overview of EU radiation protection
A. Gangi; Strasbourg/FR legislation [A-485]
» How to implement investigator-initiated or J. Griebel; Neuherberg/DE
industry-sponsored trials in interventional oncology: » Regulators’ expectations [A-486]
SORAMIC vs SIRFLOX [A-414] S. Ebdon-Jackson; Didcot/UK
W. Richter; Berlin/DE
» Tools to support implementation of the BSS Directive:
» Design of a clinical trial in oligometastatic GIST: ESR perspective [A-487]
results from the MITIGATE consortium [A-415] G. Frija; Paris/FR
C. Decristoforo; Innsbruck/AT
» Discussion medical physicists’ perspective [A-488]
4 Friday, March 4, 14:00–15:30, Room D2

March radiographers’ perspective [A-489]
MIR @ ECR Session (Management in Radiology) S.J. Foley; Dublin/IE
MIR 2 Improving quality and safety » Discussion: Regulators’ vs practitioners’ perspective:
in radiology two sides of the same coin
Chairs: . Frija; Paris/FR (ESR)

G
Moderators: E.J. Adam; London/UK
S. Ebdon-Jackson; Didcot/UK (HERCA)
D.A. Koff; Hamilton, ON/CA
A. How to run a safe department? [A-416] Panellists: . Griebel; Neuherberg/DE (HERCA)
J
P. Cavanagh; Taunton/UK J. Damilakis; Iraklion/GR (EFOMP)
S.J. Foley; Dublin/IE (EFRS)
B. Patient satisfaction with radiology
N. Denjoy; Belgium/BE (COCIR)
departments: are we doing our best? [A-417]
C. Is there any evidence for decision support? [A-418] This session is part of the EuroSafe Imaging campaign.
G. Boland; Boston, MA/US
D. Dose monitoring and benchmarking: 4 Friday, March 4, 16:00–17:30, Room Z
opportunities to improve radiation protection [A-419] March
D. Caramella; Pisa/IT EDiR Talk

» Discussion (European Diploma in Radiology)
What you should know about the EDiR
» Chairmen’s introduction:
4
The story of the European Diploma
in Radiology (EDiR) [A-434, A-435]
Image Interpretation Quiz (IIQ) J. Vilar; Valencia/ES
Imaging with the stars Y. Menu; Paris/FR
» Evolution of EDiR [A-436 – A-440]
Moderator: A.G. Rockall; London/UK J. Vilar; Valencia/ES
» Team 1: P.C. Maly Sundgren; Lund/SE
N. Grenier; Bordeaux/FR L. McKnight; Langland/UK
M. Vernooij; Rotterdam/NL V. Iranzo; Barcelona/ES
M. Gardarsdottir; Reykjavik/IS H.T. Sarisoy; Kocaeli/TR
S.A. Taylor; London/UK » EDiR [A-441, A-442]
» Team 2: O. Dicle; Izmir/TR
I. Thomassin-Naggara; Paris/FR E. Jordan; Barcelona/ES
H.R. Jäger; London/UK
A.R. Larici; Rome/IT
T.K. Helmberger; Munich/DE

JOINT SESSIONS
4
4
MIR @ ECR Session (Management in Radiology) EIBIR Session 3
MIR 3 Improving radiology (European Institute for Biomedical Imaging
departments Research)
Gateway to European funding
Moderators: J.K. Bell; Manchester/UK
for research projects
P. Mildenberger; Mainz/DE
A. Health and wellbeing in the workplace [A-473] » Introduction [A-454]
C.L. Cooper; Manchester/UK G.P. Krestin; Rotterdam/NL
B. The role of radiology departments in patient-centred » Maximising your chances to obtain European research
care: requirements for improvement [A-474] funding: opportunities, strategies, services [A-455]
R. Arenson; San Francisco, CA/US P. Zolda; Vienna/AT
C. Key features for organisational and financial » An evaluator’s perspective [A-456]
sustainability [A-475] M. Dewey; Berlin/DE
E. Schouman-Claeys; Paris/FR
» Success story of a maximum score project
D. Clinically relevant reporting in the era in Horizon 2020 [A-457]
of precision medicine [A-476] C.K. Kuhl; Aachen/DE
H. Hricak; New York, NY/US
» Questions and answers
» Discussion
5
4
ESR Patient Advisory Group
Joint Session of the ESR and the EANM
ESR-PAG 1 Patient-centred care in clinical
(European Association of Nuclear Medicine)
radiology: do we really put our
Hybrid imaging:
patients first?
radiology and nuclear medicine
Chairpersons: V. Lewington; London/UK » Chairmen’s introduction [A-529, A-530]

K. Riklund; Umea/SE N. Bedlington; Vienna/AT
P. Cavanagh; Taunton/UK
K. Riklund; Umea/SE » Implementing the ‘driver diagram’ on
V. Lewington; London/UK patient-centred care [A-531]
» Dementia: the role of radiology [A-427]
S. Haller; Geneva/CH » View of a patient representative from the
neurological disease area [A-532]
» Dementia: the role of nuclear medicine [A-428] D. Walsh; Dublin/IE
V. Garibotto; Geneva/CH
» View of a patient with prostate cancer [A-533]
» Prostate cancer: PET/CT in early biochemical relapse E. Briers; Hasselt/BE
[A-429]
E. Lopci; Rozzano/IT » Satisfaction assessment of patient users of
an imaging department: an example from the south
» Prostate cancer: multiparametric MR in the diagnosis of France [A-534]
and clinical management of prostate cancer [A-430] D.-G. Carrié; Toulouse/FR
» Panel discussion: Question to the audience: does your
» Panel discussion: How can collaboration between department perform well in patient-centred care?
radiology and nuclear medicine develop imaging Is it really all about the patient?
and research in hybrid imaging?

JOINT SESSIONS
5
5
ESR Patient Advisory Group EIBIR Session 4
ESR-PAG 2 Mind the gap - data-sharing (European Institute for Biomedical Imaging
for better patient outcomes - Research)
the key issues for patients and The VPH-DARE@IT Project: delivering a clinical
the radiology community decision support platform for earlier dementia
diagnosis
N. Bedlington; Vienna/AT Moderator: Z.A. Taylor; Sheffield/UK
B. Brkljačić; Zagreb/HR » VPH-DARE@IT: towards early, differential diagnosis
» eHealth, EHR and data protection: friend or foe? of dementia [A-600]
[A-585] A. Frangi; Sheffield/UK
P. Mildenberger; Mainz/DE » Clinical platform for data-driven differential
» View of a patient representative from the Pelvic diagnostics of cognitive disorders [A-601]
Pain Support Network [A-586] M. van Gils; Tampere/FI
J. Birch; Poole/UK » Shared research as a service platform for translating
» View of a patient with prostate cancer [A-587] research into clinical practice for dementia [A-602]
E. Briers; Hasselt/BE S. Varma; Sheffield/UK
» Big data in radiology: how will it enhance » In silico characterisation of white matter
personalised medicine? [A-588] microstructure using diffusion MRI [A-603]
H.-U. Kauczor; Heidelberg/DE L. Beltrachini; Sheffield/UK
» Panel discussion: Big data = big issues? » Fluid transport in the ageing brain:
an integrative modelling approach [A-604]
Y. Ventikos; London/UK
5
March Saturday, March 5, 12:55–13:55, Room A » Phenomenological modelling and the RSS [A-605]
W.J. Niessen; Rotterdam/NL
Junior Image Interpretation Quiz (JIIQ)
Millennials showdown: » Discussion
the next generation of radiology
Moderator: F. Arnberg; Stockholm/SE

5
» Team 1: Joint Session of the ESR and ERS
C. Toxopeus; Amsterdam/NL (European Respiratory Society)
A. Gupta; London/UK Imaging of airways:
» Team 2: what the respirologist needs to know
F.G. Meinel; Munich/DE
D. Penha; Lisbon/PT Moderators: N. Karabulut; Denizli/TR
» Team 3: S. Ley; Munich/DE
J.A. Prat-Matifoll; Barcelona/ES » Classification and impact of bronchiectasis [A-623]
O. Urbán; Szeged/HU S. Aliberti; Milan/IT
» Team 4: » How to image and report airway disease? [A-624]
B. Fejér; Budapest/HU P.A. Grenier; Paris/FR
S. Belkacem; Monaco/MC » Role of airway obstruction and remodeling
in the progression of COPD [A-625]
I. Adcock; London/UK
» Imaging of mucus, inflammation and remodeling
in COPD and CF [A-626]
H.-U. Kauczor; Heidelberg/DE

JOINT SESSIONS
5
5
EuroSafe Imaging Session 4 Joint Session of the ESR, EFSUMB
You too can definitely do audits (European Federation of Societies for
Ultrasound in Medicine and Biology)
» Chairman’s introduction [A-685] and ESPR (European Society of Paediatric
E.J. Adam; London/UK Radiology)
» Experience from an established national Contrast enhanced ultrasound (CEUS)
programme [A-686] in paediatrics
D. Remedios; Harrow/UK
» The challenges of introducing a national audit Moderators: M. Claudon; Vandoeuvre-les-Nancy/FR
programme [A-687] C. Owens; London/UK
A. Vargha; Hidegség/HU » Legal issues with CEUS in children [A-673]
» How to make audit easy: the ESR Audit Tool [A-688] P.S. Sidhu; London/UK
P. Cavanagh; Taunton/UK » CEUS of focal liver lesions in children [A-674]
» Panel discussion M. Sellars; London/UK
» CEUS in blunt abdominal trauma in children [A-675]
A. Deganello; London/UK
» CEUS in vesical reflux in children [A-676]
5
C. Duran; Sabadell/ES
» CEUS in non-liver indications in paediatric patients
Joint Session of the ESR and ESTRO
[A-677]
(European Society for Radiotherapy and Oncology) C.F. Dietrich; Bad Mergentheim/DE
MRI and MR/PET in radiation treatment planning
- challenges and opportunities
6
March Sunday, March 6, 08:30–10:00, Room C
Joint Session of the ESR and ESHI
K. Riklund; Umeå/SE
V. Valentini; Rome/IT (European Society for Hybrid Medical Imaging)
Medical hybrid imaging
» The benefit of high tesla MRI for radiation
oncology planning [A-669]
Chairpersons: K. Riklund; Umea/SE
U. van der Heide; Amsterdam/NL
» The challenge of in room MRI for treatment delivery
[A-670]
N. Dinapoli; Rome/IT
» The aims of the new society [A-726]
» The benefit of MR/PET in radiation oncology [A-671]
K. Riklund; Umea/SE
U. Nestle; Freiburg/DE
» Training of hybrid physicians [A-727]
» The challenge of using MR/PET in radiation oncology
G. Antoch; Düsseldorf/DE
[A-672]
E.-M.B. Larsson; Uppsala/SE » The beauty of physics in hybrid imaging [A-728]
T. Beyer; Vienna/AT
» Discussion
» Functional hybrid imaging: 1+1 = 3? [A-729]
O. Clément; Paris/FR
» Practical challenges of hybrid imaging in clinical
practice [A-730]
O. Ratib; Geneva/CH
» Discussion

Enjoy Vienna’s
cultural highlights
More about opera and musical theatre in Vienna: www.myESR.org/arts_culture

Ilia Hollweg and Oedo Kuipers in Mozart! The Musical © VBW / Deen van Meer 2015
Star Alliance™ Conventions Plus
SAVE UP TO 20% ON TRAVEL WITH THE STAR ALLIANCE™ NETWORK
The Star Alliance member airlines are pleased to be

appointed as the Official Airline Network for ECR 2016.
To obtain the Star Alliance Conventions Plus discounts please follow the below steps to access the
Conventions Plus online booking tool:
» Visit www.staralliance.com/en/convention-delegates
» Under ‘Delegates login’ enter conventions code OS13S16
» The online booking tool opens in a separate window
Registered participants travelling to the event qualify for a discount of up to 20%, depending on
fare and class of travel booked.
The participating airlines for this event are:

Adria Airways, Aegean Airlines, Air Canada, Air China, Air India, Air New Zealand, ANA, Asiana, Austri-
an Airlines, Avianca, Brussels Airlines, Copa Airlines, Croatia Airlines, EgyptAir, Ethiopian Airlines, EVA
Airways, LOT Polish Airlines, Lufthansa, Scandinavian Airlines, Shenzhen Airlines, Singapore Airlines,
South African Airways, SWISS, TAP Portugal, Thai Airways, Turkish Airlines, United Airlines.
Discounts are offered on most published business and economy class fares, excluding website/
internet fares, senior and youth fares, group fares and Round the World fares.
When making your travel plans please present confirmation of your registration or proof of attend-
ance for the Event/Convention.
Special procedures to be followed for travel to/from Japan. Discounts may be offered by the
participating airlines on their own network. To obtain these discounts please contact the respective
carriers’ booking office.
Contact details can be found on

www.staralliance.com/conventionsplus/delegates/
under ‘Conventions Plus Booking Contacts’.
Please quote the event code OS13S16 for ticket reservation.
SATELLITE
SYMPOSIA
Industrial Satellite Symposia are organised by various international

companies. These sessions are a chance to get an industry perspective
on various scientific subjects, including technical updates, emerging
trends and future innovations.
The symposia vary in length from one hour to 90 minutes, with the
number of speakers also differing between companies and subjects.
For details of the programmes see separate booklet

‘Industry Programme & On-Show Guide’.
177
Industry Programme
SATELLITE SYMPOSIA
2
March Wednesday, March 2, 10:30–12:00, Studio 2016
3
SY 1a Satellite Symposium jointly organised by SY 6 Satellite Symposium organised by

Siemens Healthcare and Siemens Healthcare
Bayer HealthCare
3 Thursday, March 3, 12:30–13:30, Studio 2016

2
March
SY 7 Satellite Symposium organised by

SY 1b Satellite Symposium jointly organised by GE Healthcare

Siemens Healthcare and
Bayer HealthCare
3
2 Wednesday, March 2, 14:00–15:30, Studio 2016
March Bracco
SY 1c Satellite Symposium jointly organised by

Siemens Healthcare and
Bayer HealthCare 3
Toshiba
2
SY 1d Satellite Symposium jointly organised by

Siemens Healthcare and 3
Bayer HealthCare
Samsung
2
SY 2 Satellite Symposium organised by 3
MINT Medical
Bayer Pharma
2
SuperSonic Imagine
Bayer HealthCare
2
Mindray
SY 13 Satellite Symposium organised by Philips
3
March Thursday, March 3, 12:30–13:30, Room O 4
Siemens Healthcare SY 14 Satellite Symposium organised by
Siemens Healthcare

Industry Programme
SATELLITE SYMPOSIA
4
March Friday, March 4, 12:30–13:30, Studio 2016
4
SY 15 Satellite Symposium organised by SY 23 Satellite Symposium organised by
GE Healthcare GE Healthcare Russia
4
4
March Friday, March 4, 14:00–15:30, Room G
SY 16 Satellite Symposium organised by Bracco SY 24 Satellite Symposium jointly organised by
Bracco and Bayer HealthCare

March
SY 17 Satellite Symposium jointly organised by March
Siemens Healthcare and SY 25 Satellite Symposium organised by

Bayer HealthCare HIMSS (Healthcare Information and
Management Systems Society)
4 Friday, March 4, 12:30–13:30, Room K

March
5 Saturday, March 5, 12:30–13:30, Room C
SY 18 Satellite Symposium organised by March
Toshiba SY 26 Satellite Symposium organised by

GE Healthcare
4 Friday, March 4, 12:30–13:30, Room G

March
5 Saturday, March 5, 12:30–13:30, Room O
SY 19 Satellite Symposium organised by March
Guerbet SY 27 Satellite Symposium organised by Philips
4
5
SY 20 Satellite Symposium organised by SY 28 Satellite Symposium organised by Philips
HIMSS (Healthcare Information and
Management Systems Society)
5
SY 29 Satellite Symposium organised by Bracco
4
Hologic 5
Toshiba
4
March Friday, March 4, 14:00–15:30, Room Z
Bayer HealthCare Russia

Industry Programme
SATELLITE SYMPOSIA
www.buchkontor.at
READ ANZEIGE
SOMETHING
DI FE EN
B U C H KO N TO R
Guidebooks, cookbooks, illustrated books,

literature, postcards & souvenirs from Vienna
180 Buchkontor’s ECR Bookstore | Entrance Hall

ECR 2016 | Final Programme www.myESR.org
INDUSTRY
WORKSHOPS
Intensive practical sessions organised directly by a particular company

or commercial vendor. Classes are conducted on their own state-
of-the-art workstations with expert technical support provided by
company staff. Participants have the opportunity to learn from experts
about using computers and medical devices in the field of radiology
and gain first-hand knowledge.
As a registered attendee for the ECR, participation is free of charge.
For details of the programmes see separate booklet

‘Industry Programme & On-Show Guide’.
181
P O S TG R A D UAT E
E D U C AT I O N A L
PROGRAMME
Session numbers are prefixed by
E3, EF, EM, HL, MC, MS, NH, PC, RC, SA, SF, TF
Presentation numbers are prefixed by the letter A
Key to Abbreviations
E3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . European Excellence in Education
EF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . EFOMP Workshop
EM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .ESR/EFRS meets Session
HL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Honorary Lecture
MC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mini Course
MS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Multidisciplinary Session
NH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . New Horizons Session
PC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Professional Challenges Session
RC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Refresher Course
SA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . State of the Art Symposium
SF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Special Focus Session
TF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Radiology Trainees Forum
181
Postgraduate Educational Programme
08:30–10:00 Room A Panel discussion:

09:44 How do I approach a case in my routine clinical practice?
E3 - ECR Academies:
Interactive Teaching Sessions 08:30–10:00 Room O
E3 121 Head and neck cancer after treatment: New Horizons Session
what you need to know
NH 1 New frontiers in imaging of vascular
08:30 wall and plaque
A-001 A. Imaging after surgical treatment
M. Lell; Erlangen/DE 08:30
Learning Objectives: A-007 Chairman’s introduction: How to use the tools?
1. To become familiar with the different surgical techniques. C. Loewe; Vienna/AT
2. To become familiar with the imaging findings after surgery. Session Objectives:
09:15 1. To learn about the demands in vessel wall and plaque imaging.
2. To understand the importance of non-invasive imaging for risk
A-002 B. Imaging after radiotherapy/chemotherapy assessment.
G. Madani; London/UK
3. To appreciate the necessity of comprehensive assessment in
Learning Objectives: atherosclerosis.
1. To become familiar with common findings after medically treated
head and neck tumours. 08:35
2. To become familiar with changes after radiotherapy for head and A-008 Molecular imaging for MR
neck tumours. M.R. Makowski; Berlin/DE
Learning Objectives:
1. To understand the potential of MRI for clinical risk assessment in
08:30–10:00 Room B atherosclerosis.
2. To learn about new specific contrast agents for plaque load
GI Tract quantification and plaque remodelling visualisation.
3. To appreciate the value of MRI for predicting future atherosclerotic
RC 101 Assessing inflammation and fibrosis events.
in Crohn’s disease 08:53
A-009 New insights using nuclear and hybrid imaging
08:30 J. Knuuti; Turku/FI
A-003 Chairman’s introduction Learning Objectives:
A. Laghi; Latina/IT
1. To understand the potential of hybrid techniques for assessing
Session Objective: vulnerable plaque and atherosclerosis activity.
1. To briefly present how inflammation and fibrosis in Crohn’s disease 2. To learn about new tracers for plaque imaging.
impact in patient management and list the available tools for a 3. To appreciate the importance of functional imaging in
differential diagnosis. atherosclerosis.
08:35 09:11
A-004 A. Is sonography (CEUS and elastography) the right A-010 Ultrasound elastography: how useful can it be?
tool? N. Liasis; Athens/GR
E. Quaia; Trieste/IT Learning Objectives:
Learning Objectives: 1. To become familiar with the technical principles of ultrasound
1. To learn about CEUS technique, including imaging acquisition and elastography in vessel wall imaging.
data post-processing. 2. To learn about the potential of elastography in the identification of
2. To become familiar with US elastography, particularly with those the vulnerable plaque.
techniques useful in the assessment of the small bowel. 3. To understand the role of ultrasound elastography in atherosclerosis
3. To understand potential advantages and possible limitations of CEUS and risk assessment.
and elastography in the assessment of inflammation and fibrosis in
Crohn’s disease. 09:29
A-011 New options with CT
08:58 A. Persson; Linköping/SE
A-005 B. Is there space for MDCT (spectral imaging, iodine Learning Objectives:
map)? 1. To become familiar with the technical possibilities of modern CT in
J. Podgorska; Warsaw/PL plaque analysis.
Learning Objectives: 2. To learn about the value of multi-energy imaging for functional
1. To understand basic principles of spectral imaging, including data imaging in atherosclerosis.
post-processing. 3. To appreciate the usefulness of CT based scores for assessment of
2. To appreciate the strengths and limitations of spectral imaging in the atherosclerotic plaque burden.
abdomen.
3. To learn about advantages and possible limitations of spectral Panel discussion:
imaging in the assessment of inflammation and fibrosis in Crohn’s 09:47 Predictive role of imaging in the evolution of
disease. atherosclerosis: where do we stand?
09:21
A-006 C. Will MRI (DWI and perfusion) solve the problem?
1. To understand basic principles of DWI applied to Crohn’s disease.
2. To learn about MR-perfusion protocols and data analysis.
3. To learn about advantages and possible limitations of MRI in the
assessment of inflammation and fibrosis in Crohn’s disease.

08:30–10:00 Room N 08:30–10:00 Room L8
Computer Applications EuroSafe Imaging Session

RC 105 Daily use of mobile devices in radiology EuroSafe 1 Low-dose research in medical radiation
protection
08:30
Moderator: L. Rainford; Dublin/IE
A-012 Chairman’s introduction
O. Ratib; Geneva/CH 08:30
Session Objectives: A-016 Developing a strategic research agenda for medical
1. To give an overview of tools available on mobile devices for education
and exam reporting. radiation protection: a chance for advancing research in
2. To underline the impact of mobile devices in routine clinical activity. radiology
3. To learn about the legislative backbone and potential drawbacks of W. Stiller; Heidelberg/DE
Wednesday
mobile technology. Learning Objectives:
1. To raise awareness of the multi-disciplinary effort to define a
08:35 common strategic research agenda (SRA) for medical radiation
A-013 A. What did mobile devices change in radiology protection.
education? 2. To learn about the research topics identified in view of low-dose
E. Kotter; Freiburg/DE imaging.
Learning Objectives: 3. To understand the SRA’s potential for furthering and improving
1. To give an overview of tools available for e-learning. low-dose imaging research and its translation to clinical routine
2. To explore the potential impact of e-learning in the daily radiological application.
practice. 08:53
3. To explore future developments and limits of e-learning.
A-017 Do iodinated contrast media enhance DNA damage after
08:58 exposure to ionising radiation?
A-014 B. Is it appropriate to read a study on a smartphone or a G. Frija; Paris/FR
tablet? Learning Objectives:

E. Neri; Pisa/IT 1. To raise awareness of the interrelation of ionising radiation-induced
Learning Objectives: DNA damage and iodinated contrast media usage.
1. To give an overview of available DICOM viewers and software for 2. To understand the underlying mechanisms of radiation-induced
reporting imaging studies. DNA damage in the presence of iodinated contrast agents.
2. To discuss technical requirements of mobile devices for use in 3. To outline the clinical implications in view of contrast-enhanced
imaging interpretation. imaging employing iodinated contrast agents.
3. To provide insight on future developments of imaging viewing 09:16
technology.
A-018 Dose reduction in modern digital plain-radiography on
09:21 the basis of indication-specific, standardised quality
A-015 C. Security and ethical issues of mobile device criteria
technology D. Spira; Heidelberg/DE
E.R. Ranschaert; ‚s-Hertogenbosch/NL Learning Objectives:
Learning Objectives: 1. To learn about the definition of indication-specific objective quality-
1. To provide an overview of technical solutions for patients’ image and control criteria for radiation dose reduction in digital radiography.
data mobility. 2. To understand that objective quality-control criteria enable
2. To provide a risk assessment analysis (data loss, privacy, etc.) of indication-specific radiation dose reduction of 40-50% without loss
mobile technology. of relevant diagnostic information.
3. To give an overview of European legislation in relation to patient 3. To raise awareness of the dose reduction potential in digital plain-
image and data mobility. radiography of the entire spine, of the full leg in knee malalignment,
of the pelvis after total hip arthroplasty or osteosynthesis, and of the
Panel discussion: knee following total knee arthroplasty.
09:44 Will mobile technology overcome stationary technology 09:38
in radiology?
A-019 Paediatric imaging: are risks of ionising radiation
exposure established?
H. Ducou le Pointe; Paris/FR
1. To learn about the risks associated with the exposure to ionising
radiation in paediatric imaging.
2. To become familiar with current research methods and underlying
theories for defining the risks in paediatric patient populations.
3. To outline the clinical implications in view of paediatric imaging.

08:30–10:00 Room E1 09:30

A-026 C. Nodal staging of breast cancer: still needed?
Musculoskeletal F. Kilburn-Toppin; Cambridge/UK
RC 110 The elbow: a comprehensive approach 1. To know the current debate on sentinel node biopsy and axillary
lymph node dissection.
08:30 2. To appreciate the clinical role of staging of the axilla using ultrasound
A-020 Chairman’s introduction with selective ultrasound-guided needle biopsy.
A. Alcalá-Galiano; Madrid/ES 3. To understand the need for discriminating between minimal versus
Session Objectives: advanced nodal metastatic involvement.
1. To understand that assessing this joint requires specific technical
focus of technique, imaging protocol, choice of coils and sequences
and modalities. 08:30–10:00 Room D1
2. To learn about the pivotal role of the radiologist in evaluating
elbow imaging in order to provide essential information for the Chest
arthroscopist.
RC 104 Pneumonia
08:35
A-021 A. The tendons: anatomy, pathology and intervention 08:30
P. Peetrons; Brussels/BE
Learning Objectives: I.E. Tyurin; Moscow/RU
1. To become familiar with the normal imaging anatomy and Session Objectives:
pathological appearances of the elbow tendons. 1. To review the role of imaging in infectious lung diseases.
2. To learn about interventional radiological techniques for treating 2. To become confident in recognising typical patterns.
elbow tendon disease.
08:35
08:58
A-028 A. Community-acquired pneumonia
A-022 B. Ligament injury and instability: what to look for and I. Hartmann; Rotterdam/NL
what to say Learning Objectives:
M.C. De Jonge; Amsterdam/NL
1. To review the role of imaging examinations in the management of
Learning Objectives: community-acquired pneumonia.
1. To become familiar with patterns of abnormality seen in elbow 2. To learn about signs which suggest specific pathogens and help to
instability. discriminate from noninfectious diseases.
2. To learn about the imaging findings of elbow instability.
08:58
09:21
A-029 B. Tuberculosis
A-023 C. Nerve entrapment at the elbow E. Castañer; Sabadell/ES
L.M. Sconfienza; San Donato Milanese/IT
Learning Objectives: 1. To review typical and atypical tuberculosis manifestations on
1. To understand the radiological anatomy of the peripheral nerves at imaging.
the elbow. 2. To differentiate between acute and chronic tuberculosis infection.
2. To learn about the imaging findings of nerve entrapments at the
elbow. 09:21
A-030 C. Fungal pneumonia in immunocompromised hosts
Panel discussion: J. Mayer; Heidelberg/DE
09:44 US, CT, conventional MR, high field MR: what to choose Learning Objectives:
when? 1. To review the various expression of fungal lung infection depending
on the type of immune depression.
2. To become familiar with CT signs suggesting angio invasive fungal
08:30–10:00 Room F2 infection.
Breast Panel discussion:

09:44 What is the role of radiologists in the diagnosis and
RC 102 Breast ultrasound 2016 management of lung infections?
Moderator: A. Athanasiou; Athens/FR
08:30 08:30–10:00 Room D2

A-024 A. Evidence for screening in dense breasts
V. Girardi; Brescia/IT Physics in Radiology
1. To understand how breast density negatively impacts on sensitivity of RC 113 Single-dual-multi-energy CT
screening mammography.
2. To know the results of additional screening methods in women with 08:30
dense breasts. A-031 Chairman’s introduction
3. To be aware of cost considerations for additional screening methods. J. Damilakis; Iraklion/GR
Session Objectives:
09:00
1. To learn about the basics of dual energy CT (DECT).
A-025 B. Elastosonography: true advances or false hope? 2. To understand today’s photon counting detector technology.
C.S. Balleyguier; Villejuif/FR 3. To learn how DECT is applied in clinical practice.
1. To understand physical principles of elastosonography.
2. To become familiar with the technique of shear-wave
elastosonography of the breast.
3. To appreciate reproducibility and clinical value of elastosonography
in clinical practice.

08:35 09:21
A-032 A. Basics of diagnostic dual energy CT A-038 C. Mistakes in assessment of ovarian masses
T. Klinder; Hamburg/DE I. Thomassin-Naggara; Paris/FR
Learning Objectives: Learning Objectives:
1. To learn about the underlying physics and today’s technology. 1. To become familiar with benign masses mimicking ovarian cancer.
2. To see potential advantages compared to single energy CT. 2. To demonstrate benign and malignant diseases mimicking peritoneal
3. To appreciate the rationale behind clinical applications. carcinomatosis.
3. To learn about imaging strategies for avoiding these pitfalls.
08:58
A-033 B. Photon counting detector technology for diagnostic Panel discussion:
CT 09:44 How can we improve interdisciplinary communication
M. Danielsson; Stockholm/SE and avoid misunderstanding in our reports?
1. To learn about the underlying physics and technological solutions.
Wednesday
2. To understand the potential advantages compared to dual energy CT. 08:30–10:00 Room G
3. To appreciate how mature today’s photon counting technology is.
Neuro
09:21
A-034 C. Do we really need multi-energy CT? RC 111 Toxic brain disorders
S.T. Schindera; Basle/CH
Moderator: P. Due-Tønnessen; Oslo/NO
1. To learn about medical applications and potential benefits. 08:30
2. To see which single energy applications should be replaced by dual A-039 A. Alcohol-related changes in the brain
energy applications, and why. M. Knauth; Göttingen/DE
3. To find out what additional multi-energy CT applications would be
nice to have. Learning Objectives:
1. To document how imaging can help with diagnosing acute alcohol
poisoning and chronic alcoholic encephalopathy.
Panel discussion:
2. To discuss Wernicke encephalopathy.
09:44 How many energies do we need in CT?
3. To present the imaging findings in methanol and ethylene glycol
poisoning.
08:30–10:00 Room K 09:00
A-040 B. Recreational drugs and occupational hazards
Genitourinary L. Reneman; Amsterdam/NL
RC 107 Pitfalls in gynaecologic oncologic 1. To present an overview of recreational drugs and how they influence
imaging: how to avoid them and the brain.
minimise risks 2. To illustrate the effect of drugs on imaging studies (amphetamines,
ecstasy, cocaine, heroine, methadone, ...).
08:30 3. To understand how occupationally used toxic substances can
influence the brain (including toluene, cyanide, organophosphates,
A-035 Chairman’s introduction lead and mercury poisoning, ...).
Session Objectives: 09:30
1. To provide an overview of pitfalls and errors in interpretation of A-041 C. Treatment-induced effects on the brain parenchyma
gynaecologic cancers. J. Alvarez-Linera; Madrid/ES
2. To become familiar with strategies for avoiding pitfalls. Learning Objectives:
08:35 1. To show the imaging findings after radiation therapy in the acute,
early and late delayed stages.
A-036 A. Mistakes in assessment of cervical cancer 2. To present an overview of long-term sequelae after radiation therapy.
K. Downey; London/UK
3. To discuss treatment induced leukoencephalopathy after
Learning Objectives: chemotherapy (especially metothrexate).
1. To become familiar with pitfalls in staging of cervical cancer and in
monitoring treatment response.
2. To learn how to differentiate mimics of cervical cancer. 08:30–10:00 Room M 1
3. To understand the central role of MRI in treatment planning.
08:58 Molecular Imaging
A-037 B. Mistakes in assessment of endometrial cancer
T.M. Cunha, M. Horta; Lisbon/PT RC 106 Molecular imaging:
Learning Objectives: what can we quantify?
1. To become familiar with pitfalls in local tumour spread in Moderator: T.H. Helbich; Vienna/AT
endometrial cancer.
2. To learn how to differentiate benign and malignant mimics. 08:30
3. To appreciate the complementary value of functional MRI A-042 A. Advanced MRI techniques
techniques. C.A. Cuénod; Paris/FR
4. To understand the potential clinical impact of these mistakes in Learning Objectives:
treatment planning. 1. To learn about functional MRI (fMRI, DCE-MRI), diffusion tensor
imaging (DTI) and diffusion-weighted imaging (DWI).
2. To understand the application of these techniques in the study of the
healthy and diseased.
3. To learn about quantification using MR.

09:00 Panel discussion:

A-043 B. Advanced PET imaging techniques 09:44 Practical and economic issues in using high-end
T. Beyer; Vienna/AT guidance for interventional radiology
1. To understand the fundamentals of PET physics relevant to MR/PET
08:30–10:00 Room M 4
imaging.
2. To appreciate the advantages of MR/PET and its complementary role
in diagnostic oncology. Emergency Radiology
3. To learn about the benefits and challenges of quantification in PET.
RC 117 Abdominal trauma: does it bleed, will
09:30
it start bleeding or is something else
A-044 C. Clinical applications of quantitative hybrid imaging in
leaking?
oncology
L. Umutlu; Essen/DE Moderator: S. Wirth; Munich/DE
Learning Objectives: 08:30

1. To become familiar with the role of hybrid imaging in clinical
oncology. A-049 A. Liver and spleen
M. Scaglione; Castel Volturno/IT
2. To learn about quantification in oncology: its benefits and limitations.
3. To understand hybrid imaging applications in relationship to disease Learning Objectives:
presentations. 1. To become familiar with traumatic injuries of the liver and spleen
that can result in hemodynamic instability and other clinical
complications.
08:30–10:00 Room M 3 2. To learn how to optimise scanning protocols to diagnose these
injuries.
Interventional Radiology 3. To understand the impact of these imaging findings on further
management of patients and report accordingly.
RC 109 Image fusion for image-guided 09:00
interventions A-050 B. Pancreas, bowel and mesentery
M.A. Patak; Zurich/CH
08:30 Learning Objectives:
A-045 Chairman’s introduction 1. To become familiar with traumatic injuries of the pancreas, bowel
A. Adam; London/UK and mesentery that can result in hemodynamic instability and other
Session Objectives: clinical complications.
1. To provide an overview of 3D navigation systems. 2. To learn how to optimise scanning protocols to diagnose these
2. To learn about stereotaxis with manual and automatic aiming injuries.
devices. 3. To understand the impact of these imaging findings on further
3. To learn about cone beam CT and ultrasound guidance with image management of patients and report accordingly.
fusion. 09:30
08:35 A-051 C. Urogenital tract
A-046 A. Cone-beam CT in vascular and non-vascular R.H. Oyen; Leuven/BE
interventional procedures Learning Objectives:

T.F. Jakobs; Munich/DE 1. To become familiar with traumatic injuries of the urogenital tract
Learning Objectives: that can result in hemodynamic instability and other clinical
1. To learn how to use cone-beam CT in guiding interventional complications.
procedures. 2. To learn how to optimise scanning protocols to diagnose these
2. To learn when to use this technique in oncologic biopsies and injuries.
ablations. 3. To understand the impact of these imaging findings on further
3. To learn how to use this technique in improving efficacy and safety of management of patients and report accordingly.
intra-arterial procedures.
08:58 08:30–10:00 Room M 5
A-047 B. US image fusion
G.H. Mostbeck; Vienna/AT E3 - ECR Master Classes (Cardiac)
1. To learn about the technologies used to fuse CT/US and MR/US E3 126 Cardiac CT and new interventions
images.
2. To understand how to use them in clinical practice. 08:30
3. To understand the indications for these technologies in difficult cases. A-052 Chairman’s introduction
A. Jankauskas; Kaunas/LT
09:21
Session Objectives:
A-048 C. How can we improve targeting in image-guided 1. To appreciate the relationship between the evolution of CT
interventions: stereotaxis, robotics and advanced technology and growing innovations in cardiovascular intervention
techniques equipment.
L.A. Solbiati; Rozzano/IT 2. To learn about advantages and disadvantages of preinterventional
Learning Objectives: and postinterventional CT compared to other imaging modalities.
1. To become familiar with principles of stereotaxis and robotics for 3. To learn techniques for lowering radiation dose during preprocedural
guiding interventions. and postprocedural CT.
2. To learn about new and advanced techniques in image-guided 4. To become familiar with possible approaches for interventional
therapies. procedure and CT, as well as criteria for successful performance.
3. To understand when and how to use these techniques in oncologic
and non-oncologic interventions.

08:40 12:30–13:30 Room B

A-053 A. CT before and after transcatheter aortic valve
interventions (TAVI) E3 - The Beauty of Basic Knowledge:
J.-N. Dacher; Rouen/FR
Breast Imaging
1. To learn about the technical principles, possible complications and E3 24A Breast ultrasound: a primer
potential limitations of MDCT acquisition in TAVI candidates.
Moderator: J. Camps Herrero; Valencia/ES
2. To understand the anatomy of the aortic annulus and to learn about
CT prosthesis sizing.
3. To understand the importance of optimal communication of CT 12:30
results to the Heart Team and to learn about a structured report. A-058 Breast ultrasound: a primer
4. To learn how to anticipate the various possible complications of TAVI A. Tardivon; Paris/FR
and to learn how to detect them by postprocedural CT. Learning Objectives:
1. To review the clinical indications of breast ultrasound.
Wednesday
09:00
2. To understand the technical issues tied to a state-of-the-art US exam
A-054 B. CT before and after transcatheter mitral valve and new developments.
interventions (TMVI) 3. To learn how to deal with lesions detected at mammography and at
P. Blanke; Vancouver, BC/CA MRI.
1. To understand the anatomy and normal appearance of the mitral
apparatus on cardiac CT. 12:30–13:30 Room D1
2. To learn about common mitral valve pathologies including mitral
annular calcifications, myxomatous degeneration, mitral valve E3 - The Beauty of Basic Knowledge:
prolapse and mitral stenosis and their appearance on cardiac CT.
3. To learn about recent advances in TMVI and the role of preoperative Chest Imaging
cross-sectional imaging for patient and device selection.
4. To understand how CT-derived information can facilitate E3 25A Useful signs in chest radiology
periprocedural guidance with echocardiography and fluoroscopy. Moderator: N. Howarth; Chêne-Bougeries/CH
09:20 12:30
A-055 C. CT before and after electrophysiology interventions A-059 A. Lung parenchyma
R. Salgado; Antwerp/BE
G.R. Ferretti; Grenoble/FR
1. To learn about the evolving role of CT imaging in patients before and 1. To review the most useful signs on the chest x-ray.
after an electrophysiology intervention. 2. To learn how to interpret the chest x-ray more accurately.
2. To understand what the electrophysiologist wants to know from the 3. To know the appropriate indications of the chest x-ray.
CT examination, and how to adapt your scan protocol accordingly.
3. To become familiar with the commonly performed electrophysiology 13:00
procedures, their pathophysiological background and the most A-060 B. Mediastinum and chest wall
common complications. J. Cáceres; Barcelona/ES
Discussion: 1. To review the most useful signs on the chest x-ray.
09:40 How can CT best facilitate cardiac interventions? 2. To learn how to interpret the chest x-ray more accurately.
3. To know the appropriate indications of the chest x-ray.
10:30–12:00 Room A
16:00–17:30 Room B
E3 - ECR Academies:
Interactive Teaching Sessions E3 - ECR Master Classes
(Abdominal Viscera)
E3 221 Unexpected findings on brain MRI
10:30
E3 426a A tour around cholangiopathies
A-056 A. Large ventricles: normal or abnormal? 16:00
S. Langner; Greifswald/DE
Learning Objectives: C. Matos; Lisbon/PT
1. To gain a basic understanding of CSF production, resorption and Session Objective:
flow. 1. To briefly discuss the diagnostic challenge in cholangiopathies.
2. To learn how to differentiate the different forms of hydrocephalus.
3. To learn how to differentiate physiologic changes of the ventricular 16:05
system from hydrocephalus. A-062 A. Clinical scenarios
M. Arvanitaki; Brussels/BE
11:15
A-057 B. Incidental lesions on a brain MRI Learning Objectives:
E.T. Tali; Ankara/TR 1. To describe common and uncommon aetiologies of cholangiopathies
and their complications.
Learning Objectives: 2. To list laboratory tests to orientate the diagnosis.
1. To gain an in-depth understanding of the normal anatomy of the 3. To define questions which can be asked of radiologists in order to
brain. orientate the diagnosis.
2. To learn how to identify incidental findings on a brain MRI.
3. To be able to confidently detect and describe normal imaging
findings of the brain on x-ray, ultrasound, CT and MRI.
4. To learn how to handle the incidental findings.

16:25 16:00–17:30 Room O

A-063 B. Which imaging modalities?
J.M. Lee; Seoul/KR Paediatric
1. To describe the role of imaging modalities. RC 412 Chest imaging in paediatrics
2. To define the potential role of functional and metabolic imaging Moderator: W. Hirsch; Leipzig/DE
modalities.
3. To appraise the cost-benefit of different imaging strategies. 16:00
16:45 A-069 A. Congenital anomalies of the chest
M. Haliloglu; Ankara/TR
A-064 C. Treatment: which and when
E. Jonas; Stockholm/SE Learning Objectives:
1. To discuss best imaging techniques when evaluating congenital chest
Learning Objectives: anomalies.
1. To describe surgical and non-surgical therapeutic options 2. To have an overview of antenatal and postnatal appearances of
2. To identify criteria for personalised treatment. common congenital chest anomalies.
3. To understand the clinical significance and management of
17:05 Multidisciplinary panel discussion
congenital lung and thoracic wall anomalies.
16:30
16:00–17:30 Room C
A-070 B. Lung infection and its complications
M.L. Lobo; Lisbon/PT
New Horizons Session Learning Objectives:
1. To understand the justification for imaging children with lower
NH 4 Big data: why should radiologists care? respiratory tract infection.
2. To provide tips for accurate diagnosis and to understand differential
16:00 diagnosis.
A-065 Chairman’s introduction 3. To become familiar with complications and potential underlying
M. Dewey; Berlin/DE conditions.
Session Objectives:
17:00
1. To appreciate the opportunities and challenges of big data.
2. To understand the current status of big data in radiology. A-071 C. Imaging interstitial lung disease in children:
3. To learn about how big data could change radiology in the future. update 2016
M.P. García-Peña; Barcelona/ES
16:05
A-066 Big data: big science 1. To understand optimised protocols.
G. Zanetti; Pula/IT
2. To learn about updated nomenclature of interstitial lung diseases in
Learning Objectives: children.
1. To understand what big data is and how it will impact clinical data 3. To discuss a systematic approach for the diagnosis of common
integration and analysis. entities diffusely affecting the paediatric lung.
2. To learn about how to best use them in biomedical research.
3. To appreciate the technological challenges.
16:00–17:30 Room N
16:25
A-067 Big data: big business
B.J. Hillman; Charlottesville, VA/US
Head and Neck
Learning Objectives: RC 408 Head and neck imaging:
1. To understand the potential of computerised approaches to analyse
large volumes of data so that past experiences can advise improved don’t sell your ultrasound yet!
care for future patients. Moderator: D.-A. Varoquaux; Marseille/FR
2. To learn about how big data analytics have the potential to transform
the quality and efficiency of health care. 16:00
3. To appreciate that the business of applying big data analytics to health A-072 A. Salivary gland imaging with ultrasound
care is in its earliest stages and is likely to develop rapidly in the near S. Colley; Birmingham/UK
future. Learning Objectives:
16:45 1. To understand the limitations of clinical examination.
2. To learn about the diagnostic approach to salivary glands.
A-068 Big data: what’s in it for the patient? 3. To appreciate how to differentiate salivary gland pathology.
M.G.M. Hunink; Rotterdam/NL
1. To understand how big data can be used to improve patient care and A-073 B. Masses of the soft parts of the neck
patient outcomes. S. Robinson; Vienna/AT
2. To learn about big data sources that could be useful to patient Learning Objectives:
management decisions. 1. To become familiar with cervical ultrasound anatomy.
3. To appreciate limitations of big data in patient care, including bias in 2. To learn about benign neck masses.
the data and ethical and data privacy issues.
17:00
Panel discussion: A-074 C. Lymph nodes: differential diagnosis and fine-needle
17:05 How to make best use of big data? aspiration
R. Maroldi; Brescia/IT
1. To get acquainted with normal and abnormal findings.
2. To understand the patterns of nodal involvement.
3. To learn about technique of fine needle aspiration.

16:00–17:30 Room E1 16:30

A-081 The European paediatric imaging project
Musculoskeletal C. Owens; London/UK
RC 410 Bone trauma in the axial skeleton: 1. To discuss difficulties with data collection from diverse European
patterns of injury and how I describe radiology centres.
2. To encourage engagement using the ‘Eurosafe Imaging Stars’ model.
them 3. To analyse the impact of commercial engagement and support in
Moderator: M.-A. Weber; Heidelberg/DE dose optimisation for children.
16:00 16:40
A-075 A. Thoracic and lumbar spine A-082 The EuroSafe Imaging dose management project
V.N. Cassar-Pullicino; Oswestry/UK D. Caramella; Pisa/IT
Wednesday
1. To become familiar with the types of injury seen in the thoracic and 1. To appreciate that IT tools may enable a systematic analysis of
lumbar spine. dosimetric behaviours in radiology.
2. To learn how to describe the injuries in a manner useful to the 2. To understand how dose management may help to reduce all
clinician. variations that are not clinically justified and to trigger focused
training activities.
16:30 3. To discuss the opportunity to shift the emphasis from risk
A-076 B. Pelvis communication to safety reassurance.
K. Verstraete, F.M.H.M. Vanhoenacker, L. Jans, W. Huysse; Ghent/BE
16:50
1. To become familiar with the types of injury seen in the pelvis. A-083 AFROSAFE Imaging Alliance and Campaign
M.G. Kawooya; Kampala/UG
2. To learn how to describe the injuries in a manner useful to the
clinician. Learning Objectives:
1. To describe the process of the establishment of AFROSAFE.
17:00 2. To list the vision, mission, objectives, strategies and actions.
A-077 C. Acetabulum 3. To discuss the collaborations with EuroSafe Imaging, Image Gently &
A. Kassarjian; Majadahonda/ES Image wisely.
Learning Objectives: 4. To discuss collaboration with patients for patients’ safety (PFP)
1. To become familiar with the types of injury seen in the acetabulum. initiatives in Africa.
2. To learn how to describe the injuries in a manner useful to the 5. To review the achievements to date; namely, promotion of DRLs in
clinician. African countries and raising awareness of radiation safety among
policy makers, health-workers and the public.
17:00
16:00–17:30 Room E2
A-084 Image Wisely and Image Gently: an overview
D.P. Frush; Durham, NC/US
EuroSafe Imaging Session
EuroSafe 2 EuroSafe Imaging Alliance & Campaign 1. To review the history and evolution of the Image Gently and Image
Wisely campaigns.
- what is new? 2. To consider the potential future directions and initiatives that Image
Moderator: G. Frija; Paris/FR Gently and Image Wisely may pursue.
3. To discuss methods to insure adherence to best practices in radiation
16:00 dose monitoring and control.
A-078 An overview of the EuroSafe Imaging achievements over
17:10 Panel discussion
the past year
G. Frija; Paris/FR
Learning Objectives: 16:00–17:30 Room F1
1. To highlight the recent activities of EuroSafe Imaging.
2. To introduce the 2015/2016 EuroSafe Imaging roadmap. Oncologic Imaging
3. To point out weaknesses and strengths of the concept.
16:10 RC 416 Evaluating lymph node involvement:
A-079 Update on the concept of Diagnostic Reference Levels an impossible task?
P. Vock; Spiegel/CH
1. To review the historical development and use of Diagnostic Reference A-085 Chairman’s introduction
Levels (DRLs). D.-M. Koh; Sutton/UK
2. To analyse the advantages and limitations of current DRLs.
3. To discuss modifications and future applications of DRLs. 16:05
A-086 A. The current criteria for nodal involvement MRI/CT
16:20 W. Schima; Vienna/AT
A-080 Establishing European Diagnostic Reference Levels for Learning Objectives:
paediatric imaging: an update on the EC tender project 1. To understand the role of local nodal staging and its importance for
PiDRL management and prognosis.
J. Damilakis; Iraklion/GR 2. To become familiar with the current imaging criteria for assessment
Learning Objectives: of nodal metastases.
1. To give an overview of the PiDRL project and its achievements. 3. To understand the diagnostic performance of cross-sectional
2. To understand the methodology for establishing and using DRLs for imaging.
paediatric imaging.
3. To learn about the specific requirements for paediatric DRLs (in
comparison to DRLs for adults).

16:28 16:00–17:30 Room D1

A-087 B. Advanced MRI techniques: what do they contribute?
H.C. Thoeny; Berne/CH Chest
1. To understand the principle of DWI of nodes. RC 404 Pulmonary embolism - persistent
2. To learn about the appearances of malignant nodes on diffusion- controversies
weighted MRI.
3. To become familiar with node-specific enhanced MRI. 16:00
16:51 A-093 Chairman’s introduction
M. Rémy-Jardin; Lille/FR
A-088 C. PET and other nuclear medicine techniques
T. Barwick; London/UK Session Objectives:
1. To review the current controversies regarding PE diagnosis.
2. To appreciate the need for defining a standardised management.
1. To learn the typical appearance on nodal metastatic disease on FDG.
2. To recognise the pitfalls for interpretation. 16:05
3. To become familiar with new radiotracers, including choline PET, for
A-094 A. Subsegmental PE, incidental PE: diagnosis and
the demonstration of nodal disease.
management
Panel discussion:
17:14 Will imaging ever make diagnostic biopsy unnecessary? Learning Objectives:
1. To review the characteristics of subsegmental and incidental PE.
2. To suggest an appropriate management in both situations.
16:00–17:30 Room F2 16:28
Breast A-095 B. CT not available, contraindicated, or inconclusive:
what to do?
E.J.R. van Beek; Edinburgh/UK
RC 402 Radio-pathological correlation: more
important than you thought 1. To review the role of US and V/Q scan.
2. To learn about the current performance of MR.
16:00
A-089 Chairman’s introduction 16:51
F.J. Gilbert; Cambridge/UK A-096 C. Can we predict outcome from imaging?
Session Objectives: B. Ghaye; Brussels/BE
Radiological findings need to be verified by pathological examination Learning Objectives:
but without a strict and interactive cooperation this correlation may fail. 1. To learn how clinical findings influence the selection of the imaging
New imaging techniques and new pathological methods/approaches strategy in PE.
create new challenges. 2. To learn how imaging may predict the outcome of the patient.
3. To learn about the follow-up after treatment.
16:05
A-090 A. Pre-treatment planning Panel discussion:
17:14 How to optimise patient management?
1. To know the role of the imaging methods for preoperative staging.
2. To understand the need for imaging-guided needle sampling and 16:00–17:30 Room D2
localisation for a tailored surgery.
3. To appreciate the need for changing surgical guidelines for treating Physics in Radiology
breast cancer.
16:28 RC 413 Artefacts and pitfalls in tomography
A-091 B. Intra-operative specimen evaluation
J. Camps Herrero; Valencia/ES
16:00
Learning Objectives: A-097 Chairman’s introduction
V. Tsapaki; Athens/GR
1. To learn about different imaging techniques for pre-operative
marking and intraoperative specimen evaluation. Session Objectives:
2. To become familiar with methods for specimen orientation and 1. To learn about the origins of image artefacts in tomographic imaging.
handling. 2. To understand image distortions in hybrid imaging.
3. To understand the need for immediate reporting/reaction from 3. To learn about solutions and work-arounds.
radiological department to surgical room. 16:05
16:51 A-098 A. CT
A-092 C. The breast radiologist sitting down with the M. Kachelrieß; Heidelberg/DE
pathologist Learning Objectives:

T. Tot; Falun/SE 1. To understand the source of artefacts in clinical CT.
2. To understand the most important correction methods.
3. To find out what artefact correction techniques are actually provided
1. To understand the importance of using imaging to guide the
by the CT vendors in their systems.
pathologist in complex lesions.
2. To know the different ways of correlating radiology and pathology. 16:28
3. To learn how to enhance this cooperation in order to achieve the best
A-099 B. PET/CT
results in terms of tumour extension and tumour margins. T. Beyer; Vienna/AT
Panel discussion: Learning Objectives:

17:14 How to enhance the interaction between radiologists and 1. To understand image distortions, artefacts and bias from
pathologists? methodological pitfalls.
2. To appreciate and understand solutions to frequent image distortions.
3. To understand the methodological limitations of PET/CT.

16:51 16:00–17:30 Room G

A-100 C. MR/PET
H.H. Quick; Essen/DE E3 - ECR Academies:
Learning Objectives: Neuroradiology: from Morphology to Function
1. To identify common artefacts.
2. To understand the physical origin of and methods to resolve artefacts.
3. To understand the interrelation of MR artefacts and bias in PET E3 419 Functional MRI of the brain opens new
quantification. horizons
Panel discussion: 16:00
17:14 Imagine imaging without artefacts: dos and don’ts in A-106 Chairman’s introduction
your clinical practice T.A. Yousry; London/UK
16:03
Wednesday
16:00–17:30 Room K A-107 A. No function without structure: challenges in diffusion
MRI and fiber tractography for clinical research
E3 - ECR Master Classes (Genitourinary) A. Leemans; Utrecht/NL
E3 426b MR-targeted focal therapies for 1. To present an introduction to the use of diffusion MRI and fiber
prostate cancer tractography of the brain.
2. To illustrate how these techniques have provided new insights into
16:00 functional neuroanatomy.
A-101 Chairman’s introduction: the rationale for focal therapy 3. To raise awareness about methodological challenges and limitations
F. Cornud; Paris/FR for clinical applications.
Session Objective: 16:32
1. To provide an overview of indications, techniques and outcome of
A-108 B. Clinical utility of fMRI for pre-operative brain mapping
MR-targeted treatment of prostate cancer. H. Urbach; Freiburg/DE
A-102 A. The role of multiparametric MR in the planning phase 1. To reveal how morphometric analysis of 3D data sets can help to
reveal the true extent of a cerebral lesion in the pre-surgical work-up.
of focal therapy
2. To demonstrate how fMRI is useful for documenting the spatial
relationship of brain lesions to the adjacent eloquent cerebral cortex.
Learning Objectives: 3. To illustrate how diffusion tensor tractography can reveal important
1. To present the mpMRI criteria in the planning phase of focal white matter tracts such as the corticospinal tract and optic radiation.
treatment.
2. To understand the role of MRI in patient selection. 17:01
16:23 A-109 C. Introduction to resting state fMRI and functional
connectomics
A-103 B. MR-targeted high intensity focused ultrasound L. Nyberg; Umea/SE
M.C. Roethke; Heidelberg/DE
1. To understand how spontaneous fluctuations in activity in different
1. To become familiar with indications and technique.
parts of the brain can be used to study functional brain networks.
2. To demonstrate findings during and after treatment.
2. To review how resting-state functional MRI (rfMRI) can be used to
3. To show complications and outcome.
map the macroscopic functional connectome.
16:41 3. To highlight some upcoming challenges in functional connectomics,
A-104 C. MR-guided cryoablation and focal laser therapy using high-quality rfMRI data being generated by the Human
J.J. Fütterer; Nijmegen/NL Connectome Project.
1. To become familiar with indications and technique. 16:00–17:30 Room M 1
2. To demonstrate findings during and after treatment.
3. To show complications and outcome.
Vascular
16:59
A-105 D. MR-targeted intensity-modulated radiotherapy with RC 415 Basic principles of varicose vein
focal boost diagnosis and endovascular treatment
V. Fonteyne; Ghent/BE Moderator: D. Karnabatidis; Patras/GR
1. To become familiar with indications and technique. 16:00
2. To illustrate findings during and after treatment. A-110 A. Diagnostic cross-sectional imaging
3. To show complications/toxicity and outcome. H. Hoppe; Berne/CH
Panel discussion: 1. To become familiar with the whole spectrum of varicose vein
17:17 What are the challenges in providing focal treatment in pathology.
prostate cancer? 2. To learn about technical principles of state-of-the-art lower limb
venous imaging studies.
3. To learn how to extrapolate imaging findings into endovascular
treatment.

16:30 16:00–17:30 Room M 3

A-111 B. Saphenous vein ablation
M. Akesson; Höllviken/SE Interventional Radiology
1. To understand the principles of ablation therapy. RC 409 Basic principles of percutaneous
2. To learn the technique for ablation and how to avoid complications. tumour ablation
3. To learn about outcomes and complications.
16:00
17:00
A-112 C. Ultrasound guided sclerotherapy T. de Baère; Villejuif/FR
P.F. Sousa; Ermesinde/PT
Session Objectives:
1. To understand the basic principles of various ablation techniques.
1. To learn about the principles of venous sclerotheraphy.
2. To learn how to choose the right ablation technique for a specific
2. To learn about technical principles of US-guided sclerosis of lower
lesion.
limb veins.
3. To learn about advantages of each technique over different tissue
3. To learn about pros and cons of US-guided sclerosis versus
properties.
endovascular ablation.
16:05
A-117 A. Thermal ablation with RF
16:00–17:30 Room M 2 F. Orsi; Milan/IT
Cardiac 1. To learn about the physical and technical basis of radiofrequency
ablation.
RC 403 Imaging of cardiac valves: new trends 2. To understand the advantages and limitations of the technique.
Moderator: G. Roditi; Glasgow/UK 3. To become familiar with the current indications in oncology.
16:00 16:23
A-113 A. Echocardiography remains the reference technique A-118 B. Microwave ablation: what is the difference?
F. Knebel; Berlin/DE P.L. Pereira; Heilbronn/DE

1. To learn about state-of-the-art echo techniques to evaluate cardiac 1. To learn about the physical and technical basis of microwave ablation.
valves. 2. To understand the advantages and limitations of the technique as
2. To provide a practical approach to assessing valve pathology based on compared to RF ablation.
echocardiography. 3. To become familiar with the current indications in oncology.
3. To become familiar with the role of echo in the diagnosis, clinical 16:41
management and prognosis.
A-119 C. Cryoablation: ice can be better than heat
16:30 D.J. Breen; Southampton/UK
A-114 B. MRI is the best comprehensive approach Learning Objectives:
M. Francone; Rome/IT 1. To learn about the physical and technical basis of cryoablation.
Learning Objectives: 2. To understand the advantages and limitations of the technique.
1. To learn about the role of MRI in diagnosis and evaluation of valvular 3. To become familiar with the current indications in oncology.
disease. 16:59
2. To become familiar with state-of-the-art MRI techniques to evaluate
valvular disease. A-120 D. Irreversible electroporation: principles, technique and
3. To learn about typical imaging findings in MRI with impact on clinical applications
clinical management. A. Nilsson; Uppsala/SE
17:00
1. To understand the physical and technical basis of irreversible
A-115 C. Does CT have a role in diagnosing valvular disease? electroporation (IRE).
G. Feuchtner; Innsbruck/AT 2. To understand the advantages and limitations of the technique.
Learning Objectives: 3. To become familiar with the current indications in oncology.
1. To learn about state-of-the-art CT techniques to evaluate cardiac
valves at low dose. Panel discussion:
2. To review CT appearance of the most common conditions causing 17:17 Selection of ablation modalities: operator’s preference
valvular disease. or evidence-based?
3. To become familiar with the role of CT in the diagnosis and clinical
management.

16:00–17:30 Room M 4 16:50

A-126/A-127 Questions and answers
Emergency Radiology S. Weckbach1, J. Sellors2; 1Heidelberg/DE, 2London/UK
RC 417 ‘Special patients’ in the emergency The discussion will address the following issues:
room: when and how to image them? 1. Is it better to report or to ignore IFs?
Moderator: U. Linsenmaier; Munich/DE
2. Should there be differences for IFs in clinical imaging than in
research studies?
16:00 3. Do we need worldwide obliging guidelines for the handling of IFs?
3. Should different categories of IFs have different consequences for the
A-121 A. Children patient/study participant?
V. Miele, C.L. Piccolo, M. Trinci; Rome/IT
1. To become familiar with common non-traumatic emergencies in the
Wednesday
paediatric population.
2. To comprehend the rationale of using different diagnostic imaging
methods in emergency situations.
3. To understand the impact of imaging findings on patient
management.
16:30
A-122 B. Pregnant patients
1. To become familiar with the most common non-traumatic
emergencies in pregnant women.
2. To learn which tests to choose in pregnant patients for the diagnostic
evaluation of pulmonary embolism and acute abdomen.
3. To know current guidelines and recommendations for contrast media
administration in pregnancy.
17:00
A-123 C. Elderly patients
K. Katulska; Poznan/PL
1. To become familiar with typical and atypical clinical emergency
situations in the elderly.
2. To understand imaging strategies and the role of different imaging
methods in elderly patients.
3. To learn common and specific imaging findings in the elderly
population.
16:00–17:30 Room M 5
Pros & Cons Session

PS 427 Risks and benefits of reporting
incidental findings
Moderator: S. Weckbach; Heidelberg/DE
Teaser: J. Sellors; London/UK
16:00
A-124 A. Good reasons to ignore incidental findings
L. Berlin; Skokie, IL/US
1. To learn a correct definition of radiological ‘incidental finding’ (IF)
and understand the underlying ethical problems of IFs.
2. To learn about the impact of IFs on patients’ and study participants’
lives.
3. To understand the risks of reporting IFs.
16:25
A-125 B. Good reasons to report incidental findings
1. To become aware of the differences between reporting an IF in a
clinical setting and in a research setting.
2. To become familiar with different approaches of handling IFs.
3. To understand the benefits of reporting IFs.


08:30–10:00 Room A 08:30–10:00 Room C
E3 - ECR Academies: Special Focus Session

Interactive Teaching Sessions SF 5 Taking imaging to the cloud
E3 521 Integrating diagnostic tools in breast 08:30
imaging A-134 Chairman’s introduction
J. Reponen; Raahe/FI
08:30 Session Objectives:
A-128 A. Multimodality breast imaging 1. To introduce different models of image management and
K. Kinkel; Chêne-Bougeries/CH distribution.
Learning Objectives: 2. To discuss new possibilities provided by evolving technology.
1. To appraise the real value of combining all the diagnostic modalities
08:35
into a final report.
2. To learn how to use the new BI-RADS categorisation system A-135 How does it work?
appropriately. J. Fernandez-Bayó; Sabadell/ES
09:15 1. To learn about the basics of cloud computing.
A-129 B. Multiparametric breast MRI 2. To understand different ways in which these technologies could be
J. Camps Herrero; Valencia/ES applied to medical imaging.
Learning Objectives: 3. To appreciate how PACS architecture and work environment are
1. To learn about the different technical and clinical aspects of the MRI changing.
sequences that are used currently in breast imaging. 4. To become familiar with some practical case examples.
2. To know how to unify the information thereof provided in everyday
08:58
Thursday
clinical practice.
A-136 What are the benefits?
E.R. Ranschaert; ‚s-Hertogenbosch/NL
08:30–10:00 Room B Learning Objectives:
1. To learn about the new possibilities cloud computing brings to
Abdominal Viscera radiologists.
2. To understand how this concept can be applied in radiology practice.
RC 501 The many faces of benign liver lesions 3. To understand the benefits of imaging studies being available
independent of time and place.
08:30 4. To learn about different strategies for image storing and sharing.
M. Karcaaltincaba; Ankara/TR
A-137 What are the applications of cloud in radiology?
Session Objective: O. Ratib; Geneva/CH
1. To briefly introduce the diagnostic challenges in patients presenting Learning Objectives:
with benign liver lesions. 1. To learn about the technical challenges of cloud computing.
08:35 2. To understand what the risks are from a security and legal point-of-
view.
A-131 A. Vascular 3. To appreciate the issues related to service agreements with the cloud
F. Caseiro-Alves; Coimbra/PT
providers.
Learning Objectives: 4. To discuss the special needs of radiology.
1. To become familiar with typical and infrequent manifestations of
benign hypervascular focal liver lesions. Panel discussion:
2. To learn how to differentiate between benign and malignant lesions. 09:44 Will cloud computing be the future of image storage?
3. To appreciate the limitations and complementary roles of CT and
MR.
08:58 08:30–10:00 Room O
A-132 B. Cystic-Biliary
G. Brancatelli; Palermo/IT
Paediatric
1. To explain the embryological process of ductal plate formation.
RC 512 Imaging of foetus and infant
2. To describe the imaging features of congenital bile duct pathology. Moderator: A.M. Taylor; London/UK
3. To address how imaging helps make the differential diagnosis.
08:30
09:21 A-138 A. Foetal neuro imaging
A-133 C. Hepatocellular A. Rossi; Genoa/IT
R.L. Baron; Chicago, IL/US
Learning Objectives: 1. To learn how to perform prenatal brain MRI and to recognise normal
1. To understand the typical aspect of hepatocellular benign lesions on features during gestation.
US, CT and MRI. 2. To highlight the complementary role of brain MRI to prenatal
2. To learn when a liver-specific contrast medium can help us in the ultrasound.
proper characterisation of hepatocellular benign liver lesions. 3. To become familiar with the MRI features of the main congenital
3. To understand the classification of liver adenomas, prognosis and malformations and clastic injury.
imaging characteristics.
Panel discussion:
09:44 How do I manage an incidental and potentially benign
liver lesion?

09:00 08:35
A-139 B. Foetal body imaging A-145 Personalised imaging in practice: a myth?
F. Avni; Lille/FR F.J. Gilbert; Cambridge/UK
1. To have an overview of foetal abdominal diseases and malformations. 1. To define what personalised imaging means in daily radiology
2. To learn about the complementary roles of US and MRI. practice.
3. To understand how prenatal imaging helps in the management of the 2. To analyse the gaps between theory and practice of an individualised
foetus and the newborn. imaging approach.
3. To determine the current level of evidence regarding the concept and
09:30 practice of individualised imaging.
A-140 C. Neonatal urinary tract imaging
M. Riccabona; Graz/AT 08:52
Learning Objectives: A-146 Personalised imaging and standardised protocols: a
1. To learn about normal appearances and imaging pitfalls of the contradiction?
urinary tract (UT) at birth. S.O. Schönberg; Mannheim/DE
2. To become familiar with the findings and conditions that cause UT Learning Objectives:
dilatation (UTD) and neonatal renal parenchymal anomalies. 1. To investigate whether standardised protocols can cater to
3. To discuss imaging strategies in the neonatal period. individualised imaging.
2. To analyse which parameters influence individualised imaging.
3. To discuss the necessary adaptations of protocols to phenotypic
08:30–10:00 Room N subpopulations.
Head and Neck 09:09

A-147 En route to personalised imaging: the role of
RC 508 Pathways for tumour spread multidisciplinary conferences
Moderator: R. Hermans; Leuven/BE J.A. Verschakelen; Leuven/BE
08:30 1. To review the potential benefits and drawbacks of interdisciplinary
A-141 A. Pathways for oral cavity and oropharynx tumour conferences.
2. To determine the role of multidisciplinary conferences for patient
spread
A. Borges; Lisbon/PT treatment.
3. To discuss the political implications in the multidisciplinary
Learning Objectives: management of patients.
1. To become familiar with the anatomy of the oral cavity and
oropharynx. 09:26
2. To learn which imaging technique to use. A-148 From personalised to precision imaging: impact on
3. To understand the typical local and remote spread of oral cavity and
clinical practise
oropharynx tumours. G.P. Krestin; Rotterdam/NL
A-142 B. Pathways for nasopharyngeal tumour spread including 1. To explain the concept of precision imaging.
2. To underline the importance of precision imaging for the future of
perineural spread
V. Chong; Singapore/SG radiology.
3. To demonstrate how precision imaging is already impacting on our
Learning Objectives: daily clinical practice.
1. To become familiar with the anatomy of the nasopharynx.
2. To learn which imaging technique to use. Panel discussion:
3. To understand the typical local and remote spread of nasopharyngeal 09:43 How to enhance personalised radiology in clinical routine
tumours, including perineural spread.
09:30
08:30–10:00 Room L8
A-143 C. Pathway for laryngeal and hypopharyngeal tumour
spread New Horizons Session
R. Kohler; Sion/CH
1. To become familiar with the anatomy of the larynx and hypopharynx.
NH 5 Imaging beyond morphology
2. To learn which imaging technique to use. 08:30
3. To understand the typical local and remote spread of laryngeal and
hypopharyngeal tumours. A-149 Chairman’s introduction
Session Objectives:
08:30–10:00 Studio 2016 1. To learn about new imaging methods for quantitative imaging.
2. To understand that multimodality and data integration will play a
Professional Challenges Session major role in the future.
08:35
PC 5 Personalised radiology: myth or reality? A-150 MRI fingerprinting: the future?
S. Trattnig; Vienna/AT
08:30
A-144 Chairman’s introduction 1. To learn about the basic concept of MR fingerprinting for
C.J. Herold; Vienna/AT
quantitative MR imaging.
Session Objectives: 2. To understand the potential of MR fingerprinting for standardisation
1. To discuss the current state of personalised imaging in Europe. in MR.
2. To critically appraise the evidence associated with individualised 3. To become familiar with preliminary clinical applications of MR
imaging. fingerprinting.
3. To discuss practical aspects of personalised radiology in Europe.

09:00 08:30–10:00 Room E2

A-151 Receptor-targeted multimodal imaging
M. de Jong; Rotterdam/NL State of the Art Symposium
1. To appreciate developments in imaging platforms for multimodal SA 5 Abdominal diffusion-weighted imaging
imaging. (DWI): an update
2. To appreciate developments in imaging agents for targeted
(multimodal) imaging. 08:30
A-152 Radiomics
L.S. Fournier; Paris/FR Session Objectives:
1. To learn about the technical difficulties and clinical relevance of DW
qualitative and quantitative approaches in clinical practice.
1. To learn about new methods of image analysis derived from ‘-omics’
2. To become familiar with the role of DW imaging modalities in the
methods.
detection and quantification of different pathological entities.
2. To understand processing of big data derived from images.
3. To understand the impact of DW biomarkers in disease evaluation
3. To become familiar with new vocabulary such as Radiomics,
on different organs.
radiogenomics, clusters, heat maps, etc.
08:35
Panel discussion: A-158 Technical advances: the many faces of DWI
09:50 Imaging biomarkers: a key role for radiologists in the N. Papanikolaou; Stockholm/SE
future?
1. To review basic and advanced diffusion models on abdominal organs.
2. To become familiar with techniques and methods for body diffusion
08:30–10:00 Room E1
applications.
Thursday
3. To learn about post-processing aspects of diffusion imaging.
Musculoskeletal
09:00
RC 510 Inflammatory arthritis: A-159 Biliary ducts and pancreas: main advantages in clinical
beyond the radiograph practice
C. Matos; Lisbon/PT
A-153 Chairman’s introduction 1. To define how to incorporate DWI in clinical MR scanners to
M. Reijnierse; Leiden/NL investigate the bile ducts and the pancreas.
Session Objectives: 2. To list and compare reported data on the role of quantitative DWI
1. To gain insight into the merits of various imaging modalities in the approaches.
daily practice of radiology of rheumatology. 3. To identify major diagnostic clinical applications in a
2. To appreciate the crucial radiological contribution we need to provide multidisciplinary environment.
in order to support optimal clinical decision making. 09:25
08:35 A-160 Small bowel: main advantages in clinical practice
A-154 A. Rheumatoid arthritis: what does MRI show and how do
I do it? Learning Objectives:
I. Sudoł-Szopińska; Warsaw/PL 1. To learn about the histopathological changes underlying abnormal
diffusion in inflammatory bowel disease.
2. To appreciate optimised DWI protocols for small bowel imaging.
1. To become familiar with MRI techniques used in the assessment of
3. To understand the clinical role of DWI in the small bowel, focusing
rheumatoid arthritis.
on inflammatory bowel disease.
2. To learn about the MRI findings in rheumatoid arthritis and their
significance.
Panel discussion:
08:58 09:50 Should we do it qualitative or quantitatively?
A-155 B. The axial skeleton in spondyloarthritis: conventional
radiograph to MRI
R. Campbell; Liverpool/UK
1. To become familiar with imaging findings seen in the axial skeleton
in spondyloarthritis.
2. To understand features on imaging which distinguish
spondyolarthrtitis from other spinal diseases.
09:21
A-156 C. Ultrasound in inflammatory arthritis: what does it
show and what does it mean?
A. Klauser; Innsbruck/AT
1. To become familiar with US techniques used in the assessment of
inflammatory arthritis.
2. To learn about the US findings in inflammatory arthritis and their
significance.
Panel discussion:
09:44 How practical is it for radiologists to support ultrasound
and MRI for clinical rheumatology? Is it something the
rheumatologists should undertake themselves?

08:30–10:00 Room F1 08:58

A-167 B. Linear and reticular pattern
Oncologic Imaging F. Molinari; Lille/FR
RC 516 A multidisciplinary approach 1. To recognise and interpret typical reticular imaging patterns on
to prostate cancer: HRCT.
2. To differentiate acute and chronic diseases which cause septal pattern.
can we make a difference?
09:21
08:30
A-168 C. Ground glass opacities (GGO) and consolidation
A-161 Chairman’s introduction J. Vogel-Claussen; Hannover/DE
B. Hamm; Berlin/DE
1. To appreciate the different conditions which cause GGO pattern and
08:35
consolidation.
A-162 A. The urologist: evidence-based clinical decision 2. To learn how to interpret GGO and consolidation in different clinical
making settings.
B.A. Hadaschik; Heidelberg/DE
Learning Objectives: Panel discussion:
1. To understand how a diagnosis is established by PSA evaluation and 09:44 Is it always easy to detect a pattern? Tips for success
biopsy.
2. To learn about different treatment options: surgery, radiotherapy,
local ablative and hormonal treatment; as well as active surveillance. 08:30–10:00 Room D2
3. To learn how imaging impacts treatment selection.
4. To understand what the urologist needs to know from the radiologist. Physics in Radiology
08:58
RC 513 How to assess and communicate
A-163 B. The radiologist: evidence-based use of
multiparametric MRI
examination risks to patients and
H.-P. Schlemmer; Heidelberg/DE referring physicians?
08:30
1. To learn how to perform and interpret multiparametric MRI.
2. To become familiar with the PiRADS classification system. A-169 Chairman’s introduction
3. To become familiar with the role of imaging for patient stratification A. Torresin; Milan/IT
and treatment planning. Session Objectives:
1. To understand risks from the use of ionising and electromagnetic
09:21 radiation.
A-164 C. The interventional radiologist 2. To balance patients’ perspectives with professional attitudes.
C. Catalano; Rome/IT 3. To discuss approaches and methods for communicating risks to
Learning Objectives: patients and public.
1. To learn the rationale and scientific basis for focal therapies for
08:34
prostate cancer.
2. To learn how focal therapies are performed in prostate cancer. A-170 A. Radiation risk: a patient’s perspective
3. To learn through personal experience and from literature how E. Briers; Hasselt/BE
multiparametric MRI can guide focal therapies of the prostate. Learning Objectives:
1. To understand the fears of patients.
Panel discussion: 2. To learn what is expected from physicians and techs.
09:44 Prostate cancer: evidence-based multidisciplinary 3. To learn about ideal communication strategies.
approach to imaging and treatment
08:47
A-171 B. Radiation risks for patients and staff
08:30–10:00 Room D1 P. Gilligan; Dublin/IE
Chest 1. To get the latest information on stochastic and deterministic risks in
radiology.
RC 504 HRCT - patterns in chest radiology: 2. To learn about quantitative risk assessment in typical scenarios.
back to basics and beyond 09:10
A-172 C. Risk in MRI
08:30 R. Peeters; Leuven/BE
A-165 Chairman’s introduction Learning Objectives:
H. Prosch; Vienna/AT 1. To learn about the risks for patients from MRI procedures.
Session Objectives: 2. To learn about the contraindications for MRI scans.
1. To emphasise the importance of anatomy in reading HRCT. 3. To learn about risks for staff in an MRI department.
2. To appreciate the necessity of defining patterns to improve
radiological HRCT diagnoses. 09:33
A-173 D. Communicating risks to patients and the public
08:35 N. Leitgeb; Graz/AT
A-166 A. Secondary pulmonary lobule anatomy: essential to Learning Objectives:
tackle with the nodular pattern 1. To become familiar with communicating risk according to the
T. Frauenfelder; Zurich/CH imaging modality.
Learning Objectives: 2. To become familiar with important rules in communication.
1. To become confident in recognising the anatomical compartments of 3. To understand the relationship between hazards and parents’
the lung on HRCT. perceptions regarding imaging of their child.
2. To describe typical nodular imaging patterns of lung disease on 4. To learn how to select a risk-communication strategy suited to
HRCT using appropriate terminology. parents and children.

Panel discussion: 08:30–10:00 Room M 1

09:44 How real are the risks and how do we communicate them?
E3 - ECR Master Classes
08:30–10:00 Room K (Molecular Imaging)
E3 - Rising Stars Programme E3 526 Perfusion imaging
Basic Session 1: Neuroradiology: brain 08:30

08:30 X. Montet; Geneva/CH
A-174 White matter disorders
A. Rovira-Canellas; Barcelona/ES 08:35
A-182 A. Perfusion imaging: how I do it - by CT and/or by MRI?
09:00 C.C. Cyran; Munich/DE
A-175 Tumours Learning Objectives:
J. Walecki; Warsaw/PL 1. To review the fundamentals of perfusion imaging.
2. To review the advantages and disadvantages of CT perfusion
09:30 imaging.
A-176 Stroke 3. To review the advantages and disadvantages of MR perfusion
E.T. Tali; Ankara/TR imaging.
08:53
08:30–10:00 Room G A-183 B. Liver perfusion
V.J. Goh; London/UK
E3 - ECR Academies: Learning Objectives:
Thursday
1. To learn the clinical indications for liver perfusion imaging.
Neuroradiology: from Morphology to Function 2. To become familiar with perfusion protocols for liver imaging.
3. To learn about difficulties in liver perfusion imaging.
E3 519 Advanced imaging techniques in brain 09:11
tumours A-184 C. Lung perfusion
M. Rémy-Jardin; Lille/FR
08:30
A-177 Chairman’s introduction 1. To learn the clinical indications for lung perfusion imaging.
P.C. Maly Sundgren; Lund/SE 2. To become familiar with perfusion protocols for lung imaging
(including dual-energy CT).
08:33 3. To learn about difficulties in lung perfusion imaging.
A-178 A. Clinical utility of perfusion imaging for differentiating
09:29
brain tumours
I.N. Pronin; Moscow/RU A-185 D. Cerebral perfusion
1. To provide practical tips and tricks for performing CT and MR Learning Objectives:
perfusion in patients with brain tumours. 1. To learn the clinical indications for cerebral perfusion imaging.
2. To illustrate how certain perfusion derived parameters (rCBV) can be 2. To become familiar with perfusion protocols for cerebral imaging.
correlated with tumour histology (e.g. angiogenesis, capillary leakage, 3. To learn about difficulties in cerebral perfusion imaging.
malignancy grade).
3. To show that intense contrast enhancement is not identical to Panel discussion:
perfusion. 09:47 The pros and cons of perfusion imaging
09:02
A-179 B. Hybrid imaging with MRI/PET of brain tumours 08:30–10:00 Room M 2
N.L. Albert; Munich/DE
Learning Objectives: Cardiac
1. To show that hybrid imaging with MRI/PET is gaining increasing
importance in assessment of tumour activity and malignancy. RC 503 Novel ways to assess myocardial tissue
2. To demonstrate how MRI/PET can be useful in glioma grading. Moderator: N.N.
3. To provide information on new PET tracers (targeting tumour
hypoxia, enzymes in neoplastic metabolic pathways, etc.) and the 08:30
combination of tracers with therapeutic agents.
A-186 A. T1 mapping: technical considerations
09:31 M.R. Makowski; Berlin/DE
A-180 C. Assessment of brain tumour perfusion and abnormal Learning Objectives:

vascular structure using arterial spin-labelling 1. To learn about the principles of T1 mapping.
P. Hales; London/UK 2. To learn about specific issues of T1 mapping.
3. To learn how to do and assess T1 mapping.
1. To offer a short update on the physical principles and technique of 09:00
arterial spin-labelling in assessing brain tumour perfusion. A-187 B. T2 mapping: technical considerations
2. To review the advantages and disadvantages of ASL as compared to C. Tessa; Lido di Camaiore/IT
contrast-enhanced perfusion imaging.
3. To provide clinical examples where ASL has contributed significantly
1. To learn about the principles of T2 mapping.
to management and clinical decision making in brain tumour
2. To learn about specific issues of T2 mapping.
patients.
3. To learn how to do and assess T2 mapping.

09:30 08:30–10:00 Room M 4

A-188 C. Clinical use of T1 and T2 mapping
A. de Roos; Leiden/NL Joint Course of ESR and RSNA
Learning Objectives: (Radiological Society of North America):
1. To learn about the main fields of application for T1-T2 mapping.
2. To learn the specific parameters useful for the clinical Emergency Radiology
implementation of T1-T2 mapping.
3. To understand the incremental value of T1-T2 mapping over current MC 528 Abdominal emergencies
methodologies.
Moderators: A. Palkó; Szeged/HU,
08:30–10:00 Room M 3
08:30
Interventional Radiology A-193 A. Abdominal injuries
RC 509 Imaging and endovascular treatment of Learning Objectives:

1. To understand the significance of injury mechanism and its role
pulmonary embolism in the formation of consequent abdominal lesions and their
complications.
08:30 2. To learn about the role of proper imaging technique and diagnostic
A-189 Chairman’s introduction algorithm in the sufficiently fast diagnosis of abdominal injuries.
B. Peynircioglu; Ankara/TR 3. To learn more about the typical and unusual findings of various
Session Objectives: abdominal traumatic conditions.
1. To appreciate the value of imaging in therapy planning and follow-up. 09:00
2. To learn about patient selection and evidence in catheter directed
therapies for PE. A-194 B. The enemy within: non-traumatic abdominal
3. To learn about recent and ongoing trials in the endovascular emergencies
treatment of PE. R.J. Zagoria; San Francisco, CA/US
08:35
1. To learn how to better analyse CT scans for non-traumatic causes of
A-190 A. Imaging algorithm for pulmonary embolism abdominal pain.
B. Ghaye; Brussels/BE 2. To learn about the CT signs and causes of bowel ischaemia.
Learning Objectives: 3. To learn about the CT findings of common causes of an ‘acute’
1. To learn how clinical findings influence the selection of the imaging abdomen.
strategy in PE. 4. To learn about the imaging findings of acute, non-traumatic urinary
2. To learn about the follow-up after treatment. tract and GI tract emergencies.
3. To learn how imaging may predict the outcome of the patient.
09:30
08:58 A-195/A-196 C. Interactive case discussion
A-191 B. What is new in the recently published guidelines for A. Palkó1, R.J. Zagoria2; 1Szeged/HU, 2San Francisco, CA/US
pulmonary embolism treatment? Learning Objectives:
R. Uberoi; Oxford/UK 1. To learn how to better analyse CT scans for traumatic and non-
Learning Objectives: traumatic causes of abdominal pain.
1. To learn about the recently published guidelines for PE treatment in 2. To learn about the CT signs and causes of bowel ischaemia and
stable patients. injuries.
2. To learn about the recently published guidelines for PE treatment in 3. To learn about the CT findings of common causes of traumatic and
unstable patients. non-traumatic ‘acute’ abdomen.
3. To learn about recent therapeutic algorithms in PE treatment. 4. To learn about the imaging findings of acute, traumatic and non-
traumatic urinary tract and GI tract emergencies.
09:21
A-192 C. Updates on the endovascular treatment of massive
and submassive pulmonary embolism 08:30–10:00 Room M 5
S.C. Spiliopoulos; Patras/GR
E3 - ECR Academies:
1. To learn about the rationale of recent and ongoing trials. Diagnostic Urogenital Radiology
2. To learn about the level of evidence for interventional radiology
techniques in PE treatment.
3. To learn about clinical results and possible further developments. E3 522 Retroperitoneum and adrenals
Moderator: J. Venancio; Lisbon/PT
Panel discussion:
09:44 Appropriate diagnosis and risk stratification in the 08:30
management of acute massive and acute sub-massive A-197 A. Anatomy and imaging techniques
pulmonary embolism of the retroperitoneum
F.M. Danza; Rome/IT
1. To become familiar with new insights into the normal anatomy of the
retroperitoneum.
2. To understand the spreading of retroperitoneal diseases across
spaces.
3. To learn about the optimal CT and MR protocols for imaging of the
retroperitoneum.

09:00 10:30–12:00 Room K

A-198 B. Differential diagnoses of retroperitoneal masses
M.-F. Bellin; Le Kremlin-Bicêtre/FR E3 - Rising Stars Programme
1. To become familiar with the typical imaging features of Basic Session 2: Head and neck imaging
retroperitoneal lesions.
2. To learn about the differential diagnoses of benign and malignant 10:30
retroperitoneal masses. A-202 Orbit
3. To understand how recognise the exact extent of retroperitoneal P.C. Maly Sundgren; Lund/SE
masses.
11:00
09:30
A-203 Ear
A-199 C. Differential diagnoses of adrenal lesions B. Verbist; Leiden/NL
1. To learn about the imaging protocols of adrenal glands, including A-204 Sinuses
functional imaging. R. Maroldi; Brescia/IT
2. To understand the typical imaging features of an adenoma on CT and
MRI.
3. To become familiar with typical signs of malignancy.
10:30–12:00 Room M 4
10:30–12:00 Room A
Joint Course of ESR and RSNA
(Radiological Society of North America):
E3 - ECR Academies:
Emergency Radiology
Thursday
Interactive Teaching Sessions
MC 628 Chest emergencies
E3 621 Cardiac CT: from stenosis assessment Moderators: A. Palkó; Szeged/HU,
to risk stratification R.J. Zagoria; San Francisco, CA/US
10:30 10:30
A-200 A. CT in stable chest pain A-205 A. Thoracic injuries
R. Marano; Rome/IT J.A. Soto; Boston, MA/US
1. To learn the different criteria for risk stratification. 1. To learn how to differentiate traumatic aortic injuries from congenital
2. To learn the practical way of doing image assessment. variants that mimic injury, to distinguish minor from major aortic
injuries, and to understand how injury classification can influence
11:15 management.
A-201 B. Cardiac CT in the emergency room 2. To become familiar with the various CT appearances suggesting and
G. Feuchtner; Innsbruck/AT verifying major airway injury.
Learning Objectives: 3. To understand the various CT appearances of blood/bleeding in the
1. To understand the imaging technique. chest and how the location, quantity of blood/bleeding and patient
2. To become familiar with the differential diagnosis. clinical status determine initial treatment.
4. To appreciate the spectrum of cardiac injuries that can be diagnosed
on admission contrast-enhanced CT and those that require urgent
intervention.
11:00
A-206 B. Non-traumatic thoracic emergencies
1. To illustrate typical CXR findings made in patients entering the
ER with acute dyspnoea and to learn when CT is indicated and
diagnostically useful.
2. To learn how to analyse and interpret HRCT patterns of pulmonary
opacifications in patients with acute respiratory insufficiency.
3. To learn about radiological key features helpful for differential
diagnosis and how to integrate clinical information.
11:30
A-207/A-208 C. Interactive case discussion
J.A. Soto1, C.M. Schaefer-Prokop2; 1Boston, MA/US, 2Amersfoort/NL

10:30–12:00 Room M 5 12:30–13:30 Room D1
E3 - ECR Academies: E3 - The Beauty of Basic Knowledge:

Diagnostic Urogenital Radiology Chest Imaging
E3 622 Kidney E3 25B How to avoid misdiagnosis on the chest
Moderator: H.C. Thoeny; Berne/CH x-ray
Moderator: N. Howarth; Chêne-Bougeries/CH
10:30
A-209 A. Differential diagnoses of cystic renal masses 12:30
M. Claudon; Vandoeuvre-les-Nancy/FR
A-214 A. Neoplastic lesions
Learning Objectives: J. Vlahos; London/UK
1. To become familiar with the updated Bosniak classification. Learning Objectives:
2. To learn about the differential diagnoses of complex cystic renal 1. To review the reasons for misdiagnosis on the chest x-ray.
masses. 2. To learn how to focus on blind areas.
3. To become familiar with typical surgical and non-surgical lesions. 3. To know the consequences of a misdiagnosis.
11:00 13:00
A-210 B. Differential diagnoses of solid renal masses A-215 B. Non neoplastic lesions
R.H. Oyen; Leuven/BE A.R. Larici; Rome/IT
1. To learn about the differential diagnoses of solid renal lesions. 1. To review the reasons for misdiagnosis on the chest x-ray.
2. To become familiar with typical imaging findings of the renal cell 2. To learn how to interpret the chest x-ray more accurately.
carcinoma subtypes. 3. To know the consequences of a misdiagnosis.
3. To become familiar with potential criteria for active surveillance of
solid renal masses.
11:30 14:00–15:30 Room A
A-211 C. Acute and chronic renal infection
E3 - ECR Academies:
Learning Objectives: Interactive Teaching Sessions
1. To learn about the different aetiologies of acute renal infection,
including typical imaging findings. E3 721 Cardiac imaging
2. To learn about the time-point and possibilities for interventions.
3. To understand the causes of chronic renal infection, including typical 14:00
imaging findings.
A-216 A. Patterns of delayed enhancement
P. Hunold; Lübeck/DE
12:15–12:45 Room A Learning Objectives:

1. To learn the different patterns of delayed enhancement.
Plenary Session 2. To understand the influence regarding the prognosis.
14:45
HL 1 Wilhelm Conrad Röntgen Honorary A-217 B. Cardiomyopathies: from diagnosis to prognosis
Lecture A. Jacquier; Marseille/FR
Presiding: K. Riklund; Umeå/SE Learning Objectives:
1. To understand the diagnostic work-up of cardiomyopathies.
12:15 2. To review the association between diagnostic findings and clinical
A-212 Imaging the invisible killer: towards personalisation of outcome.
ovarian cancer care
A.G. Rockall; London/UK
12:30–13:30 Room B
E3 - The Beauty of Basic Knowledge:

Breast Imaging
E3 24B Cracking the mystery of needles and
gauges
12:30
A-213 Cracking the mystery of needles and gauges
1. To learn about the choice of techniques used for guidance in breast
interventions.
2. To know the different breast biopsy systems and their indications.
3. To learn the most common practical tips and pitfalls in these
procedures.

14:00–15:30 Room N 14:25

A-226 Novel ultrasound and MRI technologies for breast cancer
ESOR Session Advancing clinical practice:
screening
role of education N. Karssemeijer; Nijmegen/NL
Moderators: L. Donoso; Barcelona/ES, Learning Objectives:
N. Gourtsoyiannis; Athens/GR 1. To learn how effectiveness and quality breast screening with
Automated Breast Ultrasound can be improved by using CAD.
14:00 2. To learn about optimising screening workflow with fast MRI
A-218 Introduction protocols and dedicated reading tools for comparison with prior
L. Donoso; Barcelona/ES exams.
3. To understand the potential of automated quality assurance methods
14:05 for MRI and automated breast ultrasound.
A-219 ESOR in action 2016
N. Gourtsoyiannis; Athens/GR 14:40
A-227 Breast cancer risk and masking risk-based stratification
14:15 protocols: key drivers of cost-effectiveness
A-220 Role of remodelling in delivering of learning E. Gray; Manchester/UK
P. Ros; Cleveland, OH/US Learning Objectives:
Learning Objectives: 1. To learn how mammographic breast density and texture are risk
1. To review the principles of excellence in delivering medical education factors for breast cancer independent from those included in
with emphasis in radiology. the Tyrer-Cusick model and how risk estimation performance is
2. To understand how remodelling the traditional, passive learning in modestly improved by including these variables.
medicine has given way to an interactive style. 2. To appreciate the substantial uncertainty about key parameters
3. To enumerate the resources available for multimedia, interactivity determining the cost-effectiveness of personalised breast screening.
and presentations in radiology. 3. To understand how optimising personalised screening based on
Thursday
effectiveness criteria with fixed resource constraints may offer a cost-
14:27 effective improvement on one-size-fits-all screening.
A-221 Role of referral guidelines and clinical decision support
14:55
systems
L. Donoso; Barcelona/ES A-228 Histopathology images: the new kid on the block of
clinical multimodality imaging
14:39 J. van der Laak; Nijmegen/NL
A-222 MDTs and patient outcomes Learning Objectives:
R.H. Reznek; London/UK 1. To understand the specific challenges of ‘going digital’ in
histopathology.
14:51 2. To learn about the opportunities of computer aided diagnosis in
A-223 Role of research and innovation: essential ingredients for pathology.
our professional advancement 3. To know what the current ‘state of the art’ is in this exciting area of
H. Hricak; New York, NY/US research.
Awards 15:10
A-229 Quantitative treatment planning, response prediction,
and monitoring
14:00–15:30 Studio 2016 K. Pinker-Domenig; New York, NY/US
EIBIR Session 1. To understand the clinical aspects of neo-adjuvant treatment.
2. To appreciate evidence-based protocols for imaging in this clinical
EIBIR 1 Joint VPH-PRISM/ASSURE Session - setting.
from screening to therapy: innovative 3. To learn about the imaging challenges of assessment and prediction
of response to neoadjuvant treatment.
breast care concepts
14:00
14:00–15:30 Room M 4
A-224 Introduction: challenges and innovative approaches in
image-based breast care Joint Course of ESR and RSNA
H.K. Hahn; Bremen/DE
Learning Objectives: (Radiological Society of North America):
1. To learn about the importance of quantitative predictors in image-
based decision making.
Emergency Radiology
2. To understand how predictors gained from different modalities and
disciplines can be fused. MC 728 CNS emergencies
14:10 R.J. Zagoria; San Francisco, CA/US
A-225 Density patterns, breast cancer risk and masking in
screening mammograms 14:00
C. Van Gils; Utrecht/NL A-230 A. CNS trauma and neurovascular injury
H.A. Rowley; Madison, WI/US
1. To learn about the contribution of different mammographic measures Learning Objectives:
for estimation of breast cancer risk. 1. To become familiar with traumatic brain injury demographics and
2. To understand the importance of knowing the risk of a breast cancer classification schemes.
that is likely to be missed with mammography. 2. To learn how to apply appropriateness criteria for head trauma
imaging in children and adults.
3. To identify key imaging patterns and pitfalls in the evaluation of
brain and neurovascular trauma.

14:30 16:00–17:30 Room A

A-231 B. CNS non-traumatic emergencies
M. Smits; Rotterdam/NL E3 - ECR Academies:
Learning Objectives: Interactive Teaching Sessions
1. To learn about the modalities (MRI/CT) and protocols for non-
traumatic neurological emergencies.
2. To learn how to diagnose the main non-traumatic neurological E3 821 Evaluation of patients with lung
vascular and non-vascular emergencies. emphysema
3. To become aware of the pitfalls and limitations of clinical
presentation and imaging findings in non-traumatic neurological 16:00
emergencies. A-237 A. Pretherapeutic evaluation of lung emphysema
C.P. Heussel; Heidelberg/DE
15:00
A-232/A-233 C. Interactive case discussion
H.A. Rowley1, M. Smits2; 1Madison, WI/US, 2Rotterdam/NL
1. To appreciate different phenotypes.
2. To learn how to quantify emphysema.
Learning Objectives: 3. To understand how to assess collateral ventilation.
1. To learn about traumatic brain injury (TBI) and non-traumatic
neurological emergencies. 16:45
2. To become familiar with imaging manifestations of TBI and non- A-238 B. Diagnostic work-up after treatment of lung
traumatic neurological emergencies.
emphysema
3. To understand the clinical implications of radiological imaging N. Sverzellati; Parma/IT
findings in TBI and non-traumatic neurological emergencies.
4. To learn about the state-of-the-art radiological imaging options Learning Objectives:
for the assessment of acute TBI and non-traumatic neurological 1. To learn how to personalise treatment.
emergencies. 2. To appreciate successful treatment results.
3. To understand complications and failure of treatment.
14:00–15:30 Room M 5
16:00–17:30 Room B
E3 - ECR Academies: GI Tract
Diagnostic Urogenital Radiology
RC 801 CT colonography today
E3 722 Emergencies
Moderator: M. Otero-García; Vigo/ES
16:00
14:00 M. Hellström; Gothenburg/SE
A-234 A. Male pelvis emergencies Session Objective:
M. Bertolotto; Trieste/IT 1. To briefly present state-of-the-art in CT colonography, including
Learning Objectives: standardised techniques, evidences on accuracy and guidelines on
1. To become familiar with various male pelvis emergencies. indications.
2. To learn about the correct imaging techniques. 16:05
3. To understand the differential diagnoses.
A-240 A. How I perform it
14:30 P. Lefere; Roeselare/BE
A-235 B. Gynaecological emergencies Learning Objectives:
R.A. Kubik-Huch; Baden/CH 1. To learn about modern approaches to bowel preparation and faecal/
Learning Objectives: fluid tagging.
1. To be familiar with various female pelvis emergencies. 2. To become familiar with colon distention, including prevention of
2. To learn about the correct imaging techniques. possible complications.
3. To understand the differential diagnoses. 3. To learn about different scanning protocols and their use according
to patient status and clinical needs.
15:00
16:28
A-236 C. Imaging of obstetric and puerperal emergencies
M. Weston; Leeds/UK A-241 B. How I interpret it
T. Mang; Vienna/AT
1. To learn about the imaging techniques performed in pregnancy. Learning Objectives:
2. To learn about the differential diagnoses of obstetric and puerperal 1. To become familiar with different image presentations: 2D, 3D,
emergencies. enhanced views.
3. To become familiar with typical imaging findings of most common 2. To appreciate the strengths and limitations of primary 2D and
pathologies. primary 3D reading.
3. To learn about the use of Computed Assisted Diagnosis (CAD)
software.
16:51
A-242 C. Screening with CTC
D. Regge; Turin/IT
1. To understand basic principles of population and opportunistic
screening.
2. To become familiar with data on accuracy of CTC in screening
populations.
3. To learn about current guidelines on the use of CTC in screening.
Panel discussion:
17:14 Challenging cases from clinical practice

16:00–17:30 Room C 16:05

A-248 Why is it important to consider infection control issues in
Special Focus Session ultrasound? Low- vs high-risk examinations
SF 8a Common mistakes in breast imaging Learning Objectives:
1. To understand possible risks of infection transmission though
16:00 inadequate probe decontamination.
A-243 Chairman’s introduction 2. To appreciate which ultrasound examinations are of low- versus
G. Forrai; Budapest/HU higher-risk.
Session Objectives: 3. To recognise the importance of a review of current practice to keep
1. To become familiar with the common mistakes in breast imaging. patients as safe as possible.
2. To appreciate the main differences and similarities among different
16:25
breast imaging modalities’ mistakes.
3. To understand how to avoid these dangerous issues. A-249/A250 Current accepted practice of ultrasound
probe decontamination in endocarvitary and
16:05
interventional radiology
A-244 Common mistakes in mammography N. Grenier1, M. Claudon2; 1Bordeaux/FR, 2Vandoeuvre-les-Nancy/FR
E.J. Cornford; Nottingham/UK
Learning Objectives: 1. To appreciate the use of ultrasound in different settings: endovaginal,
1. To learn about the classification and types of errors. endorectal, endoscopic and guiding interventional or surgical
2. To learn about the factors that affect our error rates. procedures.
3. To appreciate that there are mechanisms for reducing our error rates. 2. To gain insight into currently used probe decontamination protocols
4. To become familiar with some examples of common mammography after interventional procedures.
errors. 3. To learn about any known complications to date.
16:30
Thursday
16:45
A-245 Common mistakes in second-look ultrasound after MRI A-251 Why current practice may not be safe: main risks of
infection transmission and published evidence
Learning Objectives: H. Humphreys; Dublin/IE
1. To learn differences between primary- and second-look ultrasound
after MRI. Learning Objectives:
2. To become familiar with common pitfalls in second-look US. 1. To gain insight into transmission of infection risks from an expert
3. To understand how mistakes can be avoided in SLU. microbiologist.
2. To understand routes of infection and which most important
16:55 pathogens need to be considered.
A-246 Common mistakes in breast MRI 3. To learn about best decontamination practices in an “ideal world”.
Panel discussion:
17:05 Safer practice vs considerable cost implications:
1. To learn about the principal artefacts in breast MR related to the
are changes needed and feasible?
patient and to technical factors, and how to deal with them.
2. To understand the importance of performing breast MR in the
correct menstrual cycle phase and the problem of background
16:00–17:30 Room N
enhancement.
3. To appreciate the most common pitfalls in breast MR interpretation.
4. To become familiar with possible mistakes related to radiologists’ Head and Neck
interpretations.
RC 808 Paediatric: how we do head and neck
Panel discussion: imaging in children
17:20 How to avoid common mistakes in breast imaging? Moderator: N.J.M. Freling; Amsterdam/NL
16:00
16:00–17:30 Room O
A-252 A. Temporal bone
B. De Foer; Antwerp/BE
ESR Working Group on Ultrasound
1. To understand how impaired function of the temporal bone has
Minimising the risk of transmitting infections major clinical consequences.
through ultrasound: is current practice 2. To learn how to perform CT and MRI in children with hearing loss.
sufficient? 3. To become familiar with the most frequent developmental,
inflammatory and neoplastic conditions of temporal bone in
16:00 children.
A-253 B. Oral, paranasal sinuses and orbit
Session Objectives: M. Lell; Erlangen/DE
1. To understand potential risks of transmitting infections through Learning Objectives:
ultrasound. 1. To have an idea of the clinical presentation of oral, paranasal sinuses
2. To appreciate the difference between low- and high-risk ultrasound and orbit in infants and children.
examinations with regard to probe decontamination. 2. To learn how to perform CT and MRI in children with pathology of
3. To discuss how current evidence may necessitate change in our the face.
current ultrasound probe decontamination procedures, despite costs 3. To become familiar with the most frequent developmental,
involved. inflammatory, vascular and neoplastic abnormalities.

17:00 16:00–17:30 Room E1

A-254 C. Cysts and lumps in the neck
A. Ailianou; Geneva/CH Musculoskeletal
1. To learn an approach to differentiating masses in children based on RC 810 Sports injuries to the knee: improving
topography. my report
2. To be able to differentiate benign congenital, neoplastic and vascular
conditions. 16:00
3. To learn how to investigate soft tissue masses and which technique
to use. V. Vasilevska Nikodinovska; Skopje/MK
Session Objectives:
16:00–17:30 Studio 2016 1. To understand how the structure of reporting influences clinical
interpretation and treatment.
2. To appreciate the value of assessing both familiar and less familiar
Professional Challenges Session structures in the traumatised knee.
PC 8a Clinical decision support (CDS) 16:05
A-261 A. Reporting meniscal tears: pitfalls and how I avoid
16:00
them
A-255 Chairman’s introduction G. Andreisek; Zurich/CH
L. Donoso; Barcelona/ES
Session Objectives: 1. To understand how normal appearances can mimic meniscal tears.
1. To understand what CDS is and how it works. 2. To understand pitfalls in the diagnosis of meniscal tears.
2. To learn more about imaging referral guidelines in Europe.
3. To understand how CDS can be successfully implemented in practice. 16:28
4. To understand the added value and cost-effectiveness of CDS. A-262 B. The collateral ligaments and posterolateral corner:
16:05 what are they, why do they matter and how do I assess
A-256 What is a clinical decision support system? them?
U. Aydingoz; Ankara/TR
1. To understand the principles of and rationale for CDS. 1. To appreciate the significance of the collateral ligaments and
2. To learn how CDS fits into the clinical workflow. posterolateral corner.
3. To understand why CDS provides much more than just a digital 2. To understand pitfalls in the diagnosis of posterolateral corner
version of guidelines. injuries.
16:20 16:51
A-257 Imaging referral guidelines in Europe A-263 C. Imaging the reconstructed ACL in athletes: how to
M.G.M. Hunink; Rotterdam/NL assess and what to report
A.P. Parkar; Bergen/NO
1. To understand the challenges of developing guidelines for Learning Objectives:
heterogeneous European countries. 1. To be able to distinguish normal from pathological postoperative
2. To learn about the varying experiences of implementing CDS and imaging features in ACL reconstruction.
imaging referral guidelines in different countries. 2. To understand the clinical relevance of postoperative ACL
3. To understand the differences between an in-depth scientific reconstruction imaging.
guideline development process and practical recommendations for
daily use of guidelines. Panel discussion:
17:14 How will the patient and clinician be most helped by our
16:35 report, and is there a role for structured reporting?
A-258 An effective clinical decision support system
G. Boland; Boston, MA/US
Learning Objectives: 16:00–17:30 Room E2
1. To understand the practical advantages and benefits of implementing
CDS. Multidisciplinary Session
2. To understand the managerial and medical challenges of introducing
CDS. MS 8 Pancreatic cancer: radiological
3. To learn more about the educational and behavioural changes
brought about by CDS.
16:50 16:00
A-259 Cost-effectiveness of clinical decision support A-264 Chairman’s introduction
P. Mildenberger; Mainz/DE L. Grenacher; Munich/DE
Learning Objectives: Session Objectives:

1. To understand the cost-benefit relation of implementing CDS. 1. To become familiar with state of the art imaging modalities for
2. To learn more about the various costs-financial and otherwise-of diagnosis, staging and therapy of pancreatic ductal carcinoma
implementing CDS. (PDAC).
3. To understand the direct and indirect benefits of CDS. 2. To learn present decision algorithms for individual therapy strategies
of PDAC in tumour boards.
Panel discussion: 3. To understand the value of new functional imaging modalities of
17:05 Is CDS really adding value to healthcare in addition to PDAC.
radiation safety? 4. To become familiar with new surgical, medical and radiation therapy
protocols for PDAC and their potential survival benefit for the
patients.

16:05 16:37
A-265 Surgical oncological management A-272 The organisational role of EIBIR in EIBALL
J. Werner; Munich/DE V. Vilgrain; Clichy/FR
1. To understand actual surgical therapeutic options of PDAC and the 1. To become familiar with the European network of EIBIR.
overall survival. 2. To learn about the role of EIBIR in the EIBALL structure.
2. To become familiar with surgical options in case of local recurrence. 3. To understand the organisational support activities of EIBIR for the
3. To understand the value of more aggressive surgical strategies. alliance.
16:20 16:54
A-266 Medical oncological management A-273 Imaging biomarker development for EIBALL by
D. Jäger; Heidelberg/DE subspecialty societies
Learning Objectives: K. Nikolaou; Tübingen/DE
1. To learn about actual chemotherapeutic therapy of PDAC and Learning Objectives:
potential benefit of combination with surgery. 1. To learn about the role of subspecialty societies in imaging biomarker
2. To understand the survival benefit of oncological therapies. development.
3. To understand the development of chemotherapeutic strategies: from 2. To understand the problems still to be solved with imaging
Gemcitabine mono to new immunological therapies. biomarkers.
16:35 3. To become familiar with the transfer from technical to clinical
validation of imaging biomarkers.
A-267 Radiology oncological management
Panel discussion:
Learning Objectives: 17:11 What is the role of EIBALL now and in the future
1. To learn about diagnosis and staging of PDAC - which modality?
2. To understand the value of new functional imaging techniques.
3. To become familiar with the role of imaging in case of local
Thursday
16:00–17:30 Room F2
recurrence.
16:50 Special Focus Session
A-268 Radiation oncological management
F. Sterzing; Heidelberg/DE SF 8b Assessing myocardium at-risk with MRI
1. To learn about indications for radiation therapy: state of the art.
2. To understand new radiation techniques and their benefit for patients A-274 Chairman’s introduction
with PDAC.
Session Objectives:
17:05 Multidisciplinary case presentation and discussion 1. To understand technique of assessing at-risk myocardium.
1. To learn about decision making in individual cases of PDAC. 2. To understand the different values of T2 imaging and delayed
2. Multidisciplinary therapy strategies in patients with PDAC: time enhancement imaging.
consuming or individual concept for significant increase of survival? 3. To understand what is useful in the acute, sub-acute and chronic
settings.
4. To learn how to perform studies with safety and accuracy for patients.
16:00–17:30 Room F1
16:05
Professional Challenges Session A-275 T2 imaging
PC 8b An introduction to European Imaging Learning Objectives:

1. To understand the concept of tissue characterisation with T2
Biomarker Alliance (EIBALL) imaging.
2. To learn the meanings of inflammation, oedema and ischaemia.
16:00
2. To become acquainted with which sequences to use and what affects
A-269 Chairman’s introduction T2 imaging.
P.M. Parizel; Antwerp/BE
1. To understand the mission and vision of EIBALL. A-276 Late gadolinium enhancement
2. To learn how EIBALL promotes imaging biomarker development. S. Kozerke; Zurich/CH
3. To become familiar with the main activities and collaborations of Learning Objectives:
EIBALL. 1. To understand the concepts of tissue characterisation with T1and T2
imaging and the concepts of delayed enhancement imaging.
16:03
2. To compare reproducibility of T1- and T2-weighted imaging vs
A-270 EIBALL and its mission quantitative T1 and T2 mapping.
S. Trattnig; Vienna/AT 3. To become acquainted with which sequences to use and what effects
Learning Objectives: delayed enhancement imaging.
1. To become familiar with the goals of EIBALL.
2. To learn about collaborations with QIBA. 16:45
3. To understand the different main strengths of EIBALL and QIBA. A-277 Prognostic value of area-at-risk assessment by T2 and
late enhancement imaging
16:20 A. de Roos; Leiden/NL
A-271 The potential role of EIBALL for EORTC multicentre trials Learning Objectives:
Y. Liu; Brussels/BE
1. To understand the concept of myocardial necrosis.
Learning Objectives: 2. To understand different ways of estimating the extent of necrosis with
1. To understand how EORTC benefits from EIBALL. delayed enhancement imaging.
2. To learn about the role of imaging biomarker in clinical multicentre 3. To understand how the combined use of delayed enhancement and
trials. T2 imaging allows us to estimate salvageable myocardium after
3. To become informed of EORTC multicentre trials jointly performed coronary occlusion and the clinical importance.
with EIBALL.

Panel discussion: Panel discussion:

17:15 How do we best assess at-risk myocardium and how do 17:17 How best to manage obesity and its implications on the
we best get the correct information across? radiology department
Discussion points:
1. What do we need to know in the acute and sub-acute setting?
2. What is the clinical use of the different methods? 16:00–17:30 Room D2
3. How do we best assess at-risk myocardium and how do we best get
the correct information across? Special Focus Session
SF 8d CT radiation dose optimisation:
16:00–17:30 Room D1
are we doing enough?
Special Focus Session 16:00
SF 8c Imaging in obesity A-283/A-284 Chairmen’s introduction
I.M. Björkman-Burtscher1, C. Malamateniou2; 1Lund/SE, 2London/UK

1. To introduce the concept of radiation dose levels and dose
S. Lee; Manchester/UK optimisation techniques used in CT.
2. To outline the main aim of the talks of the session and how they
Session Objectives: connect to each other.
1. To outline the problems that patients with obesity present to the 3. To refer to the main radiation protection initiatives in Europe led by
developed nations in the West. the ESR.
2. To quantify and understand the role of intra-abdominal fat.
3. To evaluate the role of radiology in imaging patients after bariatric 16:05
surgery A-285 CT radiation dose optimisation: what has been achieved
4. To determine the role of gastric embolisation in the treatment of
so far?
obesity. J. Santos; Coimbra/PT
A-279 Epidemiology and current trends in obesity 1. To consolidate knowledge regarding current radiation dose levels
N. Finer; London/UK used in CT.
2. To become familiar with recent advances in dose optimisation using
scanner design features and their impact on patient dose.
1. To appreciate the scale of the prevalence of obesity worldwide.
3. To understand how radiographers can optimise CT radiation doses
2. To recognise the role of the environment and of genetic
on an individual basis.
predisposition on the development of obesity.
4. To enhance understanding of international optimisation campaigns
3. To understand the impact of adiposity, and adiposity measures on
such as Image Wisely.
health and disease.
4. To critically appraise the evidence for and against an ‘obesity paradox’. 16:30
16:23 A-286 Dose reduction techniques in paediatric CT: from A to Z
A-280 Fat quantification and advanced body composition
assessment using MRI
O. Dahlqvist Leinhard; Linkoping/SE 1. To consolidate knowledge of trends in paediatric CT use and the
importance of optimisation in this cohort.
Learning Objectives: 2. To understand how paediatric CT protocols should be ‘child sized’ to
1. To describe techniques for acquisition of water- and fat-separated ensure dose optimisation in line with the Image Gently initiative.
MRI and quantitative image analysis. 3. To become familiar with the availability and use of paediatric referral
2. To describe methods for analysis of compartmental adipose tissue guidelines and diagnostic reference levels and their impact on CT use
and lean muscle tissue quantification. and justification.
3. To discuss applications of whole-body-fat and water-separated MRI 4. To consider the role of superficial shielding during CT scanning.
and their clinical translation.
16:55
16:41
A-287 Challenges and opportunities in CT dose optimisation:
A-281 Imaging of modern surgical procedures and their
what can we do in the future?
complications S.J. Foley; Dublin/IE
M. Rengo; Latina/IT
Learning Objectives: 1. To understand difficulties in dose estimation in CT using current
1. To understand the common bariatric surgical procedures. metrics of CTDI and DLP and the potential role for newer metrics
2. To understand the imaging procedures accordingly. such as size-specific dose estimate (SSDE).
3. To become familiar with the normal post-operative anatomy. 2. To become familiar with the lack of standardisation between scanners
4. To appreciate the role of imaging in the assessment of suspected and protocols across centres and the role of diagnostic reference
immediate and long-term postoperative complications. levels.
16:59 3. To gain an understanding of future developments in scanner design
that will aid radiation dose optimisation.
A-282 Is there a role for bariatric embolisation in the treatment
of the obese patient? Panel discussion:
C. Weiss; Baltimore, MD/US
17:20 What are the suggested priorities and actions for CT
Learning Objectives: dose optimisation?
1. To understand the physiologic underpinnings of bariatric
interventions.
2. To understand the pre-clinical and early clinical data behind bariatric
embolisation.
3. To understand techniques and patient selection for bariatric
embolisation.
4. To understand the potential role of bariatric embolisation in the
treatment of the obese patient.

16:00–17:30 Room K 16:00–17:30 Room G
American College of Radiology (ACR) Session E3 - ECR Academies:

ACR Delivering higher value care Neuroradiology: from Morphology to Function
in radiology: how to make it work E3 819 Cerebral blood flow quantification
in clinical practice - perspectives from
the American College of Radiology 16:00
Moderators: B. Allen, Jr.; Birmingham, AL/US, A-291 Chairman’s introduction
H.-U. Kauczor; Heidelberg/DE A. Jackson1, T. van der Zijden2; 1Manchester/UK, 2Edegem/BE
16:00 16:03
A-288 Awareness to accountability: coping with the mandates A-292 A. Functional imaging of cerebral perfusion
A. Krainik; Grenoble/FR
for documenting higher-value care
B. Allen, Jr.; Birmingham, AL/US Learning Objectives:
Learning Objectives: 1. To understand that functional imaging of perfusion enables the
1. To review radiology’s efforts to raise awareness and promote culture study of properties such as vasoreactivity to circulating gases,
change among radiologists to adapt to health system and consumer autoregulation and neurovascular coupling.
initiatives for value-driven care. 2. To show that functional imaging of perfusion can influence
2. To review organised radiology’s efforts to raise awareness and therapeutic strategy through estimation of the vascular reserve and
promote culture change among radiologists to adapt to the mandates the risk of ischaemia.
of health reform. 3. To learn that functional MRI of vasoreactivity is of value in
3. To discuss radiology societies’ role in empowering radiologists understanding functional MRI activation.
to document the delivery of higher value care through metrics 16:32
Thursday
development, policy maker engagement, and data collection/
A-293 B. Cerebral blood flow measurements with arterial spin-
registry development for reporting quality data to policy makers and
certification bodies. labelling
X. Golay; London/UK
A-289 Radiologists’ role in delivering higher-value care through 1. To reveal how arterial spin labelling (ASL) can accurately measure
population health management cerebral blood flow (CBF).
W.T. Thorwarth; Reston, VA/US 2. To present an overview of the advantages and limitations of using
Learning Objectives: ASL in adult and paediatric subjects.
1. To examine current trends and mandates for physician involvement 3. To show that the use of subject-specific model parameters (for
in population health management. example particularly blood and tissue T1) can improve the accuracy
2. To discuss the value radiologists can bring to population health of CBF estimates.
management and how this role will become an important resource 17:01
for their health systems.
A-294 C. Cerebrovascular reserve imaging and the
3. To identify the tools radiologists can use in their practices to be
effective in population health management by reducing variation in consequences of neurovascular uncoupling
radiological care. D. Mikulis; Toronto, ON/CA
16:50 1. To understand the consequences of severly reduced CVR in terms of
A-290 Involving patients in their radiological care: radiologist future risk of stroke as well as cortical thinning that can occur in the
visibility, personalised care and improving outcomes absence of acute ischaemic events.
D.C. Kushner; Virginia Beach, VA/US 2. To review the challenges facing clinical implementation.
Learning Objectives: 3. To understand the potential of CVR for informing patient selection
1. To discuss the ways radiologists can enhance patients’ experiences for revascularisation.
throughout the continuum of radiological care.
2. To identify ways to improve patient outcomes through effective
communication. 16:00–17:30 Room M 1
3. To leverage the value of patient-centred radiological care as a
resource for health systems. Vascular
17:15 Questions and answers RC 815 Carotid artery disease: so what’s new?
Moderator: T. Jargiello; Lublin/PL
16:00
A-295 A. The diagnostic assessment of carotid arteries
R. Iezzi; Rome/IT
1. To understand the role of US, CT, MR and DSA in diagnostic
assessment.
2. To learn the optimal imaging algorithm for diagnosis and follow up.
3. To appreciate the role of plaque characterisation in routine practice.


A-296 B. Carotid stenting vs endarterectomy: is the jury back 17:14 What is the preferred comprehensive imaging test in
heart failure?
yet?
S. MacDonald; Newcastle upon Tyne/UK
Learning Objectives: 16:00–17:30 Room M 3
1. To understand the evidence supporting surgery and endovascular
therapy. Interventional Radiology
2. To understand why the trials have been slow to bring clarity to
optimal therapy.
3. To learn how best to triage patients for surgery or endovascular RC 809 Current trends in transarterial
therapy. chemoembolisation (TACE) and
17:00 radioembolisation for HCC
A-297 C. Carotid interventions in the setting of acute CVA 16:00
S. Sencer; Istanbul/TR
Learning Objectives: A. Denys; Lausanne/CH
1. To understand the indications and contraindications to carotid
stenting. Session Objectives:
2. To appreciate how CT/MR can aid patient selection for carotid 1. To learn how to select HCC patients for TACE-TAE or
stenting. radioembolisation.
3. To learn about carotid stenting in the setting of acute thrombosis/ 2. To understand optimal DEB technique for TACE.
dissection. 3. To understand the role of the radiologist in radioembolisation of
HCC.
16:05
16:00–17:30 Room M 2
A-303 A. Imaging in therapy planning and follow-up
Cardiac
1. To learn how imaging influences the selection of the embolisation
RC 803 Imaging of heart failure strategy in HCC.
2. To learn about standard and advanced imaging techniques in the
16:00 follow-up after treatment.
A-298 Chairman’s introduction 3. To learn how imaging may guide the decision about re-treatment.
C. Loewe; Vienna/AT
The numbers of patients with systolic or diastolic heart failure are A-304 B. TACE and TAE for HCC: new agents, new schedules,
increasing. The role of non-invasive imaging to diagnose (the cause of) new combinations
heart failure, to assess prognosis and guide treatment, gains importance. K. Malagari; Athens/GR

1. To learn about the results of new treatment schedules and treatment
A-299 A. Current ESC and AHA guidelines: how to choose combinations.
imaging techniques in heart failure patients? 2. To learn about the rationale of recent and ongoing trials.
J.T. Ortiz-Pérez; Barcelona/ES 3. To learn about clinical results and possible further developments.
1. To become familiar with the diagnostic algorithm of heart failure 16:51
according to current guidelines. A-305 C. Radioembolisation: critical appraisal of techniques
2. To learn the strengths and weaknesses of the different imaging and guidelines for treatment
techniques in heart failure patients. J.I. Bilbao; Pamplona/ES
3. To discuss the role of imaging techniques to guide clinicians in Learning Objectives:
diagnosis, treatment and follow-up. 1. To learn about critical aspects of techniques and dosimetry.
16:28 2. To become familiar with ongoing trials and guidelines for treatment.
3. To understand the relative role of TACE/TAE and radioembolisation
A-300 B. Differentiating the causes for heart failure: is MRI the in HCC.
indisputable gold standard?
T. Leiner; Utrecht/NL Panel discussion:
Learning Objectives: 17:14 The intermediate HCC patient: how can we stratify
1. To learn about MRI techniques to evaluate heart failure and its patients and allocate them to different therapies?
potential causes.
2. To learn a practical approach for differentiating the causes of heart
failure using MRI.
3. To become familiar with the role of MRI in the clinical management
and prognosis.
16:51
A-301 C. SPECT as an alternative imaging technique
F. Caobelli; Hannover/DE
1. To learn about nuclear imaging techniques in the detection of heart
failure.
2. To appreciate imaging findings in the diagnosis of heart failure and
its causes.
3. To become familiar with the role of nuclear imaging for diagnosis
and prognosis in heart failure.

16:00–17:30 Room M 4 17:00

A-311 C. Imaging of bladder and urethra
Joint Course of ESR and RSNA J. Lopes Dias; Lisbon/PT
(Radiological Society of North America): Learning Objectives:

1. To become familiar with various diseases of the bladder and urethra.
Emergency Radiology 2. To learn about the typical imaging findings of malignant and non-
malignant disease.
MC 828 General principles: paediatric and 3. To learn about the most frequent differential diagnoses.
ENT emergencies
16:00
A-306 A. Imaging of polytrauma patients
U. Linsenmaier; Munich/DE
1. To learn about general principles of diagnostic imaging in emergency
radiology in traumatic and non-traumatic emergencies.
2. To understand the aetiology, background and management of
common radiological emergencies.
3. To appreciate the role, indications and protocols for US, CR, MDCT
in modern emergency radiology.
16:30
A-307 B. Challenges of imaging paediatric abdominal
Thursday
emergencies
C.J. Sivit; Cleveland, OH/US
1. To understand the variations of pathology that cause abdominal pain
and vomiting in infants and children.
2. To learn how to plan safe and effective imaging protocols using US,
CT, and MRI.
3. To recognise pitfalls in the diagnosis of paediatric abdominal
emergencies with imaging.
17:00
A-308 C. Imaging in ENT emergencies
D. Nunez; New Haven, CT/US
1. To understand imaging findings in patients presenting with acute
head and neck conditions using a systematic spatial approach.
2. To get an understanding of the role and indications of CT and MR in
acute non-traumatic ENT case management.
3. To learn how to identify the extent of disease and recognise specific
complications of cervicofacial infections.
16:00–17:30 Room M 5
E3 - ECR Academies:
E3 822 Upper and lower urinary tract
Moderator: V. Logager; Copenhagen/DK
16:00
A-309 A. CTU and MRU of the upper urinary tract
N.C. Cowan; Portsmouth/UK
1. To learn about the technical requirements of CTU and MRU.
2. To learn about indications, diagnostic accuracy, diagnostic strategies,
advantages and limitations of CTU and MRU.
3. To understand the normal imaging findings.
16:30
A-310 B. Imaging of kidney and ureter
M.A. Cova; Trieste/IT
1. To learn about the typical signs of urothelial carcinoma in the kidney
and ureter, including rare manifestations.
2. To learn about the most frequent differential diagnoses.
3. To understand the potential pitfalls.


08:30–10:00 Room A 08:30–10:00 Room O
E3 - ECR Academies: Paediatric

Interactive Teaching Sessions RC 912 Hepatobiliary imaging in children
Moderator: M. Raissaki; Iraklion/GR
E3 921 Diagnostic evaluation of bone tumours
08:30
08:30
A-318 A. Imaging of liver masses
A-312 A. Bone tumours: benign or malignant? H. Woodley; Leeds/UK
H.-J. van der Woude; Amsterdam/NL
Learning Objectives: 1. To learn about imaging protocols.
1. To review the features on conventional radiographs which distinguish 2. To learn about common benign and malignant lesions and
benign and malignant bone tumours. differential diagnosis.
2. To extend this knowledge to analyse features on MRI and CT which 3. To become familiar with the role of new imaging techniques and
can help to distinguish benign and malignant bone tumours. hepatocytes-specific contrast agents.
09:15 09:00
A-313 B. Pseudotumours: mimic bone tumours A-319 B. Imaging of biliary disorders
1 2 1 2
F.M.H.M. Vanhoenacker , G. Vanderschueren ; Antwerp/BE, Leuven/BE
S.G.F. Robben; Maastricht/NL
1. To review the range of lesions which mimic tumours of the bone. 1. To become familiar with the roles of US, CT and MRI.
2. To extend this knowledge to analyse features that identify 2. To learn about manifestations of common diseases.
pseudotumours of the bone. 3. To discuss the role of hepatobiliary contrast agents.
09:30
08:30–10:00 Room B A-320 C. Intervention in the hepatobiliary system
S. Franchi-Abella; Le Kremlin-Bicêtre/FR
Abdominal Viscera Learning Objectives:
1. To become familiar with liver biopsy in focal and diffuse hepatic
RC 901 Hepatocellular tumours 08:30 disorders.
A-314 Chairman’s introduction 2. To highlight the role of interventional radiology in biliary disorders.
C. Bartolozzi; Pisa/IT 3. To learn about the role of interventional radiology in hepatic vascular
Session Objective: disorder.
1. To briefly introduce the diagnostic challenge of benign and malignant
hepatocellular focal lesions.
08:30–10:00 Room N
Friday
08:35
A-315 A. The revised adenoma classification E3 - ECR Academies:
C.J. Zech; Basle/CH
Modern Cardiac Imaging
1. To describe the underlying histopathologic characteristics of
hepatocellular adenoma. E3 920 How to quantify the haemodynamic
2. To define and compare the features of different imaging techniques significance of coronary stenosis
for the correct diagnosis. Moderator: C. Loewe; Vienna/AT
3. To differentiate hepatic adenoma from other hepatocellular focal
lesions, i.e. focal nodular hyperplasia. 08:30
08:58 A-321 A. CT-angiography: new tools (TAFE, TAG, CT-FFR)
G. Pontone; Milan/IT
A-316 B. HCC staging: what is new in imaging and can predict
prognosis
C. Ayuso; Barcelona/ES 1. To understand how the haemodynamic significance of coronary
stenosis affects the choice of treatment and the patient’s prognosis.
Learning Objectives: 2. To learn about new approaches to grading of coronary stenosis with
1. To define HCC staging criteria and their impact on therapeutic the help of CTA (TAFE, TAG, CT-FFR).
management. 3. To become familiar with the diagnostic value of these tools in
2. To describe HCC imaging prognostic factors, including functional comparison with traditional methods.
and metabolic imaging.
3. To appraise the added clinical value of imaging prognostic factors in 09:00
the therapeutic management. A-322 B. Myocardial perfusion: what can be done with MR and
09:21 CT
R. Vliegenthart; Groningen/NL
A-317 C. Equivocal nodules in cirrhotic patient: how to solve
the puzzle
Y. Menu; Paris/FR 1. To appreciate the clinical need for assessment of myocardial
perfusion and viability.
Learning Objectives: 2. To understand how perfusion MR and CT are performed in clinical
1. To describe modern imaging techniques to identify and characterise settings.
nodules in cirrhotic patients. 3. To learn about diagnostic performance of perfusion MR and CT and
2. To define the added value of hepato-specific contrast agents and clinical indications for them.
multiparametric approach for the differential diagnosis.
3. To appraise an algorithm for the management of equivocal nodules.
Panel discussion:
09:44 Impact of imaging on classification and differentiation of
hepatocellular lesions

09:30 09:45
A-323 C. New players on the field: SPECT/CT, PET/CT, MR/PET A-329 What are ontologies?
S.G. Nekolla; Munich/DE B. Gibaud; Rennes/FR
1. To understand the advantages and limitations of hybrid perfusion 1. To understand the requirements for a structured and interoperable
imaging. “language”.
2. To learn about the diagnostic value of hybrid imaging for studies of 2. To learn about different ontologies and taxonomies.
myocardial perfusion. 3. To consolidate knowledge about “Minimum Information About
3. To become aware of clinical indications for hybrid myocardial Biobanking Sharing” (MIABIS) 2.0.
perfusion studies.
08:30–10:00 Room E1
08:30–10:00 Studio 2016
Professional Challenges Session
PC 9b Radiology ten years from now:
PC 9a Biobanks meet imaging where will it be?
Moderators: E. Neri; Pisa/IT, M. Pasterk; Graz/AT
08:30
A-324 How does Biobanking and BioMolecular resources C.D. Becker; Geneva/CH
Research Infrastructure - European Research Session Objectives:
Infrastructure Consortium (BBMRI-ERIC) work? 1. To define the role of the radiologist in the multidisciplinary
J.-E. Litton; Graz/AT environment.
Learning Objectives: 2. To evaluate potential synergies between radiology and pathology in a
1. To understand the diversity of human disease, biological samples and common management structure.
corresponding data. 3. To discuss the leadership challenges in radiology for the next decade.
2. To appreciate the benefits provided by biobanks for personalised 08:40
medicine.
3. To learn about how the biobanking network of BBMRI has A-331 Expanding radiology with new multidisciplinary
established quality assurance in biobanks. competencies
J.A. Reekers; Amsterdam/NL
A-325 Patient rights: data overprotection? 1. To explain the need for subspecialisation and clinical involvement for
M.T. Mayrhofer; Graz/AT future radiologists.
Learning Objectives: 2. To review the role of the subspecialised radiologist in the modern
1. To understand the rationale for patient rights. hospital environment.
2. To consolidate knowledge about the implementation of 3. To discuss strategies to increase visibility of the radiologist in the
anonymization and pseudonymization. medical community.
3. To learn about the upcoming General Data Protection Regulation.
09:00
09:00 A-332 Potential synergies between radiology and pathology
A-326 What is the difference between a PACS and a clinical R.H. Oyen; Leuven/BE
bank of radiological images? Learning Objectives:
A. van der Lugt; Rotterdam/NL 1. To describe the advantages of integrating radiology and pathology in
Learning Objectives: the same organisational structure.
1. To appreciate the need for structured and searchable image data and 2. To discuss workflow and potential synergies.
reports. 3. To review local experience with regard to integration.
2. To understand the requirements for a clinical imaging bank. 09:20
3. To learn about the intraoperability of clinical image bank and other
data repositories. A-333 The beauty of general radiology
G.H. Mostbeck; Vienna/AT
A-327 Population-based cohort biobanks: accessing large 1. To define the training requirements and related challenges for
European prospective cohorts through the biobanking complete, transverse core competences in general radiology.
2. To define the practical challenges involved with increasing
infrastructure BBMRI - large prospective cohorts (LPC) subspecialisation in radiology.
O. Törnwall; Graz/AT
3. To define the role of the general radiologist in the modern hospital
Learning Objectives: environment.
1. To learn about BBMRI - large prospective cohorts (LPC).
2. To understand how to obtain easy access to samples and data. Panel discussion:
3. To learn how to transfer expertise from established to new emerging 09:40 What are the leadership challenges for the next decade?
biobanks.
09:30
A-328 Population-based cohort: image banks
1. To appreciate the added value provided by imaging in population-
based cohorts.
2. To understand the difference between observation, incidental finding
and result.
3. To learn about the intraoperability of biobanks and image banks.

08:30–10:00 Room E2 08:30–10:00 Room F1
Special Focus Session Oncologic Imaging

SF 9c Brain hypersignals after repeated RC 916 Diffusion-weighted imaging (DWI)
gadolinium administrations in oncology: how I do it
08:30 08:30
A-334 Chairman’s introduction A-339 Chairman’s introduction
V. Runge; Berne/CH D.-M. Koh; Sutton/UK
Session Objectives:
1. To review old and recent data on gadolinium (Gd) chelates kinetics 08:35
and toxicity. A-340 A. DWI: how to optimise protocols
2. To learn about the recent abundant literature concerning brain N. Papanikolaou; Stockholm/SE
hypersignals. Learning Objectives:
3. To understand the undertakings and positions of the health agencies. 1. To learn about examination protocols and techniques.
2. To understand the different models describing diffusion in various
08:35
organs and diseases.
A-335 Chemistry of Gd chelates and fundamentals in toxicity 3. To become familiar with basic and advanced post-processing aspects.
S. Aime; Turin/IT
1. To understand the determinants of the in vivo stability of Gd A-341 B. DWI in abdominal oncology: ready for clinical
complexes. practice?
2. To understand the physicochemical aspects affecting the D.M. Lambregts; Amsterdam/NL
biodistribution of Gd. Learning Objectives:
08:52 1. To learn about the different ways diffusion imaging protocols can be
used for qualitative and quantitative evaluation of malignant tumours
A-336 Recent literature review in the abdomen.
A. Radbruch; Heidelberg/DE
2. To understand the pitfalls of using DWI in abdominal oncology.
Learning Objectives: 3. To become familiar with the current clinical applications for DWI in
1. To review published data on hyperintensities and gadolinium abdominal oncology.
deposition in the brain after repeated gadolinium administrations.
2. To review published data on the differences of hyperintensities and 09:21
gadolinium deposition in the brain after repeated administrations of A-342 C. DWI: whole body imaging
macrocyclic and linear gadolinium based contrast agents. V. Vandecaveye; Leuven/BE

1. To learn about the most common indications of whole body diffusion
Friday
A-337 Hypersignals in the brain: which clinical impact imaging in cancer staging and treatment planning.
2. To become familiar with normal anatomy and physiological signal at
Learning Objectives: whole body diffusion imaging.
1. To understand the clinically most important aspects of the function 3. To understand how to integrate qualitative and quantitative
of the dentate nucleus and basal ganglia nuclei. interpretation criteria into a structured report to optimise
2. To learn about signal variants and concerned pathologies. communication with the referring clinician.
3. To speculate about the potential implications of gadolinium
depositions. Panel discussion:
09:26 09:44 How to optimise DWI for clinical practice?
A-338 Recent FDA and EMA undertakings in the matter
08:30–10:00 Room F2
1. To learn about the pharmacovigilance actions of the European Special Focus Session
Medicines agency and the American FDA.
2. To understand the risk minimisation measures.
SF 9a Breast density: how not to be
Panel discussion: confused?
09:43 Gadolinium injections: should we change our practice?
08:30
E. Azavedo; Stockholm/SE
Session Objectives:
1. To learn why breast density is a diagnostic problem and to
understand if it is a prognostic factor.
2. To be able to identify and grade breast density.
3. To understand why dense breast could be a masking process and to
learn how to avoid false negatives.
08:35
A-344 The mammographic dense breast
1. To learn the definition of dense breast and the consequences on
mammography interpretation.
2. To understand the different methods to measure breast density on
mammography.
3. To analyse details that can be associated with abnormalities in dense
tissues.

09:00 08:35
A-345 The ultrasound dense breast A-352 A. Current status of digital mammography
L.J. Pina Insausti; Pamplona/ES C.E. Mercer; Manchester/UK
1. To learn the different categories of breast density on ultrasound 1. To appreciate the strengths and weaknesses of digital mammography
according to the new BI-RADS lexicon. in breast imaging.
2. To learn the impact of breast density on ultrasound analysis and the 2. To become familiar with the importance of optimising breast
interest of automatic breast ultrasound in breast cancer screening. compression for improving image quality.
3. To learn how to handle a transducer in dense breasts. 3. To appreciate the clinical role of digital mammography in
highlighting breast pathologies.
09:25
A-346 The MRI dense breast 08:58
P.A.T. Baltzer; Vienna/AT A-353 B. Developments in digital mammography
Learning Objectives: C. Reis; Lisbon/PT
1. To learn the differences of breast density and (breast enhancement Learning Objectives:
patterns) background parenchymal enhancement (BPE), on MRI. 1. To understand the current developments in digital mammography.
2. To understand if breast density or (breast enhancement) BPE have an 2. To become aware of the potential of tomosynthesis in breast imaging.
influence on breast cancer risk. 3. To become familiar with the current limitations of digital
3. To understand enhancement in diffusely growing malignancies in a mammography in breast imaging.
dense background.
09:21
Panel discussion: A-354 C. Breast MRI and the future
09:50 How to overcome the dense breast in screening? G. Podobnik; Ljubljana/SI
1. To appreciate the strengths and weaknesses of MRI in breast imaging.
08:30–10:00 Room D1 2. To understand the role of the radiographer in breast MRI in view of
the recent developments in MRI technology.
Chest 3. To become aware of possible future developments in and clinical
applications of breast MRI.
RC 904 Low dose and no-dose chest imaging:
Panel discussion:
opportunities and limitations 09:44 The role of multimodality imaging in breast imaging
Moderator: A.P. Parkar; Bergen/NO
08:30 08:30–10:00 Room K

A-347 A. Low-dose CT
O. Buckley; Dublin/IE EFOMP Workshop: Radiation Protection for
1. To learn about techniques for decreasing the radiation dose on CT. the female patient and female medical staff
2. To know in which clinical situations low dose CT should be
performed. EF 1 Breast imaging modalities and radiation
09:00 dose
Moderators: T. Beyer; Vienna/AT, J. Damilakis; Iraklion/GR
A-348 B. MRI
J. Dinkel; Munich/DE
08:30
1. To learn about the current lung MR protocols. A-355 Chairman’s introduction
2. To know in which clinical situations lung MRI is a helpful adjunct to
diagnosis. Session Objectives:
1. To become familiar with the advanced breast imaging modalities.
09:30 2. To learn about breast doses from these modalities.
A-349 C. US 3. To appreciate their advantages and limitations.
F. Gleeson; Oxford/UK
08:35
1. To learn when and how to perform a US study in the intensive care A-356 Breast CT: technology and patient dose
I. Sechopoulos; Nijmegen/NL
patient.
2. To become familiar with the strengths and limitations of the Learning Objectives:
technique. 1. To understand the technical aspects of breast CT.
2. To become familiar with breast dose levels from breast CT.
3. To give an overview of future improvements and developments of
08:30–10:00 Room D2 breast CT.
09:05
Radiographers A-357 Digital mammography for screening and diagnosis of
RC 914 State-of-the-art breast imaging breast cancer: breast doses and radiogenic risks
O. Morrish; Cambridge/UK

1. To learn about breast doses and radiogenic risks from a two-view
A-350/A-351 Chairmen’s introduction
V. Syrgiamiotis1, S. Zackrisson2; 1Athens/GR, 2Malmö/SE
digital mammography.
2. To become familiar with breast doses and risks of radiation-induced
Session Objectives: breast cancer associated with mammographic screening.
1. To review current methods of screen-film mammography. 3. To understand that the risk of radiation-induced breast cancer due
2. To present recent developments in digital mammography. to a properly performed mammographic screening programme is
3. To explain the future of breast MRI techniques. minimal.

09:30 08:30–10:00 Room M 1

A-358 Digital breast tomosynthesis: physical principles and
radiation dose levels Molecular Imaging
G. Gennaro; Padua/IT
Learning Objectives: RC 906 Preclinical imaging as a driver for
1. To understand the technical aspects of digital breast tomosynthesis. translational research: how I do it
2. To become familiar with breast dose levels from digital breast
tomosynthesis. 08:30
3. To give an overview of future improvements and developments of A-363 Chairman’s introduction
digital breast tomosynthesis. J. Hodler; Zurich/CH
Session Objectives:
1. To learn the translational potential of preclinical research.
08:30–10:00 Room G 2. To understand the needs of preclinical research.
3. To know the physiological differences between small animals and
E3 - ECR Academies: humans.
Neuroradiology: from Morphology to Function 08:35
A-364 A. Preclinical MR/PET imaging of cancer
E3 919 Functional imaging of the spine C. Kuntner-Hannes; Seibersdorf/AT
08:30
1. To learn the different targets for molecular imaging of cancer.
A-359 Chairman’s introduction 2. To understand the needs of standardisation in preclinical imaging.
M. Muto; Naples/IT 3. To understand the challenges in quantitative preclinical PET imaging.
08:33 08:53
A-360 A. Measuring CSF flow: technique and clinical usefulness A-365 B. What about nano-technology?
B. Ertl-Wagner; Munich/DE F.M.A. Kiessling; Aachen/DE
1. To review the physiology of CSF flow during the cardiac cycle. 1. To understand nano-technology as it is used in imaging.
2. To evaluate the reliability of the quantification of CSF flow rates by 2. To learn the potential utility and toxicity of nano probes.
use of phase contrast MRI. 3. To understand the elimination route of nano probes.
3. To show examples where alterations of CSF flow in the craniocervical
junction can influence clinical management (e.g. in patients with 09:11
Chiari Malformation Type I). A-366 C. View of the young researcher
D. Berritto; Acerra/IT
09:02
A-361 B. Diffusion tensor imaging of the spinal cord in the 1. To learn the benefits of preclinical imaging for clinical activities.
Friday
assessment of intramedullary changes 2. To learn how to translate the knowledge from pre-clinical to clinical
M. Sasiadek; Wroclaw/PL applications.
Learning Objectives: 3. To understand the limitations of translation.
1. To review the technique of diffusion tensor imaging (DTI) in the 09:29
assessment of the spinal cord.
2. To document the usefulness of DTI in the detection of cervical spinal A-367 D. View of the radiographer
R. Harris; London/UK
cord integrity alterations in different stages of degenerative spine
disease. Learning Objectives:
3. To discuss the value of DTI in other diseases of the spinal cord. 1. To understand the role of the radiographer as partner.
2. To consolidate knowledge about prerequisites for imaging phantoms
09:31 and animals.
A-362 C. Functional and quantitative MRI of symptomatic 3. To appreciate the benefits for translational and clinical research.
stenoses of the lumbar spine
K. Eberhardt; Werneck/DE Panel discussion:
Learning Objectives: 09:47 How to set-up an attractive programme
1. To review the technique for performing MR myelography of the
lumbar spine in flexion and extension.
2. To document the advantages of dynamic MR myelography 08:30–10:00 Room M 2
for quantification of stenoses, motion-related changes, and
spondylolistheses of the lumbar spine. Vascular
3. To show that dynamic MR myelography may be useful for early
detection of spinal and for aminal stenosis, and show illustrative RC 915 Fixing a leaky EVAR
clinical examples. Moderator: R. Morgan; London/UK
08:30
A-368 A. The role of US: Doppler, 3D US, CEUS
P. Ricci; Rome/IT
1. To understand the techniques of modern US assessment and follow
up with case illustration.
2. To appreciate the indications and limits of US in the modern imaging
pathway.
3. To learn the latest evidence base for US assessment of endoleaks.

09:00 08:30–10:00 Room M 4

A-369 B. 2D and 3D CTA: current concepts
A. Bücker; Homburg a.d. Saar/DE Emergency Radiology
1. To learn the optimal acquisition protocols for CT and MR assessment RC 917 Acute pain: your friend and enemy in
of endoleaks. emergency radiology
2. To appreciate the imaging characteristics of new grafts and their
leaks. 08:30
3. To understand the role of CT/MRA in endoleak therapy planning.
A-375 Chairman’s introduction: patients with acute pain -
09:30 management and therapeutic pathways
J. Walecki; Warsaw/PL
A-370 C. Endovascular management
R. Uberoi; Oxford/UK
08:35
1. To learn the natural history of endoleaks. A-376 A. Head
2. To understand the interventional therapy options.
3. To learn the outcome data on interventional therapies for endoleaks. Learning Objectives:
1. To become familiar with common clinical conditions resulting in
acute headache.
08:30–10:00 Room M 3 2. To understand the choice of the best-suited imaging modality.
3. To learn about typical imaging findings in the most common clinical
Special Focus Session scenarios.
08:59
SF 9b Imaging in the presence of orthopaedic A-377 B. Chest
hardware C.N. De Cecco; Charleston, SC/US
08:30 1. To become familiar with clinical conditions resulting in acute pain.
A-371 Chairman’s introduction 2. To understand which additional data will influence the choice of the
M. Zanetti; Zurich/CH correct imaging modality.
Session Objectives: 3. To learn about typical imaging findings in patients with acute chest
1. To learn how CT can be optimised in the presence of orthopaedic pain.
hardware.
09:23
2. To learn how MRI can be optimised in the presence of orthopaedic
hardware. A-378 C. Abdomen
3. To learn about the role of imaging in prosthetic joint infection. R. Basilico; Chieti/IT
08:35 1. To become familiar with common clinical conditions resulting in
A-372 Optimising CT for imaging metalwork acute abdominal pain.
M.-A. Weber; Heidelberg/DE 2. To understand what clinical information influences the choice of the
Learning Objectives: best-suited imaging modality.
1. To understand that orthopaedic hardware should not be considered a 3. To learn typical and less typical imaging findings in patients with
contraindication to computed tomography. acute abdominal pain.
2. To become familiar with the factors affecting the magnitude of image
artefacts. Panel discussion:
3. To learn about new techniques to minimise metal artefacts. 09:47 Where does radiology fit in the pathway?
09:00
A-373 What problems do metalwork cause for MRI and how can 08:30–10:00 Room M 5
we solve them?
J.V. Dehem; Ypres/BE E3 - ECR Academies:
1. To understand the challenges metalwork causes for MR imaging of
the joints.
2. To become familiar with new MRI metal artefact reduction E3 922 Gynaecology
techniques. Moderator: T. Cunha; Lisbon/PT
3. To appreciate the growing clinical need for MR imaging of patients
with orthopaedic hardware. 08:30
09:25 A-379 A. MR imaging techniques and normal anatomy of the
female pelvis
A-374 Imaging prosthetic joint infection: traditionally C.S. Balleyguier; Villejuif/FR
problematic, but do we have the answers now?
F. Kainberger; Vienna/AT
1. To learn about the different MR protocols according to the clinical
Learning Objectives: question.
1. To define situations in which imaging may significantly help to 2. To become familiar with normal imaging findings of the female
improve the diagnosis of infection. pelvis.
2. To apply modern concepts to the forms of inflammation following 3. To become familiar with potential pitfalls.
endoprosthetic and other orthopaedic procedures.
3. To differentiate infection from other types of hardware loosening.
Panel discussion:
09:50 What is the imaging modality of choice after plain films
in the presence of orthopaedic hardware?

09:00 10:35
A-380 B. Staging of cervical cancer A-385 Mammography screening in Denmark: implementation
R. Forstner; Salzburg/AT and results
Learning Objectives: I. Vejborg; Copenhagen/DK
1. To learn about the MR appearance of cervical cancer, including Learning Objectives:
mimics. 1. To learn about the challenges in implementation of a service cancer
2. To become familiar with the spread of disease. screening programme.
3. To understand the impact of imaging on therapeutic decision 2. To learn about the balance between positive and negative effects of a
making. population-based screening programme.
09:30 3. To discuss quality assurance of a nationwide mammography
screening programme and to present its results.
A-381 C. Differential diagnoses of adnexal masses
S. Swift; Leeds/UK 10:55
Learning Objectives: A-386 Performing MRI preoperatively in all breast cancer
1. To understand how to identify the origin of the suspicious adnexal patients in Iceland: is it worthwhile?
mass. M. Garðarsdóttir; Reykjavik/IS
2. To learn about how to differentiate benign from malignant adnexal Learning Objective:
masses, also applying functional techniques. 1. To understand the value of preoperative assessment of disease extent
3. To understand how to differentiate between benign surgical and non- as a tool in appropriate surgical planning.
surgical lesions.
11:05
A-387 Breast density, risk for breast cancer and how to
10:30–12:00 Room A
personalise screening: what are the future breast
E3 - ECR Academies: imaging modalities?
Interactive Teaching Sessions Learning Objectives:
1. To learn about the current knowledge of how to estimate breast
E3 1021 Emergency radiology I cancer risk and if this can be applied in a screening context.
2. To understand what imaging modalities for breast cancer screening
10:30 we have at hand now and for the future.
A-382 A. Abdominal vascular emergencies 11:25
A-388 Interval cancers in population-based screening
1. To understand the different types of abdominal vascular emergencies. programmes
S.R. Hoff; Aalesund/NO
2. To learn about imaging findings and treatment options.
11:15
Friday
1. To understand interval cancers, i.e. breast cancers, detected in the
A-383 B. Chest trauma interval between two screening examinations.
J.D. Dodd; Dublin/IE 2. To learn about systematic reviews of interval cancers, as the rate
Learning Objectives: of missed interval cancer can be used as a quality measure of a
1. To understand the imaging technique. screening program.
2. To become familiar with the differential diagnosis. 11:40
A-389 New developments in MRI and MR image analysis of
10:30–12:00 Room B breast cancer
J. Hakumäki; Kuopio/FI
ESR meets the Nordic Countries Learning Objectives:
1. To understand the fundamentals of DWI, DCE and MR spectroscopy
EM 1 Mammography in Nordic countries: in breast imaging.
2. To become familiar with the optimised analysis methods for DWI,
screening and new developments DCE and MRS.
Welcome the ESR President: 3. To learn about multiparametric data analysis in 3T breast MRI.
Presiding:
K. Riklund; Umea/SE 10:30–12:00 Room K
M. Garðarsdóttir; Reykjavik/IS
G. Hagen; Oslo/NO
K.R. Nielsen; Copenhagen/DK
EFOMP Workshop: Radiation Protection for
R.L. Vanninen; Kuopio/FI
the female patient and female medical staff
10:30 EF 2 Pregnancy and lactation
A-384 Introduction Moderators: P. Sharp; Aberdeen/UK, V. Tsapaki; Anixi/GR
10:30
1. To become familiar with radiology in breast cancer in Nordic A-390 Chairman’s introduction
countries. P. Sharp; Aberdeen/UK
2. To learn about screening, individualisation, risk stratification and Session Objectives:
new methods. 1. To learn how to manage and counsel pregnant patients in case of
x-ray exposure.
2. To become familiar with issues related to administration of
radiopharmaceuticals to pregnant patients and nursing mothers.
3. To learn how to protect pregnant or potentially pregnant personnel
working with x-rays.

10:35 11:30
A-391 Radiation protection of pregnant and lactating patients A-396 C. Staging of prostate cancer
in nuclear medicine A.R. Padhani; London/UK
S. Mattsson; Malmö/SE Learning Objectives:
Learning Objectives: 1. To become familiar with the imaging techniques used for staging,
1. To discuss issues related to administration of radiopharmaceuticals to including functional MRI.
pregnant patients. 2. To become familiar with the common sites of metastases.
2. To discuss issues related to administration of radiopharmaceuticals to 3. To learn about what technique to use for follow-up of metastatic
nursing mothers. disease, including functional techniques.
3. To be informed about the exposure of the embryo/foetus to radiation
during nuclear medicine procedures performed on the mother.
12:15–12:45 Room A
11:05
A-392 Dose management of pregnant patients in x-ray imaging Plenary Session
Learning Objectives: HL 2 Josef Lissner Honorary Lecture
1. To learn how to manage pregnant patients in case of intentional and Presiding: K. Riklund; Umeå/SE
accidental exposure to x-rays.
2. To be informed about the exposure of the embryo/foetus to radiation 12:15
during diagnostic and interventional x-ray procedures performed on
A-397 Liver imaging: where do we stand now?
the mother. V. Vilgrain; Clichy/FR
3. To learn about new developments in embryo/foetus dose estimation.
11:35
A-393 Occupational radiation protection: protecting pregnant 12:15–13:45 Room D2
or potentially pregnant workers in interventional
radiology
MIR @ ECR Session
MIR 1 Communication in radiology
1. To be informed about dose limits and regulations regarding Moderators: B. Hamm; Berlin/DE, S. Morozov; Moscow/RU
occupational exposure of pregnant staff working with radiation.
2. To learn how to manage pregnant staff in medical imaging 12:15
departments. A-398 A. Communication and conflict resolution in radiology:
3. To become familiar with techniques that will keep the dose to the how to recruit and retain the best team
unborn child from the mother’s occupation as low as possible. P.R. Ros; Cleveland, OH/US
1. To review the key principles of excellence in building medical
10:30–12:00 Room M 5 imaging teams.
2. To understand how to recruit and retain the best radiology team
E3 - ECR Academies: members.
3. To appreciate the value of communication in conflict resolution and
Diagnostic Urogenital Radiology high performance radiology teams.
E3 1022 Prostate 12:33

Moderator: J.J. Fütterer; Nijmegen/NL A-399 B. Impact of structured reporting on communication with
referring physicians
10:30 D. Pinto dos Santos; Mainz/DE
A-394 A. Ultrasound of the prostate Learning Objectives:
T. Fischer; Berlin/DE 1. To understand how structured reporting can improve
Learning Objectives: communication with the referring physicians.
1. To become familiar with the technical requirements for performing 2. To learn about how structured reporting can support communication
US of the prostate. and tracking of actionable findings.
2. To learn about the anatomy of the prostate. 3. To become familiar with current developments in structured
3. To understand how to detect suspicious lesions for ultrasound- reporting.
guided biopsy.
12:51
4. To understand the potential clinical utility of different ultrasound
techniques such as Doppler, elastography, CEUS and image fusion. A-400 C. Informed consent in the radiology department: when
5. To discuss the evidence for the use of these technologies in routine and how?
clinical practice. L.H. Ros Mendoza; Zaragoza/ES

1. To learn about the role and importance that informed consent
A-395 B. Multiparametric MRI of the prostate currently has in radiology departments.
G.M. Villeirs; Ghent/BE
2. To discuss the radiological procedures and techniques which do or
Learning Objectives: do not need informed consent.
1. To become familiar with technical aspects of DCE-MRI, DWI and 3. To understand the importance of a thorough and accurate design of
MR spectroscopy. informed consent.
2. To understand how to recognise the advantages and limitations of
each technique.
3. To understand how to detect significant disease of prostate cancer in
the peripheral zone.

13:09 14:00–15:30 Room B

A-401 D. Patients’ expectations in communication with
radiologists EFRS meets Sweden
Learning Objectives: EM 4 The professional role of Swedish
1. To learn about patients’ expectations when entering the radiology radiographers in medical imaging
department.
2. To understand the knowledge gap between the “average” patient and 14:00
the “average” radiologist. A-405/A-406 Introduction
3. To learn how to overcome the knowledge gap without making the H.H. Hjemly1, K. Hillergård2; 1Oslo/NO, 2Jönköping/SE
message become childish or treating the patient as a child. Session Objectives:
4. To appreciate the multiple levels of patient knowledge. 1. To become familiar with the knowledge, skills and attitudes needed
13:27 Discussion for competent Swedish radiographers.
2. To learn about the caring approach within the Swedish radiography
programme.
12:30–13:30 Room B 3. To understand the research as a process for learning in a Swedish
radiography programme.
E3 - The Beauty of Basic Knowledge: 14:05
Breast Imaging A-407 The Swedish radiographer as a professional
B.T. Andersson; Lund/SE
E3 24C Breast cancer staging: why and how Learning Objectives:

1. To gain insight into the Swedish radiographer as a professional.
Moderator: J. Camps Herrero; Valencia/ES 2. To become familiar with the knowledge, skills and attitudes needed
for competent Swedish radiographers.
12:30 3. To consolidate knowledge about core competences and their relation
A-402 Breast cancer staging: why and how to education and profession.
K. Kinkel; Chêne-Bougeries/CH 4. To appreciate the impact of person-centred care in the area of
Learning Objectives: radiography.
1. To learn the timing, limitation and advantages of the different
14:23
imaging techniques in staging breast cancer.
2. To know how to deal with additional lesions and their clinical A-408 Implementation of a caring approach within the Swedish
meaning. radiography programme
3. To understand the critical role of the radiologist in the pretreatment M. Lundén; Gothenburg/SE
evaluation of breast cancer. Learning Objectives:
1. To learn about the Swedish radiography programme.
2. To appreciate the importance of combining patient care and technical
Friday
12:30–13:30 Room D1 matters in the Swedish radiography programme.
3. To become familiar with and acknowledge the patient’s perspective in
E3 - The Beauty of Basic Knowledge: the radiography programme.
4. To understand how a caring approach can be accomplished in a
Chest Imaging radiography programme.
E3 25C Reporting chest radiology made easy 14:41

Moderator: N. Howarth; Chêne-Bougeries/CH A-409 Implementation of a research process and quality
improvement within the Swedish radiography
12:30 programme
A-403 A. Interstitial lung disease: 5 golden rules K. Fridell; Stockholm/SE
S.R. Desai; London/UK Learning Objectives:
Learning Objectives: 1. To learn about different aspects of the research process in a Swedish
1. To review diagnostic signs of interstitial lung disease. radiography programme.
2. To learn how to avoid over-diagnosis. 2. To become familiar with different methods for quality improvement
3. To know the limitations of radiological diagnoses. and how these can be integrated in a Swedish radiography
programme.
13:00 3. To understand the research as a process for learning in a Swedish
A-404 B. Pleural disease radiography programme.
C. Beigelman; Lausanne/CH
14:59
1. To review the radiological appearance of pleural disease. A-410 Cultural highlights
2. To learn how to identify typical pleural plaques. G. Örnberg; Umeå/SE
3. To know how to distinguish pleural plaques from pleural metastases.

14:00–15:30 Room L8 14:18

A-417 B. Patient satisfaction with radiology departments: are
EIBIR Session we doing our best?
EIBIR 2 MITIGATE: What does it take to Learning Objectives:
perform clinical trials in interventional 1. To learn about the importance of a harmonised and structured
radiology? communication process with patients.
2. To become aware of patients’ needs and fragilities at the point of care.
14:00 3. To understand the importance of health professionals’ teamwork as a
tool to developing a patient safety culture.
A-411/A-412 Introduction
S.O. Schönberg1, W.R. Jaschke2; 1Mannheim/DE, 2Innsbruck/AT 14:36
Session Objectives: A-418 C. Is there any evidence for decision support?
1. To introduce the aims of the session. G. Boland; Boston, MA/US
2. To highlight the importance of clinical trials in interventional Learning Objectives:
radiology. 1. To understand the goals of clinical decision support tools.
3. To introduce the related objectives of the MITIGATE project. 2. To discuss and evaluate the emerging tools available.
14:10 3. To discuss the evidence for improving clinical outcome.
A-413 Overview on clinical trials in interventional radiology in 14:54
Europe A-419 D. Dose monitoring and benchmarking: opportunities to
improve radiation protection
Learning Objectives: D. Caramella; Pisa/IT
1. To learn about the European framework for clinical trials in Learning Objectives:
interventional radiology. 1. To demonstrate the importance of systematic dose monitoring in
2 To learn about the requirements for clinical trials in interventional radiology.
radiology in Europe. 2. To understand how dose monitoring may reduce clinically unjustified
3. To learn about successfully conducted clinical trials in interventional variations within and between hospitals.
radiology. 3. To propose a paradigm shift from risk communication to safety
14:30 reassurance.
A-414 How to implement investigator-initiated or 15:12 Discussion
industry-sponsored trials in interventional oncology:
SORAMIC vs SIRFLOX
J. Ricke; Magdeburg/DE 14:00–15:30 Room M 4
1. To learn about two examples of clinical trials in interventional Joint Session of the ESR and ESMRMB
oncology.
2. To learn about the implementation of clinical trials in interventional Cardiac MRI
oncology. Moderators: J. Bremerich; Basle/CH, E.R. Danielsen; Copenhagen/DK
3. To learn more about industry involvement in clinical trials in
interventional oncology. 14:00
14:50 A-420 Overview of cardiac MR methods
A-415 Design of a clinical trial in oligometastatic GIST:
results from the MITIGATE consortium
C. Decristoforo; Innsbruck/AT
1. To become familiar with the most important methods in Cardiac
MRI covering both methods for examination of congenital and
Learning Objectives: acquired heart disease.
1. To learn about the aims of the clinical trial performed in the 2. To learn about cardiac MRI pulse sequences, the principles of ECG
MITIGATE project. gating, and how movement is handled.
2. To learn about the design of a clinical trial in oligometastatic GIST. 3. To become familiar with dynamic and anatomical cardiac MRI
3. To learn about the expected impact of the clinical trial. methods.
4. To learn how to recognise pitfalls and imaging artefacts typical for
15:10 Discussion
cardiac MRI.
5. To understand reconstruction and volume rendering principles as
they apply to cardiac MRI.
14:00–15:30 Room D2
14:30
MIR @ ECR Session A-421 Clinical use of MR in congenital cardiac disease
V. Muthurangu; London/UK
MIR 2 Improving quality and safety Learning Objectives:
in radiology 1. To learn about the variety of congenital cardiac disease that benefit
Moderators: E.J. Adam; London/UK, from MRI, and to understand which methods are useful in the
D.A. Koff; Hamilton, ON/CA different diseases.
2. To understand the imaging features and basic clinical features of
14:00 congenital heart disease including neonatal heart disease, congenital
heart disease in childhood and adult congenital heart disease.
A-416 A. How to run a safe department?
P. Cavanagh; Taunton/UK 3. To appreciate MRI features of congenital vascular anomalies of the
cardiovascular system.
Learning Objectives: 4. To appreciate the role of quantitative evaluations in cardiac MRI for
1. To understand the key drivers for developing a safe radiology service. congenital heart disease.
2. To learn about a framework that helps to implement a safe system
within a radiology department.
3. To learn about approaches that can be used in your department.

15:00 16:21
A-422 Clinical use of MR in acquired cardiac disease A-428 Dementia: the role of nuclear medicine
T. Leiner; Utrecht/NL V. Garibotto; Geneva/CH
1. To appreciate the wide range of clinical questions in acquired cardiac 1. To become familiar with the PET and SPECT tracers available for
disease that may benefit from MRI, and to understand how the molecular imaging in dementia.
different techniques assist clinical decision making. 2. To become familiar with typical patterns of hypometabolism in
2. To learn about the MRI features and basic clinical features of dementia.
cardiomyopathy including acute myocarditis, dilated cardiomyopathy, 3. To understand the added value of molecular imaging by PET and
restrictive and obstructive cardiomyopathy, cardiomyopathy related SPECT in dementia.
to systemic disease, infiltrative cardiomyopathy. 4. To discuss the potential role of hybrid MR/PET in this field.
3. To appreciate the role of quantitative evaluations in cardiac MRI for
acquired heart disease. 16:39
4. To understand the role, benefits and limitations of cardiac stress A-429 Prostate cancer: PET/CT in early biochemical relapse
testing in cardiac MRI. E. Lopci; Rozzano/IT
1. To learn about the role of PET imaging in the investigation of
16:00–17:30 Room A biochemical relapse in prostate cancer.
2. To become familiar with the role of established tracers including
E3 - ECR Academies: C-11 choline and F-18 fluoride in this clinical context.
3. To gain insight into the potential of emerging tracers, such as Ga-68
Interactive Teaching Sessions PSMA.
E3 1221 Use of staging and classification 16:57

systems A-430 Prostate cancer: multiparametric MR in the diagnosis and
clinical management of prostate cancer
16:00 F. Mrakic Sposta; Milan/IT
A-423 A. RECIST 1.1 training Learning Objectives:

A. Graser; Munich/DE 1. To learn about the role of multiparametric MRI in the investigation
Learning Objectives: of prostate cancer.
1. To understand the principle of the RECIST system. 2. To become familiar with the role of morphological sequences, DWI
2. To become familiar with the daily oncologic work-up. sequences and ADC maps in MRI exams.
3. To gain insight into the potential spectroscopy study of Choline,
16:45 Citrate and Creatine.
A-424 B. Gastrointestinal-abdominal masses
A. Ba-Ssalamah; Vienna/AT Panel discussion:
17:15 How can collaboration between radiology and nuclear
Friday
medicine develop imaging and research in hybrid
1. To learn the characteristic features of some common and atypical
imaging?
abdominal masses.
2. To identify the key imaging findings that assist surgeons or
oncologists treating specific abdominal masses.
16:00–17:30 Room C
16:00–17:30 Room B E3 - ECR Academies:

Modern Imaging in Colorectal Cancer
Joint Session of the ESR and the EANM
E3 1218 Rectal cancer: update on organ saving
Hybrid imaging: radiology and nuclear medicine
treatments
16:00 Moderator: L.K. Blomqvist; Stockholm/SE
A-425/A-426 Introduction
K. Riklund1, V. Lewington2; 1Umea/SE, 2London/UK 16:00
Session Objectives: A-431 A. The surgical perspective
G.L. Beets; Amsterdam/NL
1. To learn about collaboration in hybrid imaging.
2. To understand the added value of using both radiology and nuclear Learning Objectives:
medicine in medicine. 1. To learn about new organ saving treatments in rectal cancer and the
clinical background.
16:03 2. To know how to select and follow the patients.
A-427 Dementia: the role of radiology 3. To understand the factors relevant for clinical decision making.
S. Haller; Geneva/CH 4. To understand what the surgeon wants to know from radiologists.
1. To learn the typical atrophy patterns of various types of dementia,
notably Alzheimer Dementia and fronto-temporal lobar A-432 B. The oncological perspective
V. Valentini; Rome/IT
degeneration.
2. To understand the basic principle of arterial spin labelling (ASL). Learning Objectives:
3. To become familiar with typical patterns of hypoperfusion in 1. To understand the different radiation oncologists’ treatment
dementia. proposals based on the anatomical and pathological information
from imaging.
2. To become familiar with patients’ expectations, taking into
consideration the various preoperative radiation treatment schedules
with or without chemotherapy.
3. To know how radiation treatment can improve the number of
patients with complete response and how it is challenging for the
oncologist and the patients.

17:00 16:28
A-433 C. The radiological perspective A-445 B. Dose reduction and image quality in paediatric CT
R.G.H. Beets-Tan; Amsterdam/NL R.A.J. Nievelstein; Utrecht/NL
1. To learn how radiologists can answer the relevant clinical questions. 1. To discuss simple steps for dose reduction in paediatric CT.
2. To understand the role of imaging during the selection for and the 2. To learn about the image quality and patient dose.
follow-up of organ preservation. 3. To understand common errors when performing paediatric CT.
3. To know the performance of (MR) imaging for the assessment and
prediction of complete response after chemoradiotherapy. 16:51
A-446 C. Patient compliance and motion-free protocols in
general paediatric MRI
16:00–17:30 Room Z G. Schneider; Homburg/ Saar/DE
EdiR talk What you should know about the EDiR 1. To understand the cost of time versus quality images in paediatric
MRI.
16:00
2. To learn about the importance of safety and pre-designed protocols
A-434/A-435 Chairmen’s introduction: The story of the in paediatric MRI.
European Diploma in Radiology (EDiR) 3. To discuss options and technology available for free-breathing
J. Vilar1, Y. Menu2; 1Valencia/ES, 2Paris/FR children.
Session Objectives:
1. To become informed about the origin of the European Diploma in Panel discussion:
Radiology. 17:14 What are the essentials in education and training for
2. To become aware of the evolution and development of the EDiR. paediatric imaging
3. To learn the most relevant facts and figures about the EDiR.
16:15 16:00–17:30 Room N
A-436/A-437/A-438/A-439/A-440 Evolution of the EDiR
J. Vilar1, P.C. Maly Sundgren2, L. McKnight3, V. Iranzo4, H.T. Sarisoy5;
1
E3 - ECR Academies:
Valencia/ES, 2Lund/SE, 3Langland/UK, 4Barcelona/ES, 5Kocaeli/TR
Learning Objectives: Modern Cardiac Imaging
1. To learn some important facts regarding the recent examination at
ECR 2016. E3 1220 Essentials of modern imaging in cardiac
2. To become familiar with the new reality of the EDiR: The skills diseases
examination, how it works and practical tips.
Moderator: G.I. Kirova-Nedialkova; Sofia/BG
3. To learn some tricks that may help candidates prepare for the written
part. 16:00
4. To become informed about the future EDiR forecast.
A-447 A. Major challenges in diagnostic imaging of cardiac
17:00 diseases
A-441/A-442 EDiR M. Oudkerk; Groningen/NL
O. Dicle1, E. Jordan2; 1Izmir/TR, 2Barcelona/ES Learning Objectives:
Learning Objectives: 1. To learn about limitations of standard approaches to diagnosis and
1. To learn how to prepare for the EDiR. assessment of risk in cardiac diseases.
2. To learn how to apply for the EDiR: Where, when and how. 2. To appreciate how these limitations could be overcome with the help
3. To appreciate the real and potential benefits of taking the of cardiac diagnostic imaging.
examination: The point-of-view of an EDiR holder. 3. To learn about new opportunities for assessment of risk and
prognosis.
16:00–17:30 Room O 16:30

A-448 B. Backbone of cardiac imaging: CT and MRI
Paediatric M. Gutberlet; Leipzig/DE
RC 1212 Key issues in paediatric imaging 1. To review the technical and methodological aspects of coronary and
cardiac CT and MRI.
16:00 2. To learn about major clinical applications of coronary and cardiac
CTA.
J. Portelli; Msida/MT 3. To become familiar with clinical indications for cardiac MR from a
practical point of view.
Session Objectives:
1. To understand the importance of dose reduction parameters. 17:00
2. To learn how to improve image quality in paediatric patients when A-449 C. Hybrid systems for cardiac applications: essentials
performing studies with ionising radiation. J. Knuuti; Turku/FI
3. To learn about requisites for a safe and successful paediatric MRI
scan.
1. To learn about types of hybrid scanners for cardiac imaging.
16:05 2. To become familiar with types of tracers for cardiac imaging.
3. To become familiar with approaches to selecting scanners and tracers
A-444 A. Key issues in the x-ray department
E. Sorantin; Graz/AT according to the clinical indications.
1. To learn about the image quality and patient dose.
2. To become familiar with standards of acceptable image quality.
3. To become familiar with ways to reduce dose, especially in daily
fluoroscopy.

16:00–17:30 Studio 2016 16:15

A-455 Maximising your chances to obtain European research
Genitourinary funding: opportunities, strategies, services
P. Zolda; Vienna/AT
RC 1207 MRI for gynaecologic imaging: Learning Objectives:
how I do it 1. To learn about strategies to obtain funding under Horizon2020.
2. To learn about how EIBIR can support research consortia in the
16:00 preparation and implementation of projects.
A-450 Chairman’s introduction 3. To get useful tips for preparing a competitive proposal.
16:40
Session Objectives:
A-456 An evaluator’s perspective
1. To learn how to optimise MRI of the female pelvis. M. Dewey; Berlin/DE
2. To understand the diagnostic benefit of integration of advanced
techniques. Learning Objectives:
1. To learn from the experience of an external expert evaluator under
16:05 H2020.
A-451 A. Basics of patient preparation and T2W-imaging 2. To understand the mechanisms of proposal evaluation.
N.M. deSouza; Sutton/UK 3. To get insider information, such as what it takes to prepare a proposal
Learning Objectives: that can convince evaluators.
1. To understand the value of patient preparation. 17:00
2. To learn how to optimise and tailor protocols in female pelvic
A-457 Success story of a maximum score project in Horizon
imaging.
3. To understand the role of T2WI, and how and when to use 3D 2020
techniques.
16:28 1. To learn about a successful application on hybrid MR/PET in breast
A-452 B. Contrast agents cancer.
R.A. Kubik-Huch; Baden/CH 2. To understand the actions that led to the submission of a strong
Learning Objectives: application.
1. To become familiar with the safety considerations and guidelines for 3. To learn about next the steps of the project.
the use of gadolinium with a special focus on imaging pregnant and
lactating patients. 17:20 Questions and answers
2. To learn why, how and when to use IV contrast-enhanced imaging in
MRI of the female pelvis.
3. To understand different gadolinium T1W techniques and their 16:00–17:30 Room E1
clinical value in routine imaging, as well as to become familiar with
quantification techniques. Musculoskeletal
Friday
16:51 RC 1210 Systemic disease: what to look for in
A-453 C. Diffusion and ADC the musculoskeletal system
Moderator: A. Cotten; Lille/FR
1. To understand the technical principles of DWI. 16:00
2. To learn how to optimise and integrate DWI in pelvic imaging.
3. To illustrate the added diagnostic value of DWI in female pelvic A-458 A. Imaging the diabetic foot
J. Kramer; Linz/AT
imaging.
Panel discussion: 1. To learn about the range of imaging abnormalities seen in the
17:14 Multiparametric MRI of the female pelvis - should it diabetic foot.
replace tailored protocols? 2. To become familiar with features that distinguish infection from
other abnormalities in the diabetic foot.
16:30
16:00–17:30 Room L8
A-459 B. MSK manifestations of non-malignant haematological
EIBIR Session disease
A.H. Karantanas; Iraklion/GR
EIBIR 3 Gateway to European funding for Learning Objectives:

1. To understand the way haematological conditions can affect the
research projects musculoskeletal system.
2. To become familiar with patterns of imaging abnormality seen
16:00
in the musculoskeletal system in patients with non-malignant
A-454 Introduction haematological disorders.
G.P. Krestin; Rotterdam/NL
1. To learn about the mission, structure and general services of the A-460 C. MSK manifestations of renal disease
European Institute for Biomedical Imaging Research (EIBIR). G. Guglielmi; Andria/IT
2. To understand the framework and policy for European research Learning Objectives:
funding. 1. To demonstrate the way renal disease can affect the musculoskeletal
3. To learn about future calls relevant to the imaging community. system.
2. To become familiar with patterns of imaging abnormality seen in the
musculoskeletal system in patients with renal disease.

16:00–17:30 Room F1 16:30

A-467 Perspectives from thoracic imaging
Oncologic Imaging M. Rémy-Jardin; Lille/FR
RC 1216 New insights in bone tumour imaging 1. To describe the clinical situations justifying such an integration.
2. To discuss the most adapted scanning protocols.
16:00 3. To describe the complementarity between morphology and function
A-461 Chairman’s introduction in daily practice.
D. Vanel; Bologna/IT
16:55
Session Objectives:
1. To become familiar with the treatment strategies in bone tumours. A-468 Perspectives from cardiac imaging
J. Bremerich; Basle/CH
2. To learn about the role of current imaging techniques in management
of bone tumours. Learning Objectives:
1. To understand the role of the heart in cardiopulmonary diseases.
16:05 2. To learn about cardiac imaging modalities and their application in
A-462 A. New insights in treatment-associated changes in pulmonary diseases.
patients with bone tumours 3. To become familiar with specific cardiac imaging protocols.
C.R. Krestan; Vienna/AT
1. To understand the treatment strategies in bone tumours. 17:20 How to best increase our impact on this interdisciplinary
2. To learn the essentials of sarcoma imaging. field?
3. To understand post-treatment appearances including chemo- and
radiation-induced bone marrow changes.
16:00–17:30 Room D1
16:28
A-463 B. New insights in staging and restaging musculoskeletal Chest
tumours
J.L. Bloem; Leiden/NL RC 1204 Occupational lung diseases: the known
Learning Objectives: and the less known
1. To learn about the role of current imaging techniques in management
of bone tumours. 16:00
2. To learn the essentials in staging and restaging in bone tumours. A-469 Chairman’s introduction
N. Karabulut; Denizli/TR
16:51
Session Objectives:
A-464 C. New insights in imaging for multiple myeloma 1. To clarify the terms used to describe occupational lung diseases.
G. Sommer; Basle/CH
2. To illustrate one modern cause of OLD: denim sandblasters.
1. To understand the current concepts of evaluation of multiple 16:05
myeloma with FDG PET/CT and MR/PET. A-470 A. Silicosis and coal workers’ pneumoconiosis
2. To understand the role of diffusion-weighted MRI in patients with K. Marten-Engelke; Göttingen/DE
multiple myeloma. Learning Objectives:
1. To recognise clinical features and occupational history of silicosis and
Panel discussion: CWP.
17:14 The future of bone tumour imaging 2. To appreciate HRCT features of these disorders as well as important
differential diagnoses.
16:00–17:30 Room F2 16:28
A-471 B. Asbestos-related disease
Professional Challenges Session S.J. Copley; London/UK
PC 12a Comprehensive cardiothoracic 1. To know the wide range of findings associated with asbestos
radiology: the way to go? exposure.
2. To appreciate the role of CT-HRCT in the assessment of these
16:00 patients.
A-465 Chairman’s introduction: A perspective from both 16:51
worlds: cardiac and thoracic imaging A-472 C. Hypersensitivity pneumonitis
E.J.R. van Beek; Edinburgh/UK P.-Y. Brillet; Bobigny/FR
Session Objectives: Learning Objectives:
1. To learn about the possible integration of cardiac and thoracic 1. To know about the various professional exposures that can cause
imaging for routine patient care. HSP.
2. To understand the need for a holistic approach to cardiothoracic 2. To learn how to recognise the acute, sub-acute and chronic forms of
imaging. this disease.
3. To become familiar with the main protocols and applications of
cardiothoracic imaging. Panel discussion:
16:05 17:14 What are the key findings for diagnosing occupational
lung diseases?
A-466 Challenges and opportunities
1. To learn about challenges in training and education.
2. To learn about multi-organ interaction.
3. To learn about clinical and research opportunities.

16:00–17:30 Room D2 16:00–17:30 Room K
MIR @ ECR Session E3 - Rising Stars Programme

MIR 3 Improving radiology departments Basic Session 3: Interventional radiology:
Moderators: J.K. Bell; Manchester/UK, P. Mildenberger; Mainz/DE tumour ablation
16:00 16:00
A-473 A. Health and wellbeing in the workplace A-477 Kidney
C.L. Cooper; Manchester/UK K. Katsanos, A. Adam; London/UK
1. To assess the costs of poor health and wellbeing at work in personal 16:30
and organisational outcomes. A-478 Liver
2. To explore the workplace stressors that deplete wellbeing at work. L. Crocetti; Pisa/IT
3. To highlight strategies for enhancing wellbeing at work and
minimising stress. 17:00
16:18 A-479 Bones
A-474 B. The role of radiology departments in patient-centred
care: requirements for improvement
R.L. Arenson; San Francisco, CA/US 16:00–17:30 Room G
1. To become familiar with information system tools for radiology to Neuro
become more patient-centric.
2. To understand the importance of radiologists’ interactions with RC 1211 Cerebrovascular disease
patients.
Moderator: M. Vernooij; Rotterdam/NL
3. To appreciate the transformation needed for radiology to adapt to
new health systems.
16:00
16:36 A-480 A. Vascular distribution territories: arterial and venous
A-475 C. Key features for organisational and financial A. Dörfler; Erlangen/DE
sustainability Learning Objectives:
E. Schouman-Claeys; Paris/FR 1. To become familiar with a comprehensive vascular anatomy of the
Learning Objectives: brain.
1. To search for economies of scale, developing closer collaboration and 2. To understand the advantages and limitations of CTA and MRA.
possible merging. 3. To recognise the different imaging patterns in stroke and their
2. To promote comprehensive and customised service offers. prognostic value.
Friday
3. To rethink the role of each category of staff and develop collaborative 16:30
care.
4. To focus on the need for long-term goals and innovative policies. A-481 B. Detecting microhaemorrhages: why are they
5. To appreciate that investments on quality systems are a source of important? What are they? Should we use GRE T2* or
direct and indirect income. SWI or both?
16:54
A-476 D. Clinically relevant reporting in the era of precision 1. To understand the basic physics of the two sequences.
medicine 2. To understand the role of both sequences in stroke and other
H. Hricak; New York, NY/US disorders.
Learning Objectives: 3. To recognise imaging patterns that may mimic stroke clinically and
1. To learn about key elements of reporting for precision medicine. radiologically.
2. To understand the synergy between imaging reports and clinical
management. 17:00
3. To appreciate how advances in oncology change the requirements for A-482 C. Cerebral perfusion studies in cerebrovascular disease:
radiology reporting. techniques, indications and applications
4. To become familiar with emerging trends in molecular imaging and P.M. Parizel; Antwerp/BE
theranostics that are impacting the demands on clinical radiology. Learning Objectives:
1. To understand how imaging can help select patients for treatment of
17:12 Discussion acute ischaemic stroke.
2. To show the importance of collateral flow in ischaemic patients.
3. To explain the actual EBM treating patients with acute ischaemic
stroke.

16:00–17:30 Room M 1 Discussion:

17:15 Regulators’ vs practitioners’ perspective:
EuroSafe Imaging Session two sides of the same coin
EuroSafe 3 Joint Session of the ESR and HERCA:

16:00–17:30 Room M 2
the new EU-BSS Directive - a step
forward to patient safety E3 - ECR Master Classes (Vascular)
16:00 E3 1226a Interventional radiology for deep
A-483/A-484 Chairmen’s introduction venous thrombosis (DVT): ready for
G. Frija1, S. Ebdon-Jackson2; 1Paris/FR, 2Didcot/UK
Session Objectives:
prime time?
1. To provide information about the radiation protection legislation in Moderator: J.I. Bilbao; Pamplona/ES
Europe.
2. To provide an overview of the revised EU-BSS Directive. 16:00
3. To address important new and additional requirements, to provide A-490 A. Imaging of DVT
the status quo of the transposition, and to develop a common P. Haage; Wuppertal/DE
understanding. Learning Objectives:
16:04 1. To learn imaging techniques for diagnostic assessment.
2. To understand the indication and role of each modality.
A-485 Overview of EU radiation protection legislation 3. To appreciate how imaging helps therapy planning.
J. Griebel; Neuherberg/DE
1. To learn about the radiation protection legislation in Europe. A-491 B. Declotting in the emergency room: why not?
2. To understand the interrelation with other pieces of EU legislation R. de Graaf; Maastricht/NL
relevant for medical imaging. Learning Objectives:
3. To understand the basic framework of the revised EU-BSS Directive 1. To learn the latest evidence base for endovascular therapy of DVT.
with respect to medical exposures. 2. To understand the management of acute DVT in 2016.
16:19 3. To appreciate the impact of endovascular therapy.
A-486 Regulators’ expectations 17:00
S. Ebdon-Jackson; Didcot/UK A-492 C. Filter indications 2016: new oral anticoagulants and
Learning Objectives: other developments
1. To understand the need for meaningful justification of exposures M.J. Lee; Dublin/IE
prior to them taking place. Learning Objectives:
2. To understand the relative roles of the referring physician and the 1. To learn an update on the role of inferior vena cava (IVC) filters in
imaging specialist in the justification process for exposures. 2016.
3. To appreciate the factors that may require reporting of accidental 2. To understand the criteria for failed medical therapy in 2016.
or unintended events to the regulator when the additional dose to 3. To understand best IVC filter practice.
individuals may not be clinically significant.
16:39
16:00–17:30 Room M 3
A-487 Tools to support implementation of the BSS Directive:
ESR perspective E3 - ECR Master Classes (Paediatric)
G. Frija; Paris/FR
Learning Objectives: E3 1226b Expanding horizons in paediatric
1. To detail the current ESR potential.
2. To highlight the difficulty of the task. imaging
3. To give some proposals. Moderator: S. Franchi-Abella; Le Kremlin-Bicêtre/FR
16:51 16:00
A-488 Tools to support implementation of the BSS Directive: A-493 A. Elastography in paediatrics
medical physicists’ perspective M. Anooshiravani-Dumont; Geneva/CH
Learning Objectives: 1. To understand the basic principles.
1. To learn about the role of the Medical Physics Expert (MPE) in the 2. To learn about clinical applications.
EU-BSS Directive. 3. To discuss limitations and potentials.
2. To understand the main points of the BSS Directive and their
relevance for Medical Physicists. 16:30
3. To understand how the EU-BSS may influence European Medical A-494 B. Diffusion-weighted imaging: toy or solution?
Physicists’ professional lives. P.D. Humphries; London/UK

1. To discuss peculiarities of diffusion-weighted acquisition in children.
A-489 Tools to support implementation of the BSS Directive: 2. To demonstrate clinical applications.
radiographers’ perspective 3. To discuss perspectives and limitations.
C. Vandulek1, S.J. Foley2; 1Kaposvár/HU, 2Dublin/IE
17:00
1. To clarify the role of radiographers in the EU-BSS Directive. A-495 C. Contrast-enhanced ultrasound in children
2. To understand the challenges of implementation of the Directive at a D. Kljucevsek; Ljubljana/SI
national level from the radiographers’ perspective. Learning Objectives:
3. To understand the importance of collaborative actions to enhance the 1. To discuss safety issues.
effective implementation of the Directive. 2. To demonstrate technique and interpretation of contrast-enhanced
voiding cysto-urethro-sonography.
3. To discuss endovascular applications.

16:00–17:30 Room M 4 16:20

A-502 Teaching methods’ top tips: how you can capture and
E3 - ECR Master Classes maintain your students’ attention
(Emergency Radiology)
E3 1226c Whole body CT in trauma patients 1. To appreciate the wide variety of teaching methods available.
2. To learn how to relate these appropriately to the various settings in
Moderator: H. Alkadhi; Zurich/CH
which radiologists teach.
3. To understand how students’ interest is secured by innovative
16:00 teaching delivery.
A-496 A. Improving the triage: which patients should undergo 4. To appreciate how learning can be reinforced through quizzes and
whole-body CT (WBCT)? assessments.
D.R. Kool; Nijmegen/NL
16:35
1. To appreciate the evidence in the literature concerning the benefits of A-503 Online resources: how to find the best case material and
WBCT in trauma. tutorials for your medical students
2. To become aware of the disadvantage of WBCT in trauma patients. P. Pokieser; Vienna/AT
3. To become familiar with the literature concerning the evidence-based Learning Objectives:
selection of patients who will or will not benefit from CT. 1. To appreciate which freely available online resources exist.
2. To learn how online resources can be used in daily teaching.
16:30 3. To learn how e-learning resources can be created locally to make the
A-497 B. How can we improve our WBCT protocol? best use of teaching time and resources.
B. Leidner; Ekerö/SE
16:50
1. To become familiar with the evidence in literature concerning the A-504 Using social media for undergraduate education: this
optimal scan protocol in trauma patients in regard to necessary scan generation’s communication
phases and contrast media protocols. N. Pyatigorskaya; Paris/FR
2. To appreciate the importance of radiation dose in patients Learning Objectives:
undergoing WBCT. 1. To be aware of the use of social media as e-learning tools.
3. To become familiar with the possibilities of radiation dose reduction 2. To understand how to use media such as Facebook and Twitter to
in WBCT. keep abreast of learning trends and developments.
17:00 3. To understand how to follow social media accounts, by
demonstration.
A-498 C. Optimising the value of radiologists in trauma care
K.H. Nieboer; Brussels/BE
Panel discussion:
Learning Objectives: 17:05 Teaching the undergraduate: in what ways is this similar
1. To become familiar with the surgeons’ need for fast and accurate to teaching radiology to other groups and in what ways
Friday
information on imaging findings in trauma patients. does it differ?
2. To recognise imaging findings that influence management decisions
in trauma patients.
3. To optimise the timely communication of imaging findings in
relation to patient management priorities.
16:00–17:30 Room M 5

PC 12b How to become the undergraduate
teacher you always wanted to be
16:00
S.J. Golding1, M. Maas2; 1Oxford/UK, 2Amsterdam/NL
Session Objectives:
1. To understand how radiology teaching needs to be modified to suit
the undergraduate.
2. To understand how undergraduates’ interest is enhanced by
appropriate learning objectives and novel delivery methods.
3. To appreciate how undergraduate study embraces modern media.
16:05
A-501 The undergraduate curriculum: how to get the balance
right
1. To understand that undergraduate learning is directed to what they
need to know.
2. To understand how learning objectives are defined to support
learning.
3. To learn the role of defining appropriate curricula in teaching
undergraduates.


08:30–10:00 Room A 08:30–10:00 Room C
E3 - ECR Academies: E3 - ECR Academies:

Interactive Teaching Sessions Modern Imaging in Colorectal Cancer
E3 1321 MR imaging in sports medicine I E3 1318 Colon cancer: staging and restaging of
local disease
08:30
Moderator: P. Lefere; Roeselare/BE
A-505 A. Muscle injury in sports
M.G. Mack; Munich/DE 08:30
Learning Objectives: A-511 A. Computed tomography for staging
1. To understand the anatomy of the most common injured muscles. E. Rollven; Stockholm/SE
2. To learn the evaluation of muscle injuries and the impact regarding
recovery.
1. To understand the rationale behind local staging of colon cancer.
09:15 2. To learn how to assess and report imaging findings.
A-506 B. Knee trauma 3. To become familiar with assessment challenges.
M.O. De Maeseneer; Brussels/BE 09:00
Learning Objectives: A-512 B. Imaging for restaging after neoadjuvant treatment
1. To learn the anatomy of the most common injured structures. M. Maas; Maastricht/NL
2. To recognise typical combinations of injuries.
1. To understand the rationale behind local restaging of colon cancer.
2. To learn how to assess and report imaging findings.
08:30–10:00 Room B
3. To become familiar with assessment challenges.
Abdominal Viscera 09:30
A-513 C. Assessment of vasculature prior to laparoscopic
RC 1301 IgG4-related disease: what is it and resection
what do I need to know? A. Laghi; Latina/IT
08:30 1. To understand CT protocols for angiography.
A-507 Chairman’s introduction 2. To understand colon vascular anatomy and variants.
S.A. Jackson; Plymouth/UK 3. To learn about radiological demonstration of surgically relevant
Session Objective: findings.
1. To briefly introduce this multi facet disorders that may involve
several organs and represent a diagnostic challenge.
08:30–10:00 Room Z
08:35
A-508 A. Pancreatic manifestations Special Focus Session
R. Pozzi-Mucelli; Verona/IT
Learning Objectives: SF 13a MR/PET: role in oncology
1. To describe clinical and biological presentation of IgG4-related
pancreatitis. 08:30
2. To describe morphological and functional (DWI, PET/CT, etc.) A-514 Chairman’s introduction
imaging features of IgG4-related pancreatitis. G. Cook; London/UK
3. To identify imaging findings for the differential diagnosis with Session Objectives:
Saturday
other solid pancreatic lesions, i.e. pancreatic cancer, and to avoid 1. To understand the principles of MR/PET in oncological imaging.
unnecessary invasive therapeutic procedures. 2. To understand the strengths and weaknesses of MR/PET in
08:58 oncological applications.
3. To understand the level of evidence existing for the clinical use of
A-509 B. Hepatobiliary manifestations
M. Ronot; Clichy/FR
MR/PET in head and neck, prostate and GI cancers.
1. To describe clinical, biological presentation and morphological A-515 Principles and possibilities of MR/PET
and functional imaging findings for the diagnosis of IgG4-related A. Kjaer; Copenhagen/DK
cholangitis. Learning Objectives:
2. To discuss the role of imaging to avoid unnecessary invasive 1. To understand the principles of MR/PET in oncological imaging.
diagnostic and/or therapeutic procedures. 2. To understand the strengths and weaknesses of MR/PET in
3. To discuss the diagnostic criteria to differentiate IgG4-related oncological applications.
cholangitis from other causes of cholangitis and biliary cancer. 3. To understand possible future oncological applications of MR/PET.
09:21 08:52
A-510 C. Systemic manifestations A-516 MR/PET: imaging head and neck cancer
G. Morana; Treviso/IT
S. Bisdas; London/UK
1. To describe extra-pancreatic and extra-biliary manifestation of IgG4- 1. To understand the strengths and weaknesses of MR/PET in head and
related disease. neck cancer imaging.
2. To describe the imaging findings of the most common extra- 2. To understand the level of evidence existing for the clinical use of
pancreatic and extra-biliary organ involvement. MR/PET in head and neck cancer.
3. To discuss the role of “whole body” imaging modality for the 3. To understand possible future applications of MR/PET in head and
diagnosis and the follow up of IgG4-related systemic disease. neck cancer.
Panel discussion:
09:44 Tips and tricks in clinical practice

09:12 08:30–10:00 Room N

A-517 MR/PET: imaging prostate cancer
A.J. Beer; Ulm/DE Head and Neck
1. To understand the strengths and weaknesses of MR/PET in prostate RC 1308 Pitfalls in interpretation of head and
cancer imaging. neck disease
2. To understand the level of evidence existing for the clinical use of Moderator: J. Frühwald-Pallamar; Vienna/AT
MR/PET in prostate cancer.
3. To understand possible future applications of MR/PET in prostate 08:30
cancer.
A-522 A. Anatomical variants without clinical consequence
09:32 F.A. Pameijer; Utrecht/NL
A-518 MR/PET: imaging of GI cancer Learning Objectives:
V.J. Goh; London/UK 1. To gain insight into the great variability of head and neck anatomy.
Learning Objectives: 2. To be able to recognise pseudolesions.
1. To understand the strengths and weaknesses of MR/PET in GI 09:00
cancer.
2. To understand the level of evidence existing for the clinical use of A-523 B. Anatomical variants posing surgical risks
MR/PET in GI cancers.
3. To understand possible future applications of MR/PET in GI cancer. Learning Objectives:
1. To learn about structures at risk during functional endoscopic sinus
Panel discussion: surgery (FESS).
09:52 Which clinical indications have enough evidence for 2. To become familiar with vascular variants in the head and neck.
routine MR/PET rather than PET/CT? 3. To appreciate surgical anatomical landmarks in the head and neck.
09:30
08:30–10:00 Room O A-524 C. Distinct head and neck disease or systemic disease?
B.F. Schuknecht; Zurich/CH
Paediatric Learning Objectives:

1. To recognise head and neck manifestations of systemic disease.
2. To categorise lesions into different pathologic entities.
RC 1312 Imaging children with cancer
Moderator: P. Tomà; Rome/IT
08:30–10:00 Studio 2016
08:30
A-519 A. Imaging of abdominal masses at diagnosis: clues for Genitourinary
benignity vs malignancy
A.M.J.B. Smets; Amsterdam/NL RC 1307 Lessons I learned from mistakes in
Learning Objectives: kidney and adrenal imaging
1. To become familiar with clinical characteristics and imaging features
of a mass suggesting benignity. 08:30
2. To emphasise clinical and imaging manifestations of abdominal
malignancies. A-525 Chairman’s introduction
S. Dudea; Cluj-Napoca/RO
3. To learn how to report according to international standards.
Session Objectives:
09:00 1. To understand RECIST criteria of kidney tumours in light of
A-520 B. From whole body MRI to MR/PET molecular medicine and functional imaging.
J. Schäfer; Tübingen/DE 2. To learn about pitfalls and challenges in kidney and adrenal imaging.
1. To understand differences and pitfalls of whole body MRI and MR/
PET in children compared to adults. A-526 A. Renal cancer
T. Bäuerle; Erlangen/DE
2. To compare MR/PET to PET/CT.
3. To discuss the impact of whole body MRI and MR/PET. Learning Objectives:
1. To differentiate the most relevant subtypes of renal cell carcinoma
09:30 using morphologic and functional imaging techniques.
A-521 C. Imaging of complications of therapy 2. To learn about multiparametric CT and MRI methods for
K. McHugh; London/UK discriminate (fat-poor) angiomyolipoma and renal cell carcinoma.
Learning Objectives: 3. To become familiar with the management of complex cysts.
1. To become familiar with short- and long-term complications of 08:58
therapy.
2. To understand complications of surgery, radiotherapy and drug A-527 B. PET/CT in nephrourology
toxicity.
3. To emphasise the effects of immunosuppression in children Learning Objectives:
undergoing chemotherapy. 1. To become familiar with appropriate use of PET/CT method in
pathological entities of nephrourology.
2. To learn about the basic and advanced imaging findings of PET/CT
in nephrourology.
3. To become familiar with the common sources of mistakes in PET/CT
in the area of nephrourology.

09:21 09:25
A-528 C. Common mistakes in tumour percutaneous A-534 Satisfaction assessment of patient users of an imaging
radiofrequency ablation department: an example from the south of France
J.-M. Correas, C. Delavaud, O. Hélénon; Paris/FR D.-G. Carrié; Toulouse/FR
1. To describe adrenal and renal ablation techniques to avoid mistakes. 1. To present our experience of satisfaction assessment of patients of a
2. To learn what to look for before and during ablation to avoid medical imaging department, over a period of 8 years.
mistakes. 2. To show that this kind of regularly practised feedback evaluation
3. To learn what to look for after adrenal and renal ablation to detect allows us to identify possible failures, alert the medical and
mistakes. paramedical staff, and to try to remedy them in an appropriate way.
3. To show that the implementation of this kind of questionnaire is
Panel discussion: simple and allows us to refocus our practices around the expectations
09:44 How to manage small lesions of the kidneys incidentally of our patients.
detected in abdominal imaging
Panel discussion:
09:40 Question to the audience: does your department
08:30–10:00 Room L8 perform well in patient-centred care? Is it really all about
the patient?
ESR Patient Advisory Group (ESR-PAG)
ESR-PAG 1 Patient-centred care in clinical 08:30–10:00 Room E1
radiology: do we really put our patients Special Focus Session
first?
SF 13b Cholangiocarcinoma: an update
08:30
A-529 Chairmen’s introduction 08:30
N. Bedlington1, P. Cavanagh2; 1Vienna/AT, 2Taunton/UK
Session Objectives: R. Manfredi; Verona/IT
1. To follow up on the introduction of the ‘driver diagram’, a framework Session Objectives:
for delivering patient-centred care in radiology, presented during the 1. To illustrate diagnostic imaging findings of cholangiocarcinoma
ECR 2015. helpful in the diagnosis and in the differential diagnosis of
2. To explore concrete examples of best practice of implementing cholangiocarcinoma.
patient-centred care in the radiology department and how these 2. To illustrate diagnostic imaging findings helpful for treatment
might be replicated. planning.
3. To understand how the ESR is embedding patient-centred care in 3. To understand indication and technique of interventional radiology
audit and standards. for palliative treatment.
08:40 08:35
A-531 Implementing the ‘driver diagram’ on patient-centred A-536 Classification of cholangiocellular carcinoma (CCC)
care C. Cantwell; Dublin/IE
Learning Objectives: 1. To illustrate classification of cholangiocellular carcinoma.
1. To explore the implementation of the driver diagram for delivering 2. To become familiar with available therapeutic options according to
patient-centred care in radiology. the type of cholangiocarcinoma.
2. To understand the need for balance between professional 3. To become familiar with prognostic implication according to the type
responsibility and patient autonomy. of cholangiocarcinoma.
Saturday
3. To become familiar with methods and examples of good practice and
on how to improve the patient-doctor relationship. 08:50
A-537 Imaging in mass-forming intrahepatic (IH) type
08:55 F. Caseiro-Alves; Coimbra/PT
A-532 View of a patient representative from the neurological Learning Objectives:
disease area 1. To illustrate diagnostic imaging findings of mass forming
D. Walsh; Dublin/IE cholangiocarcinoma.
Learning Objectives: 2. To learn about diagnostic imaging findings useful for the differential
1. To learn how implementing the ‘driver diagram’ can help the diagnosis of cholangiocarcinoma.
radiology department to become really patient-centred but that they 3. To learn the surgical landmarks helpful in treatment planning.
could use some help from the same patients to reach their objectives.
09:05
2. To learn that implementing the diver diagram in their department
will be a step-by-step process that can be monitored by patients. A-538 Diagnostic assessment of periductal/infiltrating and
intraductal-growing types: the view of the diagnostic
09:10
radiologist
A-533 View of a patient with prostate cancer R. Kloeckner; Mainz/DE
Learning Objectives: 1. To illustrate diagnostic imaging findings of periductal/infiltrating and
1. To understand that procedures as from the implementation of the intraductal-growing types of cholangiocarcinoma.
‘driver diagram’ should become a continuous process of quality 2. To learn about diagnostic imaging findings useful for the differential
improvement. diagnosis of cholangiocarcinoma.
2. To understand that implementing the ‘driver diagram’ will sometimes 3. To learn the surgical landmarks helpful in treatment planning.
require a change of attitude and personal perspective to bring the
patient to the forefront instead of the radiology procedures.

09:20 09:25
A-539 Diagnostic assessment of periductal/infiltrating and A-544 Early detection of HCC
intraductal-growing types: the view of the interventional T. Denecke; Berlin/DE
radiologist Learning Objectives:

S. Terraz; Geneva/CH 1. To learn about the potential and technical prerequisites of the
Learning Objectives: available imaging techniques for early detection of HCC.
1. To illustrate diagnostic imaging findings of periductal/infiltrating and 2. To become familiar with the appearance of HCC and its precursors in
intraductal-growing types of cholangiocarcinoma. diagnostic imaging.
2. To learn about diagnostic imaging findings useful for the differential 3. To get an overview of the current recommendations and guidelines
diagnosis of cholangiocarcinoma. for early detection of HCC.
3. To illustrate criteria useful for planning a radiological interventional
procedure. Panel discussion:
09:50 How to manage the surveillance of the population at risk
09:35
A-540 Therapeutic role of interventional radiology in
08:30–10:00 Room F1
unresectable patients
G. Carrafiello; Varese/IT
E3 - European Diploma Prep Sessions
1. To illustrate diagnostic imaging findings of periductal/infiltrating and
intraductal-growing types of cholangiocarcinoma. E3 1323 Cardiac and vascular
2. To learn about diagnostic imaging findings useful for the differential
diagnosis of cholangiocarcinoma. 08:30
3. To illustrate criteria useful for planning a radiological interventional A-545 Chairman’s introduction
procedure. R. Vliegenthart; Groningen/NL
Session Objectives:
Panel discussion: 1. To understand the basic principles and techniques of cardiovascular
09:50 Can we improve diagnosis and treatment of imaging including CT and MRI of the heart and great vessels.
cholangiocarcinoma? 2. To become familiar with the imaging presentations of disorders of the
endocardium, the pericardium and the cardiac valves.
3. To understand the MR imaging presentation of disorders of the
08:30–10:00 Room E2 myocardium.
Special Focus Session 08:33

A-546 A. Cardiovascular imaging: the basics
SF 13c Non-alcoholic fatty liver disease
(NAFLD) 1. To understand the anatomy, normal variants and abnormalities of the
heart and great vessels.
08:30
2. To describe the technical aspects and methodology of cardiac and
A-541 Chairman’s introduction: Defining the clinical problem vascular CT.
C. Bartolozzi; Pisa/IT 3. To describe the technical aspects and methodology of cardiac and
Session Objectives: vascular MRI.
1. To learn about the clinical relevance of NAFLD and potential
evolution towards NASH. 09:02
2. To become familiar with the role of imaging modalities in the A-547 B. Cardiovascular imaging: valves, endocardium and aorta
detection and quantification of the different pathological elements. C. Loewe; Vienna/AT
3. To understand the incidence/risk of HCC development and its early Learning Objectives:
detection. 1. To recognise the imaging presentation of the different forms of
valvular disease.
08:35
2. To understand the causes and imaging presentations of endocarditis.
A-542 Imaging in diagnosing and quantifying liver fat 3. To describe the diagnostic evaluation and imaging presentation of
V. Vilgrain, M. Ronot, A. Faccinato, B. Leporcq, B.E. Van Beers; common diseases of the great vessels, including aortic dissection and
Clichy/FR
aneurysms.
1. To understand the respective value of imaging modalities in 09:31
diagnosing liver steatosis. A-548 C. Cardiovascular imaging: myocardium and pericardium
2. To become familiar with the most recent MR sequences for J. Bogaert; Leuven/BE
quantifying liver steatosis. Learning Objectives:
3. To learn the results and limitations of detecting NASH through 1. To describe the diagnostic evaluation and imaging presentation of
imaging. ischaemic heart disease.
09:00 2. To understand the diagnostic evaluation and imaging presentation of
myocarditis.
A-543 Imaging in diagnosing and staging liver fibrosis 3. To become familiar with the causes and imaging presentations of
pericardial effusion.
1. To understand the biological background, clinical importance and
therapeutic implications of early detection of liver fibrosis.
2. To discuss the current status of quantitative imaging evaluation of
liver fibrosis.
3. To summarise new and future prospects for novel imaging tools for
the qualitative assessment of fibrosis.

08:30–10:00 Room F2 08:54

A-554 Where is the proper place for fast FAST (focused
Breast assessment with sonography for trauma)?
RC 1302 Tailoring breast cancer screening to risk Learning Objectives:
level 1. To understand the role of emergency ultrasound.
Moderator: R. Pijnappel; Utrecht/NL 2. To become familiar with indications and protocol of FAST
examination.
08:30 3. To learn about typical, alert findings.
A-549 A. Calculating, using and improving individual risk 09:13
estimates A-555 Missed lesions in trauma patients: the Damocles’ sword
S.W. Duffy; London/UK R. Basilico; Chieti/IT
1. To know the different models for risk evaluation. 1. To become familiar with limitations in emergency imaging.
2. To understand the limitations of risk modelling for predicting the 2. To learn about the most common fatal missed injuries in polytrauma
individual risk. patients.
3. To appreciate the potential applications of risk modelling for tailoring 3. To understand the methods for avoiding misdiagnosis in polytrauma
breast cancer screening. imaging.
09:00 09:32
A-550 B. Intermediate risk: the grey zone A-556 Geriatric trauma: what is different?
S.H. Heywang-Köbrunner; Munich/DE E. Dick; London/UK
1. To become familiar with the concept of increased breast cancer risk. 1. To become familiar with limitations in emergency imaging.
2. To discuss the role of breast density in relation to cancer risk. 2. To learn about the most common fatal missed injuries in polytrauma
3. To evaluate the evidence in favour of intensive screening protocols in patients.
women at intermediate risk. 3. To understand the methods for avoiding misdiagnosis in polytrauma
09:30 imaging.
A-551 C. High risk: MRI alone?
Panel discussion:
09:51 How is the role of the radiologist changing in the
Learning Objectives: management of trauma patients?
1. To appreciate the evidence in favour of MRI for screening high-risk
women in terms of diagnostic performance and patient outcome.
2. To become aware of the value of MRI alone for screening women 08:30–10:00 Room D2
with high-risk genes.
3. To become aware of the need for using mammography as an adjunct Radiographers
to MRI when screening women who have had previous thoracic
radiation therapy.
RC 1314 Enhancing research in radiography:
a change of culture
08:30–10:00 Room D1
08:30
Special Focus Session A-557/A-558 Chairmen’s introduction
J. McNulty1, I.M. Björkman-Burtscher2; 1Dublin/IE, 2Lund/SE
SF 13d Severe trauma patients: myths, realities Session Objectives:
1. To offer recent updates on radiography research initiatives on a
Saturday
and future
European level.
08:30 2. To discuss the use of a formal mentoring scheme in improving
radiography research capacity.
M. Stajgis; Poznan/PL
3. To propose methods for improving evidence-based practice in
radiography.
Session Objectives:
1. To understand the impact of modern diagnostic imaging on 08:35
management of trauma patients. A-559 A. Radiography research updates: new collaborations
2. To become familiar with limitations in emergency imaging in and initiatives in Europe
different clinical settings. J. McNulty; Dublin/IE
3. To recognise the position of the radiologist in the polytrauma
emergency team. Learning Objectives:
1. To appreciate the importance and necessity of evidence-based
08:35 practice.
A-553 ‘When time is gold’: whole-body CT in polytrauma 2. To outline the potential for research collaborations between
radiographers both nationally and at European level to broaden the
patients
S. Wirth; Munich/DE
evidence base and enhance the reputation of the profession.
3. To identify practical measures for developing new collaborations and
Learning Objectives: initiatives, using current examples from Europe and beyond.
1. To understand the impact of imaging findings on patient
management.
2. To learn the accepted protocols in polytrauma CT imaging.
3. To become familiar with the most common typical and atypical
imaging findings.

08:58 09:00
A-560 B. FoRRM: a Formal Radiography Research Mentorship A-566 B. Don’t forget the facet joints and posterior elements
scheme as an instrument for change L. van den Hauwe, J.W. Van Goethem, M. Faure, T. Van Den Wyngaert,
C. Malamateniou; London/UK J. Huyskens, F. De Belder, C. Venstermans, P.M. Parizel; Antwerp/BE

1. To understand the importance of research in developing the 1. To become familiar with the anatomy of the facet joints and the
radiography profession. posterior elements.
2. To become familiar with research mentorship schemes as a method 2. To understand the pathophysiological principle underlying the
of disseminating knowledge, enhancing research capacity and quality degenerative changes of these structures.
and informing evidence based practice. 3. To appreciate the effect of these changes on the therapeutic approach.
3. To discuss the practicalities, challenges and opportunities emerging 09:30
from a dedicated national formal radiography research mentorship
scheme in the UK and its feasibility and potential in a European A-567 C. What to say and not to say in your report
M.M. Thurnher; Vienna/AT
perspective.
09:21 1. To understand the legal value of a report.
A-561 C. Translating research evidence into clinical practice 2. To demonstrate how detailed a report should be.
G. Paulo; Coimbra/PT 3. To understand the importance of a clinical information and the
Learning Objectives: relevance of assessing previous examinations.
1. To learn about the barriers and enablers to translating research
evidence into clinical practice.
2. To provide guidance on how radiographers can lead change and 10:30–12:00 Room A
ensure best practices are in place.
3. To be aware of useful tools for collaboration and dissemination of E3 - ECR Academies:
research evidence (e.g. EFRS Radiography Research Network).
Interactive Teaching Sessions
Panel discussion:
09:44 Research: the key to advancing the profession of E3 1421 Skull base lesions
radiography?
10:30
A-568 A. Imaging of the cavernous sinus and the anterior skull
08:30–10:00 Room K base
E3 - Rising Stars Programme Learning Objectives:
1. To understand the anatomy.
Basic Session 4: Musculoskeletal: trauma 2. To understand the most common lesions and their differential
diagnosis.
08:30
11:15
A-562 Shoulder
M. Zanetti; Zurich/CH A-569 B. Imaging of the central skull base
D.-A. Varoquaux; Marseille/FR
A-563 Knee 1. To understand the anatomy.
K. Verstraete; Ghent/BE 2. To understand the most common lesions and their differential
diagnosis.
09:30
A-564 Ankle
J. Kramer; Linz/AT 10:30–12:00 Room B
ESR meets Japan

08:30–10:00 Room G
EM 2 State-of-the-art radiology
Neuro Welcome by the ESR President:
RC 1311 Reporting the degenerative lumbar Presiding:

K. Riklund; Umea/SE
spine H. Honda; Fukuoka/JP
Moderator: D. Zlatareva; Plovdiv/BG
10:30
08:30 A-570 Introduction: Radiology today in Japan
A-565 A. Disc nomenclature: how I make my report H. Honda; Fukuoka/JP
J. Rankine; Leeds/UK Learning Objectives:
Learning Objectives: 1. To learn about the organisation of radiology in Japan.
1. To become familiar with the different nomenclatures in degenerative 2. To review the up-to-date radiology in neuro, chest, and abdomen.
disc disease and their anatomic substrates. 3. To learn about Japanese radiology and culture through photographs.
2. To learn how to differentiate between the different types of disc 4. To express appreciation to the ESR for inviting Japan to meet the ESR.
disease.
3. To appreciate how the different types of degenerative disc diseases 10:35
determine the therapeutic approach. A-571 State-of-the-art of neuroimaging
S. Aoki; Tokyo/JP
1. To have an overview of recent techniques of neuroimaging.
2. To learn about differential diagnoses of DWI abnormalities.
3. To learn fundamentals of advanced diffusion analysis beyond DTI.

10:55 11:30
A-572 Interlude: Radiologists’ intermission: refreshing photo- A-578 Intestinal ischaemia: key points for the radiologist
stream on our beautiful country (I) R. Grassi; Naples/IT
Y. Miki; Osaka/JP Learning Objectives:
1. To understand that mesenteric ischaemia is not an isolated clinical
11:00 entity, but a complex of diseases that includes occlusive forms, non-
A-573 Advanced liver imaging: improving treatment decisions occlusive forms and reperfusion damage after ischaemia.
T. Murakami; Osaka/JP 2. To appreciate that radiological findings vary widely according to
Learning Objectives: the underlying pathophysiology and the phase of damage, even if in
1. To learn about the advanced liver imaging techniques. some conditions they can overlap showing similar features.
2. To understand how to use multimodality fusion imaging of US, CT 3. To become familiar with radiological findings that may help to
and MRI for treatment of liver tumour. distinguish between the different forms of ischaemia, since a correct
3. To become familiar with advanced liver imaging of US, CT and MRI. and early etiological diagnosis is crucial to plan the therapeutic
approaches.
11:20
A-574 Interlude: Radiologists’ intermission: refreshing photo-
10:30–12:00 Room N
stream on our beautiful country (II)
T. Taoka; Nagoya/JP
Computer Applications
11:25
A-575 Diagnostic imaging of thymic tumours RC 1405 Will the good old PACS disappear?
N. Tomiyama; Osaka/JP
10:30
1. To become familiar with major types of thymic tumours and WHO A-579 Chairman’s introduction
histological classification of thymoma. D. Regge; Turin/IT
2. To learn about imaging findings of thymic tumours including CT, Session Objectives:
MRI, and PET. 1. To explain when and how to replace PACS.
3. To understand how to use CT, MRI, and PET in the diagnosis of 2. To provide insight on how to improve interconnectivity and
thymic tumours. information sharing in medicine.
3. To envisage the role of off-site archiving solutions in radiology.
Panel discussion:
10:35
11:45 Always be a pioneer: state-of-the-art technologies from
Japan A-580 A. It’s time for PACS replacement: how-to guide,
recommendations and pitfalls
10:30–12:00 Room O Learning Objectives:
1. To explain why and when PACS should be replaced.
RTF - Radiology Trainees Forum 2. To provide recommendations for PACS replacement and risk
assessment analysis including image migration issues.
TF 1 Highlighted Lectures 3. To give a practical example of how PACS is replaced in a large health
Moderators: M. Basta-Nikolic; Novi Sad/RS, facility or region.
D. Berritto; Naples/IT
10:58
10:30 A-581 B. Enterprise-based vendor-neutral archiving: is this the
A-576 Imaging of prostate cancer future of PACS?
S. Stojanovic; Novi Sad/RS J. Fernandez-Bayó; Sabadell/ES
Saturday
1. To learn about imaging modalities used for the detection of 1. To provide a definition of vendor-neutral archiving and describe its
prostate cancer, as well as imaging-guided procedures used for its key features.
histopathological verification. 2. To discuss the role of vendor-neutral archiving in archiving and
2. To become familiar with current protocols and ways of performing sharing information from different medical specialties.
these examinations. 3. To describe hurdles along the path to fully implementing enterprise
3. To learn the typical presentation of prostate cancer on different bases’ vendor-neutral archiving systems.
imaging modalities, together with the most common differential 11:21
diagnoses.4. To point out pearls and pitfalls of prostate cancer
imaging. A-582 C. Does PACS into the cloud means PACS evaporates?
J. Schillebeeckx; Knokke/BE
A-577 Rectal cancer: tips for a better staging 1. To explain the concept of cloud archiving and its advantages.
L. Curvo-Semedo; Coimbra/PT 2. To address limitations and risks of cloud PACS solutions.
Learning Objectives: 3. To give insight on future developments of cloud technology.
1. To understand how to perform an optimal MR examination for
staging rectal cancer with emphasis on the most important technical Panel discussion:
issues. 11:44 How will increased interconnection affect radiologists’
2. To become familiar with the main difficulties in diagnosis and staging day-to-day life?
of rectal cancer, and to understand the role of MRI in solving them.
3. To learn about the added value of functional imaging modalities in
rectal cancer staging.
4. To understand how to report primary staging MR imaging findings.

10:30–12:00 Room L8 10:30–12:00 Room F1
ESR Patient Advisory Group (ESR-PAG) E3 - European Diploma Prep Sessions

ESR-PAG 2 Mind the gap - data-sharing for better E3 1423 Head and neck
patient outcomes - the key issues for
10:30
patients and the radiology community
10:30
Session Objectives:
N. Bedlington1, B. Brkljačić2; 1Vienna/AT, 2Zagreb/HR 1. To become familiar with the anatomy and imaging presentation of
the most common disorders of the temporal bone and skull base.
Session Objectives: 2. To understand the imaging presentation of common inflammatory
1. To understand the importance of eHealth and interoperability, and neoplastic disorders of the nose, paranasal sinuses and
particularly in the era of big data, etc. nasopharynx.
2. To understand the legal challenges and issues with regards to data 3. To describe the typical imaging features of the most common
protection and the patient’s perspective. neoplastic disorders of the oral cavity, oropharynx, hypopharynx and
3. To learn how the proposed data protection legislation potentially larynx.
affects health research.
10:33
10:40
A-590 A. Temporal bone and skull base
A-585 eHealth, EHR and data protection: friend or foe? A. Trojanowska; Lublin/PL
P. Mildenberger; Mainz/DE
Learning Objectives: 1. To differentiate the anatomy, normal variants and congenital
1. To learn about different concepts and implementations of eHealth- disorders of the temporal bone.
Solutions throughout Europe. 2. To understand the causes and imaging features of hearing and
2. To appreciate advantages and opportunities of data-sharing. vestibular disorders.
3. To understand risks of EHR & eHealth and learn how IT and 3. To describe the imaging presentation of the most common tumours
legislation could help. of the skull base.
10:55 11:02
A-586 View of a patient representative from the Pelvic Pain A-591 B. Nose, paranasal sinuses and nasopharynx
Support Network C. Czerny; Vienna/AT
J. Birch; Poole/UK
Learning Objectives: 1. To describe the anatomy and normal variants of the nose, paranasal
1. To understand the key concerns for patients. sinuses and nasopharynx.
2. To explore whether the needs of patients can be reconciled with those 2. To differentiate the imaging features of acute and chronic
of radiologists and researchers. inflammatory changes of the nose and paranasal sinuses.
3. To understand the imaging features of benign and malignant
11:10
tumours of the nose, paranasal sinuses and nasopharynx.
A-587 View of a patient with prostate cancer
E. Briers; Hasselt/BE 11:31
Learning Objectives: A-592 C. Oral cavity, oro- and hypopharynx and larynx
1. To understand that the outcome for a patient depends on the M. Becker; Geneva/CH
collaboration and data sharing between all the medical professionals Learning Objectives:
that are taking care of the patient. 1. To describe the normal imaging anatomy of the oral cavity,
2. To explore that diagnostic data become more relevant and important oropharynx, hypopharynx and larynx.
both for patients (future patients) and clinicians if diagnostic data 2. To understand the imaging features of tumours of the oral cavity and
are linked to the outcome data to allow clinicians to improve the oropharynx.
diagnostic questions in relation to a given disease-pathology. 3. To describe the imaging features of tumours of the hypopharynx.
3. To understand that patients are willing to share their data and images 4. To understand the imaging features of tumours of the larynx.
to improve the fate of future patients, especially for patients suffering
from serious life threatening diseases like cancer.
10:30–12:00 Room K
11:25
A-588 Big data in radiology: how will it enhance personalised E3 - Rising Stars Programme
medicine?
H.-U. Kauczor; Heidelberg/DE
Basic Session 5: Neuroradiology: spine
1. To understand the main features of personalised medicine. 10:30
2. To appreciate the value of imaging biomarkers for personalised A-593 Anatomy and congenital disorders
medicine. A. Rossi; Genoa/IT
3. To learn how to exploit big data in radiology.
11:00
Panel discussion: A-594 Tumours
11:40 Big data = big issues? M.M. Thurnher; Vienna/AT
11:30
A-595 Degenerative disease of the spine
M. Sasiadek; Wroclaw/PL

12:15–12:45 Room A 13:30–15:30 Room Z
Plenary Session EIBIR Session

HL 3 Sven-Ivar Seldinger Honorary Lecture EIBIR 4 The VPH-DARE@IT Project: delivering
Presiding: K. Riklund; Umeå/SE a clinical decision support platform for
12:15
earlier dementia diagnosis
Moderator: Z.A. Taylor; Sheffield/UK
A-596 Imaging and micronavigation: time to redraw the map?
S. Holmin; Stockholm/SE
13:30
A-600 VPH-DARE@IT: towards early, differential diagnosis of
12:30–13:30 Room B dementia
A. Frangi; Barcelona/ES
E3 - The Beauty of Basic Knowledge: Learning Objectives:

1. To learn about the objectives of this major European collaborative
Breast Imaging project.
2. To understand how this project will enable earlier diagnosis of
E3 24D Ductal carcinoma in situ (DCIS): dementia and improve our understanding of it.
small tumour but big problem 13:40
Moderator: J. Camps Herrero; Valencia/ES A-601 Clinical platform for data-driven differential diagnostics
of cognitive disorders
12:30 M. van Gils, J. Mattila, J. Lötjönen, T. Urhemaa, A. Umer, A. Tolonen,
A-597 Ductal carcinoma in situ (DCIS): small tumour but big J. Koikkalainen; Tampere/FI
problem Learning Objectives:
G. Forrai; Budapest/HU 1. To appreciate the challenge of developing a clinical support platform
Learning Objectives: for cognitive disorders.
1. To understand the differences between DCIS and invasive ductal 2. To learn about the clinical decision support platform being developed
carcinoma (IDC) in terms of pathology and imaging and the clinical by the VPH-DARE@IT project.
implications thereof. 3. To understand how this platform will work in practice.
2. To learn the semiologic gamut of DCIS in the different techniques. 14:00
3. To know how to stage DCIS.
A-602 Shared research as a service platform for translating
research into clinical practice for dementia
12:30–13:30 Room D1 S. Varma; Sheffield/UK
E3 - The Beauty of Basic Knowledge: 1. To understand the implications of workflow for underlying
infrastructure.
Chest Imaging 2. To learn how the VPH-DARE@IT will enable workflows to utilise
distributed date stores for scientific analysis.
E3 25D Measurements in chest radiology 3. To learn about the emerging scientific workflows and understand the
Moderator: N. Howarth; Chêne-Bougeries/CH infrastructure in the context of VPH-DARE@IT use cases.
14:20
12:30
A-603 In silico characterisation of white matter microstructure
A-598 A. Heart and great vessels: how, why, when?
G. Fassa-Ashrafpoor; Chêne-Bougeries/CH using diffusion MRI
Saturday
L. Beltrachini; Sheffield/UK
1. To review the most useful measurements on cross-sectional imaging Learning Objectives:
of the heart and great vessels. 1. To learn how NMR is used to characterise white matter tissue.
2. To learn how to accurately perform these measurements. 2. To understand the numerical framework used in VPH-DARE@IT for
3. To know when the measurements are of clinical importance. dMRI simulations.
3. To learn about the construction of statistical computational models of
13:00 white matter microstructure.
A-599 B. Lung nodules: is volume better than size? 14:40
M. Prokop; Nijmegen/NL
A-604 Fluid transport in the ageing brain: an integrative
1. To review the management of pulmonary nodules seen on CT. modelling approach
Y. Ventikos; London/UK
2. To learn how to accurately perform the measurement of nodule
volume and size. Learning Objectives:
3. To know the limitations of the lung nodule measurement. 1. To learn what longitudinal population neuroimaging can bring to the
study of the brain.
2. To learn about the models being developed in the VPH-DARE@IT
project.
3. To appreciate the possible applications of the models in early and
differential diagnosis of dementia.

15:00 14:43
A-605 Phenomenological modelling and the RSS A-611 Sore throat
W.J. Niessen; Rotterdam/NL D. Farina; Brescia/IT
1. To understand how VPH-DARE@IT develops models of the ageing 1. To learn about the causes of sore throat.
brain. 2. To get acquainted with pattern of spread of infections.
2. To learn about the possible application of the models in early and 3. To understand the risk of tumour.
differential diagnosis of dementia.
3. To appreciate the link between genetic and environmental factors and 15:03
the brain model. A-612 Lumps of the infrahyoid neck
15:20 Discussion Learning Objectives:
1. To choose the most appropriate imaging modality for neck lumps.
2. To review congenital neck masses.
14:00–15:30 Room A 3. To become familiar with acquired causes of neck swelling.
E3 - ECR Academies: Panel discussion:

15:23 To what extent do symptoms guide your imaging
Interactive Teaching Sessions approach and interpretation?
E3 1521 Genitourinary and gastrointestinal
radiology 14:00–15:30 Room C
14:00 E3 - ECR Academies:

A-606 A. Prostate MRI using PI-RADS
Modern Imaging in Colorectal Cancer
1. To learn the clinical indications for prostate MRI. E3 1518 Colorectal cancer: synchronous and
2. To assess technical considerations for performance of multi- metachronous metastases
parametric prostate MRI. Moderator: T.K. Helmberger; Munich/DE
14:45
14:00
A-607 B. New aspects of renal tumours
A-613 A. Clinical management: what needs to be improved?
T. Holm; Stockholm/SE
1. To become familiar with the different types and classifications of
1. To understand how common distant metastases are in CRC.
renal tumours.
2. To learn about current clinical management of metastatic disease.
2. To understand the key imaging findings of the different tumours.
3. To learn about approaches aiming at improving outcome.
14:30
14:00–15:30 Room B A-614 B. Optimal diagnostic algorithm
A. Ba-Ssalamah; Vienna/AT
Special Focus Session Learning Objectives:
1. To understand the pre-treatment imaging algorithm for liver
SF 15 Head and neck radiology: from metastases.
symptoms to diagnosis 2. To learn about the role of MRI for detection of liver metastases.
3. To learn about alternative approaches and challenges.
14:00
15:00
B. Verbist; Leiden/NL A-615 C. PET/CT vs MR/PET: which and when?
P. Veit-Haibach; Zürich/CH
Session Objectives:
1. To learn how to guide imaging approach and interpretation based on Learning Objectives:
symptoms. 1. To learn about the role of FDG PET/CT for staging of CRC.
2. To discuss clinical vs radiological differential diagnoses in common 2. To learn about the role of FDG PET/CT for restaging of CRC.
ENT problems. 3. To become familiar with the possible role of MR/PET vs PET/CT.
14:03
A-609 Tinnitus 14:00–15:30 Room O
M. Lemmerling; Ghent/BE
E3 - ECR Master Classes
1. To learn about the clinical presentation of tinnitus. (Interventional Radiology)
2. To discuss the imaging algorithm for evaluation of tinnitus.
3. To get an overview of the differential diagnoses of tinnitus.
E3 1526 Fire and ice outside the liver
14:23
A-610 Stuffy and runny nose 14:00
S. Colley; Birmingham/UK A-616 Chairman’s introduction
M. Bezzi; Rome/IT
1. To understand imaging indications in case of rhinorrhea or nasal Session Objectives:
obstruction. 1. To learn about patient selection and evidence for ablation techniques
2. To learn about sinonasal infections. outside the liver.
3. To appreciate the role of imaging in sinonasal tumours. 2. To understand how to increase the safety of ablation outside the liver.
3. To learn about recent and ongoing trials of ablation outside the liver.

14:05 15:00
A-617 A. Lung ablation: update and level of evidence A-622 C. Cardiac spectroscopy: is it ready for clinical practice?
W. Prevoo; Amsterdam/NL M. Beer; Ulm/DE
1. To understand the advantages and limitations of thermal ablation in 1. To learn the essential basics of cardiac spectroscopy.
the lung. 2. To understand advantages and limitations of cardiac spectroscopy.
2. To understand the advantages and limitations of cryoablation in the 3. To appreciate the importance of spectroscopy for myocardial
lung. characterisation.
3. To learn about recent and ongoing trials and the level of evidence.
14:30 14:00–15:30 Studio 2016
A-618 B. Renal ablation: update and level of evidence
C.M. Sommer; Heidelberg/DE Joint Session of the ESR and ERS
1. To understand the advantages and limitations of thermal ablation in Imaging of airways:
the kidney.
2. To understand the advantages and limitations of cryoablation in the what the respirologist needs to know
kidney. Moderators: N. Karabulut; Denizli/TR, S. Ley; Munich/DE
14:00
14:55 A-623 Classification and impact of bronchiectasis
A-619 C. Bone and soft tissues ablation: update and level of S. Aliberti; Milan/IT
evidence Learning Objectives:
A. Gangi; Strasbourg/FR 1. To appreciate the difference between cystic fibrosis and non-cystic
Learning Objectives: fibrosis bronchiectasis.
1. To understand the advantages and limitations of thermal ablation in 2. To understand the difference between chronic bronchitis and
the bone and soft tissues. bronchiectasis.
2. To understand the advantages and limitations of cryoablation in the 3. To learn about the treatment options of bronchiectasis.
bone and soft tissues.
14:23
A-624 How to image and report airway disease?
P. Grenier; Paris/FR
Panel discussion:
15:20 How to strengthen the role of ablation beyond the liver Learning Objectives:
in everyday clinical practice and how to prove the value 1. To appreciate CT acquisition and visualisation protocols in airway
of what we do disease.
2. To consolidate knowledge on how to measure airway lumen and wall.
3. To learn how to report what the clinician needs to know.
14:00–15:30 Room N
14:46
E3 - ECR Academies: A-625 Role of airway obstruction and remodeling in the
progression of COPD
Modern Cardiac Imaging I. Adcock; London/UK
E3 1520 Myocardial characterisation: 1. To understand the pathophysiology of chronic bronchitis and airway
established modalities vs new ones obstruction.
Moderator: J. Bremerich; Basle/CH
2. To consolidate knowledge about the effects of smoking on airway
remodelling.
3. To learn about different treatment options.
Saturday
14:00
A-620 A. Hybrid systems in the assessment of myocardial 15:08
perfusion and viability A-626 Imaging of mucus, inflammation and remodeling in
D.V. Ryzhkova; St. Petersburg/RU
COPD and CF
Learning Objectives: H.-U. Kauczor; Heidelberg/DE
1. To appreciate the clinical need for assessment of myocardial Learning Objectives:
perfusion and viability. 1. To understand the concept of the COPD airway phenotype at
2. To know more about imaging modalities used for these indications. imaging.
3. To comparatively evaluate hybrid imaging vs single-modality 2. To learn about airway obstruction, air trapping and hypoxic
modalities (CT, MRI). vasoconstriction.
14:30 3. To appreciate the potential of MRI to differentiate mucus and
inflammation.
A-621 B. T1 and T2-mapping: new items in the radiology
toolbox
P. Croisille; Saint-Etienne/FR
1. To learn about technical basics of myocardial mapping in cardiac
MR.
2. To learn what types of diagnostic information could be obtained with
mapping.
3. To become familiar with results of clinical application of this
technique.

14:00–15:30 Room E1 14:21

A-633 The role of imaging in preoperative planning and follow-up
Musculoskeletal F. Rengier; Heidelberg/DE
RC 1510 Shoulder MRI: mastering technique and 1. To learn about the concepts of preoperative planning.
making my report relevant 2. To understand key figures and definitions.
3. To appreciate the use of innovative imaging methods.
14:00 4. To become familiar with the meaning of diagnostic preoperative
workup.
M. Maas; Amsterdam/NL 14:39
Session Objectives: A-634 Implantation techniques and long-term results
1. To understand the level of expertise that patients expect for adequate R. Uberoi; Oxford/UK
performance and reading of shoulder MRI.
2. To gain insight into differentiating normal age-related changes from
1. To learn about the basic concepts of endovascular techniques.
clinical relevant MR features.
2. To understand basic mechanical and anatomic considerations.
14:05 3. To appreciate the use of innovative endovascular tools.
4. To become familiar with the latest research in the field.
A-628 A. The normal MRI: techniques and anatomy
E. Llopis; Valencia/ES 14:57
Learning Objectives: A-635 Imaging and treatment of endoleaks
1. To become familiar with MRI techniques for imaging the shoulder. M. Gschwendtner; Linz/AT
2. To understand normal MRI shoulder anatomy, and normal variants
seen.
1. To learn about the nomenclature and pathophysiological backup of
14:28 endoleaks.
2. To understand the basic concepts in treatment und surveillance of
A-629 B. Rotator cuff tears: what are they and what do they
endoleaks.
look like? 3. To appreciate the use of innovative tools for treatment and
K.-F. Kreitner; Mainz/DE
surveillance.
Learning Objectives: 4. To become familiar with the key facts and figures regarding the
1. To become familiar with the anatomical basis of rotator cuff tears. scientific workup.
2. To learn about the MRI findings of rotator cuff pathology.
15:15 The key role of the radiologist in endovascular
A-630 C. Patterns of instability: what does the MRI show? abdominal aortic aneurysm repair
A.J. Grainger; Leeds/UK
1. To discuss where the further development of aortic endovascular
Learning Objectives: treatment will go.
1. To become familiar with patterns of abnormality seen in shoulder 2. To discuss the role of the radiologist in this concept.
instability. 3. To conclude where we stand now.
2. To learn about the MRI findings of shoulder instability.
Panel discussion: 14:00–15:30 Room F1

15:14 How are the indications for MR arthrography in the
shoulder changing? E3 - European Diploma Prep Sessions
E3 1523 Gynaecological and obstetrics
14:00–15:30 Room E2
14:00
State of the Art Symposium A-636 Chairman’s introduction
SA 15 Endovascular abdominal aneurysm Session Objectives:
repair (EVAR): where do we stand now? 1. To understand the imaging presentation of the most common benign
and malignant disorders of the uterus.
14:00 2. To become familiar with inflammatory and neoplastic disorders of
A-631 Chairman’s introduction the adnexa.
T. Rand; Vienna/AT 3. To understand the principles of foetal images and the imaging
Session Objectives: presentation of the most common foetal disorders.
1. To introduce the basic concepts of EVAR. 14:03
2. To underline the major role of radiology in EVAR.
A-637 A. Imaging of the uterus
14:03 R.A. Kubik-Huch; Baden/CH
A-632 Endovascular versus open surgical repair: what do we Learning Objectives:

know so far? 1. To understand the advantages and limits of ultrasound,
D.K. Tsetis; Iraklion/GR hysterosalpingography, CT and MRI in imaging the uterus.
2. To become familiar with the normal anatomy of the uterus and to
Learning Objectives: know the variations of the uterus during genital life and during the
1. To learn about the basic concepts of the treatment of abdominal menstrual cycle.
aortic aneurysms. 3. To learn about congenital anomalies as well as the most relevant
2. To understand the principles of endovascular repair. benign and malignant uterine pathologies.
3. To appreciate innovative endovascular treatment options. 4. To be able to explain the technique of a pelvic MRI and to know the
4. To become familiar with the latest research in the field. contra-indications of MRI, the required preparation of the patient
and the choice of technical parameters depending on indications.

14:32 14:30
A-638 B. Disorders of the adnexa A-644 B. Mediastinal masses: role of CT
E. Sala; New York, NY/US M. Occhipinti; Rome/IT
1. To describe the imaging features of benign tumours of the ovaries. 1. To learn the most common causes of mediastinal masses.
2. To understand the diagnostic evaluation and imaging features of 2. To recognise signs which allow us to characterise mediastinal lesions.
malignant tumours of the ovaries.
3. To explain the imaging features of inflammatory disorders of the 15:00
Fallopian tubes. A-645 C. A new look at the mediastinum: role of MRI and PET/CT
F.L. Giesel; Heidelberg/DE
15:01
A-639 C. Fundamentals of foetal imaging 1. To learn when and how to apply MR for mediastinal disease.
D. Prayer; Vienna/AT 2. To learn when and how to apply PET/CT for mediastinal masses.
1. To describe the methodology and technical principles of foetal MR
imaging. 14:00–15:30 Room D2
2. To understand the imaging presentation of common pathologies of
the foetal central nervous system. Radiographers
3. To understand the imaging presentation of common pathologies of
the foetal body. RC 1514 Innovative education in medical
imaging
14:00–15:30 Room F2
14:00
Breast A-646/A-647 Chairmen’s introduction
P. Bezzina1, M. Bachmann Nielsen2; 1Msida/MT, 2Copenhagen/DK
RC 1502 Update on BI-RADS Session Objectives:

Moderator: G. Esen; Istanbul/TR
1. To understand the role of handheld devices in medical imaging
education.
14:00 2. To appraise the use of simulators as an innovative educational tool in
radiology.
A-640 A. Mammography 3. To discuss the use of interactive application to teaching and learning
U. Bick; Berlin/DE
in medical imaging.
1. To learn about the recently updated BI-RADS® lexicon. 14:05
2. To become familiar with the mammography descriptors. A-648 A. Is there a role for smartphones and tablets in medical
3. To understand the usefulness of the BI-RADS® categories and their imaging education?
clinical application. F. Girard; Pont de Roide/FR

A-641 B. Ultrasound 1. To review the current educational uses of hand-held electronic
A. Evans; Dundee/UK devices in medical imaging.
2. To discuss the potential advantages and disadvantages of technology-
Learning Objectives: enhanced learning in medical imaging.
1. To learn about the recently updated BI-RADS® lexicon. 3. To suggest potential future uses of smartphones and tablets in
2. To become familiar with the ultrasound descriptors. radiography education.
3. To understand the usefulness of the BI-RADS® categories and their
clinical application. 14:28
A-649 B. Using simulators as an innovative teaching tool in
Saturday
15:00
A-642 C. MRI medical imaging
P. Cosson; Teeside/UK
M.H. Fuchsjäger; Graz/AT
1. To learn about the recently updated BI-RADS® lexicon. 1. To appraise the current methods used in healthcare simulation for
2. To become familiar with the MRI descriptors. education.
3. To understand the usefulness of the BI-RADS® categories and their 2. To explore the benefits and disadvantages of these methods in
clinical application. radiography education.
3. To suggest future uses and further improvements of simulators in
radiography education.
14:00–15:30 Room D1 14:51
A-650 C. Beyond eye candy: developing effective interactive
Chest animations to enhance MRI learning
D. Koumarianos; Athens/GR
RC 1504 Mediastinal disease revisited
Moderator: A. Persson; Linköping/SE 1. To review the current educational uses of interactive animations in
medical imaging.
14:00 2. To discuss the potential advantages and disadvantages of multimedia
A-643 A. The crucial role of chest x-ray: mediastinal lines and in medical imaging education.
stripes 3. To demonstrate the development of educationally effective interactive
E.E.J.G. Coche; Brussels/BE animations.
1. To become familiar with the signs that indicate mediastinal Panel discussion:
pathology. 15:14 What is the value of innovation in advancing clinical
2. To confidently identify and localise a mediastinal mass on chest x-ray. practice and education in radiography?

14:00–15:30 Room K 14:30

A-656 B. How can I improve my reporting of T2-hyperintense
Physics in Radiology lesions?
A. Rovira-Cañellas; Barcelona/ES
RC 1513 IT tools for dose tracking and workflow Learning Objectives:
optimisation 1. To understand if it is possible to use a structured report with white
brain abnormality.
14:00 2. To learn how to define a comprehensive imaging protocol for those
A-651 Chairman’s introduction patients.
A. Trianni; Udine/IT 3. To appreciate the role of modern imaging techniques for defining
Session Objectives: white brain hyperintense T2 lesions.
1. To understand the pros and cons of dose tracking in modern day 15:00
radiology imaging.
A-657 C. Is there a need for quantitative reporting of white
2. To review IT standards for dose tracking.
3. To learn about dose optimisation from using dose tracking tools. matter lesions?
F. Barkhof; London/UK, Amsterdam/NL
A-652 A. Digital Imaging and Communications in Medicine 1. To understand the importance of quantitative analysis in white
(DICOM) standard and Integrating the Healthcare matter lesions.
2. To show how to perform the quantitative analysis.
Enterprise (IHE)
D. Peck; Detroit, MI/US 3. To understand the importance of follow-up in in patients with white
matter lesions.
1. To understand the current DICOM standard.
2. To learn about new DICOM efforts which will significantly impact 16:00–17:30 Room A
imaging systems’ operations.
3. To understand how IHE coordinates the integration and
management of DICOM objects.
E3 - ECR Academies:
14:28 Interactive Teaching Sessions
A-653 B. Patient dose index tracking: a must have?
F. Zanca; Leuven/BE E3 1621 Emergency radiology II
1. To identify informatics and tools for tracking patient radiation dose.
2. To learn about some possible uses in clinical practice. A-658 A. Brain trauma
M. Smits; Rotterdam/NL
3. To learn about some examples of patient radiation dose tracking.
14:51 1. To understand the different types of brain trauma.
A-654 C. Optimising technique using patient dose index 2. To become familiar with the differential diagnosis.
tracking software: tips and tricks 16:45
R.W.R. Loose; Nuremberg/DE
A-659 B. Peripheral vascular injury
Learning Objectives: J. Ferda; Plzen/CZ
1. To learn how to use the DICOM header to improve technique and
outcome for the patient. Learning Objectives:
2. To learn how to use the DICOM header to improve performance of 1. To understand the different types of peripheral vascular injury.
the automatic exposure control system. 2. To become familiar with the different imaging techniques.
3. To take advantage of dose tracking information in order to compare 3. To become familiar with interventional treatment options.
technique among different CT scanners.
16:00–17:30 Room B
Panel discussion:
15:14 Dose index tracking in clinical practice
Abdominal Viscera
14:00–15:30 Room G RC 1601 The spleen: the forgotten organ
Neuro 16:00
L.H. Ros Mendoza; Zaragoza/ES
RC 1511 White spots in the brain
Moderator: E.T. Tali; Ankara/TR Session Objective:
1. To briefly introduce the diagnostic challenges imaging spleen.
14:00 16:05
A-655 A. White spots and blots in the brain: what are they? A-661 A. Acute and chronic splenic disease
G. Zamboni; Verona/IT
1. To understand what white spots are. 1. To describe the most common causes of acute and chronic splenic
2. To make differential diagnoses in brain white spots. disease, excluding malignant lesions.
3. To demonstrate how to study patients with brain white spots. 2. To define imaging protocols, including functional and metabolic
techniques, to apply for the detection and characterisation.

16:28 16:00–17:30 Room Z

A-662 B. The incidental splenic lesion
M. Laniado; Dresden/DE Joint Session of the ESR and ESTRO
1. To describe the most common causes of splenic incidentaloma and ESR/ESTRO MR and MR/PET in radiation
their imaging appearance. treatment planning - challenges and
2. To define imaging protocols, including functional and metabolic
techniques, for the differential diagnosis.
opportunities
3. To propose an algorithm for the management of incidental splenic
16:00
lesions.
16:51 K. Riklund1, V. Valentini2; 1Umea/SE, 2Rome/IT
A-663 C. Malignant lesions Session Objectives:
S. Gourtsoyianni; London/UK 1. To learn about the contribution of multimodality/hybrid imaging and
Learning Objectives: in-room imaging to define tumour extension to favour optimisation
1. To describe the clinical presentation and imaging findings for focal in radiation oncology treatment.
and diffuse neoplastic malignant lesions. 2. To understand the feasibility of multimodality/hybrid imaging and
2. To discuss the indication of splenic lesion biopsy and its diagnostic in-room imaging to optimise radiation oncology treatment.
contribution. 3. To appreciate the role of multimodality/hybrid imaging and in-room
imaging to drive treatment strategies for the cure of the tumour and
Panel discussion: for the quality of life of the patients.
17:14 How to manage incidental findings in clinical routine 4. To become familiar with the clinical need of multidisciplinary
practice specialists to position the role of imaging as pivotal in modern
oncology.
16:03
16:00–17:30 Room C
A-669 The benefit of high tesla MRI for radiation oncology
E3 - ECR Academies: planning
U. van der Heide; Amsterdam/NL
Modern Imaging in Colorectal Cancer Learning Objectives:
1. To learn about the contribution of MRI and in-room MRI to
E3 1618 Rectal cancer: staging and restaging define tumour extension and organ-at-risk movements to favour
local disease optimisation in radiation oncology treatment.
2. To understand the benefit of MRI in-room to optimise radiation
Moderator: D.-M. Koh; Sutton/UK
oncology treatment.
3. To appreciate the role of MRI and in-room MRI to drive treatment
16:00
strategies for the cure of the tumour and for the quality of life of the
A-664 A. Transrectal ultrasonography patients.
J.E.R. Waage; Hillerod/DK
1. To understand the role of TRUS for staging rectal tumours. A-670 The challenge of in room MRI for treatment delivery
2. To become familiar with new TRUS techniques. N. Dinapoli; Rome/IT
3. To learn about TRUS for restaging of rectal cancer. Learning Objectives:
1. To learn about the limitations to defining tumour extension and
16:30
organ-at-risk movements to favour optimisation in radiation
A-665 B. Emerging MR-techniques oncology treatment.
D.M. Lambregts; Amsterdam/NL 2. To understand the constraints of optimising radiation oncology
Learning Objectives: treatment.
Saturday
1. To understand which MR sequences are used in clinical practice. 3. To appreciate the uncertainties of driving treatment strategies for the
2. To become familiar with new imaging techniques used in rectal cure of the tumour and for the quality of life of the patients.
cancer.
3. To learn about how to use DWI for restaging of rectal cancer. 16:43
A-671 The benefit of MR/PET in radiation oncology
17:00 U. Nestle; Freiburg/DE
A-666 C. Multiparametric assessment of treatment response Learning Objectives:
N. Papanikolaou; Stockholm/SE 1. To learn about the contribution of MR/PET to defining tumour
Learning Objectives: extension and organ-at-risk movements to favour optimisation in
1. To understand the rationale behind multiparametric imaging in radiation oncology treatment.
rectal cancer. 2. To understand the benefit of MR/PET for optimising radiation
2. To learn how to approach images in a multiparametric setting. oncology treatment.
3. To get an overview of available software platforms. 3. To appreciate the role of MR/PET in driving treatment strategies for
the cure of the tumour and for the quality of life of the patients.
17:03
A-672 The challenge of using MR/PET in radiation oncology
E.-M.B. Larsson; Uppsala/SE
1. To learn about the limitations of MR/PET in defining tumour
extension and organ-at-risk movements to favour optimisation in
radiation oncology treatment.
2. To understand the constraints of MR/PET in optimising radiation
oncology treatment.
3. To appreciate the uncertainties of MR/PET in driving treatment
strategies for the cure of the tumour and for the quality of life of the
patients.
17:23 Discussion

16:00–17:30 Room O 16:00–17:30 Room N
Joint Session of the ESR, EFSUMB and ESPR E3 - ECR Academies:

Contrast enhanced ultrasound (CEUS) in paediatrics Modern Cardiac Imaging
Moderators: M. Claudon; Vandoeuvre-les-Nancy/FR, C. Owens; London/UK
E3 1620 Cardiac imaging: to new horizons
16:00 Moderator: E. Mousseaux; Paris/FR
A-673 Legal issues with CEUS in children

P.S. Sidhu; London/UK
16:00
Learning Objectives: A-678 A. New approaches for coronary atherosclerotic plaque
1. To understand the current status of unlicensed drug therapy in characterisation
children. E.J.R. van Beek; Edinburgh/UK
2. To understand the legal position of prescribing unlicensed drugs in Learning Objectives:
children. 1. To appreciate the importance of atherosclerotic plaque
3. To understand the responsibilities of performing CEUS in children. characterisation with imaging.
2. To learn about developments of PET/CT and MR/PET applications
16:18 for coronary plaque imaging.
A-674 CEUS of focal liver lesions in children 3. To become aware of new research directions in this field and their
M. Sellars; London/UK possible significance.
16:30
1. To illustrate the spectrum of focal liver lesions in the paediatric
population. A-679 B. Imaging of microvascular disease
2. To understand the role of CEUS in the diagnostic pathway of R. Manka; Zurich/CH
children with chronic liver disease. Learning Objectives:
3. To review CEUS findings of common and uncommon benign and 1. To learn about pathophysiology of coronary circulation in
malignant focal liver lesions in children. microvascular disease.
2. To appreciate the significance of imaging of microvascular disease in
16:36 a clinical setting.
A-675 CEUS in blunt abdominal trauma in children 3. To learn about advantages, limitations and further perspectives of
A. Deganello; London/UK cardiac imaging in this pathology.
17:00
1. To illustrate the usefulness of CEUS in the setting of paediatric
trauma. A-680 C. Tracking of stem cells in cardiac repair: role of MR and
2. To discuss the implications of repeated radiation exposure in children hybrid imaging
following trauma. L. Natale; Rome/IT
3. To review CEUS findings of the most frequent types of solid Learning Objectives:
abdominal organ injuries occurring in children. 1. To become familiar with the application of cardiac stem cells therapy.
16:54 2. To become familiar with techniques for stem cell labelling with
radionuclide and magnetic tracers.
A-676 CEUS in vesical reflux in children 3. To learn about the use of hybrid imaging for the assessment of
C. Duran; Sabadell/ES
cardiac repair and remodelling during therapy with stem cells.
1. To illustrate the protocol for the study of the urinary tract, including
the urethra, with second-generation contrast agents. 16:00–17:30 Studio 2016
2. To demonstrate the high quality of the images obtained with this
procedure. Multidisciplinary Session
3. To show that voiding urosonography can diagnose the most prevalent
urethral pathologies.
MS 16a Uterine myomas: radiological diagnosis
17:12 and treatment
A-677 CEUS in non-liver indications in paediatric patients
C.F. Dietrich; Bad Mergentheim/DE 16:00
Learning Objectives: A-681 Chairman’s introduction
1. To understand indications of CEUS beyond the liver. A.-M. Belli; London/UK
2. To understand extravascular and intracavitary applications of CEUS Session Objectives:
(except vesical reflux). 1. To learn about the imaging characteristics of fibroids before and after
3. To discuss off label use in children (and adults). treatment.
2. To understand the information required by gynaecologists and
interventional radiologists from imaging.
3. To learn about the different therapeutic options and their outcomes.
4. To understand the impact of fibroids and the different treatment
strategies on fertility.
16:05
A-682 Imaging of fibroids
R. Das; London/UK
1. To describe imaging characteristics of fibroids.
2. To differentiate from other relevant pathology including malignancy.
3. To report the information required by the gynaecologist before and
after surgical and radiological intervention.

16:25 16:00–17:30 Room E1

A-683 Epidemiology, clinical presentation and non radiological
therapeutic options for the treatment of fibroids Multidisciplinary Session
I. Manyonda; London/UK
Learning Objectives: MS 16b Sports injuries: diagnosis and
1. To describe the clinical presentation of fibroids. management
2. To describe the medical and surgical treatment options and their
outcomes. 16:00
3. To describe what is known about the impact of fibroids on fertility A-689 Chairman’s introduction
and how these treatments impact on this. M. Padrón; Madrid/ES

1. To understand the point-of-view of the different actors involved in a
A-684 Radiological treatments for fibroids
sport injury based on personal experiences.
2. To learn how to focus on a sport injury with a multidisciplinary
Learning Objectives: approach.
1. To describe the radiological treatment options of uterine artery 3. To review actual concepts on diagnosis and management of sports
embolisation and HIFU. injuries.
2. To present the current evidence on outcomes.
3. To describe how to manage expectations and complications. 16:05
A-690 What does the radiologist offer?
17:05 Multidisciplinary case discussion C. Faletti; Turin/IT
16:00–17:30 Room L8 1. To become familiar with the specific role the radiologist has in the
management of sports injuries.
2. To understand the relative importance of what should be and should
EuroSafe Imaging Session not be included in the radiological report.
3. To understand the role of imaging-guided intervention in the
EuroSafe 4 You too can definitely do audits management of sports injury.
16:00 16:20
A-685 Chairman’s introduction A-691 How I face a sport injury: the sport physician’s approach
E.J. Adam; London/UK J.-M. Alonso; Doha/QA
Session Objectives: Learning Objectives:
1. To learn how to introduce an effective clinical audit programme. 1. To identify the injury mechanism.
2. To introduce the ESR audit tool as an aid to improving quality in 2. To localise which anatomic structures are affected.
radiology services. 3. To select and indicate the appropriate imaging techniques.
3. To explore how the use of such a system will satisfy external
16:35
authorities.
A-692 The physiotherapist’s view
16:05 A. Zerolo; Madrid/ES
A-686 Experience from an established national programme Learning Objectives:
D. Remedios; Harrow/UK 1. To become familiar with the specific role the physiotherapist has in
Learning Objectives: the management of sports injuries.
1. To learn how an established national clinical audit programme can 2. To understand the aspects of the radiological report which are most
work effectively. important to the physiotherapist.
2. To learn how to design, run, and publish audits. 3. To understand how the radiologist goes on to influence the
3. To understand the benefits of local clinical audit. management of athletic injuries from the physiotherapist’s
Saturday
perspective.
16:30
A-687 The challenges of introducing a national audit 16:50
programme A-693 The surgeon’s perspective
A. Vargha; Hidegség/HU M. Leyes; Madrid/ES

1. To highlight which kind of critical issues could occur on a national 1. To become familiar with the specific role the surgeon has in the
level during implementing an international (EU) guideline for management of sports injuries.
clinical audit. 2. To understand the aspects of the radiological report which are most
2. To understand ways to avoid unnecessary turf battles. important to the surgeon.
3. To appreciate how to set up a realistic plan for clinical audit 3. To understand how the radiologist goes on to influence the
implementation in radiology. management of athletic injuries from the surgeon’s perspective.
4. To understand the information that orthopaedic surgeons consider
16:55 critical for preoperative planning and reconstruction of the multiple
A-688 How to make audit easy: the ESR Audit Tool ligament knee injury in sports.
17:05 Multidisciplinary case presentation and discussion:
1. To learn about the ESR Clinical Audit Tool. Which aspects of radiological practice help and which
2. To understand how it can be used at local and national levels. hinder the team approachto managing the injured
3. To explore what makes clinical audit an effective quality athlete? How can we improve on this?
improvement tool.

16:00–17:30 Room E2 16:00–17:30 Room F1
Special Focus Session E3 - European Diploma Prep Sessions

SF 16 Prostate MRI: increasing need? E3 1623 Interventional
16:00 16:00
A-694 Chairman’s introduction A-698 Chairman’s introduction
J.C. Vilanova; Girona/ES M. Szczerbo-Trojanowska; Lublin/PL
Session Objectives: Session Objectives:
1. To learn about the current role of prostate MRI in managing prostate 1. To understand the principles and techniques of angiography and
cancer. image-guided interventions.
2. To become familiar with the current recommendations and 2. To become familiar with the different methods of hepatobiliary
guidelines for multiparametric technique of prostate MRI. interventions.
3. To discuss the different indications of prostate MRI and analyse the 3. To describe the most common vascular interventions.
improved value for patients.
4. To provide an update on the new advances in prostate mpMRI. 16:03
A-699 A. Basic principles of angiography and image-guided
16:05
interventions
A-695 MRI before the first prostate biopsy: has the time come? T.K. Helmberger; Munich/DE
B. Hamm; Berlin/DE
Learning Objectives: 1. To describe the normal anatomy and normal variants of the arterial
1. To learn about the current status of TRUS-guided biopsy. and venous vascular system.
2. To discuss possible inclusion criteria for MRI before the first prostate 2. To understand diagnostic and interventional angiographic
biopsy. techniques.
3. To learn about the histological Gleason grading with special reference 3. To explain basic percutaneous image-guided techniques including
to MRI findings. abscess drainage and biopsy taking.
4. To discuss further steps for radiology in the detection of prostate
cancer. 16:32
A-700 B. Interventions of the hepatobiliary system
16:28 J.I. Bilbao; Pamplona/ES
A-696 The role of prostate MRI in active surveillance Learning Objectives:
A.R. Padhani; London/UK
1. To describe the normal anatomy and normal variants of the
Learning Objectives: hepatobiliary system.
1. To provide an overview of the concepts underpinning active 2. To explain vascular hepatic interventions including transarterial
surveillance (AS) strategies for low risk prostate cancer. chemoembolisation.
2. To discuss the role of mpMRI for confirming clinical patient selection 3. To understand percutaneous hepatobiliary interventions including
criteria for AS and highlight the benefits of mpMRI for detecting thermal ablation techniques.
cases at higher risk and thus unsuited for AS.
3. To demonstrate changing imaging phenotype during AS period and 17:01
corresponding clinical actions. A-701 C. Vascular interventions
4. To highlight need for effective communication with clinicians J.A. Reekers; Amsterdam/NL
regarding initial and continued suitability for AS. Learning Objectives:
16:51 1. To explain endovascular treatment options of atherosclerotic
diseases.
A-697 Is prostate MRI accurate enough for focal treatment 2. To understand common angioplasty procedures, such as renal, iliac
planning? and femoral angioplasties.
V. Panebianco; Rome/IT 3. To describe indications and techniques for arterial stenting
Learning Objectives: procedures.
1. To provide an overview of mpMRI in terms of accuracy, sensitivity, 4. To explain techniques of arterial embolisation and coiling.
specificity and especially PPV and PNV in the initial diagnosis of PCa.
2. To discuss the role of mpMRI as an important tool for selection
criteria for focal therapy. 16:00–17:30 Room F2
3. To demonstrate the role of mpMRI to guide the targeted therapy.
4. To underline the role of mpMRI in the follow-up of the patients Breast
treated and its reproducibility.
RC 1602 Tomosynthesis: the new mammography
Panel discussion:
Moderator: D. Bernardi; Trento/IT
17:14 Does the use of MRI improve the outcome in prostate
cancer? 16:00
A-702 A. Should we abandon 2D mammography?
1. To understand the technique of 2D mammography and what the
limits could be.
2. To know how to calculate radiation dose in 2D mammography and
ways to improve image quality.
3. To understand when 2D mammography is better than DBT.

16:30 16:23
A-703 B. Clinical validation and results in the last 5 years: where A-709 B. Safety aspects in an interventional radiology setting?
do we stand? D. Catania; Milan/IT
P. Skaane; Oslo/NO Learning Objectives:
Learning Objectives: 1. To become aware of patient and staff risk in an interventional
1. To become familiar with the technique of DBT. radiology setting.
2. To understand the results of DBT in the screening and diagnostics 2. To appreciate the importance of radiation protection measures
settings. considering the nature of interventional procedures.
3. To know the evolution of tomosynthesis in screening organisation. 3. To recognise the need for education and training in interventional
radiology settings in order to promote radiation safety.
17:00
16:46
A-704 C. The future of mammography: my predictions
E.M. Fallenberg; Berlin/DE A-710 C. An introduction to mammography safety: what can be
Learning Objectives: done?
1. To understand the role of mammography in analysing and D. O’Leary; Hertfordshire/UK
characterising breast lesions. Learning Objectives:
2. To become familiar with new developments in digital mammography 1. To understand the definition of safety in a mammography context.
such as contrast mammography, tomosynthesis and 3D contrast 2. To become aware of mammography best practices in radiation
mammography. protection, compression and infection control.
3. To learn about the new potential of combining mammography with 3. To understand the radiographer’s role as safety gatekeeper in
molecular imaging, optical imaging and texture analysis. mammography.
17:08
16:00–17:30 Room D1 A-711 D. Safety in CT: dose minimisation and beyond
R. Booij; Rotterdam/NL
E3 - ECR Master Classes (Chest) Learning Objectives:
1. To become aware of international recommendations, standards and
E3 1626 Less common infiltrative lung diseases directives in order to promote safety.
Moderator: M. Regier; Hamburg/DE
2. To consolidate knowledge in dose reduction of CT examinations.
3. To enhance understanding about the tradeoffs between dose
16:00 reduction and image quality.
A-705 A. Pleuroparenchymal fibro elastosis
A. Devaraj; London/UK
16:00–17:30 Room K
1. To become familiar with this newly recognised idiopathic interstitial Physics in Radiology
pneumonia.
2. To learn how to interpret upper zone changes on thoracic CT.
RC 1613 MR: artefacts and devices
16:30
16:00
A-706 B. Alveolar proteinosis
W.F.M. De Wever; Leuven/BE A-712 Chairman’s introduction
M. Tosetti; Pisa/IT
1. To become familiar with the CT features enabling the radiologist to Session Objectives:
suggest this diagnosis. 1. To learn about MR image distortions.
2. To learn about other diseases with crazy-paving as a predominant 2. To appreciate the appearance of metal-induced image distortions in
pattern. MRI.
3. To appreciate image distortions in perfusion- and diffusion-weighted
Saturday
17:00 imaging.
A-707 C. Lymphangioleiomyomatosis
A. Oikonomou; Toronto, ON/CA
16:05
Learning Objectives: A-713 A. Image artefacts in MRI and their mitigation
D.J. Lurie; Aberdeen/UK
1. To learn about the parenchymatous and pleural manifestations of the
disease. Learning Objectives:
2. To learn how to distinguish LLM from other cystic diseases of the 1. To identify common types of artefacts in MR images.
lung. 2. To learn about the physical origins of artefacts in MRI.
3. To learn methods of minimising artefacts on MR images.
16:28
16:00–17:30 Room D2
A-714 B. Imaging around metal implants: artefact reduction in
Radiographers MRI
C. McGrath; Belfast/IE
RC 1614 Safety issues in medical imaging Learning Objectives:

Moderators: C. Leidecker; Forchheim/DE,
1. To review the origin of signal in MRI.
J. Santos; Coimbra/PT 2. To understand the MRI physics of artefact reduction around metal
implants.
16:00 3. To understand the parameters used in an optimised imaging
protocol.
A-708 A. Safeguarding patients and staff in MRI
T. Owman; Lund/SE
1. To understand the patient and staff risk in MRI examinations.
2. To become familiar with guidelines and recommendations for patient
and staff safety.
3. To become aware of the importance of the role of radiographer in
MRI safety.

16:51
A-715 C. Artefacts in perfusion and diffusion MRI
I. Tsougos; Larissa/GR
1. To review the artefacts and pitfalls of diffusion MRI on a qualitative
basis, especially in terms of eddy currents and sensitivity to motion.
2. To review and evaluate the possible issues that can affect the accuracy
of measurements regarding dynamic susceptibility contrast (DSC)-
MRI (measurements of cerebral blood flow (CBF), cerebral blood
volume (CBV), and mean transit time (MTT)).
3. To introduce possible strategies that have been developed to mitigate
or overcome these artefacts and pitfalls.
Panel discussion:
17:14 Clinically applicable tools/strategies to minimising/
avoiding MR imaging artefacts
16:00–17:30 Room G
Neuro
RC 1611 Update on endovascular stroke
treatment: a medical breakthrough?
Moderator: S. Rohde; Dortmund/DE
16:00
A-716 A. A critical appraisal of the current literature
W. van Zwam; Maastricht/NL
1. To understand the strengths and shortcomings of the relevant multi-
centre trials assessing the role of endovascular treatment in patients
with acute ischaemic stroke.
2. To understand the outcomes of these trials, the context in which
they were achieved and how they can be ensured in a different
environment.
3. To appreciate potential differences in management of patients with
anterior vs posterior circulation strokes.
16:30
A-717 B. Which techniques can we use to reopen an occluded
cerebral blood vessel?
T. van der Zijden; Edegem/BE
1. To understand the principles underlying endovascular clot aspiration.
2. To become familiar with the different materials available for
mechanical clot retrieval.
3. To understand the circumstances in which stenting of an intracranial
blood vessel is needed.
17:00
A-718 C. Endovascular stroke treatment: ethical and
economical concerns
K.-O. Løvblad; Geneva/CH
1. To appreciate the structure that is necessary to organise
interventional stroke treatment for a large population.
2. To understand the cost implications and their mitigation.
3. To become familiar with the associated ethical concerns (such as
informed consent) and the different ways of addressing them.

08:30–10:00 Room A 08:30–10:00 Room C
E3 - ECR Academies: Joint Session of the ESR and ESHI

Interactive Teaching Sessions Medical hybrid imaging
Moderator: K. Riklund; Umea/SE
E3 1721 MR imaging in sports medicine II
08:30
08:30
A-725 Introduction
A-719 A. Sports injuries of the ankle L. Donoso; Barcelona/ES
P. Robinson; Leeds/UK
Learning Objectives: 1. To become familiar with the background of the decision to create this
1. To learn the anatomy of the ankle. new society.
2. To learn the evaluation of common ankle injuries. 2. To learn about the aims of the new society.
09:15 3. To get an overview of physics, training and medical use in hybrid
imaging.
A-720 B. Shoulder injury
M. Zanetti; Zurich/CH 08:35
Learning Objectives: A-726 The aims of the new society
1. To review the anatomy of the shoulder in 3-dimensions. K. Riklund; Umea/SE
2. To learn the evaluation of common shoulder injuries. Learning Objectives:
1. To introduce the new society.
2. To inform about the activities of the new society.
08:30–10:00 Room B
08:50
Abdominal Viscera A-727 Training of hybrid physicians
G. Antoch; Düsseldorf/DE
RC 1701 Differential diagnosis in pancreatic Learning Objectives:
imaging 1. To understand why implementation of training programs for hybrid
physicians is mandatory.
08:30 2. To become familiar with current differences in training programs
A-721 Chairman’s introduction when comparing European countries.
B. Marincek; Cleveland, OH/US 3. To recognise the need for a standardised European hybrid training
program.
Session Objective:
1. To briefly introduce the diagnostic challenge in patients presenting 09:05
cystic or solid pancreatic lesions. A-728 The beauty of physics in hybrid imaging
T. Beyer; Vienna/AT
08:35
A-722 A. Pancreatic cancer or pancreatitis Learning Objectives:
R. Manfredi; Verona/IT 1. To lay out the fundamentals of physics in hybrid imaging.
2. To illustrate physics and physicists as partners to hybrid imaging
Learning Objectives: users.
1. To learn about the inflammatory lesions, which can mimic a 3. To speculate on the future of hybrid imaging as supported through
pancreatic tumour. physics.
2. To become familiar with the imaging features, which can support the
differential diagnosis between pancreatic cancer and pancreatitis. 09:20
3. To understand the value of the integration of the imaging modalities A-729 Functional hybrid imaging: 1+1 = 3?
that define the correct diagnosis. O. Clément; Paris/FR
A-723 B. Cystic tumours vs pseudocysts 1. To learn about the functional capabilities of hybrid imaging
M.A. Bali; Brussels/BE techniques.
2. To understand that combined functional information results in
Learning Objectives: additional cross correlation and validation.
1. To become familiar with the imaging features of cystic tumours and
pseudocysts. 09:35
2. To become familiar with the clinical presentation and the radiological A-730 Practical challenges of hybrid imaging in clinical practice
signs that may be observed in cystic tumours and pseudocysts. O. Ratib; Geneva/CH
3. To understand the value of the integration of the imaging modalities
that define the correct diagnosis.
1. To review the current applications of hybrid imaging in well-
Sunday
09:21 established clinical pathways.

A-724 C. Incidental findings 2. To become familiar with the added values of hybrid imaging in
C. Stoupis; Männedorf/CH patient management.
3. To learn about opportunities beyond diagnostic applications.
1. To become familiar with the most common incidental findings in the 09:50 Discussion
pancreas with different imaging modalities.
2. To understand how to define the correct diagnosis.
3. To discuss how to manage incidental findings.
Panel discussion:
09:44 How do we manage difficult cases and incidental
findings?

08:30–10:00 Room O 08:30–10:00 Room N
Professional Challenges Session E3 - ECR Master Classes (Head and Neck)

PC 17 European variation in imaging: focus on E3 1726a Characterisation of salivary gland
technology masses
Moderator: A. Trojanowska; Lublin/PL
08:30
G. Frija; Paris/FR A-736 A. Ultrasound
Session Objectives: C. Karaman; Aydin/TR
1. To highlight the current European disparities in terms of eHealth; in Learning Objectives:
particular, teleradiology and equipment. 1. To recognise the signs of malignancy with B-mode and Doppler
2. To explore the opportunities, benefits and possible concerns arising mode.
from a harmonised European approach. 2. To become familiar with the technique and clinical applications of US
08:33 elastography and contrast-enhanced US for salivary gland tumours.
3. To be able to specify the role of fine US fine needle aspiration
A-732 PACS and eHealth cytology and US core needle biopsy.
D. Caramella; Pisa/IT
1. To understand the European perspective of interoperability issues A-737 B. CT, MRI and PET/CT
regarding radiology. N.J.M. Freling; Amsterdam/NL
2. To become familiar with the availability of departmental, enterprise- Learning Objectives:
wide and cross-enterprise communication of radiological studies and 1. To learn how to perform CT and MRI when a tumour of salivary
reports. glands is suspected.
08:48 2. To learn the morphological signs of malignancy at CT and MRI.
3. To know the role and limits of FDG PET in salivary gland tumours.
A-733 Reporting and communication
O. Ratib; Geneva/CH 09:30
Learning Objectives: A-738 C. MRI diffusion and perfusion
1. To understand the value of clinical radiology. S. Espinoza-Boireau; Paris/FR
2. To explore opportunities for improved reporting solutions, e.g. Learning Objectives:
structured reporting. 1. To become familiar with the principles of MRI diffusion and
3. To learn the requirements for communication of relevant or perfusion.
unexpected findings. 2. To understand how to integrate these techniques in the MRI protocol
09:03 in daily practice.
3. To learn the role of these techniques in mass characterisation.
A-734 Procedure codes and lexica in radiology for supporting
workflow improvements
P. Mildenberger; Mainz/DE 08:30–10:00 Studio 2016
1. To become familiar with available coding systems for procedures and Genitourinary
radiological findings.
2. To explore opportunities for a European approach. RC 1707 Prostate imaging: how I do it
09:18
08:30
A-735 Equipment and innovation
B. Brkljačić; Zagreb/HR A-739 Chairman’s introduction
H.-P. Schlemmer; Heidelberg/DE
Session Objectives:
1. To become familiar with the need for innovation of radiological
1. To learn the fundamentals of multiparametric MRI in prostate
equipment - opportunities and weaknesses for radiology departments
cancer.
throughout Europe.
2. To become familiar with the current options for image-guided biopsy.
2. To understand the dependency between radiation exposure and
3. To understand the clinical relevance of multiparametric MRI for
equipment renewal.
treatment decision-making during active surveillance and after initial
3. To understand the dependency between innovation, equipment
therapy.
renewal and quality of imaging practice and to discuss procurement
issues. 08:35
A-740 A. Detection and assessment of aggressiveness
Panel discussion: P. Puech; Lille/FR
09:33 What is the European vision on imaging technology?
1. To understand the different types of prostate cancer within the gland.
2. To become familiar with common pitfalls of prostate cancer
semiology at multiparametric MRI.
3. To understand the MRI “biomarkers” of prostate cancer
aggressiveness.
08:58
A-741 B. Image-guided biopsy and staging
J.J. Fütterer; Nijmegen/NL
1. To understand the techniques of prostate biopsy.
2. To become familiar with in-bore MR and MR/TRUS fusion guided
biopsy approaches.
3. To learn about the optimal imaging protocol for the staging of
prostate cancer.

09:21 09:35
A-742 C. Role of imaging in active surveillance and detection of A-747 Ionising radiation: when should we be concerned?
recurrence J. Damilakis; Iraklion/GR
V. Logager; Copenhagen/DK Learning Objectives:
Learning Objectives: 1. To describe the basic concepts of radiation risks to the developing
1. To learn about the role of multiparametric MRI in guiding therapy foetus at various gestational ages.
towards active surveillance. 2. To identify implementation strategies for dose reduction in
2. To learn about the imaging findings in local recurrence after emergency imaging of pregnant patients.
treatment. 3. To be familiar with medicolegal risk management guidelines.
3. To understand the impact in treatment planning as a consequence of
these findings. 09:50 Panel discussion with sample cases presentation:
Emergency in pregnancy: what is best for the mother
Panel discussion: and baby?
09:44 Multiparametric MRI: what are the challenges and
strategies to solve these?
08:30–10:00 Room E2
08:30–10:00 Room E1 Special Focus Session

State of the Art Symposium SF 17a Neuro imaging in paediatrics
SA 17 Emergency imaging of the pregnant 08:30
patient A-748 Chairman’s introduction
A. Rossi; Genoa/IT
A-743 Chairman’s introduction 1. To become familiar with the MRI features of complex
R. Basilico; Chieti/IT neuropaediatric disorders.
Session Objectives: 2. To learn how to organise specific MRI study protocols and sequences
1. To consolidate knowledge of the role and the appropriate uses of the for children with neurological disorders.
different imaging techniques. 3. To consolidate MRI as the modality of choice for paediatric
2. To become familiar with the risk of using imaging modalities in neuroimaging.
pregnant emergency patients. 08:35
3. To learn about radiation dose concerns related to emergency in
pregnancy. A-749 Imaging of metabolic disorders in children
A-744 Polytrauma: US, CT or MR 1. To learn about the concept of MRI pattern recognition in metabolic
A. Palkó; Szeged/HU disorders.
Learning Objectives: 2. To understand the value of MRI-based grouping of patients for
1. To discuss the imaging modalities used in the evaluation of pregnant genetic studies.
trauma patients. 3. To appreciate the contribution of MR techniques to the diagnosis and
2. To identify the imaging findings associated with non-pregnancy- research of metabolic disorders.
related and pregnancy-specific injuries. 4. To become familiar with more detailed MRI analysis and
3. To become familiar with a diagnostic imaging algorithm for the interpretation for metabolic disorders.
evaluation of polytrauma in pregnancy. 09:00
09:00 A-750 Imaging in paediatric epilepsy
T.A.G.M. Huisman; Baltimore, MD/US
A-745 Pulmonary embolism: CT or scintigraphy?
M.-P. Revel; Paris/FR Learning Objectives:
Learning Objectives: 1. To learn about the various pathologies that may result in paediatric
1. To review the role of CTA and pulmonary scintigraphy for the epilepsy.
diagnosis of pulmonary embolism during pregnancy. 2. To understand that a complete diagnostic workup requires a
2. To learn how to optimise CTA protocols and pulmonary scintigraphy multidisciplinary approach.
for adequately ruling out pulmonary embolism. 3. To become familiar with the MR imaging sequences that are
3. To review key imaging findings. indicated.
09:20 09:25
A-746 MRI and contrast media: what are the risks for the A-751 Imaging headache in children
E. Vázquez; Barcelona/ES
Sunday
foetus?
M. Wozniak; Lublin/PL Learning Objectives:
1. To learn about the role and value of neuroimaging in children with
Learning Objectives: the different types of headaches, mainly primary and secondary
1. To review the biological effects and safety of MRI. headaches.
2. To review procedural issues, indications and contraindications for 2. To become familiar with subtle symptoms or signs (“red flags”)
MRI in pregnant emergency patients. that raise suspicion of intracranial pathology worthy for prompt
3. To discuss the risks associated with the administration of iodinated neuroimaging.
and gadolinium-based contrast agents during pregnancy, and how to 3. To emphasise some underlying aetiologies, such as neoplasms or
monitor or avoid them. vascular disorders, that may be potentially life threatening.
Panel discussion:
09:50 Can we do without CT in paediatric neuroimaging?

08:30–10:00 Room F1 09:00

A-756 B. How can we manage the non-mass breast (enigma)
E3 - ECR Master Classes pattern?
(Oncologic Imaging)
E3 1726b Personalised medicine in oncology: 1. To learn the definition of non-mass in mammography and MRI and
to understand why interpretation is difficult.
what can imaging offer? 2. To understand the pathological correlations and the clinical
Moderator: R.G.H. Beets-Tan; Maastricht/NL problems.
3. To appraise how new technical developments can help define an
08:30 appropriate integrated strategy.
A-752 A. Personalised medicine in oncology: hope or reality? 09:30
E.E. Voest; Amsterdam/NL
A-757 C. New developments in breast MRI
Learning Objectives: L. Umutlu; Essen/DE
1. To become familiar with the concept of personalised medicine.
2. To learn about the current state-of-the-art management of metastatic Learning Objectives:
disease. 1. To know the principle of non-contrast breast MRI: texture analysis.
3. To learn how biomarkers can contribute to a personalised approach. 2. To understand advantages and limitations of DWI in breast MRI.
3. To become familiar with the main results of high field breast MRI,
08:55 including their advantages and limitations.
A-753 B. Radiogenomics: can this assist personalised medicine?
V.J. Goh; London/UK
Learning Objectives: 08:30–10:00 Room D1
1. To understand the rationale for radiogenomics in oncology.
2. To learn about the different strategies that can be used to extract data. Special Focus Session
3. To understand how radiogenomics may improve tumour
phenotyping. SF 17b Actionable pulmonary nodules: should
09:20 we rely on size only?
A-754 C. Hybrid PET/MRI: the next step in personalised cancer 08:30
care? A-758 Chairman’s introduction
A. Kjaer; Copenhagen/DK
L. Bonomo; Rome/IT
Learning Objectives: Session Objectives:
1. To learn how FDG and non-FDG PET tracers can allow us to 1. To learn about the intrinsic limitations of pulmonary nodule size by
visualise cancer cells. both 2D and 3D tools.
2. To learn about the potential of MRI/PET to improve tumour 2. To appreciate the need of integrating size with other morphological
phenotyping. characteristics as well as functional data and clinical parameters.
3. To learn how MRI/PET could contribute to a personalised approach
in oncology. 08:33
A-759 Limitations of nodule measurements
Panel discussion: A.R. Larici; Rome/IT
09:45 Can imaging facilitate a personalised medicine approach Learning Objectives:
in oncology? 1. To describe the limitations of 2D and 3D measurements of lung
nodules, including growth measurements during follow-up.
2. To investigate the role of computer-aided diagnosis (CAD) in
08:30–10:00 Room F2 defining an actionable nodule.
E3 - ECR Master Classes (Breast) 08:51
A-760 Shape and density: predictors of subtypes and mutations
E3 1726c Challenging questions for breast in NSCLC?
imaging in 2016: breast density, how O.L. Sedlaczek; Heidelberg/DE
to solve the non-mass enigma, new Learning Objectives:

1. To appreciate the relevance of morphological characteristics of
developments in breast MRI pulmonary nodules, i.e. shape and density, as predictors of subtypes
Moderator: R.M. Mann; Nijmegen/NL and mutations in NSCLC.
2. To learn how shape and density influence the management of
08:30 pulmonary nodules.
A-755 A. Breast density: what the breast radiologist needs to
09:09
know
S.J. Vinnicombe; Dundee/UK A-761 Proliferation tracers and not only
R. Boellaard; Amsterdam/NL
1. To learn the definition of dense breast and the consequences on Learning Objectives:
mammography interpretation and strategies to overcome the 1. To become familiar with tracers used in hybrid imaging, not only
limitations of the different modalities. well-known proliferation tracers but also all other tracers regarding
2. To understand the different methods to measure breast density on perfusion, hypoxia, and metabolism, helpful for characterising lung
mammography, ultrasound and MRI. nodules.
3. To understand if breast density or (breast enhancement) BPE have an 2. To have an in-depth understanding of the role of hybrid imaging in
influence on breast cancer risk. the evaluation of pulmonary nodules.

09:27 08:30–10:00 Room K

A-762 How necessary is clinical data?
A.A. Bankier; Boston, MA/US E3 - Rising Stars Programme
1. To investigate clinical data, whether it is significant or not in defining Basic Session 6: Thoracic emergencies
a nodule as actionable.
2. To describe the strategy for managing a solitary pulmonary nodule 08:30
by taking into account clinical data. A-768 Vascular
R. Morgan; London/UK
Panel discussion:
09:45 How to define an actionable nodule in daily practice? 09:00
A-769 Pulmonary
08:30–10:00 Room D2
09:30
Radiographers A-770 Cardiac
C. Loewe; Vienna/AT
RC 1714 The magic of excellent images
08:30 08:30–10:00 Room G
N. Mekis1, A.P. Parkar2; 1Ljubljana/SI, 2Bergen/NO E3 - ECR Master Classes (Neuro)
Session Objectives:
1. To understand the contribution of the radiographers in image quality E3 1726d Imaging in dementia
optimisation. Moderator: D. Van Westen; Lund/SE
2. To expand on the challenges and perspectives of image quality in
each field. 08:30
3. To discuss the importance of excellent images in patient care.
A-771 A. The neurochemistry of the Alzheimer’s continuum
08:35 S. Engelborghs; Antwerp/BE
A-765 A. Image quality optimisation in MRI: a radiographer’s Learning Objectives:

1. To introduce current concepts about the physicochemical and
perspective
M. Kiss; Miskolc/HU molecular basis of dementia.
2. To understand what misfolded proteins are, and how they play a role
Learning Objectives: in the pathogenesis of (different types of) dementia.
1. To understand the role of radiographers in MR image quality 3. To provide an insider view of current and future research avenues in
optimisation. dementia, and to illustrate the contribution of imaging studies.
2. To learn how to effectively and systematically modify scan
parameters to optimise MRI protocols. 09:00
3. To become aware of recent developments in MRI software and A-772 B. MR contribution to diagnosis and differential
hardware and how these can be used to further optimise image
diagnosis
quality in MRI. F. Barkhof; London/UK, Amsterdam/NL
A-766 B. Fine tuning of image quality in computed tomography, 1. To understand the concept of mild cognitive impairment (MCI).
2. To learn how to diagnose the different dementia forms using
the role of the radiographer
D. Pekarovic, U. Zdešar; Ljubljana/SI conventional MR.
3. To understand the role of advanced MR techniques in diagnosing
Learning Objectives: dementia.
1. To become familiar with the recent technological advances in CT and
how these can be exploited for image quality optimisation. 09:30
2. To become aware of the range of possibilities relating to image quality A-773 C. PET imaging in dementia
optimisation in CT. K. Herholz; Manchester/UK
3. To understand the role of the radiographer in optimising CT imaging
protocols.
1. To appreciate the different ligands relevant to the diagnosis of
09:21 dementia
2. To understand the sensitivity and specificity of the amyloid-tracer PIB.
A-767 C. X-ray radiography: tips and tricks for high quality
3. To appreciate the clinical relevance of PIB.
imaging on the frontline
E. Constantarogianni; Athens/GR
Sunday
1. To introduce the importance of image quality optimisation in x-ray
radiography.
2. To discuss the contribution of the radiographer in creating high
quality x-ray images.
3. To become aware of strategies for optimal use of hardware and
software to facilitate diagnosis.
Panel discussion:
09:44 The importance of excellent images for advancing the
quality of healthcare

10:30–12:00 Room A 10:35

A-780 The law of radiology in Colombia: how we arrived to it
E3 - ECR Master Classes (Musculoskeletal) R. Restrepo; Medellin/CO
E3 1826 MSK and intervention 1. To learn about government regulation of the practice of radiology in
Colombia.
10:30 2. To become familiar with the existing regulations for the practice of
A-774 Chairman’s introduction radiology in different countries.
A. Gangi; Strasbourg/FR 3. To understand the application of Act 657 of 2001, which regulates the
practice of radiology in Colombia.
10:36 4. To promote a comprehensive strategy for navigating the radiology-
A-775 A. How to biopsy soft tissue and bone tumours centred regulatory laws.
G.K.O. Åström; Uppsala/SE
10:55 Interlude: The history of radiology in Colombia
1. To learn which tumours are ‘no touch’. 11:00
2. To demonstrate how to plan a biopsy: when to culture and when to A-781 Percutaneous biopsies: how do I do it?
biopsy. F. Uriza; Bogota/CO
3. To discuss complications and how to deal with them.
10:57 1. To propose possible modifications to conventional biopsy techniques
A-776 B. Lower back pain: what can I do? tailored to certain cases where ideal conditions cannot be met.
D.J. Wilson; Oxford/UK 2. To present the local experience of a high complexity hospital in Latin
America.
Learning Objectives: 3. To determine when a multimodality imaging evaluation prior to
1. To learn which common pathologies account for lower back pain that biopsy is required.
we can treat. 4. To establish in which cases contrast administration is appropriate
2. To illustrate the common technique used in the specific pathologies. before a CT-guided biopsy is conducted.
11:18
11:20 Interlude: Colombia, magical realism
A-777 C. Injectables - steroids and platelet-rich plasma (PRP):
how and when? 11:25
M.J.C.M. Rutten; ‘s-Hertogenbosch/NL A-782 Minor interventional procedures in tropical diseases
Learning Objectives: A. Morillo; Bogota/CO
1. To learn about appropriate technique in MSK joint and tendon Learning Objectives:
intervention. 1. To learn about various manifestations of tropical diseases.
2. To learn about the complications. 2. To review cases of tropical diseases that can benefit from
3. To illustrate the evidence on the use of steroids and PRP. interventional procedures.
3. To become familiar with the role of interventional radiology in the
11:39 diagnosis and management of tropical diseases.
A-778 D. Painful solitary bone lesions: what is the most 4. To understand the indications of interventional procedures in specific
appropriate approach? manifestations of tropical diseases.
F. Arrigoni; L’Aquila/IT
1. To learn which painful bone lesions can be treated. 11:45 Minimally-invasive procedures: is there a place for the
2. To learn how to plan the treatment and how to choose the most non-interventionalradiologists?
appropriate technique.
3. To illustrate complications and diagnostic follow-up.
10:30–12:00 Room O
10:30–12:00 Room B Professional Challenges Session

ESR meets Colombia PC 18 Monitoring safety and quality
EM 3 From practice to reality: how we do it 10:30

Welcome by the ESR President: A-783/A-784 Chairmen’s introduction
L. Donoso; Barcelona/ES G. Frija1, A. Torresin2; 1Paris/FR, 2Milan/IT
Presiding: Session Objectives:
K. Riklund; Umea/SE 1. To introduce experiences of safety and quality management.
F.G. Lubinus; Bucaramanga/CO 2. To focus on the specific aspects of dose management.
3. To highlight the need of a strong IT support.
10:30
10:35
A-779 Introduction
F.G. Lubinus; Bucaramanga/CO A-785 Experience of total management of quality and safety
L. Oleaga Zufiría; Barcelona/ES
Session Objectives:
1. To have a glance at our country’s peculiarities; not only the cultural Learning Objectives:
aspects, but also its laws and management of diseases. 1. To introduce the concept of overall quality and safety in a radiology
2. To explore new ways of finding solutions to possible problems department.
presented in our profession. 2. To define the distinct aspects of quality and safety to be monitored.
3. To indicate several tools that can be used or implemented for quality
control.

10:55 11:31
A-786 Dose monitoring systems in CT A-792 C. Paediatric abdominal imaging
D. Caramella; Pisa/IT S.G.F. Robben; Maastricht/NL
1. To highlight the importance of systematic dose monitoring in CT. 1. To understand the imaging features of congenital disorders of the
2. To demonstrate that dose monitoring may reduce clinically abdomen.
unjustified variations. 2. To describe the diagnostic evaluation and imaging presentation of
3. To propose a paradigm shift from risk communication to safety appendicitis in children.
assurance. 3. To describe the diagnostic evaluation and imaging presentation of
volvulus and intussusception in children.
11:15 4. To understand the imaging presentation of the most common
A-787 Experience from a group of imaging centres oncologic disorders of the abdomen in children.
1. To explain how quality and safety management principles may be 12:30–13:30 Room B
realised in the everyday practice of radiology service providers.
2. To discuss the significance of standardising various aspects of quality E3 - The Beauty of Basic Knowledge:
and safety in workflow management, image and report quality and
patient comfort. Breast Imaging
3. To emphasise the importance of uniform attitude and networking in
a multi-centre service-providing system. E3 24E High-risk lesions: solving the dilemma
11:30
A-788 Dose monitoring systems in interventional radiology 12:30
A. England; Salford/UK
A-793 High-risk lesions: solving the dilemma
Learning Objectives: A. Linda; Udine/IT
1. To introduce the concept of dose monitoring systems within
interventional radiology.
1. To learn about the most common high risk lesions and their
2. To focus on the different dose monitoring solutions available within
respective breast cancer risks.
clinical practice.
2. To know how to manage these lesions in a multimodal way.
3. To highlight the benefit of real-time dose monitoring for patients and
3. To understand how to deal with these lesions in terms of intervention
staff.
and follow-up.
Panel discussion:
11:45 What are the bottlenecks in safety and quality 12:30–13:30 Room D1
management?
E3 - The Beauty of Basic Knowledge:
10:30–12:00 Room F1 Chest Imaging
E3 - European Diploma Prep Sessions E3 25E Dose optimisation made easy in
E3 1823 Paediatric computed tomography of the chest
Moderator: N. Howarth; Chêne-Bougeries/CH
10:30
12:30
V. Donoghue; Dublin/IE A-794 A. Dose descriptors
D. Tack; Baudour/BE
Session Objectives:
1. To understand the imaging features of the most common congenital Learning Objectives:
and neoplastic disorders of the brain in children and adolescents. 1. To review the frequently used terms in qualifying CT dose.
2. To describe the imaging presentations of the most common disorders 2. To learn how to explain dose description to your patients.
of the lung and mediastinum in the paediatric age group. 3. To know the lack of appropriateness of the terms used.
3. To be familiar with the imaging features of important acute disorders 13:00
of the abdomen in children and adolescents.
A-795 B. CT angiography and CT of lung disease
10:33 X. Montet; Geneva/CH
A-790 A. Paediatric neuro imaging Learning Objectives:
M.I. Argyropoulou; Ioannina/GR 1. To review practical methods of dose reduction in CT angiography
Learning Objectives: and CT of lung disease.
Sunday
1. To describe the normal development of the brain. 2. To learn how to apply these methods in everyday practice.
2. To explain the most common congenital disorders of the brain. 3. To know that these practical methods are independent of the CT
3. To understand the most common brain tumours in children and scanner.
adolescents.
11:02
A-791 B. Paediatric chest imaging
C. Owens; London/UK
1. To describe the normal development of the lung and mediastinum.
2. To explain imaging features of congenital disorders of the lung and
mediastinum.
3. To understand the imaging manifestations of respiratory distress and
bronchopulmonary dysplasia in infants.
4. To describe the most common tumours of the chest in children.

14:00–15:30 Room F1
E3 - European Diploma Prep Sessions

E3 1923 Urogenital
14:00
D. Akata; Ankara/TR
Session Objectives:
1. To become familiar with the imaging presentation of common
neoplastic and infectious disorders of the kidneys.
2. To describe the typical imaging features of calculous and neoplastic
disorders of the ureter and bladder.
3. To understand the imaging presentation of benign and malignant
disorders of the prostate.
14:03
A-804 A. Renal and adrenal imaging
1. To describe the normal imaging anatomy and variants of the kidney
and adrenal.
2. To understand the imaging features of benign and malignant
tumours of the kidneys.
3. To describe imaging features of benign and malignant tumours of the
adrenal glands.
4. To explain the imaging features of infectious disorders of the kidneys.
14:32
A-805 B. Imaging of the ureter and bladder
J.-M. Correas, R. Renard Pena, O. Hélénon; Paris/FR
1. To explain the imaging anatomy and variants of the ureter and
bladder.
2. To understand the diagnostic evaluation and imaging features of
calculi of the ureter and bladder.
3. To describe the imaging features of benign and malignant tumours of
the ureter and bladder.
15:01
A-806 C. Prostate imaging
1. To explain the PIRADS system in prostate imaging.
2. To describe the imaging features of benign prostatic hypertrophy.
3. To understand the imaging features of prostate cancer.
4. To describe the imaging features of inflammatory changes of the
prostate.

SCIENTIFIC
SESSIONS AND
CLINICAL TRIALS
I N R A D I O LO GY
Session numbers are prefixed by SS

Presentation numbers are prefixed by the letter B
The Clinical Trials in Radiology sessions are listed at the end of this section. (page 339)
There are 53 Invest in the Youth

scientific paper presenters at ECR 2016.
You can find their sessions marked with
SPEAKER
SUPPORTED
BY
INVEST IN
THE YOUTH
on the following pages.
259
Scientific Sessions
10:30–12:00 Room B 11:50

B-0011 CT differentiation of gallbladder neuroendocrine
Abdominal Viscera tumours from adenocarcinomas
T. Kim, S. Kim, K. Lee, J. Han; Seoul/KR
SS 201a Pancreas and bile ducts
Moderators: B. Choi; Seoul/KR, G. Zamboni; Verona/IT
10:30–12:00 Room C
10:30
B-0001 Distribution and correlation of pancreatic gland Breast
and duct dimensions on MRCP in patients without
evidence of chronic pancreatitis SS 202 Breast biopsy
F. Akisik, Q. Wang, G. Jennings, T. Tirkes, K. Sandrasegaran; Moderators: S. Allen; Sutton/UK, N.N.
Indianapolis, IN/US
10:30
10:38
B-0012 True false negative rate of benign histology after
B-0002 Use of grape molasses “Pekmez” as a negative SPEAKER
SUPPORTED stereotactic vacuum-assisted biopsy for BI-RADS IV
oral contrast agent for magnetic resonance BY
INVEST IN calcifications in the breast
cholangiopancreatography THE YOUTH F.E.M. Dams, P.J. Westenend, H.S. Roodenburg-Kooij,
B. Degirmenci, M. Kara, H. Demirtas, A. Umul, O. Yılmaz, A. Senol, M.C. Rozendaal, M.C.J.M. Kock; Dordrecht/NL
M. Kayan; Isparta/TR
10:38
10:46
B-0013 A comprehensive analysis of factors contributing to
B-0003 MRCP pancreatic dimensions as predictors of chronic SPEAKER
SUPPORTED marker migration during stereotactic core needle
pancreatitis severity BY
F. Akisik, Q. Wang, G. Jennings, T. Tirkes, K. Sandrasegaran; INVEST IN breast biopsies
THE YOUTH M. Khalid, A. Jain, M.M. Qureshi, K. Buch, A. Hirsch, M.W. Grinstaff,
Indianapolis, IN/US
J.A. Kaplan, B.N. Bloch; Boston, MA/US
10:54
10:46
B-0004 Type 1 and type 2 autoimmune pancreatitis:
SPEAKER B-0014 Vacuum-assisted breast biopsy guided by dedicated
SUPPORTED is there any difference in MRI?
BY R. Negrelli, G. Avesani, E. Boninsegna, L. Frulloni, R. Manfredi,
breast CT: first clinical experiences compared with
INVEST IN
THE YOUTH R. Pozzi Mucelli; Verona/IT conventional stereotactic breast biopsy
S. Wienbeck, E. von Fintel, J. Lotz, U. Fischer; Göttingen/DE
11:02
10:54
B-0005 MRI-MRCP findings in focal and diffuse autoimmune
pancreatitis and comparison of focal type of the head B-0015 Management strategies for benign papillomas
and of the body-tail without atypia diagnosed at percutaneous imaging
G. Avesani, R. Negrelli, E. Boninsegna, L. Frulloni, R. Manfredi, guided breast core biopsy in recently published
R. Pozzi Mucelli; Verona/IT reports
S. Moon, H. Jung, K. Ko, S. Kim; Seongnam-si/KR
11:10
B-0006 Pancreatic cysts as incidental finding in population- 11:02
based imaging: clinical relevance B-0016 Effects on short-term quality of life of vacuum
M.-L. Kromrey, J.-P. Kühn, R. Bülow, J. Hübner, N. Hosten; assissted breast biopsy: comparison between digital
Greiswald/DE
breast tomosynthesis and digital mammography
L. Gristina, F. Valdora, L. Cevasco, B. Bignotti, S. Tosto, F. Monetti,
11:18 F. Rossi, A. Tagliafico, M. Calabrese; Genoa/IT
B-0007 Multimodal MRI of the liver for detecting of acute
inflammation in patients with primary sclerotic 11:10
cholangitis B-0017 Non-surgical complete excision of small suspicious
J. Yamamura, S. Keller, H. Kooijman, F. Kording, C. Schramm, breast lesions using the breast lesion excision biopsy
T. Schuler, G. Adam; Hamburg/DE
system (BLES)
N.M. Abdel Razek; Giza/EG
11:26
B-0008 MR cholangiography screening in longstanding 11:18
IBD: prevalence of bile duct pathology indicative of B-0018 Correlation of UK 5-point breast imaging
sclerosing cholangitis in a population based cohort classification and BI-RADS classification of
1 2 1 2 3
A.K. Lunder , J.R. Hov , A. Borthne , E. Viktil , G. Johannesen ,
K. Tveit4, J. Gleditsch5, M. Vatn1, A. Negård1; 1Lørenskog/NO, calcification with final histology. Which is a better
2
Oslo/NO, 3Skien/NO, 4Kristiansand/NO, 5Fredrikstad/NO predictor of malignancy?
L. Metaxa1, T. Suaris1, K. Hunter2, P. Dilks1, S. Dani1, S. O’Keeffe1;
1
11:34 London/UK, 2Dublin/IE
B-0009 Extra-hepatic portal vein obstruction (EHPVO) with
11:26
cholangiopathy: imaging based criteria on the basis
B-0019 MR-only lesions: yield of biopsy
of CT and MRCP findings for disease classification M. Boada, J. Vilanova, J. Barcelo, M. Villalón; Girona/ES
and management
S. Thapar, S. Desai, A.S. Bhadoria, S. Pargewar, S. Rajesh, A. Mukund, 11:34
K. Bansal, B. Surekha, S.K. Sarin; New Delhi/IN
B-0020 Ultrasound-guided core-needle breast biopsy:
11:42 comparison of small-sized needles (16G/18G) versus
B-0010 Added value of point shear-wave elastography in the 14G needle diagnostic accuracy
R. Rella, M. Giuliani, F. Patrolecco, S.E. Di Giovanni, G. Carlino,
diagnosis of acute cholecystitis M. Romani, P. Rinaldi, P. Belli, L. Bonomo; Rome/IT
J.E. Kim, D.S. Choi, K. Bae, C.Y. Jeong, H.O. Kim; Jinju/KR

11:42 11:26
B-0021 Vacuum-assisted complete excision of solid B-0030 Accuracy of diffusion-weighted MR for distinguishing
intraductal/intracystic masses and complex cysts: benign conditions from tumours of the anterior
is follow-up necessary? mediastinum: comparison of perfusion sensitive vs.
V. Quinn-Laurin, J.-C. Hogue, S. Pinault, N. Duchesne; Quebec, perfusion free ADC measurements
QC/CA A. Priola, S. Priola, D. Gned, A. Veltri; Orbassano/IT
11:50 11:34
B-0022 Quantitative 3D breast ultrasound analysis may B-0031 Added value of apparent diffusion coefficient in
reduce the number of biopsies for benign breast the preoperative MRI staging of gastric cancer:
lesions comparison with postoperative histology
A.S.S. Meel-van den Abeelen, G. Weijers, J.C.M. van Zelst, F. Giganti, A. Ambrosi, D. Chiari, A. Esposito, C. Staudacher,
J.M. Thijssen, R.M. Mann, C.L. de Korte; Nijmegen/NL A. Del Maschio, F. De Cobelli; Milan/IT
Wednesday
11:42
10:30–12:00 Room Z B-0032 Gd-EOB-DTPA-enhanced magnetic resonance
imaging combined with T1 mapping predicts the
Molecular Imaging degree of differentiation in hepatocellular carcinoma
Z.M.H.S. Peng; Guangzhou/CN
SS 206 PET/CT and MR in oncology
Moderators: S. Chatziioannou; Athens/GR, N.N. 11:50
B-0033 Investigation of a novel small field of view hybrid
10:30
compact gamma camera (HCGC) for scintigraphic
B-0023 Benefit assessment of 18F-FDG-PET/CT in patients
imaging
with advanced melanoma based on the analysis M.S. Alqahtani1, J.E. Lees1, S.L. Bugby1, L.K. Jambi1, B. Bhatia1,
of clinical management changes using the “linked N. Dawood1, W. McKnight1, A.H. Ng2, A.C. Perkins2; 1Leicester/UK,
2
Nottingham/UK
evidence approach”
S.-C. Schüle, P. Martus, A. Forschner, K. Nikolaou, C. la Fougère,
B. Gückel, C. Pfannenberg; Tübingen/DE
10:30–12:00 Room O
10:38
B-0024 Tumour heterogeneity measurement using [18F] FDG GI Tract
PET/CT in patients with lung cancer
N.M. Hughes, P. Murphy, T. Mou, E. Wolsztynski, J. Huang, SS 201b A guided tour through the GI tract
F. O’Sullivan, K.N. O’Regan; Cork/IE Moderators: K. Skrobisz-Balandowska; Gdansk/PL,
B.E. Van Beers; Clichy/FR
10:46
B-0025 FDG SUVmax and metabolic tumour burden are 10:30
associated with major chemotherapy-related tumour B-0035 MR enterography in Celiac disease: correlation with
markers in NSCLC patients endoscopic, histopathologic, serologic and genetic
L. Bai, Y. Guo, X. Duan; Xi’an/CN features
A. Radmard, A. Hashemi Taheri, E. Salehian Nik, S. Kolahdoozan,
10:54 B. Mirminachi, G. Ekhlasi, M. Sotoudeh, R. Malekzadeh,
B-0026 Morphological distribution and metabolic activity of B. Shahbazkhani; Tehran/IR
brown adipose tissue in adult humans

A.S. Becker, H.W. Nagel, C. Wolfrum, I.A. Burger; Zurich/CH
10:38
B-0036 Initial experiences with ultra low-dose CT scanning in
11:02 body packers
B-0027 Evaluation of 68Ga-PSMA-PET/CT in primary staging J.P.D. Noordmans, R.W.F. Geenen, A.M. Wagenvoort, W. Kool,
P.R. Algra; Alkmaar/NL
of prostate cancer patients
C. Uprimny, A. Kroiss, L. Geraldo Roig, C. Decristoforo, D. Kendler,
E. von Guggenberg, I.J. Virgolini; Innsbruck/AT
10:46
B-0037 CT characteristics and clinical relevance of the
11:10 small-bowel faeces sign in patients with small-bowel
B-0028 Optimisation of iterative image reconstruction for obstruction: are there different faeces signs?
high-definition digital PET/CT W. Khaled1, L. Corno1, A.-M. Chuong1, M. Benadjaoud2,
K. Binzel, J. Zhang, T. Saif, A. Siva, C. Lehn, M.V. Knopp; Columbus, I. Boulay-Coletta1, M. Zins1; 1Paris/FR, 2Villejuif/FR
OH/US
10:54
11:18 B-0038 Meckel’s diverticulum revisited: MDCT by tracing
B-0029 Phase Ia trial comparing digital photon counting distal ileal artery of superior mesenteric artery for
detector PET/CT with current photomultiplier identifying origin of Meckel’s diverticulum
PET technology for Yttrium-90 imaging after Y. Ra, Y. Ku, S. Lee; Gyeonggi-do/KR
radioembolisation
C.L. Wright1, K. Binzel1, J. Zhang1, E. Wuthrick1, P. Maniawski2,
11:02
M.V. Knopp1; 1Columbus, OH/US, 2Cleveland, OH/US B-0039 Imaging of gastrointestinal melanoma metastases:
correlation with surgical and pathological findings
A.E. Othman, T. Eigentler, G. Bier, C. Kloth, C. Pfannenberg,
H. Bösmüller, C. Thiel, K. Nikolaou, B. Klumpp; Tübingen/DE

11:10 11:02
B-0040 Gastrointestinal involvement from renal cell B-0049 Prediction of the estimated 5 year risk of sudden
carcinoma: CT findings and clinicoradiologic features cardiac death (SCD) by quantitative CMR sequences
H. Park, H. Kim, S. Park, J. Lee, A. Kim, H. Ha; Seoul/KR in patients with hypertrophic cardiomyopathy (HCM)
M. Avanesov, J. Münch, J. Weinrich, L. Well, D. Säring, C. Stehning,
11:18 E. Tahir, G. Adam, G. Lund; Hamburg/DE
B-0041 Midgut neuroendocrine tumours: is there a link
between mesenteric fibrosis and carcinoid heart 11:10
disease? B-0050 Delayed myocardial enhancement in paediatric
V. Rodriguez Laval, M. Pavel, I. Steffen, B. Wiedenmann, T. Denecke; hypertrophic cardiomyopathy: correlation with LV
Berlin/DE functional and demographic parameters
N.H. Behairy, W. EL Mozy, S. El Saeidi, M. Shafik; Cairo/EG
11:26
B-0042 Imaging in dengue: what every radiologist needs to 11:18
know B-0051 Quantitative T1 mapping for detecting fibrosis and
K. Shirodkar, H. Mohanty, M. Bind, V. Mulla, S. Nandikoor, S. Reddy, myocardial interstitial expansion in hypertrophic
S. H.N, G. Mallarajapatna; Bangalore/IN
cardiomyopathy
D. An, L. Wu, B. Chen, R. Ouyang, J. Xu; Shanghai/CN
11:34
B-0043 Complex morbidity - perianal fistulae and 11:26
involvement of external genitalia: MR imaging B-0052 Native myocardial T1-times are not necessarily
findings and significance of fistulogram increased with myocardial collagen: a preclinical
S. Devu, U. Matapathi, P. Pantrangam, K. Marathu, R. Sunnadkal;
Hyderabad/IN study in hypertensive hypertrophic heart disease
U. Reiter1, G. Reiter1, G. Adelsmayr1, M. Manninger1, J. Schipke2,
A. Greiser3, C. Mühlfeld2, H. Post4, M. Fuchsjäger1; 1Graz/AT,
11:42 2
Hannover/DE, 3Erlangen/DE, 4Berlin/DE
B-0044 Image quality and diagnostic acceptability of a novel
80 kVp CT low dose protocol with automated tube 11:34
current modulation in screening of body packing B-0053 Increased epicardial fat and signs of impaired sistolic
J. Aissa, J. Boos, C. Rubbert, J. Caspers, C. Thomas, P. Kröpil, left ventricular function in NAFLD patients: MRI
G. Antoch, F. Miese; Düsseldorf/DE
evaluation and correlation with abdominal and liver
fat
C. Berzovini, R. Faletti, G. Battisti, E. Vanni, C. Gallesio, E. Mosso,
10:30–12:00 Room N E. Bugianesi, M. Rizzetto, G. Gandini; Turin/IT
Cardiac 11:42
B-0054 Compared analysis of two different software for iron
SS 203a Cardiomyopathies (1) overload quantification in cardiac MRI
Moderators: F. Bamberg; Tübingen/DE, R. Dore; Pavia/IT R. Malago, G. Sala, M. Tezza, C. Barbiani, G. Finetto, G. Tabacco,
S. Catelan, R. Pozzi Mucelli; Verona/IT
10:30
B-0045 LGE cardiac imaging on a 3-T scanner: retrospective 11:50
comparison of breath-holding two-dimensional (2D) B-0055 Radiation-induced myocardial injury after mediastinal
phase-sensitive inversion recovery (PSIR) and breath- radiotherapy for esophageal cancer
N. Kadoya, H. Ota, R. Umezawa, Y. Nakajima, M. Saito, K. Takase,
holding 2D IR sequences K. Jingu; Sendai/JP
V. Vellucci, A. Mancini, A. Di Sibio, F. Bruno, L. Panebianco, M. Paoli,
R. Masi, E. Di Cesare, C. Masciocchi; L’Aquila/IT
10:38 10:30–12:00 Room L8

B-0046 Sphericity index (SI) of the left ventricle assessed by
cardiovascular magnetic resonance imaging (CMRI)
Vascular
in non-ischemic dilated cardiomyopathies
A. Zidi, N. Mnif; Tunis/TN SS 215 Vasculopathy: form and function
Moderators: M. Reiter; Vienna/AT,
10:46 A. Van der Lugt; Rotterdam/NL
B-0047 Diagnostic implications of feature tracking derived

SPEAKER 10:30
SUPPORTED left and right atrial strain parameters in CMR-positive 18
BY B-0056 F-fluorocholine PET-CT imaging of vulnerable
INVEST IN acute myocarditis
THE YOUTH B. Baessler1, A. Dick1, F. Schaarschmidt2, G. Michels1, D. Maintz1, atherosclerotic plaques: prospective study with
A.C. Bunck1; 1Cologne/DE, 2Hannover/DE immunohistochemical validation
S.A. Vöö1, R. Kwee1, J. Sluimer1, F. Schreuder1, R. Wierts1,
10:54 R. van Oostenbrugge1, M.J. Daemen2, F.M. Mottaghy1, M. Kooi1;
1
Maastricht/NL, 2Amsterdam/NL
B-0048 Validation of a novel analytical approach to
SPEAKER
SUPPORTED quantitative myocardial edema imaging in acute 10:38
BY
INVEST IN myocarditis using T2-mapping B-0057 Assessment of endothelial dynfunction, coronary and
THE YOUTH B. Baessler1, F. Schaarschmidt2, A. Dick1, M. Treutlein1,
B. Schnackenburg3, C. Stehning3, G. Michels1, D. Maintz1, A.C. Bunck1; carotid atherosclerosis in juvenile diabetics
1
Cologne/DE, 2Hannover/DE, 3Hamburg/DE M.A.A.A. Salem; Aguza - Giza/EG

10:46 10:30–12:00 Room E1

B-0058 3D black-blood T1-mVISTA for detection of temporal
and ophthalmic artery involvement in patients with Musculoskeletal
giant cell arteritis
N.N. Sommer1, K.M. Treitl1, E. Coppenrath1, H. Kooijman2, SS 210 Trauma and inflammation
W.H. Sommer1, M.F. Reiser1, T. Saam1; 1Munich/DE, 2Hamburg/DE Moderators: R. Hemke; Amsterdam/NL,
I.-M. Noebauer-Huhmann; Vienna/AT
10:54
B-0059 Comparative study of neovascularisation in 10:30
homogeneous and heterogeneous with juxtaluminal K-03 Keynote lecture
B. Vande Berg; Brussels/BE
black area hypoechoic carotid plaques by SMI and
CEUS 10:39
Q. Yong, L. Zhang, L. Feng, J. Yuan, S. Shi, J. Bao, T. Pu; Beijing/CN
Wednesday
B-0067 Identification of specific CT features for the
11:02 diagnosis of CPPD arthropathy of the wrist
K. Ziegeler, T. Diekhoff, S. Hermann, A. Böttner, B. Hamm,
B-0060 The relation between cardiovascular risk factors and K.-G. Hermann; Berlin/DE
aortic wall characteristics in healthy, young adults
using 3D black-blood VISTA magnetic resonance 10:47
vessel wall imaging B-0068 Evaluation of inflammatory activity in psoriatic
A.L.M. Eikendal1, H.M. den Ruijter1, C. Haaring1, J.J.M. Westenberg2, arthritis of the hand with integrated 18F-PET/MRI
R.J. van der Geest2, M.L. Bots1, I.E. Hoefer1, T. Leiner1; 1Utrecht/NL, N. Guberina, A. Körber, M. Forsting, A. Bockisch, A. Sabet, T. Pöppel;
2
Leiden/NL Essen/DE
11:10 10:55
B-0061 Common genetic influence on the carotid and B-0069 Diagnostic value of MRI changes within the sacroiliac
femoral intima-media thickening: new potential in joint space in spondyloarthritis
screening? F. Laloo1, N. Herregods1, G. Varkas1, J. Jaremko2, X. Baraliakos3,
D.L. Tarnoki1, A.D. Tarnoki1, B. Fejer1, L. Littvay1, P. Maurovich Horvat1, D. Elewaut1, F. Van den Bosch1, K. Verstraete1, L. Jans1; 1Gent/BE,
2
P. Lucatelli2, C. Baracchini3, G. Schillaci4, M.A. Stazi2; 1Budapest/HU, Edmonton, AB/CA, 3Herne/DE
2
Rome/IT, 3Padua/IT, 4Terni/IT
11:03
11:18 B-0070 Does a multiplanar precontrast approach improve
B-0062 Morphology of atherosclerotic plaques in carotid our diagnostic confidence for bone marrow edema
arteries determined by computed tomography and detection and localisation in the sacroiliac joint of
10-year cardio-vascular risk assessment (risk SCORE) patients with spondyloarthritis?
in patients with hypertension C. Giraudo, M. Weber, A. Puchner, J. Grisar, F. Kainberger,
P. Gac, P. Jazwiec, M. Poreba, G. Mazur, R. Poreba; Wroclaw/PL C. Schueller-Weidekamm; Vienna/AT
11:26 11:11
B-0063 Sonographic assessment of brachial artery B-0071 Sacroiliac radiographic progression after a 2 years
reactive hyperemia in patients with diabetes and follow-up period in recent onset spondyloarthritis:
polymorphism in the gene of nitric oxide endothelial data from the DESIR cohort
M. Dougados, C. Demattei, R. van den Berg, F. Thevenin,
synthase using time interval method M. Reijnierse, D. Loeuille, A. Feydy, P. Claudepierre, D. van der Heijde;
N. Nelassov, M. Morgunov, I. Hripun, V. Dombrovsky, S. Vorobiev,
Paris/FR
O. Eroshenko, T. Karkoshka; Rostov-on-Don/RU
11:19
11:34
B-0072 Value of Dixon based MRI for the evaluation
B-0064 Genetic variability in the renin-angiotensin-
of inflammatory activity on sacroiliac joint -
aldosterone system and volume of carotid bodies
comparative with variety of fat suppression and
evaluated by carotid artery computed tomography
water-fat separation methods
angiography in hypertensive patients B. Alvarez de Sierra Garcia1, J. Calatayud2, D. Exposito2; 1Madrid/ES,
P. Jazwiec, P. Gac, M. Chaszczewska-Markowska, K. Bogunia-Kubik, 2
Mostoles/ES
G. Mazur, R. Poreba; Wroclaw/PL
11:27
11:42
B-0073 Medial collateral ligament avulsion fracture of the
B-0065 Is class III obesity increase cardiovascular risk?
M. Baykara, F.M. Yazar, N. Yurttutan, B. Kızıldağ, M.A. Sarıca; knee: classification and imaging features
Kahramanmaraş/TR H.-S. Koo, W. Jin, S. Park, J. Kim, J. Park, K. Ryu; Seoul/KR
11:50 11:35
B-0066 Ultrasonographic evaluation of CCA and FA IMT B-0074 Comparison of ssEPI-DWI derived ADC maps with
and compliance after atorvastatin treatment in standard FS PD-TSE sequences for detection of
premenopausal dyslipidaemic females traumatic bone marrow lesions (BML) after knee
N. Yurttutan1, M. Baykara1, O. Gundogdu Secen2, B. Kizildag1, trauma
M.A. Sarica1; 1Kahramanmaras/TR, 2Elazig/TR A. Klengel1, S. Klengel2, I. Boettger2, N. Roenisch2, T. Kahn1,
P. Stumpp1; 1Leipzig/DE, 2Riesa/DE

11:43 11:34
B-0075 A systematic review of studies assessing the B-0085 Comparison of the diagnostic success of MR imaging,
anatomic centres of the femoral and tibial footprints FDG- PET imaging and FDG-PET/MR fusion images in
of the anterior cruciate ligament the imaging of pharmacoresistant epilepsy
A.P. Parkar1, M.E.A.P. Adriaensen2, S. Vindfeld1, E. Solheim1; C. Eraslan, M. Calli, A. Oral, O. Kitis, S. Yilmaz; Izmir/TR
1
Bergen/NO, 2Heerlen/NL
11:42
11:51 B-0086 Hippocampal malrotation in benign temporal lobe
B-0076 Visualisation of the popliteomeniscal fascicles in epilepsy: a volumetric study
the posterolateral corner of the knee with 3D-MRI: a K. Rahmat, C.-Y. Lau, K.-S. Lim, N. Ramli; Kuala Lumpur/MY
feasibility study
A.L. Falkowski1, R.W. Huegli2, J.A. Jacobson3, M.T. Hirschmann2, 11:50
O. Magerkurth4; 1Basle/CH, 2Bruderholz/CH, 3Ann Arbor, MI/US, B-0087 Epilepsy cases: fMRI and MR tractography as
4
Baden/CH
qualitative and quantitative tools for proper
localisation and pre-operative planning
M.K. Metkees1, A.M. Sarry El Din1, Y. Abbas2, E. Geneidi2, A. Gaber2,
10:30–12:00 Room E2 W. Reda2; 1Giza/EG, 2Cairo/EG
Neuro
10:30–12:00 Room F1
SS 211a Paediatric and epilepsy
Moderators: N. Bargalló; Barcelona/ES, I. Koerte; Munich/DE Oncologic Imaging
10:30 SS 216a Hepatocellular cancer: characterisation,
B-0077 Connectivity-based parcellation of the developing
response and recurrence
foetal thalamus: topological changes during Moderators: M.A. Bali; Brussels/BE, A. Fohlen; Caen/FR
gestation
A. Jakab, G. Kasprian, G.M. Gruber, D. Prayer, G. Langs; Vienna/AT 10:30
10:38 B-0088 Comparison of HCC tumour size measured in MRI and
histopathology: does the sequence matter?
B-0078 Accuracy in antenatal ultrasound in diagnosis of
M. Armbruster, D. Nörenberg, K. Hoffmann, J. Andrassy, H. Kramer;
posterior fossa lesions with postnatal MRI correlation Munich/DE
S. Bhatnagar1, D. Shah2; 1Delhi/IN, 2Mumbai/IN
10:38
10:46
B-0089 The correlation between the minimum and average
B-0079 Graph theory analysis of single-subject grey matter ADC values of hepatocellular carcinoma and
structure may be beneficial in the diagnostic work-up pathological grade
of malformations of cortical development X. Li, K. Zhang, Z. Ye; Tianjin/CN
L.R. Kozák, G. Gyebnár, Z. Klimaj, G. Rudas, P. Barsi; Budapest/HU
10:46
10:54
B-0090 Hepatocellular carcinoma: preoperative gadoxetic
B-0080 Data-driven identification of white matter acid-enhanced MRI to predict early recurrence,
(WM) changes can help finding hard-to-identify microscopic vessel invasion and tumor grade using
malformations of cortical development (MCDs) image features and texture analysis
G. Gyebnar, Z. Klimaj, G. Rudas, P. Barsi, L.R. Kozak; Budapest/HU
S. Ahn1, J. Kim1, S. Kim1, J. Han1, Y. Jang2; 1Seoul/KR, 2Incheon/KR
11:02 10:54
B-0081 Quantitative approach to the posterior cranial fossa B-0091 The role of diffusion weighted MR imaging in
and cranio-cervical junction in asymptomatic children follow-up of response of loco regional interventional
with achondroplasia
M. Panfili, R. Calandrelli, G. D’Apolito, G. Di Lella, C. Colosimo;
therapy of hepatocelleular carcinoma
H.M.K. Imam, H.M.A.H. Seif, G.S. Seifeldein, W.M. Abbas; Assuit/EG
Rome/IT
11:02
11:10
B-0092 The role of perfusion-CT as an early predictor of
B-0082 Structural brain alterations of Down syndrome in
survival in patients with advanced hepatocellular
early childhood evaluation by DTI and volumetric
carcinoma treated with Sorafenib
analyses G. Querques, D. Ippolito, C. Talei Franzesi, P. Bonaffini, A. Nasatti,
H. Günbey1, M. Ceyhan Bilgici1, K. Aslan1, A. Has2, M. Ogur1, A. Alhan2,
S. Sironi; Monza/IT
L. Incesu1; 1Samsun/TR, 2Ankara/TR
11:10
11:18
B-0093 Diagnostic accuracy of dual-energy CT with
B-0083 The role of combined structural MR imaging and
spectral imaging compared to single-energy CT in
spect in refractory epilepsy
H. Taha, K. Rahmat, K.-S. Lim, F. Fadzli, N. Ramli; Kuala Lumpur/MY hepatocellular carcinoma: radiologic-pathologic
correlation
11:26 G. Lorenzoni, I. Bargellini, D. Lauretti, F. Turini, V. Caciagli,
B-0084 Combing interictal arterial spin-labelling (ASL) D. Campani, R. Cioni, C. Bartolozzi; Pisa/IT
MRI perfusion and FDG PET in assessment of focal

cortical dysplasia (FCD) causing intractable epilepsy
A. Garg, K. Bhullar, S. Gaikwad, M. Tripathi, M. Tripathi, G. Shukla,
M.B. Singh, S. Chandra, C.S. Bal; New Dehli/IN

11:18 11:11
B-0094 Advanced hepatocellular carcinoma: pre-treatment B-0104 Assessment of new model-based iterative
contrast-enhanced CT texture as prognostic reconstruction kernels for the detectability of small
biomarker in patients treated with sorafenib hypervascular liver lesions: a phantom study
S. Mulé1, B. Ganeshan2, A. Dohan3, G. Thiéfin1, C. Hoeffel1; 1Reims/FR, H. Pasquier, F. Gardavaud, M. Chiaradia, F. Legou, A. Rahmouni,
2
Brighton/UK, 3Paris/FR A. Luciani; Creteil/FR
11:26 11:19
B-0095 Contrast-enhanced ultrasound features for B-0105 Comparison of different iterative and FBP
differentiation of histologically proven small reconstruction techniques with respect to image
solitary (d 2cm) liver metastases and hepatocellular quality in chest CT examinations
carcinomas H.K. Andersen1, D. Völgyes2, A. Stray-Pedersen1, A.C.T. Martinsen1;
1
W. Wang, Y. Dong, X.-L. Zhang, F. Mao; Shanghai/CN Oslo/NO, 2Gjøvik/NO
Wednesday
11:34 11:27
B-0096 Diagnostic value of quantitative perfusion maps with B-0106 Model-based iterative reconstruction technique for
CT-perfusion technique in assessment of tumour low radiation dose abdominal CT: comparison with
response to Sorafenib treatment in patients with hybrid iterative reconstruction and filtered back
advanced HCC lesions projection techniques
D. Ippolito, G. Querques, C. Talei Franzesi, P.A. Bonaffini, S. Lombardi, Y. Ueno1, T. Yoshikawa1, Y. Ohno1, N. Negi1, H. Inokawa2, N. Sugihara2,
S. Sironi; Monza/IT T. Murakami1, Y. Fujisawa2, K. Sugimura1; 1Kobe/JP, 2Otawara/JP
11:42 11:35
B-0097 Imaging of tumour vessel normalisation under anti B-0107 Standard deviation and noise power spectrum as
SPEAKER critera for achievable dose reduction with three types
SUPPORTED angiogenic therapy
BY M. Bouaboula, L. Mauge, D. Bouda, I. Galy-Fauroux, G. Autret, of iterative reconstruction
INVEST IN
THE YOUTH D. Helley, D. Balvay, L. Fournier; Paris/FR G. Van Gompel, N. Buls, J. de Mey; Brussels/BE
11:50 11:43
B-0098 RGD modified nano iron probe targeted B-0108 Effect of tube voltage on CT radiation dose:
hepatocellular carcinoma cells compared with 100 kVp vs 120 kVp using iterative
Y. Xu, Y. Xu; Shanghai/CN reconstruction algorithm
K. Sim, M. Kim, B. Park, D. Sung, N. Han; Seoul/KR
10:30–12:00 Room F2
10:30–12:00 Room D1
Chest
SS 213 CT imaging: effects of body size and
use of iterative reconstruction SS 204 Pulmonary vessels and perfusion
Moderators: B.M. Gramer; Munich/DE, Moderators: E.E.J.G. Coche; Brussels/BE, N.N.
A. Jahnen; Esch-sur-Alzette/LU 10:30
10:30 B-0109 Whole lung dynamic perfusion CT for risk

K-04 Keynote lecture stratification of arterial occlusions
J. Andersson; Umeå/SE L. Jimenez-Juan1, H. Mehrez1, C. Dey1, S. Homampour1,
P. Salazer-ferrer2, N. Paul1; 1Toronto, ON/CA, 2Minnetonka, MN/US
10:39
10:38
B-0099 Is body mass index superior to body weight as a
B-0110 Dual-energy pulmonary blood volume CT for
surrogate parameter in the calculation of size specific
treatment evaluation of balloon pulmonary
dose estimates (SSDE)?
J. Boos, J. Aissa, P. Heusch, R.S. Lanzman, C. Schleich, C. Thomas, angioplasty for chronic thromboembolic pulmonary
G. Antoch, P. Kröpil; Düsseldorf/DE hypertension
H. Ota, H. Takagi, K. Sugimura, K. Takase; Sendai/JP
10:47
B-0101 Body mass index based GSI assist in abdominal CT: 10:46
investigation of radiation dose and image noise B-0111 A new CT-score predictor of haemodynamic changes
Y. Chai, J. Gao, P. Lv; Zhengzhou/CN in patients with chronic thromboembolic pulmonary
hypertension
10:55 M.B. Leone, M. Giannotta, M. Palazzini, M. Cefarelli, S. Martìn Suàrez,
B-0102 The effect of KV Assist on radiation dose reduction M.L. Bacchi Reggiani, N. Galiè, M. Zompatori; Bologna/IT
and image quality for abdominal CT in different BMI
10:54
groups
P. Hou; Zhengzhou/CN B-0112 Pulmonary vessel volume (PVV) change vs change in
forced vital capacity (FVC) as a predictor of mortality
11:03 in IPF
B-0103 Iterative reconstruction comparison in CT: model J. Jacob1, B. Bartholmai2, R. Karwoski2, A. Nair1, S. Raghunath2,
S. Rajagopalan2, S.L.F. Walsh1, A. Wells1, D. Hansell1; 1London/UK,
base (MBIR-VEO), adaptive statistical (ASIR) and 2
Rochester, MN/US
new adaptive statistical iterative (ASIR-V)
P. De Marco, M. Guernieri, D. Origgi; Milan/IT

11:02 10:46
B-0113 Prognostic value of CT-angiographic features of B-0122 Thermal ablation of benign thyroid nodules: a
SPEAKER
right ventricular dysfunction in patients with acute SUPPORTED systematic review and meta-analysis
BY A. Pisani Mainini1, L.M. Sconfienza1, M. Alì1, G. Di Leo1, F. Sardanelli1,
pulmonary embolism INVEST IN
M. Wiśniewska, P. Palczewski, M. Gołębiowski, M. Bielecki, S. Goliszek, THE YOUTH G. Mauri2; 1Milan/IT, 2San Donato Milanese/IT
P. Pruszczyk; Warsaw/PL
10:54
11:10 B-0123 Primary breast tumour percutaneous cryoablation in
SPEAKER
B-0114 The relation between severity of contrast reflux SUPPORTED patients with metastatic breast cancer
BY E. Mavrovi, H. Beji, O. Tredan, T. Bachelot, I. Ray-Coquard, P. Heudel,
into the inferior caval vein on CTA and mortality in INVEST IN
THE YOUTH M. Peix, N. Guerin, F. Pilleul; Lyon/FR
patients with acute pulmonary embolism
W. Kroon1, A. Braber2, J.-W.C. Gratama2, F. van Raamt2, P.E. Spronk2,
11:02
H.J. van der Zaag-Loonen2; 1Deventer/NL, 2Apeldoorn/NL
B-0124 Management of renal tumours by US-guided
11:18 radiofrequency ablation: our experience in 140
B-0115 Automatic assessment of cardiac load due to patients
acute pulmonary embolism: saddle vs. central and A.C. Montealegre Angarita, M. Rendon Villa, X. Serres, E. Trilla,
M. Juarez Garcia; Barcelona/ES
peripheral emboli distribution
G. Aviram, O. Sadovnik, E. Soikher, A. Bendet, T. Ziv-Baran,
11:10
S. Berliner, H. Shmueli, L. Friedensohn, Y. Topilsky; Tel-Aviv/IL
B-0125 US/CT guided percutaneous treatment of renal
11:26 tumours using radiofrequency and microwave
B-0116 Acute pulmonary embolism among patients with ablation
and without malignancy: comparison of cardiac G. Mauri, G.M. Varano, P. Della Vigna, G. Bonomo, F. Orsi; Milan/IT
measurements using CT pulmonary angiography 11:18

G. Aviram, Y. Hadad, E. Soikher, A. Bendet, S. Berliner, S. Greenberg,
Y. Topilsky, T. Ziv-Baran, A. Milwidsky; Tel-Aviv/IL B-0126 Renal T1 tumours and ablative techniques: which one
to use?
11:34 A. Velarde Pedraza, A. Gil Sierra, J. Abadal Villayandre,
B-0117 Pulmonary arteriovenous malformations in hereditary E. Galvez Gonzalez, M. Alvarez Perez; Madrid/ES
hemorrhagic telangiectasia: correlations between 11:26

computed tomography findings and cerebral
B-0127 Comparison of cryoablation and microwave ablation
complications
J. Etievant, N. Vinurel, S. Dupuis-Girod, E. Decullier, D. Gamondes,
for percutaneous renal ablation: focus upon safety
C. Khouatra, V. Cottin, D. Revel; Bron/FR and efficacy
S. Grigoriadis1, D. Filippiadis1, J. Zechlinski2, A. Mazioti1, A. Kelekis1,
11:42 S. Tutton2, N. Kelekis1; 1Athens/GR, 2Wisconsin, WI/US
B-0118 Coronary and vascular calcification assessed by 11:34

computed tomography in patients with pulmonary
B-0128 Evaluation of pain reduction after percutaneous
embolism SPEAKER
M.C. Williams1, N. Morley1, K. Muir1, E.J.H. van Beek1, J.H. Reid2, SUPPORTED thoracic cryoneurolysis in chest wall metastatic
BY
J. Murchison1; 1Edinburgh/UK, 2Melrose/UK INVEST IN patients
THE YOUTH E. Mavrovi, M. Cuinet, B. Richioud, C. Mastier, F. Pilleul, G. Chvetzoff,
11:50 A.-C. Kalenderian; Lyon/FR
B-0119 Diagnostic imaging in the diagnosis of suspected 11:42

pulmonary embolism during pregnancy and the
B-0129 Evaluation of microwave ablation (MWA) of lung
immediate post-partum period
S. Reddy, A. Hill, D. Patel; Edinburgh/UK
malignancies with real-time enhanced spatial energy
control to achieve a spherical ablation zone
T.J. Vogl, L. Basten, B. Panahi, N.-E. Nour-Eldin, N.N.N. Naguib;
Frankfurt a. Main/DE
10:30–12:00 Room D2
11:50
Interventional Radiology B-0130 MWA, RFA and LITT in patients with non-colorectal
lung metastases: comparative evaluation of tumour
SS 209 Ablation outside the liver
volume and recurrence rates
Moderators: G. Carrafiello; Varese/IT, M. Tsitskari; Athens/GR T.J. Vogl, S. Exner, S. Zangos, K. Eichler, N.-E. Nour-Eldin;
10:30
B-0120 Ultrasound-guided radiofrequency ablation (RFA) to
SPEAKER
SUPPORTED treat benign thyroid nodules: effectiveness after one 10:30–12:00 Room K
BY
INVEST IN and six months
THE YOUTH C. De Angelis, C.G. Monaco, L.C. Pescatori, F. Sardanelli, Genitourinary
L.M. Sconfienza, G. Mauri; San Donato Milanese/IT
SS 207 Technical advances
10:38
Moderators: U.G. Mueller-Lisse; Munich/DE,
B-0121 Radiofrequency ablation as an alternative local R. Turkay; Istanbul/TR
treatment for hyperfunctional solid thyroid nodules:
a single centre experience 10:30
R. Cervelli, S. Mazzeo, B. Pontillo Contillo, L. De Napoli, P. Miccoli, B-0131 Preoperative CT findings to predict postoperative
D. Caramella; Pisa/IT
inguinal hernia after robot-assisted laparoscopic
radical prostatectomy
K. Sim, D. Sung, N. Han, B. Park, M. Kim, Y. Cho, S. Cho; Seoul/KR

10:38 10:30–12:00 Room G

B-0132 MR spectroscopy in the differentiation of benign,
borderline and malignant cystic epithelial ovarian Radiographers
tumours
F. Ma, J. Qiang, G. Zhang; Shanghai/CN SS 214 Radiographers’ education: the
curriculum
10:46 Moderators: P.H. Hogg; Manchester/UK, N.N.
B-0133 Sonoelastography in differentiation between
endometrial hyperplasia and endometrial carcinoma 10:30
M. Shady, M. Abdel Latif, H. Nabil; Mansoura/EG B-0142 Continuing professional development (CPD)
considerations in a newly state registered profession
10:54 J.M. Grehan, M.-L. Butler, L.A. Rainford; Dublin/IE
B-0134 Evaluation of slice encoding for metal artefact
Wednesday
correction (SEMAC) sequences in patients with 10:38
intrauterine contraceptive device: removing metal B-0143 Emotional intelligence and academic performance in
artifacts in MR scans of female pelvic regions radiography education
C. Guo1, Z. Wang1, H. Zhang1, T. Qian2, N. Yutaka3; 1Changchun/CN, J. Mc Nulty1, S. Lewis2, S. Lane3, P. White4, S. Mackay3; 1Dublin/IE,
2
2
Beijing/CN, 3California, CA/US Sydney/AU, 3Liverpool/UK, 4Hong Kong/HK
11:02 10:46
B-0135 Perfusion and diffusion characteristics of endometrial B-0144 Social media and simulation: using a simulation suite
malignancy based on intraxovel incoherent motion and digital media to develop analytical and reflective
MR imaging at 3.0 T: differentiation from uterine non- skills in the undergraduate radiographer
E.M. Carver; Wrexham/UK
malignant tissues
J. Liu, Z. Wang; Tianjin/CN
10:54
11:10 B-0145 Inter-professional simulation-based education in
B-0136 Acustic radiation force impulse (ARFI) evaluation of trauma: human factors
M.L. Howard, C. Brown, J. Morse; Aberdeen/UK
small (<4 cm) renal masses-preliminary results
C. Bruno, A. Bucci, C. Dallaserra, R. Pozzi Mucelli; Verona/IT
11:02
11:18 B-0146 Blending healthcare and educational technologies
B-0137 Addition of diffusion-weighted imaging for the to enhance radiography healthcare information
clinical MR assessment of acute pyelonephritis technology education
J.G. Stowe, J. McNulty; Dublin/IE
(APN): a prospective multicentric study
1 2 2 2 2
F. Albarello , G.C. Parenti , I. Nanni , F. Ansaloni , A. Passari ,
M. Giganti1, P. Campioni1, M. Valentino3; 1Ferrara/IT, 2Ravenna/IT, 11:10
3
Tolmezzo/IT B-0147 The impact of education on radiologic technology as
a developing scientific discipline in Austria
11:26 G. Unterhumer, L. Handlechner; Vienna/AT
B-0138 MRI to evaluate the response of the locally advanced
cervical cancer to CCRT: MRS (magnetic resonance 11:18
spectroscopy), DWI (diffusion weighted image) and B-0148 A national survey on radiographers and research:
T2WI roles and attitudes
H. Kwon, B. Kang; Seoul/KR K.G. Vikestad1, L. Hafskjold2, E. Kjelle2, S. Sebuodegaard1, S. Hofvind1;
1
Oslo/NO, 2Kongsberg/NO
11:34
11:26
B-0139 Renal allograft shearwave elastography: a new
B-0149 Validation of a competence profile for MR
diagnostic tool to assess chronic allograft alterations
radiographers using a formal research process
compared with biopsy J. Castillo1, C.J. Caruana1, P.S. Morgan2, C. Westbrook3, A. Mizzi1;
C. Sportoletti, S. Brocchi, A. Croci Chiocchini, A. Scrivo, G. Comai, 1
Msida/MT, 2Nottingham/UK, 3Cambridge/UK
C. Serra, A. Marchetti, M. Zompatori; Bologna/IT
11:34
11:42
B-0150 Radiographer’s expectations for role development: a
B-0140 The contribution of diffusion tensor imaging in
survey in the perspective of Norwegian radiography
chronic kidney disease
N. Gaini1, E. Yilmaz1, B. Çağlı1, S.A. Tuncel1, M. Bulakci2, H. Genchellac1, students
M.E. Ünlü1; 1Edirne/TR, 2Istanbul/TR F. Tavares, A.F.C.L. Abrantes, L.P. Ribeiro, R.P.P. Almeida, J.P. Pinheiro,
K.B. Azevedo, S. Rodrigues; Faro/PT
11:50
11:42
B-0141 Zoomed EPI-DWI of the kidney using two-
B-0151 Good practice: lumbosacral spine x-ray examination
dimensional spatially-selective radiofrequency K. Paalimäki-Paakki, A. Henner; Oulu/FI
excitation pulses
1 2 2 2 2
Y. He , P. Riffel , D. Hausmann , S.O. Schönberg , U. Attenberger ; 11:50
1
Beijing/CN, 2Mannheim/DE
B-0152 Accuracy of the interpretation of chest radiographs
for the radiographers
L.P. Ribeiro1, D. Pinto1, A.F.C.L. Abrantes1, R.P.P. Almeida1,
K.B. Azevedo1, J.P. Pinheiro1, S. Rodrigues1, C.A. da Silva2; 1Faro/PT,
2
Evora/PT

10:30–12:00 Room M 1 10:30–12:00 Room M 2
Head and Neck Paediatric

SS 208 Orbits and olfaction SS 212 Brain and neck
Moderators: L.S. Politi; Worcester, MA/US, Moderators: P. Gulino; Florence/IT, D. Prayer; Vienna/AT
T. Rodt; Hannover/DE
10:30
10:30 B-0163 Arterial spin labeling predicts cerebellar tumour
K-02 Keynote lecture grading in children: correlations between
P.-Y. Marcy; Ollioules/FR
histopathological vascular density and perfusion MRI
V. Dangouloff-Ros1, C. Deroulers2, E. Shotar1, D. Grévent1, R. Calmon1,
10:39
S. Puget1, F. Brunelle1, P. Varlet1, N. Boddaert1; 1Paris/FR, 2Orsay/FR
B-0153 Usefulness of colour Doppler flow imaging in the
management of lacrimal gland lesions 10:38
A. Lecler, F. Lafitte, P. Koskas, E. Nau, P.-V. Jacomet, O. Berges; B-0164 Dynamic susceptibility-weighted contrast-enhanced
Paris/FR
(DSC) perfusion MR imaging in paediatric neuro-
10:47 oncology, first step: a clinical feasibility study
M. Martucci, A. Botto, G.M. Di Lella, E. Ruberto, R. Russo,
B-0154 Morphometric symptoms of dacryocystitis in non- T. Verdolotti, S. Gaudino, C. Colosimo; Rome/IT
enhanced computed tomography
A. Ageev1, A. Dergilev2, V. Obodov1, O. Zykov1; 1Ekaterinburg/RU, 10:46
2
Novosibirsk/RU
B-0165 Paediatric CNS T1 shortening after gadolinium:
10:55 influence of radiation and chemotherapy
S. Kinner, T.B. Schubert, S. Rebsamen, R. Bruce, S. Reeder, H. Rowley;
B-0155 Can real-time ultrasound elastography be used in Madison, WI/US
early period of Graves’ ophthalmopathy instead of
MRI? 10:54
K. Agladioglu, E.N. Cetin, G. Pekel, R. Yagci, K. Yilmaz; Denizli/TR B-0166 Subarachnoid/subdural hyper-intensity on diffusion-
11:03 weighted MRI predicts severe brain parenchymal
injury in children with meningitis?
B-0156 Diffusion tensor imaging of extraocular muscle in Z. Qiao; Shanghai/CN
thyroid associated orbitopathy
J. Han, H. Seo, H. Lee, Y. Lee; Ansansi Gyunggido/KR 11:02
11:11 B-0167 Safety of gadoteric acid in over 1,600 children
included in a prospective observational study
B-0157 Infra-orbital nerve involvement on MRI in IgG4- M. Hackenbroch, D. Chang, D. Maintz; Cologne/DE
related ophthalmic disease (IgG4-ROD): a specific
sign? 11:10
A. Lecler, J. Bensoussan, R. Deschamps, H. Picart, O. Galatoire, B-0168 Isolated and syndromic corpus callosum dysgenesis
M. Zmuda, J.-C. Sadik; Paris/FR
(CCD): diagnostic value of foetal MRI
S. Bernardo, V. Vinci, M. Saldari, E. Marchionni, A. Antonelli, A. Pizzuti,
11:19
C. Catalano, L. Manganaro; Rome/IT
B-0158 Post-orbital exenteration: CT findings
S.M. Elkhamary; Riyadh/SA 11:18
11:27 B-0169 Application of 3D cranial ultrasonography for follow-
up of neonates: can it replace follow-up 2D cranial
B-0159 Residence times of non-specific gadolinium-based
ultrasonography?
contrast media in orbital mass lesions: results of Y. Kim, Y. Choi, J.-E. Cheon, H. Choi, T. Kim, H. Cho, J.-E. Park, W. Kim,
pharmocokinetic contrast-enhanced MRI studies I.-O. Kim; Seoul/KR
K. Erb-Eigner, P. Asbach, M. Taupitz, R. Lawaczeck; Berlin/DE
11:26
11:35
B-0170 Intraoperative navigated neuroultrasound in elective
B-0160 Ocular color Doppler ultrasound (OCDUS) and urgent enfant and paediatric neurosurgery
assessment of blood flow velocities changes in A. Hambardzumyan, N.H. Dallakyan; Yerevan/AM
central retinal artery (CRA) and vein (CRV) after islet
transplantation in type 1 diabetic patients 11:34
A. Di Chiara, M. Venturini, P. Maffi, L. Piemonti, P. Fiorina, A. Secchi, B-0171 Evaluation of parotid glands with real-time
F. De Cobelli, A. Del Maschio; Milan/IT ultrasound elastography in children
G. Gungor1, N. Yurttutan1, N. Bílal1, M.S. Menzilcioglu2, M. Duymus2,
11:43 S. Avcu2, S. Citil1; 1Kahramanmaras/TR, 2Ankara/TR
B-0161 Diffusion-weighted magnetic resonance imaging in
diabetic retinopathy 11:42
V. Burulday, K. Örnek, M. Inal, H. Güler, B. Ünal Daphan, N. Örnek; B-0172 Ultrasonographic differentiation between
Kirikkale/TR thyroglossal duct cyst and dermoid cyst in children
H. Choi, Y. Choi, J.-E. Cheon, W. Kim, I.-O. Kim, S. Jang; Seoul/KR
11:51
B-0162 Evaluation of olfactory functional MRI in major 11:50
depressive patients before and after treatment B-0173 Diagnostic reference levels for emergency head CT in
S. Hibat-Allah, K. Tran Dong, D. Ducreux; Paris/FR SPEAKER
SUPPORTED paediatric patients
BY Z. Vawda, W. Groenewald, J.M. Akudugu, R.D. Pitcher;
INVEST IN
THE YOUTH Cape Town/ZA

10:30–12:00 Room M 3 11:43

B-0183 Differences in aortic valve area estimation due
Cardiac to left ventricular outflow tract area discrepancy
measured by transthoracic echocardiography and CT
SS 203b The evolving role of cardiac CT
planimetry
Moderators: F. Cademartiri; Rotterdam/NL, J. Fijalkowska, D. Galaska, J. Pienkowska, B. Regent, K. Dziadziuszko,
G. Feuchtner; Innsbruck/AT R. Galaska, E. Szurowska, M. Fijalkowski; Gdansk/PL
10:30
K-01 Keynote lecture
F. Wolf; Vienna/AT
10:30–12:00 Room M 4
10:39 Oncologic Imaging
Wednesday
B-0174 C.S.I., coronary scene investigation: plaque
composition analysis in a STEMI population
SS 216b Advanced imaging methods (2)
S.R. Fuller, D. Caruso, S. Hinen, J.L. Wichmann, C.N. De Cecco, Moderators: C. Ayuso; Barcelona/ES,
S. Mangold, C. Tesche, A. Varga-Szemes, U.J. Schoepf; Charleston, O.V. Kucheruk; Moscow/RU
SC/US
10:30
10:47 B-0184 Impact of preoperative sarcopenia and visceral
B-0175 Diagnostic accuracy of coronary CT angiography obesity, assessed through CT-scan imaging, on
with 3rd generation dual-source CT and automated postoperative outcome in pancreatic cancer patients
tube voltage selection: clinical application in a non- undergoing pancreaticoduodenectomy
obese and obese patient population A. Damascelli, G. Cristel, N. Pecorelli, G. Carrara, M. Braga,
S. Mangold1, J. Wichmann1, C. De Cecco1, A. Varga-Szemes1, A. Del Maschio, F. De Cobelli; Milan/IT
D. Caruso1, Z. Poole1, S. Fuller1, K. Nikolaou2, U.J. Schoepf1; 1Charleston,
SC/US, 2Tübingen/DE 10:38
B-0185 Interval increase in lesion enhancement on
10:55
hepatocellular phase gadoxetic acid enhanced MRI is
B-0176 Contrast media reduction in CT-angiography of associated with complete response to chemotherapy
coronary artery bypass grafts
K. Higashigaito, A. Plass, D. Husarik, F. Maisano, H. Alkadhi;
in colorectal liver metastases
S. Islam, R. Yinn, A. Riddell, H. Tam, D.-M. Koh; London/UK
Zurich/CH
10:46
11:03
B-0186 Evaluation of primary and secondary liver lesions:
B-0177 Preliminary study on high-pitch dual-source CT
dual energy CT (DECT) vs. MRI
coronary angiography with low contrast volume
T.J. Vogl, N. Ring, R. Bauer, M. Kerl; Frankfurt a. Main/DE
injection protocols at ultra low tube voltage (70kV)
Y. Yi, Y.-N. Wang, J.-M. Liu, J. Cao, Y. Wang, Z.-Y. Jin; Beijing/CN 10:54
11:11 B-0187 Hyperintensity on delayed-phase, gadobutrol-
enhanced MRI is a significant predictor of survival
B-0179 The impact of different fat compartments on the
in a nonsurgical population with colorectal liver
presence of coronary artery disease
Z.D. Drobni, M. Kolossvary, D. Horcsik, J. Karady, A. Jermendy, metastases
A.D. Tarnoki, G. Jermendy, B. Merkely, P. Maurovich-Horvat; H.M. Cheung, J. Kim, J.M. Hudson, L. Milot; Toronto, ON/CA
Budapest/HU
11:02
11:19 B-0188 Contrast-enhanced diffusion-weighted MRI vs
B-0180 Coronary computed tomographic angiography contrast-enhanced CT for detecting liver metastases
at 80 kVp and knowledge-based iterative model for potentially resectable pancreatic ductal
reconstruction is non-inferior to that at 100 kVp with adenocarcinoma
iterative reconstruction J.J. Hermans, D. Riviere, E. van Geenen, M. van Zanten, S. Radema,
J. Lee, C. Park, T. Kim; Seoul/KR K. van Laarhoven; Nijmegen/NL
11:27 11:10
B-0181 Coronary CT angiography: patient-related factors B-0189 Change of liver metastases under therapy: do target
determining image quality using a volumetric CT lesions represent the changes in the hepatic tumour
scanner burden?
O. Ghekiere1, A. Nchimi1, J. Djekic1, M. El Hachemi1, M. Isabelle1, F.O. Hofmann, V. Heinemann, J. Holch, A. Baumann, N. Hesse,
D. Hansen2, P. Vanhoenacker3, A. De Roos4, P. Dendale2; 1Liège/BE, M. D‘Anastasi, W.H. Sommer; Munich/DE
2
Hasselt/BE, 3Aalst/BE, 4Leiden/NL
11:18
11:35 B-0190 Chemical shift MRI at 3 T to differentiate
B-0182 A vulnerability marker for coronary artery plaque SPEAKER
SUPPORTED hepatocellular carcinoma and non-hepatocellular
using ECG-gated CT histographic analysis: BY
INVEST IN malignant tumors of the liver
comparison with intravascular ultrasound (IVUS) THE YOUTH K. Ozturk, E. Soylu, G. Savci; Bursa/TR
C. Lim1, J. Park1, J. Lee1, E.-J. Kang2; 1Taegu/KR, 2Busan/KR
11:26
B-0191 Whole liver CT texture analysis to predict the
development of colorectal liver metastases: a
multicentre study
R.C.J. Beckers1, D.M. Lambregts1, R.S. Schnerr1, S.-X. Rao2,
A.G.H. Kessels1, M. Maas1, G.L. Beets3, C. Verhoef4, R.G.H. Beets-Tan3;
1
Maastricht/NL, 2Shanghai/CN, 3Amsterdam/NL, 4Rotterdam/NL

11:34 11:18
B-0192 Whole volume vs segmental CT texture analysis of B-0201 Imaging and identification of gadolinium deposits in
the liver: can we predict which areas are at risk to deep cerebellar nuclei of gadodiamide-repeatedly
develop metachronous colorectal liver metastases? treated rats
R.C.J. Beckers1, D.M. Lambregts1, R.S. Schnerr1, A.G.H. Kessels1, L. Valero1, S. Marco2, N. Fretellier1, F. Baudimont3,
M. Maas1, S.R. Pruijssers1, L.A. da Costa Andrade2, G.L. Beets3, J.-L. Guerquin-Kern2, M. Rasschaert1, P. Robert1, J.-M. Idee1, C. Corot1;
R.G.H. Beets-Tan3; 1Maastricht/NL, 2Coimbra/PT, 3Amsterdam/NL 1
Roissy/FR, 2Orsay/FR, 3Saint Herblain/FR
11:42 11:26
B-0193 Quantitative functional MRI in a clinical orthotopic B-0202 Signal intensity evaluation in dentate nuclei, pons,
model of pancreatic cancer in immunocompetent globus pallidus and thalamus in patients with
Lewis rats multiple sclerosis: gadolinium retention assessment
L. Zheng, Z. Zhang, W. Li, A.C. Gordon, A.C. Larson; Chicago, IL/US C. Tramontini, J.A. Mora, F. Aluja, C. Herazo-Bustos, C. Navas;
Bogota/CO
11:50
B-0194 Multimodality imaging to assess immediate response 11:34
following irreversible electroporation in patients with B-0203 MRI analysis of diffuse axonal injury: haemorrhagic
malignant hepatic tumours lesions in the mesencephalon indicate poor long-
K. Sugimoto, K. Saito, Y. Kobayashi, F. Moriyasu; Tokyo/JP term outcome
S. Abu Hamdeh, N. Marklund, M. Lannsjö, T. Howells, R. Raininko,
J. Wikström, P. Enblad; Uppsala/SE
10:30–12:00 Room M 5 11:42

Neuro B-0204 High quality MRI data needs visual quality control: a
multicenter experience
P. Pullens1, L. Claes2, J. Verheyden2, P.M. Parizel1,
SS 211b Gadolinium deposition and trauma .. on behalf of CENTER-TBI Participants&Investigators1; 1Antwerp/BE,
Moderators: H. Hanelore; Cluj-Napoca/RO, N.N. 2
Leuven/BE
10:30 11:50
B-0195 Comparative study of Gd deposits in rat brain after B-0205 Structured reporting of traumatic brain injury
repeated, high doses of linear and macrocyclic CT images by trained neuroscientists for clinical
contrast agents for magnetic resonance imaging research: an inter-rater reliability study
J. Lohrke; Berlin/DE T. Vande Vyvere1, L. Claes2, L. van den Hauwe1, G. Wilms2, D. Smeets2,
P.M. Parizel1; 1Antwerp/BE, 2Leuven/BE
10:38
B-0196 Accumulation of gadolinium-based contrast media
in the dentate nucleus and globus pallidus: a 18-year 14:00–15:30 Room B
longitudinal study of a multiple sclerosis cohort
Y. Forslin, F. Hashim, S. Shams, G. Bergendal, J. Martola, Abdominal Viscera
M. Kristoffersen-Wiberg, S. Fredrikson, P. Aspelin, T. Granberg;
Stockholm/SE SS 301a Liver metastases: detection,
10:46 characterisation and treatment
B-0197 Does gadolinium remain in our heads? A response assessment
comparison trial of T1 signal intensity after repeated Moderators: E. Kasatkina; Heidelberg/DE,
A.M. Riddell; London/UK
administration of gadoterate meglumine
B.-N. Marincu, M. Forsting, L. Umutlu; Essen/DE
14:00
10:54 K-05 Keynote lecture
A.M. Riddell; London/UK
B-0198 High T1 signal intensity in the dentate nucleus after
multiple exposures to gadiodiamide: intra-individual 14:09
comparison between T1- weighted spin echo and 3D B-0206 Combined gadoxetic acid and gadofosveset
MP-RAGE sequences enhanced liver MRI for detection and characterisation
J. Ramalho, M. Ramalho, M. AlObaidy, R. Hoffmann Nunes,
M. Castillo, R.C. Semelka; Chapel Hill, NC/US
of liver metastases
P. Bannas1, C. Bookwalter2, T. Ziemlewicz2, U. Motosugi3,
A. Munoz del Rio2, T. Potretzke2, G. Adam1, S. Nagle2, S.B. Reeder2;
11:02 1
Hamburg/DE, 2Madison, WI/US, 3Yamanashi/JP
B-0199 Changes in brain signal intensity (SI) after repeated
injections of gadolinium-based contrast agent 14:17
(GBCA): a systematic review B-0207 Efficiency of non-contrast-enhanced liver imaging
G. Di Leo, F. Doniselli, M. Alì, F. Sardanelli; San Donato Milanese/IT sequences added to initial rectal MRI in rectal cancer
patients
11:10 S. Kim, K. Kim, S. Hwang, S. Park, H. Kim; Suwon-si/KR
B-0200 Signal change on unenhanced T1-weighted images in
dentate nucleus following gadobenate dimeglumine 14:25
in patients with and without previous multiple B-0208 Can we predict the treatment response of colorectal
administrations of gadodiamide liver metastasis using hepatobiliary phase (HBP) in
J. Ramalho, R.C. Semelka, M. AlObaidy, M. Ramalho, Gd-EOB-DTPA-enhanced MR imaging?
R. Hoffmann Nunes, M. Castillo; Chapel Hill, NC/US H. Lee, C. Lee, Y. Park, J. Lee, J. Choi, K. Kim, C. Park; Seoul/KR

14:33 14:24
B-0209 Presurgical staging of colorectal liver metastases B-0219 Radiological imaging features of breast cancer
after chemotherapy: evaluation with diffusion- according to the molecular subtypes
weighted MR imaging and gadoxetic acid-enhanced M. Nazli; Istanbul/TR
MRI at 3T device 14:32

P. Boraschi, F. Donati, L. Urbani, M. Castagna, F. Pacciardi, R. Gigoni,
F. Falaschi; Pisa/IT B-0220 Beyond choline: in vivo proton MR-spectroscopy
fingerprinting of breast lesions
14:41 P. Clauser1, M. Bazzocchi2, M. Marcon3, M.A. Marino1, C. Zuiani2,
B-0210 Effect of duration of scan acquisition on 256 Slice M. Dietzel4, P.A.T. Baltzer1; 1Vienna/AT, 2Udine/IT, 3Zurich/CH,
4
Erlangen/DE
MDCT perfusion values in liver metastates
A.K. Sharma, N. Sharma; Delhi/IN
14:40
Wednesday
14:49 B-0221 The predictive factors associated with the early and
B-0211 Respiratory gated PET/CT of the liver: a novel late recurrence in breast cancer: predictive factors on
method and its impact on the detection of colorectal radiography and clinical-pathology
B. Kim, E. Choi, S. Choi, G. Jin; Jeonju-si/KR
liver metastases
A. Schulz, J.C. Godt, J.B. Dormagen, J.E. Holtedahl, T.V. Bogsrud,
14:48
K.J. Labori, N.-E. Kløw, T. Bach-Gansmo; Oslo/NO
B-0222 Visualisation of microcalcifications by cone-
14:57 beam breast CT in comparison to full field digital
B-0212 Comparison of PET/CT and geometric accuracy for mammography
predicting local tumour progression 24 h post-RF S. Wienbeck, E. von Fintel, J. Lotz, U. Fischer; Göttingen/DE
ablation of liver metastases 14:56

F. Vandenbroucke, J. Vandemeulebroucke, J. de Mey; Brussels/BE
B-0223 Second-look US using real-time virtual sonography
15:05 increases the sonographic detection rate of MRI-
B-0213 Evaluation of primary and secondary liver lesions: detected lesions with non-mass like enhancement on
dual energy CT (DECT) vs. MRI breast MRI
T.J. Vogl, N. Ring, M.J. Kerl, R.W. Bauer; Frankfurt a. Main/DE S. Nakano, K. Fujii, J. Kousaka, Y. Mouri, T. Ando, R. Tetsuka, M. Goto,
T. Imai, T. Ishiguchi; Aichi/JP
15:13
B-0214 The value of diffusion-weighted MRI for the 15:04
differentiation of intrahepatic cholangiocellular B-0224 Hybrid PET-MR for predicting pathologic complete
carcinoma and solitary hypovascular liver metastases response to neadjuvant chemotherapy in breast
J.D. Kovac, G. Lilic, A. Djuric-Stefanovic, L. Lazic, D. Vasin, T. Nikolic, cancer - preliminary experiences
M. Mitrovic, D. Masulovic, D. Saranovic; Belgrade/RS B. Goorts, M.L. Smidt, S. Vöö, F.M. Mottaghy, J.E. Wildberger,
M.B.I. Lobbes; Maastricht/NL
15:21
B-0215 Comparision of contrast-enhanced ultrasound with 15:12
CT in differential diagnosis of liver abscess from B-0225 Diffuse reflectance spectroscopy measured during
malignant hepatic tumours biopsy procedures for tissue characterisation of
Y. Lee, H. Lee, Y. Cha, S. Wee, K. Yoon; Iksan/KR breast tissue
L.L. de Boer1, C.E. Loo1, G.A. Winter-Warnars1, J.W. Spliethoff1,
T.M. Bydlon2, B.H. Hendriks2, A. Fioole-Bruining1, M. van Loveren1,
T.J. Ruers1; 1Amsterdam/NL, 2Eindhoven/NL
14:00–15:30 Room C
15:20
Breast B-0226 A prospective evaluation of a 3D functional infrared
imaging for risk assessment in women at high risk for
SS 302 Breast innovation, biomarkers
breast cancer
Moderators: C.S. Balleyguier; Villejuif/FR, D. Izhaky1, A. Shalmon2, A. Rundstein2, Y. Servadio2, M. Gotlieb2,
M.H. Fuchsjäger; Graz/AT E. Mor1, M. Sklair-Levy2; 1Air Port City/IL, 2Ramat Gan/IL
14:00
B-0216 Quantification of microvascular hemodynamics 14:00–15:30 Room Z
in mice breast cancer using in vivo synchrotron
radiation (SR) microangiography Computer Applications
M. Torii1, T. Fukui2, M. Inoue1, S. Kanao1, T. Inagaki3, H. Tsuchimochi3,
K. Umetani4, M. Shirai3, M. Toi1; 1Kyoto/JP, 2Tokyo/JP, 3Osaka/JP,
4
Hyogo/JP SS 305 Developing tools for clinical workflow
management
14:08 Moderators: L. Faggioni; Pisa/IT, B. Gibaud; Rennes/FR
B-0217 Opto-acoustic breast imaging: downclassification
and upclassification of suspicious breast masses 14:00
R.M. Pijnappel1, C. Meeuwis2, B. Bisschops3, J. Veltman4, P.T. Lavin5, B-0227 What is the utility of three-dimensional surface
R.M. Mann6; 1Utrecht/NL, 2Arnhem/NL, 3Dordrecht/NL,
4 rendering reconstruction of volumetric CT data in
Hengelo/NL, 5Framingham, MA/US, 6Nijmegen/NL
routine CT reporting?
14:16 J.S.Z. Lee1, E.K. Woo2; 1Oxford/UK, 2Buckinghamshire/UK
B-0218 First clinical experiences with a noncontrast cone- 14:08

beam breast CT for the detection of breast masses
S. Wienbeck, E. von Fintel, J. Lotz, U. Fischer; Göttingen/DE
B-0228 Structured reporting: evidence-based?
M. Nobel, S.G.F. Robben; Maastricht/NL

14:16 14:17
B-0229 Structured reporting of CT examinations in acute B-0239 Standard and ultra low-dose CT colonography:
pulmonary embolism comparison of performance of filtered back
B.O.T. Sabel, J. Plum, N. Kneidinger, G. Leuschner, B. Raziorrouh, projection, hybrid iterative reconstruction technique
L. Koletzko, R. Schinner, M.F. Reiser, F.G. Meinel; Munich/DE
and iterative model reconstruction
L. Lambert1, P. Ourednicek2, W. Giepmans3, J. Jahoda1, L. Hruska1,
14:24
A. Lambertova1, J. Danes1; 1Prague/CZ, 2Brno/CZ, 3Best/NL
B-0230 Identifying structural quality deficits by systematic
reporting of erroneous action 14:25
A. Escher, S. Schindera, A. Streuber; Basle/CH B-0240 Initial study on radiation dose and image quality of
14:32 ultra-low current and voltage CT colonography with
iterative model reconstruction
B-0231 Radiology reporting workflows: the development and Y. Lian1, W. Cao2, J. Dong1, H. Wang1, Y. Jiang1, J. Gao1;
testing of a semi-naturalistic observational technique 1
Zhengzhou/CN, 2Guangzhou/CN
using eyetracking, scene video and screen capture
S.J. Rickaby, M. Colbert; Kingston upon Thames/UK 14:33
B-0241 Follow-up of acute complicated diverticulitis: role of
14:40
CT colonography
B-0232 Automatic indication detection for imaging decision M. Bassi, E. Raimondi, Z. Ferrante, B. Malta, C. Montalto, R. Rizzati,
support in clinical workflows M. Giganti, G. Benea; Ferrara/IT
E. Pons, L.M.M. Braun, J.A. Kors, M.G.M. Hunink; Rotterdam/NL
14:41
14:48 B-0243 Visceral fat volume as a predictor of acute
B-0233 CARDS: the decision support tool for radiologists SPEAKER
SUPPORTED complicated diverticulitis
BY V.S. Martín, C.A. León, M.N. Hinestroza, L.O. Robador, F.D. Formoso,
examining head CT images INVEST IN
P. Martynov, N. Mitropolskii, K. Kukkola, L. Mutanen, J. Reponen, THE YOUTH L.S. Toledo, M.T. Mohamad, M.A. Armas, M.S. Rodriguez;
A. Makynen; Oulu/FI Las Palmas de Gran Canaria/ES
14:56 14:49
B-0234 Big Data in optimising radiology management: from B-0244 MR imaging in preoperative staging of primary colon
SPEAKER
passive storage to real-time response SUPPORTED cancer patients: a feasibility study
BY E. Nerad1, M. Lahaye2, D.M. Lambregts3, E. Kersten1,
O. Pianykh; Boston, MA/US INVEST IN
THE YOUTH H. van den Bosch1, F. Bakers3, G. Beets2, H. Grabsch3,
R.G.H. Beets-Tan2; 1Eindhoven/NL, 2Amsterdam/NL, 3Maastricht/NL
15:04
B-0235 Is explorative data analysis one milestone on the way 14:57
to value based radiology? B-0245 Diagnostic performance of MR imaging in
A. Escher, J. Truong, A. Streuber; Basle/CH SPEAKER
SUPPORTED preoperative staging of primary colon cancer
BY
15:12 INVEST IN patients
THE YOUTH E. Nerad1, M. Lahaye2, D.M. Lambregts3, E. Kersten1,
B-0236 Estimating prevalence of rare diseases using a large H.C.M. van den Bosch1, G. Beets2, F. Bakers3, H. Grabsch3,
radiology report database R.G.H. Beets-Tan2; 1Eindhoven/NL, 2Amsterdam/NL, 3Maastricht/NL
C.E. Kahn; Philadelphia, PA/US
15:05
15:20
B-0247 Management of active colonic bleeding detected by
B-0237 Identification of rare imaging findings: application of angio- MDCT: interventional radiology versus surgery
natural language processing M. Pannatier, P. Bize, D. Hahnloser, R. Meuli, S. Schmidt;
E. Pons, J.J. Visser, M.G.M. Hunink; Rotterdam/NL Lausanne/CH
14:00–15:30 Room O 14:00–15:30 Room N
GI Tract Cardiac
SS 301b Colon SS 303a Cardiomyopathies (2)
Moderators: R. Maksimović; Belgrade/RS, T. Mang; Vienna/AT Moderators: J. Broncano; Cordoba/ES, A. de Roos; Leiden/NL
14:00 14:00
K-06 Keynote lecture B-0248 The role of cardiac magnetic resonance (CMR)
M. Hellström; Gothenburg/SE
imaging in the differentiation of arrhythmogenic
14:09 right ventricular cardiomyopathy (ARVC) and
B-0238 Diagnostic value of CAD-assisted CT colonography athlete’s heart
H. Vago, C. Czimbalmos, I. Csecs, A. Toth, F.I. Suhai, O. Kiss, N. Sydo,
in the assessment of nonpolypoid colorectal lesions D. Becker, B. Merkely; Budapest/HU
(NPLs) using CT colonography: a single-centre
experience 14:08
M. Santoni, M. Ciolina, A. Pichi, P. Baldassari, M. Iannitti, C. Cavallini, B-0249 Role of T1 mapping in cardiac amyloidosis
D. Diacinti, F. Iafrate; Rome/IT M. Dal Corso, E. Gavazzi, D. Farina, R. Maroldi; Brescia/IT

14:16 14:08
B-0250 Left-ventricular geometry associated with B-0260 Tack optimised balloon angioplasty below the knee
outflow obstruction in patients with hypertrophic (TOBA-BTK): six months results
cardiomyopathy: 3D CT analysis M. Brodmann1, C. Wissgott2, A. Holden3, R. Staffa4, T. Zeller5,
Y. Song, D. Yang; Seoul/KR T. Vasudevan6, P. Schneider7; 1Graz/AT, 2Heide/DE,
3
Grafton Auckland/NZ, 4Brno/CZ, 5Bad Krozingen/DE,
6
Hamilton/NZ, 7Honolulu, HI/US
14:24
B-0251 Cardiac MR or delayed enhanced CT in patients 14:16
with sudden occurrence of ventricular arrhythmias B-0261 Subclavian artery stent fractures: prevalence and
and normal coronary arteries: comparison with predisposing factors
endomyocardial biopsy A. Hüttl, A. Hüttl, E.M. Végh, H. Sarkadi, B. Nemes, K. Hüttl, E. Dósa;
A. Palmisano, A. Esposito, C. Colantoni, M. Cava, S. Sala, Budapest/HU
F. De Cobelli, A. Del Maschio; Milan/IT
Wednesday
14:24
14:32 B-0262 Below-the-knee angioplasty in dialysis patients with
B-0252 Late gadolinium enhancement and systolic function critical limb ischemia- outcomes with respect to
in non-ischemic dilated cardiomyopathy pedal arch involvement
M. Scarabello, P.M. Cannaò, M. Petrini, F. Riva, F. Secchi, F. Sardanelli; A. Meyer, A. Schmid, W. Lang, U. Rother; Erlangen/DE
Milan/IT
14:32
14:40
B-0263 Impact of a noise-optimized virtual monoenergetic
B-0253 T1mapping: diagnostic value in hypertrophic
reconstruction algorithm on stent visualization and
cardiomyopathy with no apparent fibrosis in late
detection of in-stent restenosis in lower extremity
gadolinium enhancement
R. Ouyang, L. Wu, J. Xu; Shanghai/CN run-off CT angiography
S. Mangold1, J. Wichmann1, C. De Cecco1, A. Varga-Szemes1,
D. Caruso1, A. Stubenrauch1, S. Fuller1, K. Nikolaou2, U.J. Schoepf1;
14:48 1
Charleston, SC/US, 2Tübingen/DE
B-0254 Role of cardiac magnetic resonance in the diagnosis
of ARVC/D and phenocopies 14:40
A.M. Amadu1, J.C.L. Rodrigues2, A. Ghosh Dastidar2, A. Baritussio2, B-0264 Noise-optimised virtual monochromatic imaging
C.B. Lawton2, G. Venuti2, G.B. Meloni1, M. Conti1, C. Bucciarelli-Ducci2;
1
Sassari/IT, 2Bristol/UK improves image quality in 3rd-generation dual-
source dual-energy CT angiography of the lower
14:56 extremity run-off
B-0255 Early cardiac involvement in asymptomatic patients J.L. Wichmann1, C.N. De Cecco2, A. Varga-Szemes2, S. Mangold2,
T.J. Vogl1, U.J. Schoepf2; 1Frankfurt a. Main/DE, 2Charleston, SC/US
with systemic sclerosis (Ssc) established using
cardiac magnetic resonance (CMR) 14:48
V. Vellucci, A. Di Sibio, A. Gennarelli, V. Felli, C. Marsecano,
G. Michelini, R. Masi, E. Di Cesare, C. Masciocchi; L’Aquila/IT B-0265 Nonenhanced MR angiography of the foot with flow
spoiled-fresh blood imaging(FS-FBI): feasibility
15:04 study and comparison of different parameters
B-0256 Cardiac magnetic resonance (CMR) findings in Y. Zhang1, D. Cao1, S. Yu2; 1Fuzhou/CN, 2Nanyang/CN
patients with new onset of ventricular arrhythmias

M. Cava, A. Esposito, G. Benedetti, D. Vignale, A. Palmisano,
14:56
A. Del Maschio, F. De Cobelli; Milan/IT B-0266 2D-Perfusion angiography of the foot: technical
considerations and initial analysis
15:12 T. Rodt1, T. Murray2, M. McCavert2, M. Given2, F. McGrath2, M. Lee2;
1
B-0257 Dobutamine stress-induced impairment of cardiac Hannover/DE, 2Dublin/IE
and myocardial performance in a preclinical model of

15:04
HFpEF: a cardiac magnetic resonance imaging study
1 1 1 1
U. Reiter , G. Reiter , G. Adelsmayr , M. Manninger , A. Alogna , 2 B-0267 Outcomes of infrapopliteal angioplasty for limb
A.F. Stalder3, D. Scherr1, H. Post2, M. Fuchsjäger1; 1Graz/AT, salvage in critical limb ischaemia
2
Berlin/DE, 3Erlangen/DE M. Sheehan, H. Kok, P. Thanaratnam, E. Ryan, H. Asadi, R. Bajwa,
K. Pennycooke, M. Given, M. Lee; Dublin/IE
15:20
B-0258 CT vs MRI: comparison of right atrium volumetry 15:12
S. Rheinheimer, C. Reh, J. Figiel, A.H. Mahnken; Marburg/DE B-0268 Radiation dose and contrast medium volume
reduction in lower extremity CT angiography with
iterative model reconstruction (IMR) algorithm
14:00–15:30 Room L8 W.-L. Qian1, D.-J. Zhou1, C. Feng1, H. Wang1, Y. Jiang2, J.-M. Xu1;
1
Suzhou/CN, 2Shanghai/CN
Vascular
15:20
SS 315 Peripheral arteries: imaging and B-0269 Extreme low radiation dose CT angiography of low-
therapy dose extremity using iterative model reconstruction
Moderators: M. de Bucourt; Berlin/DE, algorithm
J.T. Ortiz-Pérez; Barcelona/ES W.-L. Qian1, D.-J. Zhou1, C. Feng1, H. Wang1, Y. Jiang2, J.-M. Xu1;
1
Suzhou/CN, 2Shanghai/CN
14:00
B-0259 The angiosome concept evaluated on the base of
micro-perfusion - an O2C guided study
U. Rother, W. Lang, R.E. Horch, A. Meyer; Erlangen/DE

14:00–15:30 Room E1 15:20

B-0280 Do we need image guidance for subacromial
Musculoskeletal subdeltoid injections?
G.M. Allen, M. DeDea, D.J. Wilson; Oxford/UK
SS 310 Ultrasound
Moderators: P. Peetrons; Brussels/BE,
L.M. Sconfienza; San Donato Milanese/IT 14:00–15:30 Room E2
14:00 Neuro
B-0270 Ultrasonography-guided injection for quadriceps
fat pad edema: a 6-month clinical and radiological SS 311a Cerebral tumours (1)
follow-up Moderators: A. Falini; Milan/IT, F.P. Kuhn; Zurich/CH
Z. Maras Ozdemir1, U. Aydingoz2, M.F. Korkmaz1, V. Tunay Bayrakcı2,
F.B. Ergen2, O.A. Atay2, O. Baysal1; 1Malatya/TR, 2Ankara/TR 14:00
P. Due-Tonnessen; Oslo/NO
B-0271 MR - US fusion imaging to guide lumbar facet joint
injections 14:09
A. Corazza, R. Sartoris, P. Caruso, G. Turtulici, A. Arcidiacono,
B-0281 Intraoperative MR imaging of cerebral oxygen
S. Perugin Bernardi, D. Orlandi, E. Silvestri; Genoa/IT
metabolism in patients with brain tumours
14:16 A. Stadlbauer, A. Merkel, B. Sommer, S. Brandner, M. Zimmermann,
M. Buchfelder, K. Rössler; Erlangen/DE
B-0272 MR T2 mapping to evaluate the effect of ultrasound
(US)-guided intra-articular injection of hyaluronic 14:17
acid (HA) on articular cartilage B-0282 Assessment of tumour oxygenation and its impact on
G. Ferrero1, E. Fabbro1, F. Fiz2, D. Dettore2, G. Serafini1;
1
treatment response in bevacizumab treated recurrent
Pietra Ligure/IT, 2Genoa/IT
glioblastoma
14:24 D. Bonekamp1, K. Mouridsen2, A. Radbruch1, A. Wick1,
H.-P. Schlemmer1, W. Wick1, M. Bendszus1, L. Østergaard2,
B-0273 New approach for B-mode ultrasound (US) P. Kickingereder1; 1Heidelberg/DE, 2Aarhus/DK
measurements of the plantar aponeurosis in healthy
volunteers 14:25
M.M.H. Abd Ellah, C. Kornreif, C. Kremser, W. Jaschke, A. Klauser; B-0283 Magnetic resonance imaging biomarkers for
Innsbruck/AT
assessment of vascular pathologies in glioma
A. Stadlbauer1, M. Zimmermann1, K. Rössler1, S. Oberndorfer2,
14:32 M. Buchfelder1, A. Dörfler1, G. Heinz2; 1Erlangen/DE, 2St. Pölten/AT
B-0274 Shear wave ultrasound elastography is a reliable and
repeatable method to measure elastic modulus of 14:33
patellar and achilles tendons B-0284 Multiparametric MR imaging of oxygen metabolism
S. Tas, M. Onur, A. Soylu, S. Yilmaz, F. Korkusuz; Ankara/TR and angiogenesis in glioma patients
A. Stadlbauer1, M. Zimmermann1, K. Rössler1, S. Oberndorfer2,
14:40 M. Buchfelder1, A. Dörfler1, G. Heinz2; 1Erlangen/DE, 2St. Pölten/AT
B-0275 Ultrasound evaluation of meniscal implant extrusion,
14:41
after meniscus reconstruction and impact of the
B-0285 Comparison of ferumoxytol and gadolinium
extrusion on patients quality of life
1 1 1 2 1
T. Pobozy , K. Slynarski , K. Sklinda , M. Frel ; Warsaw/PL, enhancement changes in response to Avastin in high
2
Otwock/PL grade glioma patients
A. Horváth1, C. Várallyay2, D. Schwartz2, P. Ambady2, P. Bogner1,
14:48 E. Neuwelt2; 1Pécs/HU, 2Portland, OR/US
B-0276 Ulnar neuropathy at the elbow: visualisation of cause
SPEAKER 14:49
SUPPORTED of ulnar entrapment with high-resolution ultrasound
BY B-0286 Prognostic value of preoperative dynamic contrast-
INVEST IN is predictive of outcome after transposition
THE YOUTH M. Schertz, J. Silvera, C. Mutschler, C. Bernard, E. Masmejean; enhanced MRI perfusion parameters for high-grade
Paris/FR glioma patients
A. Ulyte1, M. Skardelly2, J. Schittenhelm2, C. Braun2, B. Bender2,
14:56 S. Bisdas3; 1Vilnius/LT, 2Tübingen/DE, 3London/UK
B-0277 Therapeutic implications of nerve ultrasound in
14:57
leprosy
Y. Aswani, S. Saifi; Mumbai/IN B-0287 Prognosis prediction of non-enhancing T2 high
signal intensity lesion after standard treatment
15:04 in glioblastoma: application of dynamic contrast-
B-0278 Visualisation of the deep branch of the ulnar nerve enhanced MR imaging
using high-resolution ultrasound R. Kim, S. Choi; Seoul/KR
G. Riegler, D. Lieba-Samal, H. Platzgummer, C. Pivec, S. Jengojan,
P. Brugger, M. Vierhapper, G. Bodner; Vienna/AT 15:05
B-0288 Intravoxel incoherent motion diffusion-weighted MR
15:12
imaging in differentiation of meningiomas: initial
B-0279 Visualisation of the recurrent motor branch of the
study
median nerve using high-resolution ultrasound Y. Lu1, K. Shek2, B. Yin1, D. Geng1; 1Shanghai/CN, 2Honkong/CN
G. Riegler, D. Lieba-Samal, C. Pivec, H. Platzgummer, S. Jengojan,
P. Brugger, M. Vierhapper, G. Bodner; Vienna/AT

15:13 14:56
B-0289 Quantitatively evaluate the efficacy of diffusion B-0298 Contrast-enhanced PET/CT for oncologic indications:
kurtosis imaging in grading gliomas: a preliminary reproducibility and comparison to the two-step
study procedure, including PET/CT and contrast-enhanced
J. Chu1, Y. Wang1, J. Zhao1, X. Yan2, X. Li1; 1Guangzhou/CN, CT from radiology (COMBITEP study)
2
Shanghai/CN A.L. Cazeau, S. Ferron, M. Pulido, C. Bellera, S. Mathoulin Pelissier,
J. Palussiere, A. Dutertre, Y. Godbert, E. Descat; Bordeaux/FR
15:21
B-0290 Diagnostic accuracy of MR imaging techniques for 15:04
treatment response assessment in patients with high B-0299 Diagnostic value of whole-body ultra low dose CT
grade glioma: a systematic review and meta-analysis (WBULDCT) in comparison with spinal magnetic
B.R.J. van Dijken, P.J. van Laar, G.A. Holtman, A. van der Hoorn; resonance imaging (SMRI) in the assessment of
Groningen/NL
disease in patients with multiple myeloma (MM)
Wednesday
S. Spiga, D. Ippolito, C. Talei Franzesi, V. Besostri, E. Orsini, S. Sironi;
Monza/IT
14:00–15:30 Room F1
15:12
Oncologic Imaging B-0300 [18F]-FDG-PET/MR for staging and restaging of
lymphoma patients: is the use of DWI justified?
SS 316 Dealing with metastatic disease C. Giraudo, D. Senn, G. Karanikas, M. Weber, M. Raderer,
Moderators: D.M. Lambregts; Amsterdam/NL, M. Mayerhoefer; Vienna/AT
A. Sohaib; London/UK
15:20
14:00 B-0301 The quantitative CEUS features of clinically
B-0291 The application of DW-MRI in the staging of suspicious non-Hodgkin lymphoma involved
oesophageal cancer: prospective comparison with superficial lymph nodes: a preliminary study
EUS and MDCT J. Shi; Shanghai/CN
F. Giganti, P.G. Arcidiacono, R. Nicoletti, A. Ambrosi, E. Orsenigo,
E. Mazza, A. Del Maschio, F. De Cobelli; Milan/IT
14:00–15:30 Room F2
14:08
B-0292 One-step one-phase vs. multi-step multi-phase Physics in Radiology
whole-body staging CT - comparison of radiation
dose and diagnostic confidence SS 313 Radiation risk assessment and
D. Zinsser, R. Marcus, E. Körner, A. Othman, F. Bamberg, K. Nikolaou,
M. Notohamiprodjo; Tübingen/DE
awareness
Moderators: N. Buls; Brussels/BE, O. Ciraj-Bjelac; Belgrade/RS
14:16
14:00
B-0293 Sentinel lymph node (SLN) melanoma
micrometastasis managed conservatively: V. Tsapaki; Athens/GR
sonography (US) patterns of recurrence
1 1 2 1 1
O. Catalano , C. Caracò , A. Nunziata , F. Sandomenico , A. Petrillo ; 14:09
1
Naples/IT, 2Ercolano/IT
B-0302 The transatlantic race of CT radiation dose: Europe vs
14:24 United States
A. Euler, A. Parakh, S. Schindera; Basle/CH
B-0294 Can unenhanced multiparametric MRI substitute
gadolinium-enhanced MRI in the characterisation of 14:17
vertebral marrow infiltrative lesions? B-0303 Patient organ dose with computed tomography
D.Z. Zidan, H. El Ghazaly; Cairo/EG
- a review of present methodology and DICOM
14:32 information: executive summary of the joint report of
B-0295 Association of quality and quantity of bone AAPM task group 246 and EFOMP
J.S. Andersson1, W. Pavlicek2; 1Umeå/SE, 2Scottsdale, AZ/US
metastases as well as volumetric bone mineral
density with the prevalence of vertebral fractures in 14:25
breast cancer patients B-0304 Are the existing national diagnostic reference levels
V. Neuhaus, N. Abdullayev, M. Hellmich, S. Krämer, D. Maintz, B. Krug,
J. Borggrefe; Cologne/DE for CT outdated?
A. Euler, A. Parakh, S. Schindera; Basle/CH
14:40
14:33
B-0296 Primary tumor detection in CUP of neuroendocrine
B-0305 Awareness and knowledge of ionising radiation
origin: additional value of 68Ga-DOTA-TATE-PET/CT
hazard among medical students and residents in
compared to contrast-enhanced CT
P. Kazmierczak, A. Rominger, V. Wenter, C. Spitzweg, Kabul, Afghanistan
C. Auernhammer, M. Angele, C. Rist, M.F. Reiser, C.C. Cyran; S. Maroof, T. Alam; Kabul/AF
Munich/DE
14:41
14:48 B-0306 Improving radiation awareness and feeling of
B-0297 Patterns of metastatic spread and its implications on personal security of non-radiological medical
follow up strategies in uveal melanoma staff in computed tomography scanning room by
C. Kloth, A. Othman, G. Bier, R. Syha, T. Eigentler, C. Garbe,
K. Nikolaou, B. Klumpp; Tübingen/DE
implementing a traffic light system
C. Heilmaier, A. Mayor, N. Zuber, P. Fodor, D. Weishaupt; Zurich/CH

14:49 14:32
B-0307 Radiation risk from screening mammography B-0316 Pulmonary thin-section MR imaging with ultra-
R.M.K. M.Ali, A. England, A. Tootell, P. Hogg; Manchester/UK short TE: comparison of capability for lung nodule
14:57 detection and nodule type classification with low-
and standard-dose thin-section CTs
B-0308 A successful dose management quality improvement Y. Ohno1, Y. Kishida1, S. Seki1, H. Koyama1, T. Yoshikawa1, M. Yui2, A. Lu3,
project (QIP): data-driven multi-disciplinary M. Miyazaki3, K. Sugimura1; 1Kobe/JP, 2Otawara/JP, 3Vernon Hills,
approach to managing patient radiation in computed IL/US
tomography (CT)
L. Laurent; Park Ridge, IL/US
14:40
B-0317 Dynamic contrast-enhanced MRI of malignant
15:05 SPEAKER
SUPPORTED pleural mesothelioma: a comparative study of
BY
B-0309 Utilising a server based simulation to compare INVEST IN pharmacokinetic models and correlation with
THE YOUTH
effective organ dose of 70kV dynamic CT mRECIST criteria
examinations to diagnostic standard triphasic M. Vivoda Tomšič1, K. Šurlan Popovič1, S. Bisdas2, V. Kovač1, I. Serša1;
1
Ljubljana/SI, 2London/UK
abdominal CT
J.F.M. Gawlitza; Mannheim/DE
14:48
15:13 B-0318 A role of diffusion-weighted MRI in prediction of
B-0310 Introducing a dose monitoring software in mediastinal lymph node metastasis in patients with
conventional x-ray imaging: initial experiences NSCLC: comparison to PET results
C. Heilmaier, N. Zuber, D. Weishaupt; Zurich/CH E.U.A.K. Yilmaz; Izmir/TR
15:21 14:56
B-0311 Conventional x-ray dose analysis in emergency rooms B-0319 Chemical exchange saturation transfer (CEST)
in different hospitals using a centralised electronic imaging vs FDG-PET/CT: capability for differentiation
platform of malignant from benign pulmonary lesions
E. Fraile Moreno, C. Benito, J. Azpeitia, J. Albillos, E. Dominguez, Y. Ohno1, M. Yui2, M. Miyazaki3, Y. Kishida1, S. Seki1, H. Koyama1,
P. Fraga, J. Galobardes, T. Villarejo; Madrid/ES T. Yoshikawa1, K. Sugimura1; 1Kobe/JP, 2Otawara/JP, 3Vernon Hills,
IL/US
15:04
14:00–15:30 Room D1
B-0320 Diaphragmatic dynamic magnetic resonance imaging
Chest (MRI): preliminary results and perspectives
R. Lotte, S. Boussouar, F. Le Pimpec-Barthes, A. Charpentier,
K. Dang Tran, C. Rivera, B. Lambert, P. Halimi, A.-C. Hernigou;
SS 304 Lung MRI Paris/FR
Moderators: P. Ciet; Rotterdam/NL, N.N.
15:12
14:00 B-0321 3 Tesla MRI evaluation of pectus carinatum with
B-0312 Free-breathing 3D T1-weighted fat-saturated breath-hold imaging
contrast-enhanced gradient-echo sequence with R. Lee, G. Lo Goh, H. Ai, K. Chan, C. Yuen, W. Chung, M. Hung;
Hong Kong/CN
radial data sampling in thoracic and cardiovascular
MRI 15:20
C. Ruff1, R. Grimm2, A. Hornung1, M. Kündel1, J. Weiß1, F. Bamberg1,
K. Nikolaou1, M. Notohamiprodjo1; 1Tübingen/DE, 2Erlangen/DE B-0322 Pulmonary embolism detection with 3D ultrashort
echo time MRI: experimental study in canines
14:08 P. Bannas1, L.C. Bell2, K.M. Johnson2, M.L. Schiebler2, C.J. Francois2,
U. Motosugi2, D. Consigny2, S.B. Reeder2, S.K. Nagle2; 1Hamburg/DE,
B-0313 Automated 3D segmentation of pulmonary magnetic 2
Madison, WI/US
resonance angiography in patients with pulmonary
arterial hypertension: correlation with pulmonary
arterial systolic pressure 14:00–15:30 Room D2
C. Melzig1, S. Wörz1, S. Ley2, C. Fink3, S. Partovi4, K. Rohr1,
H.-U. Kauczor1, E. Grünig1, F. Rengier1; 1Heidelberg/DE, 2Munich/DE,
3
Celle/DE, 4Cleveland, OH/US
14:16 SS 309 Musculoskeletal
B-0314 Pulmonary perfusion phase imaging using self- Moderators: A. Diamantopoulos; London/UK,
S. Marcia; Cagliari/IT
gated Fourier decomposition MRI reveals perfusion
inhomogeneities in patients with cystic fibrosis 14:00
S. Veldhoen, D. Stäb, A.M. Weng, A.S. Kunz, A. Fischer, C. Wirth,
H. Hebestreit, T.A. Bley, H. Köstler; Würzburg/DE
B-0323 Retrospective analysis in 20 consecutive patients
undergoing percutaneous MR-guided cryoablation
14:24 of Morton’s neuroma: clinical results and insight on a
B-0315 Semi-quantitative visual scoring of fibrosing lung new emerging treatment
disease using T2-weighted BLADE sequences R. Cazzato1, J. Garnon1, G. Tsoumakidou1, G. Koch1, J. Caudrelier1,
X. Buy2, P. Rao1, M.-A. Thenint1, A. Gangi1; 1Strasbourg/FR,
and comparison with multidetector computed 2
Bordeaux/FR
tomography
M.T.A. Buzan1, J. Dinkel2, M. Eichinger3, D. Colombi4, M. Kreuter3,
F. Herth3, H.-U. Kauczor3, C. Pop1, C. Heussel3; 1Cluj-Napoca/RO,
2
Munich/DE, 3Heidelberg/DE, 4Parma/IT

14:08 14:00–15:30 Room K

B-0324 Treatment of supraspinatus tendinopathy: dry
needling as a stand-alone procedure vs dry needling Genitourinary
and platelet-rich plasma (prp)
F. Bruno, A. La Marra, S. Mariani, F. Arrigoni, L. Zugaro, A. Barile, SS 307 Prostate cancer: targeted biopsy and
C. Masciocchi; L’Aquila/IT beyond
Moderators: M. Meissnitzer; Salzburg/AT, N.N.
14:16
B-0325 Percutaneous long bone cementoplasty for palliation 14:00
of malignant lesions of the limbs in 196 patients B-0334 Prospective randomised evaluation of MR-guided in-
E. Lanza1, R. Cazzato2, R. Grasso3, X. Buy4, J. Palussiere4, V. Pedicini1,
L. Balzarini1, D. Poretti1; 1Rozzano/IT, 2Strasbourg/FR, 3Rome/IT,
bore versus MRI/ultrasound fusion plus TRUS-guided
4
Bordeaux/FR prostate biopsy in patients with prior negative
Wednesday
biopsies
14:24 F. Dietzel, L. Schimmöller, M. Quentin, D. Blondin, C. Arsov,
B-0326 Usefulness of O2-O3 intradiscal versus steroid R. Rabenalt, G. Antoch, H.E. Gabbert, P. Albers; Düsseldorf/DE
intraforaminal injection in back pain control: a 14:08

prospective double-blind trial in patients with
B-0335 Are single shot biopsies sufficient for targeted MR-
different discovertebral pathologies
M. Perri1, T. Popolizio1, C. Marsecano2, M. Varrassi2, A. Splendiani2,
guided prostate cancer detection?
T. Ullrich, L. Schimmöller, M. Quentin, F. Dietzel, C. Arsov, R. Rabenalt,
M. Carlo2; 1San Giovanni Rotondo/IT, 2L’Aquila/IT
D. Blondin, P. Albers, G. Antoch; Düsseldorf/DE
14:32
14:16
B-0327 Effectiveness of percutaneous vertebroplasty in
B-0336 MRI-targeted prostate biopsy outcomes after
cases of multiple myeloma with vertebral pain
M. Inecikli1, Ö. Nas2, B. Hakyemez2; 1Rize/TR, 2Bursa/TR
previous negative TRUS-guided random biopsy:
correlation to risk-based patient selection
14:40 A.R. Alberts, M.J. Roobol, L.P. Bokhorst, C.H. Bangma, I.G. Schoots;
Rotterdam/NL
B-0328 Cementoplasty for arthrodesis screw loosening: a
technique to prolong the useful life of an implant 14:24
S. Perez Aguilera, M. Zauner Jakubik; Sabadell/ES
B-0337 Qualification biopsies by elastic fusion registration in
14:48 active surveillance for localised prostate cancer
D. Portalez, R. Aziza, M. Roumiguie, S. Sanson, B.A. Malavaud;
B-0329 Radiological percutaneous osteosynthesis and Toulouse/FR
SPEAKER
SUPPORTED cementoplasty for impending malignant pathological
BY 14:32
INVEST IN fracture of the proximal femur
THE YOUTH E. Mavrovi, H. Beji, A.-C. Kalenderian, G. Vaz, C. Mastier, P. Thiesse, B-0338 Sepsis and other complications related to TRUS-
B. Richioud; Lyon/FR
guided prostate biopsy: 3-year experience at a
14:56 regional cancer centre
C. Crowley1, A. Cahill2, J. Buckley2, F. O’ Brien2, K. O’ Regan2;
B-0330 Percutaneous intra-articular neurolysis with pulsed 1
Dublin/IE, 2Cork/IE
radiofrequency in knee osteoarthritis
D. Filippiadis, S. Grigoriadis, A. Mazioti, S. Spiliopoulos, E. Brountzos, 14:40
N. Kelekis, A. Kelekis; Athens/GR
B-0339 Should MRI after prostate biopsy be delayed?
J. Choi, S. Jung, M. Choi; Seoul/KR
15:04
B-0331 Role of CT-guided percutaneuos cryoablation 14:48
SPEAKER
SUPPORTED combined with cementoplasty for bone lesion in B-0340 Risk-based patient selection for MRI-targeted
BY
INVEST IN weight-bearing areas prostate biopsy after negative transrectal ultrasound-
THE YOUTH S. Quarchioni, F. Arrigoni, S. Mariani, A. La Marra, L. Zugaro, A. Barile,
C. Masciocchi; L’Aquila/IT
guided random biopsy avoids unnecessary MRI scans
A.R. Alberts, I.G. Schoots, L.P. Bokhorst, G.J.L.H. Leenders,
C.H. Bangma, M.J. Roobol; Rotterdam/NL
15:12
B-0332 Efficacy of ultrasound-guided needle tenotomy for 14:56
the treatment of chronic tendinopathies B-0341 Localisation of primary prostate cancer by
F. Bruno, A. La Marra, S. Mariani, F. Arrigoni, L. Zugaro, A. Barile,
simultaneous 68gallium-HBED-CC-PSMA PET/MRI
M. Eiber, G. Weirich, K. Holzapfel, M. Souvatzoglou, I. Rauscher,
B. Haller, M. Schwaiger, T. Maurer; Munich/DE
15:20
B-0333 Combined microwave ablation and percutaneous 15:04
screws fixation plus cementoplasty in the treatment B-0342 Magnetic resonance spectroscopy of the prostate: in
of painful bone metastases vitro comparison of the choline-plus-creatine-over-
C. Pusceddu, N. Ballicu, B. Sotgia, R. Fele, L. Melis; Cagliari/IT
citrate ratio at 1.5 T and 3.0 T
U.G. Mueller-Lisse1, M. Scherr2, A. Meister1, M.F. Reiser1,
U.L. Mueller-Lisse1; 1Munich/DE, 2Murnau a. Staffelsee/DE
15:12
B-0343 ADC in the evaluation of side-specific extracapsular
extension of prostate cancer: development and
internal validation of a nomogram of clinical utility
F. Giganti, A. Coppola, A. Ambrosi, S. Ravelli, A. Esposito, A. Briganti,
F. Montorsi, A. Del Maschio, F. De Cobelli; Milan/IT

15:20 15:13
B-0344 Index lesion characterised by 11C-choline PET/CT B-0353 Multi-center analysis of incidental findings on low
and 3-Tesla MRI spectroscopy in primary prostate resolution CT attenuation correction (CTAC) images:
carcinoma: clinical implications in the era of image- an extended study
guided therapy J. Coward1, R. Lawson1, T. Kane2, M. Elias3, A. Howes4, J. Birchall5,
M.D. Hernández-Argüello, J. Solorzano, I. Pascual, A. Benito, P. Hogg1; 1Manchester/UK, 2Blackpool/UK, 3Wrexham/UK,
4
M. Collantes, C. Padula, M. Cabaleros, J. Pardo, J.A. Richter; Prestcot/UK, 5Derby/UK
Pamplona/ES
15:21
B-0354 The visible and the invisible in cone beam CT: the
14:00–15:30 Room G role of radiographer
M. Simoncini1, M. Biondi1, L. Amata1, M. Virgilio2, L. Giuliani2,
Radiographers C. Ottonello1; 1Pomezia/IT, 2Rome/IT
SS 314 CT parameters: juggling or struggling?

14:00–15:30 Room M 1
Moderators: E. Agadakos; Athens/GR, E. Sorantin; Graz/AT
14:00 Head and Neck

A. Hartvig Sode; Odense/DK SS 308 Salivary glands, neck, parathyroid
Moderators: G. Conte; Milan/IT, C. Czerny; Vienna/AT
14:09
B-0345 Optimisation of chest computed tomography using 14:00
a phantom: impact of mAs and reconstruction B-0355 MRI: the technique of choice in the study of Warthin
techniques on image quality tumours
C.S. Reis1, T. Faquir2, V. Harsaker3, P. Hogg2, L. Kristoffersen3, B. Brea Alvarez, L. Esteban, Y. García-Hidalgo, M. Tuñón;
I.L. van Rein4, K. Stancombe2, N.C. Warmerdam4, C. Wergeland3; Majadahonda/ES
1
Lisbon/PT, 2Salford/UK, 3Oslo/NO, 4Groningen/NL
14:08
14:17 B-0356 MRI with diffusion weighted imaging of salivary
B-0346 Noise variations across clinically accepted paediatric gland tumours, prediction of the benignancy and
SPEAKER
SUPPORTED body CT scans malignancy
BY M. O’Connor, S. Foley; Dublin/IE A. Youssef, D. Abdelhady Mohammed, R. Edward; Cairo/EG
INVEST IN
THE YOUTH
14:16
14:25 B-0357 Assessment of salivary gland tumours using MRI and
B-0347 Short and long term effects of clinical audit on CT: impact of experience on diagnostic accuracy
compliance with procedures in CT scanning T.J. Vogl, T. Stark-Paulsen, M. Albrecht, N.-E. Nour-Eldin,
A. Oliveri1, N. Howarth2, H. Salame1, P. Gevenois1, D. Tack1; 1Ath/BE, H. Ackermann, A. Maataoui; Frankfurt a. Main/DE
2
Chenes-Bougeries/CH
14:24
14:33 B-0358 Ultrasound-guided salivary gland core needle biopsy:
B-0348 Analysis of CT exposure parameters, dose values and the road to take
image noise in order to promote the harmonisation M.A. Schuller Arteaga, L. Antón Mendez,
M. Udondo González del Tánago, J.L. Del Cura Rodríguez,
of CT examinations
A. Bilbao González, R.M. Zabala Landa, I. Korta Gómez,
A. Carriço, F. Palumbo, R. Cristina, G. Paulo, J. Santos; Coimbra/PT
A. Viteri Jusue, D. Grande Icarán; Bilbao/ES
14:41
14:32
B-0349 Coronary computed tomography angiography:
B-0359 Assessing the influence of MRI scan position on
evaluation of the effects of cradle sagging on stair-
image quality of head and neck MR images for
step artifacts
S. Lee, J. Kang, H. Koo, S. Kim, D. Seo; Seoul/KR
radiotherapy treatment planning
L. Xiao, M. Yuen, Y. Tung, P. Wong, H. Ho; New Territories/HK
14:49
14:40
B-0350 Optimisation of CT follow-up protocol’s in patients
B-0360 Cervical adipose tissue to airway volume ratio
with gastrointestinal stromal cancer
R. Pinilla1, M.I.R. Ortega1, E.M. Campos1, M. Monteiro2; 1Madrid/ES,
(CAT:AV): a novel anthropometric measure,
2
Coimbra/PT its anatomic relationship to sleep apnea,
cerebrovascular accident and overall mortality
14:57 H.S. Maresky1, P.A. Gottlieb1, L. Copel1, D. Ahoubim2, S. Tal1; 1Zrifin/IL,
2
B-0351 Assessment of image quality criteria from abdominal Miami, FL/US
CT examinations 14:48
A.F.C.L. Abrantes, P. Paias, L.P. Ribeiro, A.M. Ribeiro, R.P.P. Almeida,
K.B. Azevedo; Faro/PT B-0361 Accuracy of magnetic resonance imaging for
subglottic stenosis grading in patients with
15:05 granulomatosis with polyangiitis
B-0352 Carotid plaque PET/CT standardised uptake values M. Kupka, P. Bannas, L. Linsenhoff, G. Adam, F. Henes; Hamburg/DE
measurements as a biomarker for stroke: software
14:56
reproducibility challenges
N. Giannotti, J. McNulty, S. Foley, P. Kelly; Dublin/IE B-0362 MRI of neck victims of survived strangulation:
evaluation of cases
C. Bruguier, J. Grimm, J.-B. Zerlauth, K. Michaud, P. Mangin, R. Meuli,
S. Grabherr; Lausanne/CH

15:04 14:57
B-0363 Multi-modality imaging of patients with carotidynia B-0373 Comparison of organ doses between 70 kVp chest
and clinical correlation CT and 100 kVp chest CT with a dedicated tin filter
A. Lecler, G. Volle, M. Obadia, P. Roux, J. Savatovsky, O. Gout, for spectral shaping using thermoluminescent
J.-C. Sadik; Paris/FR
dosimeter measurements in a pediatric phantom
C. Hagelstein1, M. Weis1, T. Henzler1, U. Lechel2, K. Neff1, G. Brix2,
15:12
S.O. Schönberg1, A. Schegerer2; 1Mannheim/DE, 2Neuherberg/DE
B-0364 Preliminary results of 18F-Fluorocholine PET/MRI
show excellent accuracy in patients with primary 15:05
hyperparathyroidism and inconclusive conventional B-0374 Feasibility of low dose 18FDG PET/CT in pediatric
imaging oncology
W.P. Kluijfhout1, T.A. Hope1, M.R. Vriens2, J.E. Gosnell1, W.T. Shen1, J. Zhang, N. Hall, K. Binzel, M. Natwa, M.V. Knopp; Columbus, OH/US
Q.-Y. Duh1, C.M. Glastonbury1, I. Suh1, M.H. Pampaloni1; 1San Francisco,
Wednesday
CA/US, 2Utrecht/NL 15:13
B-0375 Use of diagnostic computed tomography in
15:20
paediatric PET-CT: is diagnostic CT essential?
B-0365 One-stop SPECT-CT-guided ultrasound for C. Loberg, C. Kuhl, A. Heinzel, F. Mottaghy, F. Verburg; Aachen/DE
parathyroid adenoma localisation - a single centre
experience
P. Touska1, A. Elstob1, N. Rao2, A. Parthipun1; 1London/UK, 14:00–15:30 Room M 3
2
Birmingham/UK
Cardiac
14:00–15:30 Room M 2
SS 303b CT perfusion
Paediatric Moderators: R. Fischbach; Hamburg/DE, M. Francone; Rome/IT
14:00
SS 312 Thorax and musculoskeletal
B-0376 Quantification of myocardial perfusion defects at
Moderators: C. Balassy; Vienna/AT, Z. Yazici; Bursa/TR
third-generation dual-source CT in an ex-vivo porcine
14:00 heart model
G. Pelgrim1, S. Van Tuijl2, K. Slump3, M. Stijnen2, M. Oudkerk1,
K-09 Keynote lecture R. Vliegenthart1; 1Groningen/NL, 2Eindhoven/NL, 3Enschede/NL
A.C. Offiah; Sheffield/UK
14:08
14:09
B-0377 Computed tomography coronary angiography
B-0366 Juvenile idiopathic arthritis (JIA): whole-body MRI
vs stress cardiac magnetic resonance for the
(WBMRI) approach in diagnosis and assessment of
management of symptomatic revascularized patients:
therapeutic efficacy
P. Arcuri1, S. Roccia2, G. Raiola1, M. Cirillo1, A. Pingitore1, G. Fodero1; a cost effectiveness study
1
Catanzaro/IT, 2Lamezia Terme/IT G. Pontone1, D. Andreini1, C. Rota1, M. Guglielmo1, S. Mushtaq1,
A. Baggiano1, A. Solbiati1, A. Guaricci2, M. Pepi1; 1Milan/IT, 2Foggia/IT
14:17
14:16
B-0367 Radiological phenotype/ genotype correlations
B-0378 Comparison between CT perfusion imaging of
of constitutional bone diseases involving the
the myocardium and intracoronary transluminal
parathyroid hormone (PTH) and its signaling
attenuation gradient in coronary CT angiography for
pathways
M. Lahkim, A. Durand, V. Merzoug, A. Linglart, C. Adamsbaum; the assessment of coronary artery stenosis
Le Kremlin-Bicêtre Cedex/FR B.M. Gramer, I. Baur, M. Rasper, M. Rasper, A. Leber; Munich/DE
14:25 14:24
B-0368 Serial analysis of aortic haemodynamics in patients B-0379 Computed tomography angiography and perfusion
with repaired aortic coarctation by 4D flow MRI CT to assess coronary artery stenosis causing
J. Geiger1, J. Romberg2, D. Hirtler2, K. Gottfried2, B. Stiller2; perfusion defects
1
Zurich/CH, 2Freiburg/DE R. Boughrarou; Algiers/DZ
14:33 14:32
B-0369 Role of dual-source computed tomography in B-0380 Optimal timing of static CT iodine distribution scans
identification of respiratory symptomatic patients based on dynamic CT myocardial perfusion imaging
affected by true isolated vascular rings data
T.P. Santangelo, M. Trezzi, G. Muscogiuri, M. Maurizi Enrici, G. Pelgrim1, E.R. Nieuwenhuis1, J.L. Wichmann2, C.N. De Cecco2,
S. Albanese, A. Carotti, P. Tomà, A. Secinaro; Rome/IT R. Van der Geest3, K.H. Slump4, M. Oudkerk1, U.J. Schoepf2,
R. Vliegenthart1; 1Groningen/NL, 2Charleston, SC/US, 3Leiden/NL,
14:41 4
Enschede/NL
B-0370 Lung perfusion with dual-energy CT: can we achieve
14:40
a diagnostic image quality in children?
M. Remy-Jardin, T. Santangelo, A. Deschildre, J.-B. Faivre, A. Hutt, B-0381 Morphological coronary stenosis characteristics
J. Rémy; Lille/FR by CCTA: comparison with invasive fractional flow
reserve
14:49 L. Macron, J.-L. Sablayrolles; Saint Denis/FR
B-0372 Multi-detector computed tomography of paediatric
large airway diseases: comparison between virtual
bronchoscopy and fiberoptic bronchoscopy
T.S. Jugpal, A. Garg, J. Kumar, G.R. Sethi; New Delhi/IN

14:48 14:24
B-0382 Adenosine triphosphate stress dynamic perfusion B-0390 Microinfarcts detected on MRI - another important
CT imaging to identify myocardial ischemia: imaging biomarker in cognitive impairment?
correlation with coronary CTA and invasive coronary S. Shams1, M. Larvie2, M. Lev2, J. Martola1, A. Charidimou2,
M. Kristoffersen Wiberg1, L.-O. Wahlund1; 1Stockholm/SE, 2Boston,
angiography MA/US
E. Tahir1, T. Kido1, Y. Tanabe1, N. Fukuyama1, T. Kido1, J. Yamamura2,
G.K. Lund2, G. Adam2, T. Mochizuki1; 1Toon, Ehime/JP, 2Hamburg/DE
14:32
14:56 B-0391 Analysis of hippocampal subfield in patients with
B-0383 Acceptance of combined coronary CT angiography mild Alzheimer’s disease
Y. Liu, H. Yuan, X. Zeng, Z. Wang; Beijing/CN
and myocardial CT perfusion versus conventional
coronary angiography in patients with coronary 14:40
stents B-0392 Brain MR pallidal index do not correlate with clinical
S. Feger1, M. Rief1, P. Martus2, M. Laule1, M. Dewey1, E. Schönenberger3;
1
Berlin/DE, 2Tübingen/DE, 3Hannover/DE
functional scale in extrapiramidal syndromic cirrhotic
patients
15:04 E. Soligo, A. Stecco, M. Carecchio, R. Matheoud, A. Carriero;
Novara/IT
B-0384 Potential usefulness of cardiac output and total
peripheral resistance as indicators of adequate 14:48
vasodilation in myocardial perfusion imaging B-0393 Altered brain connectivity in dementia: a correlation
N. Nagasawa, K. Kitagawa, A. Yamazaki, H. Sakuma; Tsu/JP
study between functional and structural data
V. Onofrj1, F. Piludu1, F. Vecchio1, F. Miraglia1, G. Granata1, M. Caulo2,
15:12 P. Bramanti3, P.M. Rossini1, C. Colosimo1; 1Rome/IT, 2Chieti/IT,
3
B-0385 Optimal scan delay time for quantitative CT Messina/IT
myocardial perfusion imaging
N. Nagasawa, K. Kitagawa, A. Yamazaki, H. Sakuma; Tsu/JP 14:56
B-0394 Iterative metal artifact reduction in computed
15:20 tomography following deep-brain-stimulation (DBS)
B-0386 Relationship of cardiovascular risk factors to surgery
myocardial perfusion parameters using dynamic J. Aissa, J. Boos, C. Schleich, R. Lanzman, P. Kröpil, G. Antoch,
C. Thomas; Düsseldorf/DE
computed tomography myocardial perfusion imaging
G. Pelgrim1, R. Vliegenthart1, F.G. Meinel2, J.L. Wichmann3,
F. Pugliese4, C.N. De Cecco3, M. Oudkerk1, U.J. Schoepf3; 15:04
1
Groningen/NL, 2Munich/DE, 3Charleston, SC/US, 4London/UK B-0395 Alterations of white matter integrity in HIV-
associated neurocognitive disorder: a tract-based
spatial statistics study
14:00–15:30 Room M 4 S. Oh1, W. Lee2, N.-Y. Shin2, S.-K. Lee2, S. Lim2; 1Cheonan/KR,
2
Seoul/KR
Neuro
15:12
SS 311b Dementia B-0396 Changes of systolic cerebrospinal fluid flow in
Moderators: N. Pyatigorskaya; Paris/FR, patients with normal pressure hydrocephalus exceed
M.A. van Buchem; Leiden/NL age-related alterations
S. Stoecklein1, S. Lause1, A. Pomschar1, R. Schniepp1, S. Lee2, K. Jahn1,
14:00 N. Alperin2, B. Ertl-Wagner1; 1Munich/DE, 2Miami, FL/US
B-0387 The clinical impact of 18F-fluorodeoxyglucose
15:20
(FDG) positron emission tomography/computed
tomography (PET/CT) in patients with cognitive B-0397 Rating scores of medial temporal atrophy from CT
impairment and MR images are highly correlated
D. Van Westen1, M. Johnsson2, C. Håkansson1, L. Minthon3,
H. Motara1, T. Olusoga2, G. Russell3, S. Jamieson1, S. Ahmed2, A. Pillai3,
O. Lindberg3, S. Palmqvist3, O. Hansson3; 1Lund/SE, 2Trelleborg/SE,
A. Scarsbrook1, C. Patel1, F. Chowdhury1; 1Leeds/UK, 2Harrogate/UK, 3
3 Malmö/SE
Saltaire/UK
14:08
B-0388 Medial temporal lobe atrophy grades in a 14:00–15:30 Room M 5
homogeneous 75-year-old cognitively normal
Neuro
population
1 1 2 1 1
V. Velickaite , J. Kullberg , L. Cavallin , L. Lind , H. Ahlström ,
L. Kilander1, E. Westman2, E.-M.B. Larsson1; 1Uppsala/SE, SS 311c Neurovascular interventions (1)
2
Stockholm/SE Moderators: A. Biondi; Besancon/FR, H.P. Schemuth; Essen/DE
14:16 14:00
B-0389 The role of quantitative MR R2* brain iron deposition K-08 Keynote lecture
in patients with Alzheimer disease and its correlation A. Biondi; Besancon/FR
with cerebral perfusion
R. Esposito, M. Maccarone, S. Salice, G. Caracciolo, S. Delli Pizzi,
14:09
L. Valentino, P. Chiacchiaretta, A. Ferretti, A. Tartaro; Chieti/IT B-0398 Results of the acute recanalisation of thrombo-
embolic ischaemic stroke with pREset (ARTESp) trial
W. Kurre1, B. Schwaiger2, A. Gersing2, T. Niederstadt3, W. Reith4,
S. Felber5, S. Prothmann2; 1Stuttgart/DE, 2Munich/DE, 3Münster/DE,
4
Homburg/DE, 5Koblenz/DE

14:17
B-0399 Impact of patient transfer on clinical outcome after
endovascular recanalisation - analysis from the acute
recanalisation of thrombo-embolic ischaemic stroke
with pREset (ARTESp) trial
W. Kurre1, B. Schwaiger2, A. Gersing2, W. Reith3, T. Niederstadt4,
S. Felber5, S. Prothmann2; 1Stuttgart/DE, 2Munich/DE, 3Homburg/DE,
4
Münster/DE, 5Koblenz/DE
14:25
B-0400 Reduction in cerebral embolic lesions during
Transcatheter Aortic Valve Replacement (TAVR) with
an embolic protection device (MISTRAL-C)
Wednesday
H. Ahmad1, A. van der Lugt1, L. van Gils1, N.M. van Mieghem1,
H.W. van der Werf2, G. Brueren3, A.F.M. van den Heuvel2,
P. Koudstaal1, P.P.T. de Jaegere1; 1Rotterdam/NL, 2Groningen/NL,
3
Eindhoven/NL
14:33
B-0401 Endovascular occlusion of intracranial vessels using
nBCA embolisation, controlled by adenosine-induced
asystole
F. Thaher, M. Aguilar, C. Harmening, W. Kurre, R. Martinez, P. Kurucz,
O. Ganslandt, H. Henkes; Stuttgart/DE
14:41
B-0402 Prediction of long-term functional outcome after
subarachnoid hemorrhage using machine learning
C. Rubbert, R. May, D. Martens, B. Turowski, C. Mathys, J. Caspers;
Düsseldorf/DE
14:49
B-0403 Thrombo-embolic complications during intracranial
arterial endovascular procedures treated with stent
retrievers by mechanical thrombectomy: technical
and clinical results
M. Voormolen, T. van der Zijden, T. Menovsky, L. Yperzeele, I. Baar,
O. d‘Archambeau, F. De Belder, P.M. Parizel; Edegem/BE
14:57
B-0404 CT angiography/perfusion (CTA-CTP) for early
detection of vascular complications after
subarachnoid haemorrage (SH) due to aneurysm
rupture
E. Puglielli, L. Gregori, V. Di Mizio, R. Lattanzi, A. Bernardini,
V. Di Egidio; Teramo/IT
15:05
B-0405 Imaging anatomy of dural blood supply from pial
arteries: evaluated by 3D rotational angiography in
normal subjects and pathologic conditions
S. Tanoue1, H. Kiyosue1, H. Mori1, T. Kubo1, K. Sugita1, R. Ishibashi2,
A. Ishii2; 1Oita/JP, 2Kitakyushu/JP
15:13
B-0406 Safety and efficacy of intravenous tirofiban as
antiplatelet premedication for stent-assisted coiling
in acutely ruptured intracranial aneurysms
J. Lee, B. Kim, M. Kang, S. Kim, S. Choi; Busan/KR
15:21
B-0407 Association of automatically quantified blood
volume after aneurysmal subarachnoid haemorrhage
with delayed cerebral ischemia
I.A.J. Zijlstra; Amsterdam/NL


10:30–12:00 Room B 11:42

B-0417 Volume CT-perfusion of the liver and spleen: is there
Abdominal Viscera a correlation between hepatic venous pressure
gradient (HVPG) and perfusion in patients with liver
SS 601a Chronic liver disease and primary liver
cirrhosis?
tumours E. Talakic, S. Schaffellner, D. Kniepeiss, H. Müller, R. Stauber,
Moderators: D.E. Malone; Dublin/IE, P. Rodriguez; Madrid/ES H. Schöllnast; Graz/AT
10:30
B-0408 Surveillance for hepatocellular carcinoma in high-risk 10:30–12:00 Room C
patients: abdominal ultrasound compared to cross-
sectional imaging: results of 5-year cohort follow-up
Breast
L. van Dam, F.E.J.A. Willemssen, R.S. Dwarkasing; Rotterdam/NL
SS 602a Breast MRI: new sequences and
10:38 applications
B-0409 Comparison of diagnostic performance of gadoxetic Moderators: A. Sever; Maidstone/UK,
acid-enhanced liver MR imaging with multidetector I. Thomassin-Naggara; Paris/FR
CT in detection of Dysplastic nodules and early
10:30
hepatocellular carcinoma
B. Kim, J. Lee, J. Kim; Seoul/KR B-0419 Breast cancer detection in dense breast with
abbreviated breast MRI protocol: first hundred cases
10:46 M. Nadrljanski, D. Pavlovic - Stankovic, N. Spasic,
V. Plesinac - Karapandzic, M. Nikitovic, Z. Milosevic; Belgrade/RS
B-0410 Added value of Gd-EOB-DTPA enhanced liver MRI for
diagnosis of small HCC and atypical hepatic nodules
Thursday
10:38
(d2cm) B-0420 Only in invasive lobular cancers breast MRI use
J. Yoon, J. Lee, K. Lee, J. Han; Seoul/KR
is associated with a lower risk of surgical margin
10:54 involvement and reduced number of mastectomies: a
B-0411 Evaluation of combined read-out of Gd-EOB-DTPA “real world” analysis in the Netherlands
M. Lobbes1, I. Vriens1, G. Nieuwenhuijzen2, L. Boersma1, T. van Dalen3,
and gadobutrol magnetic resonance imaging for the
H. Struikmans4, S. Siesling3, A. Voogd1, V. Tjan-Heijnen1;
prediction of hepatocellular carcinoma grading 1
Maastricht/NL, 2Eindhoven/NL, 3Utrecht/NL, 4The Hague/NL
S. Kinner, T.C. Lauenstein, J. Best, S. Bertram, M. Reinboldt, J. Goebel;
Essen/DE 10:46
11:02 B-0421 Abbreviated combined MR protocol: a new faster
B-0412 Quantitative assessment of washout in hepatocellular strategy for characterising breast lesions
M. Telegrafo, T. Introna, L. Coi, L. Rella, A. Stabile Ianora, G. Angelelli,
carcinoma using MRI M. Moschetta; Bari/IT
R. Kloeckner, D. Pinto dos Santos, K.-F. Kreitner, A. Leicher-Düber,
A. Weinmann, J. Mittler, C. Düber; Mainz/DE 10:54
11:10 B-0422 Breast MRI in the screening setting: is maximum
B-0413 Hepatocellular carcinoma in non-cirrhotic liver. intensity projection (MIP) a reliable technique for
Multimodality imaging findings cancer detection?
M. Orsi, M. Cellina, E. Battaglia, F. Barmettler, G. Oliva; Milan/IT
M. Diaz-Zamudio, J. Dosal Bañuelos, C. Escalona-Huerta,
A. Hernandez-Martinez, F. Hofmann Gonzalez; Mexico City/MX
11:02
11:18 B-0423 Intraductal breast disease in magnetic resonance
B-0414 Comparison of imaging features of intrahepatic imaging: a systematic diagnostic approach
P. Clauser1, M. Marcon2, M. Mahajan3, M.A. Marino1, P. Kapetas1,
mass-forming cholangiocarcinoma on gadoxetic
R. Woitek1, P.A.T. Baltzer1; 1Vienna/AT, 2Zurich/CH, 3Ottawa, ON/CA
acid-enhanced MR imaging with and without chronic
liver disease 11:10
J. Kim, J.-Y. Choi; Seoul/KR
B-0424 B1+ field correction of T1 estimation is necessary for
11:26 quantitative breast DCE MRI even at 1.5T
W. Tsai, K. Kao, K. Chang, C.E. Lin; Taipei/TW
B-0415 Intrahepatic mass-forming cholangiocarcinoma in
high-risk patients for hepatocellular carcinoma: 11:18
how does LI-RADS v2014 work on gadoxetic acid- B-0425 Breast structure and risk of breast cancers: the MR
enhanced MRI? risk factors
I. Joo, J. Lee, S. Lee, J. Lee, J. Park, J. Han; Seoul/KR C. Iacconi1, C. Marini2, G. Angelini2, D. Della Latta3, M. Giannelli2,
M. Moretti2, D. Mazzotta2; 1Carrara/IT, 2Pisa/IT, 3Massa/IT
11:34
B-0416 Comparison of the accuracy between liver and 11:26
spleen elastography using acoustic radiation force B-0426 Pure ductal carcinoma in situ: evaluation of early-
impulse and other noninvasive tests in predicting the phase dynamic characteristics on ultrafast breast MRI
C. Borelli1, R.D. Mus2, S. Vreemann2, M. Dalmis2, A. Gubern-Mérida2,
presence of esophageal varices R.M. Mann2; 1Rome/IT, 2Nijmegen/NL
H. Kwon, B. Kim, J. Lee, J. Cho, J. Oh, J. Lee, S. Lee; Busan/KR

11:34 11:10
B-0427 Are the magnetic resonance imaging (MRI) features B-0435 Texture analysis of blood flow maps in CT perfusion
of the pleomorphic variant of invasive lobular studies of NSCLC: correlation with the overall survival
carcinoma (ILC) different from classic ILC of the S. Baiocco1, D. Barone2, G. Gavelli2, A. Bevilacqua1; 1Bologna/IT,
2
Meldola/IT
breast?
P.M. Yeap, A. Evans, C. Purdie, J. Lee, S. Waugh, S. Vinnicombe;
11:18
Dundee/UK
B-0436 Impact of segmentation techniques on the
11:42 performance of a CT texture-based lung nodule
B-0428 Influence of fat separation and spatial resolution classification system
on the results of automated volumetric MRI J.M.Y. Willaime, L.C. Pickup, D. Boukerroui, A. Talwar, M.J. Gooding,
F.V. Gleeson, T. Kadir; Oxford/UK
measurements of fibroglandular breast tissue
G.J. Wengert, K. Pinker-Domenig, T.H. Helbich, W.-D. Vogl,
11:26
P. Clauser, H. Bickel, M.-A. Marino, H. Magometschnigg, P.A.T. Baltzer;
Vienna/AT B-0437 Automatic method to support radiologists in
choosing the most representative slices in CT
11:50 perfusion of lung cancer
B-0429 The value of breast MRI for patients with a biopsy S. Malavasi1, D. Barone2, S. Baiocco1, A. Bevilacqua1, G. Gavelli2;
1
showing atypical ductal hyperplasia (ADH): can we Bologna/IT, 2Meldola/IT
safely follow patients rather than perform surgery? 11:34

K. Tsuchiya1, D. Schacht1, D. Sheth1, N. Mori2, K. Kulkarni1, R. Reddy1,
J. Mueller1, G. Karczmar1, H. Abe1; 1Chicago, IL/US, 2Sendai/JP B-0438 The unfolded chest cage: flat rib projection is
superior in the detection of rib fractures for trauma
surgeons and medical laypersons compared to
10:30–12:00 Room Z conventional multi planar reformation
S. Mauf, U. Held, D. Gascho, R. Baumeister, W. Schweitzer, P. Flach,
Computer Applications T. Ruder, T. Nguyen-Kim, M.J. Thali, T. Jentzsch; Zurich/CH
SS 605 Image processing techniques (1) 11:42

Moderators: S. Bickelhaupt; Heidelberg/DE, B-0439 Evaluation of a new fully automated pulmonary lobe
M. de Bruijne; Rotterdam/NL segmentation algorithm on inspiratory and expiratory
MDCT scans over 4 time-points
10:30 O. Weinheimer1, M.O. Wielpütz1, P. Konietzke1, C.P. Heußel1,
B-0430 An optimum combination of biological fingerprints H.-U. Kauczor1, C.J. Galban2, T.E. Robinson3; 1Heidelberg/DE,
SPEAKER
2
Ann Arbor, MI/US, 3Palo Alto, CA/US
SUPPORTED extracted from edge-enhanced chest radiograph to
BY
INVEST IN identify misfiled images in a picture archiving and 11:50
THE YOUTH
communication system B-0440 Surface fitting based automatic segmentation and
Y. Shimizu, Y. Matsunobu, J. Morishita; Fukuoka/JP
quantification of pulmonary fissures and lobes
Y. Hong, T. Nair, J. Lee; Suwon-city/KR
10:38
B-0431 A patient identification system using a combination
of objective and subjective similarities in bedside 10:30–12:00 Room O
chest radiographs to prevent filing mistakes
Y. Sakai, T. Kato, K. Iwase, K. Takahashi, A. Hattori, Y. Nakamura,
J. Morishita; Fukuoka/JP
GI Tract
10:46 SS 601b Multimodality imaging of Crohn’s
B-0432 Development and evaluation of a computer-aided disease
diagnosis system for diagnosis of interstitial lung Moderators: S. Gourtsoyianni; London/UK, C. Hoeffel; Reims/FR
diseases in high-resolution CT
S.S. Martin, M.H. Albrecht, T.J. Vogl, V. Jacobi; Frankfurt/DE
10:30
B-0441 Diagnostic value of 4th generation iterative
10:54 reconstrution algorithm with low dose CT-
B-0433 Comparison of manual vs. fully automated lobe- enterography protocol in follow-up of Crohn’s
based quantification of pulmonary air-trapping on disease patients: comparison with standard dose
paired inspiratory-expiratory MDCT in school age S. Lombardi, D. Ippolito, C. Talei Franzesi, C. Trattenero, P. Bonaffini,
S. Sironi; Monza/IT
children with CF
P. Konietzke1, O. Weinheimer1, M.O. Wielpütz1, C.P. Heußel1,
H.-U. Kauczor1, C.J. Galban2, T.E. Robinson3; 1Heidelberg/DE,
10:38
2
Ann Arbor, MI/US, 3Palo Alto, CA/US B-0442 Warm CO2 CT enteroclysis or virtual enteroscopy
(VE): preliminary experience of a new technique
11:02
for small bowel imaging on Crohn’s patients with
B-0434 Improvement of perfusion characterisation in two subocclusive or complicated disease
lung tumour subtypes using de-noised CT perfusion D. Szapiro, L. Bidaut, J. Serhan, A. Matthews, T. Hartley, A. Gangi;
maps Kirkcaldy/UK
S. Baiocco1, D. Barone2, G. Gavelli2, A. Bevilacqua1; 1Bologna/IT,
2
Meldola/IT 10:46
B-0443 The value of dual energy CT in the detection of
pathological intestinal segments in patients with
Crohn disease (CD)
A. Villanueva, G. Tardáguila, C. Martínez, C. Varela; Vigo/ES

10:54 10:38
B-0444 Long-term performance of readers trained in grading B-0453 Simultaneous positron emission tomography-
Crohn’s disease activity using MRI magnetic resonance imaging for the early detection
C.A.J. Puylaert, J.A.W. Tielbeek, S. Bipat, T.N. Boellaard, C.Y. Nio, of cardiac involvement in patients with Anderson-
J. Stoker; Amsterdam/NL
Fabry disease
L. Barbuto, C. Nappi, A. Ponsiglione, M. Puglia, M. Imbriaco,
11:02
E. Nicolai, L. Spinelli, A. Cuocolo; Naples/IT
B-0445 Diffusion-weighted MRI for evaluating ileocolonic
inflammation in Crohn’ disease: how does it 10:46
contribute to diagnose disease activity? B-0454 Relationship between myocardial fibrosis and left
X. Li1, X. Jiang1, Z. Zhang2, S. Huang1, J. Lin1, L. Huang1, C. Sun1, Z. Li1; ventricular functional impairment in diabetes mellitus
1
Guangzhou/CN, 2Dallas, TX/US
type-II: preliminary results
N. Galea, F. Ciolina, R. Pofi, T. Feola, C. Catalano, M. Francone,
11:10
I. Carbone; Rome/IT
B-0446 Evaluation of three MRE index for grading Crohn’s
disease activity 10:54
J. Rimola1, A. Alvarez-Cofiño2, T. Pérez-Jeldres3, C. Ayuso1, B-0455 Dependency of prevalence and extent of infarct
S. Rodríguez1, I. Alfaro1, I. Ordás1, J. Panés1; 1Barcelona/ES, 2Gijón/ES,
3
Santiago de Chile/CL size (IS) and microvascular obstruction (MO) on
the timing of imaging and constrast injection after
11:18 infarction
B-0447 In vivo axial-strain sonoelastography helps T. Emrich, N. Abegunewardene, A. Theruvath, K. Oberholzer,
T. Muenzel, C. Dueber, K.-F. Kreitner; Mainz/DE
distinguish acutely inflamed from fibrotic terminal
ileum strictures in patients with Crohn’s disease 11:02
L.M. Sconfienza1, L. Pescatori2, F.M. Doniselli2, F. Cavallaro1, G. Tontini1,
Thursday
L. Pastorelli1, M. Vecchi1, F. Sardanelli1; 1San Donato Milanese/IT, B-0456 Detection and quantification of myocardial infarction
2
Milan/IT using a dark blood late gadolinium enhancement
technique
11:26 A. Varga-Szemes1, G. Muscogiuri1, P. Suranyi1, W.G. Rehwald2,
B-0448 Dynamic contrast enhanced MRI of small bowel: C.N. De Cecco1, S. Mangold1, D. Caruso1, S.R. Fuller1, U.J. Schoepf1;
1
Charleston, SC/US, 2Chicago, IL/US
diagnostic value of quantitative perfusion analysis
in vascular assessment between inflammatory and 11:10
fibrotic lesions in Crohn’s disease B-0457 Cardiac magnetic resonance characteristics of
S. Lombardi, D. Ippolito, C. Talei Franzesi, S. Sironi; Monza/IT SPEAKER
SUPPORTED patients with the clinical signs of ST-elevation
BY
11:34 INVEST IN myocardial infarction and normal coronary
THE YOUTH
B-0449 Comparison of magnetisation transfer and diffusion- angiography
F. Suhai, C. Czimbalmos, I. Csécs, A. Tóth, B. Horváth,
weighted MRI for detection of bowel fibrosis in E. Szima Mármarosi, D. Becker, B. Merkely, H. Vágó; Budapest/HU
Crohn’s disease: initial experience
X. Jiang1, X. Li1, Z. Zhang2, S. Huang1, J. Lin1, L. Huang1, C. Sun1, Z. Li1; 11:18
1
Guangzhou/CN, 2Dallas, TX/US
B-0459 Cardiac magnetic resonance volume analysis in
11:42 patients with single ventricle
F. Secchi, M. Petrini, A. Cozzi, P. Cannaò, F. Sardanelli; Milan/IT
B-0450 Evaluation of quantitative PET/MR-E biomarkers for
discriminating inflammatory from fibrotic strictures 11:26
in Crohn’s disease B-0460 Patient satisfaction with coronary CT angiography,
O.A. Catalano, M. Gee, D. Sahani, U. Mahmood, B. Rosen, D. Gervais;
Boston, MA/US myocardial CT perfusion, myocardial perfusion
MRI, SPECT myocardial perfusion imaging and
11:50 conventional coronary angiography
B-0451 MRI features of proctitis in Crohn’s disease S. Feger1, M. Rief1, E. Zimmermann1, F. Richter1, R. Röhle1, M. Dewey1,
C.J. Tutein Nolthenius, S. Bipat, B. Mearadji, A. Spijkerboer, E. Schönenberger2; 1Berlin/DE, 2Hannover/DE
A. Montauban van Swijndregt, C.I.J. Ponsioen, J. Stoker;
Amsterdam/NL 11:34
B-0461 Contrast enhanced magnetic resonance imaging of
the heart in the quantification of myocardial damage
10:30–12:00 Room N
in drug-resistant hypertension
O. Mochula, W. Ussov; Tomsk/RU
Cardiac
11:42
SS 603 Evolving techniques B-0462 Cardiac magnetic resonance (CMR) evaluation of
Moderators: A.J.B.S. Madureira; Porto/PT, non-compacted myocardium: comparison of two
M. Meyer; Mannheim/DE
software packages
E. Pershina1, M. Gutberlet2, M. Grothoff2; 1Moscow/RU, 2Leipzig/DE
10:30
B-0452 Self-navigated 3D radial whole-heart MRA for
the assessment of coronary artery anomalies in
paediatric patients: comparison with coronary CTA
A. Varga-Szemes1, G. Muscogiuri1, C.N. De Cecco1, P. Suranyi1,
S. Mangold1, D. Piccini2, A. Hlavacek1, A.C. Nutting1, U.J. Schoepf1;
1
Charleston, SC/US, 2Lausanne/CH

10:30–12:00 Studio 2016 11:51

B-0472 Guidelines for intra-luminal uterine hypodensity
Genitourinary (ILUH) seen on CTs of postmenopausal women
M. Yassin, M. Amitai, N. Kanana, S. Apter, S. Raskin, E. Konen,
SS 607a Female pelvis E. Klang; Ramat Gan/IL
Moderators: O. Nikolic; Novi Sad/RS, K. Pyra; Lublin/PL
10:30 10:30–12:00 Room L8

D. Akata; Ankara/TR Vascular
10:39 SS 615 Optimising vascular imaging techniques
B-0463 Preoperative prediction using clinical and CT Moderators: A.L.J. Bojanovic; Nis/RS, T. Rand; Vienna/AT
parameters for optimal resection in advanced ovarian
cancer 10:30
B. Kim, S. Kim; Daegu/KR B-0473 Effects on intra-coronary attenuation using different
iodine concentrations (240, 300 and 370 mg/ml)
10:47
whilst maintaining identical IDR (EICAR-trial)
B-0464 CT predictors for selecting conservative surgery or B.M.F. Hendriks, C. Mihl, M. Kok, S. Altintas, B.L.J.H. Kietselaer,
adnexectomy to treat adnexal torsion J.E. Wildberger, M. Das; Maastricht/NL
Y. Yim, S. Jung, M. Yu, H. Park, Y. Kim, H. Jeon; Seoul/KR
10:38
10:55 B-0474 Measurement of blood velocities in renal, intrarenal
B-0465 MRI to evaluate myometrium invasion in patients with and carotid arteries: comparison of Ultrafast Doppler
placenta previa: correlation with histological findings and conventional color duplex Doppler
G. Frauenfelder, M.I. Ginocchio, M. Morlando, P.P. Mainenti, G. Ivanac, M. Dzoic Dominkovic, K. Ivanac, B. Brkljačić; Zagreb/HR
P. Martinelli, S. Maurea; Naples/IT
10:46
11:03
B-0475 Perfusion quantification of vascular malformations
B-0466 Magnetic resonance elastography as a predictor of SPEAKER
SUPPORTED using contrast-enhanced ultrasound (CEUS) with
response to treatment of magnetic resonance-guided BY
INVEST IN time intensity curve analysis (TIC) before and after
focused ultrasound surgery for uterine fibroids: a THE YOUTH
percutaneous treatment
preliminary study I. Wiesinger, W.A. Wohlgemuth, C. Stroszczynski, E.M. Jung;
S. Ichikawa1, U. Motosugi1, M. Omori1, K. Sano2, S. Hirata1, H. Onishi1; Regensburg/DE
1
Chuo-shi, Yamanashi/JP, 2Hidaka-shi, Saitama/JP
10:54
11:11
B-0476 As low as reasonabily achievable: lowest dose
B-0467 A leiomyoma scoring system for selecting patients
CT angiography in patients with endoleak after
for uterine artery embolisation
N.N.N. Naguib, N.-E.A. Nour-Eldin, T. Gruber-Rouh, R. Hammerstingl, endovascular aneurysm repair
S. Zangos, T.J. Vogl; Frankfurt a. Main/DE R. Pizzolato, M. Belgrano, G. Poillucci, A. Spezzacatene, M. Cova;
Trieste/IT
11:19
11:02
B-0468 Colorectal infiltrating endometriosis: can MRI predict
B-0477 Ultra-low dose and volume contrast medium (CM) for
the need of intestinal resection?
1 2 1
A. Scardapane , F. Lorusso , P. Pignataro , A.A. Stabile Ianora , 1 aorta CTA: using IMR for substantial dose and volume
G. Angelelli1; 1Bari/IT, 2Castellana Grotte/IT CM reduction in a prospective clinical study
P. Hou; Zhengzhou/CN
11:27
B-0469 Role and benefits of intraoperative ultrasound 11:10
guidance in intracavitary brachytherapy for cervical B-0478 Multi-spectral MPI for real time 3D tracking of
cancer endovascular devices
T. Akbas, G. Ugurluer, M. Acil, T. Arpaci, M. Serin; Adana/TR M. Hofmann, J. Salamon, C. Jung, M.G. Kaul, A. vom Scheidt,
G. Adam, H. Ittrich, T. Knopp; Hamburg/DE
11:35
11:18
B-0470 Leiomyoma maximal diameter versus leiomyoma
B-0479 Investigation into MR angiography as a possible
volume: which is more reliable for proper patient
replacement for rotational angiography or CT
selection for uterine artery embolisation
N.N.N. Naguib, N.-E.A. Nour-Eldin, T. Gruber-Rouh, T. Lehnert, angiography for cerebrovascular computational fluid
S. Zangos, T.J. Vogl; Frankfurt a. Main/DE dynamics
H. Isoda1, Y. Yoneyama1, A. Fukuyama1, M. Terada2, M. Kamiya2,
11:43 K. Otsubo2, T. Kosugi3, Y. Komori4, S. Naganawa1; 1Nagoya/JP,
2
Iwata/JP, 3Hamamatsu/JP, 4Tokyo/JP
B-0471 Evaluation of pre-embolisation MRI-parameters of
uterine fibroids for predicting volume reduction and 11:26
quality-of-life score after uterine artery embolisation B-0480 Submillisievert CT angiography for carotid arteries
(UAE) using new adaptive statistical iterative reconstruction
I. Kalina, A. Tóth, É. Valcseva, P. Kaposi, N. Ács, S. Várbíró, V. Bérczi;
Budapest/HU -V
A.D. Annoni, A. Formenti, G. Pontone, E. Nobili, A. Baggiano,
E. Conte, P. Montorsi, M. Pepi, D. Andreini; Milan/IT

11:34 11:26
B-0481 Comparison of quantitative analysis to qualitative B-0491 Five-year follow-up T2 mapping of the lumbar
SPEAKER
SUPPORTED analysis for interpretation of lower limb intervertebral disc at 3.0 Tesla: quantified imaging
BY
INVEST IN lymphoscintigraphy methods for prognostic patient assessment
THE YOUTH E.C. Nganga; Nairobi/KE M. Raudner, D. Stelzeneder, C. Kronnerwetter, K. Pieber,
R. Windhager, V. Juras, S. Trattnig; Vienna/AT
11:42
B-0482 Head and neck CT-angiography (HNCTA): Low and 11:34
patient tailored versus standard contrast medium B-0492 The impact of MRI total spine on targeted patient
protocol selection for surgical therapy of geriatric vertebral
L. Capitolo, F. Cesarani, C. Vaudagna, E. Armando; Asti/IT fractures
C. Weber, C. Ossadnik, T. Abel, H. Hentschel, P. Bannas;
11:50 Hamburg/DE
B-0483 Diagnostic accuracy for the detection of arterial

11:42
bleeding of the abdomen can be improved with
B-0493 Comparison of changes in quantitative computed
noise-optimized virtual monoenergetic dual-energy
tomography bone structure and bone density using
CT
S.S. Martin, J.L. Wichmann, J.-E. Scholtz, H. Weyer, A.M. Bucher, two different iterative reconstruction methods
R.W. Bauer, V. Jacobi, T.J. Vogl, M.H. Albrecht; Frankfurt/DE J. Borggrefe1, N. Abdullayev1, F. Thomsen2, M. Hellmich1, T. Damm3,
C.-C. Glüer3, B. Krug1; 1Cologne/DE, 2Bahía Blanca/AR, 3Kiel/DE
11:50
10:30–12:00 Room E1
B-0494 Evaliation of diffusion-weighted MRI in osteoporosis
Q. Ren; Shijiazhuang/CN
Musculoskeletal
Thursday
SS 610a Body composition 10:30–12:00 Room E2
Moderators: G. Guglielmi; Andria/IT, A.S. Issever; Berlin/DE
Neuro
10:30
B-0484 The diagnostic efficiency of CT value in the patients SS 611 Cerebrovascular disease (1)
with osteoporosis compared with bone mineral Moderators: K.M. Thierfelder; Munich/DE, P. Vilela; Almada/PT
density (BMD) based on quantitative computed
tomography (QCT) 10:30
P. Lei, J. Jiao, X. Chai; Guiyang/CN K-14 Keynote lecture
P. Vilela; Almada/PT
10:38
B-0485 Association of MRS-based bone marrow fat fraction 10:39
and unsaturation level with vertebral bone strength B-0495 Collateral flow assessment in intracranial major trunk
T. Baum1, S. Ruschke1, C. Cordes1, M. Dieckmeyer1, H. Kooijman2, stenoocclusive diseases by fast non-contrast time-
R. Burgkart1, E.J. Rummeny1, J.S. Bauer1, D.C. Karampinos1;
1
Munich/DE, 2Hamburg/DE
resolved MR angiography using arterial spin labelling
K. Tsuchiya, M. Yamashita, S. Ichisaka, M. Hara, M. Kokan, T. Suzuki;
Tokyo/JP
10:46
B-0486 MRI to evaluate the effectiveness of enzyme 10:47
replacement therapy in type 1 Gaucher’s disease B-0496 Internal carotid artery stenosis and collateral
patients recruitment in stroke patients
B.C.S. Rabelo, R.R. Nobre, A.M.A. Lopes, R.T. Domingues, R.M.V. Mota, J.W. Dankbaar, K. Kerckhoffs, A.D. Horsch, I.C. van der Schaaf,
R.G. Horta, L.L.S. Gavio, R. Strecker; Belo Horizonte/BR L.J. Kappelle, B.K. Velthuis; Utrecht/NL
10:54 10:55
B-0487 Body mass is associated with chronic adventitial B-0497 Comparison of four different collateral scores in
shearing injuries in subcutaneous fat SPEAKER
SUPPORTED acute ischemic stroke by CT angiography
T.C. Gaunt, F. Carey, A. Toms; Norwich/UK BY F. Seker, A. Potreck, M. Möhlenbruch, M. Bendszus, M. Pham;
INVEST IN
THE YOUTH Heidelberg/DE
11:02
B-0488 Current smokers have a faster decline in bone density 11:03
than former smokers: a longitudinal CT study B-0498 Perfusion CT indexes and derived blood-brain barrier
F.A.A. Mohamed Hoesein1, E. Pompe1, J. Bartstra1, H.J.J. Verhaar1, permeability predicts hemorrhagic transformation
M. Oudkerk2, H.J. de Koning3, J.-W.J. Lammers1, P.A. de Jong1;
1
Utrecht/NL, 2Groningen/NL, 3Rotterdam/NL
risk after intravenous thrombolysis in acute stroke
G. Carbo1, V. Cuba1, J. Puig1, G. Blasco1, J. Daunis-i-Estadella1,
M. Castellanos1, C. Van Eendenburg1, C. Aboud2, S. Pedraza1;
11:10 1
Girona/ES, 2Valencia/ES
B-0489 Validity of estimating muscles and fat volume from
single MRI slice in older adults with sarcopenia and 11:11
sarcopenic obesity B-0499 Blood brain barrier disruption after endovascular
Y.X. Yang, M.S. Chong, L. Tay, S. Yew, A. Yeo, C.H. Tan; Singapore/SG stroke therapy: prediction of infarct development
with dual-energy computed tomography
11:18 T. Djurdjevic, B. Glodny, M. Knoflach, B. Matosevic, S. Kiechl,
B-0490 Sex estimation using cross sectional MDCT anatomy E.R. Gizewski, A.E. Grams; Innsbruck/AT
of C1 vertebrae
A. Solmaz Tuncer1, S. Gürel2, S. Halıcıoğlu2, E. Dağıstan2, Z. Coşgun2,
S. Gür2; 1Manisa/TR, 2Bolu/TR

11:19 11:02
B-0500 Cerebrovascular reserve mapping in severe B-0509 Thyroid incidentalomas on 18F-FDG PET/CT in
intracranial arterial stenosis oncology patients: are there any predictors for
A. Krainik, O. Heck, N. Boudiaf, I. Favre, E. Condamine, J. Pietras, malignancy?
K. Boubagra, F. Tahon, O. Detante; Grenoble/FR H.A. Nasr1, H.R.S. Farghaly2, A.O. Al Qarni3; 1Cairo/EG, 2Assiut/EG,
3
Riyadh/SA
11:27
B-0501 CT-perfusion (CTP) and lepto-meningeal score (LMs) 11:10
for imaging based patient selection thrombectomy in B-0510 Comparison of clinicoradiologic characteristics
acute ischemic stroke of lung adenocarcinomas harbouring ALK
E. Puglielli, R. Lattanzi, S. Roiati, V. Di Mizio, L. Gregori, V. Di Egidio; rearrangements or EGFR mutations treated by
Teramo/IT
surgical resection
H. Wang1, M. Schabath2, Y. Liu1, Y. Han1, Q. Li1, R. Gillies2, Z. Ye1;
11:35 1
Tianjin/CN, 2Tampa, FL/US
B-0502 Utility of diffusion and perfusion MRI for predicting
perihemorrhagic edema growth after intracerebral 11:18
haemorrhage B-0511 Intravoxel incoherent motion diffusion weighted
G. Carbo, V. Cuba, J. Puig, G. Blasco, J. Daunis-i-Estadella, imaging in evaluating the radio-sensitivity of
M. Terceño, Y. Silva, J. Serena, S. Pedraza; Girona/ES
nasopharyngeal carcinoma xenografts
Y. Xiao, Y. Chen, J. Pan, D. Zheng, X. Zheng, Y. Chen; Fuzhou/CN
11:43
B-0503 Combining motor function and diffusion tensor 11:26
imaging in the hyperacute intracerebral haemorrhage B-0512 Pseudoprogression in cancer immunotherapy:
accurately predict functional motor outcome diagnostic imaging features
V.L. Cuba Camasca, G. Carbó, J. Puig, G. Blasco, S. Pedraza; V. Kurra, R.J. Sullivan, J.F. Gainor, F.S. Hodi, L. Gandhi, C.A. Sadow,
Girona/ES G.J. Harris, K.T. Flaherty, S.I. Lee; Boston, MA/US
11:51 11:34
B-0504 Iterative model reconstruction in brain CT in patients B-0513 Potential prognostic impact of CT-quantified
with stroke abdominal muscle and fat re-distribution under
X. Liu, L. Chen, W. Qi, Y. Jiang, Y. Liu, M. Zhang, N. Hong; Beijing/CN
chemotherapy in lung cancer patients
J. Nattenmüller, R. Wochner, T. Muley, M. Steins, S. Hummler,
H.-U. Kauczor, M.O. Wielpütz, C.P. Heussel; Heidelberg/DE
10:30–12:00 Room F1
11:42
Oncologic Imaging B-0514 Intravenous vs intratumoral: effect of different
inection routes on biodistribution and tumour
SS 616 Advanced imaging methods (1) accumulation of Pluronic-P94
Moderators: V. Panebianco; Rome/IT, C. Santini1, A. Arranja2, A. Dankova3, F. Schosseler2, K. Morawska4,
B.M. Schaarschmidt; Düsseldorf/DE P. Dubruel4, E. Mendes3, M. de Jong1, M. Bernsen1; 1Rotterdam/NL,
2
Strasbourg/FR, 3Delft/NL, 4Gent/BE
10:30
B-0505 Nasopharyngeal carcinoma: predictive value of IVIM- 11:50
DWI on the radio-sensitivity B-0515 CT perfusion heterogeneity as a prognostic
Y. Xiao, Y. Chen, Y. Chen, Z. He, J. Pan; Fuzhou/CN biomarker in NSCLC
S. Baiocco1, D. Barone2, G. Gavelli2, A. Bevilacqua1; 1Bologna/IT,
10:38 2
Meldola/IT
B-0506 Intravoxel incoherent motion imaging (IVIM) in head
and neck cancers and nodal metastases: can we
10:30–12:00 Room F2
predict patient outcome?
R. Balaji, D. Arivudainambi; Chennai/IN
Emergency Radiology
10:46
B-0507 Image quality and radiation dose of third generation SS 617 Cardiothoracic emergencies
dual-energy CT of the head and neck compared with Moderators: F. Carbonetti; Rome/IT, J.B. Dormagen; Oslo/NO
a standard acquisition
S. Suntharalingam, A. Wetter, E. Stenzel, N. Guberina, A. Ringelstein,
10:30
T. Schlosser, M. Forsting, K. Nassenstein; Essen/DE K-15 Keynote lecture
V.E. Sinitsyn; Moscow/RU
10:54
B-0508 Dual phase dual-energy CT in patients treated with 10:39
erlotinib for advanced non-small cell lung cancer: B-0516 Radiological pattern of bomb blast injuries
A. Raouf, R. Sayani; Karachi/PK
possible benefits of iodine quantification in response
assessment 10:47
J. Baxa1, T. Matouskova1, T. Flohr2, B. Schmidt2, M. Sedlmair2, J. Ferda1;
1
Plzen/CZ, 2Forchheim/DE
B-0517 Volume of intra-abdominal air measured by CT:
a potential marker for abdominal compartment
syndrome in trauma patients?
E.C. Schubert, E.J. Rummeny, K.-G. Kanz, K. Holzapfel; Munich/DE

10:55 10:55
B-0518 Cardiovascular signs suggestive of thoracic B-0528 Comparison of SRmax, SRave and color map of
compartment syndrome (TCS) in emergency setting elastography in differentiating malignant from
C. Liguori1, G. Frauenfelder1, F. Giurazza2, P.P. Saturnino1, benign breast lesions
C. Acampora1, L. Romano1; 1Naples/IT, 2Rome/IT J. Moon, J. Cheung, S. Koh, K. Lee; Anyang, Gyeonggi-do/KR
11:03 11:03
B-0519 Triple rule-out CT in the emergency department B-0529 HER2 positive breast cancer: correlation with
patient: should we just do it? quantitative contrast-enhanced ultrasound
F. Morsbach, K. Higashigaito, D. Benz, H. Alkadhi; Zurich/CH
parameters
W. Jia, J.-N. Shi, X.-C. Fei, K.-W. Shen, M. Chen; Shanghai/CN
11:11
B-0520 Assessment of the adequacy of the coronary CT scan 11:11
SPEAKER
SUPPORTED requests at the Emergency Department B-0530 The added value of breast ultrasound elastography
BY V. García de Pereda De Blas, I. Tavera Bahillo, E. Camuera González,
INVEST IN for differentiating between benign and malignant
THE YOUTH J. Correa Zapata, I. Arrieta Artieda, M. Carreras Aja; Barakaldo/ES
lesions
11:19 H.-J. Kim1, S. Kim1, M. Jang1, B. Yun1, J. Chang2, N. Cho2;
1
Gyeonggi-do/KR, 2Seoul/KR
B-0521 Pulmonary embolism: do we evaluate the risk factors
properly in the ED? Pulmonary angio-CT in risk 11:19
stratified patients according to the revised Geneva B-0531 Impact of Real-time Virtual Sonography, a
score coordinated US and MRI system, on the detection of
M. Arias L., H. Maestre, M. Lorente, R. Jimenez, J. Perez, F. Garcia,
A. Mas, A. Franco; San Juan de Alicante/ES conventional B-mode-occult lesions in second-look
US for MRI-detected breast lesions
Thursday
11:27 S. Nakano, R. Tetsuka, K. Fujii, J. Kousaka, Y. Mouri, T. Ando, M. Goto,
T. Imai, T. Ishiguchi; Aichi/JP
B-0522 First-line diagnosis of paediatric pneumonia in
emergency: lung ultrasound in addiction to chest-XR 11:27
and its role in follow-up B-0532 Breast elastography: does strain ratio value depend
C.L. Piccolo, S. Ianniello, B. Sessa, G.L. Buquicchio, M. Trinci, V. Miele;
Rome/IT on Regions Of Interest (ROIs) placement?
E. Maggini, E. Mancuso, V. Maldur, F. Pediconi, P. Ricci; Rome/IT
11:35
11:35
B-0523 Comparisons of CT grading with clinical outcome of
B-0533 Categorisation of focal breast lesions according to
gastric corrosive injury at emergency room SPEAKER
Y.-C. Wong, L.-J. Wang, C.-H. Wu; Taoyuan City/TW SUPPORTED the BI-RADS US lexicon: role of a computer-aided
BY
INVEST IN decision-making support (S-Detect)
11:43 THE YOUTH A.A.M. Orlando, M. Safina, L. Lodato, G. Buffa, A. Cirino, R. Ienzi,
A. Taibbi, T.V. Bartolotta; Palermo/IT
B-0525 Value of multi-detector CT in identifying diagnostic
findings in blunt bowel and/or mesenteric trauma: 11:43
our experience B-0534 Ultrasound within the Austrian mammography
M.C. Firetto, A.A. Lemos, E. Perucchini, T. Canini, P.R. Biondetti;
Milan/IT screening: benefit of regular quality assurance for
clinical partners
S. Wildner, C. Kollmann; Vienna/AT
10:30–12:00 Room D1
11:51
Breast B-0535 Imaging molecular subtypes of invasive ductal
carcinoma in automated 3D breast ultrasound: how
SS 602b Breast ultrasound to recognise cancers with a poor prognosis
J. van Zelst, M. Balkenhol, M. Imhof-Tas, N. Karssemeijer, R. Mann;
Moderators: B. Brkljačić; Zagreb/HR, A. Domingo; Tarragona/ES
Nijmegen/NL
10:30
B. Brkljačić; Zagreb/HR 10:30–12:00 Room D2
10:39 Interventional Radiology

B-0526 Does pleomorphic invasive lobular carcinoma (ILC)
have different mammographic and ultrasound
SS 609 Non-vascular techniques in the
features compared with classical ILC? abdomen
P.M. Yeap, S. Vinnicombe, C. Purdie, J. Lee, A. Evans; Dundee/UK Moderators: O. Akhan; Ankara/TR, D. Kuhelj; Ljubljana/SI
10:47 10:30
B-0527 Fast and accurate screening of women with dense B-0536 The minimally-invasive-treatment of ureteric stenosis
breasts with a dedicated computer-aided detection- in children with balloon-angioplasty and double-J-
based reading protocol in automated 3D breast stenting
ultrasound A. Sanabria, S. Lombardo, J. Espejo, M. Perez, L. Zurera,
J. van Zelst1, A. Gubern-Merida1, D. Drieling2, T. Tan1, M. Rutten3, J. Betancourth; Cordoba/ES
N. Karssemeijer1, R. Mann1; 1Nijmegen/NL, 2Bremen/DE,
3
‘s-Hertogenbosch/NL

10:38 10:30–12:00 Room G

B-0537 Combined endoscopic-radiological ureteral
rendezvous: technique and results Musculoskeletal
C. Zini, M. Corona, C. Cirelli, P. Lucatelli, G. Ricciuti, F.M. Salvatori;
Rome/IT SS 610b Cartilage assessment
Moderators: E.H.G. Oei; Rotterdam/NL, S. Trattnig; Vienna/AT
10:46
B-0538 Colonic stenting: is still useful in the treatment of 10:30
malignant obstruction? B-0547 Grating-based x-ray phase-contrast imaging: a new
P. Crivelli, M. Carboni, S. Profili, M. Conti, G. Meloni; Sassari/IT
high-resolution non-contrast enhanced quantitative
11:54 cartilage imaging technique? An experimental
B-0539 Percutaneous radiologic gastrostomy in amyotrophic feasibility study
P.M. Jungmann1, L. Birnbacher2, M. Viermetz2, P. Föhr1,
lateral sclerosis (ALS) patients with minimal D.C. Karampinos1, F. Lohöfer1, M. Wildgruber1, E.J. Rummeny1,
intravenous analgesia: technical success, safety and J. Herzen2; 1Munich/DE, 2Garching/DE
efficacy
N. Mani1, R.K. Varma2; 1St. Louis, MO/US, 2Pittsburgh, PA/US 10:38
B-0548 Focal cartilage defects are associated with cartilage
11:02 damage progression in the same subregion and
B-0540 Endoluminal RFA assisted percutaneous new cartilage damage development in the same
recanalisation of biliary and main pancreatic duct tibiofemoral compartment: the MOST Study
obstruction, caused by inoperable malignancy A. Guermazi1, D. Hayashi1, F.W. Roemer1, J. Niu1, E.K. Quinn1,
M. Mizandari1, N. Habib2; 1Tbilisi/GE, 2London/UK M.D. Crema1, M.C. Nevitt2, D.T. Felson1; 1Boston, MA/US,
2
San Francisco, CA/US
11:10
10:46
B-0541 Does preoperative percutaneous transhepatic
B-0549 Weight loss is associated with slower cartilage
biliary drainage (PTBD) plays a role in reducing
degeneration over 96 months in obese and
complications after pancreaticoduodenectomy for
overweight subjects: data from the Osteoarthritis
pancreatic head carcinoma?
M. Fronda, G. Di Guardia, S. Silvestri, A. Discalzi, A. Doriguzzi Breatta, Initiative
D. Righi, P. Fonio, G. Gandini; Turin/IT A.S. Gersing, B.J. Schwaiger, J. Zarnowski, G. Feuerriegel,
J. Guimaraes, L. Facchetti, N. Chancheck, M.C. Nevitt, T.M. Link;
11:18 San Francisco, CA/US
B-0542 Hepatic encephalopathy after TIPS: time to improve 10:54

the classification? B-0550 Quantitative T2* analysis of articular cartilage of the
A. Discalzi, M. Calandri, E. Soncin, M. Fronda, A. Doriguzzi Breatta,
C. Gazzera, D. Righi, P. Fonio, G. Gandini; Turin/IT tibiotalar joint in professional soccer players and
healthy individuals at 3T MRI
11:26 C. Behzadi, F.O. Henes, A. Quitzke, M.G. Kaul, G. Adam, M. Regier;
Hamburg/DE
B-0543 Tunnelled peritoneal catheter placement in the
palliative treatment of malignant ascites: technical 11:02
results and overall clinical outcome B-0551 Chondrocalcinosisis associated with accelerated
I. Indesteege, A. Laenen, C. Verslype, H. Prenen, I. Vergote, G. Maleux;
Leuven/BE degeneration of the knee joint: data from the
Osteoarthritis Initiative
11:34 A. Gersing1, B.J. Schwaiger1, U. Heilmeier1, L. Facchetti1,
N. Lane2, M.C. Nevitt1, C.E. McCulloch1, L.S. Steinbach1, T.M. Link1;
B-0544 Outcomes of fluoroscopic and ultrasound guided 1
San Francisco, CA/US, 2Sacramento, CA/US
placement versus laparoscopic placement of
peritoneal dialysis catheters 11:10
A.M.K. Abdel Aal1, A.S. Moustafa1, M.F. Hamed2, N. Ertel1; 1Birmingham,
B-0552 The role of MRI in the diagnosis of early forms of
AL/US, 2Tuscaloosa, AL/US SPEAKER
SUPPORTED osteoarthritis at visualisation of articular cartilage
BY
11:42 INVEST IN lesions of knee and ankle joints in young athletes
THE YOUTH I.N. Dutova, A. Karpenko; St. Petersburg/RU
B-0545 CT-guided placement of hyperthermia catheters
in oncologic patients to support regional deep 11:18
hyperthermia treatment B-0553 Efficacy of an outpatient musculoskeletal
P. Kröpil, R. Wessalowski, C. Thomas, G. Antoch, R. Lanzman;
Düsseldorf/DE interventional radiology practice model in the
treatment of knee osteoarthritis using autologous
11:50 blood derived growth factors
B-0546 Radiologic placement of uncovered stents for the A.X. Doss; Nedlands/AU
treatment of malignant colonic obstruction at
11:26
ascending and transverse colon
J. Yoon, S. Kwon; Seoul/KR B-0554 Value of fat-suppressed fluid-sensitive MRI sequences
for the detection and characterisation of Modic I end-
plate changes of the lumbar spine
T. Finkenstaedt1, F. Del Grande2, N. Bolog1, N. Ulrich1, S. Tok1,
O. Kolokythas3, J. Steurer1, G. Andreisek1, S. Winklhofer4; 1Zurich/CH,
2
Lugano/CH, 3Winterthur/CH, 4San Francisco, CA/US

11:34 11:18
B-0555 Cross-sectional and longitudinal layer-specific B-0564 Estimation of tumour and lymph node volumes
femorotibial cartilage T2 mapping in knees without in head and neck cancer to predict response to
risk of, with risk of, and with early knee osteoarthritis radiochemotherapy
W. Wirth1, F.W. Roemer2, S. Maschek1, F. Eckstein1; 1Salzburg/AT, G. Widmann, C. Url, D. Dejaco, A.-K. Haug, N. Fischer, D. Riedl,
2
Erlangen/DE H. Riechelmann; Innsbruck/AT
11:42 11:26
B-0556 Initial experience of high resolution PET/MRI imaging B-0565 Role of dynamic contrast-enhanced and diffusion
of ACL graft viability using 18F-FDG and 3T weighted MRI in the differentiation between post-
K. Binzel1, R. Magnussen1, C. Kaeding1, D. Flanigan1, W. Wei1, treatment changes and recurrent laryngeal cancers
M.U. Knopp2, M.V. Knopp1; 1Columbus, OH/US, 2Malibu, CA/US S.D. Abouelenein; Alexandria/EG
11:50 11:34
B-0557 Sensitivity and specificity of the Whole-Organ B-0566 Change in ADC as a promising imaging biomarker for
Magnetic Resonance Imaging Score (WORMS) in predicting long-term loco-regional control for locally
patients after anterior cruciate ligament injury advanced head and neck cancer treated with chemo-
B.J. Schwaiger1, A.S. Gersing1, B. Ma1, S.A. Rodeo2, A.J. Krych3,
T.M. Link1, S. Majumdar1; 1San Francisco, CA/US, 2New York, NY/US, radiotherapy
3
Rochester, MN/US A. Balbo Mussetto, M. Petracchini, A. Tribunella, A. Macera,
S. Cavanna, C. Lario, T. Gallo, S. Cirillo; Turin/IT
11:42
10:30–12:00 Room M 1
B-0567 Discrimination post-therapeutic changes from local
Head and Neck residual / recurrent tumoural tissue in malignant
Thursday
neck masses following therapy using MR diffusion
SS 608 Pre- and post-operative imaging in weighted imaging
A. Baiomy, A. Youssef, E.M.M. Mahmoud, M.A.M. Yehya; Cairo/EG
oncology
Moderators: A. Borges; Lisbon/PT, S. Steens; Nijmegen/NL 11:50
B-0568 Detection of cartilage invasion in laryngeal
10:30
carcinoma with dynamic-contrast enhanced CT
B-0558 Diffusion-weighted imaging using readout- J.W. Dankbaar, J. Oosterbroek, E.A. Jager, H.W. de Jong,
segmented EPI sequence (RESOLVE) in the head and F.A. Pameijer, C.P. Raaijmakers, S.M. Willems, C.H. Terhaard,
neck cancer M.E. Philippens; Utrecht/NL
S. Kim, S. Jung; Seoul/KR
10:38 10:30–12:00 Room M 2

B-0559 SR EPI DWI vs. SS EPI DWI in head and neck cancer
I. Platzek, H.H. Kitzler, V. Plodeck, H. Leonhardt, V. Gudziol, Genitourinary
M. Laniado; Dresden/DE
10:46
SS 607b New frontiers: urolithiasis and renal
B-0560 Differentiation of incidental tracer uptake in the head
function
Moderators: M.-F. Bellin; Le Kremlin-Bicêtre/FR,
and neck area: a comparison between 18F-FDG PET/ J. Lopes Dias; Lisbon/PT
CT and 18F-FDG PET/MRI
B.M. Schaarschmidt1, B. Gomez2, C. Buchbender1, J. Grueneisen2, 10:30
L.M. Sawicki1, V. Ruhlmann2, A. Wetter2, G. Antoch1, P. Heusch1;
1
Düsseldorf/DE, 2Essen/DE B-0569 Determination of optimal imaging setting for
urolithiasis CT using FBP, statistical IR, and
10:54 knowledge-based IMR: physical human phantom
B-0561 Role of pre-operative ultrasonography for tumour study
thickness evaluation in guiding management in S. Park; Seoul/KR
patients with oral tongue squamous cell carcinoma
A.V. Nair1, P. Meera2, P.K. Nazer2, P.V. Ramachandran2; 1Trivandrum/IN, 10:38
2
Kochi/IN B-0570 Feasibility of in vitro differentiation of urinary stones
using manufacturer-recommended and dose-
11:02
optimised protocols with single-source split-filter
B-0562 Vascular pattern analysis on microvascular
dual-energy CT
ultrasonography in differentiating metastatic A. Parakh1, A. Euler1, D. Boll1, F. Morsbach2, D. Mueller2,
lymphadenopathy from tuberculous lymphadenitis Z. Szucs-Farkas3, S. Schindera1; 1Basle/CH, 2Zurich/CH, 3Berne/CH
I. Ryoo, S. Suh, S. Chae, A. Park, M. Ku, H. Shin, H. Seol; Seoul/KR
10:46
11:10 B-0571 Attenuation-based automatic tube voltage selection
B-0563 Standardisation of diffusion weighted MRI technique with tube current adaption in nonenhanced CT for
in characterisation of cervical lymphadenopathy detection of urolithiasis: diagnostic performance and
A.M. Aboelsouad, H. Atta, M. Abd Ellah, A. Gabr, H.M.K. Imam;
Assuit/EG radiation exposure
G.-M. Zhang, H. Sun, H.-D. Xue, Z.-Y. Jin; Beijing/CN

10:54 10:38
B-0572 Virtual nonenhancced images generated from B-0581 Single energy scanning of large adult patients: can
spectral CT: determinants of detection of urinary we improve image quality with spectral shaping?
calculi in the renal collecting system R. Daghistani, V. Delannoy, J.-B. Faivre, J. Giordano, J. Rémy,
Y. Chen, P.J. Lv, J.B. Gao; Zhengzhou/CN, Henan/CN M. Remy-Jardin; Lille/FR
11:02 10:46
B-0573 Prediction of surgically induced chronic kidney B-0582 What is the optimal monochromatic keV level
disease after total nephrectomy: body surface area for lung parenchyma analysis in spectral CT? A
adjusted virtually calculated renal cortical volume on qualitative study on 50 patients
M. Ohana, A. Labani, M.-Y. Jeung, C. Roy; Strasbourg/FR
CT
S. Hwang, D. Sung, S. You, N. Han, B. Park, M. Kim, S. Cho; Seoul/KR
10:54
11:10 B-0583 Diagnosis of solitary pulmonary nodule: one-step
B-0574 Evaluation of Iterative model reconstruction (IMR) spectral and perfusion imaging
S. Wang, J. Gao; Zhengzhou/CN
in ultra low-dose MDCT for urinary stone detection:
a comparison to filtered-back-projection and iDose 11:02
level 4 B-0584 Can spectral CT imaging improve the differentiation
J. Schmidt-Holtz, A. Laqmani, S. Butscheidt, M. Kurfürst,
M. Avanesov, C. Behzadi, H.-D. Nagel, G. Adam, M. Regier;
between malignant and benign solitary pulmonary
Hamburg/DE nodules?
Y. Zhang, J. Cheng, X. Hua, M. Yu, C. Xu, F. Zhang, J. Xu, H. Wu;
11:18 Shanghai/CN
B-0575 Non-invasive measurements of renal haemodynamics 11:10

over 24 hours in healthy volunteers using ASL, BOLD
B-0585 Patient information in connection with radiological
and phase contrast
P. Eckerbom1, E. Cox2, I. Subasic1, J. Weis1, F. Palm1, P. Hansell1,
examinations is inadequate
L. Ukkola, H. Oikarinen, A. Henner, O. Tervonen; Oulu/FI
S. Francis2, P. Liss1; 1Uppsala/SE, 2Nottingham/UK
11:26 11:18
B-0576 Comparison of CT findings between bacteremic B-0586 Mortality prediction in pulmonary fibrosis:
and non-bacteremic acute pyelonephritis due to comparison of computer and visual CT analysis and
Escherichia coli pulmonary function tests (PFT) with the gender, age,
D. Kim, S. Oh, B.-K. Je, S. Lee, D. Hong; Ansan/KR physiology (GAP) staging system
J. Jacob1, B. Bartholmai2, A. Brun1, R. Egashira1, A. Nair1,
11:34 S. Rajagopalan2, S.L.F. Walsh1, A. Wells1, D. Hansell1; 1London/UK,
2
Rochester, MN/US
B-0577 Radiation dose and image quality of 80 kVp renal
artery CT angiography with SAFIRE: comparison with 11:26
120 kVp renal artery CT angiography with FBP B-0587 Prognostication using longitudinal change in
P. Lei, G. Shen, J. Jiao, X. Wang; Guiyang/CN
idiopathic pulmonary fibrosis (IPF): analysis of
11:42 change in computer and visual CT variables and
B-0578 Contrast-induced nephropathy, does it occur in forced vital capacity (FVC)
SPEAKER J. Jacob1, B. Bartholmai2, R. Karwoski2, A. Nair1, S. Raghunath2,
SUPPORTED an unselected cohort with normal or moderately S. Rajagopalan2, S. Walsh1, A. Wells1, D. Hansell1; 1London/UK,
BY 2
INVEST IN reduced renal function? A prospective study Rochester, MN/US
THE YOUTH J. Carlqvist, J. Brandberg, M. Hellström; Göteborg/SE
11:34
11:50 B-0588 Impact of different types and levels of iterative
B-0579 Measurement of CT perfusion parameters in kidneys reconstructions on emphysema quantification by
with single renal artery vs double renal arteries: is it computed tomography scanner
different? S.P. Martin, J. Gariani, A.-L. Hachulla-Lemaire, D. Adler, W. Karenovics,
M.T. El-Diasty, G. Gaballa, M.E. Abou-Elghar, T.A. El-Diasty; X. Montet; Geneva/CH
Mansoura/EG
11:42
B-0589 Computed tomography quantification of emphysema
10:30–12:00 Room M 3 with COPD module in IntelliSpace Portal7
E. De Boer, N. Warringa, L. Meijering, J. Wiersma, S. Walen,
Chest J.W.K. van den Berg, M.F. Boomsma; Zwolle/NL
11:50
SS 604 Spectral CT, advanced CT analysis and
B-0590 Is spectral separation improved with the third-
emphysema
generation of dual-source CT systems?
Moderators: F. Molinari; Lille/FR, M. Silva; Parma/IT
M. Remy-Jardin, C. Bortolotto, S. Khung, J.-B. Faivre, A. Duhamel,
J. Rémy; Lille/FR
10:30
B-0580 Transforming thoracic oncologic CT examinations
into a CT pulmonary angiography for the detection
of pulmonary embolism using ultra low keV
monoenergetic reconstructions
H. Haubenreisser, A. Tecl, M. Meyer, S.O. Schönberg, T. Henzler;
Mannheim/DE

14:00–15:30 Room B 15:12

B-0600 Spectral CT combined with dynamic contrast-
Abdominal Viscera enhanced magnetic resonance imaging in evaluation
on the blood perfusion and the correlation with
SS 701a Functional imaging of liver and spleen
angiogenesis of rabbit VX2 liver tumour
Moderators: P. Leander; Malmö/SE, A. Wibmer; Vienna/AT M. Wang, J. Gao; Zhengzhou/CN
14:00 15:20
B-0591 Diffusion-weighted imaging (DWI) of the liver in B-0601 Unexpected increase of apparent diffusion
assessing chronic liver disease: effects of the fat and coefficient (ADC) value in conversion from
iron deposition on apparent diffusion coefficient regenerative nodule/degenerative nodule (RN/DN)
(ADC) values to hepatocellular carcinoma (HCC)
A. Kahraman, B. Kahraman, Z. Ozdemir, C. Gormeli, N. Sahin, J. Kim, C. Lee, Y. Park, J. Lee, J. Choi, K. Kim, C. Park, H. Lee;
S. Yilmaz; Malatya/TR Seoul/KR
14:08
B-0592 The ADC value of focal solid liver lesions: does it 14:00–15:30 Room C
depend on tumour cellularity?
K.K. Lomovtseva, A. Glotov, D. Babaeva, D. Kalinin,
G. Karmazanovsky; Moscow/RU
Breast
14:16 SS 702 Breast MRI-DWI (1)
B-0593 A step towards scan time minimisation: simultaneous Moderators: F. Pediconi; Rome/IT, F. Thibault; Paris/FR
multislice-accelerated diffusion-weighted imaging of 14:00
Thursday
the liver
J. Taron1, P. Martirosian1, M. Erb1, T. Kuestner2, J. Weiss1,
B-0602 Diffusion tensor imaging (DTI) is an accurate
M. Notohamiprodjo1, N. Schwenzer1, K. Nikolaou1, C. Schraml1; and solid imaging biomarker for early response
1
Tübingen/DE, 2Stuttgart/DE evaluation to neoadjuvant chemotheraphy
E. Garcia Oliver1, J. Camps Herrero1, M. Forment Navarro1,
14:24 V. Ricart Selma1, E. Furman-Haran2, N. Nissan2, H. Degani2; 1Alzira/ES,
2
B-0594 Diffusion weighted imaging of upper abdominal Rehovot/IL
organs in different time points: value of normalisation 14:08

using spleen as a reference organ
J. Song, J. Byon, E. Kim; Jeonju/KR
B-0603 Microstructural environment analysis of breast lesions
with diffusion kurtosis imaging
14:32 L. Nogueira1, F. Borlinhas2, S. Brandão3, R.G. Nunes2, J. Loureiro3,
I. Ramos3, H.A. Ferreira2; 1Vila Nova de Gaia/PT, 2Lisbon/PT,
B-0595 Biexponential model of intravoxel incoherent motion 3
Porto/PT
MRI in evaluation of the hepatic warm ischemia
reperfusion injury: A preliminary experimental study 14:16
in a rabbit model B-0604 Apparent diffusion coefficient values of breast
Q. Ji, Z.-Q. Chu; Tianjin/CN cancer and normal breast tissue in diffusion-
weighted imaging: effects of the menstrual cycle and
14:40
menopausal status
B-0596 The characteristics for metabolism and diffusion in J. Kim, H. Kang; Busan/KR
various hepatic masses: a preliminary study
E. Kong, I. Cho; Daegu/KR 14:24
B-0605 DCIS (ductal carcinoma in situ) in breast MRI:
14:48
comparison of diffusion-weighted imaging findings
B-0597 The value of Gadoxetic acid-enhanced and diffusion-
in pure DCIS and in DCIS with associated invasive
weighted MR imaging for distinguishing benign and
cancer or microinvasion
malignant splenic masses S. Bednarova, I. Bednarova, P. d’Angelo, A. Linda, R. Girometti,
S.-Y. Choi1, S. Kim2, K. Jang2, T. Kang2, K. Song2, J. Moon2; C. Zuiani, M. Bazzocchi; Udine/IT
1
Bucheon/KR, 2Seoul/KR
14:32
14:56
B-0606 The usefulness of the qualitative analysis of breast
B-0598 Role of apparent diffusion coefficient values using
lesions at high-resolution diffusion-weighted MRI as
3T magnetic resonance imaging in differentiation of
an adjunct to quantitative analysis
hepatic alveolar echinococcosis from primary hepatic Y. An1, J. Byeon1, B. Kang2; 1Suwon/KR, 2Seoul/KR
tumours
H. Ogul1, L. Karaca1, R. Sade1, M. Kantarci1, U. Bayraktutan1, 14:40
B. Gündogdu1, N. Karabulut2, Y. Akyuz3, M. Turkeli1; 1Erzurum/TR,
2
Denizli/TR, 3Yozgat/TR
B-0607 Role of diffusion weighted imaging with background
suppresion in early detection of breast cancer in
15:04 young patients
B-0599 Spectral CT combined with contrast-enhanced K.E. Allam; Cairo/EG
ultrasonography (CEUS) in evaluation on the blood 14:48

perfusion and the correlation with angiogenesis of
B-0608 Predicting tumour proliferation and aggressiveness
rabbit VX2 liver tumour
M. Wang, J. Gao; Zhengzhou/CN
with breast MRI: role of quantitative diffusion-
weighted imaging (DWI)
G. Cristel, A. Damascelli, C. Losio, E. Schiani, M. Panzeri,
M. Rodighiero, P. Panizza, F. De Cobelli, A. Del Maschio; Milan/IT

14:56 14:49
B-0609 Inter-observer agreement of semi-automated B-0618 Paclitaxel-coated balloon vs plain balloon
quantitative lesion analysis in breast diffusion- angioplasty for the treatment of symptomatic central
weighted imaging venous stenosis in dialysis access
H. Dijkstra1, M.D. Dorrius1, M. Wielema1, K. Jaspers1, R.M. Pijnappel2, P.M. Kitrou, S. Spiliopoulos, P. Papadimatos, V. Theodosiadou,
M. Oudkerk1, P.E. Sijens1; 1Groningen/NL, 2Utrecht/NL A. Lepida, N. Christeas, D. Karnabatidis; Patras/GR
15:04 14:57
B-0610 The additional value of ADC and IVIM in dynamic B-0619 Influence of renal denervation on aortic distensibility
contrast-enhanced MRI of the breast in ApoE-deficient rats: assessment by ultrahigh field
M.D. Dorrius1, H. Dijkstra1, M. Wielema1, K. Jaspers1, R.M. Pijnapel2, MRI
M. Oudkerk1, P.E. Sijens1; 1Groningen/NL, 2Utrecht/NL P. Fries, A. Müller, J. Stroeder, M. Hohl, D. Linz, M. Böhm, F. Mahfoud,
G. Schneider, A. Buecker; Homburg/DE
15:12
B-0611 Apparent diffusion coefficient values for 15:05
discriminating benign and malignant breast MRI B-0620 2-years experience in endovascular treatment of
lesions ruptured cerebral aneurysms: comparison between
D. Rajgopal1, K. Bhawat2; 1Manglore/IN, 2Davangere/IN simple coiling and stent-assisted-coiling
F. Giurazza1, R. Pimentel Silva2, M. Tecame3, G. Guarnieri3, M. Muto3;
15:20 1
Rome/IT, 2Lisbon/PT, 3Naples/IT
B-0612 Role of MRI diffusion as an adjunct to contrast
enhanced MRI of the breast for the evaluation 15:13
of breast cancer patients receiving neoadjuvant B-0621 Placement of central venous catheters in the routine
chemotherapy clinical setting: estimation of the costs and the
H.H.N. El Kassas, M. Helal, A. Abu Rabia, N. Abd El Razik, S. Gareer, learning curve of radiologist newly learning the
A. Farahat, M.H. Zedan; Cairo/EG implantation procedures
R. Rotzinger1, B. Gebauer1, D. Schnapauff1, F. Streitparth1, G. Wieners1,
C. Grieser1, P. Freyhardt1, B. Hamm1, M.H. Maurer2; 1Berlin/DE,
2
14:00–15:30 Room Z Berne/CH
15:21
Vascular
B-0622 Radiation dose reduction during transjugular
SS 715 Endovascular therapies: what’s new? intrahepatic portosystemic shunt (TIPS) implantation
Moderators: F. Fanelli; Rome/IT, D.K. Tsetis; Iraklion/GR using a novel image-processing platform
C. Spink, T. Schmidt, M. Grass, M. Avanesov, G. Adam, P. Bannas,
A. Koops; Hamburg/DE
14:00
F. Fanelli; Rome/IT
14:00–15:30 Room O
14:09
B-0613 TPA immobilisation on iron oxide nanocubes and GI Tract
localised magnetic hyperthermia accelerate blood
SS 701b Advanced imaging of the oesophagus
clot lysis
E. Vörös1, M. Cho2, Z. Garami2, I. Battyáni1, P. Decuzzi3, K. Tóth1; and stomach
1
Pecs/HU, 2Houston, TX/US, 3Genoa/IT Moderators: O. Ekberg; Malmö/SE, M.A. Mazzei; Siena/IT
14:17 14:00
B-0614 3D-guidance for catheter-based interventions B-0623 Quantitative radiomics features as prognostic
with tessellated heart models for cardiovascular indicator of esophageal cancer undergoing
interventions in congenital heart disease (CHD) chemoradiotherapy
M. Glöckler, N. Ehret, O. Rompel, S. Dittrich; Erlangen/DE Y. Cho, C. Park, S. Park, J. Goo; Seoul/KR
14:25 14:08
B-0615 Balloon-assisted n-butyl cyanoacrylate glue B-0624 Role of qualitative CT features in differential
embolisation mixed with Lipiodol and ethanol to diagnosis of post-inflammatory oesophageal
reduce catheter adhesion strictures (corrosive, peptic) from oesophageal
J. Koizumi1, T. Hara1, T. Sekiguchi1, C. Itou1, T. Ichikawa1, B.J. d’Othee2;
1
Isehara City/JP, 2Baltimore, MD/US cancer using two-phase dynamic MDCT
S.A. Buryakina, G.G. Karmazanovsky, D.V. Ruchkin, Q. Yang,
A.V. Vishnevskaya; Moscow/RU
14:33
B-0616 Rotational atherothrombectomy in combination with 14:16
drug eluting balloon angioplasty for femoropopliteal B-0625 The efficacy of cine-magnetic resonance imaging in
occlusions: 12 month outcome accurate evaluation of the invasion level of tumour
F. Scheer, C. Luedtke, E. Schlöricke, P. Kamusella, R. Andresen,
C. Wissgott; Heide/DE tissue in esophageal carcinoma
M. Ozgokce1, F. Alper2, A. Yavuz1, H. Ogul2, Y. Aydin2, A. Batur1,
A. Eroglu2; 1Van/TR, 2Erzurum/TR
14:41
B-0617 Time extended lyse-and-wait technique for
thrombosed hemodialysis access
S. Regus, W. Lang, M. Heinz, M. Uder, A. Schmid; Erlangen/DE

14:24 14:16
B-0626 Pre-treatment contrast-enhanced CT texture analysis B-0636 Characteristic MR signal intensity pattern of exercise-
(CTTA) of gastric cancer to predict response to induced rhabdomyolysis in thigh muscle: differential
neoadjuvant chemotherapy: comparison with point from other causes and its clinical significance
histological tumour regression grade (TRG) E. Yeon; Seoul/KR
P. Marra, A. Salerno, S. Antunes, F. Giganti, A. Esposito, F. De Cobelli,
A. Del Maschio; Milan/IT 14:24
B-0637 Can we diagnose piriformis muscle syndrome via
14:32 sonoelastography: preliminary findings of twenty-
B-0627 Usefulness of dynamic CT transmural sign to one patients
evaluate T staging of gastric cancer: histopathologic M. Baykara, A. Demirel, E. Berk, B. Kızıldağ, M.A. Sarıca, N. Yurttutan;
correlation Kahramanmaraş/TR
S. Lee, D. Chung; Seoul/KR
14:32
14:40 B-0638 From myocardial to skeletal muscle: late gadolinium
B-0628 The prognostic significance of extramural venous enhancement as a new tool to reveal involvement in
invasion detected by multiple-row detector idiopathic inflammatory myopathies
computed tomography in stage III gastric cancer G. Benedetti, A. Esposito, M. Cava, M. Colombo, D. Velardo,
J. Cheng, J. Wu, Y. Ye, C. Zhang, Y. Zhang, Y. Wang; Beijing/CN S. Previtali, P. Rovere Querini, A. Del Maschio, F. De Cobelli; Milan/IT
14:48 14:40
B-0629 Gastric cancer: texture analysis from multidetector B-0639 MRI of acute groin injury in athletes with a focus
computed tomography as a potential prognostic on the adductor muscles: reliability and patterns of
biomarker injury
Thursday
F. Giganti, S. Antunes, A. Salerno, A. Ambrosi, P. Marra, E. Orsenigo, F.W. Roemer1, A. Serner2, P. Hölmich3, K. Thorborg3, A. Weir2, J.L. Tol2,
A. Esposito, A. Del Maschio, F. De Cobelli; Milan/IT A. Guermazi4; 1Erlangen/DE, 2Doha/QA, 3Amager-Hvidovre/DK,
4
Boston, MA/US
14:56
14:48
B-0631 Comparison between CT Net enhancement and PET/
B-0640 Do iliopsoas and gluteus maximus change with
CT SUV for N staging of gastric cancer
A.A. Stabile Ianora, N.M. Lucarelli, M. Telegrafo, A. Scardapane, aging? A MRI investigation in healthy adult
A.A. Niccoli, P. Pignataro, M. Moschetta, G. Angelelli; Bari/IT volunteers.
R. Crawford1, S. Franckenberg2, P. Kälin2, M.A. Fischer2, D. Nanz2,
15:04 E.J. Ulbrich2; 1Winterthur/CH, 2Zurich/CH
B-0632 Can we identify the normal and abnormal

14:56
radiological findings after laparoscopic, adjustable
B-0641 Can echo intensity obtained from ultrasonography
gastric banding (LAGB)?
M. Andronikou- Zouvani; Paralimni/CY images reflect muscle strength in the frail elderly
population?
15:12 R. Mirón Mombiela, C. Borrás, F. Facal de Castro, P. Moreno;
Valencia/ES
B-0633 Contribution of CT in management of acute
abdominal pain after gastric bypass: correlation 15:04
between radiological and surgical findings B-0642 Comparison of T2* relaxation times of articular
F. Cuccioli, P. Karila Cohen, J. Laissy, J. Marmuse, K. Arapis; Paris/FR
cartilage of the knee in elite professional soccer
players and age-and BMI-matched volunteers
C. Behzadi, G.H. Welsch, F.O. Henes, A. Quitzke, G. Schoen, G. Adam,
14:00–15:30 Room E1 M. Regier; Hamburg/DE
Musculoskeletal 15:12
B-0643 Association of physical activity measured by
SS 710 Muscles accelerometer with longitudinal changes of knee
Moderators: J. Oudeman; Amsterdam/NL, joint abnormalities and cartilage T2: data from the
Osteoarthritis Initiative
A. Gersing1, M. Kretzschmar1, C. Claudi1, B.J. Schwaiger1, G.B. Joseph1,
14:00
D. Dunlop2, M.C. Nevitt1, C.E. McCulloch1, T. Link1; 1San Francisco,
B-0634 Diffusion tensor imaging-based tractography of the CA/US, 2Chicago, IL/US
myopathic and dystrophic skeletal muscle
S. Keller1, A. Golsari1, M. Gelderblom1, H. Kooijman-Kurfuerst1, 15:20
J. Wang2, G. Adam1, J. Yamamura1; 1Hamburg/DE, 2Dallas, TX/US B-0644 Application of a sub-set of skinfold sites for
SPEAKER
14:08 SUPPORTED ultrasound measurement of subcutaneous adiposity
BY
INVEST IN and percentage body fat estimation in athletes
B-0635 Assessment of fatty degeneration of the THE YOUTH D.C. O’Neill, O. Cronin, S.B. O’Neill, D. Herlihy, D. Keohane, T. Woods,
gastrocnemius and soleus muscles in patients with M. Molloy, E. Falvey; Cork/IE
achillodynia using MRI: reliability of the Goutallier
classification system
B.C.S. Rabelo, R.R. Nobre, A.M.A. Lopes, E.J.S. Ribeiro, D.S. Baumfeld,
R. Strecker; Belo Horizonte/BR

14:00–15:30 Room E2 14:00–15:30 Room F1
Neuro Oncologic Imaging

SS 711 Cerebrovascular disease (2) SS 716 Whole body imaging
Moderators: U. Lamot; Ljubljana/SI, Z. Merhemic; Sarajevo/BA Moderators: J. Sosna; Jerusalem/IL,
T.D. Westwood; Manchester/UK
14:00
B-0645 Added value of morphologic characteristics of 14:00
intracranial arteries to future stroke risk K-19 Keynote lecture
N. Han, J. Jang, H. Byun, K. Lee, J. Koo, H. Choi, S.-L. Jung, K.-J. Ahn, J. Sosna; Jerusalem/IL
B.-S. Kim; Seoul/KR
14:09
14:08 B-0655 Whole-body MRI with and without DWI: comparison
B-0646 Morphological characteristics of intracranial arteries: of capability for recurrence assessment with PET/CT,
their association with atherosclerotic risk factors and PET/MRI and conventional radiological examination
white matter hyperintensities in NSCLC patients
H. Byun, J. Jang, N. Han, S. Lee, H. Choi, S. Jung, K. Ahn, B.-S. Kim; Y. Ohno1, Y. Kishida1, S. Seki1, H. Koyama1, K. Aoyagi2, H. Yamagata2,
Seoul/KR K. Sugimura1; 1Kobe/JP, 2Otawara/JP
14:16 14:17
B-0647 Intracranial atherosclerotic plaque enhancement: is it B-0656 Comparative performance of 18F-FDG PET/
a predictive marker of ischaemic stroke? MRI and 18F-FDG PET/CT regarding detection
A.H. Elmokadem1, F. Sherazi2, T.J. Carroll2, A. Honarmand2, and characterisation of pulmonary lesions in 121
A. Shaibania2, M.C. Hurley2, S.A. Ansari2; 1Mansoura/EG, 2Chicago,
IL/US oncologic patients
L.M. Sawicki1, J. Grueneisen2, C. Buchbender1, B.M. Schaarschmidt1,
V. Ruhlmann2, A. Wetter2, L. Umutlu2, G. Antoch1, P. Heusch1;
14:24 1
Düsseldorf/DE, 2Essen/DE
B-0648 Intracranial vascular findings in a large tri-ethnic
cohort 14:25
A.J. Schmitt, L. Smith, A. Hughes, N. Chaturvedi, R.H. Jager; B-0657 Influence of staging differences between 18F-FDG
London/UK
PET/CT and 18F-FDG PET/MRI on therapeutic
14:32 decisions in non-small cell lung cancer patients
B.M. Schaarschmidt1, J. Grueneisen2, M. Metzenmacher2, B. Gomez2,
B-0649 Is there any relationship between carotid artery P. Heusch1, V. Ruhlmann2, L. Umutlu2, G. Antoch1, C. Buchbender1;
plaque and cerebral micro bleed? 1
Düsseldorf/DE, 2Essen/DE
F. Mubarak; Karachi/PK
14:33
14:40
B-0658 Osteonecrosis detected by whole body magnetic
B-0650 Distinction of atherosclerotic intimal and non-intimal resonance (WB-MRI) in patients with Hodgkin
calcification in the intracranial carotid artery on CT: a lymphoma treated by BEACOPP
histopathological comparison D. Albano, C. Patti, L. La Grutta, E. Grassedonio, A. Mulè, R. Lagalla,
R. Kockelkoren, A. Vos, W. van Hecke, A. Vink, W.P.T.M. Mali, M. Midiri, M. Galia; Palermo/IT
J. Hendrikse, D.H. Koek, P.A. de Jong, J. de Vis; Utrecht/NL
14:41
14:48
B-0659 Qualitative and quantitative evaluation of whole
B-0651 The importance of interface irregularity between body MRI with DWI for bone marrow involvement in
the tumour and brain parenchyma in differentiating follicular lymphoma
between typical and atypical meningiomas: A. Balbo Mussetto1, C. Saviolo1, M. Petracchini1, E. Vietti1, C. Lario1,
correlation with pathology A. De Libero1, D. Gottardi1, C. Tarella2, S. Cirillo1; 1Turin/IT, 2Milan/IT
J. Lee, K. Ahn, B. Kim, S. Jung, H. Choi, J. Jang, S. Lee; Seoul/KR
14:49
14:56 B-0660 Pre- and post-treatment relationship of glycolytic
B-0652 Diagnostic accuracy of 3D black blood MR imaging activity on [18F]-FDG-PET and cell density on
with high resolution T1 SPACE in the evaluation of diffusion-weighted MRI: preliminary results of an
intracranial arterial thrombosis [18F]-FDG-PET/MR study
A.H. Elmokadem1, T.J. Carroll2, M.C. Hurley2, A. Shaibani2, S.A. Ansari2; C. Giraudo, M. Weber, M. Raderer, D. Senn, G. Karanikas,
1
Mansoura/EG, 2Chicago, IL/US M. Mayerhoefer; Vienna/AT
15:04 14:57
B-0653 Added value of 3D proton-density weighted images B-0661 Assessing progressive disease in myeloma patients
in diagnosis of intracranial arterial dissection with whole-body diffusion-weighted imaging: a
W. Lee, J. Kim, N.-Y. Shin, Y. Kim, S. Lim, S.-K. Lee; Seoul/KR
prospective study comparing whole body T1-WI, T2-
15:12 STIR-WI and laboratory findings
S. Pans, V. Goosens, N. Noppe, F. De Keyzer, M. Delforge; Leuven/BE
B-0654 High-resolution magnetic resonance (HR-MR)
findings of intracranial artery dissection based on 15:05
quantitative analysis B-0662 Efficacy of whole-body low-dose CT (WBLDCT) in
N. Lee, S. Jung, H. Kim, C.-G. Choi, S. Kim, D. Lee, D. Suh; Seoul/KR
the staging of patients with multiple myeloma (MM):
comparison with whole-boby magnetic resonance
imaging (WBMRI)
E.B. Orsini, D. Ippolito, C. Talei Franzesi, V. Besostri, S. Spiga, S. Sironi;
Monza/IT

15:13 14:48
B-0663 A comparative study between whole body diffusion B-0671 Facilitated diagnosis of pneumothoraces in mice
imaging with background signal suppression using x-ray dark-field radiography
(DWIBS) and FDG PET/CT in assessment of K. Hellbach1, A. Yaroshenko2, K. Willer2, S. Auweter1, M.F. Reiser1,
A. Hilgendorff3, O. Eickelberg3, F. Pfeiffer2, F.G. Meinel1; 1Munich/DE,
lymphoma patients 2
Garching/DE, 3Neuherberg/DE
A.M. Wafaie1, M. Kotb2, M. El-Azab2, A. Abo El-Regal2; 1Giza/EG,
2
Cairo/EG
14:56
15:21 B-0672 Novel x-ray detector technology for quantitative
B-0664 Generating evidence for clinical benefit of PET/CT material information in digital radiography
J.J. Cowling1, G. Gibson1, N. Loxley1, P. Scott1, P. White2, K.J. Robson2,
based on the results of an oncologic PET/CT registry B. Lopez3; 1Sedgefield/UK, 2Newcastle upon Tyne/UK, 3Durham/UK
- filling the gap between diagnostic accuracy and
patient outcome? 15:04
C. Pfannenberg, B. Gueckel, S.-C. Schuele, N. Schwenzer, B-0673 Large volume data acquisition for intraoperative
S. Kaufmann, A.-C. Mueller, C. la Fougere, K. Nikolaou, P. Martus;
Tübingen/DE
imaging with mobile C-Arm CT systems
J. Kuntz1, M. Knaup1, C. Fleischmann2, M. Kachelrieß1; 1Heidelberg/DE,
2
Nürnberg/DE
14:00–15:30 Room F2 15:12

B-0674 CT thermometry for temperature monitoring in
Physics in Radiology tumour hyperthermal treatments: influence of ROI
size and scan setting
SS 713 Innovations in radiology G. Frauenfelder1, F. Giurazza2, E. Schena2, P. Saccomandi2,
Moderators: Y. Bouchareb; London/UK, C. Massaroni2, B. Beomonte Zobel2; 1Naples/IT, 2Rome/IT
Thursday
R. Raupach; Forcheim/DE
15:20
14:00 B-0675 The impact of dual axis rotational coronary
B-0665 In vivo skin moisturizing measurement by high- angiography (DARCA) on patient and staff exposure
resolution 3-T MR imaging while using novel X-ray imaging technology
J. Mesrar, J. Ognard, S. Ghomadi, D. Chechin, L. Misery, D. Ben Salem; D. Buytaert, B. Drieghe, J. De Pooter, Y. Taeymans, K. Bacher;
Brest/FR Gent/BE
14:08
B-0666 Cycled superselective pseudo-continuous Arterial 14:00–15:30 Room D1
Spin Labeling without the need for acquiring a
control image Chest
T. Lindner1, O. Jansen1, M. Helle2; 1Kiel/DE, 2Hamburg/DE
SS 704 Lung cancer
14:16
Moderators: G. Aviram; Tel Aviv/IL, E. Jon; Vitoria/ES
B-0667 Whole-Body MRI: Inter- and Intra-Reproducibility
of Quantitative, Organ-specific Measures across 14:00
different 3 Tesla MR Scanners in the Pilot-Study of K-16 Keynote lecture
the German National Cohort C.J. Herold; Vienna/AT
C.L. Schlett1, T. Hendel2, J. Hirsch3, T. Ittermann4, H.-U. Kauczor1,
M. Forsting5, F. Bamberg6, .. the German National Cohort1; 14:09
1
Heidelberg/DE, 2Munich/DE, 3Bremen/DE, 4Greifswald/DE,
5
B-0676 Preoperative CT predicting recurrence of surgically
Essen/DE, 6Tübingen/DE
resected adenocardinoma of the lung
14:24 H. Lee1, H. Koo1, H. Xu2, C.-M. Choi1, J. Song1, H. Kim1, J. Lee1, M. Kim1;
1
Seoul/KR, 2Nanjing/CN
B-0668 Application of MR-based joint estimation of
attenuation and activity distributions to clinical non- 14:17
TOF PET/MR B-0677 Role of delayed enhanced phase in the intra-thoracic
T. Heußer1, C.M. Rank1, M.T. Freitag1, A. Dimitrakopoulou-Strauss1,
staging of lung cancer: what does it add?
H.-P. Schlemmer1, T. Beyer2, M. Kachelrieß1; 1Heidelberg/DE,
2
P. Franchi, A.R. Larici, A. del Ciello, A. Farchione, G. Cicchetti,
Vienna/AT
M. Occhipinti, L. Bonomo; Rome/IT
14:32 14:25
B-0669 Respiratory motion compensation for simultaneous B-0678 Inflammatory myofibroblastic tumour of the lung
PET/MR based on strongly undersampled MR data in adults: CT and 18 FDG PET characteristics with
C.M. Rank, T. Heußer, A. Wetscherek, H.-P. Schlemmer, M. Kachelrieß;
Heidelberg/DE pathologic correlations in a single tertiary referral
center
14:40 S. Lim, M. Kim; Seoul/KR
B-0670 Multi-purpose robotic x-ray system enabling 2D/3D
14:33
imaging of standing patients: assessment of 3D
B-0679 Baseline results from an Italian CT lung cancer
imaging performance
A. Fieselmann, J. Steinbrener, A.K. Jerebko, T. Mertelmeier; screening program compared to the NLST data
Erlangen/DE M. Occhipinti, P. Franchi, M. Ciliberto, L. Tonetti, G. Cicchetti,
A.R. Larici, L. Bonomo; Rome/IT

14:41 14:24
B-0680 Gynecomastia seen on CT examinations in the B-0689 Costal cartilage fractures: an overlooked injury in
general male population polytrauma patients? A review of 978 consecutive
N. Kanana, M. Amitai, S. Raskin, M. Yassin, M. Sklair, E. Konen, blunt trauma patients
E. Klang; Ramat Gan/IL M.T. Nummela1, F.V. Bensch1, S.K. Koskinen2; 1Helsinki/FI,
2
Stockholm/SE
14:49
B-0681 Lung cancers in patients with fibrothorax and chronic 14:32
empyema caused by tuberculosis B-0690 Nontraumatic incidental findings in patients
H. Xu1, H.J. Koo2, H.N. Lee2, S. Lim2, M.Y. Kim2; 1Nanjing/CN, 2Seoul/KR undergoing whole-body computed tomography at
14:57 initial emergency admission
E. Kroczek1, G. Wieners1, I. Steffen1, T. Lindner1, F. Streitparth1,
B-0682 Multi-detector computed tomography features B. Hamm1, M.H. Maurer2; 1Berlin/DE, 2Berne/CH
of peripheral lung cancer associated with cystic
airspace 14:40
Y. Wang, L. Fan, S. Liu; Shanghai/CN B-0691 Screening for blunt cerebrovascular injury (BCVI) by
two-phased whole body CT (WBCT) after acute blunt
15:05
trauma using modified Denver criteria: a review of
B-0683 CT-guided core needle biopsy of pulmonary nodules 373 cases
SPEAKER
SUPPORTED smaller than 2 cm: analysis of 469 procedures E.A. Varjonen1, F.V. Bensch1, S.K. Koskinen2; 1Helsinki/FI,
BY S. Gálvez García1, A. Prieto Fernández1, A. Muñoz Ruiz1, 2
Stockholm/SE
INVEST IN
THE YOUTH E. Nava Tomás1, H. Chung2, J. Sanz Díaz1, S. Sánchez García1,
M. Morán Hevia1, M. Vicente Quílez1; 1Oviedo/ES, 2Los Ángeles, 14:48
CA/US
B-0692 “Concordance” revisited: a multi-disciplinary
15:13 appraisal of concordant preliminary abdominopelvic
B-0684 Dynamic contrast-enhanced perfusion area-detector CT reports
J.M. Brown, E. Dickerson, R. Kaza, R. Cohan, J. Ellis, M. Davenport;
CT vs FDG-PET/CT: capability for therapeutic Ann Arbor, MI/US
outcome prediction in non-small cell lung cancer
patients with chemoradiotherapy 14:56
Y. Ohno1, Y. Kishida1, S. Seki1, H. Koyama1, Y. Fujisawa2, N. Sugihara2, B-0693 Use of IV-contrast versus IV-and oral-contrast in the
T. Yoshikawa1, K. Sugimura1; 1Kobe/JP, 2Otawara/JP
evaluation of abdominal pain on CT in the emergency
15:21 department
M. Wasserman1, K. Melamud2, J. Soto1; 1Boston, MA/US, 2Philadelphia,
B-0685 Dynamic CE-perfusion area-detector CT: comparison PA/US
of capability for N-stage assessment with FDG-PET/
CT in non-small cell lung cancer patients 15:04
Y. Ohno1, Y. Kishida1, S. Seki1, H. Koyama1, Y. Fujisawa2, N. Sugihara2, B-0694 Contribution of diffusion-weighted MR imaging
T. Yoshikawa1, K. Sugimura1; 1Kobe/JP, 2Otawara/JP
to non-enhanced CT in evaluation of acute
abdominopelvic pain
O. Ozdemir, Y. Metin, N. Orhan Metin, Ö. Yavaşi, Ö. Bilir, S. Kalcan;
14:00–15:30 Room D2 Rize/TR
Emergency Radiology 15:12

B-0695 Clinical relevance of consecutive CT scans for
SS 717 Trauma of the brain and body the evaluation and monitoring of geriatric pelvic
Moderators: J.M. Artigas; Zaragoza/ES,
fractures
C. Weber, T.H. Schroeder; Hamburg/DE
14:00
B-0686 Excess use of minor head injury CT examinations in
14:00–15:30 Room K
the emergency department (ER)
A. Beytelman1, E. Klang1, E. Konen1, D. Greenberg2, E. Zimlichman1;
1
Ramat Gan/IL, 2Beer Sheva/IL
Genitourinary
14:08 SS 707 Prostate cancer: routine and novel MRI
B-0687 Head CT scans from Emergency Department: a techniques
misplaced screening? Moderators: D. Bonekamp; Hirschberg/DE,
A. Bernardini, S. Roiati, R. Lattanzi, M. Di Bartolomeo, F. Iannessi, N.C. Cowan; Portsmouth/UK
F. Navarra, L.M. Gregori, E.G. Puglielli, V. Di Egidio; Teramo/IT
14:00
14:16 B-0697 Correlation of prostate volume and cancer detection
B-0688 Acute cervical traumatic spinal cord injury: MRI as assessed by MRI volumetry
with diffusion-weighted imaging correlated with M. Haas, H. Cash, B. Hamm, P. Asbach; Berlin/DE
neurologic outcome
T. Nakagawa1, J. Isogai2, N. Harata2, T. Miyazaki2; 1Kawasaki-city, 14:08
Kanagawa/JP, 2Asahi-city, Chiba/JP B-0698 Comparison of image quality and patient discomfort
in prostate MRI using a pelvic array or an endorectal
coil
B.K. Barth1, A. Cornelius2, D. Nanz1, D. Eberli1, O.F. Donati1; 1Zurich/CH,
2
Aarau/CH

14:16 14:00–15:30 Room G

B-0699 Apparent diffusion coefficient value is a strong
predictor of unsuspected aggressiveness of prostate Radiographers
cancer before radical prostatectomy
R. Renard-Penna, G. Cancel-Tassin, E. comperat, P. Mozer, P. Leon, SS 714 Quality issues in ultrasound and CT
M. Roupret, M.-O. Bitker, O. Lucidarme, O. Cussenot; Paris/FR Moderators: C. Beardmore; London/UK, K. Lang; Malmö/SE
14:24 14:00
B-0700 Pre-active surveillance multiparametric MRI predicts B-0708 Abdominal CT for obese patients: investigating
short-term outcomes optimal scan parameters
F. Sanguedolce1, G. Petralia2, H. Sokhi3, N. Anyamene4, G. Hellawell5, A.A. Qurashi1, L.A. Rainford1, A. Ajlan2, K. Khashoggi2, L. Ashkar2,
A. Padhani4; 1Northampton/UK, 2Milan/IT, 3Uxbridge/UK, M. Alraddadi3, M. Alghamdi2, M. Althubaiti2, S.J. Foley1; 1Dublin/IE,
4
Northwood/UK, 5Harrow/UK 2
Jeddah/SA, 3Madinah/SA
14:32 14:08
B-0701 Differences in quantitative perfusion parameters B-0709 Body composition changes in obese population
between normal transitional, normal peripheral S.J.M. Alqahtani, K.M. Knapp, R.M. Palfrey, S.J. Hopkins, J.R. Meakin,
J. Fulford; Exeter/UK
and tumour regions from 3T DCE-MR images of the
prostate 14:16
R. Sanz-Requena, L. Marti-Bonmati, R. Perez, G. Garcia-Marti,
A. Mañas-Garcia; Valencia/ES
B-0710 Manual vs automated visceral adipose tissue
SPEAKER
SUPPORTED quantification in paedatric CT: which is best?
14:40 BY M. O’Connor, S. Foley; Dublin/IE
INVEST IN
THE YOUTH
B-0702 Index lesion detection with diffusion-weighted
imaging at 3 Tesla MRI and its correlation with
Thursday
14:24
choline kinase-Alfa-Į overexpression in primary B-0711 An analysis of the validity and reliability of a
prostate carcinoma handheld ultrasound device for measuring rectus
M.D. Hernández-Argüello, J. Solorzano, A. Benito, M. Collantes,
M. Rodríguez-Fraile, I. Pascual, J. Madrid, J. Pardo, J. Richter; femoris muscle size
Pamplona/ES W. Nijholt1, A. Bakker1, A. Bennet2, M. Borgen3, A. Ellermann1,
P. Hogg2, P. Gamboa4, L. Vorster5, I.-J. Aandahl3; 1Groningen/NL,
2
Salford/UK, 3Oslo/NO, 4Lisbon/PT, 5Bloemfontein/ZA
14:48
B-0703 Diagnostic performance of the monoexponential 14:32
model and diffusion kurtosis imaging in the analysis B-0712 Reproducibility of ultrasound parameters (echo-
of prostate cancer intensity and thickness) of quadriceps muscle
N. Adubeiro1, L. Nogueira1, E. Ribeiro1, J.M. La Fuente1, H.A. Ferreira2; R.A. Santos, P. Armada-da-Silva; Coimbra/PT
1
Porto/PT, 2Lisbon/PT
14:40
14:56
B-0713 Assessment of musculoskeletal ultrasound
B-0704 Effect of temporal resolution on diagnostic
pathologies by radiographers and undergraduated
performance of DCE-MRI of the prostate
A. Othman, F. Falkner, J. Weiss, S. Kruck, P. Martirosian, K. Nikolaou, radiography students
M. Notohamiprodjo; Tübingen/DE A.F.C.L. Abrantes, I. Rodrigues, R.P.P. Almeida, J.P. Pinheiro,
O. Lesyuk; Faro/PT
15:04
14:48
B-0705 Potential role of diffusion weighted MRI for
B-0714 Do radiologists agree when reviewing ultrasound
predicting extracapsular extension of prostate cancer
P. Pricolo, S. Alessi, P. Summers, E. Tagliabue, G. Petralia; Milan/IT examinations performed by a sonographer and a
radiologist?
15:12 C. Stenman1, R. Glavas1, K. Jansson1, A.-L. Enlund1, L. Thorelius2,
Ö. Smedby3; 1Linköping/SE, 2Barcelona/ES, 3Stockholm/SE
B-0706 Prostate DCE-MRI: improved SNR with 32-element
receiver arrays 14:56
S. Riederer, E. Borisch, A. Froemming, R. Grimm, A. Kawashima,
J. Trzasko; Rochester, MN/US B-0715 Quality assurance in Irish ultrasound departments
A.M. Ward, M.T. Stanton; Dublin/IE
15:20
15:04
B-0707 Image quality evaluation of a high-resolution 3D
B-0716 Are physical measures good indicators of clinical
SPACE T2-weighted sequence (SPACE) in prostate
image quality at low dose levels? A pilot study
multiparametric MRI (mp-MRI) L. Lanca1, E.N. Andersen2, G. Carvalho1, M. van Gerwen3, J. Jorge4,
E. Armando, L. Capitolo, F. Cesarani; Asti/IT M. Kleiker5, B. Markali2, P. Nightingale6, P. Hogg6; 1Lisbon/PT,
2
Oslo/NO, 3Eindhoven/NL, 4Lausanne/CH, 5Groningen/NL,
6
Manchester/UK
15:12
B-0717 Effectiveness of the American Association of Physics
in Medicine criteria to assess diagnostic monitors
K.B. Azevedo, N. Messias, L.P. Ribeiro, J.P. Pinheiro, R.P.P. Almeida,
P. Sousa, A.M. Ribeiro, A.F.C.L. Abrantes; Faro/PT
15:20
B-0718 Use of anatomical side markers (ASMs) during planar
x-ray imaging
S. Attard, J.G. Couto, F. Zarb; Msida/MT

14:00–15:30 Room M 1 14:00–15:30 Room M 2
Head and Neck Abdominal Viscera

SS 708 Temporal bone SS 701c Advances in CT
Moderators: S. Kösling; Halle a.d. Saale/DE, Moderators: E. Akchurina; Moscow/RU, N.N.
K. Markiet; Gdansk/PL
14:00
14:00 B-0729 Image quality - cutting through noise
K-17 Keynote lecture D.M. Jackson, K.K. Lau, A. Borsaru; Clayton/AU
F. Veillon; Strasbourg/FR
14:08
14:09 B-0730 Image quality and radiation dose warrants routine
B-0719 Structured reporting of the petrous bone: potential use of abdominal dual energy CT
effects on surgical planning D. Schmidt, M. Söderberg, C. Lee Christoffersen, H. Lindvall,
M. Armbruster, S. Gassenmaier, M. Haack, W. Sommer, F. Braun; M. Nilsson, P. Leander; Malmö/SE
Munich/DE
14:16
14:17 B-0731 Dilute concentration or reduce injection rate?
B-0720 Fractures of the temporal bone: an easier way to read Optimisation of reducing iodine delivery rate for low-
SPEAKER
SUPPORTED your CT energy contrast enhanced body CT
BY A. Venkatasamy1, F. Veillon1, B. Rock1, S. Riehm1, P. Meriot2, P. Baur1,
INVEST IN S. Takahashi, N. Negi, K. Kagawa, E. Suehiro, T. Nishii, Y. Ueno,
THE YOUTH A. Charpiot1; 1Strasbourg/FR, 2Brest/FR A. Kono, H. Kawamitsu, K. Sugimura; Kobe/JP
14:25 14:24
B-0722 Determination of cochlea length via flat panel CT is B-0732 Preserving image quality in low contrast media
reliable and safe and radiation dose abdominal MDCT using iterative
C. Loberg, J. Ilgner, M. Westhofen, C. Kuhl; Aachen/DE
reconstruction algorithm in normal-weight patients
E. Belousova, E. Kondratyev, G. Karmazanovsky; Moscow/RU
14:33
B-0723 Reduction of cochlear implant metal artifact in 1024 14:32
high-resolution CT: value of orthopedic metal artifact B-0733 Virtual monochromatic spectral CT in small feeding
reduction (O-MAR) algorithm arteries of abdominal tumours: can spectral image
C. Ding, X. Lu, Q. Wang; Shenyang/CN
fusion optimise the image quality?
Y. Zhou, J.B. Gao; Zhengzhou/CN
14:41
B-0724 Flat panel computed tomography versus multislice 14:40
computed tomography in diagnosis of superior canal B-0734 Dose performance of virtual monochromatic spectral
dehinscence CT protocol optimised for “double low scanning” on
C. Loberg, J. Ilgner, C.K. Kuhl; Aachen/DE
oesophageal cancer?
14:49
B-0725 Multiplanar reconstruction of the internal auditory 14:48
canal using high resolution MR-imaging: effect of B-0735 Optimal monochromatic spectral computed
constitutional differences on the size of the cochlear tomography with low iodine concentration contrast
and facial nerves medium in a rabbit VX2 liver model: investigation of
N.N.N. Naguib, N.-E. Nour-Eldin, T. Gruber-Rouh, M. Harth, T.J. Vogl;
Frankfurt a. Main/DE image quality and detection
14:57
14:56
B-0726 Diagnostic accuracy of TSE diffusion weighted MR
B-0736 Comparison of iterative model reconstruction (IMR)
imaging for the diagnosis of cholesteatoma
B. Ozgen Mocan, E. Bulut, A. Dolgun, D. Bajin, L. Sennaroglu; and hybrid iterative reconstruction (iDose4) in lymph
Ankara/TR nodes evaluation and diagnostic confidence with
40% radiation dose reduction
15:05 Y. Gao, X. Lu, P. Wang; Shenyang/CN
B-0727 Repeated postoperative follow-up DWI to detect
residual or recurrent cholesteatoma 15:04
W. Venderink, S. Steens, D. Kunst, A. Meijer, E. Mylanus; B-0737 Efficacy of water-equivalent diameter for radiation
Nijmegen/NL
dose optimisation
K.K. Lau, O. Wong, R. Evans, A. Kuganesan, K. Buchan;
15:13 Melbourne/AU
B-0728 Follow-up MRI of vestibular schwannoma: is it worthy
to measure volume? 15:12
J. Lisý, M. Chovanec, L. Mikšík, J. Betka, R. Pipková, E. Zvěřina; B-0738 Why have we adopted 120 kVp in abdominal CT for
Prague/CZ
decades? 100 kVp is enough
J. Choi, S. Jung, M. Choi; Seoul/KR

15:20 14:56
B-0739 Quantitative response evaluation of hepatocellular B-0747 Semmelweis cardiac CT registry: the feasibility
carcinoma after transarterial chemoembolisation of automated data collection with a structured
using 70 kVp 4D volume perfusion CT of the liver reporting tool
X. Wang1, T. Henzler2, S. Diehl2, S.O. Schönberg2, Z.-Y. Jin1, H.-D. Xue1, P. Maurovich-Horvat, J. Karady, M. Kolossvary, A.L. Jermendy,
A. Smakic2; 1Beijing/CN, 2Mannheim/DE A. Bartykowszki, M. Karolyi, A. Panajotu, Z. Bagyura, B. Merkely;
Budapest/HU
15:04
14:00–15:30 Room M 3
B-0748 Atherosclerotic burden and cardiac remodelling in
Cardiac healthy South Asian and European adults: a cohort
comparison study
SS 703 Epidemiology, prognosis and trials J. Weir-McCall, D. Cassidy, J.J.F. Belch, S. Gandy, G. Houston,
M. Lambert, R. Littleford, A.D. Struthers, F. Khan; Dundee/UK
Moderators: K. Gruszczynska; Katowice/PL, N.N.
15:12
14:00
B-0749 Cystatin C is associated with non-obstructive
B-0740 The most powerful high-risk coronary plaque criteria
coronary artery disease determined by coronary
by coronary CTA for prediction of major cardiac
computed tomography angiography
events (MACE): a long term follow-up study E.B. Brolin1, S. Agewall2, K. Cederlund1, C. Ekenbäck1, L. Henareh1,
G. Feuchtner, J. Kerber, P. Burghard, A. Klauser, A. Mayr, F. Plank; K. Malmqvist1, A. Rück1, A. Svensson1, P. Tornvall1; 1Stockholm/SE,
Innsbruck/AT 2
Oslo/NO
14:08 15:20
B-0741 Impact of computed tomography coronary B-0750 Intravascular ultrasound in pulmonary arterial
Thursday
angiography on clinical management and outcomes hypertension vasoreactivity testing
in patients with suspected angina due to coronary O. Sagaydak, N. Danilov, Y. Matchin, T. Martinuk, I. Chazova;
heart disease Moscow/RU
M.C. Williams1, A. Hunter1, A. Shah1, V. Assi1, S. Lewis1, G. Roditi2,
E.J.R. van Beek1, A. Timmis3, D.E. Newby1; 1Edinburgh/UK,
2
Glasgow/UK, 3London/UK
14:16
B-0742 Coronary atherosclerosis features for the prediction
of ischaemic events (CAFÉ-PIE study): a CT scan
integrated score from a bi-center registry
A. Guaricci1, N. Brunetti1, F. De Rosa1, M. Guglielmo2, S. Mushtaq2,
L. Mascarini1, D. Andreini2, M. Pepi2, G. Pontone2; 1Foggia/IT, 2Milan/IT
14:24
B-0743 Performance of cardiac CT compared to functional
testing in women and men with suspected coronary
artery disease: the multicenter, randomized
CRESCENT trial
M.M. Lubbers, A. Dedic, A. Coenen, T. Galema, M. Ouhlous, A. Niezen,
M. Hunink, G. Krestin, K. Nieman; Rotterdam/NL
14:32
B-0744 Quantitative coronary plaque analysis predicts
high-risk plaque morphology on coronary computed
tomography: the results from the ROMICAT II trial
T. Liu1, P. Maurovich-Horvat2, T. Mayrhofer2, S. Puchner2,
M. Lu2, K. Ghemigian2, P. Kitslaar2, U. Hoffmann2, M. Ferencik2;
1
Shenyang/CN, 2Boston, MA/US
14:40
B-0745 Prognostic value of CT coronary angiography in
asymptomatic patients with suspected coronary
artery disease: meta-analysis of observational studies
M. Fusaro, G. Balestriero, L. La torre, C. Bortolanza, G. Morana;
Treviso/IT
14:48
B-0746 Assessment of semi-automatic plaque quantification
of non-calcified plaque as a predictor of outcome for
acute chest pain patients at coronary CT angiography
A.M. Bucher1, R. Wang2, J.L. Wichman1, F.G. Meinel3, C.N. De Cecco4,
T.J. Vogl1, U.J. Schoepf4; 1Frankfurt a. Main/DE, 2Beijing/CN,
3
Munich/DE, 4Charleston, SC/US


10:30–12:00 Room C 11:50

B-0761 MR spectroscopy evaluation of breast cancer using
Breast Signal-to-Noise Ratio (SNR) as a prognostic indicator
S.B. Grover, P. Jain, S.K. Jain, A. Mandal; New Delhi/IN
SS 1002 Breast MRI-DWI (2) and various MRI
applications
Moderators: M. Di Matteo; Rome/IT, N.N. 10:30–12:00 Room Z
10:30 Vascular
B-0751 Potential of intravoxel incoherent motion and
diffusion in MR imaging of ductal carcinoma of SS 1015 Thoracic aorta: novel imaging and
breast: new vistas interventions
R. Balaji, D. Arivudainambi; Chennai/IN Moderators: A. Contegiacomo; Rome/IT, N.N.
10:38 10:30
B-0752 Monoexponential, Biexponential and Stretched- B-0762 Percutaneous valvuloplasty: minimal-invasive
exponential diffusion-weighted MR imaging in the restoration of vein valve function using cross-linked
differentiation of benign and malignant breast hyaluronan
lesions J. Ragg; Berlin/DE
Y. Jin; Zhengzhou/CN
10:38
10:46 B-0763 Reduced strain and distensibility of the ascending
B-0753 The influence of regions of interest demarcation aorta in human STAT3 deficiency patients with
approaches on apparent diffusion coefficient in frequent medium-size-artery aneurysms
breast lesions A.A. Azarine, O. Chandesris, E. Mousseaux, Z. Mallat, N. Kachenoura,
L. Nogueira1, S. Brandão1, R.G. Nunes2, H.A. Ferreira2, J. Loureiro1, C. Picard, O. Clément, A. Redheuil; Paris/FR
I. Ramos1; 1Porto/PT, 2Lisbon/PT
10:46
10:54 B-0764 Noninvasive 4D pressure difference mapping derived
B-0754 Diagnostic performance of DWI and DCE-MR for from 4D flow MRI in patients with syndromic aortic
evaluating residual breast cancer after local excision root aneurysm
I. Youn, S. Choi, Y. Choi, S. Kook; Seoul/KR T.A.U. Leidenberger1, M. Farag1, C. Weis1, M. Müller-Eschner1,
K. Kallenbach1, R. Dillmann2, H.-U. Kauczor1, C. Beller1, F. Rengier1;
11:02 1
Heidelberg/DE, 2Karlsruhe/DE
B-0755 Diagnostic performance of diffusion-weighted
Friday
10:54
imaging in breast lesions: comparison among
B-0765 Aortic coarctation: assessment of stent patency
diffusion-weighted imaging, dynamic contrast
with computed tomography vs magnetic resonance
enhanced MRI and combined MRI
K. Kim1, Y. Kim1, J. Seo1, C. Hwang1, H. Han1, C.M. Kuzmiak2; imaging
1
Daejeon/KR, 2Chapel Hill, NC/US R.W. van Hamersvelt1, A.M. den Harder1, D. Sucha1, J.P.J. Martens1,
A.M.R. Schilham1, C. Bos1, R.P.J. Budde2, J.M.P.J. Breur1, T. Leiner1;
1
11:10 Utrecht/NL, 2Rotterdam/NL
B-0756 Single screening breast MR imaging for early 11:02

surveillance after breast conservation therapy: pilot B-0766 Heritability estimates of aortic root geometry based
study on computed tomography and echocardiography
S. Kim, B.-M. Gil, B. Kang; Seoul/KR
C. Celeng1, M. Kolossváry1, A. Kovács1, A. Molnár1, Á. Jermendy1,
D. Tárnoki1, S. Voros2, B. Merkely1, P. Maurovich-Horvat1;
11:18 1
Budapest/HU, 2Richmond, VA/US
B-0757 Motion artefacts in breast MRI: impact on diagnostic
performance 11:10
P. Clauser1, M. Dietzel2, C.G. Kaiser3, M.A. Marino1, P. Kapetas1, B-0767 Diagnostic value of Low kV MDCT angiography
R. Woitek1, P.A.T. Baltzer1; 1Vienna/AT, 2Erlangen/DE, 3Mannheim/DE
protocol with low contrast medium volume in
11:26 transcatheter aortic valve implantation (TAVI)
B-0758 A simple scoring system for breast MRI planning
C.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, F. Del Buono,
interpretation: does it compensate for reader L. Riva, S. Sironi; Monza/IT
experience?
M.A. Marino, P. Clauser, R. Woitek, G.J. Wengert, P. Kapetas, 11:18
M. Bernathova, K. Pinker-Domenig, T.H. Helbich, P.A.T. Baltzer;
B-0768 3D black-blood VISTA magnetic resonance vessel
Vienna/AT
wall imaging of the thoracic aorta in healthy, young
11:34 adults: reproducibility and indications for sample
B-0759 Recall rates in surveillance breast MRIs performed in sizes in therapeutic trials
A.L.M. Eikendal1, B.A. Blomberg1, C. Haaring1, T. Saam2,
women at high risk of developing breast cancer
R.J. van der Geest3, M.L. Bots1, H.M. den Ruijter1, I.E. Hoefer1, T. Leiner1;
S. O’Keeffe, C. Longman, T. Suaris; London/UK 1
Utrecht/NL, 2Munich/DE, 3Leiden/NL
11:42
11:26
B-0760 Incidental breast lesions detected on body-MRI:
B-0769 Aortic tortuosity: a new finding in patients with
frequency, clinical relevance, and patient outcomes
B. Bignotti, F. Nosenzo, L. Gristina, M. Perinetti, S. Barbagallo,
Mucopolysaccharidosis type IVa (MPS IVa)
Y. Tanyildizi, S. Gökce, E. Mengel, C. Kampmann, W. Müller-Forell,
L. Secondini, G. Succio, M. Calabrese, A. Tagliafico; Genoa/IT
J. Hennermann; Mainz/DE

11:34 11:19
B-0770 Contrast-enhanced T1 free-breathing gradient echo B-0778 The value of tumoural volume change measured on
sequences in comparison with standard T1 breath- MR images to identify responders after neoadjuvant
hold gradient echo sequences in the evaluation of chemo-radiation therapy in patient with locally
thoraco-abdominal aortic disease advanced rectal cancer
C.R.G.L. Talei Franzesi, D. Ippolito, S. Drago, S. Lombardi, S. Spiga, E. Quaia, A. Gennari, V. Ulcigrai, M. Cova; Trieste/IT
S. Sironi; Monza/IT
11:27
11:42 B-0779 T2 weighted-MRI volumetry at different time
B-0771 The aortic mechanical properties in patients with the points for prediction of pathological response to
essential hypertension environmentally exposed to neoadjuvant chemoradiation therapy (CRT) in locally
cigarette smoke advanced rectal cancer
P. Gac, M. Poreba, G. Mazur, R. Poreba; Wroclaw/PL A. Di Chiara, A. Palmisano, A. Esposito, P. Passoni, N. Slim, C. Fiorino,
N. Di Muzio, A. Del Maschio, F. De Cobelli; Milan/IT
11:50
B-0772 Thoracic endovascular aortic repair for complicated 11:35
type B intramural hematoma (IMH) and penetranting B-0780 Evaluation of rectal cancer response to therapy: role
ulcers (PAU): endoleak, follow up and long term of magnetic resonance tumour regression grade (MR-
survival TRG) to predict pathological complete response
F. Barbosa, E. De Febis, P. Brambillasca, M. Solcia, C. Migliorisi, S. Picchia, M. Rengo, D. De Santis, M. Zerunian, T. Biondi, S. Badia,
M. Nichelatti, A. Lista, F. Romani, A. Rampoldi; Milan/IT A. Laghi; Latina/IT
11:43
10:30–12:00 Room O B-0781 Multiparametric MRI for prediction of pathological
complete response (pCR) to neoadjuvant
GI Tract chemoradiation therapy (CRT) in locally advanced
rectal cancer (LARC)
SS 1001a Rectal cancer: staging and restaging A. Palmisano, A. Esposito, A. Di Chiara, P. Passoni, N. Slim,
Moderators: L. Curvo-Semedo; Coimbra/PT, L. Albarello, A. Del Maschio, F. De Cobelli; Milan/IT
A. Plumb; London/UK
11:51
10:30 B-0782 Local nodal metastasis in rectal cancer in patients
K-20 Keynote lecture SPEAKER
SUPPORTED with and without neoadjuvant therapy: correlation of
C. Stoupis; Männedorf/CH BY
INVEST IN MRI findings with histopathological results in an Irish
THE YOUTH
10:39 tertiary referral centre
C. Fenelon, N. Sheehy; Dublin/IE
B-0773 Iodine quantification to distinguish T stage in rectal
cancer by computed tomographic gemstone spectral
imaging: initial experience 10:30–12:00 Room N
X. Li, Y. Li, Z. Ye; Tianjin/CN
10:47
Cardiac
B-0774 Diagnostic accuracy of MDCT imaging in assessment SS 1003 CT of the coronary arteries
of mesorectal fascia invasion in rectal cancer: Moderators: D. Brisbois; Liège/BE, J.M. Kerl; Darmstadt/DE
comparison study with standard magnetic resonance
imaging 10:30
S.G. Drago, D. Ippolito, C. Talei Franzesi, D. Fior, S. Sironi; Monza/IT K-21 Keynote lecture
C.N. De Cecco; Charleston, SC/US
10:55
B-0775 Diagnostic value of 4th generation iterative 10:39
reconstruction algorithm with low dose CT-protocol B-0783 An optimised correction factor for calcium scoring
in assessment of mesorectal fascia in rectal cancer: using advanced modeled iterative reconstruction in
comparison with magnetic resonance 3rd generation dual-source CT: in vitro and in vivo
S.G. Drago, D. Ippolito, C. Talei Franzesi, A. Casiraghi, S. Sironi; analysis
Monza/IT D. Caruso1, J.L. Wichmann1, C.N. De Cecco1, S. Mangold1, C. Tesche1,
C. Canstein1, A. Varga-Szemes1, A. Laghi2, U.J. Schoepf1; 1Charleston,
11:03 SC/US, 2Rome/IT
B-0776 Prediction of sphincter preserving by MRI: accuracy
and reproducibility between a radiologist and a 10:47
surgeon B-0784 CT calcium score of coronary artery calcification
J. Krdzalic, M. Maas, S. Engelen, J. van Griethuysen, D.M. Lambregts, progression in rheumatoid arthritis over a 10-year
G. Beets, R.G.H. Beets-Tan; Maastricht/NL period and risk factors for progression
M.-Y. Ng, J.-H. Liu, K.-F. Mak, C.-S. Lau, H.-F. Tse, K.-H. Yiu;
11:11 Hong Kong/CN
B-0777 Diagnostic accuracy of dynamic contrast-enhanced
MRI for locoregionar staging of rectal cancer 10:55
M. Armbruster, W. Sommer, M.F. Reiser, M. Brandlhuber; Munich/DE B-0785 Cardiac CT and coronary angiography evaluation in
an NSTEMI population
S.R. Fuller, D. Caruso, J. Rames, J.L. Wichmann, C.N. De Cecco,
S. Mangold, C. Tesche, A. Varga-Szemes, U.J. Schoepf; Charleston,
SC/US

11:03 10:46
B-0786 Morphological features of left atrial appendage in B-0795 Experience and outcomes in the use of a pipeline
748 consecutive coronary computed tomography embolisation device (PED) for the treatment of
angiography patients without atrial fibrillation intracranial aneurysms: a single-centre study
M. Korhonen1, J. Parkkonen1, M. Hedman1, A.T. Muuronen1, J. Onatsu1, K. James, P. Nicholson, J. Murphy, G. Wyse, N. Fanning; Cork/IE
P. Mustonen2, R. Vanninen1, M. Taina1; 1Kuopio/FI, 2Jyväskylä/FI
10:54
11:11 B-0796 Cost-effectiveness of mechanical thrombectomy in
B-0787 Prognostic value of coronary CT angiography: a SPEAKER
SUPPORTED acute ischaemic stroke: an independent study of a
meta-analysis BY
INVEST IN UK centre
R.A.P. Takx1, B. Szilveszter2, H. Emami2, T. Mayrhofer3, T. Leiner1, THE YOUTH S. Gargalas1, J. Jones2; 1Oxford/UK, 2Cambridge/UK
U. Hoffmann2; 1Utrecht/NL, 2Boston, MA/US, 3Stralsund/DE
11:02
11:19
B-0797 Cerebral aneurysms: accuracy of 256-MDCT
B-0788 The effect of sleep duration on the presence of
non-subtracted and subtracted volumetric CT
coronary artery disease
G. Marosi, Z. Drobni, B. Szilveszter, M. Kolossváry, T. Csűry, angiography in diagnosis
M. Vecsey-Nagy, A. Molnár, B. Merkely, P. Maurovich-Horvat; A.K. Sharma, N.S. Sharma; Delhi/IN
Budapest/HU
11:10
11:27 B-0798 Manual aspiration thrombectomy using penumbra
B-0789 Dose reduction with high-pitch spiral mode coronary catheter in patients with acute M1 occlusion: a single
calcium scanning in high and irregular heart rates center study
M. Vonder1, R. Vliegenthart1, P.M.A. van Ooijen1, J.W. Gratama2, Y. Kim, H. Kwak, G. Chung, S. Hwang; Jeonju-si/KR
D. Kuijpers3, C.M. van der Aalst4, M. van Aerde4, H.J. de Koning4,
M. Oudkerk1; 1Groningen/NL, 2Apeldoorn/NL, 3Den Haag/NL, 11:18
4
Rotterdam/NL
B-0799 The use of practice parameters for quality assurance
11:35 of diagnostic craniocervical catheter angiographic
B-0790 Dual source cardiac CT angiography (CCTA) in the procedures
A. Lai, T. Lee, B. Lai, K. Tang, W. Leung, S. Lo, J. Khoo;
preparticipation screening of competitive athletes Hong Kong/HK
C. Rutigliano, C. Santangelo, C. Grippo, B. Merlino, G. Savino,
R. Marano, L. Bonomo; Rome/IT
11:26
11:43 B-0800 Role of CT-angiography and digital subtractional
B-0791 Aortic valve stenosis evaluation: differences in angiography in cerebral aneurysm volume estimation
A. Navichenka, A. Beimanov, P. Konovalov, B. Piskun, A. Gontchar;
estimated aortic valve area and aortic stenosis
Friday
Minsk/BY
severity comparing echocardiography and CTA
results 11:34
B. Horehledova, M. Kok, N.G. Eijsvoogel, B.M.F. Hendriks, B-0801 Automated detection of coiled aneurysm recurrence
B.L.J.H. Kietselaer, J.E. Wildberger, M. Das; Maastricht/NL
using 3D TOF MRA
A.S. Tuan, R.W. Hurst, M. Bilello; Philadelphia, PA/US
11:51
B-0792 Prevalence and clinical impact of incidental CTA 11:42
findings in the work-up for transcatheter aortic valve B-0802 Acute ischemic stroke (AIS), outcome predictors
implantation after intra-arterial thrombectomy
F. van Kesteren, E.M.A. Wiegerinck, J. Stoker, J. Baan Jr., E. Puglielli, R. Lattanzi, L. Gregori, V. Di Mizio, V. Di Egidio; Teramo/IT
R.N. Planken; Amsterdam/NL
11:50
B-0803 Thrombo-aspiration in acute ischemic cerebral
10:30–12:00 Studio 2016
stroke: first results
M. Voormolen, T. van der Zijden, O. d‘Archambeau, F. De Belder,
Neuro J. Maes, L. Yperzeele, I. Baar, P.M. Parizel; Edegem/BE
SS 1011a Neurovascular interventions (2)

Moderators: T. Kau; Klagenfurt/AT, N.N. 10:30–12:00 Room E1
10:30 Musculoskeletal
B-0793 Prediction of stent-retriever thrombectomy outcomes
by dynamic CT angiography in patients with acute SS 1010a Oncology
carotid T or MCA occlusions Moderators: S. Boudabbous; Geneva/CH,
K.M. Thierfelder, W.H. Sommer, B. Ertl-Wagner, S.E. Beyer, F.G. Meinel, K. Wörtler; Munich/DE
W.G. Kunz, M.F. Reiser, H. Janssen; Munich/DE
10:30
B-0794 Endovascular therapy of low and intermediate grade K. Wörtler; Munich/DE
lateral intracranial dural arteriovenous fistulas: results
10:39
and complications of different technical approaches
L.M. Ertl, H. Brückmann, M. Kunz, A. Crispin, G. Fesl; Munich/DE B-0804 Differentiation of benign and malignant marrow
infiltration with multiparametric MR imaging: pilot
study
J. Baik, J.-Y. Jung, W.-H. Jee; Seoul/KR

10:47 10:38
B-0805 Staging multiple myeloma patients: quantitative B-0814 Relationship of acute brain lesions on MRI after
analysis of apparent diffusion coefficient (ADC) maps cardiac arrest treated with hypothermia to
as potential marker for bone marrow involvement neurological outcome 6 months later
characterisation E. Wallin, S. Rubertsson, I.-M. Larsson, M.-L. Kristofferzon,
P.A. Bonaffini, D. Ippolito, A. Casiraghi, A. Nasatti, C. Talei Franzesi, E.-M.B. Larsson, R. Raininko; Uppsala/SE
S. Sironi; Monza/IT
10:46
10:55 B-0815 Susceptibility-diffusion mismatch in hyperacute
B-0806 Differentiation of multiple myeloma and metastases stroke: correlation with perfusion-diffusion mismatch
of the spine using diffusion-weighted MR imaging and clinical outcome
including ADC histogram moments at 3T M. Dejobert, X. Cazals, M. Annan, S. Debiais, J.-P. Cottier; Tours/FR
G. Park, W.-H. Jee, S.-Y. Lee, J.-Y. Jung, K.-Y. Ha, C.-K. Min, Y. Son,
M. Paek; Seoul/KR 10:54
B-0816 Large vessel acute ischemic stroke active reperfusion
11:03 therapy comparison
B-0807 Usefulness of computer-aided detection (CADe) A. Balodis, M. Radzina, M. Preinbergs, K. Kupcs, E. Miglāne,
using temporal subtraction and 3D non-rigid J. Savlovskis, H. Kidikas, A. Veiss; Riga/LV
registration for detecting bone metastasis on whole 11:02

body thin-slice CT
1 1 1 1
D. Hasegawa , Y. Ichikawa , R. Nakayama , Y. Kurobe , S. Chino , 1 B-0817 Comparison of high-resolution magnetic resonance
M. Ishida1, K. Kitagawa1, S. Murashima2, H. Sakuma1; 1Tsu/JP, with digital subtraction angiography in intracranial
2
Matsusaka/JP artery disease
N. Lee, S. Jung, H. Kim, C.-G. Choi, S. Kim, D. Lee, D. Suh; Seoul/KR
11:11
B-0808 Chondrogenic tumours: role of advanced magnetic 11:10
resonance imaging B-0818 Subdural and convexity subarachnoid haemorrhage
W.M. Amin, H.T. Kotb, A.A. Farahat, M.S. Barakat, A.E. Rafallah, are more frequently associated with acute
S.H. Fadel; Alexandria/EG
spontaneous lobar haematoma in cerebral amyloid
11:19 angiopathy
A. Viguier, S. Patsoura, N. Raposo, V. Cazzola, L. Claviere,
B-0809 Dynamic contrast-enhanced MR imaging in J.F. Albucher, F. Chollet, V. Larrue, F. Bonneville; Toulouse/FR
osteoid osteoma: relationships with clinical and CT
characteristics 11:18
P. Pottecher1, E. Sibileau2, L. Emerich2, S. Touraine2, B. Hamze2, B-0819 Dual-energy CT of the brain: comparison between
C. Parlier2, D. Petrover2, J. Laredo2, V. Bousson2; 1Dijon/FR, 2Paris/FR
virtual unenhanced images and true unenhanced
11:27 ones in the detection of intracranial hemorrhage
M. Bonatti1, F. Lombardo2, G. Zamboni2, A. Cipriani1, R. Pozzi Mucelli2,
B-0810 Multivariate data analysis as a clinical tool for G. Bonatti1; 1Bolzano/IT, 2Verona/IT
differentiating intraarticular synovial sarcomas from
localised pigmented villonodular synovitis 11:26
D. Nordemar1, J. Öberg2, O. Brosjö2, M. Skorpil2; 1Stockholm/SE, B-0820 Crossed cerebellar diaschisis in patients with
2
Solna/SE
acute MCA infarction: analysis of CT perfusion
11:35 characteristics
W.H. Sommer, K. Thierfelder, H. Janssen, L. von Baumgarten;
B-0811 Enchondroma vs low-grade chondrosarcoma: the role Munich/DE
of dynamic contrast MRI
D. Costachescu; Timisoara/RO 11:34
B-0821 Raw arterial spin labelling data can help identify
11:43
arterial occlusion in acute ischaemic stroke
B-0812 Diagnostic performance of conventional MRI M. Majer, M. Mejdoubi, M. Schertz, S. Colombani, A. Arrigo;
and apparent diffusion coefficient values in Fort De France/FR
differentiating benign and malignant soft tissue
11:42
tumours
Y. Yoon, D. Oh, Y. Song; Seoul/KR B-0822 Quantifying intracranial plaque permeability with
dynamic contrast enhanced MRI
P. Vakil1, A.H. Elmokadem2, F. Sherazi1, C.G. Cantrell1, T.J. Carroll1,
S. Ansari1; 1Chicago, IL/US, 2Mansoura/EG
10:30–12:00 Room E2
11:50
Neuro
B-0823 Acute/subacute small ischaemic lesions on DWI
SS 1011b Cerebrovascular disease (3) in patients with cerebral amyloid angiopathy and
Moderators: M. Buruian; Targu-Mures/RO, cortical superficial siderosis
T. Rostovtseva; St. Petersburg/RU E. Gangemi1, A. Charidimou2, D. Werring2, R. Jäger2; 1Rome/IT,
2
London/UK
10:30
B-0813 Predictive value of perfusional CT parameters in
evaluating reperfusional effectiveness in acute
ischemic stroke patients
A. Bernardoni, E. Raimondi, A. Clarizia, M. Padroni, E. Groppo,
C. Tamborino, A. Saletti, M. Giganti, E. Fainardi; Ferrara/IT

10:30–12:00 Room F1 11:42

B-0833 Diffusion-weighted MRI of urinary bladder: non-
Oncologic Imaging invasive quantification of tumor heterogeneity to
differentiate malignant from benign tissues
SS 1016 Prostate and renal tract cancers: H.T. Nguyen1, Z. Shah1, A. Mortazavi1, K. Pohar1, L. Wei1, G. Jia2,
advanced detection methods D. Zynger1, M. Knopp1; 1Columbus, OH/US, 2Baton Rouge, LA/US
Moderators: J. Rørvik; Bergen/NO, W.H. Sommer; Munich/DE
11:50
10:30 B-0834 Role of contrast-enhanced ultrasound (CEUS)
B-0824 Sensitivity of a biparametric (T2 and diffusion- after inconclusive contrast-enhanced computed
SPEAKER tomography or magnetic resonance in evaluating
SUPPORTED weighted) 3T magnetic resonance imaging protocol
BY hypovascular small renal masses
INVEST IN for prostate cancer imaging
THE YOUTH A. Stanzione, V. Chianca, N. Longo, F. Fusco, R. Liuzzi, M. Imbriaco, E. Raimondi, M. Bassi, M. Tilli, S. Dall’ara, R. Rizzati, M. Simone,
A. Brunetti; Naples/IT M. Giganti, G. Benea; Ferrara/IT
10:38
B-0825 The feasibility of k-means clustering of dynamic 10:30–12:00 Room F2
contrast-enhanced MRI pharmacokinetic parameters
in predicting prostate cancer risk stratification
Abdominal Viscera
S.N. Elias1, F.G. Petros1, G. Jia2, H. Nguyen1, Z. Shah1, D. Zynger1,
R. Abaza3, M.V. Knopp1; 1Columbus, OH/US, 2Baton Rouge, LA/US, SS 1001b Hepatocellular carcinoma: evaluation of
3
Dublin, OH/US
therapeutic response
10:46 Moderators: D. Akata; Ankara/TR,
B-0826 TRUS-MRI image navigation for prostate cancer
recurrence targeted biopsy: initial experience 10:30
V. Kapustin, A. Gromov, V. Shirokorad, D. Koshurnikov; Moscow/RU
B-0835 Dynamic contrast enhanced perfusion CT imaging as
10:54 an early predictor for tumour response to Sorafenib
B-0827 Multidetector computed tomographic urography treatment in patients with advanced HCC lesions:
(MDCTU): its practical role in the diagnosis of upper preliminary results
D. Ippolito, G. Querques, C. Talei Franzesi, P.A. Bonaffini, D. Fior,
tract urothelial cancer in high-risk patients S. Sironi; Monza/IT
S. Kravchick1, E. Cherniavsky2, R. Topopolsky2, L. Linov2; 1Tzrefin/IL,
2
Ashkelon/IL
10:38
11:02 B-0836 Comparison between quantitative dual-energy CT
Friday
B-0828 Diffusion tensor imaging of the prostate: assessing iodine maps and dynamic volume perfusion CT
response following cyber knife therapy parameters in patients with hepatocellular carcinoma
R. Balaji; Chennai/IN before and after TACE
X. Wang1, T. Henzler2, S. Diehl2, S.O. Schönberg2, H.-D. Xue1, Z.-Y. Jin1,
11:10 A. Smakic2; 1Beijing/CN, 2Mannheim/DE
B-0829 Detection of prostate cancer lesions with

10:46
multiparametric MRI (mp-MRI): what is the difference
B-0837 Predictive value of paradoxical uptake on
between pelvic phased-array of 32 channels and
hepatobiliary phase of Gd-EOB-DTPA-enhanced
endorectal-pelvic phased-array coils
N. Dervishi1, A. Fornari2, M. Petracchini2, M. Manfredi1, A. Tribunella2, MRI for response to transcatheter arterial
D. Gned1, A. De Pascale1, A. Veltri1, S. Cirillo2; 1Orbassano/IT, 2Turin/IT chemoembolisation in hepatocellular carcinoma
J. Kim, C. Lee, Y. Park, J. Lee, J. Choi, K. Kim, C. Park, H. Lee;
11:18 Seoul/KR
B-0830 Diagnostic efficacy of MRI-guided in-bore prostate

10:54
biopsy in patients with inconclusive results of
B-0838 Prognostic significance of liver stiffness
transrectal ultrasound (TRUS) or TRUS-guided biopsy
V. Kuplevatsky, M. Cherkashin, D. Roschin, N. Berezina, N. Vorobyov; measurements on MR elastrography in patients
St. Petersburg/RU with hepatocellular carcinoma treated with
radiofrequency ablation
11:26 J. Kim, J. Lee, D. Lee, W. Chang, J. Han; Seoul/KR
B-0831 Our experience with whole body MRI for metastatic
prostate cancer detection 11:02
E. Kvyatkovskaya, V. Kuplevatsky, M. Cherkashin, N. Berezina, B-0839 Evaluation of treatment response of radiotherapy
D. Roschin; St. Petersburg/RU for HCC using pre- and post-treatment magnetic
11:34 resonance imaging
S. Song, W. Jeong, J. Kim, Y. Kim, D. Choi, H. Park, J. Yu, J.-H. Lee;
B-0832 Comparison between Likert scale, prostate imaging Seoul/KR
SPEAKER
SUPPORTED reporting and data system (PIRADS) v1 and v2 in
BY 11:10
INVEST IN detection and characterisation of prostate cancer
THE YOUTH B-0840 Assessment of post interventional hepatocellular
using multiparametric (mp) MRI
L. Zantedeschi, D. Cenzi, M. Motton, G. Schenal, A. Borsato, carcinoma using morphological and functional MR
S. Montemezzi; Verona/IT data
M.A.M. Saad, A.M. Magdy; Fayoom/EG

11:18 11:10
B-0841 Hypointensity rim of hepatocellular carcinoma on B-0851 Chest x-ray in acute nontraumatic disease, is it a
SPEAKER
arterial phase of dynamic contrast-enhanced MRI can SUPPORTED reliable diagnostic tool?
BY A. Fuentealba, D. Ramirez, J. Durán, N. Rossel, R. Aris, S. Aguirre,
predict low recurrence rate after hepatectomy INVEST IN
Y. Fujinaga, M. Kurozumi, A. Fujita, A. Yamada, K. Ueda, T. Uehara, THE YOUTH A. Pizarro, M. Castro; Santiago/CL
M. Kadoya; Matsumoto/JP
11:18
11:26 B-0852 Chest x-ray and detecting acute heart failure: what is
B-0842 Value of registration of preprocedure MR imaging the clinical value?
and postprocedure multidetect CT for therapeutic D. Goei, P. Visser, I. Koster, P. van der Valk, M. Kock; Dordrecht/NL
response assessment of radiofrequency ablation for 11:26

hepatocellular carcinoma
J. Park, J. Lee, D. Lee, I. Joo, J. Yoon, J. Park, J. Yoon, J. Han;
B-0853 Computed tomography-based differentiation of
Seoul/KR acute mediastinitis from postoperative residuals after
thoracic surgery with sternotomy
11:34 B. Foldyna, M. Müller, C. Luecke, M. Haensig, S. Nitzsche, T. Klemm,
B-0843 Microwave ablation of large HCCs using a new F. Mohr, M. Gutberlet, L. Lehmkuhl; Leipzig/DE
device: a case series 11:34

L. Tarantino1, P. Ambrosino2; 1Pagani/IT, 2Naples/IT
B-0854 Chest CT findings of toxocariasis: correlation with
11:42 laboratory results
B-0844 Microwave ablation of large HCCs by simultaneous M. Koh, I. Lee; Anyang city/KR
multiple antennae insertion: long term follow-up 11:42

L. Tarantino1, P. Tarantino2, P. Ambrosino2; 1Pagani/IT, 2Naples/IT
B-0855 Value of computed tomography of the chest in
11:50 patients with acute respiratory distress syndrome
B-0845 Percutaneous ablation of small HCCs: comparison of C. Berliner, S. Marcel, S. Braune, M. Metschke, H. Klose, S. Kluge,
G. Adam, A. Laqmani; Hamburg/DE
3 commercially available microwave devices
L. Tarantino1, P. Ambrosino2; 1Pagani/IT, 2Naples/IT
11:50
B-0856 Comparison of HRCT features of pneumocystis
10:30–12:00 Room D1 Jiroveci pneumonia in patients with and without HIV
M.A. Karimi, S. Kahkouee, F. Mami; Tehran/IR
Chest
10:30–12:00 Room D2
SS 1004 Imaging methods: something old,
something new Interventional Radiology
Moderators: J. Mayer; Heidelberg/DE,
E.J. Stern; Seattle, WA/US
SS 1009 Liver ablation
Moderators: J. Garnon; Strasbourg/FR, N.N.
10:30
B-0846 Added value of dual energy subtraction radiography 10:30
compared to standard conventional radiography K-23 Keynote lecture
using computed tomography as standard of N.N.
reference
K. Martini, M. Bässler, T. Frauenfelder; Zurich/CH 10:39
B-0857 Thermal ablation for hepatocellular carcinoma:
10:38 a large-scale analysis of long-term outcome and
B-0847 Bone suppression images improve radiologists’ prognostic factors
performance on detection of lung nodules on chest X. Jing, J. Ding, Y. Wang, F. Wang, Y. Wang; Tianjin/CN
radiographs
Y. Wang, L. Fan, Y. Guan, Y. Xia, S. Liu, W. Zou; Shanghai/CN 10:47
B-0858 Post-surgical recurrence of HCC along the resection
10:46 margin treated by percutaneous US-guided ablation
B-0848 Digital tomosynthesis as problem-solving technique M. Calandri1, C. Gazzera1, S. Yevich2, A. Veltri3, P. Fonio1, G. Gandini1;
1
to confirm or exclude pulmonary lesions in the Turin/IT, 2Villejuif/FR, 3Orbassano/IT
hidden areas 10:55

E. Baratella, E. Quaia, P. Gabriele, S. Kus, C. Cercato, M. Cova;
Trieste/IT B-0859 Intraparenchymal hydrodissection in liver to
minimise flow mediated cooling from vessels during
10:54 radiofrequency ablation of hepatocellular carcinoma
B-0849 Digital tomosynthesis in the diagnosis of chest A.K. Chaturvedi; New Delhi/IN
diseases and injuries
V. Nechaev; Moscow/RU 11:03
B-0860 Evaluation of thermal microwave ablation (MWA)
11:02 of liver malignancy with real-time enhanced spatial
B-0850 Radiological interpretation quality in lung imaging energy control to achieve a spherical ablation zone
of organ donors and its clinical relevance - a T.J. Vogl, L. Basten, B. Panahi, N.N.N. Naguib, N.-E. Nour-Eldin;
retrospective analysis Frankfurt a. Main/DE
G. Bozovic1, C. Adlercreutz1, P. Höglund1, I. Bjorkman-Burtscher1,
P. Reinstrup1, R. Ingemansson1, C. Schaefer-Prokop2, R. Siemund1,
M. Geijer1; 1Lund/SE, 2Utrecht/NL

11:11 11:10
B-0861 MR-guided microwave ablation in hepatic tumours: B-0871 Skindoses in cardiac intervention at St. Olavs
initial results in clinical routine University Hospital Norway
R. Hoffmann, H. Rempp, D. Kessler, J. Weiss, K. Nikolaou, S. Clasen; T. Berglund; Trondheim/NO
Tübingen/DE
11:18
11:19 B-0872 An evaluation of organ doses and effective dose with
B-0862 Microwave ablation in colorectal liver metastases: dual-energy CT (DECT) and single-energy CT (SECT)
comparison of volume decrease, progression time, using adult whole body imaging protocols
recurrence and survival rates with two different K. Yagami1, T. Miyoshi1, S. Shigeyama1, H. Okada1, T. Ukai2, S. Suzuki2;
1
microwave systems Gifu/JP, 2Toyoake/JP
T.J. Vogl, A. Hagar, E. Mbalisike, S. Zangos; Frankfurt a. Main/DE
11:26
11:27 B-0873 Exposure index in digital radiology
B-0863 Applied energy and ablation volume after CT-guided L.P. Ribeiro, J. Ribeiro, R.P.P. Almeida, S. Rodrigues, A.F.C.L. Abrantes,
K.B. Azevedo, J.P. Pinheiro, O. Lesyuk; Faro/PT
radiofrequency- and microwave ablation of colorectal
liver metastases 11:34
W.J. Heerink, R. Vliegenthart, M. Oudkerk, K.P. de Jong;
Groningen/NL
B-0874 Dosimetric advantage of percutaneous femoral
artery approach vs radial approach in coronary
11:35 angiography: preliminary analysis
B-0864 Does DEB-TACE enhance the local effect of IRE? D. Aviano1, S. Presilla1, M. Mangiarotti2, F. Ruda1, M. Moccetti1;
1
Lugano/CH, 2Varese/IT
Imaging and histopathological evaluation in a
porcine model 11:42
P. Isfort1, P. Rauen1, H.-S. Na1, N. Ito2, C. Wilkmann1, C. Kuhl1,
P. Bruners1; 1Aachen/DE, 2Tokyo/JP
B-0875 Effect of patient size on radiation dose for abdominal
MDCT performed with automatic exposure control
11:43 O. Seraydarmansour; Tehran/IR
B-0865 Iterative metal artefact reduction for CT-guided 11:50

microwave antenna positioning: impact on image
B-0876 Study of the effect of classification of patients on CT
quality for different exposure settings
1 1 1 2 1 1
T.D. Do , C. Schlett , C. Melzig , T. Gockner , P. Flechsig , P.L. Peireira ,
radiation dose
S. Kwon1, J. Lee1, D. Han2; 1Seoul/KR, 2Sungnam-si/KR
H.-U. Kauczor1, W. Stiller1, C.M. Sommer1; 1Heidelberg/DE, 2Mainz/DE
10:30–12:00 Room G 10:30–12:00 Room M 1
Friday
Radiographers Head and Neck
SS 1014 High dose antidotes SS 1008 Maxillofacial imaging

Moderators: N.I. Traykova; Plovdiv/BG,
Moderators: I. Arkhipova; Moscow/RU, S. Brandão; Porto/PT
G. Widmann; Innsbruck/AT
10:30
10:30
B-0866 Patient doses in lumbar spine
A. Henner, K. Paalimäki-Paakki; Oulu/FI
B-0877 Advanced modeled iterative reconstruction in low-
tube-voltage contrast-enhanced neck CT: evaluation
10:38 of objective and subjective image quality
B-0867 Patient skin dose in interventional radiology: an J.-E. Scholtz, M. Kaup, K. Hüsers, M.H. Albrecht, B. Bodelle,
R.W. Bauer, T. Lehnert, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main/DE
international review of procedures
L. O’Hora1, M.-L. Butler1, D. Catania2, M. Ong3, R. Decoster4,
10:38
J. Offermans5, T. Starc6, L. Rainford1; 1Dublin/IE, 2Milan/IT,
3
Singapore/SG, 4Brussles/BE, 5Maastricht/NL, 6Ljubljana/SI B-0878 3rd dual-source CT of the neck using automated tube
voltage adaptation in combination with advanced
10:46 modeled iterative reconstruction: evaluation of
B-0868 Small fov cone beam computed tomography: image quality and radiation dose
dosimetry for temporomandibular joint exam J.-E. Scholtz, J.L. Wichmann, K. Hüsers, M.H. Albrecht, M. Beeres,
M.V.L. Oliveira1, M. Andrade Almeida2, W. Batista1, P. Flores1; S. Fischer, R.W. Bauer, T.J. Vogl, B. Bodelle; Frankfurt a. Main/DE
1
Salvador/BR, 2recife/BR
10:46
10:54 B-0879 Low-dose CT of the paranasal sinuses: minimising
B-0869 Quantification of tertiary scatter radiation in a CT x-ray exposure with spectral shaping
room W. Wuest, M. May, M. Uder, M. Lell; Erlangen/DE
R.P.P. Almeida, A. Calafate, P. Sousa, S. Rodrigues, L.P. Ribeiro,
J.P. Pinheiro, K.B. Azevedo, A.F.C.L. Abrantes; Faro/PT 10:54
B-0880 Effect of spectral shaping on radiation dose in
11:02
computed tomography of the paranasal sinuses
B-0870 Analysis of overexposed areas in paediatric plain M.S. May, M. Lell, M. Uder, W. Wüst; Erlangen/DE
radiography
A. Pereira, B. Poiares, B. Esteves, G. Paulo, J. Santos; Coimbra/PT

11:02 10:46
B-0881 Radiation exposure (RE) and image quality of low- B-0890 Accuracy of ultrasound signs, ARFI and clinico-
dose computed tomography (CT) of the paranasal laboratoristic data for detection of biliary atresia in
sinuses (PS) using iterative reconstructions (IR) cholestatic patients
M. Cellina, G. Sciveres, D. Mariani, M. Orsi, B. Tagliaferri, G. Oliva; L. Monti, M. Salsano, G. Soglia, M. Colella Bisogno, A. Simonetti,
Milan/IT G. Torre, P. Rossi, L. Bonomo, P. Tomà; Rome/IT
11:10 10:54
B-0882 Cone beam CT (CBCT) and multislice CT (MSCT) B-0893 Bowel contraction amplitude measured in CINE MR
in the diagnostic imaging of the maxillary sinuses: enterography (MRE) as a marker of inflammatory
evaluation of patient radiation dose and radiographic activity in children with Crohn’s disease
assessment of findings J. Podgorska, R. Pacho, P. Albrecht, I. Łazowska-Przeorek;
E. Saukko, H. Niiniviita, H. Lauren; Turku/FI Warsaw/PL
11:18 11:02
B-0883 Incidental findings in cone beam CT of the B-0894 MRI-US fusion imaging in real-time virtual
maxillofacial region sonography for the evaluation of foetal anomalies:
M.J. Braun1, T. Rauneker2, T. Hoffmann2, F. Dammann3, J. Dreyhaupt2, preliminary study
M. Beer2; 1Günzburg/DE, 2Ulm/DE, 3Göppingen/DE S. Bernardo, V. Vinci, M. Saldari, A. Giancotti, C. Catalano,
L. Manganaro; Rome/IT
11:26
B-0884 Bisphosphonate-induced osteonecrosis of the jaws: 11:10
CT image spectrums and their correlation with B-0895 Comparison of amniotic fluid volumetry between
disease prognosis fetal sonography (AFI) und MRI (AFVMRI) and its’
H. Kim, J. Kim, S.-Y. Jeong; Seoul/KR correlation to diffusion parameters (ADC) of the
foetal kidney
11:34 E. Kudryavtseva1, D. Güllmar1, A. Fiedler1, U. John1, D. Renz1,
B-0885 Morphometric analysis of joint elements and D. Schlembach2, E. Schleußner1, U. Schneider1, H.-J. Mentzel1;
1
Jena/DE, 2Berlin/DE
masticatory muscles in temporomandibular joint
dysfunction 11:18
F. Duman1, A.E. Cicekcibasi2, N. Atci1, I. Damlar1, E. Dogru1, F. Öztürk1,
T. Duman1; 1Hatay/TR, 2Konya/TR B-0896 Can fetal MRI predit the need for neonatal
SPEAKER
SUPPORTED emergency procedures?
11:42 BY M. Saldari, V. Vinci, S. Bernardo, L. Manganaro, C. Catalano; Rome/IT
INVEST IN
THE YOUTH
B-0886 Sleep MRI with EEG: assessment of mechanism and
obstruction level in patients with obstructive sleep 11:26
apnea syndrome B-0897 Fetal MRI: 3T or 1.5T?
P. Kavcic, A. Koren, B. Koritnik, L. Dolenc Groselj; Ljubljana/SI K. Pegoretti, S. Arulkumaran, J. Allsop, M.J. Fox, A. Price, J. Hajnal,
M. Rutherford, C. Malamateniou; London/UK
11:50
B-0887 Diagnosing bone involvement in buccal malignancies 11:34
with DWIBS (diffusion-weighted whole body imaging B-0898 Postmortem MRI as a method of evaluating the
with background signal suppression): is it a better degree of maceration at intrauterine fetal death
S.M. Voevodin, U.N. Tumanova, V.M. Liapin, A.I. Shchegolev,
tool?
G.T. Sukhikh; Moscow/RU
R. Balaji; Chennai/IN
10:30–12:00 Room M 2 10:30–12:00 Room M 3
Paediatric Molecular Imaging
SS 1012 Abdominal and foetal imaging SS 1006 Advanced hybrid imaging in oncology
Moderators: A.M. Herneth; Vienna/AT, N.N.
Moderators: G. Kasprian; Vienna/AT,
G. Papaioannou; Athens/GR
10:30
G. Cook; London/UK
B-0888 Can we avoid unnecessary scrotal exploration?
The value of the sonographic chondral sign in the 10:39
diagnosis of hydatid of Morgagni torsion in children: B-0899 Variations of clinical PET/MR operations: an
a decade’s experience international web-based survey
V.N. Zefov, S.M. El-Maadawy, D. Abdul Rahman; Dubai/AE
T. Beyer1, K. Herrmann2, J. Czernin3; 1Vienna/AT, 2Würzburg/DE,
3
Los Angeles, CA/US
10:38
B-0889 Diffusion-weighted imaging (DWI) in paediatric liver 10:47
MRI - confuses or helps? B-0900 Comparison of [18F] choline PET/CT with [18F]
E. Petrash, E. Mikhaylova, D. Sevryukov; Moscow/RU
choline MRI/PET in patients with suspected recurrent
prostate cancer: a prospective study
A. Wetter1, B. Schaarschmidt2, S. Lütje1, H. Rübben1, T. Lauenstein1;
1
Essen/DE, 2Düsseldorf/DE

10:55 10:38
B-0901 Focal 18F-FDG uptake in PET/MRI indicates activated B-0910 Utility of MR arthrography with and without leg
facet arthrosis and guides facet block therapy traction in detection of loose bodies in the hip joint
L.M. Sawicki1, B.M. Schaarschmidt1, P. Heusch1, C. Buchbender1, F. Schmaranzer1, M. Kogler2, M. Reichkendler2, E. Schmaranzer2;
S. Rosenbaum-Krumme2, L. Umutlu2, A. Bockisch2, G. Antoch1, 1
Innsbruck/AT, 2St. Johann i. Tirol/AT
F.W. Floeth1; 1Düsseldorf/DE, 2Essen/DE
10:46
11:03 B-0911 MRI assessment of hip joint cartilage in patients with
B-0902 A comparison between 18F-FDG-PET/CT and femoroacetabular impingement (FAI): usability and
18F-FDG-PET/MRI for detection of primary head-and- comparison of radial sequences and reconstructions
neck cancer A. Pomianowska1, J. Walecki1, J. Czubak1, M. Złotorowicz1,
P. Stumpp, Y. Risy, S. Purz, M. Gawlitza, O. Sabri, T. Kahn; Leipzig/DE J. Ludwikowska2, M. Frel1; 1Otwock/PL, 2Warsaw/PL
11:11 10:54
B-0903 Comparison of whole-body PET/MRI and whole- B-0912 Validation of joint space mapping: a new 3D
body DWI/MRI for the evaluation of patients with approach to quantitative multimodal hip joint space
lymphoma assessment
J. Grueneisen1, L. Sawicki2, B. Schaarschmidt2, S. Suntharalingam1, T.D. Turmezei, A.H. Gee, K.E.S. Poole, G.M. Treece; Cambridge/UK
H. Quick1, M. Forsting1, L. Umutlu1; 1Essen/DE, 2Düsseldorf/DE
11:02
11:19 B-0913 Scoring hip OA with MRI (SHOMRI) for the
B-0904 SUV-quantification of physiological lung tissue in an longitudinal assessment of MRI in hip osteoarthritis in
integrated PET/MR-system: impact of lung density correlation with clinical progression
and bone tissue B.J. Schwaiger, A.S. Gersing, S. Lee, L. Nardo, M.A. Samaan,
F.F. Seith, H. Schmidt, I. Bezrukov, S.-C. Schüle, C. Schraml, R.B. Souza, T.M. Link, S. Majumdar; San Francisco, CA/US
C. Pfannenberg, C. La Fougère, K. Nikolaou, N. Schwenzer;
Tübingen/DE 11:10
B-0914 Evaluation of usability and comparison of radial
11:27
sequences and reconstructions in MRI assessment of
B-0905 Evaluation of a FAST-protocol for simultaneous PET/
hips with femoroacetabular impingement (FAI)
MRI used for staging patients with lymphoma A. Pomianowska1, J. Walecki1, J. Czubak1, M. Złotorowicz1,
J. Grueneisen1, L. Sawicki2, B. Schaarschmidt2, S. Suntharalingam1, J. Ludwikowska2, M. Frel1; 1Otwock/PL, 2Warsaw/PL
H. Quick1, M. Forsting1, L. Umutlu1; 1Essen/DE, 2Düsseldorf/DE
11:18
11:35
B-0915 Osteophytes of the fovea capitis femoris are a
B-0906 Simultaneous 18F-FDG PET/MRI in comparison
common finding in MRI of asymptomatic volunteers
Friday
to 18F-FDG PET/CT in patients with suspected S. Bensler, C.A. Agten, C.W.A. Pfirrmann, R. Sutter; Zurich/CH
recurrence or residual manifestation of head and
neck cancer 11:26
P. Stumpp, R. Diogo, M. Gawlitza, S. Purz, A. Boehm, O. Sabri, B-0916 A review of 10 years’ experience: prevalence and
T. Kahn; Leipzig/DE
patterns of radiographically occult femoral and pelvic
11:43 fractures detected by MRI following low-energy
B-0907 Impact of combined FDG-PET/CT and MRI on trauma
P.M. Yeap, T.B. Oliver; Dundee/UK
detection of local recurrence and nodal metastases
of thyroid cancer 11:34
J.-M. Hempel1, R. Kloeckner2, S. Krick2, S. Schadmand-Fischer2,
M. Schreckenberger2, M. Miederer2; 1Tübingen/DE, 2Mainz/DE B-0917 Non-contrast enhanced MRI with diffusion-weighted
imaging: diagnostic performance for abscess
11:51 formation in cellulitis patients in comparison with
B-0908 Sentinel lymph node detection and in vivo/ex vivo contrast-enhanced MRI
assessment of melanin distribution by means of J. Baik1, J.-Y. Jung1, C.-W. Chun2, W.-H. Jee1; 1Seoul/KR,
2
Uijeongbu/KR
multispectral optoacoustic tomography in patients
with malignant melanoma 11:42
I. Stoffels1, S. Morscher2, N.C. Burton2, J. Klode1; 1Essen/DE,
2
Munich/DE B-0918 Diagnostic accuracy of conventional MRI in detecting
long biceps muscle tendon abnormalities
R. Lee, S. Choi, J. Ahn, C. Kang, D. Shin, M. Lee, K. Lee;
Gangneung-si/KR
10:30–12:00 Room M 4
Musculoskeletal
SS 1010b Hip and shoulder
Moderators: S.E. Anderson; Baden/CH, T. Geith; Munich/DE
10:30
B-0909 Indirect arthrography with 3D PD SPACE and 3D T1
VIBE at 3 T MRI for the detection of acetabular labral
tears
A. Lazik, O. Kraff, K. Körsmeier, S. Landgraeber, J.M. Theysohn;
Essen/DE


10:30–12:00 Room C 11:42

B-0930 Breast cancers missed by screening radiologists can
Breast be detected by reading mammograms from distance
I.L. Schreutelkamp1, R.M. Kwee2, P. Veekmans3, M.S.O. van Wissen2,
SS 1402a Screening M.E.A.P. Adriaensen2; 1Maastricht/NL, 2Heerlen/NL, 3Weert/NL
Moderators: S. Perez Rodrigo; Madrid/ES,
10:30–12:00 Room Z
10:30
B-0920 Screen detected cancers vs interval cancers: Molecular Imaging
influence of image modality and breast density
L. Timmermans1, L. Bleyen1, I. De Brabander2, K. Lemmens3, SS 1406 Advanced experimental imaging
A. Van Steen3, C. Van Ongeval3, K. Van Herck1, K. Bacher1,
Moderators: S. Walker-Samuel; London/UK,
H. Thierens1; 1Gent/BE, 2Brussels/BE, 3Leuven/BE
B. Wängler; Mannheim/DE
10:38
10:30
B-0921 Prognostic factors of interval carcinomas occurring in
B-0931 Įvß3-integrin-targeted MRI for the assessment of
an intermediate and high risk breast cancer screening
early anti-angiogenic therapy effects in experimental
program
S. Vreemann, A. Gubern-Mérida, S. Lardenoije, N. Karssemeijer,
breast cancer
P.M. Kazmierczak, M. Schneider, T. Habereder, H. Hirner-Eppeneder,
R.M. Mann; Nijmegen/NL
R. Eschbach, M. Moser, M.F. Reiser, C.C. Cyran; Munich/DE
10:46
10:38
B-0922 Interpretation time in a population-based breast
B-0932 In vivo imaging of prostate cancer using an anti-
screening program: digital breast tomosynthesis
PSMA fragment as a probe
versus 2D mammography C. Mazzocco1, N. Grenier1, G. Fracasso2, C. Germain-Genevois1,
A. Nitrosi1, M. Bertolini1, C. Campari1, L. Braglia1, V. Iotti1, R. Vacondio1, N. Dugot-Senant1, F. Couillaud1; 1Bordeaux/FR, 2Verona/IT
V. Ginocchi2, P. Pattacini1, M. Iori1; 1Reggio Emilia/IT, 2Guastalla/IT
10:46
10:54 68
B-0933 Ga-TRAP-(RGD)3-PET/CT for the in vivo assessment
B-0923 Poulation-based biennal mammographic screening:
SPEAKER of Įvß3-integrin expression as biomarker of early anti-
SUPPORTED how many women ask for more?
BY A. Pisani Mainini1, L.A. Carbonaro2, C. De Angelis1, I. Ioan1,
angiogenic therapy effects in experimental breast
INVEST IN
THE YOUTH A. Benedek2, L. Menicagli2, R.M. Trimboli2, R. Lucchini3, F. Sardanelli2; cancer
1
Milan/IT, 2San Donato Milanese/IT, 3Vimodrone/IT P. Kazmierczak, A. Todica, H. Hirner-Eppeneder, A. Rominger,
M.F. Reiser, C.C. Cyran; Munich/DE
11:02
10:54
B-0924 Engaging users in service improvement using social
media: an example from breast screening B-0934 Multiparametric contrast-enhanced ultrasound with
L. Robinson1, C. Ure1, J. Wray1, M. Griffiths1, C. Hill2, G. Shires2, VEGFR-2-targeted microbubbles and DCE-MRI
J. Stein Hodgins3, B. Scragg4; 1Salford/UK, 2Manchester/UK, for monitoring the effects of regorafenib on colon
3
Bolton/UK, 4Burnley/UK
carcinoma xenografts in rats
R.S. Eschbach, D.A. Clevert, H. Hirner-Eppeneder, P.M. Kazmierczak,
11:10 M. Moser, M. Schneider, D. Tadros, M.F. Reiser, C.C. Cyran; Munich/DE
B-0925 Type and extent of surgery for screen-detected
and interval cancers at blinded vs non-blinded 11:02
Saturday
double reading in a population-based screening B-0935 RGD peptide-modified PEGylated dendrimer-
mammography programme entrapped gold nanoparticles for targeted CT
R.J.P. Weber1, R.M.G. van Bommel1, W. Setz-Pels1, A.C. Voogd1, imaging of breast carcinoma
E.G. Klompenhouwer1, M.W. Louwman1, L.J.A. Strobbe2, K. Li; Shanghai/CN
V.C.G. Tjan-Heijnen3, L.E.M. Duijm1; 1Eindhoven/NL, 2Nijmegen/NL,
3
Maastricht/NL
11:10
11:18 B-0936 Radiolabeled somatostatin receptor agonist versus
B-0926 15 years of imaging of the male breast: a antagonist for molecular imaging and therapy
S. Dalm, J. Nonnekens, G. Doeswijk, E. de Blois, D. van Gent,
retrospective analysis M. Konijnenberg, M. de Jong; Rotterdam/NL
O. Scholz, H. Amer, F. Schmitzberger, K.-J. Winzer,
H. Schmuschkowitsch, E.M. Fallenberg; Berlin/DE
11:18
11:26 B-0937 Probing thePI3K/Akt/mTOR signalling inhibitors
B-0928 A four year review of screening-detected breast response in breast cancer cellsby 31P-NMR
SPEAKER spectroscopy
SUPPORTED cancers with discordant interpretations on double
BY S.M. Phyu, T.A.D. Smith, C.-C. Tseng; Aberdeen/UK
INVEST IN read screening mammography
THE YOUTH B. Batohi, M.J. Michell, D. Evans, J. Goligher, J. Morel, C. Peacock,
11:26
K. Satchithananda, R. Wasan, S. Wijesuriya, R. Rahim; London/UK
B-0938 Semi-quantitative dynamic contrast-enhanced
11:34 magnetic resonance imaging parameters for
B-0929 Complaints against radiologist submitted to evaluating tumour hypoxia in a maxillofacial VX2
disciplinary tribunals (DT) in the Netherlands (2007- rabbit model
2014) L. Zheng1, Y. Li2, Z. Zhang1, G. Zhang2; 1Chicago, IL/US, 2Shanghai/CN
G.J. Jager, M.J.C.M. Rutten; ‚s-Hertogenbosch/NL

11:34 11:27
B-0939 The complement system and its influence on the B-0948 The variability of prostate cancer volume by
development of acute renal failure: non-invasive renal multiparametric MRI (mpMRI): results from an active
perfusion measurement by MRI surveillance cohort
B.J.U. Hensen, A. Thorenz, R. Chen, M. Meier, A. Klos, F. Wacker, F. Giganti, N. Petrides, C. Moore, M. Emberton, C. Allen, A. Kirkham;
D. Hartung, F. Güler, K. Hüper; Hannover/DE London/UK
11:42 11:35
B-0940 Treatment of murine colon tumours using gold B-0949 Accuracy of multiparametric MRI in detection and
nanoparticles and localised hyperthermia extension of high-grade prostate cancer using
B.-F. Lee, N.-T. Chiu; Tainan/TW PIRADS version 2 criteria
N. Demany, V. Tissot, J. Ognard, A. Valeri, D. Ben Salem; Brest/FR
11:50
B-0941 USPIO-labeling in M1 and M2 macrophage 11:43
population: an in vitro MR study B-0950 Low PI-RADS scores exclude extracapsular extension
C. Zini1, M. Venneri1, S. Miglietta1, M. Rengo1, N. Porta2, A. Isidori1, of prostate cancer: a histology validated study
V. Petrozza2, A. Laghi1; 1Rome/IT, 2Latina/IT
including 301 operated patients
S. Alessi, P. Pricolo, P. Summers, E. Tagliabue, G. Petralia; Milan/IT
10:30–12:00 Studio 2016 11:51

B-0951 Validation of 3T MRI including diffusion-weighted
Genitourinary imaging for nodal staging of newly diagnosed
SS 1407 Multi-parametric MR of prostate cancer: intermediate- and high-risk prostate cancer
C.M. von Below; Uppsala/SE
an update
Moderators: D. Junker; Innsbruck/AT, J.C. Vilanova; Girona/ES
10:30–12:00 Room E1
10:30
K-26 Keynote lecture Musculoskeletal
10:39
SS 1410 Applications in CT and MR: something
B-0942 Comparison of the prostate imaging reporting
old, something new
Moderators: A. Cotten; Lille/FR, N.N.
and data system version 1 and 2 in a cohort of 245
patients with histopathological and long term follow 10:30
up B-0952 Can we predict who can benefit from axial-loaded
P.J.L. De Visschere, E. Pattyn, P. Ost, T. Claeys, G. Villeirs; Gent/BE
MRI?
T. Lorenc, P. Palczewski, D. Wojcik, M. Golebiowski; Warsaw/PL
10:47
B-0943 Does PI-RADS version 2 perform better than version 10:38
1.0 in the classification of prostate lesions in mpMRI? B-0953 Effects of contrast enhancement on phantom-less
S. Lucarini1, L. Noferini1, L.N. Mazzoni2, L. Galastri1, S. Busoni1,
I. Menchi1; 1Florence/IT, 2Siena/IT bone mineral density measurements in computed
tomography
10:55 N. Abdullayev1, V.-F. Neuhaus1, G. Bratke1, S. Voss1, A. Wulff2,
D. Maintz1, J. Borggrefe1; 1Cologne/DE, 2Quakenbrück/DE
B-0944 Head-to-head comparison of PI-RADS v1 and v2
in prostate lesions biopsied by MR-guided in-bore 10:46
biopsy B-0954 Metal artefact reduction capacity of virtual
S. Polanec, H. Bickel, D. Georg, K. Pinker Domenig, M. Susani,
T.H. Helbich, P.A.T. Baltzer; Vienna/AT monochromatic dual-layer detector spectral
CT-imaging in unilateral and bilateral total hip
11:03 prostheses
B-0945 Influence of the PI-RADS version on the scoring of R.H.H. Wellenberg1, M.F. Boomsma1, J.A.C. van Osch1,
A. Vlassenbroek2, J. Milles3, M.A. Edens1, G.J. Streekstra4,
prostatic lesions M. Maas4, C.H. Slump5; 1Zwolle/NL, 2Brussels/BE, 3Eindhoven/NL,
P. Asbach, H. Cash, B. Hamm, M. Haas; Berlin/DE 4
Amsterdam/NL, 5Enschede/NL
11:11 10:54
B-0946 Multiparametric magnetic resonance imaging B-0955 Clinical evaluation of a commercially available
of prostate cancer: diagnosis and stratification algorithm for metal artefact reduction for CT in
of patients with PIRADS 3 pattern through a patients with orthopaedic implants
multivariate statistical analysis D. Schmitz, R. Seidel, R. Dabew, A. Buecker; Homburg/DE
11:02
11:19
B-0956 Intra-subject comparison of 3 metal artifact reduction
B-0947 Multiparametric MRI in the follow-up of low-risk SPEAKER
SUPPORTED techniques for MDCT of arthroplasty implants
prostate cancer patients on active surveillance BY V. Kalia1, M.K. Fuld2, S.R. Raman2, E.K. Fishman2, J. Fritz2; 1Burlington,
INVEST IN
A.R. Padhani1, G. Petralia2, H. Sokhi3, F. Sanguedolce4, N. Anyamene1, THE YOUTH VT/US, 2Baltimore, MD/US
G. Hellawell5; 1Northwood/UK, 2Milan/IT, 3Uxbridge/UK,
4
Northampton/UK, 5Harrow/UK

11:10 10:54
B-0957 Image quality of iterative reconstructions compared B-0966 Cerebral blood flow measured by 3D arterial spin
with filtered back projection in cervical spine CT labelling MRI in MELAS patients with m.3243A>G
M. Geijer1, T. Malmquist1, S. Götestrand1, E. Gunnlaugsson1, A. Löve2, mutation: a preliminary study
H. Geijer3; 1Lund/SE, 2Reykjavik/IS, 3Örebro/SE Y. Li, J. Lin, H. Li, Y. Bao; Shanghai/CN
11:18 11:02
B-0958 The role of contrast enhanced computed tomography B-0967 Advanced virtual monoenergetic reconstruction of
in the diagnosis of necrotising fasciitis and unenhanced head CT for detection of intracranial
comparison with the laboratory risk indicator for hemorrhage: optimisation of kiloelectron volt
necrotising fasciitis (LRINEC) settings to improve image contrast
F. Carbonetti, A. Cremona, V. Carusi, M. Guidi, M. Di Girolamo, J.-E. Scholtz, M.H. Albrecht, S. Martin, S. Mahmoudi, C. Frellesen,
E. Iannicelli, G. Francione, V. David; Rome/IT R.W. Bauer, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main/DE
11:26 11:10
B-0959 Application of DTI in the evaluation of peripheral B-0968 Diagnostic accuracy of whole-brain CT perfusion in
nerve tumours and in the preoperative planning of MRI-confirmed infratentorial infarctions
surgical intervention K.M. Thierfelder, C. Bollwein, B. Ertl-Wagner, L. von Baumgarten,
L. Patriarca, S. Mariani, A. La Marra, F. Arrigoni, A. Barile, H. Janssen, M.F. Reiser, W.H. Sommer; Munich/DE
11:18
11:34 B-0969 Perivascular spaces in the hippocampus are
B-0960 Role of diffusion tensor imaging and tractography of associated with markers of vascular disease only, and
median nerve as a quantitative method in diagnosing not of Alzheimer´s disease
carpal tunnel syndrome (CTS) D. Van Westen, C. Panizo, L. Minthon, S. Palmqvist, O. Hansson;
M.M.H. Abd Ellah, C. Kremser, F. Cartez-Zumelzu, E. Gizewski, Lund/SE
A. Klauser; Innsbruck/AT
11:26
11:42 B-0970 Imaging the remodeling of ipsilateral internal capsule
B-0961 Whole-body MRI: can it be used as a screening tool following focal cerebral ischemia in rats by DKI
in multiple hereditary exostoses (MHE) and Ollier X. Zhang, Y. Yang, L. Yin, X. Hao, J. Tian; Shanghai/CN
disease?
R. Giggens, K. Partington; Oxford/UK 11:34
B-0971 Amigo: a new tool to report functional MRI of
11:50 cerebrovascular reserve
B-0962 Low-dose full-spine CT with iterative model E. Condamine, O. Heck, N. Boudiaf, T. Perret, J. Pietras, C. Remy,
reconstruction (IMR) algorithm in children with A. Krainik; Grenoble/FR
scoliosis 11:42
A.-N. Hu1, Y. Jiang2, B. Zhu1; 1Nanjing/CN, 2Shanghai/CN
B-0972 Patient selection using the e-ASPECTS software for
automated detection of acute ischaemic stroke on a
10:30–12:00 Room E2 mobile stroke unit
I. Grunwald1, A. Kühn2, K. Fassbender3; 1Chelmsford/UK, 2Worcester,
Neuro MA/US, 3Homurg/DE
11:50
Saturday
SS 1411a Cerebrovascular disease (4)
B-0973 Cerebral whole brain CT-Perfusion with single
Moderators: D. Bos; Rotterdam/NL, C. Calli; Izmir/TR
rotation angiography (srCTA) of the neck - evaluation
10:30 of a one-stop-shopping CT stroke protocol
S. Wong, L. De-Paoli, K. Hausegger; Klagenfurt/AT
B-0963 Interpretation and clinical use of amide proton
transfer imaging signal MTRasym(3.5ppm) in acute
ischemic stroke 10:30–12:00 Room F2
X. Luo1, M. Chen1, J. Zhou2; 1Beijing/CN, 2Baltimore, MD/US
10:38 Abdominal Viscera

B-0964 CT perfusion CBV and blood-brain barrier
SS 1401 Advances in abdominal MRI
permeability measured in infarct core and ischaemic
Moderators: A.J. van der Molen; Leiden/NL, N.N.
penumbra of acute ischemic stroke patients with
haemorrhagic transformation 10:30
A. Clarizia, E. Raimondi, G. Di Cecco, E. Groppo, A. Bernardoni,
A. Saletti, M. Giganti, E. Fainardi; Ferrara/IT
B-0974 Evaluation of hypointense liver lesions during
hepatobiliary phase MR imaging in normal and
10:46 cirrhotic livers: is increasing flip angle reliable?
B-0965 Predictive value of small vessel occlusions detected Y.-D. Xiao; Changsha/CN
by CT perfusion-based wavelet-transformed 10:38

angiography in patients with acute ischemic stroke
W.G. Kunz, W.H. Sommer, B. Ertl-Wagner, O. Dietrich, L. Havla,
B-0975 A short breath-hold high-resolution technique may
M.F. Reiser, K.M. Thierfelder; Munich/DE be the first step to overcoming degraded hepatic
arterial phase in liver MR imaging: a prospective
randomised control study
C.-H. Lee, J. Kim, J. Yoo, Y. Park, C. Park; Seoul/KR

10:46 10:30–12:00 Room D1

B-0976 Impact of CAIPIRINHA VIBE on interobserver
agreement in comparison with conventional VIBE Chest
sequences in contrast-enhanced MRI of focal liver
SS 1404 Chest CT dose reduction
lesions
M.H. Albrecht, J.L. Wichmann, B. Bodelle, P. Dewes, A.M. Bucher, Moderators: T. Henzler; Mannheim/DE, D. Tack; Baudour/BE
R.W. Bauer, S. Zangos, T. Lehnert, T.J. Vogl; Frankfurt a. Main/DE
10:30
B-0977 Gadoxetic acid-enhanced MR-imaging in chronic liver J. Neuwirth; Prague/CZ
disease - correlation of perfusion parameters and 10:39

hepatic uptake function with histology
B. Leporq1, J.-L. Daire1, C. Pastor2, C. Sempoux3, R. Meuli3, P. Deltenre3,
B-0985 Ultra low dose unenhanced chest CT with iterative
B. van Beers1, S. Schmidt3; 1Paris/FR, 2Geneva/CH, 3Lausanne/CH reconstruction: should we acquire it at 80kV or
135kV? A qualitative and quantitative prospective
11:02
study on 51 patients
B-0978 Influence of different contrast agent application C. Ludes; Strasbourg/FR
protocols on transient severe motion (TSM) at
10:47
gadoxetate disodium-enhanced MRI
K.I. Ringe, C. von Falck, H.-J. Raatschen, F. Wacker, J. Hinrichs; B-0986 Radiation dose reduction with 320-row sequential
Hannover/DE wide-volume over helical acquisitions in chest CT: a
11:10 prospective study in an ultra-low-dose setting
E. Meyer1, A. Labani1, F. Severac1, M.-Y. Jeung1, C. Ludes1, A. Meyer1,
B-0979 Impact of injection protocol on arterial tumour K. Haouin2, C. Roy1, M. Ohana1; 1Strasbourg/FR, 2Puteaux/FR
enhancement, artifacts, and arterial blood gases in
10:55
rabbit VX2 tumour model: comparison of Gd-EOB-
DTPA and Gd-DTPA B-0987 Effect of tin filtration on image quality and radiation
T. Tsuboyama1, J. Gregor2, T. Kim1, M. Hori1, H. Onishi1, M. Tatsumi1, dose: preliminary experience with a third-generation
M. Sakane1, P. Hubertus2, N. Tomiyama1; 1Suita/JP, 2Berlin/DE dual-source CT system in 133 adult patients
R. Daghistani, S. Khung, J.-B. Faivre, A. Duhamel, J. Rémy,
11:18 M. Remy-Jardin; Lille/FR
B-0980 Measuring liver fat content on MRI: the effect on
11:03
accuracy of simplified sampling protocols
J. Sun, A.J. Procter, P. Malcolm, A. Toms; Norwich/UK B-0988 Image quality and sharpness of ground-glass nodules
on ultralow-dose CT at 0.3 mSv using Tin filtration:
11:26
comparison of five iterative reconstruction strengths
B-0981 Quantification of liver proton-density fat fraction in V. Ai1, R. Wong1, K. Otani2, W. Chin3, S. Lau1, L. Leung1, G. Lo1;
1
ultra-high-field MR systems: magnitude and complex Hong Kong/HK, 2Tokyo/JP, 3Singapore/SG
fitting approach 11:11

J.-P. Kühn, C. Mahlke, B. Mensel, M.-L. Kromrey, N. Hosten;
Greiswald/DE B-0989 Detection of artificial pulmonary lung nodules in
ultralow-dose CT using an ex vivo lung phantom
11:34 C.A. Burgard, T. Gaaß, D. Bondesson, M.F. Reiser, J. Dinkel;
B-0982 Quantitative MR imaging of hepatic steatosis: Munich/DE
validation in ex vivo human livers 11:19

P. Bannas1, H. Kramer2, D. Hernando3, R. Agni3, U. Motosugi3,
S.D. Sharma3, L. Fernandez3, G. Adam1, S.B. Reeder3; 1Hamburg/DE, B-0990 Equal delineation of mediastinal, hilar, and peripheral
2
Munich/DE, 3Madison, WI/US lymph nodes at 64-row-MDCT of the chest with
11:42 a one-millisievert protocol when compared with
standard dose
B-0983 Optimum slice-based MRI estimates of visceral U.G. Mueller-Lisse, L. Marwitz, A. Tufman, R. Huber, M.F. Reiser,
adipose tissue volumes in patients with excess M. Paolini; Munich/DE
weight: influence of gender, age and BMI range
A. Schaudinn, N. Linder, N. Garnov, M. Blüher, T. Karlas, A. Dietrich, 11:27
T. Schütz, T. Kahn, H. Busse; Leipzig/DE B-0991 The application of kV assist in low-dose chest CT
11:50 screening
Z.-L. Zhang; Beijing/CN
B-0984 Monitoring of abdominal fat compartments by
magnetic resonance imaging in obese subjects 11:35
during a low-calorie weight-loss program B-0992 Chest CT for airway stent evaluation in patients
J.-P. Kühn, M.-L. Kromrey, L. Vogt, C. Mahlke, J. Mayerle, M. Lerch, with malignant tracheal stenosis with iterative
N. Hosten; Greiswald/DE
reconstruction algorithms
T. Li1, Z. Yonggao1, J. Yan2, G. Jianbo1; 1Zhenzhou/CN, 2Shanghai/CN
11:43
B-0993 Image quality of CT pulmonary angiography at
reduced radiation exposure and contrast material
volume using iterative model image reconstruction
and iDose4 technique in comparison to FBP
A. Laqmani1, S. Butscheidt1, M. Kurfürst1, J. Schmidt-Holtz1,
C. Behzadi1, S. Sehner1, H. Nagel2, G. Adam1, M. Regier1; 1Hamburg/DE,
2
Buchholz/DE

11:51 11:34
B-0994 Spine evaluation in 70 kV thoracic CT: dose B-1003 Unresectable isolated hepatic metastases from uveal
effectiveness and image quality melanoma: treatment with chemosaturation with
C. Polkowski, B. Bodelle, T.J. Vogl; Frankfurt a. Main/DE percutaneous hepatic perfusion of melphalan
T.J. Vogl1, S. Koch1, B. Gebauer2, W. Willinek3, C. Engelke4, R. Brüning5,
F. Wacker6, A. Enk7; 1Frankfurt a. Main/DE, 2Berlin/DE, 3Trier/DE,
4
10:30–12:00 Room D2 Göttingen/DE, 5Hamburg/DE, 6Hannover/DE, 7Heidelberg/DE
11:42
B-1004 Transarterial chemoembolisation (TACE) treatment
SS 1409 Intra-arterial therapies in the liver of liver metastases: intraprocedural volume
Moderators: R.F. Dondelinger; Liège/BE, measurement by FAST C-arm-CT during treatment
C. Schmid-Tannwald; Munich/DE T.J. Vogl, F. Dörr, S. Zangos, N.N.N. Naguib; Frankfurt a. Main/DE
10:30 11:50
B-0995 Yttrium-90 radioembolisation for colorectal cancer B-1005 Tace of liver metastases from CR cancer with DEBIRI
liver metastases: a prospective cohort study on tecniquein association with CHT: five years of our
circulating angiogenic factors and treatment experience and follow-up
G. Scevola, M. Rastelli, G. Loreni; Rome/IT
response
C. Rosenbaum, A. van den Hoven, M. Braat, M. Koopman, M. Lam,
B. Zonnenberg, H. Verkooijen, M. van den Bosch; Utrecht/NL
10:30–12:00 Room G
10:38
B-0996 Selective internal radiation therapy in patients with Radiographers
progressing neuroendocrine liver metastases
C. Ebeling Barbier, U. Garske-Roman, M. Sandström, R. Nyman, SS 1414 Safety and patient care in medical
D. Granberg; Uppsala/SE
imaging
10:46 Moderators: A. Henner; Oulu/FI, D. Miletić; Rijeka/HR
B-0997 Reduced peri-procedural analgesia following 10:30

replacement of water for injection (WFI) with B-1006 Work-place related ergonomic conditions as
glucose 5% (G5) as the infusion medium for prognostic factors for work-related musculoskeletal
90yttrium resin microspheres disorders (WRMD) in radiographers
K.J. Paprottka, S. Lehner, W.P. Fendler, H. Ilhan, A. Rominger,
L.P. Ribeiro, I. Bodião, O. Lesyuk, A.F.C.L. Abrantes, R.P.P. Almeida,
W. Sommer, D.A. Clevert, M.F. Reiser, P.M. Paprottka; Munich/DE
J.P. Pinheiro; Faro/PT
10:54 10:38
B-0998 Trends for using lipiodol-Doxorubicin vs drug- B-1007 An investigation of radiography staff uniforms as
eluting beads-Doxorubicin for transarterial vectors for infection: comparing home-laundering
chemoembolisation in hepatocellular carcinoma: a processes with hospital-laundering
single-centre experience P. Hogan, J. Lowe; Dublin/IE
A.S. Moustafa, A.M.K. Abdel Aal, D. Redden, S. Saddekni, D. Dubay;
Birmingham, AL/US 10:46
11:02 B-1008 An investigation into the effectiveness of common
cleaning wipes in removing infection control risks
Saturday
B-0999 Surgical resection versus radiofrequency ablation
from radiographic cassettes
plus drug-eluting beads transcatheter arterial
M.J. Mann, K. Szczepura, A. England; Manchester/UK
chemoembolisation in the treatment of single large
hepatocellular carcinoma 10:54
A. Posa, R. Iezzi, G. Coppola, E.G.M. Antonuccio, A. Gasbarrini, B-1009 Development in radiological department practices:
L. Bonomo; Rome/IT
an analysis of clinical audits in the years 2002 - 2014
K. Miettunen1, E. Metsälä2; 1Vantaa/FI, 2Helsinki/FI
11:10
B-1000 Radiation exposition of staff in SIRT: a proposal for a 11:02
better ß radiation protection B-1010 Survey on patient safety culture: an approach into
R. Adamus, E. Guni, R. Loose; Nuremberg/DE
imaging departments
K.B. Azevedo, E. Bernardino, A.F.C.L. Abrantes, A.M. Ribeiro,
11:18
C.A. da Silva, R.P.P. Almeida, N.M. Pinto, L.P. Ribeiro; Faro/PT
B-1001 Single-session combined radiofrequency ablation
and transarterial chemoembolisation in the treatment 11:10
of hepatocellular carcinoma B-1011 Complementary alternative medicine (CAM) to
A.M. Gabr1, M.A. Dawoud1, R.E. Mohamed1, M.S. El Waraki2; 1Tanta/EG, reduce MRI anxiety
2
Shebin El Koum/EG S.I. Glenn; Portland, OR/US
11:26 11:18
B-1002 Local hepatic tumour control in patients with HCC B-1012 The radiographers’ role in information giving prior to
undergoing transarterial lipiodol embolisation consent for computed tomography scans: a cross-
followed by microwave ablation sectional survey
R. Seidel, A. Massmann, P. Fries, G. Schneider, A. Buecker; L.C. Hadley, D. O’Leary, T. Watson; Hertfordshire/UK
Homburg/DE

11:26 11:18
B-1013 Patient participation in MRI: patient experiences and B-1023 Papillary thyroid cancer: optimal scan delay for
image quality addressing breath-hold acquisitions contrast-enhanced CT in detecting lateral lymph
E.M. Funk, A. Anderzen-Carlsson, P. Thunberg; Örebro/SE node metastasis by quantitative assessment of
11:34 enhancement
D. Park, J. Park, J. Lee, Y. Choi, J. Baek; Seoul/KR
B-1014 Evaluation of magnetic resonance acoustic noise in
1.5 and 3 Tesla scanners 11:26
V.M. Silva, I. Ramos, J. Moreira, M. Marques; Porto/PT B-1024 Which nodules should have repeat biopsies: the role
11:42 of thyroid imaging and reporting system (TI-RADS)
in cases of nodiagnostic cytology
B-1015 Patient perceptions of radiographer communication M.A. Öztek, K. Çeken, G.A. Ocak, A. Dablan, E. Durmaz,
skills A. Kabaalioğlu, E.I. Gürer, A. Apaydın, T. Sindel; Antalya/TR
J. Vieira, L.P. Ribeiro, R.P.P. Almeida, A.F.C.L. Abrantes; Faro/PT
11:34
11:50
B-1025 The role of core needle biopsy as first-line in
B-1016 First year radiography students’ perceptions of diagnosis for initially detected thyroid nodules: core
professionalism needle biopsy could achieve highly diagnostic yield
T. Kukkes1, V. Challen2, Z. Läänelaid1; 1Tartu/EE, 2Lancaster/UK
H. Kim, Y. Kim, J. Seo, J. Lee, H. Han, K. Kim, S. Park; Daejeon/KR
11:42
10:30–12:00 Room M 1 B-1026 Perfusion analysis in malignant and benign thyroid
SPEAKER
SUPPORTED lesions: analysis of microvascularisation in contrast-
Head and Neck BY
INVEST IN enhanced ultrasound (CEUS)
THE YOUTH I. Wiesinger, E. Kroiss, C. Stroszczynski, E.M. Jung; Regensburg/DE
SS 1408 Thyroid nodules
Moderators: K.S.S. Bhatia; Shatin/HK, N.N. 11:50
B-1027 Thyroid ultrasound in patients with chronic hepatitis
10:30
C treated with interferon alpha
B-1017 Sonographic assessment of thyroid nodules: a A. Bianek-Bodzak, K. Skrobisz- Balandowska, L. Obolonczyk,
comparison of current guidelines K. Sworczak; Gdansk/PL
P. Navin, A.M. Egan, B. Hutchinson, D. Bergin, M. Bell, J. Bruzzi;
Galway/IE
10:30–12:00 Room M 2
10:38
B-1018 The assessment of thyroid imaging reporting Oncologic Imaging
and data system (TIRADS) in malignancy risk
stratification SS 1416 Pelvic and breast cancer
P. Priedītis, M. Tirāne, K. Stepanovs, M. Radziņa, M. Rauda, I. Štrumfa,
Moderators: O. Abeyakoon; Cambridge/UK,
M. Sperga; Riga/LV
B. Klumpp; Tübingen/DE
10:46 10:30
B-1019 Malignancy risk stratification of multinodular Goitre: B-1028 MpMRI of endometrial adenocarcinoma: association
a retrospective review of ultrasound features and of the ADC histographic analysis and MRI tumour
their impact on histopathology and cancer risk volumetry with histological features of biologic
B.S. Kelly; Dublin/IE
aggressiveness
10:54 E. Venturini, M. Jannone, A. Palmisano, F. Giganti, A. Esposito,
G. Mangili, M. Candiani, A. Del Maschio, F. De Cobelli; Milan/IT
B-1020 Relationship between elasticity imaging and
ultrasonography in the assessment of the thyroid 10:38
nodule B-1029 Role of MR imaging in selection of patients with
F.J. Campoy-Balbontín, M.C. Jurado-Gómez, J.C. Pérez-Tejada,
cervical cancer for abdominal radical trachelectomy
C. Almeida-Gonzalez, R. Aznar-Méndez; Sevilla/ES
Z. Jiang, X. Ju, W. Peng, B. Yu; Shanghai/CN
11:02 10:46
B-1021 Ultrasound features of conventional papillary thyroid B-1030 Pre-operative DWI MRI and PET studies of uterine
carcinoma and follicular variant papillary thyroid cervical cancer lesions: added value of combined
carcinoma quantitative and volumetric analysis
N.M. Hughes, J. Barry, L. Feeley, P. Sheahan; Cork/IE
P.A. Bonaffini, C. Crivellaro, M. Cuzzocrea, A. Casiraghi, D. Ippolito,
C. Talei Franzesi, C. Landoni, S. Sironi; Monza/IT
11:10
B-1022 Contrast enhanced ultrasound in diagnosis of solitary 10:54
thyroid nodules, preliminary study on papillary B-1031 Three-dimensional contrast enhanced ultrasound in
cancer treatment prediction for breast cancer: comparison
P. Prieditis, M. Radzina, I. Strumfa, Z. Narbuts, A. Ozolins, A. Vanags;
with dynamic contrast-enhanced magnetic resonance
Riga/LV
imaging and pathology
M. Chen, W. Jia, L. Tang, W.-M. Chai, D.-B. Wang, X.-C. Fei, J.-R. He,
W.-P. Wang; Shanghai/CN

11:02 10:54
B-1032 Method of contour analysis of neoplasms in x-ray B-1042 The feasibility of body-weight and BMI based
mammograms individualised protocol in CT pulmonary angiography
V. Sevastyanov, E. Romanycheva, Y. Furman; Yoshkar-Ola/RU L. Li, J. Gao, J. Liu; Zhengzhou/CN
11:10 11:02
B-1033 Can contrast-enhanced ultrasound features of B-1043 Automated 3D MRI volumetry of the pulmonary
metastatic axillary lymph nodes reflect biological arteries for predicting pulmonary hypertension has
performances of primary breast cancer? excellent intra- and interobserver agreement
W. Jia, J.-n. Shi, X.-c. Fei, K.-w. Shen, M. Chen; Shanghai/CN C. Melzig1, S. Wörz1, S. Ley2, C. Fink3, S. Partovi4, K. Rohr1,
H.-U. Kauczor1, E. Grünig1, F. Rengier1; 1Heidelberg/DE, 2Munich/DE,
3
11:18 Celle/DE, 4Cleveland, OH/US
B-1034 Urinary bladder mass: histopathological and cell type

11:10
prediction by apparent diffusion coefficient
H.M.K. Imam, D.A. Hameed, G.S. Seifeldein, E.M. Moussa, R.S. Al Johi; B-1044 Chronic thromboembolic pulmonary hypertension:
Assuit/EG cone beam computed tomography vs. 64-row multi-
detector computed tomography
11:26 J.B. Hinrichs, J. Renne, M.M. Hoeper, K. Olsson, F. Wacker, B.C. Meyer,
B-1035 USPIO-enhanced MRI as a potential predictor of C. von Falck; Hannover/DE
tumour aggressiveness
P. Seyfer1, C. Hengl1, A.H. Mahnken1, J.T. Heverhagen2; 1Marburg/DE,
11:18
2
Berne/CH B-1045 Contrast-enhanced MRI for quantitative lung
perfusion imaging using the dual-bolus approach:
11:34
comparison of three different contrast agents and
B-1036 Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, recommendation of feasible doses
MRI, and CT in whole-body staging of recurrent S. Veldhoen1, M. Oechsner2, A. Fischer1, A.M. Weng1, A.S. Kunz1,
breast cancer: initial results T.A. Bley1, H. Köstler1, C.O. Ritter3; 1Würzburg/DE, 2Munich/DE,
3
L.M. Sawicki1, J. Grueneisen2, B. Schaarschmidt1, C. Buchbender1, Göttingen/DE
P. Heusch1, V. Ruhlmann2, L. Umutlu2, G. Antoch1, S. Kinner2;
1
Düsseldorf/DE, 2Essen/DE 11:26
B-1046 Cardiac and hemodynamic effect of arterial
11:42
obstruction in cancer-related acute pulmonary
B-1037 Whole body diffusion-weighted MRI for tumour embolism
characterisation, staging and prediction of complete J. Plasencia-Martínez1, A. Carmona-Bayonas1, D. Calvo-Temprano2,
resection in ovarian carcinoma: a comparison with CT P. Jiménez-Fonseca2, M. Benegas-Urtega3, M. Sánchez-González3,
K.L.M. Michielsen1, I. Vergote1, R. Vanslembrouck1, E. Mussen1, D. Varona-Porres3, D. Martínez-de-la-Haza3, S. Hernández-Muñiz4;
1
F. Amant1, K. Leunen1, F. De Keyzer1, G. Souverijns2, V. Vandecaveye1; Murcia/ES, 2Oviedo/ES, 3Barcelona/ES, 4Madrid/ES
1
Leuven/BE, 2Hasselt/BE
11:34
11:50 B-1047 Quantitative evaluation of linear models to estimate
B-1038 Whole-body diffusion-weighted magnetic resonance CT-perfusion from single-acquisition dual-energy
imaging for staging of women with cancer during iodine maps acquired at peak tissue enhancement
pregnancy: a pilot study S. Skornitzke, F. Fritz, M. Koell, P. Mayer, J. Hansen, G. Pahn, M. Klauß,
R. Dresen, S. Han, K. Michielsen, F. De Keyzer, F. Amant, H.-U. Kauczor, W. Stiller; Heidelberg/DE
V. Vandecaveye; Leuven/BE
11:42
Saturday
B-1048 CT measured pulmonary artery trunk diameter in a
10:30–12:00 Room M 3 rheumatoid arthritis population without pulmonary
hypertension: association with disability and disease
Vascular activity
T.S. Vieira, C. Esteves, M. Bernardes, A. Sá Pinto, D. Gonçalves,
SS 1415 Pulmonary vasculature: new and J.G. Pereira; Porto/PT
improved 11:50
Moderators: N.N.
B-1049 Embolisation of pulmonary arterio-venous
10:30 malformations using hydrogel-coated coils mid-term
B-1039 Intermittent contrast injection method for triple rule results
J.-P. Pelage, A. Letellier, V. Le Pennec, M.-A. Jegonday, A. Fohlen;
out computed tomography Caen/FR
T. Fujikawa, K. Ishida, H. Nobusawa, S. Yamamoto, S. Sasaguri;
Kawasaki/JP
10:38
B-1040 Individually tailored contrast enhancement in CT
pulmonary angiography
B.M.F. Hendriks, M. Kok, C. Mihl, J.E. Wildberger, M. Das;
Maastricht/NL
10:46
B-1041 Suction/inspiration against resistance: a new
breathing technique to improve contrast density
within the pulmonary artery
A. Gutzeit; Zurich/CH

10:30–12:00 Room M 4 11:42

B-1059 The role of diffusion tensor imagin (DTI) and dynamic
Neuro susceptibility perfusion (DSP) MRI in the evaluation
of meningioma grades and subtypes
SS 1411b Cerebral tumours (2) A. Zikou, G. Alexiou, A. Goussia, P. Kosta, V. Xydis, M. Argyropoulou I;
Moderators: J. Gillard; Cambridge/UK, S. Looby; Dublin/IE Ioannina/GR
10:30 11:50
B-1050 Differentiation between high-grade gliomas and B-1060 Multiparametric analysis of follow-up of low grade
metastatic brain tumours using diffusion tensor gliomas: comparison between perfusion and
imaging metrics diffusion MR and F-DOPA PET
A.E.E. El-Morsy, L.G. El-Serougy, A.A.k.A. Razek, A.E. Mousa, M. Rossi Espagnet, A. Romano, V. Mancuso, F. Tavanti, F. Cicone,
H.F. Eldawoody; Al Monsoura/EG C. Scaringi, A. Bozzao; Rome/IT
10:38
B-1051 Evaluation of vascular permeability in gliomas by 10:30–12:00 Room M 5
dynamic susceptibility contrast (DSC) method using
“K2” value and histogram analysis Breast
T. Taoka, H. Kawai, T. Nakane, S. Naganawa; Nagoya/JP
SS 1402b Contrast-spectral mammography and
10:46 MRI update in background parenchymal
B-1052 A preliminary study for differential diagnosis of
enhancement
brain mass: quantitative evaluation from asymmetric
Moderators: M. Bernathova; Vienna/AT,
magnetization transfer ratio (MTRasym) by amide L.J. Pina Insausti; Pamplona/ES
proton transfer imaging
J. Chu1, X. Li1, J. Zhao1, X. Yan2, Y. Wang1; 1Guangzhou/CN, 10:30
2
Shanghai/CN
B-1061 Contrast enhanced spectral mammography (CESM)
10:54 as first exam in symptomatic patients: a monocentric
B-1053 Brain F-18Fluorocholine PET and the correlation prospective study on 226 patients
J. Smadja, C. Balleyguier, J. Arfi-Rouche, M.-C. Mathieu, C. Mazouni,
between MRI in the diagnosis and follow-up of S. Delaloge, A. Dunant, C. Dromain; Villejuif/FR
gliomas
S. Bonilla Saborido, E. Granell Moreno, F. Nuñez Marín, 10:38
A. Lozano Martinez, M. Camacho Marti, A. Fernandez Leon,
B-1062 Monitoring neo-adjuvant chemotherapy: comparison
B. Gomez Ansón; Barcelona/ES
of contrast-enhanced spectral mammography
11:02 (CESM) and MRI versus breast cancer characteristics
V. Iotti1, S. Ravaioli1, R. Sghedoni1, C. Coriani1, R. Vacondio1, S. Caffarri2,
B-1054 Potential role of quantitative MRI assessment in
A. Nitrosi1, G. Tondelli3, P. Pattacini1; 1Reggio Emilia/IT, 2Guastalla/IT,
differentiating high from low-grade gliomas 3
Scandiano/IT
E.A.S. Geneidi, L.A. Habib, N.A. Chalabi; Cairo/EG
10:46
11:10
B-1063 Comparison of breast cancer screening with contrast-
B-1055 Quantification of diminished glioma volume
enhanced mammography vs MRI
following neurosurgical resection and correlation to M.S. Jochelson, D.D. Dershaw, J.S. Sung, M.C. Hughes, D.A. Goldman,
survival C.S. Moskowitz, D.A. Mangino, M.E. Robson, E.A. Morris; New York,
A. Blomstergren, A. Rydelius, J. Lätt, J. Bengzon, P.C. Sundgren; NY/US
Lund/SE
10:54
11:18 B-1064 Contrast-enhanced spectral mammography in recalls
B-1056 A pilot study of differentiating different intraaxial from the breast cancer screening program: validation
brain tumours: quantitative evaluation of of results in a larger multireader, multicase study
multiparameters from diffusion kurtosis imaging in U. Lalji1, S. Gommers1, M. van Goethem2, S. Vanwetswinkel1,
R. Pijnappel3, P. Nelemans1, M. Smidt1, J.E. Wildberger1, M. Lobbes1;
tumour parenchyma 1
Maastricht/NL, 2Antwerp/BE, 3Utrecht/NL
J. Chu1, Y. Wang1, J. Zhao1, X. Yan2, X. Li1; 1Guangzhou/CN,
2
Shanghai/CN
11:02
11:26 B-1065 Pre-operative evaluation of breast cancer by contrast
B-1057 The role of MR-perfusion in the follow-up of primitive enhanced digital mammography
S.A. Tawfik, N.M. Abdel Razek, Y.M. Tuhamy, O.Z. Youssif, A.E. Eissa;
cerebral malignant neoplasms: single-center Cairo/EG
experience on 36 patients
R. Pimentel Silva1, R. Senese2, F. Zeccolini2, F. Giurazza3, 11:10
F.M. Giugliano2, R. Izzo2, M. Muto2; 1Lisbon/PT, 2Naples/IT, 3Rome/IT
B-1066 Comparative study between tomosynthesis,
11:34 contrast enhanced spectral mammography and
B-1058 Place of value of integrated [18F] FDG-PET/MRI in breast ultrasound as complementary techniques in
cerebral staging of NSCLC patients mammography of dense breasts
C. Deuschl1, F. Nensa1, J. Grueneisen1, P. Heusch2, T. Poeppel1, M.M.H.H. Hanafy, R.M.K. Fouad, H.A.M.A. Azzam, A.A.Y. Youssef;
M. Forsting1, L. Umutlu1, M. Schlamann3; 1Essen/DE, 2Düsseldorf/DE, Cairo/EG
3
Gießen/DE

11:18 14:32
B-1067 Breast MRI background parenchymal enhancement B-1076 Submillisievert computed tomography with MBIR
(BPE) correlates with the risk of breast cancer before pulmonary veins radiofrequency catheter
M. Moschetta, M. Telegrafo, T. Introna, L. Coi, L. Rella, ablation of atrial fibrillation: impact on radiation
A. Stabile Ianora, G. Angelelli; Bari/IT
exposure and outcome
G. Pontone, D. Andreini, A. Annoni, M. Petullà, E. Russo, E. Innocenti,
11:26
M. Guglielmo, S. Mushtaq, M. Pepi; Milan/IT
B-1068 Repeated surgery in invasive lobular breast cancer
after pre-surgical MRI: role of additional ductal 14:40
carcinoma in situ and background parenchymal B-1077 Using coronary CT angiography for guiding invasive
enhancement coronary angiography: Potential role to reduce intra-
H. Preibsch, V. Richter, B.M. Wietek, M. Hahn, A. Staebler, K. Nikolaou, procedural radiation exposure
B. Wiesinger; Tübingen/DE C.R.T. Arendt, P. Dewes, J.L. Wichmann, J.M. Kerl, T.J. Vogl,
R.W. Bauer; Frankfurt a. Main/DE
11:34
B-1069 Quantitative evaluation of background parenchymal 14:48
enhancement (BPE) on breast MRI: a feasibility B-1078 Routine MDCT results in an increased diagnostic
study with a semi-automatic and automatic software certainty and a therapeutic change in patients with
compared to observer-based scores suspected prosthetic heart valve dysfunction
B. Bignotti, A. Tagliafico, G. Tagliafico, L. Gristina, L. Cevasco, D. Suchá1, P. Symersky2, R.B.A. van den Brink2, W. Tanis3, M.F.L. Meijs4,
F. Valdora, A. Signori, S. Tosto, M. Calabrese; Genoa/IT J. Habets1, S.A.J. Chamuleau1, L.A. van Herwerden1, R.P.J. Budde5;
1
Utrecht/NL, 2Amsterdam/NL, 3The Hague/NL, 4Twente/NL,
5
11:42 Rotterdam/NL
B-1070 The assessment of background parenchymal

14:56
enhancement (BPE) in the high risk population: What
B-1079 Ejection fraction and left-atrial diameter are
causes BPE? SPEAKER
1 2 2 2 1 1
C. You , C. Kaiser , A. Kaiser , J. Knaudt , Y.J. Gu , W.J. Peng , SUPPORTED predictors of NT-proBNP recovery after transcatheter
BY
S.O. Schönberg2; 1Shanghai/CN, 2Mannheim/DE INVEST IN aortic valve implantation
THE YOUTH J. Schmid, R. Maderthaner, K. Ablasser, T. Stojakovic, J.S. Binder,
11:50 P. Rainer; Graz/AT
B-1071 Background parenchymal enhancement as a

15:04
predictor of breast cancer grade: a pilot study
1 1 2
S. Vreemann , A. Gubern-Mérida , C. Borelli , N. Karssemeijer , 1 B-1080 Reduction in risk of contrast-induced nephropathy
R.M. Mann1; 1Nijmegen/NL, 2Rome/IT (CIN) in Pre-TAVI CT coronary angiography using a
novel low-volume, low-viscosity contrast protocol
M. Crawford Jefferson, P. Donnelly, P. Ball; Belfast/UK
14:00–15:30 Room M 1
15:12
Cardiac B-1081 Left atrial appendage thrombus as a preventable
cause of stroke: complex imaging modalities versus
SS 1503 Interventional applications prone position MDCT
Moderators: D. Maintz; Cologne/DE, E. Pershina; Moscow/RU M. Kantarci, R. Sade, H. Ogul, S. Sevimli, I. Tanboga, A. Colak,
L. Karaca; Erzurum/TR
14:00
15:20
B-1072 Preoperative CT evaluation of minimally invasive
B-1082 Biological aortic heart valves deform after surgical
Saturday
Leipzig loop repair of the mitral valve apparatus:
implantation: a multidetector-row computed
direct comparison with intra-surgical measurements
S.R. Fuller, D. Caruso, M. Stroebel, P. Burghard, C.N. De Cecco, tomography study
S. Mangold, C. Tesche, A. Varga-Szemes, U.J. Schoepf; Charleston, D. Suchá1, P. Symersky2, L.M. de Heer1, W.P.T.M. Mali1,
SC/US L.A. van Herwerden1, R.P.J. Budde3; 1Utrecht/NL, 2Amsterdam/NL,
3
Rotterdam/NL
14:08
B-1073 Aortic valve planimetry by high-resolution
14:00–15:30 Room M 2
3-dimensional MR image acquisition with a breath-
hold Abdominal Viscera
H. Kim, Y. Choe, S. Kim, M. Kim, Y. Kim, S.-J. Park; Seoul/KR
14:16 SS 1501 Liver fibrosis: imaging assessment

B-1074 Integrated electroanatomic mapping with three- Moderators: F. Caseiro-Alves; Coimbra/PT,
S.K. Venkatesh; Rochester, MN/US
dimensional computed tomographic images for
real-time guided ablations: comparison with standard 14:00
procedure B-1083 Liver stiffness is better than serum biomarkers in
A. Palmisano, A. Esposito, S. Antunes, C. Colantoni, C. Bisceglia,
F. Baratto, P. Della Bella, F. De Cobelli, A. Del Maschio; Milan/IT liver fibrosis staging: study on surgical specimens in
patients with chronic hepatitis B
14:24 Q. Lu, Y. Luo, C.-L. Lu; Chengdu/CN
B-1075 Comparison of transthoracic echocardiography

14:08
versus cardiac magnetic for ICD therapy in primary
B-1084 Real-time elastography (RTE): noninvasive diagnostic
prevention strategy dilated cardiomyopathy patients
1 1 1 1
G. Pontone , D. Andreini , A. Solbiati , M. Guglielmo , S. Mushtaq , 1 tool in evaluation of liver stiffness in patients with
A. Baggiano1, C. Rota1, A. Guaricci2, M. Pepi1; 1Milan/IT, 2Foggia/IT chronic viral hepatitis, correlated to biopsy
M. Schiavone, D. Ippolito, C. Talei Franzesi, P. Bonaffini, S. Sironi;
Monza/IT

14:16 14:08
B-1085 Accuracy of the QElaXto® shear wave technique for B-1095 Dynamic and morphologic evaluation of erectile
staging liver fibrosis dysfunction on penile Doppler sonography and
G. Ferraioli, L. Maiocchi, R. Lissandrin, C. Tinelli, C. Filice; Pavia/IT contrast cavernosography
A. Ismail, M. Abdulkadir Tabari; Kano/NG
14:24
B-1086 How many valid measurements are necessary to 14:16
assess liver stiffness using 2D-SWE.GE? B-1096 Prostatic artery embolization (PAE) for patients with
F.B. Bende, I. Sporea, A. Popescu, R. Sirli, R. Mare, R. Lupusoru; high surgical risk, prostatic hyperplasia and users of
Timisoara/RO
permanent urinary catheter
P. Largo Flores, K. Vivancos Costaleite, J. Cuesta Pérez,
14:32
A. Friera Reyes; Madrid/ES
B-1087 The performance of 2D SWE.GE compared to
transient elastography for the evaluation of liver 14:24
stiffness: preliminary results B-1097 Uterine artery embolisation for prevention and
I. Sporea, F. Bende, A. Popescu, R. Sirli, R. Mare, R. Lupusoru; treatment of obstetric bleeding
Timisoara/RO B. Abishev; Astana/KZ
14:40 14:32
B-1088 Quantitative 3T MR imaging techniques for staging B-1099 Longitudinal monitoring of hepatic blood flow before
SPEAKER
SUPPORTED liver fat steatosis and fibrosis in chronic liver and after TIPS implantation using 4D-flow MRI
BY
INVEST IN diseases: the HEPATOMAP protocol P. Bannas1, A. Roldan-Alzate2, K.M. Johnson2, O. Ozkan2,
THE YOUTH L. Cuminal1, O. Beuf1, B. Leporq2, J. Dumortier1, S. Gaillard1, V. Hervieu1, U. Motosugi2, O. Wieben2, G. Adam1, S.B. Reeder2, H. Kramer3;
O. Guillaud1, A. Muller1, P.-J. Valette1; 1Lyon/FR, 2Villeurbanne/FR 1
Hamburg/DE, 2Madison, WI/US, 3Munich/DE
14:48 14:40
B-1089 Feasibility of different b values of MRI diffusion in B-1100 Use of GnRH-agonist therapy in patients affected
quantitative assessment of liver fibrosis by uterine fibroids treated with uterine artery
M.A. ElRefaei1, M. Refaat2, M. ElTohamy1; 1Zagazig/EG, 2Benha/EG embolizstion: MRI evaluation of necrotic area
14:56 reabsorption time and clinical outcome
F. Smaldone, F. Ferrari, F. Arrigoni, A. Miccoli, S. Carducci,
B-1090 Liver fibrosis staging with diffusion-weighted A. Giordano, C. Masciocchi; L’Aquila/IT
imaging: a systematic review and meta-analysis
J. Chen, R. Gao, B. Song; Chengdu/CN 14:48
B-1101 Visceral artery aneurysms (VAA) single center case
15:04
series in endovascular treatment using up-to-date
B-1091 Fractionally encoded 3D MR elastography in non- materials, based on 11 patients during the past 2
alcoholic fatty liver disease: comparison with years
histological grading A. Pellegrin, P. Divis, V. Gavrilovic, M. Puppato, A. Vit, M. Sponza;
J.H. Runge1, L.P. Smits1, J. Verheij1, R. Sinkus2, A.J. Nederveen1, Udine/IT
U.H. Beuers1, J. Stoker1; 1Amsterdam/NL, 2London/UK
14:56
15:12
B-1102 The effect of Dexamethasone on inflammatory
B-1092 Coefficient of variation as imaging biomarker of response after uterine artery embolisation
hepatic fibrosis in chronic hepatitis B patients on J. Kim, S. Kim, M. Kim, M. Shin, W. Shin, G. Kim, S. Park, J. Won,
Gd-EOB MRI; feasibility for prediction of HCC and D. Lee; Seoul/KR
comparison to clinical biomarker

J. Lee, G. Lee, K.-H. Yoon, Y. Lee, J. Ryu, H. Jun, T.-H. Kim; Iksan City,
15:04
Jeonbuk/KR B-1103 Effects on renal function of transcatheter
embolisation in renal bleeding
15:20 L. Spezia, C. Sozzi, A. Contro, G. Mansueto, R. Pozzi Mucelli;
B-1093 Gd-EOB-DTPA-enhanced MRI: perfusion and multi- Verona/IT
hepatocyte-phase images for the evaluation of liver

15:12
fibrosis induced by carbon tetrachloride in rats
1 1 1 1 2 1 1
J. Xu , X. Wang , Y. You , Q. Wang , H. Liu , J. Lei , H.D. Xue , Z.Y. Jin ; 1 B-1104 First experiences of prostatic artery embolisation
1
Beijing/CN, 2Shanghai/CN for large benign prostatic hyperplasia ahead of a
randomised controlled trial
A. Massmann, M. Saar, G.K. Schneider, M. Stoeckle, S. Siemer,
14:00–15:30 Room M 3 A. Buecker, C. Niklas; Homburg a.d. Saar/DE
Vascular
SS 1515 New observations in visceral imaging
and therapy
Moderators: J.I. Bilbao; Pamplona/ES, N.N.
14:00
B-1094 Pelvic artery imaging: comparison of carbon dioxide
enhanced digital subtraction angiography (CO2-DSA)
and C-Arm computed tomography (CO2-CACT)
J. Hinrichs, T. Werncke, F. Wacker, B. Meyer, C. von Falck;
Hannover/DE

14:00–15:30 Room M 4 15:12

B-1114 Increased volume of adenoids in patients with
Neuro multiple sclerosis: a MRI study
A. Pomschar, K. Moritz, F. Schwarz, T. Kümpfel, M.F. Reiser,
SS 1511 Multiple sclerosis B. Ertl-Wagner; Munich/DE
Moderators: K.-O. Løvblad; Geneva/CH, R. Woitek; Vienna/AT
15:20
14:00 B-1115 Multiple sclerosis imaging at 3-Tesla MR: comparison
B-1105 Increased cortical grey matter lesion detection between 3D-FLAIR sequence and standard T2-TSE
SPEAKER for the detection of inflammatory lesions
SUPPORTED in multiple sclerosis with 7T MRI: a postmortem
BY A.S. Alhasan1, K. Gaillot2, P. Bertrand2, A. Guennoc2, M. Lauvin2,
INVEST IN verification study
THE YOUTH I.D. Kilsdonk1, L.E. Jonkman1, R. Klaver1, S.J. Van Veluw2,
J. Cottier2; 1Madinah/SA, 2Tours/FR
P.J.W. Pouwels1, M.P. Wattjes1, P.R. Luijten2, F. Barkhof1, J.J.G. Geurts1;
1
Amsterdam/NL, 2Utrecht/NL
14:00–15:30 Room M 5
14:08
B-1106 Presence of central veins and susceptibility weighted Breast
SPEAKER
SUPPORTED imaging for evaluating lesions in multiple sclerosis
BY SS 1502 Breast density: an update
INVEST IN and leukoaraiosis
THE YOUTH U. Lamot, K. Šurlan Popovič, J. Avsenik; Ljubljana/SI Moderators: R. Schulz-Wendtland; Erlangen/DE, N.N.
14:16 14:00
B-1107 Comparison of diffusion weighted image and B-1116 BI-RADS-based subjective estimation of
enhanced T1- weighted sequence in patients with fibroglandular breast tissue with magnetic resonance
multiple sclerosis imaging: comparison to automated quantitative
A. Abolhasani Foroughi, A. Nikseresht, M. Nazeri, R. Salahi,
H. Heidari; Shiraz/IR
assessment
G.J. Wengert1, T.H. Helbich1, R. Woitek1, P. Kapetas1, P.A.T. Baltzer1,
W.-D. Vogl1, M. Weber1, A. Meyer-Baese2, K. Pinker-Domenig1;
14:24 1
Vienna/AT, 2Tallahassee, FL/US
B-1108 Real-time elastography for the assessment of
spasticity: our experience in multiple sclerosis 14:08
patients B-1117 Breast density measurements with ultrasound
G. Illomei, G. Coghe, J. Frau, G. Spinicci, M. Marrosu; Cagliari/IT tomography: a comparison with non-contrast MRI
E. O’flynn1, J. Fromageau1, A. Ledger1, A. Messa1, A. D’Aquino1,
14:32 M. Schmidt1, N. Duric2, A. Swerdlow1, J. Bamber1; 1Sutton/UK, 2Detroit,
MI/US
B-1109 Association of MR features, clinical presentation and
levels of matrix metalloproteinases in patients with 14:16
clinically isolated syndrome and relapsing remiting B-1118 Mammographic breast density and HER2
multiple sclerosis overexpression assessment improves the Nottingham
D. Stojanov, S. Jjubisavljevic, I. Stojanovic, S. Vojinovic; Nis/RS
Prognostic Index prognostic ability in patients with
14:40 invasive breast cancer
A.N.J. Masarwah, P. Auvinen, M. Sudah, V. Dabravolskaite,
B-1110 Normal-appearing white matter hypoperfusion in
O. Arponen, A. Sutela, S. Oikari, V.-M. Kosma, R. Vanninen; Kuopio/FI
multiple sclerosis: assessment with DCE MRI
M. Ingrisch1, S. Sourbron2, M. Schneider1, S. Herberich1, T. Kümpfel1, 14:24
Saturday
R. Hohlfeld1, M.F. Reiser1, B. Ertl-Wagner1; 1Munich/DE, 2Leeds/UK
B-1119 Error in recorded compressed breast thickness
14:48 measurement impacts on volumetric density
B-1111 Atrophy and other MRI-parameters as predictors of classification
G.G. Waade1, R. Highnam2, I.H.R. Hauge1, M.F. McEntee3,
neurological deficit in relapsing remitting multiple
S. Hofvind1, E. Denton4, J.F. Kelly5, J.J. Sarwar6, P. Hogg6; 1Oslo/NO,
sclerosis: a 3-year follow-up study 2
Wellington/NZ, 3Sydney/AU, 4Norfolk/UK, 5Chester/UK,
I. Krotenkova, V. Bryukhov, M. Zakharova, M. Krotenkova, 6
Salford/UK
S. Morozova, L. Askarova; Moscow/RU
14:32
14:56
B-1120 Disagreement between the 4th and 5th editions of
B-1112 Longitudinal analysis of imaging biomarkers from MR
the BI-RADS density lexicon
segmentation of white matter lesion in patients with M. Abdolell1, K.M. Tsuruda1, S.E. Iles1, J. Caines1, C.B. Lightfoot1,
multiple sclerosis P. Brown1, S.A. Raza2, G.H. Schaller1; 1Halifax, NS/CA, 2Sydney, NS/CA
L. Lajarín Cano, J. Tomás Cucarella, A. Alberich-Bayarri, B. Casanova,
L. Marti-Bonmati; Valencia/ES 14:40
B-1121 Decrease of breast density in BRCA patients
15:04
following oophorectomy, using Volpara software
B-1113 Assessment of the diagnostic accuracy of double A. Lecler, A. Dunant, C. Dromain, S. Delaloge, O. Caron,
inversion recovery sequence in comparison with C. Balleyguier; Paris/FR
FLAIR and T2W_TSE in detection of brain multiple
14:48
sclerosis plaques
1 1 2 1 2
Z. Abidi , F. Faeghi , Z. Mardanshahi ; Tehran/IR, Sari/IR B-1122 The impact of breast density on radiologist fixation
time in mammography
W. Alomaim1, D. O’Leary2, J. Ryan1, L. Rainford1, S. Foley1; 1Dublin/IE,
2
Hertfordshire/UK

14:56
B-1123 Is mammographic breast density related to breast
SPEAKER
SUPPORTED cancer risk based on personal/family history?
BY I. Ioan1, A. Pisani Mainini1, C. De Angelis1, I. Riva2, G. Di Leo2,
INVEST IN
THE YOUTH F. Sardanelli2; 1Milan/IT, 2San Donato Milanese/IT
15:04
B-1124 Classification of mammographic densities and breast
cancer risk: results from the Egyptian national breast
screening study
N.A.M. Chalabi; Cairo/EG
15:12
B-1125 Agreement between radiologists’ visual assessments
and automated software: BI-RADS 5th edition density
classifications
M. Abdolell1, K. Tsuruda1, S.E. Iles1, J. Caines1, C.B. Lightfoot1, P. Brown1,
S.A. Raza2, G. Schaller1; 1Halifax, NS/CA, 2Sydney, NS/CA
15:20
B-1126 Background parenchymal enhancement is not
associated with breast cancer in a non-high-risk
population
B. Bennani-Baiti1, M. Dietzel2, P.A.T. Baltzer1; 1Vienna/AT,
2
Erlangen/DE

10:30–12:00 Room C 11:51

B-1136 Does previous reader performance in a test
Breast set of DBT images predict performance in a
retrospective reading trial using DBT in addition to
SS 1802 Digital breast tomosynthesis: an update
mammography?
Moderators: T. Knogler; Vienna/AT, A. Selim; Cairo/EG E.F. Harkness1, S. Astley1, L. Tucker2, S. Duffy3, F.J. Gilbert2;
1
Manchester/UK, 2Cambridge/UK, 3London/UK
10:30
T.H. Helbich; Vienna/AT 10:30–12:00 Room Z
10:39
Computer Applications
B-1127 A comparison of FFDM and synthetic 2D images with
DBT: which images do readers prefer for assessment SS 1805 Image processing techniques (2)
of different radiological features? Moderators: A. Alberich-Bayarri; Valencia/ES, U. Bick; Berlin/DE
1 1 2 2 1
L. Tucker , S. Ramasundara , J. Myles , S.W. Duffy , F.J. Gilbert ;
1
Cambridge/UK, 2London/UK
10:30
10:47 B-1137 Automated volumetric lesion quantification in
B-1128 The influence of inmuhistochemical patterns of automated 3D breast ultrasound: comparison of 5
breast tumours in the detection of additional cancers breast lesion segmentation algorithms
O. Diaz1, R. Agarwal1, A. Gubern-Merida2, J. van Zelst2, Y. Diez3,
by digital breast tomosyntesis and ultrasound R. Martí1; 1Girona/ES, 2Nijmegen/NL, 3Sendai/JP
1 1 2
J.M. Madrid , M. Caballeros , P. Matínez-Miravete ,
N. Rodriquez-Spiteri1, A. Elizalde1, L. Pina1; 1Pamplona/ES,
2
10:38
Zaragoza/ES
B-1138 Computerised image quality assessment in
10:55 automated 3D breast ultrasound images
B-1129 Digital breast tomosynthesis: is peritumoral fat an J. Schwaab1, A. Malavé Dos Santos1, Y. Diez2, R. Martí2, J. van Zelst3,
A. Bensouda Mourri4, J. Gregori1, M. Günther5; 1Heidelberg/DE,
ally in breast cancer detection? 2
Girona/ES, 3Nijmegen/NL, 4Brussels/BE, 5Bremen/DE
J.M. Madrid, F.M. Caballeros, P. Garcia-Barquin, M. Millor, L. Pina,
A. Elizalde; Pamplona/ES
10:46
11:03 B-1139 Displaying inguinal lymph nodes prior to
B-1130 Synthetic mammography (SM) reconstructed from transplantation in a deep inferior epigastric
digital breast tomosynthesis (DBT): has anything perforator flap breast reconstruction using an
changed in the BI-RADS category assignment? innovative projection method
M. Fasciano, M. Durando, G. Mariscotti, F. Esposito, C. Casella, S. Hummelink, L.J. Schultze Kool, D.J.O. Ulrich; Nijmegen/NL
P. Campanino, P. Fonio, G. Gandini; Turin/IT
10:54
11:11 B-1140 Automated nipple detection in 3D breast ultrasound
B-1131 Reduction in digital breast tomosynthesis scans
interpretation time by slabbing of the reconstructed M. Costa1, D. Ermacora2, S. Pesente3, A. Nicolucci4, S. Kus1, R. Longo1;
1
Trieste/IT, 2Udine/IT, 3Turin/IT, 4Firenze/IT
slices
G. Agasthya1, C.J. D’Orsi1, A. Holbrook1, C. Ho1, M. Piraner1, M. Newell1,
11:02
L. Gilliland1, I. Sechopoulos2; 1Atlanta, GA/US, 2Nijmegen/NL
B-1141 1D-histogram feature analysis of the apparent
11:19 diffusion coefficient improves diffusion-weighted
B-1132 Digital breast tomosynthesis: thick vs thin slices - imaging for lymph node characterisation in cervical
clinical performance and reading time cancer
A. Stork, D.F. Seitz, E. Wegjan, P. Begemann, J. Kemper; I.F. Vieira1, M. Koole1, F.D. Keyzer1, E. Dresen1, S. Han1, I. Vergote1,
Düsseldorf/DE F. Amant1, F.R.A. Lima2, V. Vandecaveye1; 1Leuven/BE, 2Recife/BR
11:27 11:10
B-1133 Comparison of lesion detection and characterisation B-1142 Texture analysis with CT in GIST tumours: correlation
of benign and malignant masses with digital with mitotic index and risk’s assessment
mammography, synthesised 2D mammography (SM) F. Carbonetti1, G. Quarta Colosso1, C. Briani1, A. Laghi2, M. Rengo2,
V. David1, E. Iannicelli1; 1Rome/IT, 2Latina/IT
and digital breast tomosynthesis (DBT)
Sunday
L. Sinn, K. Wong, T. Lam, S. Lam, V. Lau, J. Ip, G. Ho, J. Leung,

11:18
W. Lam; Hong Kong/HK
B-1143 A new ultrasound-based method to detect liver
11:35 steatosis using CT as reference standard
B-1134 Assessment of the extent of microcalcifications to L.C. Pescatori1, R. Casale2, C. Messina1, F.M. Doniselli1,
G. Di Leo3, F. Sardanelli3, L.M. Sconfienza3; 1Milan/IT, 2Rome/IT,
predict the size of a DCIS: comparison between 3
San Donato Milanese/IT
tomosynthesis and conventional mammography
N. Berger, S. Dubach-Schwizer, Z. Varga, C. Rageth, T. Frauenfelder, 11:26
A. Boss; Zurich/CH
B-1144 Software for CT-based quantification of abdominal
11:43 adipose tissue: preliminary evaluation in normal
B-1135 Digital breast tomosynthesis vs mammography: weight patients
A. Schaudinn, A. Hudak, N. Linder, N. Garnov, G. Stocker, U. Hacker,
which modality provides more accurate prediction of T. Kahn, H. Busse; Leipzig/DE
margin status in specimen radiography?
H. Amer1, F. Schmitzberger1, J. Kussmaul1, M.F. El Tohamy2,
H.I. Tantawy2, E.M. Fallenberg1; 1Berlin/DE, 2Zagazig/EG

11:34 11:26
B-1145 Automatic segmentation of visceral fat in 7T MRI of B-1155 Magnetic resonance evaluation of myocardial and
mice liver iron deposition using T1 and T2* mapping
P. Marra, S. Antunes, T. Canu, F. De Cobelli, C. Tacchetti, A. Esposito, methods: a phantom study
A. Del Maschio; Milan/IT T. Kaasalainen, J. Peltonen, M. Soikkeli, S. Heikkinen, M. Timonen,
O. Sipilä; Helsinki/FI
11:42
B-1146 A novel method for the assessment of joint space 11:34
width and subchondral bone micro architecture B-1156 Reproducibility of native and contrast-enhanced CMR
R. Ljuhar1, H. Canhão2, J. Branco2, A. Rodrigues2, N. Gouveia2, techniques to measure lesion size following acute
J. Hladuvka1, T. Haftner1, D. Ljuhar1, B. Norman1, S. Nehrer3,
A. Fahrleitner-Pammer4, H.-P. Dimai4; 1Vienna/AT, 2Lisbon/PT, myocardial infarction
3
Krems/AT, 4Graz/AT E. Tahir, M. Sinn, M. Avanesov, J. Wien, D. Saering, U.K. Radunski,
K. Muellerleile, G. Adam, G.K. Lund; Hamburg/DE
11:50
11:42
B-1147 Joint space mapping: a novel platform for
B-1158 Patients without aortic disease and with aortic
multiparametric quantitative 3D joint analysis from
dissection using velocity encoding 4D MRI:
multimodal cross-sectional imaging data
T.D. Turmezei, A.H. Gee, K.E.S. Poole, G.M. Treece; Cambridge/UK assessment of wall shear stress and peak velocity
A. Huber, J. Rudolph, M. Rasper, A. Sträter, M. Settles, C. Reeps,
H.-H. Eckstein, E.J. Rummeny; Munich/DE
10:30–12:00 Room N
10:30–12:00 Studio 2016
Cardiac
Oncologic Imaging
SS 1803 MR (1)
Moderators: K. Pagonidis; Iraklion/GR, N.N. SS 1816 Gastrointestinal cancer: prediction and
10:30 assessment of therapeutic response
B-1148 4D flow MRI in stented versus stentless aortic valve Moderators: S. Battisti; Rome/IT, N.N.
bioprosthesis at 1 year after surgery 10:30

F. van Kesteren, L.W.L.M. Wollersheim, J. Baan Jr., A. Nederveen,
B.A.J.M. de Mol, P. van Ooij, R.N. Planken; Amsterdam/NL B-1160 Long-term follow-up features on rectal MRI during
‘wait-and-see’ in clinical complete responders after
10:38 chemoradiotherapy: an update of 68 patients
B-1149 Myocardial alterations in grating-based phase- M.M. van Heeswijk1, D.M. Lambregts1, B.J.P. Hupkens1, R.C.J. Beckers1,
contrast computed tomography (gb-PCCT) M. Maas1, M.E. van der Sande2, G.L. Beets1, R.G.H. Beets-Tan1;
1
S. Notohamiprodjo1, N. Webber1, L. Birnbacher2, M. Willner2, Maastricht/NL, Amsterdam/NL, 2Amsterdam/NL
J. Herzen2, D. Mayr1, H. Bartsch1, T. Saam1, H. Hetterich1; 1Munich/DE,
2
Garching/DE 10:38
B-1161 Comparison of perfusion parameters calculated from
10:46 dynamic volume perfusion CT and perfusion MRI in
B-1150 Real-time SPARSE-SENSE cine imaging in atrial patients with rectal cancer
fibrillation: a feasibility study S. Sudarski, T. Floss, T. Gaa, U. Attenberger, H. Haubenreisser,
J. Goebel, E. Tezgah, F. Nensa, H.P. Schemuth, S. Maderwald, S.O. Schönberg, T. Henzler; Mannheim/DE
M. Gratz, H.H. Quick, T. Schlosser, K. Nassenstein; Essen/DE
10:46
10:54 B-1162 Application of texture analysis based on ADC maps
B-1151 Conception and realisation of a amagnetic pulsatil in discriminating different stages of rectal cancer
flow phantom to compare 2D phase contrast post L. Liu; Beijing/CN
treatment software
K. Warin-Fresse1, P. Guérin1, B. Guyomarc‘h Delassale1, D. Le Touze1, 10:54
T. Senage1, J. Dacher2; 1Nantes/FR, 2Rouen/FR B-1163 Clinical assessment of diffusion-weighted MRI for
restaging rectal cancer: is there a learning curve?
11:02 M.M. van Heeswijk1, D.M. Lambregts2, L. Andrade3, M. Maas1,
B-1152 SPARSE-SENSE cine imaging with high spatial G.L. Beets1, R.G.H. Beets-Tan1; 1Maastricht/NL, Amsterdam/NL,
2
and high temporal resolution for left ventricular Maastricht/Amsterdam/NL, 3Coimbra/PT, Maastricht/NL
functional assessment 11:02

J. Goebel, F. Nensa, H.P. Schemuth, S. Maderwald, M. Gratz,
H.H. Quick, T. Schlosser, K. Nassenstein; Essen/DE B-1164 MRI of rectal cancer: pathologic correlation of
preoperative tumour staging
11:10 T. Rostovtseva, N. Ananyeva, S. Vasilyev, E. Smirnova, R. Ezhova;
B-1153 Native slice-averaged T1 mapping as screening tool St. Petersburg/RU
for diffuse cardiac pathologies 11:10

J. Goebel, I. Seifert, F. Nensa, H.P. Schemuth, S. Maderwald,
T. Schlosser, C. Jensen, K. Nassenstein; Essen/DE B-1165 Dynamic contrast enhanced MRI in rectal cancer:
tumours with poor prognosis show low vascularity
11:18 M. Maas1, G. Shakirin2, D.M. Lambregts1, M. Weibrecht2, M. Perkuhn2,
B-1154 Myocardial T1 mapping in asymptomatic subjects: M. Martens1, R. Dijkhoff1, G. Beets3, R.G.H. Beets-Tan3; 1Maastricht/NL,
2
Aachen/DE, 3Amsterdam/NL
variations according to left ventricular segments and
correlation with cardiovascular risk factors
Y. Kim, M. Kim, H. Kim, Y. Choe, S. Cho, S. Kim, S.-C. Lee; Seoul/KR

11:18 11:03
B-1166 Multiparametric functional imaging assessment of B-1173 Low kV CT-angiography (CTA) with low contrast
primary rectal cancer: correlation between diffusion, medium volume using a 256 MDCT scanner in the
perfusion, magnetisation transfer and signal intensity evaluation of abdominal aorta disease: diagnostic
measurements quality and radiation dose reduction
D.M. Lambregts1, G. Shakirin2, M. Maas1, M. Weibrecht2, M.J. Lahaye3, C.R.G.L. Talei Franzesi, D. Ippolito, D. Fior, C. Cangiotti, G. Brembilla,
M.M. van Heeswijk1, G.L. Beets1, M. Perkuhn2, R.G.H. Beets-Tan1; S. Sironi; Monza/IT
1
Maastricht/NL, Amsterdam/NL, 2Aachen/DE, 3Amsterdam/NL
11:11
11:26 B-1174 CT angiography in long-term follow-up after
B-1167 Anal cancer: local response assessment using MRI at endovascular aneurysm repair (EVAR) - combined
3 and 6 month post chemoradiotherapy dose reduction techniques
R. Kochhar, A.G. Renehan, D. Mullan, B. Chakrabarty, B.M. Carrington; R.A. Rotzinger, J. Kahn, G. Böning, B. Hamm, F. Streitparth;
Manchester/UK Berlin/DE
11:34 11:19
B-1168 Assessment of rectal tumour height and length on B-1175 CT vs. PET-CT: correlations and differences in the
MRI: effect of using DWI instead of T2-weighted MRI diagnosis of aorto-iliac prosthetic vascular graft
M.M. van Heeswijk1, D.M. Lambregts1, L. den Ouden2,
M.C. Ageitos-Casais3, M. Maas1, G.L. Beets1, R.G.H. Beets-Tan1; infections
1
Maastricht/NL, Amsterdam/NL, 2Maastricht/NL, D. Klug, W.J. Hofmann, A. Becherer, M. Cejna; Feldkirch/AT
3
Santiago de Compostela/ES, Maastricht/NL
11:27
11:42 B-1176 Isolated iliac artery aneurysms: a single centre
B-1169 Preoperative CT and MRI prediction of non- experience
resectability in patients treated for pseudomyxoma G. Leale, R. Fossaceca, G. Guzzardi, P. Cerini, I. Divenuto, G. Parziale,
A. Carriero; Novara/IT
peritonei from mucinous appendiceal neoplasms
B. Menassel1, A. Duclos1, G. Passot1, A. Dohan2, C. Payet1, S. Isaac1,
P.-J. Valette1, O. Glehen1, P. Rousset1; 1Lyon/FR, 2Paris/FR
11:35
B-1177 The evaluation of different tube voltages
multidetector CT angiography in assessment of aorta
10:30–12:00 Room L8 and lower peripheral arterial occlusive disease
D. Zhang, H. Xue, X. Wang, Z. Jin; Beijing/CN
Vascular
11:43
SS 1815 Abdominal aortic and other aneurysms B-1178 Comparison of different virtual monoenergetic
Moderators: I. Bargellini; Pisa/IT, E. Brountzos; Athens/GR and linear-blended algorithms for dual-energy CT
angiography of the thorax and abdomen: effects on
10:30 contrast and image quality
K-32 Keynote lecture M.H. Albrecht1, S.S. Martin2, J.-E. Scholtz2, N.-E.A. Nour-Eldin2,
E. Brountzos; Athens/GR S. Fischer2, R.W. Bauer2, U.J. Schoepf1, T.J. Vogl2, J.L. Wichmann2;
1
Charleston, SC/US, 2Frankfurt am Main/DE
10:39
11:51
B-1170 Investigation of reference levels and radiation dose
associated with abdominal EVAR (endovascular B-1179 The prevalence of posterior circumflex humeral
aneurysm repair) procedures across several European artery aneurysms in elite volleyball players
D. van de Pol, P.P.F.M. Kuijer, M. Pannekoek-Hekman, A. Terpstra,
centres M. Maas, R.N. Planken; Amsterdam/NL
E. Tuthill1, L. O’ Hora1, M. O’ Donohoe1, S. Panci2, D. Campion3,
R. Trenti4, E. Fox1, D. Catania5, L. Rainford1; 1Dublin/IE, 2Florence/IT,
3
Turin/IT, 4Bologna/IT, 5Milan/IT
10:30–12:00 Room E1
10:47
B-1171 Does dynamic volumetric CT angiography of Musculoskeletal
endoleak after endovascular aortic aneurysm
repair using 320-detector row CT add additional
SS 1810 Ligaments, tendons and joints
Moderators: A.H. Karantanas; Iraklion/GR, A. Sachs; Vienna/AT
information with dynamic CT angiography?
M. Inoue, Y. Yamada, M. Tamura, S. Nakatsuka, S. Oguro, M. Jinzaki;
Sunday
Tokyo/JP
10:30
10:55 M.F. Reiser; Munich/DE
B-1172 Preliminary validation of a new protocol in EVAR

10:39
follow-up: digital tomosynthesis and CEUS vs
B-1180 MRI of the painful carpal boss: variations at the
computed tomography angiography SPEAKER
S. Guerrini1, M.A. Mazzei1, F.G. Mazzei1, N. Cioffi Squitieri1, SUPPORTED extensor carpi radialis brevis insertion and imaging
BY
G. de Donato1, G. Galzerano1, F. Setacci2, C. Setacci1, L. Volterrani1; INVEST IN findings in regional traumatic and overuse injuries
1
Siena/IT, 2Rome/IT THE YOUTH M.T. Nevalainen1, J.B. Roedl2, W.B. Morrison2, A.C. Zoga2; 1Oulu/FI,
2
Philadelphia, PA/US
10:47
B-1181 Cone-beam CT in diagnosis of scaphoid fractures
R. Edlund, M. Skorpil, G. Lapidus, J. Backlund; Stockholm/SE

10:55 10:55
B-1182 Structured reporting vs free-text reporting of MRI B-1192 Early cervical spine degenerative changes in MS
examinations of the shoulder: impact on surgical patients under 35 years of age
planning T. Almansoori, R. Glikstein, P. Hamagandi, S. Patro, C. Torres,
W.H. Sommer, M. Armbruster, M.F. Reiser, F. Haasters, T. Helfen, B. Schwarz; Ottawa, ON/CA
N. Sommer; Munich/DE
11:03
11:03 B-1193 CT findings predict clinical outcome after dynamic
B-1183 MRI features of acute gouty arthritis on top of posterior stabilisation in patients with painful
chronic gouty involvement in different joints segmental instability of the lower spine
Y. Ragab, Y. Emad; Cairo/EG B.J. Schwaiger, A.S. Gersing, M. Behr, C. Zimmer, F. Ringel, J.S. Bauer;
Munich/DE
11:11
B-1184 Diagnostic value of CT arthrography at the ankle 11:11
P.M. Jungmann, J.S. Bauer, T. Baum, S. Braun, C. Holwein, B-1194 MRI criteria for disease management decision in
E.J. Rummeny, A.B. Imhoff, K. Wörtler; Munich/DE patients with herniated intravertebral discs
A. Smirnova1, A. Tkachev2, N. Plakhotina1, D. Archakov2;
11:19 1
St. Petersburg/RU, 2Volgograd/RU
B-1185 The importance of the talonavicular ligament in ankle
sprain 11:19
M. De Dea, G.M. Allen, M. Watson, D.J. Wilson; Oxford/UK B-1195 Dynamic DTI of the cervical spine shows diffusivity
changes in healthy subjects
11:27 F.P. Kuhn, A. Feydy, N. Launay, M.-M. Lefèvre-Colau, S. Poiraudeau,
B-1186 Assessment of hindfoot malalignment using S. Laporte, P. Lindberg; Paris/FR
MRI: evaluation of the apparent moment arm

11:27
measurements (Saltzman view) on non-weight-
B-1196 Anterior screw fixation of traumatic type 2 odontoid
bearing coronal MR images
1 2 2 2 1
N.E. Bueber , A. Frigg , M. Zanetti , N. Mamisch-Saupe ; Grabs/CH, fractures with Xper-CT and fluoroscopic. Our
2
Zurich/CH preliminary experience in angiographical suite
D. Leni, F. Vacirca, D. Fior, A. Vimercati, D. Ippolito, P. Allegranza,
11:35 R. Corso; Monza/IT
B-1187 Magnetic resonanace imaging findings in early

11:35
stage diabetic foot and correlation with etiologies
B-1197 Automated adaptive multiplane-multiangle oblique
vasculopathy and neuropathy
I. Karalok, L. Ulusoy; Istanbul/TR (AAMO) rendering of volumetric spine CT
N. Titelbaum, I. Corcuera-Solano, A. Doshi, P. Pawha,
L.N. Tanenbaum; New York, NY/US
11:43
B-1188 CAIPIRINHA acceleration for rapid high-spatial- 11:43
SPEAKER
SUPPORTED resolution isotropic 3D MRI of the ankle B-1198 Changes of mental imaginary motor task fMRI
BY V. Kalia1, G.K. Thawait2, R. Johnson3, W.D. Gilson2, E. Raithel4, J. Fritz2;
INVEST IN activation in chronic spinal cord injury treated by
THE YOUTH 1
South Burlington, VT/US, 2Baltimore, MD/US, 3Cary, NC/US,
4
Erlangen/DE intrathecal baclofen
J. Keller, R. Jech, I. Stetkarova; Prague/CZ
11:51
B-1189 MR finding of peroneal tendon subluxation: a key 11:51
structure of fibrous ridge B-1199 Magnetic resonance image findings of adjacent
Y. Kobashi, A. Baba, Y. Nozawa, S. Yamazoe, T. Mogami; Chiba/JP segment degeneration in isthmic and degenerative
spondylolisthesis
O. Elibol1, B. Guclu1, M. Tiryaki1, K.Y. Safak1, A.Y. Demirci2, B. Kömür1,
10:30–12:00 Room E2 E. Gur1, D. Gulabi1, T. Baysal1; 1Istanbul/TR, 2Bursa/TR
Neuro
10:30–12:00 Room F2
SS 1811 Spine
Moderators: S. Morozova; Moscow/RU,
SS 1813 Practical radiation risk management
10:30 Moderators: M. Koutalonis; Colchester/UK,
K-30 Keynote lecture R.W.R. Loose; Nürnberg/DE
10:30
10:39 B-1200 Effect of the topogram projection angle on organ
B-1190 Correlation of age- and gender-dependent bone dose in chest CT with tube current modulation
marrow fat of the lumbar spine with body fat N. Saltybaeva, H. Alkadhi; Zurich/CH
measures: an MRI study using water-fat separation

10:38
MRI in a healthy population with normal BMI
E. Dappa, L. Filli, D. Nanz, M.A. Fischer, E.J. Ulbrich; Zurich/CH B-1201 Impact of the scout view orientation on the
radiation exposure and image quality in thoracic and
10:47 abdominal CT
B-1191 Dynamic lumbar myelography using EOS imaging: S. Suntharalingam, A. Wetter, N. Guberina, J. Theysohn,
A. Ringelstein, T. Schlosser, M. Forsting, K. Nassenstein; Essen/DE
validation against computed radiography (CR)
F.P. Kuhn, S. Hammoud, G. Corcos, S. Charlon, N.-E. Regnard,
M.-M. Lefèvre-Colau, J.-L. Drapé, A. Feydy; Paris/FR

10:46 10:47
B-1202 Scan direction and scout acquisition influences the B-1212 Endobronchial valve treatment in pulmonary
dose reducing effect of automatic tube current emphysema: is objective evaluation of the best target
modulation in CT lobe with quantitative CT beneficial for outcome?
C. Franck, K. Bacher; Ghent/BE F. Doellinger1, A. Poellinger2, R.-H. Huebner1, J.-M. Kuhnigk3,
D. Herzog1, C. Thomsen1, V. Schreiter1, D. Theilig1; 1Berlin/DE,
2
10:54 Berne/CH, 3Bremen/DE
B-1203 Impact of automated attenuation-based tube voltage

10:55
selection on radiation dose at CT: an observational
B-1213 Association between 18F-FDG-PET/CT metabolic
study on a global scale
F. Meinel1, J. Spearman2, U.J. Schoepf2, M. Rottenkolber1, I. Driesser3, activity and CT density of the aortic wall and severity
C. Canstein4, K. Thierfelder1, A. Krazinski2, C. De Cecco5; 1Munich/DE, of lung emphysema
2
Charleston, SC/US, 3Forchheim/DE, 4Malvern, PA/US, 5Rome/IT A. Marin, A. Gangi, J. Murchison, W. MacNee, E. van Beek,
S. Mirsadraee; Edinburgh/UK
11:02
B-1204 Variable SD scanning for dose reduction in chest, 11:03
abdomen and pelvic CT B-1214 Rib fractures: a common comorbidity in COPD
M. Paravasthu, S. Kandel, C. Farrell, P. Rogalla; Toronto, ON/CA A. Rai, R. Rubtsov, C. Brunner, M. Wielpütz, T. Muley, R. Eberhardt,
M. Eichinger, H.-U. Kauczor, C.P. Heußel; Heidelberg/DE
11:10
11:11
B-1205 Breast bismuth shielding in coronary CT angiography:
B-1215 Chemotherapy induced interstitial pneumonitis: thin-
is it worth it?
N. Moraitis, K. Perisinakis, K. Pagonidis, A. Tzedakis, J. Damilakis; section CT characteristics and longitudinal CT follow-
Iraklion/GR up
L. Han Na, M. Kim; Seoul/KR
11:18
B-1206 Assessment of diagnostic low dose CT chest 11:19
protocols in the province of Nova Scotia B-1216 Influence of exposure parameters and iterative
E. Tonkopi, D. Manos, M. Abdolell; Halifax, NS/CA reconstruction on automatic airway degmentation
and analysis on MDCT: an ex-vivo phantom study
11:26 P. Leutz1, O. Weinheimer1, M. Lederlin2, H.-U. Kauczor1, C.P. Heussel1,
B-1207 Low dose CT protocol optimisation for the M.O. Wielpütz1; 1Heidelberg/DE, 2Rennes/FR
assessment of acute appendicitis: a phantom study

H. Niiniviita, J. Virtanen; Turku/FI
11:27
B-1217 Relationship between CT patterns of lung injury
11:34 and serum N-terminal-peptide type III procollagen
B-1208 An investigation into the impact of the ‘anode (NT-PCP-III) in patients with severe acute respiratory
heel effect’ on patient gonadal dose in AP pelvis distress syndrome (ARDS)
radiographic examination A. Nair, L. Camporata, N.A. Barrett, N. Sharma, S.R. Desai;
H.A.A.B. Mraity, A. England, P. Hogg; Salford/UK London/UK
11:42 11:35
B-1209 Ultra-low dose chest CT: lung dose and radiation- B-1218 The identification of systemic integrin activation in
induced cancer risk reduction idiopathic and systemic sclerosis pulmonary fibrosis
N. Saltybaeva, H. Alkadhi; Zurich/CH using 18F-fluciclatide positron emission tomography
S. Mirsadraee, A. Marin, W. Jenkins, M. Connell, A. Tavares,
11:50 A. Fletcher, N. Hirani, E.J. van Beek; Edinburgh/UK
B-1210 Comparison of radiation exposure associated
11:43
with intraoperative CBCT and follow-up MDCT for
B-1219 Diagnostic contribution of HRCT in the diagnosis
evaluating EVAR procedures
A. Steuwe, P. Geisbüsch, C.J. Schulz, D. Böckler, H.-U. Kauczor, and differentiation of interstitial lung diseases using
W. Stiller; Heidelberg/DE ICOERD visual grading score and Bayes’ rule for post
hoc probability prediction
C. Weber1, K. Peldschus1, G. Adam1, K.F. Rabe2, L. Welker2,
10:30–12:00 Room D1 T.H. Schroeder1; 1Hamburg/DE, 2Grosshansdorf/DE
Chest 11:51
Sunday
B-1220 Chest x-ray and CT aspects of lung involvement in

SPEAKER
SS 1804 COPD and infiltrative lung diseases SUPPORTED microscopic polyangiitis
BY M. Robella, R. Placido, G. Cortese, G. Quattrocchio, D. Roccatello;
Moderators: D. Kienzl-Palma; Vienna/AT, N.N. INVEST IN
THE YOUTH Turin/IT
10:30
P.A. Grenier; Paris/FR
10:39
B-1211 Long-term effect of smoking cessation on
emphysema progression in smokers-at-risk in a lung
cancer screening population
B. Jobst, M. Trauth, O. Weinheimer, N. Becker, S. Delorme,
H.-U. Kauczor, M. Wielpütz; Heidelberg/DE

10:30–12:00 Room D2 10:30–12:00 Room K
Interventional Radiology Genitourinary

SS 1809 Peri- and postprocedural imaging SS 1807 Tumours of the urinary tract and
Moderators: A. Bharadwaz; Aarhus/DK, A.D. Kelekis; Athens/GR adrenals
Moderators: G. Heinz-Peer; St. Pölten/AT,
10:30 R. Huzjan Korunić; Zagreb/HR
B-1222 Dynamic 4D-CT angiography of the upper abdomen
for guiding TACE: impact on reduction of contrast 10:30
material, operator radiation exposure, catheter B-1232 CT prediction of histologic grade of small clear cell
consumption and diagnostic confidence renal cell carcinoma
M.H. Albrecht, T.J. Vogl, J.L. Wichmann, S. Fischer, K. Sim, D. Sung, S. Choi, N. Han, B. Park, M. Kim, S. Cho; Seoul/KR
R. Hammerstingl, M. Harth, A. Thalhammer, S. Zangos, R.W. Bauer;
Frankfurt a. Main/DE 10:38
B-1233 Evaluation of enhancement degree in small
10:38
renal masses using multiphasic CT scan: can we
B-1223 A novel approach to predict local tumor progression discriminate between renal cell tumours and
for hepatocellular carcinoma after radiofrequency oncocytomas?
ablation: 3D measurement of tumor area exposed to M. Di Carlo, C. Gaudiano, F. Busato, A. Poerio, S. Pucci, R. Golfieri;
post-ablation margins Bologna/IT
A. Hocquelet1, H. Trillaud1, P. Balageas1, N. Frulio1, C. Salut1,
B. Denis de Senneville2; 1Bordeaux/FR, 2Talence/FR 10:46
B-1234 Clear cell adenocarcinoma of the urethra: MR
10:46
image findings for differentiation from non-
B-1224 Real-time 3D MPI-guided angioplasty using an MRI adenocarcinomas
road map and blood pool agent approach: next steps T. Kim, S. Kim, K. Moon, S. Woo, J. Cho, S. Kim; Seoul/KR
towards interventional MPI
J. Salamon, M. Hofmann, C. Jung, M.G. Kaul, R. Reimer, 10:54
A. vom Scheidt, G. Adam, T. Knopp, H. Ittrich; Hamburg/DE B-1235 Can quantitative CT texture analysis be used to
10:54 differentiate between low- and high-grade urothelial
carcinoma?
B-1225 CT-guided radiopharmaceutical marking of lung G.-M. Zhang, H. Sun, H.-D. Xue, Z.-Y. Jin; Beijing/CN
nodules: technical and results
C. Grassi Zamora, M. de Albert, G. Solana Tubau, F. Martinez Torrens, 11:02
E. Carreño G, L. Farras Roca, D. Nova Vaca; Barcelona/ES
B-1236 Qualitative assessment and quantitative assessment
11:02 for evaluation of optimal linear blending image in
B-1226 MRI evaluation of uterine morphology and clinical dual-source dual-energy CT for detection of renal
response in women treated by MRgFUS: 4 year solid mass
P. Lei1, X. Wang1, X. Wang2, J. Jiao1; 1Guiyang/CN, 2Beijing/CN
follow-up
F. Smaldone, F. Ferrari, A. Miccoli, F. Arrigoni, S. Iafrate, I. Capretti,
C. Masciocchi; L’Aquila/IT 11:10
B-1238 Complementary value of contrast-enhanced
11:10 ultrasound (CEUS) in the diagnostic algorithm of
B-1227 Dose reference levels in paediatric interventional complex renal cysts
radiology E. Raimondi, M. Bassi, Z. Ferrante, M. Tilli, S. Dall’ara, R. Rizzati,
B. Habib Geryes1, A. Bak2, O. Naggara1, F. Brunelle1, G. Saliou2; M. Giganti, G. Benea; Ferrara/IT
1
Paris/FR, 2Le Kremlin-Bicêtre/FR
11:18
11:18 B-1239 Peritoneal seeding of renal cell carcinoma: analysis of
B-1228 Value of contrast-enhanced ultrasound in guidance of histologic characteristics and prognosis
percutaneous biopsy of anterior mediastinal lesions S. Park, H. Jang, S. Park, Y. Oh, D. Jung; Seoul/KR
Y. Dong, W.-P. Wang, F. Mao, Z.-B. Ji; Shanghai/CN
11:26
11:26 B-1240 Diffusion-weighted MRI of the bladder as a biomarker
B-1229 Preliminary in vitro and in vivo results of a MR-safe for prediction of bladder cancer aggressiveness
guidewire L. Ponhold1, S. Sevcenco2, G. Heinz1, P.A.T. Baltzer2; 1St. Pölten/AT,
2
A. Massmann, A. Buecker, G.K. Schneider; Homburg a.d. Saar/DE Vienna/AT
11:34 11:34
B-1230 MRI-guided biopsies and MR-guided wire localisation B-1241 The value of chemical shift MRI in characterising
biopsies of soft tissue tumours based on contrast- adrenal incidentalomas found in routine contrast-
enhanced images enhanced CT
G. Schneider, J. Stroeder, A. Raguwaran, A. Buecker; Y.-W. Wu, C. Tan; Singapore/SG
Homburg a.d. Saar/DE
11:42
11:42 B-1242 Radiological formula for differentiating between
B-1231 FDG PET/CT guided biopsy secreting and non secreting adrenal adenomas
S. Brocchi, A. Cappelli, C. Mosconi, M. Renzulli, F. Modestino, C. Mosconi, V. Vicennati, D. Papadopoulos, R. Pasquali, R. Golfieri;
C. Nanni, T. Balbi, S. Fanti, R. Golfieri; Bologna/IT Bologna/IT

10:30–12:00 Room G 14:00–15:30 Room A
Radiographers Breast
SS 1814 Getting the radiation dose as low as SS 1902a Multiparametric breast MRI, PET
possible Moderators: E.M. Fallenberg; Berlin/DE, G. Forrai; Budapest/HU
Moderators: H. Ståhlbrandt; Eksjö/SE, F. Zarb; Msida/MT
14:00
K. Pinker-Domenig; New York, NY/US
P. Bezzina; Msida/MT
14:09
10:39 B-1253 Correlation between 3T multiparametric MRI and
B-1243 Positioning for a conventional skyline patella prognostic indicators in breast cancer
L. Camera, C. Cavedon, I. Baglio, G. Meliadò, G. Barbazeni,
projection: evaluation of torso position and its S. Montemezzi; Verona/IT
relationship with eye lens and thyroid dose
J. Li, K. Szczepura, A. Tootle, A. England; Manchester/UK 14:17
10:47 B-1254 3T MR spectroscopy in the multi-parametric MRI
evaluation of breast lesions: a pattern recognition
B-1244 The use of secondary lead rubber protection in
approach
paediatric extremity radiographic examinations C. Cavedon, L. Camera, I. Baglio, G. Meliadò, F. Caumo,
C. Bloomfield, A. England; Manchester/UK
S. Montemezzi; Verona/IT
10:55
14:25
B-1245 The impact of paediatric computed tomography tube
B-1255 Multiparametric analysis of morphologic and
current and tube voltage modulation intensity in
functional MRI signs with correlation to degree of
organ dose and image quality
M. Alves, P. Fernandes, D. Costa, G. Paulo, J. Santos; Coimbra/PT
nuclear atypia at DCIS
L. Vanovcanova, V. Lehotska, K. Rauova; Bratislava/SK
11:03 14:33
B-1246 Radiation dose reduction on lens and thyroid in B-1256 Time-signal intensity curve analysis in breast MRI: still
orthopantomography exams a role for lesion characterisation?
R.P.P. Almeida, J.R. Santos, S. Rodrigues, P. Sousa, L.P. Ribeiro,
M. Telegrafo, T. Introna, L. Coi, L. Rella, A. Stabile Ianora, G. Angelelli,
K.B. Azevedo, J.P. Pinheiro, A.F.C.L. Abrantes; Faro/PT
M. Moschetta; Bari/IT
11:11 14:41
B-1247 An investigation of how to improve recall and B-1257 The impact of incorporating Dynamic Contrast-
awareness of radiation dose levels associated with Enhanced MRI in the diagnostic workup of
cardiovascular interventional procedures
S. Mullen, J. Mc Nulty, L. O’Hora, V. Mc Guire, T. Buchanan, P. Gilligan,
inflammatory breast disorders
R.M. Kamal, E. Faker, R. Farouk, D. El Messeidy, A. Hatw; Cairo/EG
L. Rainford; Dublin/IE
14:49
11:19
B-1258 Evaluating the diagnostic sensitivity of computed
B-1248 Additional copper filtration for adult chest imaging
diffusion-weighted MR imaging in the detection of
and it’s impact on dose and image quality
N. Mekiš1, S. Foley2, G. Paulo3, T. Starc1, L. Rainford2, J. Santos3; breast cancer
1
Ljubljana/SI, 2Dublin/IE, 3Coimbra/PT E.A.M. O’Flynn, M. Blackledge, D. Collins, K. Downey, S. Doran,
S. Dumontiel, W. Mok, M.O. Leach, D.-M. Koh; Sutton/UK
11:27
14:57
B-1249 Radioprotection in thorax CT: an approach with the
B-1259 Combined evaluation of contrast-enhanced magnetic
application of bismuth breast shield
R.P.P. Almeida, E. Santos, P. Sousa, S. Rodrigues, L.P. Ribeiro, resonance imaging and diffusion weighted imaging
K.B. Azevedo, N.M. Pinto, A.F.C.L. Abrantes; Faro/PT of the breast: a multi-reader study
M.A. Marino, P. Clauser, R. Woitek, G. Wengert, P. Kapetas,
11:35 M. Bernathova, K. Pinker-Domenig, T.H. Helbich, P.A.T. Baltzer;
B-1250 Does radiation awareness of CT technologists Vienna/AT
Sunday
change, when a dose monitoring software is used for 15:05

real-time monitoring of patient dose?
C. Heilmaier, N. Zuber, D. Weishaupt; Zurich/CH
B-1260 Diffusion tensor imaging parametric 1 maps are
more accurate than grey-scale parametric ADC
11:43 maps in evaluating early response to neoadjuvant
B-1251 Radioprotection in mobile x-ray examinations chemotherapy
A.F.C.L. Abrantes, C. Rebelo, P. Sousa, S. Rodrigues, R.P.P. Almeida, E. Taberner López, J. Camps Herrero, C. Martinez Rubio,
J.P. Pinheiro, K.B. Azevedo, L.P. Ribeiro; Faro/PT J. Cano Gimeno, J. Cuevas Sanz, M. Taberner Bonastre,
J. Lorca Chapa; Alzira/ES
11:51
B-1252 Paediatric imaging radiation dose awareness and use 15:13
of referral guidelines amongst radiology practitioners B-1261 Accuracy of diffusion kurtosis imaging in
and radiographers characterisation of breast lesions
J.L. Portelli1, J. McNulty2, P. Bezzina1, L. Rainford2; 1Msida/MT, A. Christou1, A. Ghiatas2, D. Priovolos2, K. Veliou3, H. Bougias3;
1
2
Dublin/IE Doncaster/UK, 2Athens/GR, 3Ioannina/GR

15:21 15:13
B-1262 Analysis and correlation of 18F-FDG uptake in B-1271 Magnetic resonance pancreatic fat-fraction and
different immuno-histochemical subtypes of breast volume: association with obesity
carcinoma V. Cuba, A. Gimeno, G. Blasco, J. Puig, S. Pedraza, J. Fernández-Real;
H.S. Mohanty, G. Rajan Mj, K. Shirodkar, S. Kumar Gg, S. Nandikoor; Girona/ES
Bangalore/IN
15:21
B-1272 Solid pseudopapillary tumour of the pancreas:
14:00–15:30 Room B gadoxetic-acid-enhanced MRI and DWI with
emphasis on differentiation from neuroendocrine
Abdominal Viscera neoplasm
Y. Choi, C. Park, G. Han, S. Kim, N. Lee; Busan/KR
SS 1901a Benign and malignant pancreatic
diseases
Moderators: J.M. Lee; Seoul/KR, 14:00–15:30 Room C
M. Spirovski; Sremska Kamenica/RS
Breast
14:00
K-33 Keynote lecture SS 1902b Preoperative imaging, neoadjuvant
J.M. Lee; Seoul/KR chemotherapy, imaging of the axilla
Moderators: C. Dromain; Villejuif/FR, P. Panizza; Milan/IT
14:09
B-1263 Nonhypervascular pancreatic neuroendocrine 14:00
tumour: differential diagnosis from pancreatic ductal B-1273 Baseline breast evaluation with multiparametric
adenocarcinoma on MR imaging MRI: prediction of pathological complete response
S. Jeon, J. Lee, I. Joo, E. Lee, H. Park, J. Han, J. Park; Seoul/KR
to neoadjuvant chemotherapy in locally advanced
14:17 breast cancer
M. Panzeri, C. Losio, A. Palmisano, R. Cavallin, R. Maria Grazia,
B-1264 MDCT features of pancreatic neuroendocrine P. Panizza, F. De Cobelli, A. Del Maschio; Milan/IT
tumours correlate with intratumoral microvascular
density and predict tumour grade 14:08
E. Belousova, A. Glotov, D. Kalinin, G. Karmazanovsky; Moscow/RU B-1274 Can MRI features before and after neoadjuvant
14:25 chemotherapy predict surgical margins?
Q. Zhao1, O. Abeyakoon2, A. Muellner3, L. Carbonaro4, E. Sutton3,
B-1265 Insulinoma localisation with cross-sectional imaging: S. Wang1, E. Morris3; 1Shanghai/CN, 2Cambridge/UK, 3New York,
head-to-head comparison of CECT, DCE-CT and NY/US, 4San Donato Milanese/IT
multi-sequence MR
L. Zhu, H.-D. Xue, Z.-Y. Sun, H. Sun, X. Wang, Z.-Y. Jin; Beijing/CN
14:16
B-1275 Tumour volume analysis TVA vs RECIST
14:33 A. Gordon, J. Morden, A. Lim, S. Cleator; London/UK
B-1266 Localisation of CT-equivocal insulinomas: value of

14:24
multi-sequence pancreatic MR
L. Zhu, H.-D. Xue, Z.-Y. Sun, X. Wang, H. Sun, Z.-Y. Jin; Beijing/CN B-1276 Hybrid PET-MR imaging for accurate nodal staging
prior to neoadjuvant chemotherapy in breast cancer
14:41 patients - preliminary results
B-1267 Quantitative assessment of the pancreatic tumours B. Goorts, M.L. Smidt, S. Vöö, T.J.A. van Nijnatten, F.M. Mottaghy,
J.E. Wildberger, M.B.I. Lobbes; Maastricht/NL
by means of perfusion-related parameters derived
from low-dose CT perfusion 14:32
Y.I. Nerestyuk, G. Karmazanovsky, Y. Gepalova; Moscow/RU
B-1277 Preoperative planning using an MRI-US fusion
14:49 imaging system for breast-conserving surgery in
B-1268 Differentiation of heterogeneously enhancing patients with non-mass-like enhancement on breast
pancreatic lesions: key features on multiphasic MRI
T. Ando, S. Nakano, K. Fujii, J. Kousaka, Y. Mouri, R. Tetsuka, M. Goto,
multidetector CT T. Imai, T. Ishiguchi; Aichi/JP
L. Zhu, H.-d. Xue, W. Liu, X. Wang, H. Sun, Z.-y. Jin; Beijing/CN
14:40
14:57
B-1278 Contrast enhanced ultrasound in axillary sentinel
B-1269 Contrast-enhanced ultrasound with quantitative
node assessment: does risk stratification improve
perfusion analysis for early pancreatic ductal
yield
adenocarcinoma in C57BL/6 mouse model: N. Larkman, N. Sharma, I. Haigh; Leeds/UK
comparison with PET-CT
Y. Dong, W.-P. Wang, Y.-J. Jiang, J.-Y. Cao; Shanghai/CN 14:48
B-1279 Can MRI diffusion accurately detect complete
15:05
pathological response in breast cancer patients
B-1270 Diffusion weighted imaging of pancreatic
receiving neoadjuvant chemotherapy?
adenocarcinoma: which model is the most S.W.Y. Gareer, H.H.N. El Kassas, M. Helal, A. Abu Rabia,
appropriate? N. Abd El Razik, M.H. Zedan, A. Farahat; Cairo/EG
G.C. Manikis1, K. Nikiforaki1, N. Papanikolaou2, N. Albiin2, N. Kartalis2,
K. Marias1; 1Iraklion/GR, 2Stockholm/SE

14:56 14:41
B-1280 Radiologic imaging features of breast cancer B-1288 Big-data analytics and visualisation of a three-
according to the molecular subtypes year CT radiation dose optimisation program at an
M.A. Nazli, I.N. Mutlu, Ö.N. Kilickesmez, C. Kelten, D. Can Tirabulus, academic center using radiation dose monitoring
A.H. Yardimci, T.F. Cermik; Istanbul/TR
software
A. Parakh, A. Euler, S. Schindera; Basle/CH
15:04
B-1281 Diagnostic performance of standard breast MRI for 14:49
axillary nodal staging B-1289 Metal artifact reduction of hip prostheses:
T.J.A. van Nijnatten, E.H. Ploumen, B. Goorts, S. Vanwetswinkel,
P.J. Nelemans, M. Schavemaker, R.G.H. Beets-Tan, M.L. Smidt, comparison of an iterative algorithm with virtual
M.B.I. Lobbes; Maastricht/NL monoenergetic extrapolations from dual-energy CT
K. Higashigaito1, F. Angst1, V.M. Runge2, H. Alkadhi1, O. Donati1;
15:12 1
Zurich/CH, 2Berne/CH
B-1282 Axillary lymph node fine-needle aspiration biopsy
14:57
in invasive breast cancer: usefulness of adding
B-1290 DICOM and HL7 security worldwide: adoption maps
core-needle biopsy when cytological diagnosis is
and country ratings
discordant or insufficient O. Pianykh; Newton Highlands, MA/US
J. Oliver Goldaracena, C. Martinez Gamarra, V. Córdoba Chicote,
A. Verón Sánchez, M. Roca Navarro, A. Andres Mateo; Madrid/ES
15:05
15:20 B-1291 Is ISO 9001:2015 standard better for teleradiology
B-1283 Evaluation of residual tumour after neoadjuvant services for reduction of risks for patients, doctors
chemotherapy (NAC) in patients with breast cancers: and healthcare providers than the old version 2008?
P. Sögner1, T. Möller2; 1Feldkirch/AT, 2Dillingen/DE
can we settle on DWI-MR sequence?
I. Leconte, B. Lacoste, L. Fellah, M. Berliere, C. Galant, N. Michoux;
Brussels/BE
15:13
B-1292 Preliminary assessment of a radiological safety
management platform shared in six hospitals
14:00–15:30 Room Z P. Fraga, C. Benito, E. Fraile, J. Azpeitia, J. Albillos; Madrid/ES
Computer Applications 15:21

B-1293 Knowledge of radiology informatics among
SS 1905 Quality control and safety issues in radiologists and residents in training in a developing
radiology country
A. Kharat, A. Shah; Pune/IN
Moderators: R. Salvador; Barcelona/ES,
P.M.A. van Ooijen; Groningen/NL
14:00 14:00–15:30 Room O

B. Kelly; Belfast/UK Abdominal Viscera
14:09 SS 1901b Abdominal surgery: the added value of
B-1284 The adaptive statistical iterative reconstruction V radiology
technique for radiation dose reduction in abdominal Moderators: I. Dudás; Budapest/HU, D. Vorwerk; Ingolstadt/DE
CT
B. Kim, H. Kwon, J. Lee, J. Cho, J. Oh, S. Lee; Busan/KR 14:00
B-1295 Prediction of late postoperative hemorrhage after
14:17
the Whipple procedure by CT performed at early
B-1285 The feasibility of ultra-low dose 80 kVp and 20 ml postoperative periods
contrast medium pulmonary CT angiography with G. Han, S. Kim, N. Lee; Busan/KR
iterative reconstruction
J. Liu, J. Gao; Zhengzhou/CN 14:08
B-1296 Pancreatic volume and texture as radiological
14:25 SPEAKER
SUPPORTED predictors of pancreatic fistula after Whipple
B-1286 Benchmarking of CT radiation dose parameters: BY
INVEST IN procedure
Sunday
comparison of two academic institutions in THE YOUTH I. Shrainer, V. Voropaev, E. Mershina, V. Lyadov, V. Sinitsyn;
Switzerland Moscow/RU
S.T. Schindera1, R. LeCoultre2, J. Bize2, E.M. Merkle1, R. Meuli2,
F.R. Verdun2; 1Basle/CH, 2Lausanne/CH 14:16
B-1297 MR elastography for the preoperative estimation
14:33
of liver regeneration capacity in patients with
B-1287 Quality control in a radiology department by hepatocellular carcinoma after major hepatectomy
protocol standardisation and high dose justification S. Jang, J. Lee, D. Lee, I. Joo, J. Yoon, W. Chang, J. Han; Seoul/KR
T. De Bondt1, F. Zanca2, J. De Roeck1, L. Brouhon1, M. Geldof1,
F. Deferme1, P.M. Parizel1; 1Antwerp/BE, 2Diegem/BE 14:24
B-1298 Different strategies to induce hypertrophy of the
future liver remnant (FLR) in case of major hepatic
resection: a prospective comparative study in 118
patients
P. Marra, M. Venturini, C. Sallemi, F. Ratti, F. De Cobelli, L. Aldrighetti,
A. Del Maschio; Milan/IT

14:32 14:32
B-1299 Accuracy of simple approaches to assessing liver B-1309 Diagnostic performance of 3.0-T whole-heart
volume in radiological imaging coronary MR angiography performed as a part of
J.-P. Kühn, A.-M. Roloff, M.-L. Kromrey, N. Hosten, P. Heiss; routine contrast-enhanced CMR study
Greiswald/DE A. Yamada, M. Ishida, Y. Goto, M. Uno, S. Nakamori, Y. Ichikawa,
M. Nagata, K. Kitagawa, H. Sakuma; Tsu, Mie/JP
14:40
B-1300 Intraoperative constrast enhanced ultrasound and 14:40
color coded elastography for characterisation of liver B-1310 Assessment of left-ventricle non-compacted
lesions before surgical resection myocardium magnetic resonance parameters
N. Platz Batista da Silva, M. Loss, M. Hornung, C. Stroszczynski, modified by novel semi-automatic pixel intensity-
E.M. Jung; Regensburg/DE
based approach of trabeculae measurement
E. Pershina, V. Sinitsin, E. Mershina; Moscow/RU
14:48
B-1301 Biliary cast syndrome: which T1 weighted sequence 14:48
is able to show it best in patients after liver B-1311 Late gadolinium enhancement (LGE) at 1.5 and 3
transplantation? Tesla GE: can stronger fields detect more areas of
S. Kinner1, P. Hunold2, A. Dechene1, T. Lauenstein1, A. Laader1;
1
Essen/DE, 2Lübeck/DE fibrosis/necrosis? Preliminary evaluation
A. Mancini, V. Vellucci, L. Patriarca, F. Bruno, L. Panebianco, M. Paoli,
R. Masi, E. Di Cesare, C. Masciocchi; L’Aquila/IT
14:56
B-1302 Pre-operative prediction of operating time 14:56
for laparoscopic cholecystectomy using B-1312 Accuracy and time-efficiency of an automated
ultrasonographic and MRCP parameters software tool to assess left ventricular volumes in
S. Vujnovic1, D. Stojanov2; 1Banjaluka/BA, 2Niš/RS
cardiac MRI
P. Bartolome, P. Garcia Barquin, A. Quilez, M. Caballeros, J.C. Pueyo,
15:04
G. Bastarrika; Pamplona/ES
B-1303 Nutritional status as a negative prognostic
factor for postoperative complications after 15:04
pancreaticoduodenectomy B-1313 Quantification of myocardial extra-cellular volume
R. Cervelli, C. Cappelli, L. Barbarello, U. Boggi, C. Bartolozzi; Pisa/IT (ECV) in adenosine stress/rest perfusion CMR
15:12 examinations: effect of contrast dose
M. Caballeros, J. Madrid, P. Garcia Barquin, P. Bartolome, J. Pueyo,
B-1304 Correlation between MRI imaging of intestinal G. Bastarrika; Pamplona/ES
endometriosis and laparoscopy in 80 lesions
A. Brandão, B. Barbosa, L. Cardeman, C. Crispi; Rio de Janeiro/BR 15:12
B-1314 Is it possible to distinguish infarcted area and area-
at-risk using native T1 map in patients with acute
14:00–15:30 Room N ST-elevation myocardial infarction?
N. Galea, M. Francone, A. Fiorelli, L. De Luca, L. Agati, C. Catalano,
Cardiac I. Carbone; Rome/IT
SS 1903 MR (2) 15:20

Moderators: A. Esposito; Milan/IT, C. Herzog; Munich/DE B-1315 Evaluation of left atrial function with MRI in patients
with atrial fibrillation before and after pulmonary
14:00 vein isolation and linear catheter ablation of the left
B-1305 Evaluation of miocardial viability in patients with atrial anterior line
coronary hearth disease: MR-diagnostics A. Curta, S. Fichtner, R. Wakili, H. Estner, H. Kramer; Munich/DE
A. Ikramov, N. Djuraeva, M. Pirnazarov, A. Amirkhamzaev,
A. Chekeridi, T. Zulina; Tashkent/UZ
14:00–15:30 Studio 2016
14:08
B-1306 Comparison of cardiac imaging planes for Oncologic Imaging
quantification of T1 maps and myocardial extra-
cellular volume (ECV) SS 1916 Assessment and prediction of
M. Caballeros, J.M. Madrid, P. Bartolome, P. Garcia Barquin, J. Pueyo,
G. Bastarrika; Pamplona/ES treatment response
Moderators: L.S. Fournier; Paris/FR,
14:16 A. Gogbashian; Middlesex/UK
B-1307 Diagnostic image contribution of gadolinium-

14:00
enhanced VIBE sequences in cardiac MRI
N. Guberina, T. Schlosser, F. Nensa, M. Forsting, K. Naßenstein; K-37 Keynote lecture
Essen/DE L.S. Fournier; Paris/FR
14:24 14:09
B-1308 Simple and rapid evaluation of left ventricular B-1316 Tumour response evaluation in daily practice:
function in cardiac MRI comparison between free-text evaluation and RECIST
A. Zidi, N. Mnif; Tunis/TN 1.1 criteria
J. Goebel1, J. Hoischen2, H.P. Schemuth1, S. Kinner1, F. Nensa1,
K. Nassenstein1; 1Essen/DE, 2Düsseldorf/DE

14:17 14:00–15:30 Room L8

B-1317 Prognosis of pN0 esophageal cancer: determined
by characteristic of lymph nodes on pre- and post Genitourinary
neoadjuvant chemotherapy multi-detector row CT
Y.-K. Chi, Y. Chen, X.-T. Li, Y.-S. Sun; Beijing/CN SS 1907 Imaging of the reproductive system
Moderators: G. Masselli; Rome/IT, K.B. Puzakov; Moscow/RU
14:25
B-1318 Enhancement on subtraction MRI can predict lesion 14:00
progression of hepatic metastasis in malignant B-1326 The added value of diffusion-weighted MRI
melanoma patients in diagnosis of polycystic ovary syndrome: a
M. Lee, S.-E. Baek, H. Kim; Seoul/KR preliminary study
M. Deveer1, R. Deveer1, N. Cullu1, O. Yeniceri1, A. Sivrioglu2; 1Mugla/TR,
2
14:33 Istanbul/TR
B-1319 18F-FDG PET/CT prognostic value in the treatment
14:08
of metastatic melanoma with anti-PD1 monoclonal
B-1327 Cyclic changes of the junction zone on 3T MR images
antibodies
L. Facchetti, L. Nardo, K. Loo, A. Algazi, K. Tsai, A. Daud, in young and middle-aged females during the
M.H. Pampaloni; San Francisco, CA/US menstrual cycle: anatomical and functional values
Y. He, N. Ding, H. Xue; Beijing/CN
14:41
B-1320 Prognostic value of baseline 18F-FDG PET/CT and 14:16
laboratory parameters in treatment of metastatic B-1328 Placental elasticity and histopathological findings
melanoma with anti-PD1 monoclonal antibodies in normal and intrauterine growth restriction
L. Nardo, L. Facchetti, K. Loo, A. Algazi, K. Tsai, A. Daud, pregnancies assessed with strain elastography in ex
M.H. Pampaloni; San Francisco, CA/US
vivo placenta
G. Durhan, H. Ünverdi, C. Deveci, M. Büyükşireci, T. Değirmenci,
14:49 A. Bayrak, P. Koşar, S. Hücümenoğlu, Y. Ergün; Ankara/TR
B-1321 Early shear-wave elastography measurements in
liver metastasis after neoadjuvant chemotherapy: 14:24
preliminary results B-1329 Apparent diffusion coefficient is significantly
J.F. Carlsen, C. Ewertsen, C. Lauritzen, M.B. Nielsen; Copenhagen/DK decreased in monochorionic diamniotic twin
pregnancies with selective intrauterine growth
14:57
restriction
B-1322 Estimated relative hepatic tumour burden at baseline L. Fu; Shanghai/CN
CT in a colorectal cancer cohort treated first-line with
targeted therapy: predictive relevance with respect 14:32
to overall survival B-1330 The value of preoperative static and dynamic MRI for
N. Hesse, V. Heinemann, J. Holch, F. Hofmann, A. Baumann, predicting occult stress urinary incontinence
M. D‘Anastasi, W. Sommer; Munich/DE N. Li, C. Yu; Tianjin/CN
15:05 14:40
B-1323 Neuroendocrine tumours treated with 90Y-DOTATOC B-1331 Adnexal torsion: added diagnostic value of coronal
radionuclide therapy: early response assessment with reformations at CT
whole body diffusion-weighted MRI predicts survival Y. Yim, S. Jung, M. Yu, H. Park, Y. Kim, H. Jeon; Seoul/KR
V. Vandecaveye, S. Van Binnebeek, R. Dresen, K. Haustermans,
C. Verslype, E. Van Cutsem, F. De Keyzer, D. Christophe; Leuven/BE 14:48
B-1332 Role of diffusion-weighted magnetic resonance
15:13
imaging of testes in patients with testicular
B-1324 Added value of pre-treatment apparent diffusion varicocele
coefficient in rectal cancer for predicting local J. Asogan Vaishnavi, S. C.R., A. Ali, H. Bhat, S. Sharma; Chennai/IN
recurrence
M. Lee, S. Cho, G. Kim, H. Kim, K. Shin, S. Lee, W. Kim, J. Park, 14:56
G. Choi; Daegu/KR B-1333 Injection free Imaging: evaluation of diffusion
15:21 weighted MRI over contrast enhanced MRI in
testicular torsion
B-1325 Pretreatment tumour CT density is associated with
Sunday
B. Jeevanandham; Coimbatore/IN
overall and progression-free survival and tumour
growth in patients with metastatic renal cell 15:04
carcinoma under antiangiogenic therapy B-1334 Quantitative evaluation of dynamic contrast
S. Matoori, A. Sohaib, D.-M. Koh, Y. Thian, A. Gutzeit; Sutton/UK SPEAKER
SUPPORTED enhanced MRI in the differentiation between benign
BY
INVEST IN and malignant testicular lesions
THE YOUTH M. Saldari, V. Vinci, S. Bernardo, L. Manganaro, C. Catalano; Rome/IT
15:12
B-1335 The role of imaging in paratesticular sarcomas
D. Ap Dafydd, C. Messiou, K. Thway, E. Moskovic; London/UK

14:00–15:30 Room E2 15:20

B-1347 Special aspects of hippocampal morphology in
Neuro patients with depressive disorders compared
to healthy volunteers: neurocognitive and MRI
SS 1911 Movement disorders and
comparison
neurodegenerative diseases R. Ezhova, N. Ananyeva, I. Galsman, M. Davletkhanova,
Moderators: L. Haider; Vienna/AT, S. Lehéricy; Paris/FR T. Rostovtseva; St. Petersburg/RU
14:00
B-1337 Can 3D FLAIR reflect intact presynaptic 14:00–15:30 Room F2
dopaminergic function in patients with parkinsonism?
S. Oh1, W. Lee2, N.-Y. Shin2, S.-K. Lee2, S. Lim2; 1Cheonan/KR, Physics in Radiology
2
Seoul/KR
SS 1913 Physics of dual-energy CT and breast
14:08
imaging
B-1338 Peculiarities of tremor-related brain activation in
Moderators: H. de las Heras Gala; Zorneding/DE,
Parkinson’s disease during motion: fMRI study I.A. Tsalafoutas; Athens/GR
O. Omelchenko, Z. Rozhkova, I. Karaban; Kyiv/UA
14:00
14:16
B-1348 Evaluation of optimal dual-energy (DE) blending
B-1339 Increased connectivity between sensorimotor and
ratios for linearly generated DE-blended images
attentional areas in Parkinson’s Disease
M. Onu; Bucharest/RO in dependency of radiation exposure level and
acquisition mode
14:24 J. Hansen1, C.M. Sommer2, S. Würstlin2, G. Pahn1, S. Skornitzke1,
H.-U. Kauczor1, G.M. Richter2, W. Stiller1; 1Heidelberg/DE,
B-1340 Magnetic resonance spectroscopy of supraventricular 2
Stuttgart/DE
areas and immunological markers in Parkinson
disease 14:08
J. Khomenko, E. Gromova, G. Kataeva, M. Karpenko, I. Milukhina, B-1349 Dual Energy CT (DE-CT) bone densitometry:
A. Bogdan; St. Petersburg/RU
assessing a potential alternative to DXA and
14:32 quantitative CT (qCT) in imaging-based bone mineral
B-1341 Functional connectivity and gray matter volume density analysis
P.C. Hofmann1, M. Sedlmair1, B. Krauss1, B. Schmidt1, J.L. Wichmann2,
changes in the Multiple-Demand Network of R.W. Bauer2, T.G. Flohr1, A.H. Mahnken1; 1Forchheim/DE,
Parkinson patients 2
C. Mathys1, F. Hoffstaedter2, J. Caspers1, M. Südmeyer1, C. Eickhoff2,
K. Reetz3, B. Turowski1, A. Schnitzler1, S. Eickhoff1; 1Düsseldorf/DE, 14:16
2
Jülich/DE, 3Aachen/DE
B-1350 Clinical investigation of single source dual energy
14:40 computed tomography (SSDECT) accuracy in
B-1342 Differential functional connectivity changes of right quantification of iodine concentration in calf liver
DLPFC subdivisions in Parkinson’s disease simulated lesions
J. Caspers, F. Hoffstaedter, C. Mathys, M. Südmeyer, E.C. Cieslik, C. Riedl, U. Mahmood, A. Agostini, L. Mannelli; New York, NY/US
C. Rubbert, B. Turowski, A. Schnitzler, S.B. Eickhoff; Düsseldorf/DE
14:24
14:48 B-1351 Spectral filtration in paediatric and adult chest CT
B-1343 Utility of susceptibility weighted imaging in examinations: a phantom study on dose reduction
differentiating patterns of iron deposition in and image quality
Parkinson disease and the Parkinson-plus syndromes S. Suntharalingam1, S. Labus1, T. Allmendinger2, K. Nassenstein1,
C.S. Oustwani, A.W. Korutz, M. Lester, Y. Kianirad, T. Simuni, T. Hijaz; A. Wetter1; 1Essen/DE, 2Forchheim/DE
Chicago, IL/US
14:32
14:56 B-1352 Quantitative comparison of single-acquisition dual-
B-1344 1H MRS and fMRI investigation of metabolism energy iodine maps as an alternative to abdominal
and dysfunction of the resting state default mode CT-perfusion measured with the Patlak model
network in patients with Parkinson’s disease and S. Skornitzke1, F. Fritz1, M. Klauß1, J. Hansen1, G. Pahn1, L. Grenacher2,
H.-U. Kauczor1, W. Stiller1; 1Heidelberg/DE, 2Munich/DE
different level of cognitive impairment
Z.Z. Rozhkova, O. Omelchenko; Kiev/UA
14:40
15:04 B-1353 Computed tomography blood flow measurements: a
B-1345 Quantitative susceptibility mapping at 7T to evaluate phantom experiment
S. Prevrhal, C. Spink, M. Grass, M. Bless, A. Schlaefer, H. Ittrich,
the primary motor cortex of ALS patients M. Regier, G. Adam; Hamburg/DE
G. Donatelli, M. Costagli, L. Biagi, D. Frosini, G. Siciliano, M. Tosetti,
M. Cosottini; Pisa/IT
14:48
15:12 B-1354 Beam width and beam edge measurements in CT,
B-1346 Involvement of corpus callosum differs in bulbar vs. mammography and radiotherapy with a sustainable
limb onset amyotrophic lateral sclerosis electronic ruler
M.P. Vora; Himachal Pradesh/IN H. de las Heras1, K. Mair2, O. Blanck3, Q. AlZoubi4, B. Renger5,
R. Klausz6, Y. Popova6, D. Coll-Segarra7, F. Schöfer1; 1Zorneding/DE,
2
Kempten/DE, 3Lübeck/DE, 4Amman/JO, 5Munich/DE, 6Buc/DE,
7
Nashville, TN/US

14:56 14:40
B-1355 Towards a framework to objectively assess clinical B-1364 FIRST vs AIDR 3D vs. FBP methods: accuracy
image quality in digital mammography of computer-aided volumetry (CADv) for low-
C. Balta1, R.W. Bouwman1, R.E. van Engen1, S. Schopphoven2, dose lung cancer CT screening protocols in QIBA
I. Sechopoulos1, N. Karssemeijer1, M.J.M. Broeders1, W.J.H. Veldkamp3;
1
Nijmegen/NL, 2Marburg/DE, 3Leiden/NL recommended lung nodule phantom study
Y. Ohno1, A. Yaguchi2, T. Okazaki2, K. Aoyagi3, N. Sugihara3,
S. Kaminaga3, T. Yoshikawa1, K. Sugimura1; 1Kobe/JP, 2Kawasaki/JP,
15:04 3
Otawara/JP
B-1356 Comparison of phantom target detectability for
synthetic and conventional digital mammograms 14:48
L. Cockmartin, N.W. Marshall, E. Martens, G. Yegin, H. Bosmans; B-1365 Influence of computed tomography dose reduction
Leuven/BE
and iterative reconstruction on pulmonary nodule
15:12 volumetry
A.M. den Harder1, M.J. Willemink1, R.W. van Hamersvelt1,
B-1357 Phantom and visual grading analysis of three breast E.-j.P. Vonken1, A.M. Schilham1, J.-W.J. Lammers1, R.P. Budde2,
tomosynthesis reconstruction methods T. Leiner1, P.A. de Jong1; 1Utrecht/NL, 2Rotterdam/NL
K. Michielsen, C. Van Ongeval, A. Van Steen, M. Keupers, J. Soens,
H. Ghunaim, D. Petrov, L. Cockmartin, J. Nuyts; Leuven/BE 14:56
B-1366 Prediction of decline in forced vital capacity by
texture-based automated quantification of regional
14:00–15:30 Room D1
disease patterns on initial CT in idiopathic pulmonary
Chest fibrosis
H. Park, S. Lee, J. Seo, S. Lee, N. Kim, S. Oh, J. Song; Seoul/KR
SS 1904 Computer-based quantification and 15:04

texture analysis B-1367 Longitudinal analysis in idiopathic pulmonary
Moderators: R. Cesar; Golnik/SI, M. Regier; Hamburg/DE fibrosis: changes in lung mass as a new biomarker for
14:00 quantitative computed tomography
T. Kracke, B. Hensen, T.A. Alten, O. Solyanik, T. Werncke, A. Prasse,
B-1358 CT-texture analysis of pulmonary ground glass A. Großhennig, F. Wacker, H.-O. Shin; Hannover/DE
nodules: tumour heterogeneity correlates with
in-situ/minimally and invasive adenocarcinoma 15:12
pathology B-1368 Baseline prognostication in diffuse fibrosing lung
J.G. Cohen1, E. Reymond1, M. Medici1, M. Lederlin2, F. Laurent3, diseases (FLD): evaluation of computer-based
A.-C. Toffart1, A. Jankowski1, S. Lantuejoul1, G.R. Ferretti1; quantitative CT analysis against visual CT analysis
1
Grenoble/FR, 2Rennes/FR, 3Bordeaux/FR
and pulmonary function tests (PFT)
J. Jacob1, B. Bartholmai2, A. Brun1, R. Egashira3, R. Karwoski2,
14:08
M. Kokosi1, S. Raghunath2, A. Wells1, D. Hansell1; 1London/UK,
B-1363 Performance of semi-automated software in 2
Rochester, MN/US, 3Saga/JP
segmenting ground-glass and solid components
and comparison of software and pathology
measurements in resected pulmonary 14:00–15:30 Room D2
adenocarcinomas
J.G. Cohen1, R.-E. Yoo2, C. Park2, C. Lee2, D. Chung2, Y. Kim2, Interventional Radiology
G. Ferretti1, B. Van Ginneken3, J. Goo2; 1Grenoble/FR, 2Seoul/KR,
3
Nijmegen/NL SS 1909 Endovascular
Moderators: V. Bérczi; Budapest/HU,
14:16 M. Krokidis; Cambridge/UK
B-1360 CT texture analysis for independent prediction
of tumour recurrence in patients with surgically 14:00
resected adenocarcinoma of the lung K-36 Keynote lecture
J. Jang1, H. Koo1, Y. Sung1, H. Xu2, C.-M. Choi1, J. Lee1, M. Kim1; C. Binkert; Winterthur/CH
1
Seoul/KR, 2Nanjing/CN
14:09
14:24 B-1376 Fabrication and assessment of 3D printed anatomical
B-1361 Lung cancer textural analysis: to contrast or not to models of the lower limb for femoral vessel access
Sunday
contrast training in interventional radiology

A. Farchione, A. Larici, N. Dinapoli, R. Gatta, C. Masciocchi, M.K. O’Reilly, G. Sugrue, T. Geoghegan, J.F.X. Jones; Dublin/IE
A. Damiani, P. Franchi, V. Valentini, L. Bonomo; Rome/IT
14:17
14:32
B-1369 Prostatic artery embolisation for benign prostatic
B-1362 Temporal subtraction of chest CT in lung cancer
hyperplasia: anatomical factors affecting the
screening
E.T. Scholten1, C. Jacobs1, C. Schaefer-Prokop1, J. Rühaak2, procedure performance
H.J. de Koning3, M. Oudkerk4, P.A. de Jong5, M. Prokop1, A. Cannavale1, B. Maher2, T. Bryant2, N. Hacking2; 1Canterbury/UK,
2
B. van Ginneken1; 1Nijmegen/NL, 2Lübeck/DE, 3Rotterdam/NL, Southampton/UK
4
Groningen/NL, 5Utrecht/NL
14:25
B-1370 Uterine artery embolisation for adenomyosis:
portending factors affecting the clinical outcome
A. Cannavale1, D. Miligkos2, B. Maher2, B. Karunyam2, I. Wilson2,
N. Hacking2; 1Canterbury/UK, 2Southampton/UK

14:33 14:24
B-1371 Fourteen-year experience of PAVMs embolisation in B-1382 Optimisation of image quality and dose in direct
patients with hereditary haemorrhagic telangiectasia: digital chest radiography for a neonatal chest
what has changed? phantom, using Cu filtration
S. Bongiovanni, A. Antonietti, A. Balderi, F. Pedrazzini, D. Sortino, V. Harsaker, A. Raszkowski, C. Cin, S. Bamboi, T. Granhus; Oslo/NO
M. Grosso; Cuneo/IT
14:32
14:41 B-1383 Computed ultra high b value diffusion-weighted MR
B-1372 Endosaccular embolisation of visceral artery imaging of the prostate: what is the clinical added
aneurysms with adjunctive techniques value of extrapolated b3000 images for prostate
M. Maruno, H. Kiyosue, S. Tanoue, N. Hongo, S. Matsumoto, H. Mori;
Yufu-shi/JP cancer detection?
M. Hakkert, M. Hakkert; Haarlem/NL
14:49
14:40
B-1373 Investigation of international conformance of
B-1384 Magnetic resonance cholangiopancreatography
health economic analyses by comparing open and
applying a natural negative oral contrast - black tea
endovascular repair of abdominal aortic aneurysm A.R.R. Videira, S.R.R. Martins, M.C.P. Ribeiro, P.J. Sousa,
regarding costs and outcomes J.G.C. Mascarenhas; Lisbon/PT
A. Nagy, E. Nagy, A. Palkó, Z. Palásthy, T. Takács, L. Baráth;
Szeged/HU 14:48
B-1385 Optimisation of MR imaging for the evaluation of
14:57
human placental anatomy
B-1374 Inducing false lumen thrombosis in type B aortic E. Routledge, C. Malamateniou, M. Lohezic, J.M. Allsop, M.J. Fox,
dissection by selectively excluding true lumen re- B. Kainz, A. Price, J.V. Hajnal, M.A. Rutherford; London/UK
entry points
M. Wojtaszek, E. Wnuk, R. Maciag, K. Lamparski, K. Korzeniowski, 14:56
O. Rowinski; Warsaw/PL B-1386 Assessment of image quality criteria from brain MRI
examinations
15:05 L.P. Ribeiro, C. Alves, A.M. Ribeiro, A.F.C.L. Abrantes, K.B. Azevedo,
B-1375 Endovenous radiofrequency ablation for the O. Lesyuk, N.M. Pinto, R.P.P. Almeida; Faro/PT
treatment of varicose veins: a single center
15:04
experience
S. Riva, G. Guzzardi, R. Fossaceca, P. Cerini, A. Galbiati, A. Carriero; B-1387 Reducing metal artefacts in MRI: a retrospective
Novara/IT analysis of improved diagnostic quality and
reporting confidence without the use of specialised
15:13
commercial pulses/techniques
B-1377 In vitro quantitative analysis of blood flow C. Pereira, K. Partington; Oxford/UK
blockage effect of Amplatzer vascular plugs (AVP):
comparison of AVP-I and AVP-II 15:12
K. Hidaka, T. Tajikawa, K. Osuga; Suita/JP B-1388 Reduction in respiratory motion artefacts on
gadoxetate-enhanced (Primovist) MRI after training
15:21
technicians
B-1378 Carotid stents: seven-year experience A. Gutzeit, J. Fröhlich, S. Matoori; Zurich/CH
T. Kokovic, V. Till, A. Petres, D. Ilic, S. Stojanovic; Novi Sad/RS
15:20
B-1389 Evaluation of the corpus callosum by MRI related to
14:00–15:30 Room G
the frontal atrophy in the elderly people
M.C.P. Ribeiro, J.E. O’Neill, J.F. Cruz-Maurício; Lisbon/PT
Radiographers
SS 1914 How to improve image quality in MRI
and mammography
Moderators: B. Bougias; Ioannina/GR, E. Szabó; Szeged/HU
14:00
B-1379 Breast compression: an exploration of decision
making in mammography
J.M. Nightingale, F.J. Murphy, L. Robinson; Greater Manchester/UK
14:08
B-1380 A system for automatic mammography images
quality control - images acquisition and examination
A. Golja, S. Androjna, U. Štrekelj, I. Koceva, J. Izlakar, N. Mekiš,
J. Žibert; Ljubljana/SI
14:16
B-1381 A system for automatic mammography images
quality control: a development of a system for
automatic image artifacts detection
A. Iskra, G. Bensa, J. Šomen, K. Lokar, M. Podvratnik, U. Zdešar,
N. Mekiš, J. Žibert; Ljubljana/SI

Clinical Trials in Radiology
12:30–13:30 Room D2
Clinical Trials in Radiology 1

Moderators: R. Arenson; San Francisco, MI/US
M. Dewey; Berlin/DE
12:30
The Swedish CArdioPulmonary BioImage Study
(SCAPIS): objectives and design
G. Bergström1, A. Blomberg2, J. Brandberg1, K. Cederlund3,
G. Engström4, J. Engvall5, M.G. Hansson6, T. Jernberg3, L. Lind6,
E. Lindberg6, M. Persson4, A. Rosengren1, J. Sundström6,
S. Söderberg2, K. Torén1, C. Östgren5; 1Gothenburg/SE, 2Umeå/SE,
3
Stockholm/SE, 4Lund/SE, 5Linköping/SE, 6Uppsala/SE
Wednesday
12:40
Discussant:
G. Krombach; Giessen/DE
12:45
NSsaFe study: observational study on the incidence
of nephrogenic systemic fibrosis in renal impaired
patients following gadoteric acid administration
A. Gottschalk, B. Kress; Frankfurt a. Main/DE
12:55
Discussant:
13:00
Computed tomography angiography vs Agatston
score for diagnosis of coronary artery disease: results
from the international Collaborative Meta-Analysis of
Cardiac CT (COME-CCT)
V. Wieske1, H. Alkadhi2, S. Leschka3, B.L. Nørgaard4,
J. Knuuti5, A.C.P. Diederichsen6, B.A. Halvorsen7, H. Mickley6,
K. Sun8, R.R. Büchel2, S. Muraglia9, R. Marcus10, M. Walther11,
P. Schlattmann11, M. Dewey1; 1Berlin/DE, 2Zurich/CH, 3St. Gallen/CH,
4
Aarhus/DK, 5Turku/FI, 6Odense C/DK, 7Fredrikstad/NO,
8
Inner Mongolia Province/CN, 9Trento/IT, 10Tübingen/DE, 11Jena/DE
13:10
Discussant:
L. Saba; Cagliari/IT
13:15
Efficient use of medical imaging in Belgium: where
does it go wrong in prescribing imaging studies
for the lumbar spine and abdomen? A national
multicentric study
N. Stichelbaut, P. Hoste, B. De Roo, L. Annemans, K. Verstraete;
Ghent/BE
13:25
Discussant:

Clinical Trials in Radiology
12:30–13:30 Room D2
Clinical Trials in Radiology 2

Moderators: R. Arenson; San Francisco, CA/US
M. Dewey; Berlin/DE
12:30
MR-targeted vs TRUS-guided prostate biopsy
in patients with high PSA values: a randomized
controlled trial
F. Russo1, S. Mazzetti1, V. Giannini1, A. Giacobbe2, D. Collura2,
E. Castelli2, G. Muto3, D. Regge1; 1Candiolo/IT, 2Turin/IT, 3Rome/IT
12:40
Discussant:
P. Asbach; Berlin/DE
12:45
The multicentre DISCHARGE trial pilot study: Image
quality and protocol adherence results
G. De Rubeis1, M. Dewey2, on behalf of the DISCHARGE Consortium;
1
Rome/IT, 2Berlin/DE
12:55
Discussant:
Thursday
R. Vliegenthart; Groningen/NL
13:00
Dynamic stress perfusion CT for detection of
inducible myocardial ischemia: rationale and design
of the SPECIFIC-trial
F. Bamberg1, B. Ghoshhajra2, U. Hoffmann2, K. Kitakawa3, A. Kono4,
R. Vliegenthart5, P. van der Harst5, H. Alkadhi6, R. Manka6,
U. Schoepf7, D. Steinberg7, S. Achenbach8, M. Lell8, T. Geisler1,
K. Nikolaou1, F. Pugliese9, A. Coenen10, K. Nieman10; 1Tübingen/DE,
2
Boston, MA/US, 3Mie/JP, 4Kobe/JP, 5Groningen/NL, 6Zurich/CH,
7
Charlston, SC/US, 8Erlangen/DE, 9London/GB, 10Rotterdam/NL
13:10
Discussant:
S. Kajander; Turku/FI
13:15
The impact of breast MRI on surgical planning and
reoperation rate: first results from the MIPA study
R.M. Trimboli1, G. Di Leo1, D. Sacchetto2, R. Mann3, M. Álvarez Benito4,
C. Zuiani5, E. Wenkel6, K. Siegmann-Luz7, M. Lobbes8, C. Balleyguier9,
K. Pinker-Domenig10, M. Calabrese11, J. Veltman12, U. Aksoy Ozcan13,
F. Pediconi14, J. Camps Herrero15, G. Forrai16, S. Harms17, I.-M. Obdeijn18,
M. Van Goethem19, M. Docema20, J. Anderson21, C. Losio22, F. Gilbert23,
T. Helbich10, N. Houssami24, F. Sardanelli1; 1San Donato Milanese/IT,
2
Turin/IT, 3Nijmegen/NL, 4Cordoba/IT, 5Udine/IT, 6Erlangen/DE,
7
Tübingen/DE, 8Maastricht/NL, 9Villejuif/FR, 10Vienna/AT, 11Genoa/IT,
12
Almelo/NL, 13Istanbul/TR, 14Rome/IT, 15Alzira/ES, 16Budapest/HU,
17
Fayetteville, AR/US, 18Rotterdam/NL, 19Edegem/BE,
20
São Paulo/BR, 21Perth/AU, 22Milan/IT, 23Cambridge/GB,
24
Sydney/AU
13:25
Discussant:
E.M. Fallenberg; Berlin/DE

LIST OF
AU T H O R S &
C O -AU T H O R S
341
List of Authors & Co-Authors
A Agni R.: B-0982 Allmendinger T.: B-1351

Aandahl I.-J.: B-0711 Agostini A.: B-1350 Allsop J.: B-0897
Abadal Villayandre J.: B-0126 Agten C.A.: B-0915 Allsop J.M.: B-1385
Abaza R.: B-0825 Aguilar M.: B-0401 Almansoori T.: B-1192
Abbas W.M.: B-0091 Aguirre S.: B-0851 Almeida R.P.P.: B-0150, B-0152, B-0351,
Abbas Y.: B-0087 Ahlström H.: B-0388 B-0713, B-0717, B-0869, B-0873, B-1006,
Abd El Razik N.: B-0612, B-1279 Ahmad H.: B-0400 B-1010, B-1015, B-1246, B-1249, B-1251,
Abd Ellah M.: B-0563 Ahmed S.: B-0387 B-1386
Abd Ellah M.M.H.: B-0273, B-0960 Ahn J.H.: B-0918 Almeida-Gonzalez C.: B-1020
Abdel Aal A.M.K.: B-0544, B-0998 Ahn K.: B-0646 AlObaidy M.: B-0198, B-0200
Abdel Latif M.: B-0133 Ahn K.J.: B-0651 Alogna A.: B-0257
Ahn K.-J.: B-0645 Alomaim W.: B-1122
Abdel Razek N.M.: B-0017, B-1065
Ahn S.J.: B-0090 Alonso J.-M.: A-691
Abdelhady Mohammed D.: B-0356
Ahoubim D.: B-0360 Alper F.: B-0625
Abdolell M.: B-1120, B-1125, B-1206
Ai H.G.V.: B-0321 Alperin N.: B-0396
Abdul Rahman D.: B-0888
Ai V.: B-0988 Alqahtani M.S.: B-0033
Abdulkadir Tabari M.: B-1095
Ailianou A.: A-254 Alqahtani S.J.M.: B-0709
Abdullayev N.: B-0295, B-0493, B-0953
Aime S.: A-335 Alraddadi M.: B-0708
Abe H.: B-0429
Aissa J.: B-0044, B-0099, B-0394 Alt C.D.: A-450, A-636
Abegunewardene N.: B-0455
Ajlan A.: B-0708 Alten T.A.: B-1367
Abel T.: B-0492
Akata D.: A-803, K-13 Althubaiti M.: B-0708
Abeyakoon O.: B-1274
Akbas T.: B-0469 Altintas S.: B-0473
Abidi Z.: B-1113
Akesson M.: A-111 Aluja F.: B-0202
Abishev B.: B-1097
Akisik F.: B-0001, B-0003 Álvarez Benito M.: CTiR 2
Ablasser K.: B-1079
Aksoy Ozcan U.: CTiR 2 Alvarez de Sierra Garcia B.: B-0072
Abo El-Regal A.: B-0663
Akudugu J.M.: B-0173 Alvarez Perez M.J.: B-0126
Aboelsouad A.M.: B-0563
Akyuz Y.: B-0598
Abolhasani Foroughi A.: B-1107 Alvarez-Cofiño A.: B-0446
Al Johi R.S.: B-1034
Aboud C.: B-0498 Alvarez-Linera J.: A-041
Al Qarni A.O.: B-0509
Abouelenein S.D.: B-0565 Alves C.: B-1386
Alam T.: B-0305
Abou-Elghar M.E.: B-0579 Alves M.: B-1245
Albanese S.: B-0369
Abrantes A.F.C.L.: B-0150, B-0152, B-0351, AlZoubi Q.: B-1354
Albano D.: B-0658
B-0713, B-0717, B-0869, B-0873, B-1006, Amadu A.M.: B-0254
Albarello F.: B-0137
B-1010, B-1015, B-1246, B-1249, B-1251, Amant F.: B-1037, B-1038, B-1141
Albarello L.: B-0781
B-1386 Amata L.: B-0354
Alberich-Bayarri A.: B-1112
Abu Hamdeh S.: B-0203 Ambady P.: B-0285
Albers P.: B-0334, B-0335
Abu-Eid M.: B-0721 Ambrosi A.: B-0031, B-0291, B-0343,
Albert N.L.: A-179
Abu Rabia A.: B-0612, B-1279 B-0629
Alberts A.R.: B-0336, B-0340
Acampora C.: B-0518 Ambrosino P.: B-0843, B-0844, B-0845
Albiin N.: B-1270
Achenbach S.: CTiR 2 Amer H.: B-0926, B-1135
Albillos J.C.: B-0311, B-1292
Acil M.: B-0469 Amin W.M.: B-0808
Albrecht M.H.: B-0357, B-0432, B-0483,
Ackermann H.: B-0357 Amirkhamzaev A.: B-1305
B-0877, B-0878, B-0967, B-0976, B-1178,
Ács N.: B-0471 Amitai M.: B-0472, B-0680
B-1222
Adam A.: A-045, A-477 Albrecht P.: B-0893 An D.: B-0051
Adam E.J.: A-685 Albucher J.F.: B-0818 An Y.Y.: B-0606
Adam G.: B-0007, B-0049, B-0206, B-0361, Alcalá-Galiano A.: A-020 Ananyeva N.: B-1164, B-1347
B-0382, B-0478, B-0550, B-0574, Aldrighetti L.: B-1298 Andersen E.N.: B-0716
B-0622, B-0634, B-0642, B-0855, Alessi S.: B-0705, B-0950 Andersen H.K.: B-0105
B-0982, B-0993, B-1099, B-1156, B-1219, Alexiou G.: B-1059 Anderson J.: CTiR 2
B-1224, B-1353 Alfaro I.: B-0446 Andersson B.T.: A-407
Adamsbaum C.: B-0367 Algazi A.: B-1319, B-1320 Andersson J.: K-04
Adamus R.: B-1000 Alghamdi M.: B-0708 Andersson J.S.: B-0303
Adcock I.: A-625 Algra P.R.: B-0036 Anderzen-Carlsson A.: B-1013
Adelsmayr G.: B-0052, B-0257 Alhan A.: B-0082 Ando T.: B-0223, B-0531, B-1277
Adler D.: B-0588 Alhasan A.S.: B-1115 Andrade Almeida M.E.: B-0868
Adlercreutz C.: B-0850 Ali A.: B-1332 Andrade L.: B-1163
Adriaensen M.E.A.P.: B-0075, B-0930 Alì M.: B-0122, B-0199 Andrassy J.: B-0088
Adubeiro N.: B-0703 Aliberti S.: A-623 Andreini D.: B-0377, B-0480, B-0742,
Agarwal R.: B-1137 Alkadhi H.: A-122, A-554, B-0176, B-0519, B-1075, B-1076
Agasthya G.: B-1131 B-1200, B-1209, B-1289, CTiR 1, CTiR 2 Andreisek G.: A-261, B-0554
Agati L.: B-1314 Allam K.E.: B-0607 Andres Mateo A.: B-1282
Ageev A.: B-0154 Allegranza P.: B-1196 Andresen R.: B-0616
Ageitos-Casais M.C.: B-1168 Allen C.: B-0948 Androjna S.: B-1380
Agewall S.: B-0749 Allen G.M.: B-0280, B-1185 Andronikou- Zouvani M.: B-0632
Agladioglu K.: B-0155 Allen, Jr. B.: A-288 Angele M.: B-0296

Angelelli G.: B-0421, B-0468, B-0631, Atay O.A.: B-0270 Balderi A.: B-1371
B-1067, B-1256 Atci N.: B-0885 Balestriero G.: B-0745
Angelini G.: B-0425 Atta H.: B-0563 Bali M.A.: A-723
Angst F.: B-1289 Attard S.: B-0718 Balkenhol M.: B-0535
Annan M.: B-0815 Attenberger U.: B-0141, B-1161 Ball P.: B-1080
Annemans L.: CTiR 1 Auernhammer C.: B-0296 Balleyguier C.S.: A-025, A-379, B-1061,
Annoni A.: B-1076 Autret G.: B-0097 B-1121, CTiR 2
Annoni A.D.: B-0480 Auvinen P.: B-1118 Ballicu N.: B-0333
Anooshiravani-Dumont M.: A-493 Auweter S.: B-0671 Balodis A.: B-0816
Ansaloni F.: B-0137 Avanesov M.: B-0049, B-0574, B-0622, Balta C.: B-1355
Ansari S.: B-0822 B-1156 Baltzer P.A.: B-1126
Ansari S.A.: B-0647, B-0652 Avcu S.: B-0171 Baltzer P.A.T.: A-245, A-346, A-527, B-0220,
Antoch G.: A-727, B-0044, B-0099, B-0334, Avesani G.: B-0004, B-0005 B-0423, B-0428, B-0757, B-0758,
B-0335, B-0394, B-0545, B-0560, Aviano D.: B-0874 B-0944, B-1116, B-1240, B-1259
B-0656, B-0657, B-0901, B-1036 Aviram G.: B-0115, B-0116 Balvay D.: B-0097
Antón Mendez L.: B-0358 Avni F.E.: A-139 Balzarini L.: B-0325
Antonelli A.: B-0168 Avsenik J.: B-1106 Bamber J.: B-1117
Antonietti A.: B-1371 Aydin Y.: B-0625 Bamberg F.: A-328, B-0292, B-0312,
Antonuccio E.G.M.: B-0999 Aydingoz U.: A-262, B-0270 B-0667, CTiR 2
Antunes S.: B-0626, B-0629, B-1074, B-1145 Ayuso C.: A-316, B-0446 Bamboi S.: B-1382
Anyamene N.: B-0700, B-0947 Azarine A.A.A.: B-0763 Bangma C.H.: B-0336, B-0340
Aoki S.: A-571 Azavedo E.: A-343 Bankier A.A.: A-762
Aoyagi K.: B-0655, B-1364 Azevedo K.B.: B-0150, B-0152, B-0351, Bannas P.: B-0206, B-0322, B-0361,
Ap Dafydd D.: B-1335 B-0717, B-0869, B-0873, B-1010, B-1246, B-0492, B-0622, B-0982, B-1099
Apaydın A.: B-1024 B-1249, B-1251, B-1386 Bansal K.: B-0009
Apter S.: B-0472 Aziza R.: B-0337 Bao J.: B-0059
Arapis K.: B-0633 Aznar-Méndez R.: B-1020 Bao Y.: B-0966
Archakov D.: B-1194 Azpeitia J.: B-0311, B-1292 Baracchini C.: B-0061
Arcidiacono A.: B-0271 Azzam H.A.M.A.: B-1066 Barakat M.S.: B-0808
Arcidiacono P.G.: B-0291 Baraliakos X.: B-0069
Arcuri P.P.: B-0366 B Baratella E.: B-0848
Arendt C.R.T.: B-1077 Baan Jr. J.: B-0792, B-1148 Baráth L.: B-1373
Arenson R.L.: A-474 Baar I.: B-0403, B-0803 Baratto F.: B-1074
Arfi-Rouche J.: B-1061 Baba A.: B-1189 Barbagallo S.: B-0760
Argyropoulou I M.: B-1059 Babaeva D.: B-0592 Barbarello L.: B-1303
Argyropoulou M.I.: A-790 Bacchi Reggiani M.L.: B-0111 Barbazeni G.: B-1253
Arias L. M.E.: B-0521 Bachelot T.: B-0123 Barbiani C.: B-0054
Aris R.: B-0851 Bacher K.: B-0675, B-0920, B-1202 Barbosa B.: B-1304
Arivudainambi D.: B-0506, B-0751 Bach-Gansmo T.: B-0211 Barbosa F.: B-0772
Armada-da-Silva P.: B-0712 Bachmann Nielsen M.: A-647 Barbuto L.: B-0453
Armando E.: B-0482, B-0707 Backlund J.: B-1181 Barcelo J.: B-0019
Armas M.A.: B-0243 Badia S.: B-0780 Bargellini I.: B-0093
Armbruster M.: B-0088, B-0719, B-0777, Bae K.: B-0010 Barile A.: B-0324, B-0331, B-0332, B-0959
B-1182 Baek J.H.: B-1023 Baritussio A.: B-0254
Arpaci T.: B-0469 Baek S.-E.: B-1318 Barkhof F.: A-657, A-772, B-1105
Arponen O.: B-1118 Baessler B.: B-0047, B-0048 Barmettler F.: B-0422
Arranja A.: B-0514 Baggiano A.: B-0377, B-0480, B-1075 Baron R.L.: A-133
Arrieta Artieda I.: B-0520 Baglio I.: B-1253, B-1254 Barone D.: B-0434, B-0435, B-0437, B-0515
Arrigo A.: B-0821 Bagyura Z.: B-0747 Barrett N.A.: B-1217
Arrigoni F.: A-778, B-0324, B-0331, B-0332, Bai L.: B-0025 Barry J.: B-1021
B-0959, B-1100, B-1226 Baik J.S.: B-0804, B-0917 Barsi P.: B-0079, B-0080
Arsov C.: B-0334, B-0335 Baiocco S.: B-0434, B-0435, B-0437, Barth B.K.: B-0698
Arulkumaran S.: B-0897 B-0515 Bartholmai B.: B-0112, B-0586, B-0587,
Arvanitaki M.: A-062 Baiomy A.: B-0567 B-1368
Asadi H.: B-0267 Bajin D.: B-0726 Bartolome P.: B-1306, B-1312, B-1313
Asbach P.: B-0159, B-0697, B-0945 Bajwa R.: B-0267 Bartolotta T.V.: B-0533
Ashkar L.: B-0708 Bak A.: B-1227 Bartolozzi C.: A-314, A-541, B-0093, B-1303
Askarova L.: B-1111 Bakers F.: B-0244, B-0245 Bartsch H.: B-1149
Aslan K.: B-0082 Bakker A.: B-0711 Bartstra J.: B-0488
Asogan Vaishnavi J.: B-1332 Bal C.S.: B-0084 Bartykowszki A.: B-0747
Aspelin P.: B-0196 Balageas P.: B-1223 Barwick T.: A-088
Assi V.: B-0741 Balaji R.: B-0506, B-0751, B-0828, B-0887 Basilico R.: A-378, A-555, A-743
Astley S.: B-1136 Balbi T.: B-1231 Ba-Ssalamah A.: A-424, A-614
Åström G.K.O.: A-775 Balbo Mussetto A.: B-0566, B-0659 Bassi M.: B-0241, B-0834, B-1238
Aswani Y.: B-0277 Baldassari P.: B-0238 Bässler M.: B-0846

Bastarrika G.: B-1306, B-1312, B-1313 Beltrachini L.: A-603 Bezzi M.: A-616
Basten L.: B-0129, B-0860 Ben Salem D.: B-0665, B-0949 Bezzina P.: A-646, B-1252, K-31
Batista W.: B-0868 Benadjaoud M.: B-0037 Bhadoria A.S.: B-0009
Batohi B.: B-0928 Bende F.: B-1087 Bhat H.: B-1332
Battaglia E.: B-0422 Bende F.B.: B-1086 Bhatia B.: B-0033
Battisti G.: B-0053 Bender B.: B-0286 Bhatnagar S.: B-0078
Battyáni I.: B-0613 Bendet A.: B-0115, B-0116 Bhawat K.: B-0611
Batur A.: B-0625 Bendszus M.: B-0282, B-0497 Bhullar K.: B-0084
Baudimont F.: B-0201 Benea G.: B-0241, B-0834, B-1238 Biagi L.: B-1345
Bauer J.S.: B-0485, B-1184, B-1193 Benedek A.: B-0923 Bianek-Bodzak A.: B-1027
Bauer R.: B-0186 Benedetti G.: B-0256, B-0638 Bick U.: A-640
Bauer R.W.: B-0213, B-0483, B-0877, Benegas-Urtega M.: B-1046 Bickel H.: B-0428, B-0944
B-0878, B-0967, B-0976, B-1077, B-1178, Bengzon J.: B-1055 Bidaut L.: B-0442
B-1222, B-1349 Benito A.: B-0344, B-0702 Bielecki M.: B-0113
Bäuerle T.: A-526 Benito C.: B-0311, B-1292 Bier G.: B-0039, B-0297
Baum T.: B-0485, B-1184 Bennani-Baiti B.: B-1126 Bignotti B.: B-0016, B-0760, B-1069
Baumann A.: B-0189, B-1322 Bennet A.: B-0711 Bílal N.: B-0171
Baumeister R.: B-0438 Bensa G.: B-1381 Bilbao González A.: B-0358
Baumfeld D.S.: B-0635 Bensch F.V.: B-0689, B-0691 Bilbao J.I.: A-305, A-700
Baur I.: B-0378 Bensler S.: B-0915 Bilello M.: B-0801
Baur P.: B-0720 Bensouda Mourri A.: B-1138 Bilir Ö.: B-0694
Baxa J.: B-0508 Bensoussan J.: B-0157 Bind M.: B-0042
Baykara M.: B-0065, B-0066, B-0637 Benz D.: B-0519 Binder J.S.: B-1079
Bayrak A.: B-1328 Beomonte Zobel B.: B-0674 Binkert C.: K-36
Bayraktutan U.: B-0598 Bérczi V.: B-0471 Binzel K.: B-0028, B-0029, B-0374, B-0556
Baysal O.: B-0270 Berezina N.: B-0830, B-0831 Biondetti P.R.: B-0525
Baysal T.: B-1199 Bergendal G.: B-0196 Biondi A.: K-08
Bazzocchi M.: B-0220, B-0605 Berger N.: B-1134 Biondi M.: B-0354
Becherer A.: B-1175 Berges O.: B-0153 Biondi T.: B-0780
Becker A.S.: B-0026 Bergin D.: B-1017 Bipat S.: B-0444, B-0451
Becker C.D.: A-330 Berglund T.: B-0871 Birch J.: A-586
Becker D.: B-0248, B-0457 Bergström G.: CTiR 1 Birchall J.: B-0353
Becker M.: A-592 Berk E.: B-0637 Birnbacher L.: B-0547, B-1149
Becker N.: B-1211 Berliere M.: B-1283 Bisceglia C.: B-1074
Beckers R.C.J.: B-0191, B-0192, B-1160 Berlin L.: A-124 Bisdas S.: A-516, B-0286, B-0317
Bedlington N.: A-529, A-583 Berliner C.: B-0855 Bisschops B.: B-0217
Bednarova I.: B-0605 Berliner S.: B-0115, B-0116 Bitker M.-O.: B-0699
Bednarova S.: B-0605 Bernard C.: B-0276 Bize J.: B-1286
Beer A.J.: A-517 Bernardes M.: B-1048 Bize P.: B-0247
Beer M.: A-622, B-0883 Bernardini A.: B-0404, B-0687 Björkman-Burtscher I.M.: A-283, A-558,
Beeres M.: B-0878 Bernardino E.: B-1010 B-0850
Beets G.: B-0244, B-0245, B-0776, B-1165 Bernardo S.: B-0168, B-0894, B-0896, Blackledge M.: B-1258
Beets G.L.: A-431, B-0191, B-0192, B-1160, B-1334 Blanck O.: B-1354
B-1163, B-1166, B-1168 Bernardoni A.: B-0813, B-0964 Blanke P.: A-054
Beets-Tan R.G.H.: A-433, B-0191, B-0192, Bernathova M.: B-0758, B-1259 Blasco G.: B-0498, B-0502, B-0503, B-1271
B-0244, B-0245, B-0776, B-1160, B-1163, Bernsen M.: B-0514 Bless M.: B-1353
B-1165, B-1166, B-1168, B-1281 Berritto D.: A-366 Bley T.A.: B-0314, B-1045
Begemann P.: B-1132 Bertolini M.: B-0922 Bleyen L.: B-0920
Behairy N.H.: B-0050 Bertolotto M.: A-234 Bloch B.N.: B-0013
Behr M.: B-1193 Bertram S.: B-0411 Bloem J.L.: A-463
Behzadi C.: B-0550, B-0574, B-0642, Bertrand P.: B-1115 Blomberg A.: CTiR 1
B-0993 Berzovini C.M.: B-0053 Blomberg B.A.: B-0768
Beigelman C.: A-404 Besostri V.: B-0299, B-0662 Blomstergren A.: B-1055
Beimanov A.: B-0800 Best J.: B-0411 Blondin D.: B-0334, B-0335
Beji H.: B-0123, B-0329 Betancourth J.E.: B-0536 Bloomfield C.: B-1244
Belch J.J.F.: B-0748 Betka J.: B-0728 Blüher M.: B-0983
Belgrano M.: B-0476 Beuers U.H.: B-1091 Boada M.: B-0019
Bell L.C.: B-0322 Beuf O.: B-1088 Bockisch A.: B-0068, B-0901
Bell M.: B-1017 Bevilacqua A.: B-0434, B-0435, B-0437, Böckler D.: B-1210
Beller C.J.: B-0764 B-0515 Boddaert N.: B-0163
Bellera C.: B-0298 Beyer S.E.: B-0793 Bodelle B.: B-0877, B-0878, B-0976,
Belli A.-M.: A-681, A-684 Beyer T.: A-043, A-099, A-728, B-0668, B-0994
Belli P.: B-0020 B-0899 Bodião I.: B-1006
Bellin M.-F.: A-198 Beytelman A.: B-0686 Bodner G.: B-0278, B-0279
Belousova E.: B-0732, B-1264 Bezrukov I.: B-0904 Boehm A.: B-0906

Boellaard R.: A-761 Bozovic G.: B-0850 Buchbender C.: B-0560, B-0656, B-0657,
Boellaard T.N.: B-0444 Bozzao A.: B-1060 B-0901, B-1036
Boersma L.: B-0420 Braat M.: B-0995 Büchel R.: CTiR 1
Boettger I.: B-0074 Braber A.: B-0114 Bucher A.M.: B-0483, B-0746, B-0976
Bogaert J.: A-548 Braga M.: B-0184 Buchfelder M.: B-0281, B-0283, B-0284
Bogdan A.: B-1340 Braglia L.: B-0922 Bücker A.: A-369
Boggi U.: B-1303 Bramanti P.: B-0393 Buckley J.: B-0338
Bogner P.: B-0285 Brambillasca P.: B-0772 Buckley O.: A-347
Bogsrud T.V.: B-0211 Brancatelli G.: A-132 Budde R.P.: B-1365
Bogunia-Kubik K.: B-0064 Branco J.: B-1146 Budde R.P.J.: B-0765, B-1078, B-1082
Böhm M.: B-0619 Brandão A.: B-1304 Bueber N.E.: B-1186
Bokhorst L.P.: B-0336, B-0340 Brandão S.: B-0603, B-0753 Buecker A.: B-0619, B-0955, B-1002, B-1104,
Boland G.: A-258, A-418 Brandberg J.: B-0578, CTiR 1 B-1229, B-1230
Boll D.: B-0570 Brandlhuber M.: B-0777 Buffa G.: B-0533
Bollwein C.: B-0968 Brandner S.: B-0281 Bugby S.L.: B-0033
Bolog N.: B-0554 Bratke G.: B-0953 Bugianesi E.: B-0053
Bonaffini P.A.: B-0092, B-0096, B-0441, Braun C.: B-0286 Bulakci M.: B-0140
B-0767, B-0805, B-0835, B-1030, B-1084 Braun F.: B-0719 Bülow R.: B-0006
Bonatti G.: B-0819 Braun L.M.M.: B-0232 Buls N.: B-0107
Bonatti M.: B-0819 Braun M.J.: B-0883 Bulut E.: B-0726
Bondesson D.: B-0989 Braun S.: B-1184 Bunck A.C.: B-0047, B-0048
Bonekamp D.: B-0282 Braune S.: B-0855 Buquicchio G.L.: B-0522
Bongiovanni S.: B-1371 Brea Alvarez B.: B-0355 Burgard C.A.: B-0989
Bonilla Saborido S.: B-1053 Breen D.J.: A-119 Burger I.A.: B-0026
Böning G.: B-1174 Brembilla G.: B-1173 Burghard P.: B-0740, B-1072
Boninsegna E.: B-0004, B-0005 Bremerich J.: A-468 Burgkart R.: B-0485
Bonneville F.: B-0818 Breur J.M.P.J.: B-0765 Burton N.C.: B-0908
Bonomo G.: B-0125 Briani C.: B-1142 Burulday V.: B-0161
Bonomo L.: A-758, B-0020, B-0677, Briers E.: A-170, A-401, A-533, A-587 Buryakina S.A.: B-0624
B-0679, B-0790, B-0890, B-0999, B-1361 Briganti A.: B-0343 Busato F.: B-1233
Booij R.: A-711 Brillet P.-Y.: A-472 Busoni S.: B-0943
Bookwalter C.: B-0206 Brix G.: B-0373 Busse H.: B-0983, B-1144
Boomsma M.F.: B-0589, B-0954 Brkljačić B.: A-584, A-735, B-0474, K-12 Butler M.L.: B-0867
Boos J.: B-0044, B-0099, B-0394 Brocchi S.: B-0139, B-1231 Butler M.-L.: B-0142
Boraschi P.: B-0209 Brodmann M.: B-0260 Butscheidt S.: B-0574, B-0993
Borelli C.: B-0426, B-1071 Broeders M.J.M.: B-1355 Buy X.: B-0323, B-0325
Borgen M.: B-0711 Brolin E.B.: B-0749 Buytaert D.: B-0675
Borges A.: A-141 Brosjö O.: B-0810 Büyükşireci M.: B-1328
Borggrefe J.: B-0295, B-0493, B-0953 Brouhon L.: B-1287 Buzan M.T.A.: B-0315
Borisch E.: B-0706 Brountzos E.: B-0330, K-32 Bydlon T.M.: B-0225
Borlinhas F.: B-0603 Brown C.: B-0145 Byeon J.H.: B-0606
Borrás C.: B-0641 Brown J.M.: B-0692 Byon J.H.: B-0594
Borsaru A.: B-0729 Brown P.: B-1120, B-1125 Byun H.: B-0645, B-0646
Borsato A.: B-0832 Bruce R.: B-0165
Borthne A.: B-0008 Brückmann H.: B-0794 C
Bortolanza C.: B-0745 Brueren G.: B-0400 C.R. S.: B-1332
Bortolotto C.: B-0590 Brugger P.: B-0278, B-0279 Cabaleros M.: B-0344
Bos C.: B-0765 Bruguier C.: B-0362 Caballeros F.M.: B-1129
Bosmans H.: B-1356 Brun A.L.: B-0586, B-1368 Caballeros M.: B-1128, B-1306, B-1312, B-1313
Bösmüller H.: B-0039 Brunelle F.: B-0163, B-1227 Cáceres J.: A-060
Boss A.: B-1134 Bruners P.: B-0864 Caciagli V.: B-0093
Bots M.L.: B-0060, B-0768 Brunetti A.: B-0824 Caffarri S.: B-1062
Böttner A.: B-0067 Brunetti N.D.: B-0742 Çağlı B.: B-0140
Botto A.: B-0164 Brüning R.: B-1003 Cahill A.: B-0338
Bouaboula M.: B-0097 Brunner C.: B-1214 Caines J.: B-1120, B-1125
Boubagra K.: B-0500 Bruno C.: B-0136 Calabrese M.: B-0016, B-0760, B-1069,
Bouda D.: B-0097 Bruno F.: B-0045, B-0324, B-0332, B-1311 CTiR 2
Boudiaf N.: B-0500, B-0971 Bruzzi J.: B-1017 Calafate A.: B-0869
Boughrarou R.: B-0379 Bryant T.: B-1369 Calandrelli R.: B-0081
Bougias H.: B-1261 Bryukhov V.: B-1111 Calandri M.: B-0542, B-0858
Boukerroui D.: B-0436 Bucci A.: B-0136 Calatayud J.: B-0072
Boulay-Coletta I.: B-0037 Bucciarelli-Ducci C.: B-0254 Calli M.C.: B-0085
Bousson V.: B-0809 Buch K.: B-0013 Calmon R.: B-0163
Boussouar S.: B-0320 Buchan K.: B-0737 Calvo-Temprano D.: B-1046
Bouwman R.W.: B-1355 Buchanan T.: B-1247 Camacho Marti M.D.V.: B-1053

Camera L.: B-1253, B-1254 Caruana C.J.: B-0149 Chalabi N.A.: B-1054
Campani D.: B-0093 Carusi V.: B-0958 Chalabi N.A.M.: B-1124
Campanino P.: B-1130 Caruso D.: B-0174, B-0175, B-0263, B-0456, Challen V.: B-1016
Campari C.: B-0922 B-0783, B-0785, B-1072 Chamuleau S.A.J.: B-1078
Campbell R.: A-155 Caruso P.: B-0271 Chan K.M.: B-0321
Campion D.: B-1170 Carvalho G.: B-0716 Chancheck N.: B-0549
Campioni P.: B-0137 Carver E.M.: B-0144 Chandesris O.: B-0763
Camporata L.: B-1217 Casale R.: B-1143 Chandra S.: B-0084
Campos E.M.: B-0350 Casanova B.: B-1112 Chang D.H.: B-0167
Campoy-Balbontín F.J.: B-1020 Caseiro-Alves F.: A-131, A-537 Chang J.M.: B-0530
Camps Herrero J.: A-091, A-129, B-0602, Casella C.: B-1130 Chang K.: B-0424
B-1260, CTiR 2 Cash H.: B-0697, B-0945 Chang W.: B-0838, B-1297
Camuera González E.: B-0520 Casiraghi A.: B-0775, B-0805, B-1030 Charidimou A.: B-0390, B-0823
Can Tirabulus D.: B-1280 Caspers J.: B-0044, B-0402, B-1341, B-1342 Charlon S.: B-1191
Cancel-Tassin G.: B-0699 Cassar-Pullicino V.N.: A-075 Charpentier A.: B-0320
Candiani M.: B-1028 Cassidy D.: B-0748 Charpiot A.: B-0720, B-0721
Cangiotti C.: B-1173 Castagna M.: B-0209 Chaszczewska-Markowska M.: B-0064
Canhão H.: B-1146 Castañer E.: A-029 Chaturvedi A.K.: B-0859
Canini T.: B-0525 Castellanos M.: B-0498 Chaturvedi N.: B-0648
Cannaò P.M.: B-0252, B-0459 Castelli E.: CTiR 2 Chazova I.: B-0750
Cannavale A.: B-1369, B-1370 Castillo J.: B-0149 Chechin D.: B-0665
Cano Gimeno J.: B-1260 Castillo M.: B-0198, B-0200 Chekeridi A.: B-1305
Canstein C.: B-0783, B-1203 Castro M.: B-0851 Chen B.: B-0051
Cantrell C.G.: B-0822 Catalano C.: A-164, B-0168, B-0454, Chen J.: B-1090
Cantwell C.: A-536 B-0894, B-0896, B-1314, B-1334 Chen L.: B-0504
Canu T.: B-1145 Catalano O.: B-0293 Chen M.: B-0529, B-0963, B-1031, B-1033
Cao D.: B-0265 Catalano O.A.: B-0450 Chen R.: B-0939
Cao J.: B-0177 Catania D.: A-709, B-0867, B-1170 Chen Y.: B-0505, B-0511, B-0572, B-1317
Cao J.-Y.: B-1269 Catelan S.: B-0054 Cheng J.: B-0584, B-0628
Cao W.: B-0240 Caudrelier J.: B-0323 Cheon J.-E.: B-0169, B-0172
Caobelli F.: A-301 Caulo M.: B-0393 Cherkashin M.: B-0830, B-0831
Capitolo L.: B-0482, B-0707 Caumo F.: B-1254 Cherniavsky E.: B-0827
Cappelli A.: B-1231 Cava M.: B-0251, B-0256, B-0638 Cheung H.M.: B-0187
Cappelli C.: B-1303 Cavallaro F.: B-0447 Cheung J.Y.: B-0528
Capretti I.: B-1226 Cavallin L.: B-0388 Chi Y.-K.: B-1317
Caracciolo G.: B-0389 Cavallin R.N.: B-1273 Chiacchiaretta P.: B-0389
Caracò C.: B-0293 Cavallini C.: B-0238 Chianca V.: B-0824
Caramella D.: A-082, A-419, A-732, A-786, Cavanagh P.: A-416, A-530, A-531, A-688 Chiaradia M.: B-0104
B-0121 Cavanna S.: B-0566 Chiari D.: B-0031
Carbo G.: B-0498, B-0502, B-0503 Cavedon C.: B-1253, B-1254 Chin W.L.: B-0988
Carbonaro L.A.: B-0923, B-1274 Cazals X.: B-0815 Chino S.: B-0807
Carbone I.: B-0454, B-1314 Cazeau A.L.: B-0298 Chiu N.-T.: B-0940
Carbonetti F.: B-0958, B-1142 Cazzato R.L.: B-0323, B-0325 Cho H.S.: B-0169
Carboni M.: B-0538 Cazzola V.: B-0818 Cho I.: B-0596
Cardeman L.: B-1304 Cederlund K.: B-0749; CTiR 1 Cho J.: B-0416, B-1284
Carducci S.: B-1100 Cefarelli M.: B-0111 Cho J.Y.: B-1234
Carecchio M.: B-0392 Cejna M.: B-1175 Cho M.: B-0613
Carey F.: B-0487 Çeken K.: B-1024 Cho N.: B-0530
Carlino G.: B-0020 Celeng C.: B-0766 Cho S.B.: B-0131, B-0573, B-1232
Carlo M.: B-0326 Cellina M.: B-0422, B-0881 Cho S.H.: B-1324
Carlqvist J.: B-0578 Cenzi D.: B-0832 Cho S.J.: B-1154
Carlsen J.F.: B-1321 Cercato C.: B-0848 Cho Y.: B-0623
Carmona-Bayonas A.: B-1046 Cerini P.: B-1176, B-1375 Cho Y.H.: B-0131
Caron O.: B-1121 Cermik T.F.: B-1280 Choe Y.H.: B-1073, B-1154
Carotti A.: B-0369 Cervelli R.: B-0121, B-1303 Choi C.-G.: B-0654, B-0817
Carrafiello G.: A-540 Cesarani F.: B-0482, B-0707 Choi C.-M.: B-0676, B-1360
Carrara G.: B-0184 Cetin E.N.: B-0155 Choi D.: B-0839
Carreño G E.: B-1225 Cevasco L.: B-0016, B-1069 Choi D.S.: B-0010
Carreras Aja M.: B-0520 Ceyhan Bilgici M.: B-0082 Choi E.J.: B-0221
Carriço A.: B-0348 Cha Y.: B-0215 Choi G.S.: B-1324
Carrié D.-G.: A-534 Chae S.Y.: B-0562 Choi H.I.: B-0169, B-0172
Carriero A.: B-0392, B-1176, B-1375 Chai W.-M.: B-1031 Choi H.S.: B-0645, B-0646, B-0651
Carrington B.M.: B-1167 Chai X.: B-0484 Choi J.: B-0339, B-0738
Carroll T.J.: B-0647, B-0652, B-0822 Chai Y.: B-0101 Choi J.W.: B-0208, B-0601, B-0837
Cartez-Zumelzu F.: B-0960 Chakrabarty B.: B-1167 Choi J.-Y.: B-0414

Choi M.H.: B-0339, B-0738 Colantoni C.: B-0251, B-1074 Crema M.D.: B-0548
Choi S.: B-0406, B-0754 Colbert M.: B-0231 Cremona A.: B-0958
Choi S.A.: B-0221 Colella Bisogno M.: B-0890 Crispi C.: B-1304
Choi S.H.: B-0287 Collantes M.: B-0344, B-0702 Crispin A.: B-0794
Choi S.J.: B-0918 Colley S.: A-072, A-610 Cristel G.: B-0184, B-0608
Choi S.Y.: B-1232 Collins D.: B-1258 Cristina R.: B-0348
Choi S.-Y.: B-0597 Coll-Segarra D.: B-1354 Crivellaro C.: B-1030
Choi Y.: B-0172, B-1272 Collura D.: CTiR 2 Crivelli P.: B-0538
Choi Y.H.: B-0169 Colombani S.: B-0821 Crocetti L.: A-303, A-478
Choi Y.J.: B-0754, B-1023 Colombi D.: B-0315 Croci Chiocchini A.L.: B-0139
Chollet F.: B-0818 Colombo M.: B-0638 Croisille P.: A-621
Chong M.S.: B-0489 Colosimo C.: B-0081, B-0164, B-0393 Cronin O.: B-0644
Chong V.: A-142 Comai G.: B-0139 Crowley C.: B-0338
Chovanec M.: B-0728 Comperat E.: B-0699 Cruz-Maurício J.F.: B-1389
Chowdhury F.: B-0387 Condamine E.: B-0500, B-0971 Csecs I.: B-0248, B-0457
Christeas N.: B-0618 Connell M.C.: B-1218 Csűry T.D.: B-0788
Christophe D.: B-1323 Consigny D.: B-0322 Cuba Camasca V.L.: B-0503
Christou A.: B-1261 Constantarogianni E.: A-767 Cuba V.: B-0498, B-0502, B-1271
Chu J.P.: B-0289, B-1052, B-1056 Conte E.: B-0480 Cuccioli F.: B-0633
Chu Z.-Q.: B-0595 Conti M.: B-0254, B-0538 Cuénod C.A.: A-042
Chun C.-W.: B-0917 Contro A.: B-1103 Cuesta Pérez J.J.: B-1096
Chung D.H.: B-1363 Cook G.: A-514, K-22 Cuevas Sanz J.M.: B-1260
Chung D.J.: B-0627 Cooper C.L.: A-473 Cuinet M.: B-0128
Chung G.H.: B-0798 Copel L.: B-0360 Cullu N.: B-1326
Chung H.: B-0683 Copley S.J.: A-471 Cuminal L.: B-1088
Chung W.K.: B-0321 Coppenrath E.: B-0058 Cunha T.M.: A-037
Chuong A.-M.: B-0037 Coppola A.: B-0343 Cuocolo A.: B-0453
Chvetzoff G.: B-0128 Coppola G.: B-0999 Curta A.: B-1315
Cicchetti G.: B-0677, B-0679 Corazza A.: B-0271 Curvo-Semedo L.: A-577
Cicekcibasi A.E.: B-0885 Corcos G.: B-1191 Cussenot O.: B-0699
Cicone F.: B-1060 Corcuera-Solano I.: B-1197 Cuzzocrea M.: B-1030
Cieslik E.C.: B-1342 Cordes C.: B-0485 Cyran C.C.: A-182, B-0296, B-0931, B-0933,
Ciliberto M.: B-0679 Córdoba Chicote V.: B-1282 B-0934
Cin C.: B-1382 Coriani C.: B-1062 Czernin J.: B-0899
Cioffi Squitieri N.: B-1172 Cornelius A.: B-0698 Czerny C.: A-591
Ciolina F.: B-0454 Cornford E.J.: A-244 Czimbalmos C.: B-0248, B-0457
Ciolina M.: B-0238 Corno L.: B-0037 Czubak J.: B-0911, B-0914
Cioni R.: B-0093 Cornud F.: A-101
Cipriani A.: B-0819 Corona M.: B-0537 D
Cirelli C.: B-0537 Corot C.: B-0201 da Costa Andrade L.A.: B-0192
Cirillo M.: B-0366 Correa Zapata J.C.: B-0520 da Silva C.A.: B-0152, B-1010
Cirillo S.: B-0566, B-0659, B-0829 Correas J.-M.: A-528, A-805 Dabew R.: B-0955
Cirino A.: B-0533 Corso R.: B-1196 Dablan A.: B-1024
Citil S.: B-0171 Cortese G.: B-1220 Dabravolskaite V.: B-1118
Claes L.: B-0204, B-0205 Coşgun Z.: B-0490 Dacher J.N.: B-1151
Claeys T.: B-0942 Cosottini M.: B-1345 Dacher J.-N.: A-053
Clarizia A.: B-0813, B-0964 Cosson P.: A-649 Daemen M.J.: B-0056
Clasen S.: B-0861 Costa D.: B-1245 Daghistani R.: B-0581, B-0987
Claudepierre P.: B-0071 Costa M.: B-1140 Dağıstan E.: B-0490
Claudi C.: B-0643 Costachescu D.: B-0811 Dahlqvist Leinhard O.: A-280
Claudon M.: A-209, A-250 Costagli M.: B-1345 Daire J.-L.: B-0977
Clauser P.: B-0220, B-0423, B-0428, Cottier J.P.: B-1115 Dal Corso M.: B-0249
B-0757, B-0758, B-1259 Cottier J.-P.: B-0815 Dallakyan N.H.: B-0170
Claviere L.: B-0818 Cottin V.: B-0117 Dall’ara S.: B-0834, B-1238
Cleator S.: B-1275 Couillaud F.: B-0932 Dallaserra C.: B-0136
Clément O.: A-149, A-338, A-729, B-0763 Couto J.G.: B-0718 Dalm S.: B-0936
Clevert D.A.: B-0934, B-0997 Cova M.: B-0476 Dalmis M.: B-0426
Coche E.E.J.G.: A-643 Cova M.A.: A-310, B-0778, B-0848 Damascelli A.: B-0184, B-0608
Cockmartin L.: B-1356, B-1357 Cowan N.C.: A-309 Damiani A.: B-1361
Coenen A.: B-0743, CTiR 2 Coward J.: B-0353 Damilakis J.: A-031, A-080, A-355, A-392,
Coghe G.: B-1108 Cowling J.J.: B-0672 A-488, A-747, B-1205
Cohan R.: B-0692 Cox E.: B-0575 Damlar I.: B-0885
Cohen J.G.: B-1358, B-1363 Cozzi A.: B-0459 Damm T.: B-0493
Coi L.: B-0421, B-1067, B-1256 Crawford Jefferson M.: B-1080 Dammann F.: B-0883
Colak A.: B-1081 Crawford R.: B-0640 Dams F.E.M.: B-0012

D’Anastasi M.: B-0189, B-1322 de Mol B.A.J.M.: B-1148 Dershaw D.D.: B-1063
Danes J.: B-0239 De Napoli L.: B-0121 Dervishi N.: B-0829
Dang Tran K.: B-0320 De Pascale A.: B-0829 Desai S.: B-0009
d’Angelo P.: B-0605 De Pooter J.: B-0675 Desai S.R.: A-403, B-1217
Dangouloff-Ros V.: B-0163 De Roeck J.: B-1287 Descat E.: B-0298
Dani S.: B-0018 De Roo B.: CTiR 1 Deschamps R.: B-0157
Danielsson M.: A-033 de Roos A.: A-188, A-277, A-466, B-0181 Deschildre A.: B-0370
Danilov N.: B-0750 De Rosa F.: B-0742 deSouza N.M.: A-451
Dankbaar J.W.: B-0496, B-0568 De Rubeis G.: CTiR 2 Detante O.: B-0500
Dankova A.: B-0514 De Santis D.: B-0780 Dettore D.: B-0272
Danza F.M.: A-197 de Vis J.: B-0650 Deuschl C.: B-1058
D’Apolito G.: B-0081 De Visschere P.J.L.: B-0942 Devaraj A.: A-705
Dappa E.: B-1190 De Wever W.F.M.: A-706 Deveci C.: B-1328
D’Aquino A.: B-1117 Debiais S.: B-0815 Deveer M.: B-1326
d’Archambeau O.: B-0403, B-0803 Dechene A.: B-1301 Deveer R.: B-1326
Das M.: B-0473, B-0791, B-1040 Decoster R.: B-0867 Devu S.: B-0043
Das R.: A-682 Decristoforo C.: A-415, B-0027 Dewes P.: B-0976, B-1077
Daud A.: B-1319, B-1320 Decullier E.: B-0117 Dewey M.: A-065, A-456, B-0383, B-0460,
Daunis-i-Estadella J.: B-0498, B-0502 Decuzzi P.: B-0613 CTiR 1, CTiR 2
Davenport M.: B-0692 DeDea M.: B-0280 Dey C.: B-0109
David V.: B-0958, B-1142 Dedic A.: B-0743 Di Bartolomeo M.P.: B-0687
Davletkhanova M.: B-1347 Deferme F.: B-1287 Di Carlo M.: B-1233
Dawood N.: B-0033 Deganello A.: A-675 Di Cecco G.: B-0964
Dawoud M.A.A.: B-1001 Degani H.: B-0602 Di Cesare E.: B-0045, B-0255, B-1311
de Albert M.: B-1225 Degirmenci B.: B-0002 Di Chiara A.: B-0160, B-0779, B-0781
De Angelis C.: B-0120, B-0923, B-1123 Değirmenci T.: B-1328 Di Egidio V.: B-0404, B-0501, B-0687,
de Baère T.: A-116 Dehem J.V.: A-373 B-0802
De Belder F.: A-566, B-0403, B-0803 Dejaco D.: B-0564 Di Giovanni S.E.: B-0020
de Blois E.: B-0936 Dejobert M.: B-0815 Di Girolamo M.: B-0958
De Boer E.: B-0589 Del Buono F.: B-0767 Di Guardia G.: B-0541
de Boer L.L.: B-0225 del Ciello A.: B-0677 Di Lella G.M.: B-0081, B-0164
De Bondt T.: B-1287 Del Cura Rodríguez J.L.: B-0358 Di Leo G.: B-0122, B-0199, B-1123, B-1143,
De Brabander I.: B-0920 Del Grande F.: B-0554 CTiR 2
De Cecco C.N.: A-377, B-0174, B-0175, Del Maschio A.: B-0031, B-0160, B-0184, Di Mizio V.: B-0404, B-0501, B-0802
B-0263, B-0264, B-0380, B-0386, B-0251, B-0256, B-0291, B-0343, B-0608, Di Muzio N.: B-0779
B-0452, B-0456, B-0746, B-0783, B-0626, B-0629, B-0638, B-0779, Di Sibio A.: B-0045, B-0255
B-0785, B-1072, B-1203, K-21 B-0781, B-1028, B-1074, B-1145, B-1273, Diacinti D.: B-0238
De Cobelli F.: B-0031, B-0160, B-0184, B-1298 Diaz O.: B-1137
B-0251, B-0256, B-0291, B-0343, B-0608, Delaloge S.: B-1061, B-1121 Diaz-Zamudio M.: B-0413
B-0626, B-0629, B-0638, B-0779, Delannoy V.: B-0581 Dick A.: B-0047, B-0048
B-0781, B-1028, B-1074, B-1145, B-1273, Delavaud C.: A-528 Dick E.: A-556
B-1298 Delforge M.: B-0661 Dickerson E.: B-0692
De Dea M.: B-1185 Della Bella P.: B-1074 Dicle O.: A-441
de Donato G.: B-1172 Della Latta D.: B-0425 Diederichsen A.: CTiR 1
De Febis E.: B-0772 Della Vigna P.: B-0125 Dieckmeyer M.: B-0485
De Foer B.: A-252 Delli Pizzi S.: B-0389 Diehl S.: B-0739, B-0836
de Graaf R.: A-491 Delorme S.: B-1211 Diekhoff T.: B-0067
de Heer L.M.: B-1082 Deltenre P.: B-0977 Dietrich A.: B-0983
de Jaegere P.P.T.: B-0400 Demany N.: B-0949 Dietrich C.F.: A-677
de Jong H.W.: B-0568 Demattei C.: B-0071 Dietrich O.: B-0965
de Jong K.P.: B-0863 Demirci A.Y.: B-1199 Dietzel F.: B-0334, B-0335
de Jong M.: A-151, B-0514, B-0936 Demirel A.: B-0637 Dietzel M.: B-0220, B-0757, B-1126
de Jong P.A.: B-0488, B-0650, B-1362, Demirtas H.: B-0002 Diez Y.: B-1137, B-1138
B-1365 den Harder A.M.: B-0765, B-1365 Dijkhoff R.: B-1165
De Jonge M.C.: A-022 den Ouden L.: B-1168 Dijkstra H.: B-0609, B-0610
De Keyzer F.: B-0661, B-1037, B-1038, den Ruijter H.M.: B-0060, B-0768 Dilks P.: B-0018
B-1323 Dendale P.: B-0181 Dillmann R.: B-0764
de Koning H.J.: B-0488, B-0789, B-1362 Denecke T.: A-544, B-0041 Dimai H.-P.: B-1146
de Korte C.L.: B-0022 Denis de Senneville B.: B-1223 Dimitrakopoulou-Strauss A.: B-0668
de las Heras H.: B-1354 Denton E.: B-1119 Dinapoli N.: A-670, B-1361
De Libero A.: B-0659 Denys A.: A-302 Ding C.: B-0723
De Luca L.: B-1314 De-Paoli L.: B-0973 Ding J.: B-0857
De Maeseneer M.O.: A-506 Derchi L.E.: A-247, A-804 Ding N.: B-1327
De Marco P.: B-0103 Dergilev A.: B-0154 Dinkel J.: A-348, B-0315, B-0989
de Mey J.: B-0107, B-0212 Deroulers C.: B-0163 Diogo R.: B-0906

Discalzi A.: B-0541, B-0542 Ducreux D.: B-0162 El Tohamy M.F.: B-1135
Dittrich S.: B-0614 Dudea S.: A-525 El Waraki M.S.: B-1001
Divenuto I.: B-1176 Dueber C.: B-0455 El-Azab M.S.: B-0663
Divis P.: B-1101 Due-Tonnessen P.: K-07 Eldawoody H.F.: B-1050
Djekic J.: B-0181 Duffy S.: B-1136 El-Diasty M.T.: B-0579
Djuraeva N.: B-1305 Duffy S.W.: A-549, B-1127 El-Diasty T.A.: B-0579
Djurdjevic T.: B-0499 Dugot-Senant N.: B-0932 Elewaut D.: B-0069
Djuric-Stefanovic A.: B-0214 Duh Q.-Y.: B-0364 Elias M.: B-0353
Do T.D.: B-0865 Duhamel A.: B-0590, B-0987 Elias S.N.: B-0825
Docema M.: CTiR 2 Duijm L.E.M.: B-0925 Elibol O.: B-1199
Dodd J.D.: A-383 Duman F.: B-0885 Eliezer M.: B-0721
Doellinger F.: B-1212 Duman T.: B-0885 Elizalde A.: B-1128, B-1129
Doeswijk G.: B-0936 Dumontiel S.: B-1258 Elkhamary S.M.: B-0158
Dogru E.: B-0885 Dumortier J.: B-1088 Ellermann A.: B-0711
Dohan A.: B-0094, B-1169 Dunant A.: B-1061, B-1121 Ellis J.: B-0692
Dolenc Groselj L.: B-0886 Dunlop D.: B-0643 El-Maadawy S.M.: B-0888
Dolgun A.: B-0726 Dupuis-Girod S.: B-0117 Elmokadem A.H.: B-0647, B-0652, B-0822
Dombrovsky V.: B-0063 Duran C.: A-676 El-Morsy A.E.-M.E.: B-1050
Domingues R.T.: B-0486 Durán J.P.: B-0851 ElRefaei M.A.: B-1089
Dominguez E.: B-0311 Durand A.: B-0367 El-Serougy L.G.: B-1050
Donatelli G.: B-1345 Durando M.: B-1130 Elstob A.: B-0365
Donati F.: B-0209 Durhan G.: B-1328 ElTohamy M.: B-1089
Donati O.: B-1289 Duric N.: B-1117 Emad Y.: B-1183
Donati O.F.: B-0698 Durmaz E.: B-1024 Emami H.: B-0787
Dong J.: B-0240 Dutertre A.: B-0298 Emberton M.: B-0948
Dong Y.: B-0095, B-1228, B-1269 Dutova I.N.: B-0552 Emerich L.: B-0809
Doniselli F.: B-0199 Duymus M.: B-0171 Emrich T.: B-0455
Doniselli F.M.: B-0447, B-1143 Dwarkasing R.S.: B-0408 Enblad P.: B-0203
Donnelly P.: B-1080 Dziadziuszko K.: B-0183 Engelborghs S.: A-771
Donoghue V.: A-789 Dzoic Dominkovic M.: B-0474 Engelen S.: B-0776
Donoso L.: A-218, A-221, A-255, A-725 Engelke C.: B-1003
Doran S.: B-1258 E England A.: A-788, B-0307, B-1008, B-1208,
Dörfler A.: A-480, B-0283, B-0284 Ebdon-Jackson S.: A-484, A-486 B-1243, B-1244
Doriguzzi Breatta A.: B-0541, B-0542 Ebeling Barbier C.: B-0996 Engström G.: CTiR 1
Dormagen J.B.: B-0211 Eberhardt K.: A-362 Engvall J.: CTiR 1
Dörr F.: B-1004 Eberhardt R.: B-1214 Enk A.: B-1003
Dorrius M.D.: B-0609, B-0610 Eberli D.: B-0698 Enlund A.-L.: B-0714
D’Orsi C.J.: B-1131 Eckerbom P.: B-0575 Eraslan C.: B-0085
Dósa E.: B-0261 Eckstein F.: B-0555 Erb M.: B-0593
Dosal Bañuelos J.D.: B-0413 Eckstein H.-H.: B-1158 Erb-Eigner K.: B-0159
Doshi A.: B-1197 Edens M.A.: B-0954 Ergen F.B.: B-0270
Doss A.X.: B-0553 Edlund R.: B-1181 Ergün Y.: B-1328
d’Othee B.J.: B-0615 Edward R.: B-0356 Ermacora D.: B-1140
Dougados M.: B-0071 Egan A.M.: B-1017 Eroglu A.: B-0625
Downey K.: A-036, B-1258 Egashira R.: B-0586, B-1368 Eroshenko O.: B-0063
Drago S.: B-0770 Ehret N.: B-0614 Ertel N.: B-0544
Drago S.G.: B-0774, B-0775 Eiber M.: B-0341 Ertl L.M.: B-0794
Drapé J.-L.: B-1191 Eichinger M.: B-0315, B-1214 Ertl-Wagner B.: A-360, A-501, A-749,
Dresen E.: B-1141 Eichler K.: B-0130 B-0396, B-0793, B-0965, B-0968, B-1110,
Dresen R.: B-1038, B-1323 Eickelberg O.: B-0671 B-1114
Dreyhaupt J.: B-0883 Eickhoff C.: B-1341 Escalona-Huerta C.: B-0413
Drieghe B.: B-0675 Eickhoff S.: B-1341 Eschbach R.: B-0931
Drieling D.: B-0527 Eickhoff S.B.: B-1342 Eschbach R.S.: B-0934
Driesser I.: B-1203 Eigentler T.: B-0039, B-0297 Escher A.: B-0230, B-0235
Drobni Z.: B-0788 Eijsvoogel N.G.: B-0791 Espejo J.J.: B-0536
Drobni Z.D.: B-0179 Eikendal A.L.M.: B-0060, B-0768 Espinoza-Boireau S.: A-738
Dromain C.: B-1061, B-1121 Eissa A.E.: B-1065 Esposito A.: B-0031, B-0251, B-0256,
Duan X.: B-0025 Ekenbäck C.: B-0749 B-0343, B-0626, B-0629, B-0638,
Dubach-Schwizer S.: B-1134 Ekhlasi G.: B-0035 B-0779, B-0781, B-1028, B-1074, B-1145
Dubay D.: B-0998 El Ghazaly H.: B-0294 Esposito F.: B-1130
Düber C.: B-0412 El Hachemi M.: B-0181 Esposito R.: B-0389
Dubruel P.: B-0514 El Kassas H.H.N.: B-0612, B-1279 Esteban L.: B-0355
Duchesne N.: B-0021 El Messeidy D.: B-1257 Esteves B.: B-0870
Duclos A.: B-1169 EL Mozy W.: B-0050 Esteves C.: B-1048
Ducou le Pointe H.: A-019 El Saeidi S.: B-0050 Estner H.: B-1315

Etievant J.: B-0117 Fernandes P.: B-1245 Fonteyne V.: A-105

Euler A.: B-0302, B-0304, B-0570, B-1288 Fernandez L.: B-0982 Forment Navarro M.: B-0602
Evans A.: A-641, B-0427, B-0526 Fernandez Leon A.: B-1053 Formenti A.: B-0480
Evans D.: B-0928 Fernandez-Bayó J.: A-135, A-581 Formoso F.J.D.: B-0243
Evans R.: B-0737 Fernández-Real J.M.: B-1271 Fornari A.: B-0829
Ewertsen C.: B-1321 Ferraioli G.: B-1085 Forrai G.: A-243, A-597, CTiR 2
Exner S.: B-0130 Ferrante Z.: B-0241, B-1238 Forschner A.: B-0023
Exposito D.: B-0072 Ferrari F.: B-1100, B-1226 Forslin Y.: B-0196
Ezhova R.: B-1164, B-1347 Ferreira H.A.: B-0603, B-0703, B-0753 Forsting M.: B-0068, B-0197, B-0507,
Ferrero G.: B-0272 B-0667, B-0903, B-0905, B-1058, B-1201,
F Ferretti A.: B-0389 B-1307
Fabbro E.: B-0272 Ferretti G.: B-1363 Forstner R.: A-380
Facal de Castro F.: B-0641 Ferretti G.R.: A-059, B-1358 Fossaceca R.: B-1176, B-1375
Facchetti L.: B-0549, B-0551, B-1319, B-1320 Ferron S.: B-0298 Fouad R.M.K.: B-1066
Faccinato A.: A-542 Fesl G.: B-0794 Fournier L.: B-0097, K-37
Fadel S.H.: B-0808 Feuchtner G.: A-115, A-201, B-0740 Fournier L.S.: A-152
Fadzli F.: B-0083 Feuerriegel G.: B-0549 Fox E.: B-1170
Faeghi F.: B-1113 Feydy A.: B-0071, B-1191, B-1195 Fox M.J.: B-0897, B-1385
Fahrleitner-Pammer A.: B-1146 Fichtner S.: B-1315 Fracasso G.: B-0932
Fainardi E.: B-0813, B-0964 Fiedler A.: B-0895 Fraga P.: B-0311, B-1292
Faivre J.-B.: B-0370, B-0581, B-0590, Fieselmann A.: B-0670 Fraile E.: B-1292
B-0987 Figiel J.: B-0258 Fraile Moreno E.: B-0311
Faker E.: B-1257 Fijalkowska J.: B-0183 Franchi P.: B-0677, B-0679, B-1361
Falaschi F.: B-0209 Fijalkowski M.: B-0183 Franchi-Abella S.: A-320
Faletti C.: A-690 Filice C.: B-1085 Francione G.: B-0958
Faletti R.: B-0053 Filippiadis D.: B-0127, B-0330 Francis S.: B-0575
Falkner F.: B-0704 Filli L.: B-1190 Franck C.: B-1202
Falkowski A.L.: B-0076 Finer N.: A-279 Franckenberg S.: B-0640
Fallenberg E.M.: A-704, B-0926, B-1135 Finetto G.: B-0054 Franco A.: B-0521
Falvey E.: B-0644 Fink C.: B-0313, B-1043 Francois C.J.: B-0322
Fan L.: B-0682, B-0847 Finkenstaedt T.: B-0554 Francone M.: A-114, B-0454, B-1314
Fanelli F.: K-18 Fioole-Bruining A.: B-0225 Frangi A.: A-600
Fanning N.: B-0795 Fior D.: B-0774, B-0835, B-1173, B-1196 Frau J.: B-1108
Fanti S.: B-1231 Fiorelli A.: B-1314 Frauenfelder G.: B-0465, B-0518, B-0674
Faquir T.: B-0345 Fiorina P.: B-0160 Frauenfelder T.: A-166, B-0846, B-1134
Farag M.: B-0764 Fiorino C.: B-0779 Fredrikson S.: B-0196
Farahat A.: B-0612, B-1279 Firetto M.C.: B-0525 Freitag M.T.: B-0668
Farahat A.A.-K.: B-0808 Fischer A.: B-0314, B-1045 Frel M.: B-0275, B-0911, B-0914
Farchione A.: B-0677, B-1361 Fischer M.A.: B-0640, B-1190 Freling N.J.M.: A-737
Farghaly H.R.S.: B-0509 Fischer N.: B-0564 Frellesen C.: B-0967
Farina D.: A-523, A-568, A-611, B-0249 Fischer S.: B-0878, B-1178, B-1222 Fretellier N.: B-0201
Farouk R.: B-1257 Fischer T.: A-394 Freyhardt P.: B-0621
Farras Roca L.: B-1225 Fischer U.: B-0014, B-0218, B-0222 Fridell K.: A-409
Farrell C.: B-1204 Fishman E.K.: B-0956 Friedensohn L.: B-0115
Fasciano M.: B-1130 Fiz F.: B-0272 Friera Reyes A.: B-1096
Fassa-Ashrafpoor G.: A-598 Flach P.: B-0438 Fries P.: B-0619, B-1002
Fassbender K.: B-0972 Flaherty K.T.: B-0512 Frigg A.: B-1186
Faure M.: A-566 Flanigan D.: B-0556 Frija G.: A-017, A-078, A-483, A-487, A-731,
Favre I.: B-0500 Flechsig P.: B-0865 A-783
Feeley L.: B-1021 Fleischmann C.: B-0673 Fritz F.: B-1047, B-1352
Feger S.: B-0383, B-0460 Fletcher A.: B-1218 Fritz J.: B-0956, B-1188
Fei X.-C.: B-0529, B-1031, B-1033 Floeth F.W.: B-0901 Froemming A.: B-0706
Fejer B.: B-0061 Flohr T.: B-0508 Fröhlich J.: B-1388
Felber S.: B-0398, B-0399 Flohr T.G.: B-1349 Fromageau J.: B-1117
Fele R.M.: B-0333 Flores P.: B-0868 Fronda M.: B-0541, B-0542
Fellah L.: B-1283 Floss T.: B-1161 Frosini D.: B-1345
Felli V.: B-0255 Fodero G.: B-0366 Frulio N.: B-1223
Felson D.T.: B-0548 Fodor P.: B-0306 Frulloni L.: B-0004, B-0005
Fendler W.P.: B-0997 Fohlen A.: B-1049 Frush D.P.: A-084
Fenelon C.: B-0782 Föhr P.: B-0547 Fu L.: B-1329
Feng C.: B-0268, B-0269 Foldyna B.: B-0853 Fuchsjäger M.H.: A-642, B-0052, B-0257
Feng L.: B-0059 Foley S.: B-0346, B-0352, B-0710, B-1122, Fuentealba A.: B-0851
Feola T.: B-0454 B-1248 Fujii K.: B-0223, B-0531, B-1277
Ferda J.: A-659, B-0508 Foley S.J.: A-287, A-489, B-0708 Fujikawa T.: B-1039
Ferencik M.: B-0744 Fonio P.: B-0541, B-0542, B-0858, B-1130 Fujinaga Y.: B-0841

Fujisawa Y.: B-0106, B-0684, B-0685 Gao R.: B-1090 Geurts J.J.G.: B-1105
Fujita A.: B-0841 Gao Y.: B-0736 Gevenois P.A.: B-0347
Fukui T.: B-0216 Garami Z.: B-0613 Ghaye B.: A-096, A-190
Fukuyama A.: B-0479 Garbe C.: B-0297 Ghekiere O.: B-0181
Fukuyama N.: B-0382 Garcia Barquin P.: B-1306, B-1312, B-1313 Ghemigian K.: B-0744
Fuld M.K.: B-0956 García de Pereda De Blas V.: B-0520 Ghiatas A.: B-1261
Fulford J.: B-0709 Garcia F.: B-0521 Ghomadi S.: B-0665
Fuller S.: B-0175, B-0263 Garcia Oliver E.: B-0602 Ghosh Dastidar A.: B-0254
Fuller S.R.: B-0174, B-0456, B-0785, B-1072 Garcia-Barquin P.: B-1129 Ghoshhajra B.: CTiR 2
Funk E.M.: B-1013 García-Hidalgo Y.: B-0355 Ghunaim H.: B-1357
Furman Y.: B-1032 Garcia-Marti G.: B-0701 Giacobbe A.: CTiR 2
Furman-Haran E.: B-0602 García-Peña M.P.: A-071 Giancotti A.: B-0894
Fusaro M.: B-0745 Gardarsdottir M.: A-274, A-386 Giannelli M.: B-0425
Fusco F.: B-0824 Gardavaud F.: B-0104 Giannini V.: CTiR 2
Fütterer J.J.: A-104, A-741 Gareer S.: B-0612 Giannotta M.: B-0111
Gareer S.W.Y.: B-1279 Giannotti N.: B-0352
G Garg A.: B-0084, B-0372 Gibaud B.: A-329
Gaa T.: B-1161 Gargalas S.: B-0796 Gibson G.: B-0672
Gaaß T.: B-0989 Gariani J.: B-0588 Giepmans W.: B-0239
Gaballa G.: B-0579 Garibotto V.: A-428 Giesel F.L.: A-645
Gabbert H.E.: B-0334 Garnon J.: B-0323 Giganti F.: B-0031, B-0291, B-0343, B-0626,
Gaber A.: B-0087 Garnov N.: B-0983, B-1144 B-0629, B-0948, B-1028
Gabr A.: B-0563 Garske-Roman U.: B-0996 Giganti M.: B-0137, B-0241, B-0813, B-0834,
Gabr A.M.: B-1001 Gasbarrini A.: B-0999 B-0964, B-1238
Gabriele P.: B-0848 Gascho D.: B-0438 Giggens R.: B-0961
Gac P.: B-0062, B-0064, B-0771 Gassenmaier S.: B-0719 Gigoni R.: B-0209
Gaikwad S.: B-0084 Gatta R.: B-1361 Gil B.-M.: B-0756
Gaillard S.: B-1088 Gaudiano C.: B-1233 Gil Sierra A.: B-0126
Gaillot K.: B-1115 Gaudino S.: B-0164 Gilbert F.J.: A-089, A-145, A-344, B-1127,
Gaini N.: B-0140 Gaunt T.C.: B-0487 B-1136, CTiR 2
Gainor J.F.: B-0512 Gavazzi E.: B-0249 Gillies R.: B-0510
Galant C.: B-1283 Gavelli G.: B-0434, B-0435, B-0437, B-0515 Gilligan P.: A-171, B-1247
Galaska D.: B-0183 Gavio L.L.S.: B-0486 Gilliland L.: B-1131
Galaska R.: B-0183 Gavrilovic V.: B-1101 Gilson W.D.: B-1188
Galastri L.: B-0943 Gawlitza J.F.M.: B-0309 Gimeno A.: B-1271
Galatoire O.: B-0157 Gawlitza M.: B-0902, B-0906 Ginocchi V.: B-0922
Galban C.J.: B-0433, B-0439 Gazzera C.: B-0542, B-0858 Ginocchio M.I.: B-0465
Galbiati A.: B-1375 Gebauer B.: B-0621, B-1003 Giordano A.V.: B-1100
Galea N.: B-0454, B-1314 Gee A.H.: B-0912, B-1147 Giordano J.: B-0581
Galema T.: B-0743 Gee M.: B-0450 Girard F.: A-648
Galia M.: B-0658 Geenen R.W.F.: B-0036 Girardi V.: A-024
Galiè N.: B-0111 Geiger J.: B-0368 Giraudo C.: B-0070, B-0300, B-0660
Gallesio C.: B-0053 Geijer H.: B-0957 Girometti R.: B-0605
Gallo T.: B-0566 Geijer M.: B-0850, B-0957 Giugliano F.M.: B-1057
Galobardes J.: B-0311 Geisbüsch P.: B-1210 Giuliani L.: B-0354
Galsman I.: B-1347 Geisler T.: CTiR 2 Giuliani M.: B-0020
Gálvez García S.: B-0683 Gelderblom M.: B-0634 Giurazza F.: B-0518, B-0620, B-0674,
Galvez Gonzalez E.: B-0126 Geldof M.: B-1287 B-1057
Galy-Fauroux I.: B-0097 Genchellac H.: B-0140 Given M.: B-0266, B-0267
Galzerano G.: B-1172 Geneidi E.: B-0087 Gizewski E.: B-0960
Gamboa P.: B-0711 Geneidi E.A.S.: B-1054 Gizewski E.R.: B-0499
Gamondes D.: B-0117 Geng D.: B-0288 Glastonbury C.M.: B-0364
Gandhi L.: B-0512 Gennarelli A.: B-0255 Glavas R.: B-0714
Gandini G.: B-0053, B-0541, B-0542, Gennari A.G.: B-0778 Gleditsch J.: B-0008
B-0858, B-1130 Gennaro G.: A-358 Gleeson F.: A-349
Gandy S.: B-0748 Geoghegan T.: B-1376 Gleeson F.V.: B-0436
Ganeshan B.: B-0094 Georg D.: B-0944 Glehen O.: B-1169
Gangemi E.: B-0823 Gepalova Y.: B-1267 Glenn S.I.: B-1011
Gangi A.: A-413, A-479, A-619, A-774, Geraldo Roig L.: B-0027 Glikstein R.: B-1192
B-0323, B-0442, B-1213 Germain-Genevois C.: B-0932 Glöckler M.: B-0614
Ganslandt O.: B-0401 Gersing A.: B-0398, B-0399, B-0551, Glodny B.: B-0499
Gao J.: B-0101, B-0240, B-0583, B-1042, B-0643 Glotov A.: B-0592, B-1264
B-1285 Gersing A.S.: B-0549, B-0557, B-0913, Glüer C.-C.: B-0493
Gao J.B.: B-0572, B-0599, B-0600, B-0733, B-1193 Gned D.: B-0030, B-0829
B-0734, B-0735 Gervais D.: B-0450 Gockner T.: B-0865

Godbert Y.: B-0298 Gregor J.: B-0979 Gündogdu B.: B-0598

Godt J.C.: B-0211 Gregori J.: B-1138 Gundogdu Secen O.: B-0066
Goebel J.: B-0411, B-1150, B-1152, B-1153, Gregori L.: B-0404, B-0501, B-0802 Gungor G.: B-0171
B-1316 Gregori L.M.: B-0687 Guni E.: B-1000
Goei D.: B-0852 Grehan J.M.: B-0142 Gunnlaugsson E.: B-0957
Goh V.J.: A-183, A-518, A-753 Greiser A.: B-0052 Günther M.: B-1138
Gökce S.: B-0769 Grenacher L.: A-264, A-267, B-1352 Guo C.: B-0134
Golay X.: A-293 Grenier N.: A-211, A-249, A-607, B-0932 Guo Y.: B-0025
Golding S.J.: A-499 Grenier P.A.: A-624, K-28 Gur E.: B-1199
Goldman D.A.: B-1063 Grévent D.: B-0163 Gür S.G.: B-0490
Gołębiowski M.: B-0113, B-0952 Griebel J.: A-485 Gürel S.: B-0490
Golfieri R.: B-1231, B-1233, B-1242 Grieser C.: B-0621 Gürer E.I.: B-1024
Goligher J.: B-0928 Griffiths M.: B-0924 Gutberlet M.: A-275, A-448, A-546, B-0462,
Goliszek S.: B-0113 Grigoriadis S.: B-0127, B-0330 B-0853
Golja A.: B-1380 Grimm J.: B-0362 Gutzeit A.: B-1041, B-1325, B-1388
Golsari A.: B-0634 Grimm R.: B-0312, B-0706 Guyomarc’h Delassale B.: B-1151
Gomez Ansón B.: B-1053 Grinstaff M.W.: B-0013 Guzzardi G.: B-1176, B-1375
Gomez B.: B-0560, B-0657 Grippo C.: B-0790 Gyebnár G.: B-0079, B-0080
Gommers S.: B-1064 Grisar J.: B-0070
Gonçalves D.: B-1048 Gristina L.: B-0016, B-0760, B-1069 H
Gontchar A.: B-0800 Groenewald W.: B-0173 H.N S.: B-0042
Goo J.M.: B-0623, B-1363 Gromov A.: B-0826 Ha H.K.: B-0040
Gooding M.J.: B-0436 Gromova E.: B-1340 Ha K.-Y.: B-0806
Goorts B.: B-0224, B-1276, B-1281 Groppo E.: B-0813, B-0964 Haack M.: B-0719
Goosens V.: B-0661 Großhennig A.: B-1367 Haage P.: A-490
Gordon A.: B-1275 Grosso M.: B-1371 Haaring C.: B-0060, B-0768
Gordon A.C.: B-0193 Grothoff M.: B-0462 Haas M.: B-0697, B-0945
Gormeli C.A.: B-0591 Grover S.B.: B-0761 Haasters F.: B-1182
Gosnell J.E.: B-0364 Gruber G.M.: B-0077 Habereder T.: B-0931
Götestrand S.: B-0957 Gruber-Rouh T.: B-0467, B-0470, B-0725 Habets J.: B-1078
Gotlieb M.: B-0226 Grueneisen J.: B-0560, B-0656, B-0657, Habib Geryes B.: B-1227
Goto M.: B-0223, B-0531, B-1277 B-0903, B-0905, B-1036, B-1058 Habib L.A.: B-1054
Goto Y.: B-1309 Grünig E.: B-0313, B-1043 Habib N.: B-0540
Gottardi D.: B-0659 Grunwald I.Q.: B-0972 Hachulla-Lemaire A.-L.: B-0588
Gottfried K.: B-0368 Gschwendtner M.: A-635 Hackenbroch M.: B-0167
Gottlieb P.A.: B-0360 Gu Y.J.: B-1070 Hacker U.: B-1144
Gottschalk A.: CTiR 1 Guan Y.: B-0847 Hacking N.: B-1369, B-1370
Gourtsoyianni S.: A-663 Guaricci A.I.: B-0377, B-0742, B-1075 Hadad Y.: B-0116
Gourtsoyiannis N.: A-219 Guarnieri G.L.: B-0620 Hadaschik B.A.: A-162
Goussia A.: B-1059 Guberina N.: B-0068, B-0507, B-1201, Hadley L.C.: B-1012
Gout O.: B-0363 B-1307 Haensig M.: B-0853
Gouveia N.: B-1146 Gubern-Mérida A.: B-0426, B-0527, B-0921, Hafskjold L.: B-0148
Grabherr S.: B-0362 B-1071, B-1137 Haftner T.: B-1146
Grabsch H.: B-0244, B-0245 Gückel B.: B-0023 Hagar A.: B-0862
Grainger A.J.: A-630 Guclu B.: B-1199 Hagelstein C.: B-0373
Gramer B.M.: B-0378 Gudziol V.: B-0559 Hahn H.K.: A-224
Grams A.E.: B-0499 Gueckel B.: B-0664 Hahn M.: B-1068
Granata G.: B-0393 Guennoc A.M.: B-1115 Hahnloser D.: B-0247
Granberg D.: B-0996 Guerin N.: B-0123 Haigh I.: B-1278
Granberg T.: B-0196 Guérin P.: B-1151 Hajnal J.: B-0897
Grande Icarán D.: B-0358 Guermazi A.: B-0548, B-0639 Hajnal J.V.: B-1385
Granell Moreno E.: B-1053 Guernieri M.: B-0103 Håkansson C.: B-0397
Granhus T.: B-1382 Guerquin-Kern J.-L.: B-0201 Hakkert M.: B-1383
Graser A.: A-423 Guerrini S.: B-1172 Hakumäki J.: A-389
Grass M.: B-0622, B-1353 Guglielmi G.: A-460 Hakyemez B.: B-0327
Grassedonio E.: B-0658 Guglielmo M.: B-0377, B-0742, B-1075, Hales P.: A-180
Grassi R.: A-578 B-1076 Halıcıoğlu S.: B-0490
Grassi Zamora C.: B-1225 Guidi M.: B-0958 Haliloglu M.: A-069
Grasso R.F.: B-0325 Guillaud O.: B-1088 Halimi P.: B-0320
Gratama J.W.: B-0789 Guimaraes J.: B-0549 Hall N.: B-0374
Gratama J.-W.C.: B-0114 Gulabi D.: B-1199 Haller B.: B-0341
Gratz M.: B-1150, B-1152 Güler F.: B-0939 Haller S.: A-427
Gray E.: A-227 Güler H.A.: B-0161 Halvorsen B.: CTiR 1
Greenberg D.: B-0686 Güllmar D.: B-0895 Hamagandi P.: B-1192
Greenberg S.: B-0116 Günbey H.P.: B-0082 Hambardzumyan A.: B-0170

Hamed M.F.: B-0544 Heikkinen S.: B-1155 Heußer T.: B-0668, B-0669
Hameed D.A.: B-1034 Heilmaier C.: B-0306, B-0310, B-1250 Heverhagen J.T.: B-1035
Hamm B.: A-161, A-695, B-0067, B-0621, Heilmeier U.: B-0551 Heywang-Köbrunner S.H.: A-550
B-0690, B-0697, B-0945, B-1174 Heinemann V.: B-0189, B-1322 Hibat-Allah S.: B-0162
Hammerstingl R.: B-0467, B-1222 Heinz G.: B-0283, B-0284, B-1240 Hidaka K.: B-1377
Hammoud S.: B-1191 Heinz M.: B-0617 Higashigaito K.: B-0176, B-0519, B-1289
Hamze B.: B-0809 Heinzel A.: B-0375 Highnam R.: B-1119
Han D.K.: B-0876 Heinz-Peer G.: A-199 Hijaz T.: B-1343
Han G.: B-1272, B-1295 Heiss P.: B-1299 Hilgendorff A.: B-0671
Han H.: B-0755 Helal M.: B-0612, B-1279 Hill A.: B-0119
Han H.Y.: B-1025 Helbich T.H.: B-0758, B-1259, K-27, B-0428, Hill C.: B-0924
Han J.K.: B-0011, B-0090, B-0410, B-0415, B-0944, B-1116, CTiR 2 Hillergård K.: A-406
B-0838, B-0842, B-1263, B-1297 Held U.: B-0438 Hillman B.J.: A-067
Han J.S.: B-0156 Hélénon O.: A-528, A-805 Hinen S.: B-0174
Han N.H.: B-0645, B-0646 Helfen T.: B-1182 Hinestroza M.F.N.: B-0243
Han N.Y.: B-0108, B-0131, B-0573, B-1232 Hellawell G.: B-0700, B-0947 Hinrichs J.: B-0978, B-1094
Han Na L.: B-1215 Hellbach K.: B-0671 Hinrichs J.B.: B-1044
Han S.: B-1038, B-1141 Helle M.: B-0666 Hirani N.: B-1218
Han Y.: B-0510 Helley D.: B-0097 Hirata S.: B-0466
Hanafy M.M.H.H.: B-1066 Hellmich M.: B-0295, B-0493 Hirner-Eppeneder H.: B-0931, B-0933,
Handlechner L.: B-0147 Hellström M.: A-239, B-0578, K-06 B-0934
Hansell D.: B-0112, B-0586, B-0587, B-1368 Helmberger T.K.: A-699 Hirsch A.: B-0013
Hansell P.: B-0575 Hempel J.-M.: B-0907 Hirsch J.: B-0667
Hansen D.: B-0181 Henareh L.: B-0749 Hirschmann M.T.: B-0076
Hansen J.: B-1047, B-1348, B-1352 Hendel T.: B-0667 Hirtler D.: B-0368
Hansson M.: CTiR 1 Hendriks B.H.: B-0225 Hjemly H.H.: A-405
Hansson O.: B-0397, B-0969 Hendriks B.M.F.: B-0473, B-0791, B-1040 Hladuvka J.: B-1146
Hao X.: B-0970 Hendrikse J.: B-0650 Hlavacek A.: B-0452
Haouin K.: B-0986 Henes F.O.: B-0361, B-0550, B-0642 Ho C.: B-1131
Hara M.: B-0495 Hengl C.: B-1035 Ho G.: B-1133
Hara T.: B-0615 Henkes H.: B-0401 Ho H.S.: B-0359
Harata N.: B-0688 Henner A.: B-0151, B-0585, B-0866 Hocquelet A.: B-1223
Harkness E.F.: B-1136 Hennermann J.: B-0769 Hodi F.S.: B-0512
Harmening C.: B-0401 Hensen B.: B-1367 Hodler J.: A-363
Harms S.: CTiR 2 Hensen B.J.U.: B-0939 Hoefer I.E.: B-0060, B-0768
Harris G.J.: B-0512 Hentschel H.: B-0492 Hoeffel C.: B-0094
Harris R.: A-367 Henzler T.: B-0373, B-0580, B-0739, Hoeper M.M.: B-1044
Harsaker V.: B-0345, B-1382 B-0836, B-1161 Hoff S.R.: A-388
Harth M.: B-0725, B-1222 Herazo-Bustos C.: B-0202 Hoffmann K.: B-0088
Hartley T.: B-0442 Herberich S.: B-1110 Hoffmann Nunes R.: B-0198, B-0200
Hartmann I.: A-028 Herholz K.: A-773 Hoffmann R.: B-0861
Hartung D.: B-0939 Herlihy D.: B-0644 Hoffmann T.: B-0883
Hartvig Sode A.: K-11 Hermann K.-G.: B-0067 Hoffmann U.: B-0744, B-0787, CTiR 2
Has A.C.: B-0082 Hermann S.: B-0067 Hoffstaedter F.: B-1341, B-1342
Hasegawa D.: B-0807 Hermans J.J.: B-0188 Hofmann F.: B-1322
Hashemi Taheri A.P.: B-0035 Hernández-Argüello M.D.: B-0344 Hofmann F.O.: B-0189
Hashim F.: B-0196 Hernández-Argüello M.D.D.: B-0702 Hofmann Gonzalez F.: B-0413
Hattori A.: B-0431 Hernandez-Martinez A.: B-0413 Hofmann M.: B-0478, B-1224
Hatw A.: B-1257 Hernández-Muñiz S.: B-1046 Hofmann P.C.: B-1349
Haubenreisser H.: B-0580, B-1161 Hernando D.: B-0982 Hofmann W.J.: B-1175
Haug A.-K.: B-0564 Hernigou A.-C.: B-0320 Hofvind S.: B-0148, B-1119
Hauge I.H.R.: B-1119 Herold C.J.: A-144, K-16 Hogan P.: B-1007
Hausegger K.: B-0973 Herregods N.: B-0069 Hogg P.: B-0307, B-0345, B-0353, B-0711,
Hausmann D.: B-0141 Herrmann K.: B-0899 B-0716, B-1119, B-1208
Haustermans K.: B-1323 Herth F.: B-0315 Höglund P.: B-0850
Havla L.: B-0965 Hervieu V.: B-1088 Hogue J.-C.: B-0021
Hayashi D.: B-0548 Herzen J.: B-0547, B-1149 Hohl M.: B-0619
He J.-R.: B-1031 Herzog D.: B-1212 Hohlfeld R.: B-1110
He Y.: B-0141, B-1327 Hesse N.: B-0189, B-1322 Hoischen J.: B-1316
He Z.: B-0505 Hetterich H.: B-1149 Holbrook A.: B-1131
Hebestreit H.: B-0314 Heudel P.E.: B-0123 Holch J.: B-0189, B-1322
Heck O.: B-0500, B-0971 Heusch P.: B-0099, B-0560, B-0656, Holden A.: B-0260
Hedman M.: B-0786 B-0657, B-0901, B-1036, B-1058 Holm T.: A-613
Heerink W.J.: B-0863 Heussel C.P.: A-237, B-0315, B-0433, Hölmich P.: B-0639
Heidari H.: B-1107 B-0439, B-0513, B-1214, B-1216 Holmin S.: A-596

Holtedahl J.E.: B-0211 Hunter K.: B-0018 Isabelle M.: B-0181

Holtman G.A.: B-0290 Hüper K.: B-0939 Isfort P.: B-0864
Holwein C.: B-1184 Hupkens B.J.P.: B-1160 Ishibashi R.: B-0405
Holzapfel K.: B-0341, B-0517 Hurley M.C.: B-0647, B-0652 Ishida K.: B-1039
Homampour S.: B-0109 Hurst R.W.: B-0801 Ishida M.: B-0807, B-1309
Honarmand A.: B-0647 Husarik D.: B-0176 Ishiguchi T.: B-0223, B-0531, B-1277
Honda H.: A-570 Hüsers K.: B-0877, B-0878 Ishii A.: B-0405
Hong D.: B-0576 Hutchinson B.: B-1017 Isidori A.: B-0941
Hong N.: B-0504 Hutt A.: B-0370 Iskra A.: B-1381
Hong Y.: B-0440 Hüttl A.: B-0261 Islam S.: B-0185
Hongo N.: B-1372 Hüttl K.: B-0261 Ismail A.: B-1095
Hope T.A.: B-0364 Huyskens J.: A-566 Isoda H.: B-0479
Hopkins S.J.: B-0709 Huysse W.: A-076 Isogai J.: B-0688
Hoppe H.: A-110 Hwang C.M.: B-0755 Ito N.: B-0864
Horch R.E.: B-0259 Hwang S.B.: B-0798 Itou C.: B-0615
Horcsik D.: B-0179 Hwang S.S.: B-0207 Ittermann T.: B-0667
Horehledova B.: B-0791 Hwang S.T.: B-0573 Ittrich H.: B-0478, B-1224, B-1353
Hori M.: B-0979 Ivanac G.: B-0474
Hornung A.: B-0312 I Ivanac K.: B-0474
Hornung M.: B-1300 Iacconi C.: B-0425 Iwase K.: B-0431
Horsch A.D.: B-0496 Iafrate F.: B-0238 Izhaky D.: B-0226
Horta M.: A-037 Iafrate S.: B-1226 Izlakar J.: B-1380
Horta R.G.: B-0486 Iannessi F.: B-0687 Izzo R.: B-1057
Horváth A.: B-0285 Iannicelli E.: B-0958, B-1142
Horváth B.: B-0457 Ianniello S.: B-0522 J
Hoste P.: CTiR 1 Iannitti M.: B-0238 Jackson A.: A-291
Hosten N.: B-0006, B-0981, B-0984, B-1299 Ichikawa S.: B-0466 Jackson D.M.: B-0729
Hou P.: B-0102, B-0477 Ichikawa T.: B-0615 Jackson S.A.: A-507
Houssami N.: CTiR 2 Ichikawa Y.: B-0807, B-1309 Jacob J.: B-0112, B-0586, B-0587, B-1368
Houston G.: B-0748 Ichisaka S.: B-0495 Jacobi V.: B-0432, B-0483
Hov J.R.: B-0008 Idee J.-M.: B-0201 Jacobs C.: B-1362
Howard M.L.: B-0145 Ienzi R.: B-0533 Jacobson J.A.: B-0076
Howarth N.: B-0347 Iezzi R.: A-295, B-0999 Jacomet P.-V.: B-0153
Howells T.: B-0203 Ikramov A.: B-1305 Jacquier A.: A-217
Howes A.: B-0353 Iles S.E.: B-1120, B-1125 Jäger D.: A-266
Hricak H.: A-223, A-476 Ilgner J.: B-0722, B-0724 Jager E.A.: B-0568
Hripun I.: B-0063 Ilhan H.: B-0997 Jager G.J.: B-0929
Hruska L.: B-0239 Ilic D.: B-1378 Jäger H.R.: A-185, A-481
Hu A.-N.: B-0962 Illomei G.: B-1108 Jäger R.: B-0823
Hua X.: B-0584 Imai T.: B-0223, B-0531, B-1277 Jager R.H.: B-0648
Huang J.: B-0024 Imam H.M.K.: B-0091, B-0563, B-1034 Jahn K.: B-0396
Huang L.: B-0445, B-0449 Imbriaco M.: B-0453, B-0824 Jahoda J.: B-0239
Huang S.: B-0445, B-0449 Imhoff A.B.: B-1184 Jain A.: B-0013
Huber A.: B-1158 Imhof-Tas M.: B-0535 Jain P.: B-0761
Huber R.: B-0990 Inagaki T.: B-0216 Jain S.K.: B-0761
Hubertus P.: B-0979 Inal M.: B-0161 Jakab A.: B-0077
Hübner J.: B-0006 Incesu L.: B-0082 Jakobs T.F.: A-046
Hücümenoğlu S.: B-1328 Indesteege I.: B-0543 Jambi L.K.: B-0033
Hudak A.: B-1144 Inecikli M.F.: B-0327 James K.: B-0795
Hudson J.M.: B-0187 Ingemansson R.: B-0850 Jamieson S.: B-0387
Huebner R.-H.: B-1212 Ingrisch M.: B-1110 Jang H.: B-1239
Huegli R.W.: B-0076 Innocenti E.: B-1076 Jang J.: B-0645, B-0646
Hughes A.: B-0648 Inokawa H.: B-0106 Jang J.H.: B-0651
Hughes M.C.: B-1063 Inoue M.: B-0216, B-1171 Jang J.K.: B-1360
Hughes N.M.: B-0024, B-1021 Introna T.: B-0421, B-1067, B-1256 Jang K.M.: B-0597
Huisman T.A.G.M.: A-750 Ioan I.: B-0923, B-1123 Jang M.: B-0530
Hummelink S.: B-1139 Iori M.: B-0922 Jang S.: B-1297
Hummler S.: B-0513 Iotti V.: B-0922, B-1062 Jang S.W.: B-0172
Humphreys H.: A-251 Ip J.: B-1133 Jang Y.R.: B-0090
Humphries P.D.: A-494 Ippolito D.: B-0092, B-0096, B-0299, Jankauskas A.: A-052
Hung M.L.B.: B-0321 B-0441, B-0448, B-0662, B-0767, Jankowski A.: B-1358
Hunink M.G.M.: A-068, A-257, B-0232, B-0770, B-0774, B-0775, B-0805, Jannone M.: B-1028
B-0237, B-0743 B-0835, B-1030, B-1084, B-1173, B-1196 Jans L.: A-076, B-0069
Hunold P.: A-216, B-1301 Iranzo V.: A-439 Jansen O.: B-0666
Hunter A.: B-0741 Isaac S.: B-1169 Janssen H.: B-0793, B-0820, B-0968

Jansson K.: B-0714 Joseph G.B.: B-0643 Kang T.W.: B-0597

Jaremko J.: B-0069 Ju X.: B-1029 Kantarci M.: B-0598, B-1081
Jaschke W.R.: A-412, B-0273 Juarez Garcia M.: B-0124 Kanz K.-G.: B-0517
Jaspers K.: B-0609, B-0610 Jugpal T.S.: B-0372 Kao K.: B-0424
Jazwiec P.: B-0062, B-0064 Jun H.Y.: B-1092 Kapetas P.: B-0423, B-0757, B-0758, B-1116,
Je B.-K.: B-0576 Jung C.: B-0478, B-1224 B-1259
Jech R.: B-1198 Jung D.C.: B-1239 Kaplan J.A.: B-0013
Jee W.-H.: B-0804, B-0806, B-0917 Jung E.M.: B-0475, B-1026, B-1300 Kaposi P.N.: B-0471
Jeevanandham B.: B-1333 Jung H.K.: B-0015 Kappelle L.J.: B-0496
Jegonday M.-A.: B-1049 Jung J.-Y.: B-0804, B-0806, B-0917 Kapustin V.: B-0826
Jengojan S.: B-0278, B-0279 Jung S.C.: B-0654, B-0817 Kara M.: B-0002
Jenkins W.: B-1218 Jung S.E.: B-0339, B-0738 Karaban I.: B-1338
Jennings G.: B-0001, B-0003 Jung S.I.: B-0464, B-1331 Karabulut N.: A-469, B-0598
Jensen C.: B-1153 Jung S.L.: B-0558, B-0646, B-0651 Karaca L.: B-0598, B-1081
Jentzsch T.: B-0438 Jung S.-L.: B-0645 Karady J.: B-0179, B-0747
Jeon H.J.: B-0464, B-1331 Jungmann P.M.: B-0547, B-1184 Karalok I.: B-1187
Jeon S.K.: B-1263 Jurado-Gómez M.C.: B-1020 Karaman C.Z.: A-736
Jeong C.Y.: B-0010 Juras V.: B-0491 Karampinos D.C.: B-0485, B-0547
Jeong S.-Y.: B-0884 Karanikas G.: B-0300, B-0660
Jeong W.K.: B-0839 K Karantanas A.H.: A-459
Jerebko A.K.: B-0670 Kaasalainen T.: B-1155 Karcaaltincaba M.: A-130
Jermendy A.: B-0179 Kabaalioğlu A.: B-1024 Karczmar G.: B-0429
Jermendy A.L.: B-0747, B-0766 Kachelrieß M.: A-098, B-0668, B-0669, Karenovics W.: B-0588
Jermendy G.: B-0179 B-0673 Karila Cohen P.: B-0633
Jernberg T.: CTiR 1 Kachenoura N.: B-0763 Karimi M.A.: B-0856
Jeung M.-Y.: B-0582, B-0986 Kadir T.: B-0436 Karkoshka T.: B-0063
Ji Q.: B-0595 Kadoya M.: B-0841 Karlas T.: B-0983
Ji Z.-B.: B-1228 Kadoya N.: B-0055 Karmazanovsky G.: B-0592, B-0732,
Jia G.: B-0825, B-0833 Kaeding C.: B-0556 B-1264, B-1267
Jia W.R.: B-0529, B-1031, B-1033 Kagawa K.: B-0731 Karmazanovsky G.G.: B-0624
Jianbo G.: B-0992 Kahkouee S.: B-0856 Karnabatidis D.: B-0618
Jiang X.: B-0445, B-0449 Kahn C.E.: B-0236 Karolyi M.: B-0747
Jiang Y.: B-0240, B-0268, B-0269, B-0504, Kahn J.: B-1174 Karpenko A.K.: B-0552
B-0962 Kahn T.: B-0074, B-0902, B-0906, B-0983, Karpenko M.: B-1340
Jiang Y.-J.: B-1269 B-1144 Karssemeijer N.: A-226, B-0527, B-0535,
Jiang Z.: B-1029 Kahraman A.S.: B-0591 B-0921, B-1071, B-1355
Jiao J.: B-0484, B-0577, B-1236 Kahraman B.: B-0591 Kartalis N.: B-1270
Jimenez R.: B-0521 Kainberger F.: A-374, B-0070 Karunyam B.: B-1370
Jiménez-Fonseca P.: B-1046 Kainz B.: B-1385 Karwoski R.: B-0112, B-0587, B-1368
Jimenez-Juan L.: B-0109 Kaiser A.: B-1070 Kasprian G.: B-0077
Jin G.Y.: B-0221 Kaiser C.: B-1070 Kassarjian A.: A-077
Jin W.: B-0073 Kaiser C.G.: B-0757 Kataeva G.: B-1340
Jin Y.: B-0752 Kalcan S.: B-0694 Kato T.: B-0431
Jin Z.: B-1177 Kalenderian A.-C.: B-0128, B-0329 Katsanos K.: A-477
Jin Z.Y.: B-1093 Kalia V.: B-0956, B-1188 Katulska K.: A-123
Jin Z.-Y.: B-0177, B-0571, B-0739, B-0836, Kälin P.: B-0640 Kauczor H.-U.: A-588, A-626, B-0313,
B-1235, B-1265, B-1266, B-1268 Kalina I.: B-0471 B-0315, B-0433, B-0439, B-0513, B-0667,
Jing X.: B-0857 Kalinin D.: B-0592, B-1264 B-0764, B-0865, B-1043, B-1047, B-1210,
Jingu K.: B-0055 Kallenbach K.: B-0764 B-1211, B-1214, B-1216, B-1348, B-1352
Jinzaki M.: B-1171 Kamal R.M.: B-1257 Kaufmann S.: B-0664
Jjubisavljevic S.: B-1109 Kaminaga S.: B-1364 Kaul M.G.: B-0478, B-0550, B-1224
Jobst B.: B-1211 Kamiya M.: B-0479 Kaup M.: B-0877
Jochelson M.S.: B-1063 Kampmann C.: B-0769 Kavcic P.: B-0886
Johannesen G.: B-0008 Kamusella P.: B-0616 Kawai H.: B-1051
John U.: B-0895 Kanana N.: B-0472, B-0680 Kawamitsu H.: B-0731
Johnson K.M.: B-0322, B-1099 Kanao S.: B-0216 Kawashima A.: B-0706
Johnson R.: B-1188 Kandel S.: B-1204 Kawooya M.G.: A-083
Johnsson M.: B-0397 Kane T.: B-0353 Kayan M.: B-0002
Jonas E.: A-064 Kang B.C.: B-0138 Kaza R.: B-0692
Jones J.: B-0796 Kang B.J.: B-0606, B-0756 Kazmierczak P.: B-0296, B-0933
Jones J.F.X.: B-1376 Kang C.H.: B-0918 Kazmierczak P.M.: B-0931, B-0934
Jonkman L.E.: B-1105 Kang E.-J.: B-0182 Kelekis A.: B-0127, B-0330
Joo I.: B-0415, B-0842, B-1263, B-1297 Kang H.J.: B-0604 Kelekis N.: B-0127, B-0330
Jordan E.: A-442 Kang J.W.: B-0349 Keller J.: B-1198
Jorge J.: B-0716 Kang M.: B-0406 Keller S.: B-0007, B-0634

Kelly B.: K-35 Kim K.: B-0755 Kloth C.: B-0039, B-0297
Kelly B.S.: B-1019 Kim K.A.: B-0207, B-0208, B-0601, B-0837 Kløw N.-E.: B-0211
Kelly J.F.: B-1119 Kim K.W.: B-1025 Klug D.: B-1175
Kelly P.: B-0352 Kim M.D.: B-1102 Kluge S.: B-0855
Kelten C.: B-1280 Kim M.J.: B-0108, B-0131, B-0573, B-1232 Kluijfhout W.P.: B-0364
Kemper J.: B-1132 Kim M.Y.: B-0676, B-0678, B-0681, B-1073, Klumpp B.: B-0039, B-0297
Kendler D.: B-0027 B-1154, B-1215, B-1360 Knapp K.M.: B-0709
Keohane D.: B-0644 Kim N.: B-1366 Knaudt J.: B-1070
Kerber J.: B-0740 Kim R.: B-0287 Knaup M.: B-0673
Kerckhoffs K.: B-0496 Kim S.: B-0406, B-0558, B-0756, B-1272, Knauth M.: A-039
Kerl J.M.: B-1077 B-1295 Knebel F.: A-113
Kerl M.: B-0186 Kim S.H.: B-0011, B-0463, B-0597, B-1234 Kneidinger N.: B-0229
Kerl M.J.: B-0213 Kim S.J.: B-0015, B-0207, B-0654, B-0817 Kniepeiss D.: B-0417
Kersten E.: B-0244, B-0245 Kim S.K.: B-0349 Knoflach M.: B-0499
Kessels A.G.H.: B-0191, B-0192 Kim S.M.: B-0530, B-1073, B-1154 Knopp M.: B-0833
Kessler D.E.: B-0861 Kim S.T.: B-0090 Knopp M.U.: B-0556
Keupers M.: B-1357 Kim S.Y.: B-1102, B-1234 Knopp M.V.: B-0028, B-0029, B-0374,
Keyzer F.D.: B-1141 Kim T.: B-0979 B-0556, B-0825
Khaled W.: B-0037 Kim T.H.: B-0011, B-0169, B-0180, B-1234 Knopp T.: B-0478, B-1224
Khalid M.: B-0013 Kim T.-H.: B-1092 Knuuti J.: A-009, A-449, CTiR 1
Khan F.: B-0748 Kim W.H.: B-1324 Ko K.H.: B-0015
Kharat A.: B-1293 Kim W.S.: B-0169, B-0172 Kobashi Y.: B-1189
Khashoggi K.: B-0708 Kim Y.D.: B-0653 Kobayashi Y.: B-0194
Khomenko J.: B-1340 Kim Y.J.: B-0169, B-0464, B-0755, B-1025, Koceva I.: B-1380
Khoo J.L.S.: B-0799 B-1331 Koch G.: B-0323
Khouatra C.: B-0117 Kim Y.K.: B-0839 Koch S.: B-1003
Khung S.: B-0590, B-0987 Kim Y.P.: B-1073, B-1154 Kochhar R.: B-1167
Kianirad Y.: B-1343 Kim Y.S.: B-0798 Kock M.: B-0852
Kickingereder P.: B-0282 Kim Y.T.: B-1363 Kock M.C.J.M.: B-0012
Kidikas H.: B-0816 Kinkel K.: A-128, A-402 Kockelkoren R.: B-0650
Kido T.: B-0382 Kinner S.: B-0165, B-0411, B-1036, B-1301, Koek D.H.: B-0650
Kiechl S.: B-0499 B-1316 Koell M.: B-1047
Kiessling F.M.A.: A-365 Kirkham A.: B-0948 Kogler M.: B-0910
Kietselaer B.L.J.H.: B-0473, B-0791 Kishida Y.: B-0316, B-0319, B-0655, B-0684, Koh D.-M.: A-085, A-339, B-0185, B-1258,
Kilander L.: B-0388 B-0685 B-1325
Kilburn-Toppin F.: A-026 Kiss M.: A-765 Koh M.: B-0854
Kilickesmez Ö.N.: B-1280 Kiss O.: B-0248 Koh S.H.: B-0528
Kilsdonk I.D.: B-1105 Kitagawa K.: B-0384, B-0385, B-0807, Kohler R.: A-143
Kim A.Y.: B-0040 B-1309 Koikkalainen J.: A-601
Kim B.: B-0221, B-0409, B-0416, B-0463 Kitakawa K. : CTiR 2 Koizumi J.: B-0615
Kim B.R.: B-0406, B-1284 Kitis O.: B-0085 Kok H.K.: B-0267
Kim B.S.: B-0651 Kitrou P.M.: B-0618 Kok M.: B-0473, B-0791, B-1040
Kim B.-S.: B-0645, B-0646 Kitslaar P.: B-0744 Kokan M.: B-0495
Kim D.J.: B-0576 Kitzler H.H.: B-0559 Kokosi M.: B-1368
Kim E.Y.: B-0594 Kiyosue H.: B-0405, B-1372 Kokovic T.: B-1378
Kim G.C.: B-1324 Kızıldağ B.: B-0065, B-0066, B-0637 Kolahdoozan S.: B-0035
Kim G.M.: B-1102 Kjaer A.: A-515, A-754 Koletzko L.: B-0229
Kim H.: B-1318 Kjelle E.: B-0148 Kollmann C.: B-0534
Kim H.A.: B-0207 Klang E.: B-0472, B-0680, B-0686 Kolokythas O.: B-0554
Kim H.C.: B-1025 Klauser A.: A-156, B-0273, B-0740, B-0960 Kolossvary M.: B-0179, B-0747, B-0766,
Kim H.J.: B-0040, B-1073, B-1154, B-1324 Klauß M.: B-1047, B-1352 B-0788
Kim H.-J.: B-0530 Klausz R.: B-1354 Komori Y.: B-0479
Kim H.O.: B-0010 Klaver R.: B-1105 Kömür B.: B-1199
Kim H.R.: B-0676 Kleiker M.: B-0716 Kondratyev E.: B-0732
Kim H.S.: B-0654, B-0817 Klemm T.: B-0853 Konen E.: B-0472, B-0680, B-0686
Kim H.W.: B-0884 Klengel A.: B-0074 Kong E.: B-0596
Kim I.-O.: B-0169, B-0172 Klengel S.: B-0074 Konietzke P.: B-0433, B-0439
Kim J.: B-0409, B-1102 Klimaj Z.: B-0079, B-0080 Konijnenberg M.: B-0936
Kim J.E.: B-0010, B-0838 Klinder T.: A-032 Kono A.: B-0731, CTiR 2
Kim J.H.: B-0090, B-0839 Kljucevsek D.: A-495 Konovalov P.: B-0800
Kim J.K.: B-0187 Klode J.: B-0908 Koo H.J.: B-0349, B-0676, B-0681, B-1360
Kim J.M.: B-0414 Kloeckner R.: A-538, B-0412, B-0907 Koo H.-S.: B-0073
Kim J.S.: B-0073 Klompenhouwer E.G.: B-0925 Koo J.: B-0645
Kim J.W.: B-0601, B-0653, B-0837, B-0975 Klos A.: B-0939 Kooi M.E.: B-0056
Kim J.Y.: B-0604, B-0884 Klose H.: B-0855 Kooijman H.: B-0007, B-0058, B-0485

Kooijman-Kurfuerst H.: B-0634 Kristoffersen-Wiberg M.: B-0196 Kwon S.O.: B-0876

Kook S.H.: B-0754 Kristofferzon M.-L.: B-0814
Kool D.R.: A-496 Kroczek E.: B-0690 l
Kool W.: B-0036 Kroiss A.: B-0027 la Fougère C.: B-0023, B-0664, B-0904
Koole M.: B-1141 Kroiss E.: B-1026 La Fuente J.M.: B-0703
Koopman M.: B-0995 Kromrey M.-L.: B-0006, B-0981, B-0984, La Grutta L.: B-0658
Koops A.: B-0622 B-1299 La Marra A.: B-0324, B-0331, B-0332,
Körber A.: B-0068 Kronnerwetter C.: B-0491 B-0959
Kording F.: B-0007 Kroon W.: B-0114 La torre L.E.: B-0745
Koren A.: B-0886 Kröpil P.: B-0044, B-0099, B-0394, B-0545 Laader A.: B-1301
Korhonen M.: B-0786 Krotenkova I.: B-1111 Läänelaid Z.: B-1016
Koritnik B.: B-0886 Krotenkova M.: B-1111 Labani A.: B-0582, B-0986
Korkmaz M.F.: B-0270 Kruck S.: B-0704 Labori K.J.: B-0211
Korkusuz F.: B-0274 Krug B.: B-0295, B-0493 Labus S.: B-1351
Körner E.: B-0292 Krych A.J.: B-0557 Lacoste B.: B-1283
Kornreif C.: B-0273 Ku M.C.: B-0562 Laenen A.: B-0543
Kors J.A.: B-0232 Ku Y.M.: B-0038 Lafitte F.: B-0153
Körsmeier K.: B-0909 Kubik-Huch R.A.: A-235, A-452, A-637 Lagalla R.: B-0658
Korta Gómez I.: B-0358 Kubo T.: B-0405 Laghi A.: A-003, A-513, B-0780, B-0783,
Korutz A.W.: B-1343 Kudryavtseva E.: B-0895 B-0941, B-1142
Korzeniowski K.: B-1374 Kuestner T.: B-0593 Lahaye M.: B-0244, B-0245
Koşar P.: B-1328 Kuganesan A.: B-0737 Lahaye M.J.: B-1166
Koshurnikov D.: B-0826 Kuhl C.: B-0375, B-0722, B-0864 Lahkim M.: B-0367
Koskas P.: B-0153 Kuhl C.K.: A-090, B-0724 Lai A.Y.T.: B-0799
Koskinen S.K.: B-0689, B-0691 Kuhl C.K.K.: A-457 Lai B.M.H.: B-0799
Kosma V.-M.: B-1118 Kühn A.L.: B-0972 Laissy J.P.: B-0633
Kosta P.: B-1059 Kuhn F.P.: B-1191, B-1195 Lajarín Cano L.: B-1112
Koster I.: B-0852 Kühn J.-P.: B-0006, B-0981, B-0984, B-1299 Lalji U.: B-1064
Köstler H.: B-0314, B-1045 Kuhnigk J.-M.: B-1212 Laloo F.: B-0069
Kosugi T.: B-0479 Kuijer P.P.F.M.: B-1179 Lam M.: B-0995
Kotb H.T.: B-0808 Kuijpers D.: B-0789 Lam S.: B-1133
Kotb M.: B-0663 Kukkes T.: B-1016 Lam T.: B-1133
Kotter E.: A-013 Kukkola K.: B-0233 Lam W.: B-1133
Koudstaal P.: B-0400 Kulkarni K.: B-0429 Lambert B.: B-0320
Koumarianos D.: A-650 Kullberg J.: B-0388 Lambert L.: B-0239
Kousaka J.: B-0223, B-0531, B-1277 Kumar Gg S.: B-1262 Lambert M.: B-0748
Kovac J.D.: B-0214 Kumar J.: B-0372 Lambertova A.: B-0239
Kovač V.: B-0317 Kümpfel T.: B-1110, B-1114 Lambregts D.: B-0244, B-0245, B-0776,
Kovács A.: B-0766 Kündel M.: B-0312 B-1165
Koyama H.: B-0316, B-0319, B-0655, Kunst D.: B-0727 Lambregts D.M.: A-341, A-665
B-0684, B-0685 Kuntner-Hannes C.: A-364 Lambregts D.M.J.: B-0191, B-0192, B-1160,
Kozák L.R.: B-0079, B-0080 Kuntz J.: B-0673 B-1163, B-1166, B-1168
Kozerke S.: A-276, A-420 Kunz A.S.: B-0314, B-1045 Lammers J.-W.J.: B-0488, B-1365
Kracke T.: B-1367 Kunz M.: B-0794 Lamot U.: B-1106
Kraff O.: B-0909 Kunz W.G.: B-0793, B-0965 Lamparski K.: B-1374
Krainik A.: A-292, B-0500, B-0971 Kupcs K.: B-0816 Lanca L.: B-0716
Kramer H.: B-0088, B-0982, B-1099, B-1315 Kupka M.: B-0361 Landgraeber S.: B-0909
Kramer J.: A-458, A-564 Kuplevatsky V.: B-0830, B-0831 Landoni C.: B-1030
Krämer S.: B-0295 Kurfürst M.: B-0574, B-0993 Lane N.: B-0551
Krauss B.: B-1349 Kurobe Y.: B-0807 Lane S.: B-0143
Kravchick S.: B-0827 Kurozumi M.: B-0841 Lang W.: B-0259, B-0262, B-0617
Krazinski A.W.: B-1203 Kurra V.: B-0512 Langner S.: A-056
Krdzalic J.: B-0776 Kurre W.: B-0398, B-0399, B-0401 Langs G.: B-0077
Kreitner K.F.: B-0412 Kurucz P.: B-0401 Laniado M.: A-662, B-0559
Kreitner K.-F.: A-629, B-0455 Kus S.: B-0848, B-1140 Lannsjö M.: B-0203
Kremser C.: B-0273, B-0960 Kushner D.C.: A-290 Lantuejoul S.: B-1358
Kress B.: CTiR 1 Kussmaul J.: B-1135 Lanza E.: B-0325
Krestan C.R.: A-462 Kuzmiak C.M.: B-0755 Lanzman R.: B-0545
Krestin G.: B-0743 Kvyatkovskaya E.: B-0831 Lanzman R.S.: B-0099, B-0394
Krestin G.P.: A-148, A-454 Kwak H.S.: B-0798 Lapidus G.: B-1181
Kretzschmar M.: B-0643 Kwee R.: B-0056 Laporte S.: B-1195
Kreuter M.: B-0315 Kwee R.M.: B-0930 Laqmani A.: B-0574, B-0855, B-0993
Krick S.: B-0907 Kwon H.: B-0416, B-1284 Lardenoije S.: B-0921
Kristoffersen L.: B-0345 Kwon H.Y.: B-0138 Laredo J.D.: B-0809
Kristoffersen Wiberg M.: B-0390 Kwon S.H.: B-0546 Largo Flores P.: B-1096

Larici A.R.: A-215, A-759, B-0677, B-0679, Lee J.B.: B-0676, B-1360 Leporq B.: B-0977, B-1088
B-1361 Lee J.H.: B-1023, B-1092 Lerch M.M.: B-0984
Lario C.: B-0566, B-0659 Lee J.-H.: B-0839 Leschka S.: CTiR 1
Larkman N.: B-1278 Lee J.M.: A-063, B-0208, B-0409, B-0410, Lester M.: B-1343
Larrue V.: B-0818 B-0415, B-0651, B-0838, B-0842, B-1025, Lesyuk O.: B-0713, B-0873, B-1006, B-1386
Larson A.C.: B-0193 B-1263, B-1297, K-33 Letellier A.: B-1049
Larsson E.-M.B.: A-672, B-0388, B-0814 Lee J.S.: B-0040, B-0415 Leunen K.: B-1037
Larsson I.-M.: B-0814 Lee J.S.Z.: B-0227 Leung J.: B-1133
Larvie M.: B-0390 Lee K.: B-0528, B-0645 Leung L.: B-0988
Lätt J.: B-1055 Lee K.B.: B-0011, B-0410 Leung W.K.W.: B-0799
Lattanzi R.: B-0404, B-0501, B-0687, Lee K.W.: B-0918 Leuschner G.: B-0229
B-0802 Lee M.: B-0266, B-0267, B-1318 Leutz P.: B-1216
Lau C.-S.: B-0784 Lee M.A.: B-1324 Lev M.: B-0390
Lau C.-Y.: B-0086 Lee M.H.: B-0918 Lewington V.: A-426
Lau K.K.: B-0729 Lee M.J.: A-492 Lewis S.: B-0143, B-0741
Lau K.K.-P.: B-0737 Lee N.: B-1272, B-1295 Ley S.: B-0313, B-1043
Lau S.M.: B-0988 Lee N.J.: B-0654, B-0817 Leyes M.: A-693
Lau V.: B-1133 Lee R.: B-0321 Li H.: B-0966
Lauenstein T.C.: B-0411, B-0900, B-1301 Lee R.W.: B-0918 Li J.: B-1243
Laule M.: B-0383 Lee S.: A-278, B-0416, B-0646, B-0651, Li K.: B-0935
Launay N.: B-1195 B-0913, B-1284 Li L.: B-1042
Lauren H.: B-0882 Lee S.-C.: B-1154 Li N.: B-1330
Laurent F.: B-1358 Lee S.E.: B-0627 Li Q.: B-0510
Laurent L.: B-0308 Lee S.H.: B-0396, B-0576 Li T.: B-0992
Lauretti D.L.: B-0093 Lee S.I.: B-0512 Li W.: B-0193
Lauritzen C.: B-1321 Lee S.-K.: B-0395, B-0653, B-1337 Li X.: B-0089, B-0445, B-0449, B-0773
Lause S.: B-0396 Lee S.L.: B-0038 Li X.B.: B-0289, B-1052, B-1056
Lauvin M.A.: B-1115 Lee S.M.: B-0415, B-1324, B-1366 Li X.-T.: B-1317
Lavin P.T.: B-0217 Lee S.W.: B-0349 Li Y.: B-0773, B-0938, B-0966
Lawaczeck R.: B-0159 Lee S.-Y.: B-0806 Li Z.: B-0445, B-0449
Lawson R.: B-0353 Lee T.F.: B-0799 Lian Y.: B-0240
Lawton C.B.: B-0254 Lee W.K.: B-0395, B-0653, B-1337 Liapin V.M.: B-0898
Lazic L.: B-0214 Lee Y.: B-0156 Liasis N.: A-010
Lazik A.: B-0909 Lee Y.H.: B-0215, B-1092 Lieba-Samal D.: B-0278, B-0279
Łazowska-Przeorek I.: B-0893 Leemans A.: A-107 Lightfoot C.B.: B-1120, B-1125
Le Pennec V.: B-1049 Leenders G.J.L.H.: B-0340 Liguori C.: B-0518
Le Pimpec-Barthes F.: B-0320 Lees J.E.: B-0033 Lilic G.: B-0214
Le Touze D.: B-1151 Lefere P.: A-240 Lim A.: B-1275
Leach M.O.: B-1258 Lefèvre-Colau M.-M.: B-1191, B-1195 Lim C.: B-0182
Leale G.: B-1176 Legou F.: B-0104 Lim K.-S.: B-0083, B-0086
Leander P.: B-0730 Lehmkuhl L.: B-0853 Lim S.: B-0678, B-0681
Leber A.: B-0378 Lehn C.: B-0028 Lim S.M.: B-0395, B-0653, B-1337
Lechel U.: B-0373 Lehner S.: B-0997 Lima F.R.A.: B-1141
Lecler A.: B-0153, B-0157, B-0363, B-1121 Lehnert T.: B-0470, B-0877, B-0976 Lin C.E.: B-0424
Leconte I.: B-1283 Lehotska V.: B-1255 Lin J.: B-0445, B-0449, B-0966
LeCoultre R.: B-1286 Lei J.: B-1093 Lind L.: B-0388, CTiR 1
Lederlin M.: B-1216, B-1358 Lei P.: B-0484, B-0577, B-1236 Linda A.: A-793, B-0605
Ledger A.: B-1117 Leicher-Düber A.: B-0412 Lindberg E.: CTiR 1
Lee B.-F.: B-0940 Leidenberger T.A.U.: B-0764 Lindberg O.: B-0397
Lee C.H.: B-0208, B-0601, B-0837, B-1363 Leidner B.: A-497 Lindberg P.: B-1195
Lee C.-H.: B-0975 Leiner T.: A-300, A-422, B-0060, B-0765, Linder N.: B-0983, B-1144
Lee Christoffersen C.: B-0730 B-0768, B-0787, B-1365 Lindner T.: B-0666, B-0690
Lee D.H.: B-0654, B-0817, B-0838, B-0842, Leitgeb N.: A-173 Lindvall H.: B-0730
B-1297 Lell M.: A-001, A-253, B-0879, B-0880, Linglart A.: B-0367
Lee D.Y.: B-1102 CTiR 2 Link T.: B-0643
Lee E.S.: B-1263 Lemmens K.: B-0920 Link T.M.: B-0549, B-0551, B-0557, B-0913
Lee G.M.: B-1092 Lemmerling M.: A-609 Linov L.: B-0827
Lee H.: B-0156 Lemos A.A.: B-0525 Linsenhoff L.: B-0361
Lee H.A.: B-0215 Leni D.: B-1196 Linsenmaier U.: A-306
Lee H.J.: B-0208, B-0601, B-0837 León C.A.: B-0243 Linz D.: B-0619
Lee H.N.: B-0676, B-0681 Leon P.: B-0699 Liss P.: B-0575
Lee I.J.: B-0854 Leone M.B.: B-0111 Lissandrin R.: B-1085
Lee J.: B-0180, B-0182, B-0406, B-0416, Leonhardt H.: B-0559 Lista A.: B-0772
B-0427, B-0440, B-0526, B-0601, Lepida A.: B-0618 Lisý J.: B-0728
B-0837, B-0876, B-1284 Leporcq B.: A-542 Littleford R.: B-0748

Litton J.-E.: A-324 Lu A.: B-0316 Mahmood U.: B-0450, B-1350

Littvay L.: B-0061 Lu C.-L.: B-1083 Mahmoud E.M.M.: B-0567
Liu H.: B-1093 Lu M.: B-0744 Mahmoudi S.: B-0967
Liu J.: B-0135, B-1042, B-1285 Lu Q.: B-1083 Mahnken A.H.: B-0258, B-1035, B-1349
Liu J.-H.: B-0784 Lu X.: B-0723, B-0736 Mainenti P.P.: B-0465
Liu J.-M.: B-0177 Lu Y.: B-0288 Maintz D.: B-0047, B-0048, B-0167, B-0295,
Liu L.: B-1162 Lubbers M.M.: B-0743 B-0953
Liu S.: B-0682, B-0847 Lubinus F.G.: A-779 Maiocchi L.: B-1085
Liu T.: B-0744 Lucarelli N.M.: B-0631 Mair K.: B-1354
Liu W.: B-1268 Lucarini S.: B-0943 Maisano F.: B-0176
Liu X.: B-0504 Lucatelli P.: B-0061, B-0537 Majer M.: B-0821
Liu Y.: A-271, B-0391, B-0504, B-0510 Lucchini R.: B-0923 Majumdar S.: B-0557, B-0913
Liuzzi R.: B-0824 Luciani A.: B-0104 Mak K.-F.: B-0784
Ljuhar D.: B-1146 Lucidarme O.: B-0699 Makowski M.R.: A-008, A-186
Ljuhar R.: B-1146 Ludes C.: B-0985, B-0986 Makynen A.: B-0233
Llopis E.: A-628 Ludwikowska J.: B-0911, B-0914 Malagari K.: A-304
Lo G.: B-0988 Luecke C.: B-0853 Malago R.: B-0054
Lo Goh G.: B-0321 Luedtke C.W.: B-0616 Malamateniou C.: A-284, A-560, B-0897,
Lo S.S.W.: B-0799 Luijten P.R.: B-1105 B-1385
Lobbes M.: B-0420, B-1064, CTiR 2 Lund G.: B-0049 Malavasi S.: B-0437
Lobbes M.B.I.: B-0224, B-1276, B-1281 Lund G.K.: B-0382, B-1156 Malavaud B.A.: B-0337
Loberg C.: B-0375, B-0722, B-0724 Lundén M.: A-408 Malavé Dos Santos A.M.: B-1138
Lobo M.L.: A-070 Lunder A.K.: B-0008 Malcolm P.: B-0980
Lodato L.: B-0533 Luo X.: B-0963 Maldur V.: B-0532
Loeuille D.: B-0071 Luo Y.: B-1083 Malekzadeh R.: B-0035
Loewe C.: A-007, A-298, A-547, A-770 Lupusoru R.: B-1086, B-1087 Maleux G.: B-0543
Logager V.: A-742 Lurie D.J.: A-713 Mali W.P.T.M.: B-0650, B-1082
Lohezic M.: B-1385 Lütje S.: B-0900 Mallarajapatna G.: B-0042
Lohöfer F.: B-0547 Lv P.: B-0101 Mallat Z.: B-0763
Lohrke J.: B-0195 Lv P.J.: B-0572 Malmquist T.: B-0957
Lokar K.: B-1381 Lyadov V.: B-1296 Malmqvist K.: B-0749
Lombardi S.: B-0096, B-0441, B-0448, Malta B.: B-0241
B-0770 M Maly Sundgren P.C.: A-177, A-202, A-376,
Lombardo F.: B-0819 M.Ali R.M.K.: B-0307 A-437
Lombardo S.: B-0536 Ma B.: B-0557 Mami F.: B-0856
Lomovtseva K.K.: B-0592 Ma F.H.: B-0132 Mamisch-Saupe N.: B-1186
Longman C.: B-0759 Maas M.: A-500, A-512, A-627, B-0191, Mañas-Garcia A.: B-0701
Longo N.: B-0824 B-0192, B-0776, B-0954, B-1160, B-1163, Mancini A.: B-0045, B-1311
Longo R.: B-1140 B-1165, B-1166, B-1168, B-1179 Mancuso E.: B-0532
Loo C.E.: B-0225 Maataoui A.: B-0357 Mancuso V.: B-1060
Loo K.: B-1319, B-1320 Maccarone M.: B-0389 Mandal A.: B-0761
Loose R.: B-1000 MacDonald S.: A-296 Manfredi M.: B-0829
Loose R.W.R.: A-654 Macera A.: B-0566 Manfredi R.: A-535, A-722, B-0004, B-0005
Lopci E.: A-429 Maciag R.: B-1374 Mang T.: A-241
Lopes A.M.A.: B-0486, B-0635 Mack M.G.: A-505, A-589, A-612 Manganaro L.: B-0168, B-0894, B-0896,
Lopes Dias J.: A-311 Mackay S.: B-0143 B-1334
Lopez B.: B-0672 MacNee W.: B-1213 Mangiarotti M.: B-0874
Lorca Chapa J.: B-1260 Macron L.: B-0381 Mangili G.: B-1028
Lorenc T.: B-0952 Madani G.: A-002 Mangin P.: B-0362
Loreni G.: B-1005 Maderthaner R.: B-1079 Mangino D.A.: B-1063
Lorente M.F.: B-0521 Maderwald S.: B-1150, B-1152, B-1153 Mangold S.: B-0174, B-0175, B-0263,
Lorenzoni G.: B-0093 Madrid J.M.: B-0702, B-1128, B-1129, B-1306, B-0264, B-0452, B-0456, B-0783,
Lorusso F.: B-0468 B-1313 B-0785, B-1072
Losio C.: B-0608, B-1273, CTiR 2 Maes J.: B-0803 Mani N.B.S.: B-0539
Loss M.: B-1300 Maestre H.: B-0521 Maniawski P.: B-0029
Lötjönen J.: A-601 Maffi P.: B-0160 Manikis G.C.: B-1270
Lotte R.: B-0320 Magdy A.M.: B-0840 Manka R.: A-679, CTiR 2
Lotz J.: B-0014, B-0218, B-0222 Magerkurth O.: B-0076 Mann M.J.: B-1008
Loureiro J.: B-0603, B-0753 Maggini E.: B-0532 Mann R.: B-0527, B-0535
Louwman M.W.: B-0925 Magnussen R.: B-0556 Mann R.M.: B-0022, B-0217, B-0426,
Løvblad K.-O.: A-718 Magometschnigg H.: B-0428 B-0921, B-1071, CTiR 2
Löve A.: B-0957 Mahajan M.: B-0423 Mannelli L.: B-1350
Lowe J.: B-1007 Maher B.: B-1369, B-1370 Manninger M.: B-0052, B-0257
Loxley N.: B-0672 Mahfoud F.: B-0619 Manos D.: B-1206
Lozano Martinez A.: B-1053 Mahlke C.: B-0981, B-0984 Mansueto G.: B-1103

Manyonda I.: A-683 Martus P.: B-0023, B-0383, B-0664 Mazzocco C.: B-0932
Mao F.: B-0095, B-1228 Martynov P.: B-0233 Mazzoni L.N.: B-0943
Marano R.: A-200, B-0790 Maruno M.: B-1372 Mazzotta D.: B-0425
Maras Ozdemir Z.: B-0270 Marwitz L.: B-0990 Mbalisike E.: B-0862
Marathu K.K.: B-0043 Mas A.: B-0521 Mc Guire V.: B-1247
Marcel S.: B-0855 Masarwah A.N.J.: B-1118 Mc Nulty J.: B-0143, B-1247
Marchetti A.: B-0139 Mascarenhas J.G.C.: B-1384 McCavert M.: B-0266
Marchionni E.: B-0168 Mascarini L.: B-0742 McCulloch C.E.: B-0551, B-0643
Marco S.: B-0201 Maschek S.: B-0555 McEntee M.F.: B-1119
Marcon M.: B-0220, B-0423 Masciocchi C.: B-0045, B-0255, B-0324, McGrath C.: A-714
Marcus R.: B-0292, CTiR 1 B-0331, B-0332, B-0959, B-1100, B-1226, McGrath F.: B-0266
Marcy P.-Y.: K-02 B-1311, B-1361 McHugh K.: A-521
Mardanshahi Z.: B-1113 Masi R.: B-0045, B-0255, B-1311 McKnight L.: A-438
Mare R.: B-1086, B-1087 Masmejean E.: B-0276 McKnight W.: B-0033
Maresky H.S.: B-0360 Massaroni C.: B-0674 McNulty J.: A-557, A-559, B-0146, B-0352,
Maria Grazia R.: B-1273 Massmann A.: B-1002, B-1104, B-1229 B-1252
Mariani D.: B-0881 Mastier C.: B-0128, B-0329 Meakin J.R.: B-0709
Mariani S.: B-0324, B-0331, B-0332, B-0959 Masulovic D.: B-0214 Mearadji B.: B-0451
Marias K.: B-1270 Matapathi U.: B-0043 Medici M.: B-1358
Marin A.: B-1213, B-1218 Matchin Y.: B-0750 Meel-van den Abeelen A.S.S.: B-0022
Marincek B.: A-721 Matheoud R.: B-0392 Meera P.: B-0561
Marincu B.-N.: B-0197 Mathieu M.-C.: B-1061 Meeuwis C.: B-0217
Marini C.: B-0425 Mathoulin Pelissier S.: B-0298 Mehrez H.: B-0109
Marino M.A.: B-0220, B-0423, B-0757 Mathys C.: B-0402, B-1341, B-1342 Meier M.: B-0939
Marino M.-A.: B-0428 Matínez-Miravete P.: B-1128 Meijer A.: B-0727
Marino M.A.A.: B-0758, B-1259 Matoori S.: B-1325, B-1388 Meijering L.: B-0589
Mariscotti G.: B-1130 Matos C.: A-061, A-159 Meijs M.F.L.: B-1078
Markali B.: B-0716 Matosevic B.: B-0499 Meinel F.: B-1203
Marklund N.: B-0203 Matouskova T.: B-0508 Meinel F.G.: B-0229, B-0386, B-0671,
Marmuse J.P.: B-0633 Matsumoto S.: B-1372 B-0746, B-0793
Maroldi R.: A-074, A-204, B-0249 Matsunobu Y.: B-0430 Meister A.: B-0342
Maroof S.: B-0305 Matthews A.: B-0442 Mejdoubi M.: B-0821
Marosi G.: B-0788 Mattila J.: A-601 Mekis N.: A-763, B-1248, B-1380, B-1381
Marques M.: B-1014 Mattsson S.: A-391 Melamud K.: B-0693
Marra P.: B-0626, B-0629, B-1145, B-1298 Mauf S.: B-0438 Meliadò G.: B-1253, B-1254
Marrosu M.: B-1108 Mauge L.: B-0097 Melis L.: B-0333
Marsecano C.: B-0255, B-0326 Maurea S.: B-0465 Meloni G.B.: B-0254, B-0538
Marshall N.W.: B-1356 Maurer M.H.: B-0621, B-0690 Melzig C.: B-0313, B-0865, B-1043
Marten-Engelke K.: A-470 Maurer T.: B-0341 Menassel B.: B-1169
Martens D.: B-0402 Mauri G.: B-0120, B-0122, B-0125 Menchi I.: B-0943
Martens E.: B-1356 Maurizi Enrici M.: B-0369 Mendes E.: B-0514
Martens J.P.J.: B-0765 Maurovich Horvat P.: B-0061 Mengel E.: B-0769
Martens M.: B-1165 Maurovich-Horvat P.: B-0179, B-0744, Menicagli L.: B-0923
Martí R.: B-1137, B-1138 B-0747, B-0766, B-0788 Menovsky T.: B-0403
Martí-Bonmatí L.: A-157, A-543, B-0701, Mavrovi E.: B-0123, B-0128, B-0329 Mensel B.: B-0981
B-1112 May M.: B-0879 Mentzel H.-J.: B-0895
Martin S.: B-0967 May M.S.: B-0880 Menu Y.: A-317, A-435
Martin S.P.: B-0588 May R.: B-0402 Menzilcioglu M.S.: B-0171
Martin S.S.: B-0432, B-0483, B-1178 Mayer J.: A-030 Mercer C.E.: A-352
Martìn Suàrez S.: B-0111 Mayer P.: B-1047 Meriot P.: B-0720
Martín V.S.: B-0243 Mayerhoefer M.: B-0300, B-0660 Merkel A.: B-0281
Martinelli P.: B-0465 Mayerle J.: B-0984 Merkely B.: B-0179, B-0248, B-0457, B-0747,
Martínez C.: B-0443 Mayor A.: B-0306 B-0766, B-0788
Martinez Gamarra C.: B-1282 Mayr A.: B-0740 Merkle E.M.: B-1286
Martinez R.: B-0401 Mayr D.: B-1149 Merlino B.: B-0790
Martinez Rubio C.: B-1260 Mayrhofer M.T.: A-325 Mershina E.: B-1296, B-1310
Martinez Torrens F.: B-1225 Mayrhofer T.: B-0744, B-0787 Mertelmeier T.: B-0670
Martínez-de-la-Haza D.: B-1046 Mazioti A.: B-0127, B-0330 Merzoug V.: B-0367
Martini K.: B-0846 Mazouni C.: B-1061 Mesrar J.: B-0665
Martins S.R.R.: B-1384 Mazur G.: B-0062, B-0064, B-0771 Messa A.: B-1117
Martinsen A.C.T.: B-0105 Mazza E.: B-0291 Messias N.: B-0717
Martinuk T.: B-0750 Mazzei F.G.: B-1172 Messina C.: B-1143
Martirosian P.: B-0593, B-0704 Mazzei M.A.: B-1172 Messiou C.: B-1335
Martola J.: B-0196, B-0390 Mazzeo S.: B-0121 Metaxa L.: B-0018
Martucci M.: B-0164 Mazzetti S.: CTiR 2 Metin Y.: B-0694

Metkees M.K.: B-0087 Mohamed R.E.-E.-D.: B-1001 Mota R.M.V.: B-0486

Metsälä E.: B-1009 Mohanty H.: B-0042 Motara H.: B-0387
Metschke M.: B-0855 Mohanty H.S.: B-1262 Motosugi U.: B-0206, B-0322, B-0466,
Metzenmacher M.: B-0657 Möhlenbruch M.: B-0497 B-0982, B-1099
Meuli R.: B-0247, B-0362, B-0977, B-1286 Mohr F.W.: B-0853 Mottaghy F.: B-0375
Meyer A.: B-0259, B-0262, B-0986 Mok W.: B-1258 Mottaghy F.M.: B-0056, B-0224, B-1276
Meyer B.: B-1094 Molinari F.: A-167 Motton M.: B-0832
Meyer B.C.: B-1044 Möller T.: B-1291 Mou T.: B-0024
Meyer E.: B-0986 Molloy M.: B-0644 Mouri Y.: B-0223, B-0531, B-1277
Meyer M.: B-0580 Molnár A.Á.: B-0766, B-0788 Mouridsen K.: B-0282
Meyer-Baese A.: B-1116 Monaco C.G.: B-0120 Mousa A.E.: B-1050
Miccoli A.: B-1100, B-1226 Monetti F.: B-0016 Moussa E.M.: B-1034
Miccoli P.: B-0121 Montalto C.: B-0241 Mousseaux E.: B-0763
Michaud K.: B-0362 Montauban van Swijndregt A.: B-0451 Moustafa A.S.: B-0544, B-0998
Michelini G.: B-0255 Montealegre Angarita A.C.: B-0124 Mozer P.: B-0699
Michell M.J.: B-0928 Monteiro M.: B-0350 Mraity H.A.A.B.: B-1208
Michels G.: B-0047, B-0048 Montemezzi S.: B-0832, B-1253, B-1254 Mrakic Sposta F.: A-430
Michielsen K.: B-1038, B-1357 Montet X.: A-181, A-795, B-0588 Mubarak F.: B-0649
Michielsen K.L.M.: B-1037 Monti L.: B-0890 Mueller A.-C.: B-0664
Michoux N.: B-1283 Montorsi F.: B-0343 Mueller D.: B-0570
Mickley H.: CTiR 1 Montorsi P.: B-0480 Mueller J.: B-0429
Midiri M.: B-0658 Moon J.H.: B-0528 Muellerleile K.: B-1156
Miederer M.: B-0907 Moon J.Y.: B-0597 Mueller-Lisse U.: B-0342, B-0990
Miele V.: A-121, B-0522 Moon K.C.: B-1234 Mueller-Lisse U.L.: B-0342
Miese F.: B-0044 Moon S.M.: B-0015 Muellner A.: B-1274
Miettunen K.: B-1009 Moore C.: B-0948 Muenzel T.: B-0455
Miglāne E.: B-0816 Mor E.: B-0226 Mühlfeld C.: B-0052
Miglietta S.: B-0941 Mora J.A.: B-0202 Muir K.: B-0118
Migliorisi C.: B-0772 Moraitis N.: B-1205 Mukund A.: B-0009
Mihl C.: B-0473, B-1040 Morán Hevia M.: B-0683 Mulè A.: B-0658
Mikhaylova E.: B-0889 Morana G.: A-510, B-0745 Mulé S.: B-0094
Miki Y.: A-572 Morawska K.: B-0514 Muley T.: B-0513, B-1214
Mikšík L.: B-0728 Morden J.: B-1275 Mulla V.: B-0042
Mikulis D.: A-294 Moreira J.: B-1014 Mullan D.: B-1167
Mildenberger P.: A-259, A-585, A-734 Morel J.: B-0928 Mullen S.: B-1247
Miligkos D.: B-1370 Moreno P.: B-0641 Müller A.: B-0619, B-1088
Milles J.: B-0954 Moretti M.: B-0425 Müller H.: B-0417
Millor M.: B-1129 Morgan P.S.: B-0149 Müller M.: B-0853
Milosevic Z.: B-0419 Morgan R.: A-768 Müller-Eschner M.: B-0764
Milot L.: B-0187 Morgunov M.: B-0063 Müller-Forell W.: B-0769
Milukhina I.: B-1340 Mori H.: B-0405, B-1372 Münch J.: B-0049
Milwidsky A.: B-0116 Mori N.: B-0429 Munoz del Rio A.: B-0206
Min C.-K.: B-0806 Morillo A.: A-782 Muñoz Ruiz A.L.: B-0683
Minthon L.: B-0397, B-0969 Morishita J.: B-0430, B-0431 Muraglia S.: CTiR 1
Miraglia F.: B-0393 Moritz K.: B-1114 Murakami T.: A-573, B-0106
Mirminachi B.: B-0035 Moriyasu F.: B-0194 Murashima S.: B-0807
Mirón Mombiela R.: B-0641 Morlando M.: B-0465 Murchison J.: B-0118, B-1213
Mirsadraee S.: B-1213, B-1218 Morley N.: B-0118 Murphy F.J.: B-1379
Misery L.: B-0665 Morozov S.: A-580 Murphy J.: B-0795
Mitropolskii N.: B-0233 Morozova S.: B-1111 Murphy P.: B-0024
Mitrovic M.: B-0214 Morris E.A.: B-1063, B-1274 Murray T.: B-0266
Mittler J.: B-0412 Morrish O.: A-357 Mus R.D.: B-0426
Miyazaki M.: B-0316, B-0319 Morrison W.B.: B-1180 Muscogiuri G.: B-0369, B-0452, B-0456
Miyazaki T.: B-0688 Morsbach F.: B-0519, B-0570 Mushtaq S.: B-0377, B-0742, B-1075, B-1076
Miyoshi T.: B-0872 Morscher S.: B-0908 Mussen E.: B-1037
Mizandari M.: B-0540 Morse J.: B-0145 Mustonen P.: B-0786
Mizzi A.: B-0149 Mortazavi A.: B-0833 Mutanen L.: B-0233
Mnif N.: B-0046, B-1308 Moschetta M.: B-0421, B-0631, B-1067, Muthurangu V.: A-421
Moccetti M.: B-0874 B-1256 Mutlu I.N.: B-1280
Mochizuki T.: B-0382 Mosconi C.: B-1231, B-1242 Muto G.: CTiR 2
Mochula O.: B-0461 Moser M.: B-0931, B-0934 Muto M.: A-359, B-0620, B-1057
Modestino F.: B-1231 Moskovic E.: B-1335 Mutschler C.: B-0276
Mogami T.: B-1189 Moskowitz C.S.: B-1063 Muuronen A.T.: B-0786
Mohamad M.T.: B-0243 Mosso E.: B-0053 Mylanus E.: B-0727
Mohamed Hoesein F.A.A.: B-0488 Mostbeck G.H.: A-047, A-333 Myles J.: B-1127

N Nelassov N.: B-0063 Noferini L.: B-0943

Na H.-S.: B-0864 Nelemans P.: B-1064 Nogueira L.: B-0603, B-0703, B-0753
Nabil H.: B-0133 Nelemans P.J.: B-1281 Nonnekens J.: B-0936
Nadrljanski M.: B-0419 Nemes B.: B-0261 Noordmans J.P.D.: B-0036
Naganawa S.: B-0479, B-1051 Nensa F.: B-1058, B-1150, B-1152, B-1153, Noppe N.: B-0661
Nagasawa N.: B-0384, B-0385 B-1307, B-1316 Nordemar D.: B-0810
Nagata M.: B-1309 Nerad E.: B-0244, B-0245 Nørgaard B.: CTiR 1
Nagel H.D.: B-0993 Nerestyuk Y.I.: B-1267 Nörenberg D.: B-0088
Nagel H.-D.: B-0574 Neri E.: A-014 Norman B.: B-1146
Nagel H.W.: B-0026 Nestle U.: A-671 Nosenzo F.: B-0760
Naggara O.: B-1227 Neuhaus V.: B-0295 Notohamiprodjo M.: B-0292, B-0312,
Nagle S.: B-0206 Neuhaus V.-F.: B-0953 B-0593, B-0704
Neuwelt E.: B-0285 Notohamiprodjo S.: B-1149
Nagle S.K.: B-0322
Neuwirth J.: K-25 Nour-Eldin N.-E.: B-0129, B-0130, B-0357,
Naguib N.: B-1004
Nevalainen M.T.: B-1180 B-0725, B-0860
Naguib N.N.N.: B-0467, B-0470, B-0725,
Nevitt M.C.: B-0548, B-0549, B-0551, Nour-Eldin N.-E.A.: B-0467, B-0470, B-1178
B-0860
B-0643 Nova Vaca D.: B-1225
Naguib N.N.N.N.: B-0129
Newby D.E.: B-0741 Nozawa Y.: B-1189
Nagy A.: B-1373
Newell M.: B-1131 Nummela M.T.: B-0689
Nagy E.: B-1373
Ng A.H.: B-0033 Nunes R.G.: B-0603, B-0753
Nair A.: B-0112, B-0586, B-0587, B-1217
Ng M.-Y.: B-0784 Nunez D.: A-308
Nair A.V.: B-0561
Nganga E.C.: B-0481 Nuñez Marín F.: B-1053
Nair T.: B-0440
Nguyen H.: B-0825 Nunziata A.: B-0293
Nakagawa T.: B-0688
Nguyen H.T.: B-0833 Nutting A.C.: B-0452
Nakajima Y.: B-0055
Nguyen-Kim T.D.L.: B-0438 Nuyts J.: B-1357
Nakamori S.: B-1309
Niccoli A.A.: B-0631 Nyberg L.: A-109
Nakamura Y.: B-0431
Nichelatti M.: B-0772 Nyhsen C.: A-248, A-502
Nakane T.: B-1051
Nicholson P.: B-0795 Nyman R.: B-0996
Nakano S.: B-0223, B-0531, B-1277
Nicolai E.: B-0453
Nakatsuka S.: B-1171
Nicoletti R.: B-0291 O
Nakayama R.: B-0807
Nicolucci A.: B-1140 O’ Brien F.: B-0338
Nandikoor S.: B-0042, B-1262
Nieboer K.H.: A-498 O’ Hora L.: B-1170
Nanni C.: B-1231
Niederstadt T.: B-0398, B-0399 O’ Regan K.: B-0338
Nanni I.: B-0137
Nielsen M.B.: B-1321 O’ Donohoe M.: B-1170
Nanz D.: B-0640, B-0698, B-1190 O’Leary D.: B-1122
Nieman K.: B-0743, CTiR 2
Nappi C.: B-0453 Niessen W.J.: A-605 Obadia M.: B-0363
Narbuts Z.: B-1022 Nieuwenhuijzen G.: B-0420 Obdeijn I.-M.: CTiR 2
Nardo L.: B-0913, B-1319, B-1320 Nieuwenhuis E.R.: B-0380 Öberg J.: B-0810
Nas Ö.F.: B-0327 Nievelstein R.A.J.: A-445 Oberholzer K.: B-0455
Nasatti A.: B-0092, B-0805 Niezen A.: B-0743 Oberndorfer S.: B-0283, B-0284
Nasr H.A.: B-0509 Nightingale J.M.: B-1379 Obodov V.: B-0154
Nassenstein K.: B-0507, B-1150, B-1152, Nightingale P.: B-0716 Obolonczyk L.: B-1027
B-1153, B-1201, B-1307, B-1316, B-1351 Niiniviita H.: B-0882, B-1207 Ocak G.A.: B-1024
Natale L.: A-680 Nijholt W.: B-0711 Occhipinti M.: A-644, B-0677, B-0679
Nattenmüller J.: B-0513 Nikiforaki K.: B-1270 O’Connor M.: B-0346, B-0710
Natwa M.: B-0374 Nikitovic M.: B-0419 Oechsner M.: B-1045
Nau E.: B-0153 Niklas C.: B-1104 Offermans J.: B-0867
Nava Tomás E.: B-0683 Nikolaou K.: A-273, B-0023, B-0039, Offiah A.C.: K-09
Navarra F.: B-0687 B-0175, B-0263, B-0292, B-0297, B-0312, O’flynn E.: B-1117
Navas C.: B-0202 B-0593, B-0664, B-0704, B-0861, O’Flynn E.A.M.: B-1258
Navichenka A.: B-0800 B-0904, B-1068, CTiR 2 Ognard J.: B-0665, B-0949
Navin P.: B-1017 Nikolic T.: B-0214 Ogul H.: B-0598, B-0625, B-1081
Nazer P.K.: B-0561 Nikseresht A.: B-1107 Ogur M.G.: B-0082
Nazeri M.: B-1107 Nilsson A.: A-120 Oguro S.: B-1171
Nazli M.A.: B-0219, B-1280 Nilsson M.: B-0730 Oh D.K.: B-0812
Nchimi A.: B-0181 Nio C.Y.: B-0444 Oh J.: B-0416, B-1284
Nechaev V.: B-0849 Nishii T.: B-0731 Oh S.J.: B-0576
Nederveen A.: B-1148 Nissan N.: B-0602 Oh S.W.: B-0395, B-1337
Nederveen A.J.: B-1091 Nitrosi A.: B-0922, B-1062 Oh S.Y.: B-1366
Neff K.W.: B-0373 Nitzsche S.: B-0853 Oh Y.T.: B-1239
Negård A.: B-0008 Niu J.: B-0548 Ohana M.: B-0582, B-0986
Negi N.: B-0106, B-0731 Nobel M.: B-0228 Ohno Y.: B-0106, B-0316, B-0319, B-0655,
Negrelli R.: B-0004, B-0005 Nobili E.: B-0480 B-0684, B-0685, B-1364
Nehrer S.: B-1146 Nobre R.R.: B-0486, B-0635 O’Hora L.: B-0867, B-1247
Nekolla S.G.: A-323 Nobusawa H.: B-1039 Oikari S.: B-1118

Oikarinen H.: B-0585 Ouyang R.: B-0051 Paprottka P.M.: B-0997

Oikonomou A.: A-707 Ouyang R.Z.: B-0253 Parakh A.: B-0302, B-0304, B-0570, B-1288
Okada H.: B-0872 Owens C.: A-081, A-791 Paravasthu M.: B-1204
Okazaki T.: B-1364 Owman T.: A-708 Pardo J.: B-0344, B-0702
O’Keeffe S.: B-0018, B-0759 Oyen R.H.: A-051, A-210, A-332 Parenti G.C.C.: B-0137
Oleaga Zufiría L.: A-785 Ozdemir O.: B-0694 Pargewar S.: B-0009
O’Leary D.: A-710, B-1012 Ozdemir Z.M.: B-0591 Parizel P.M.: A-269, A-482, A-566, B-0204,
Oliva G.: B-0422, B-0881 Ozgen Mocan B.: B-0726 B-0205, B-0403, B-0803, B-1287
Oliveira M.V.L.: B-0868 Ozgokce M.: B-0625 Park A.: B-0562
Oliver Goldaracena J.M.: B-1282 Ozkan O.: B-1099 Park B.J.: B-0108, B-0131, B-0573, B-1232
Oliver T.B.: B-0916 Ozolins A.: B-1022 Park C.: B-1272
Oliveri A.: B-0347 Öztek M.A.: B-1024 Park C.H.: B-0180
Olsson K.: B-1044 Öztürk F.: B-0885 Park C.M.: B-0208, B-0601, B-0623,
Olusoga T.: B-0387 Ozturk K.: B-0190 B-0837, B-0975, B-1363
Omelchenko O.: B-1338, B-1344 Park D.: B-1023
Omori M.: B-0466 P Park G.E.: B-0806
on behalf of CENTER-TBI Ramachandran P.V.: B-0561 Park H.C.: B-0839
Participants&Investigators.: B-0204 Paalimäki-Paakki K.: B-0151, B-0866 Park H.J.: B-0040, B-1263, B-1366
Onatsu J.: B-0786 Pacciardi F.: B-0209 Park H.S.: B-0464, B-1331
O’Neill D.C.: B-0644 Pacho R.: B-0893 Park J.: B-0182, B-0842, B-1263
O’Neill J.E.: B-1389 Padhani A.R.: A-396, A-696, B-0700, Park J.E.: B-1023
O’Neill S.B.: B-0644 B-0947 Park J.-E.: B-0169
Ong M.: B-0867 Padrón M.: A-689 Park J.S.: B-0073, B-1324
Onishi H.: B-0466, B-0979 Padroni M.: B-0813 Park J.Y.: B-0415, B-0842
Onofrj V.: B-0393 Padula C.: B-0344 Park S.B.: B-0569
Onu M.: B-1339 Paek M.Y.: B-0806 Park S.H.: B-0040, B-1239
Onur M.R.: B-0274 Pagonidis K.: B-1205 Park S.I.: B-1102
Oosterbroek J.: B-0568 Pahn G.: B-1047, B-1348, B-1352 Park S.J.: B-0623
Oral A.: B-0085 Paias P.: B-0351 Park S.-J.: B-1073
Ordás I.: B-0446 Palásthy Z.: B-1373 Park S.Y.: B-0073, B-0207, B-1025, B-1239
O’Regan K.N.: B-0024 Palazzini M.: B-0111 Park Y.S.: B-0208, B-0601, B-0837, B-0975
O’Reilly M.K.: B-1376 Palczewski P.: B-0113, B-0952 Parkar A.P.: A-263, A-764, B-0075
Orhan Metin N.: B-0694 Palfrey R.M.: B-0709 Parkkonen J.: B-0786
Origgi D.: B-0103 Palkó A.: A-193, A-195, A-382, A-744, A-787, Parlier C.: B-0809
Orlandi D.: B-0271 B-1373 Parthipun A.: B-0365
Orlando A.A.M.: B-0533 Palm F.: B-0575 Partington K.: B-0961, B-1387
Örnberg G.: A-410 Palmisano A.: B-0251, B-0256, B-0779, Partovi S.: B-0313, B-1043
Örnek K.: B-0161 B-0781, B-1028, B-1074, B-1273 Parziale G.: B-1176
Örnek N.: B-0161 Palmqvist S.: B-0397, B-0969 Pascual I.: B-0344, B-0702
Orsenigo E.: B-0291, B-0629 Palumbo F.: B-0348 Pasquali R.: B-1242
Orsi F.: A-117, B-0125 Palussiere J.: B-0298, B-0325 Pasquier H.: B-0104
Orsi M.: B-0881 Pameijer F.A.: A-522, B-0568 Passari A.: B-0137
Orsi M.A.: B-0422 Pampaloni M.H.: B-0364, B-1319, B-1320 Passoni P.: B-0779, B-0781
Orsini E.: B-0299 Pan J.: B-0505, B-0511 Passot G.: B-1169
Orsini E.B.: B-0662 Panahi B.: B-0129, B-0860 Pastor C.: B-0977
Ortega M.I.R.: B-0350 Panajotu A.: B-0747 Pastorelli L.: B-0447
Ortiz-Pérez J.T.: A-299 Panci S.: B-1170 Patak M.A.: A-050
Ossadnik C.: B-0492 Panebianco L.: B-0045, B-1311 Patel C.: B-0387
Ost P.: B-0942 Panebianco V.: A-102, A-697, B-0946 Patel D.: B-0119
Østergaard L.: B-0282 Panés J.: B-0446 Patriarca L.: B-0959, B-1311
Östgren C.J.: CTiR 1 Panfili M.: B-0081 Patro S.: B-1192
Osuga K.: B-1377 Panizo C.: B-0969 Patrolecco F.: B-0020
O’Sullivan F.: B-0024 Panizza P.: B-0608, B-1273 Patsoura S.: B-0818
Ota H.: B-0055, B-0110 Pannatier M.: B-0247 Pattacini P.: B-0922, B-1062
Otani K.: B-0988 Pannekoek-Hekman M.: B-1179 Patti C.: B-0658
Othman A.: B-0292, B-0297, B-0704 Pans S.: B-0661 Pattyn E.: B-0942
Othman A.E.: B-0039 Pantrangam P.: B-0043 Paul N.: B-0109
Otsubo K.: B-0479 Panzeri M.M.: B-0608, B-1273 Paulo G.: A-417, A-561, B-0348, B-0870,
Ottonello C.: B-0354 Paoli M.: B-0045, B-1311 B-1245, B-1248
Oudkerk M.: A-447, B-0376, B-0380, Paolini M.: B-0990 Pavel M.: B-0041
B-0386, B-0488, B-0609, B-0610, Papadimatos P.: B-0618 Pavlicek W.: B-0303
B-0789, B-0863, B-1362 Papadopoulos D.: B-1242 Pavlovic - Stankovic D.: B-0419
Ouhlous M.: B-0743 Papanikolaou N.: A-158, A-340, A-666, Pawha P.: B-1197
Ourednicek P.: B-0239 B-1270 Payet C.: B-1169
Oustwani C.S.: B-1343 Paprottka K.J.: B-0997 Peacock C.: B-0928

Peck D.: A-652 Pfirrmann C.W.A.: B-0915 Poeppel T.: B-1058

Pecorelli N.: B-0184 Pham M.: B-0497 Poerio A.: B-1233
Pedicini V.: B-0325 Philippens M.E.: B-0568 Pofi R.: B-0454
Pediconi F.: A-246, A-756, B-0532, CTiR 2 Phyu S.M.: B-0937 Pohar K.: B-0833
Pedraza S.: B-0498, B-0502, B-0503, Pianykh O.: B-0234, B-1290 Poiares B.: B-0870
B-1271 Picard C.: B-0763 Poillucci G.: B-0476
Pedrazzini F.: B-1371 Picart H.: B-0157 Poiraudeau S.: B-1195
Peeters R.: A-172 Picchia S.: B-0780 Pokieser P.: A-503
Peetrons P.: A-021 Piccini D.: B-0452 Polanec S.: B-0944
Pegoretti K.: B-0897 Piccolo C.L.: A-121, B-0522 Polkowski C.: B-0994
Peireira P.L.: B-0865 Pichi A.: B-0238 Pomianowska A.: B-0911, B-0914
Peix M.: B-0123 Pickup L.C.: B-0436 Pompe E.: B-0488
Pekarovic D.: A-766 Pieber K.: B-0491 Pomschar A.: B-0396, B-1114
Pekel G.: B-0155 Piemonti L.: B-0160 Ponhold L.: B-1240
Pelage J.-P.: B-1049 Pienkowska J.: B-0183 Pons E.: B-0232, B-0237
Peldschus K.: B-1219 Pietras J.: B-0500, B-0971 Ponsiglione A.: B-0453
Pelgrim G.J.: B-0376, B-0380, B-0386 Pignataro P.: B-0468, B-0631 Ponsioen C.I.J.: B-0451
Pellegrin A.: B-1101 Pijnapel R.M.: B-0610 Pontillo Contillo B.: B-0121
Peltonen J.: B-1155 Pijnappel R.M.: A-213, B-0217, B-0609, Pontone G.: A-321, B-0377, B-0480, B-0742,
Peng W.: B-1029 B-1064 B-1075, B-1076
Peng W.J.: B-1070 Pillai A.: B-0387 Poole K.E.S.: B-0912, B-1147
Peng Z.M.J.H.C.S.-T.F.: B-0032 Pilleul F.: B-0123, B-0128 Poole Z.: B-0175
Pennycooke K.: B-0267 Piludu F.: B-0393 Pop C.M.: B-0315
Pepi M.: B-0377, B-0480, B-0742, B-1075, Pimentel Silva R.: B-0620, B-1057 Popescu A.: B-1086, B-1087
B-1076 Pina Insausti L.J.: A-345 Popolizio T.: B-0326
Pereira A.: B-0870 Pina L.: B-1128, B-1129 Popova Y.: B-1354
Pereira C.: B-1387 Pinault S.: B-0021 Pöppel T.: B-0068
Pereira J.G.: B-1048 Pingitore A.: B-0366 Poreba M.: B-0062, B-0771
Pereira P.L.: A-118 Pinheiro J.P.: B-0150, B-0152, B-0713, Poreba R.: B-0062, B-0064, B-0771
Perez Aguilera S.: B-0328 B-0717, B-0869, B-0873, B-1006, B-1246, Poretti D.: B-0325
Perez J.: B-0521 B-1251 Porta N.: B-0941
Perez M.E.: B-0536 Pinilla R.: B-0350 Portalez D.: B-0337
Perez R.: B-0701 Pinker-Domenig K.: A-229, B-0428, B-0758, Portelli J.: A-443
Pérez-Jeldres T.: B-0446 B-0944, B-1116, B-1259, K-34, CTiR 2 Portelli J.L.: B-1252
Pérez-Tejada J.C.: B-1020 Pinto D.: B-0152 Posa A.: B-0999
Perinetti M.: B-0760 Pinto dos Santos D.: A-399, B-0412 Post H.: B-0052, B-0257
Perisinakis K.: B-1205 Pinto N.M.: B-1010, B-1249, B-1386 Potreck A.: B-0497
Perkins A.C.: B-0033 Pipková R.: B-0728 Potretzke T.: B-0206
Perkuhn M.: B-1165, B-1166 Piraner M.: B-1131 Pottecher P.: B-0809
Perret T.: B-0971 Pirnazarov M.: B-1305 Pouwels P.J.W.: B-1105
Perri M.: B-0326 Pisani Mainini A.: B-0122, B-0923, B-1123 Pozzi Mucelli R.: B-0004, B-0005, B-0054,
Pershina E.: B-0462, B-1310 Piskun B.: B-0800 B-0136, B-0819, B-1103
Persson A.: A-011 Pitcher R.D.: B-0173 Pozzi-Mucelli R.: A-508
Persson M.: CTiR 1 Pivec C.: B-0278, B-0279 Prasse A.: B-1367
Perucchini E.: B-0525 Pizarro A.: B-0851 Prayer D.: A-639, B-0077
Perugin Bernardi S.: B-0271 Pizzolato R.: B-0476 Preibsch H.: B-1068
Pescatori L.C.: B-0120, B-0447, B-1143 Pizzuti A.: B-0168 Preinbergs M.: B-0816
Pesente S.: B-1140 Placido R.: B-1220 Prenen H.: B-0543
Petracchini M.: B-0566, B-0659, B-0829 Plakhotina N.: B-1194 Presilla S.: B-0874
Petralia G.: B-0700, B-0705, B-0947, Plank F.: B-0740 Previtali S.: B-0638
B-0950 Planken R.N.: B-0792, B-1148, B-1179 Prevoo W.: A-617
Petrash E.: B-0889 Plasencia-Martínez J.M.: B-1046 Prevrhal S.: B-1353
Petres A.: B-1378 Plass A.: B-0176 Price A.: B-0897, B-1385
Petrides N.: B-0948 Platz Batista da Silva N.: B-1300 Pricolo P.: B-0705, B-0950
Petrillo A.: B-0293 Platzek I.: B-0559 Priedītis P.: B-1018, B-1022
Petrini M.: B-0252, B-0459 Platzgummer H.: B-0278, B-0279 Prieto Fernández A.: B-0683
Petros F.G.: B-0825 Plesinac - Karapandzic V.: B-0419 Priola A.M.: B-0030
Petrov D.: B-1357 Plodeck V.: B-0559 Priola S.M.: B-0030
Petrover D.: B-0809 Ploumen E.H.: B-1281 Priovolos D.: B-1261
Petrozza V.: B-0941 Plum J.: B-0229 Procter A.J.: B-0980
Petullà M.: B-1076 Pobozy T.: B-0275 Profili S.: B-0538
Peynircioglu B.: A-189 Podgorska J.: A-005, B-0893 Prokop M.: A-599, B-1362
Pfannenberg C.: B-0023, B-0039, B-0664, Podobnik G.: A-354 Pronin I.N.: A-178
B-0904 Podvratnik M.: B-1381 Prosch H.: A-165
Pfeiffer F.: B-0671 Poellinger A.: B-1212 Prothmann S.: B-0398, B-0399

Pruijssers S.R.: B-0192 Rahmat K.: B-0083, B-0086 Reetz K.: B-1341
Pruszczyk P.: B-0113 Rahmouni A.: B-0104 Refaat M.: B-1089
Pu T.: B-0059 Rai A.: B-1214 Regent B.: B-0183
Pucci S.: B-1233 Raimondi E.: B-0241, B-0813, B-0834, Regge D.: A-242, A-579, CTiR 2
Puchner A.: B-0070 B-0964, B-1238 Regier M.: B-0550, B-0574, B-0642,
Puchner S.: B-0744 Rainer P.: B-1079 B-0993, B-1353
Puech P.: A-740 Rainford L.: B-0867, B-1122, B-1170, B-1247, Regnard N.-E.: B-1191
Pueyo J.: B-1306, B-1313 B-1248, B-1252 Regus S.: B-0617
Pueyo J.C.: B-1312 Rainford L.A.: B-0142, B-0708 Reh C.: B-0258
Puget S.: B-0163 Raininko R.: B-0203, B-0814 Rehwald W.G.: B-0456
Puglia M.: B-0453 Raiola G.: B-0366 Reichkendler M.: B-0910
Puglielli E.: B-0404, B-0501, B-0802 Raithel E.: B-1188 Reid J.H.: B-0118
Puglielli E.G.: B-0687 Rajagopalan S.: B-0112, B-0586, B-0587 Reijnierse M.: A-153, B-0071
Pugliese F.: B-0386, CTiR 2 Rajan Mj G.: B-1262 Reimer R.: B-1224
Puig J.: B-0498, B-0502, B-0503, B-1271 Rajesh S.: B-0009 Reinboldt M.: B-0411
Pulido M.: B-0298 Rajgopal D.: B-0611 Reinstrup P.: B-0850
Pullens P.: B-0204 Ramalho J.: B-0198, B-0200 Reis C.: A-353
Puppato M.: B-1101 Ramalho M.: B-0198, B-0200 Reis C.S.D.: B-0345
Purdie C.: B-0427, B-0526 Raman S.R.: B-0956 Reiser M.F.: B-0058, B-0229, B-0296,
Purz S.: B-0902, B-0906 Ramasundara S.: B-1127 B-0342, B-0671, B-0777, B-0793, B-0931,
Pusceddu C.: B-0333 Rames J.: B-0785 B-0933, B-0934, B-0965, B-0968,
Puylaert C.A.J.: B-0444 Ramirez D.: B-0851 B-0989, B-0990, B-0997, B-1110, B-1114,
Pyatigorskaya N.: A-504 Ramli N.: B-0083, B-0086 B-1182, K-29
Ramos I.: B-0603, B-0753, B-1014 Reiter G.: B-0052, B-0257
Q Rampoldi A.: B-0772 Reiter U.: B-0052, B-0257
Qi W.: B-0504 Rand T.: A-631 Reith W.: B-0398, B-0399
Qian T.: B-0134 Rank C.M.: B-0668, B-0669 Rella L.: B-0421, B-1067, B-1256
Qian W.-L.: B-0268, B-0269 Rankine J.: A-565 Rella R.: B-0020
Qiang J.W.: B-0132 Ranschaert E.R.: A-015, A-136 Remedios D.: A-686
Qiao Z.: B-0166 Rao N.: B-0365 Rempp H.: B-0861
Quaia E.: A-004, B-0778, B-0848 Rao P.: B-0323 Remy C.: B-0971
Quarchioni S.: B-0331 Rao S.-X.: B-0191 Rémy J.: B-0370, B-0581, B-0590, B-0987
Quarta Colosso G.: B-1142 Raouf A.: B-0516 Rémy-Jardin M.: A-093, A-184, A-467,
Quattrocchio G.: B-1220 Raposo N.: B-0818 B-0370, B-0581, B-0590, B-0987
Quentin M.: B-0334, B-0335 Raskin S.: B-0472, B-0680 Ren Q.: B-0494
Querques G.: B-0092, B-0096, B-0835 Rasper M.: B-0378, B-1158 Renard Pena R.: A-805
Quick H.: B-0903, B-0905 Rasschaert M.: B-0201 Renard-Penna R.: B-0699
Quick H.H.: A-100, B-1150, B-1152 Rastelli M.: B-1005 Rendon Villa M.: B-0124
Quilez A.: B-1312 Raszkowski A.: B-1382 Renehan A.G.: B-1167
Quinn E.K.: B-0548 Ratib O.: A-012, A-137, A-730, A-733 Reneman L.: A-040
Quinn-Laurin V.: B-0021 Ratti F.: B-1298 Renger B.: B-1354
Quitzke A.: B-0550, B-0642 Rauda M.: B-1018 Rengier F.: A-633, B-0313, B-0764, B-1043
Qurashi A.A.: B-0708 Raudner M.: B-0491 Rengo M.: A-281, B-0780, B-0941, B-1142
Qureshi M.M.: B-0013 Rauen P.: B-0864 Renne J.: B-1044
Rauneker T.: B-0883 Renz D.: B-0895
R Rauova K.: B-1255 Renzulli M.: B-1231
Ra Y.: B-0038 Rauscher I.: B-0341 Reponen J.: A-134, B-0233
Raaijmakers C.P.: B-0568 Ravaioli S.: B-1062 Restrepo R.: A-780
Raatschen H.-J.: B-0978 Ravelli S.: B-0343 Revel D.: B-0117
Rabe K.F.: B-1219 Ray-Coquard I.: B-0123 Revel M.-P.: A-745
Rabelo B.C.S.: B-0486, B-0635 Raza S.A.: B-1120, B-1125 Reymond E.: B-1358
Rabenalt R.: B-0334, B-0335 Razek A.A.K.A.: B-1050 Reznek R.H.: A-222
Radbruch A.: A-336, B-0282 Raziorrouh B.: B-0229 Rheinheimer S.: B-0258
Radema S.: B-0188 Rebelo C.: B-1251 Ribeiro A.M.: B-0351, B-0717, B-1010, B-1386
Raderer M.: B-0300, B-0660 Rebsamen S.: B-0165 Ribeiro E.: B-0703
Radmard A.R.: B-0035 Reda W.: B-0087 Ribeiro E.J.S.: B-0635
Radunski U.K.: B-1156 Redden D.: B-0998 Ribeiro J.: B-0873
Radzina M.: B-0816, B-1018, B-1022 Reddy R.: B-0429 Ribeiro L.P.: B-0150, B-0152, B-0351, B-0717,
Rafallah A.E.: B-0808 Reddy S.: B-0042, B-0119 B-0869, B-0873, B-1006, B-1010, B-1015,
Ragab Y.: B-1183 Redheuil A.: B-0763 B-1246, B-1249, B-1251, B-1386
Rageth C.: B-1134 Reeder S.: B-0165 Ribeiro M.M.C.P.: B-1384, B-1389
Ragg J.C.: B-0762 Reeder S.B.: B-0206, B-0322, B-0982, Ricart Selma V.: B-0602
Raghunath S.: B-0112, B-0587, B-1368 B-1099 Riccabona M.: A-140
Raguwaran A.: B-1230 Reekers J.A.: A-331, A-701 Ricci P.: A-368, B-0532
Rahim R.: B-0928 Reeps C.: B-1158 Ricciuti G.: B-0537

Richioud B.: B-0128, B-0329 Roedl J.B.: B-1180 Ruder T.: B-0438
Richter F.: B-0460 Roemer F.W.: B-0548, B-0555, B-0639 Rudolph J.: B-1158
Richter G.M.: B-1348 Roenisch N.: B-0074 Ruers T.J.: B-0225
Richter J.A.: B-0344, B-0702 Roethke M.C.: A-103 Ruff C.: B-0312
Richter V.: B-1068 Rogalla P.: B-1204 Rühaak J.: B-1362
Rickaby S.J.: B-0231 Röhle R.: B-0460 Ruhlmann V.: B-0560, B-0656, B-0657,
Ricke J.: A-414 Rohr K.: B-0313, B-1043 B-1036
Riddell A.: B-0185 Roiati S.: B-0501, B-0687 Rummeny E.: B-1158
Riddell A.M.: K-05 Roldan-Alzate A.: B-1099 Rummeny E.J.: B-0485, B-0517, B-0547,
Riechelmann H.: B-0564 Rollven E.: A-511 B-1184
Riederer S.: B-0706 Roloff A.-M.: B-1299 Rundstein A.: B-0226
Riedl C.: B-1350 Romani F.: B-0772 Runge J.H.: B-1091
Riedl D.: B-0564 Romani M.: B-0020 Runge V.: A-334
Rief M.: B-0383, B-0460 Romano A.: B-1060 Runge V.M.: B-1289
Riegler G.: B-0278, B-0279 Romano L.: B-0518 Ruschke S.: B-0485
Riehm S.: B-0720 Romanycheva E.: B-1032 Russell G.: B-0387
Riffel P.: B-0141 Romberg J.: B-0368 Russo E.: B-1076
Righi D.: B-0541, B-0542 Rominger A.: B-0296, B-0933, B-0997 Russo F.: CTiR 2
Riklund K.: A-425, A-667, A-726 Rompel O.: B-0614 Russo R.: B-0164
Rimola J.: B-0446 Ronot M.: A-509, A-542 Rutherford M.: B-0897
Rinaldi P.: B-0020 Roobol M.J.: B-0336, B-0340 Rutherford M.A.: B-1385
Ring N.: B-0186, B-0213 Roodenburg-Kooij H.S.: B-0012 Rutigliano C.: B-0790
Ringe K.I.: B-0978 Ros Mendoza L.H.: A-400, A-660 Rutten M.: B-0527
Ringel F.: B-1193 Ros P.R.: A-220, A-398 Rutten M.J.C.M.: A-777, B-0929
Ringelstein A.: B-0507, B-1201 Roschin D.: B-0830, B-0831 Ryan E.: B-0267
Rist C.: B-0296 Rosen B.: B-0450 Ryan J.: B-1122
Risy Y.: B-0902 Rosenbaum C.: B-0995 Rydelius A.: B-1055
Ritter C.O.: B-1045 Rosenbaum-Krumme S.: B-0901 Ryoo I.: B-0562
Riva F.: B-0252 Rosengren A.: CTiR 1 Ryu J.H.: B-1092
Riva I.: B-1123 Rossel N.: B-0851 Ryu K.N.: B-0073
Riva L.: B-0767 Rossi A.: A-138, A-593, A-748 Ryzhkova D.V.: A-620
Riva S.: B-1375 Rossi Espagnet M.C.: B-1060
Rivera C.: B-0320 Rossi F.: B-0016 S
Riviere D.: B-0188 Rossi P.: B-0890 Sá Pinto A.: B-1048
Rizzati R.: B-0241, B-0834, B-1238 Rossini P.M.: B-0393 Saad M.A.M.: B-0840
Rizzetto M.: B-0053 Rössler K.: B-0281, B-0283, B-0284 Saam T.: B-0058, B-0768, B-1149
Robador L.O.: B-0243 Rostovtseva T.: B-1164, B-1347 Saar M.: B-1104
Robben S.G.F.: A-319, A-792, B-0228 Rota C.: B-0377, B-1075 Sabel B.O.T.: B-0229
Robella M.: B-1220 Rother U.: B-0259, B-0262 Sabet A.: B-0068
Robert P.: B-0201 Rottenkolber M.: B-1203 Sablayrolles J.-L.: B-0381
Robinson L.: B-0924, B-1379 Rotzinger R.: B-0621 Sabri O.: B-0902, B-0906
Robinson P.: A-719 Rotzinger R.A.: B-1174 Sacchetto D.: CTiR 2
Robinson S.: A-073 Roumiguie M.: B-0337 Saccomandi P.: B-0674
Robinson T.E.: B-0433, B-0439 Roupret M.: B-0699 Saddekni S.: B-0998
Robson K.J.: B-0672 Rousset P.: B-1169 Sade R.: B-0598, B-1081
Robson M.E.: B-1063 Routledge E.: B-1385 Sadik J.-C.: B-0157, B-0363
Roca Navarro M.J.: B-1282 Roux P.: B-0363 Sadovnik O.: B-0115
Roccatello D.: B-1220 Rovere Querini P.: B-0638 Sadow C.A.: B-0512
Roccia S.: B-0366 Rovira-Canellas A.: A-174, A-656 Saering D.: B-1156
Rock B.: B-0720 Rowinski O.: B-1374 Safak K.Y.: B-1199
Rockall A.G.: A-212 Rowley H.: B-0165 Safina M.: B-0533
Rodeo S.A.: B-0557 Rowley H.A.: A-230, A-232 Sagaydak O.: B-0750
Rodighiero M.: B-0608 Roy C.: B-0582, B-0986 Sahani D.: B-0450
Roditi G.: B-0741 Rozendaal M.C.: B-0012 Sahin N.: B-0591
Rodrigues A.: B-1146 Rozhkova Z.: B-1338 Saif T.: B-0028
Rodrigues I.: B-0713 Rozhkova Z.Z.: B-1344 Saifi S.: B-0277
Rodrigues J.C.L.: B-0254 Rübben H.: B-0900 Saito K.: B-0194
Rodrigues S.: B-0150, B-0152, B-0869, Rubbert C.: B-0044, B-0402, B-1342 Saito M.: B-0055
B-0873, B-1246, B-1249, B-1251 Ruberto E.: B-0164 Sakai Y.: B-0431
Rodriguez Laval V.: B-0041 Rubertsson S.: B-0814 Sakane M.: B-0979
Rodriguez M.Á.S.: B-0243 Rubtsov R.: B-1214 Sakuma H.: B-0384, B-0385, B-0807,
Rodríguez S.: B-0446 Ruchkin D.V.: B-0624 B-1309
Rodríguez-Fraile M.: B-0702 Rück A.: B-0749 Sala E.: A-035, A-453, A-638
Rodriquez-Spiteri N.: B-1128 Ruda F.: B-0874 Sala G.: B-0054
Rodt T.: B-0266 Rudas G.: B-0079, B-0080 Sala S.: B-0251

Salahi R.: B-1107 Scaglione M.: A-049 Schmidt M.: B-1117

Salame H.: B-0347 Scarabello M.: B-0252 Schmidt S.: B-0247, B-0977
Salamon J.: B-0478, B-1224 Scardapane A.: B-0468, B-0631 Schmidt T.: B-0622
Salazer-ferrer P.: B-0109 Scaringi C.: B-1060 Schmidt-Holtz J.: B-0574, B-0993
Saldari M.: B-0168, B-0894, B-0896, B-1334 Scarsbrook A.: B-0387 Schmitt A.J.: B-0648
Salehian Nik E.: B-0035 Scevola G.: B-1005 Schmitz D.: B-0955
Salem M.A.A.A.: B-0057 Schaarschmidt B.: B-0900, B-0903, Schmitzberger F.: B-0926, B-1135
Salerno A.: B-0626, B-0629 B-0905, B-1036 Schmuschkowitsch H.: B-0926
Saletti A.: B-0813, B-0964 Schaarschmidt B.M.: B-0560, B-0656, Schnackenburg B.: B-0048
Salgado R.: A-055 B-0657, B-0901 Schnapauff D.: B-0621
Salice S.: B-0389 Schaarschmidt F.: B-0047, B-0048 Schneider G.: A-446, B-0619, B-1002,
Saliou G.: B-1227 Schabath M.: B-0510 B-1230
Sallemi C.: B-1298 Schacht D.: B-0429 Schneider G.K.: B-1104, B-1229
Salsano M.: B-0890 Schadmand-Fischer S.: B-0907 Schneider M.: B-0931, B-0934, B-1110
Saltybaeva N.: B-1200, B-1209 Schaefer-Prokop C.M.: A-094, A-206, Schneider P.: B-0260
Salut C.: B-1223 A-208, A-769, B-0850, B-1362 Schneider U.: B-0895
Salvatori F.M.: B-0537 Schäfer J.: A-520 Schnerr R.S.: B-0191, B-0192
Samaan M.A.: B-0913 Schaffellner S.: B-0417 Schniepp R.: B-0396
Sanabria A.B.: B-0536 Schaller G.: B-1125 Schnitzler A.: B-1341, B-1342
Sánchez García S.: B-0683 Schaller G.H.: B-1120 Schoen G.: B-0642
Sánchez-González M.: B-1046 Schaudinn A.: B-0983, B-1144 Schoepf U.J.: B-0174, B-0175, B-0263,
Sandomenico F.: B-0293 Schavemaker M.: B-1281 B-0264, B-0380, B-0386, B-0452,
Sandrasegaran K.: B-0001, B-0003 Scheer F.: B-0616 B-0456, B-0746, B-0783, B-0785, B-1072,
Sandström M.: B-0996 Schegerer A.: B-0373 B-1178, B-1203, CTiR 2
Sanguedolce F.: B-0700, B-0947 Schemuth H.P.: B-1150, B-1152, B-1153, B-1316 Schöfer F.: B-1354
Sano K.: B-0466 Schena E.: B-0674 Schöllnast H.: B-0417
Sanson S.: B-0337 Schenal G.: B-0832 Scholten E.T.: B-1362
Santangelo C.: B-0790 Scherr D.: B-0257 Scholtz J.-E.: B-0483, B-0877, B-0878,
Santangelo T.: B-0370 Scherr M.: B-0342 B-0967, B-1178
Santangelo T.P.: B-0369 Schertz M.: B-0276, B-0821 Scholz O.: B-0926
Santini C.: B-0514 Schiani E.: B-0608 Schönberg S.O.: A-146, A-411, B-0141,
Santoni M.: B-0238 Schiavone M.V.: B-1084 B-0373, B-0580, B-0739, B-0836,
Santos E.: B-1249 Schiebler M.L.: B-0322 B-1070, B-1161
Santos J.: A-285, B-0348, B-0870, B-1245, Schilham A.M.: B-1365 Schönenberger E.: B-0383, B-0460
B-1248 Schilham A.M.R.: B-0765 Schoots I.G.: B-0336, B-0340
Santos J.R.: B-1246 Schillaci G.: B-0061 Schopphoven S.: B-1355
Santos R.A.M.: B-0712 Schillebeeckx J.: A-582 Schosseler F.: B-0514
Sanz Díaz J.: B-0683 Schima W.: A-086 Schouman-Claeys E.: A-475
Sanz-Requena R.: B-0701 Schimmöller L.: B-0334, B-0335 Schraml C.: B-0593, B-0904
Saranovic D.: B-0214 Schindera S.: B-0230, B-0302, B-0304, Schramm C.: B-0007
Sardanelli F.: A-256, A-551, B-0120, B-0122, B-0570, B-1288 Schreckenberger M.: B-0907
B-0199, B-0252, B-0447, B-0459, Schindera S.T.: A-034, B-1286 Schreiter V.: B-1212
B-0923, B-1123, B-1143,CTiR 2 Schinner R.: B-0229 Schreuder F.: B-0056
Sarıca M.A.: B-0065, B-0066, B-0637 Schipke J.: B-0052 Schreutelkamp I.L.: B-0930
Sarin S.K.: B-0009 Schittenhelm J.: B-0286 Schroeder T.H.: B-0695, B-1219
Säring D.: B-0049 Schlaefer A.: B-1353 Schubert E.C.: B-0517
Sarisoy H.T.: A-440 Schlamann M.: B-1058 Schubert T.B.: B-0165
Sarkadi H.: B-0261 Schlattmann P.: CTiR 1 Schuele S.-C.: B-0664
Sarry El Din A.M.: B-0087 Schleich C.: B-0099, B-0394 Schueller-Weidekamm C.: B-0070
Sartoris R.: B-0271 Schlembach D.: B-0895 Schuknecht B.F.: A-524
Sarwar J.J.: B-1119 Schlemmer H.-P.: A-163, A-739, B-0282, Schüle S.-C.: B-0023, B-0904
Sasaguri S.: B-1039 B-0668, B-0669 Schuler T.: B-0007
Sasiadek M.: A-361, A-595 Schlett C.: B-0865 Schuller Arteaga M.A.: B-0358
Satchithananda K.: B-0928 Schlett C.L.: B-0667 Schultze Kool L.J.: B-1139
Saturnino P.P.: B-0518 Schleußner E.: B-0895 Schulz A.: B-0211
Saukko E.: B-0882 Schlöricke E.: B-0616 Schulz C.J.: B-1210
Savatovsky J.: B-0363 Schlosser T.: B-0507, B-1150, B-1152, B-1153, Schütz T.: B-0983
Savci G.: B-0190 B-1201, B-1307 Schwaab J.: B-1138
Savino G.: B-0790 Schmaranzer E.: B-0910 Schwaiger B.: B-0398, B-0399
Saviolo C.: B-0659 Schmaranzer F.: B-0910 Schwaiger B.J.: B-0549, B-0551, B-0557,
Savlovskis J.: B-0816 Schmid A.: B-0262, B-0617 B-0643, B-0913, B-1193
Sawicki L.: B-0903, B-0905 Schmid J.: B-1079 Schwaiger M.: B-0341
Sawicki L.M.: B-0560, B-0656, B-0901, Schmidt B.: B-0508, B-1349 Schwartz D.: B-0285
B-1036 Schmidt D.: B-0730 Schwarz B.A.: B-1192
Sayani R.: B-0516 Schmidt H.: B-0904 Schwarz F.: B-1114

Schweitzer W.: B-0438 Sghedoni R.: B-1062 Simone M.: B-0834

Schwenzer N.: B-0664, B-0904 Shady M.: B-0133 Simonetti A.: B-0890
Schwenzer N.F.: B-0593 Shafik M.: B-0050 Simuni T.: B-1343
Sciveres G.: B-0881 Shah A.: B-0741, B-1293 Sindel T.: B-1024
Sconfienza L.M.: A-023, B-0120, B-0122, Shah D.: B-0078 Singh M.B.: B-0084
B-0447, B-1143 Shah Z.: B-0825, B-0833 Sinitsyn V.E.: B-1296, B-1310, K-15
Scott P.: B-0672 Shahbazkhani B.: B-0035 Sinkus R.: B-1091
Scragg B.: B-0924 Shaibani A.: B-0652 Sinn L.: B-1133
Scrivo A.: B-0139 Shaibania A.: B-0647 Sinn M.: B-1156
Sebuodegaard S.: B-0148 Shakirin G.: B-1165, B-1166 Sipilä O.: B-1155
Secchi A.: B-0160 Shalmon A.: B-0226 Sirli R.: B-1086, B-1087
Secchi F.: B-0252, B-0459 Shams S.: B-0196, B-0390 Sironi S.: B-0092, B-0096, B-0299, B-0441,
Sechopoulos I.: A-356, B-1131, B-1355 Sharma A.K.: B-0210, B-0797 B-0448, B-0662, B-0767, B-0770,
Secinaro A.: B-0369 Sharma N.: B-0210, B-1217, B-1278 B-0774, B-0775, B-0805, B-0835,
Secondini L.: B-0760 Sharma N.S.: B-0797 B-1030, B-1084, B-1173
Sedlaczek O.L.: A-760 Sharma S.: B-1332 Siva A.: B-0028
Sedlmair M.: B-0508, B-1349 Sharma S.D.: B-0982 Sivit C.J.: A-307
Sehner S.: B-0993 Sharp P.: A-390 Sivrioglu A.K.: B-1326
Seidel R.: B-0955, B-1002 Shchegolev A.I.: B-0898 Skaane P.: A-703
Seif H.M.A.H.: B-0091 Sheahan P.: B-1021 Skardelly M.: B-0286
Seifeldein G.S.: B-0091, B-1034 Sheehan M.: B-0267 Sklair M.: B-0680
Seifert I.: B-1153 Sheehy N.: B-0782 Sklair-Levy M.: B-0226
Seith F.F.: B-0904 Shek K.: B-0288 Sklinda K.: B-0275
Seitz D.F.: B-1132 Shen G.: B-0577 Skornitzke S.: B-1047, B-1348, B-1352
Seker F.: B-0497 Shen K.-W.: B-0529, B-1033 Skorpil M.: B-0810, B-1181
Seki S.: B-0316, B-0319, B-0655, B-0684, Shen W.T.: B-0364 Skrobisz- Balandowska K.: B-1027
B-0685 Sherazi F.: B-0647, B-0822 Slim N.: B-0779, B-0781
Sekiguchi T.: B-0615 Sheth D.: B-0429 Sluimer J.: B-0056
Sellars M.: A-674 Shi J.: B-0301 Slump C.H.: B-0954
Sellors J.: A-127 Shi J.-N.: B-0529, B-1033 Slump K.: B-0376
Semelka R.C.: B-0198, B-0200 Shi S.: B-0059 Slump K.H.: B-0380
Sempoux C.: B-0977 Shigeyama S.: B-0872 Slynarski K.: B-0275
Senage T.: B-1151 Shimizu Y.: B-0430 Smadja J.: B-1061
Sencer S.: A-297 Shin D.R.: B-0918 Smakic A.: B-0739, B-0836
Senese R.: B-1057 Shin H.-O.: B-1367 Smaldone F.: B-1100, B-1226
Senn D.: B-0300, B-0660 Shin H.S.: B-0562 Smedby Ö.: B-0714
Sennaroglu L.: B-0726 Shin K.M.: B-1324 Smeets D.: B-0205
Senol A.: B-0002 Shin M.: B-1102 Smets A.M.J.B.: A-519
Seo D.K.: B-0349 Shin N.-Y.: B-0395, B-0653, B-1337 Smidt M.: B-1064
Seo H.S.: B-0156 Shin W.: B-1102 Smidt M.L.: B-0224, B-1276, B-1281
Seo J.B.: B-1366 Shirai M.: B-0216 Smirnova A.: B-1194
Seo J.Y.: B-0755, B-1025 Shires G.: B-0924 Smirnova E.: B-1164
Seol H.Y.: B-0562 Shirodkar K.: B-0042, B-1262 Smith L.: B-0648
Serafini G.: B-0272 Shirokorad V.: B-0826 Smith T.A.D.: B-0937
Seraydarmansour O.: B-0875 Shmueli H.: B-0115 Smits L.P.: B-1091
Serena J.: B-0502 Shotar E.: B-0163 Smits M.: A-231, A-233, A-658
Serhan J.: B-0442 Shrainer I.: B-1296 Söderberg M.: B-0730
Serin M.: B-0469 Shukla G.: B-0084 Söderberg S.: CTiR 1
Serner A.: B-0639 Sibileau E.: B-0809 Soens J.: B-1357
Serra C.: B-0139 Siciliano G.: B-1345 Soglia G.: B-0890
Serres X.: B-0124 Sick H.: B-0721 Sögner P.: B-1291
Serša I.: B-0317 Sidhu P.S.: A-673 Sohaib A.: B-1325
Servadio Y.: B-0226 Siegmann-Luz K. : CTiR 2 Soikher E.: B-0115, B-0116
Sessa B.: B-0522 Siemer S.: B-1104 Soikkeli M.: B-1155
Setacci C.: B-1172 Siemund R.: B-0850 Sokhi H.: B-0700, B-0947
Setacci F.: B-1172 Siesling S.: B-0420 Solana Tubau G.: B-1225
Sethi G.R.: B-0372 Signori A.: B-1069 Solbiati A.: B-0377, B-1075
Settles M.: B-1158 Sijens P.E.: B-0609, B-0610 Solbiati L.A.: A-048
Setz-Pels W.: B-0925 Silva V.M.: B-1014 Solcia M.: B-0772
Sevastyanov V.: B-1032 Silva Y.: B-0502 Solheim E.: B-0075
Sevcenco S.: B-1240 Silvera J.: B-0276 Soligo E.: B-0392
Severac F.: B-0986 Silvestri E.: B-0271 Solmaz Tuncer A.: B-0490
Sevimli S.: B-1081 Silvestri S.: B-0541 Solorzano J.L.: B-0344, B-0702
Sevryukov D.: B-0889 Sim K.C.: B-0108, B-0131, B-1232 Solyanik O.: B-1367
Seyfer P.: B-1035 Simoncini M.: B-0354 Šomen J.: B-1381

Sommer B.: B-0281 Stanton M.T.: B-0715 Suehiro E.: B-0731

Sommer C.M.: A-618, B-0865, B-1348 Stanzione A.: B-0824 Sugihara N.: B-0106, B-0684, B-0685,
Sommer G.: A-464 Starc T.: B-0867, B-1248 B-1364
Sommer N.: B-1182 Stark-Paulsen T.: B-0357 Sugimoto K.: B-0194
Sommer N.N.: B-0058 Stauber R.: B-0417 Sugimura K.: B-0106, B-0110, B-0316,
Sommer W.: B-0719, B-0777, B-0997, Staudacher C.: B-0031 B-0319, B-0655, B-0684, B-0685, B-0731,
B-1322 Stazi M.A.: B-0061 B-1364
Sommer W.H.: B-0058, B-0189, B-0793, Stecco A.: B-0392 Sugita K.: B-0405
B-0820, B-0965, B-0968, B-1182 Steens S.: B-0727 Sugrue G.: B-1376
Son Y.: B-0806 Steffen I.: B-0041, B-0690 Suh D.C.: B-0654, B-0817
Soncin E.: B-0542 Stehning C.: B-0048, B-0049 Suh I.: B-0364
Song B.: B-1090 Stein Hodgins J.: B-0924 Suh S.: B-0562
Song J.S.: B-0594, B-0676 Steinbach L.S.: B-0551 Suhai F.I.: B-0248, B-0457
Song J.W.: B-1366 Steinberg D.: CTiR 2 Sukhikh G.T.: B-0898
Song K.D.: B-0597 Steinbrener J.: B-0670 Sullivan R.J.: B-0512
Song S.: B-0839 Steins M.: B-0513 Summers P.: B-0705, B-0950
Song Y.: B-0250, B-0812 Stelzeneder D.: B-0491 Sun C.: B-0445, B-0449
Sorantin E.: A-286, A-444 Stenman C.: B-0714 Sun H.: B-0571, B-1235, B-1265, B-1266,
Sortino D.: B-1371 Stenzel E.: B-0507 B-1268
Sosna J.: K-19 Stepanovs K.: B-1018 Sun J.: B-0980
Sotgia B.: B-0333 Sterzing F.: A-268 Sun K.: CTiR 1
Soto J.: B-0693 Stetkarova I.: B-1198 Sun Y.-S.: B-1317
Soto J.A.: A-205, A-207 Steurer J.: B-0554 Sun Z.-Y.: B-1265, B-1266
Sotoudeh M.: B-0035 Steuwe A.: B-1210 Sundgren P.C.: B-1055
Sourbron S.: B-1110 Stichelbaut N.: CTiR 1 Sundström J.: CTiR 1
Sousa P.: B-0717, B-0869, B-1246, B-1249, Stijnen M.: B-0376 Sung D.J.: B-0108, B-0131, B-0573, B-1232
B-1251 Stiller B.: B-0368 Sung J.S.: B-1063
Sousa P.F.: A-112 Stiller W.: A-016, B-0865, B-1047, B-1210, Sung Y.S.: B-1360
Sousa P.J.: B-1384 B-1348, B-1352 Sunnadkal R.: B-0043
Souvatzoglou M.: B-0341 Stocker G.: B-1144 Suntharalingam S.: B-0507, B-0903,
Souverijns G.: B-1037 Stoeckle M.: B-1104 B-0905, B-1201, B-1351
Souza R.B.: B-0913 Stoecklein S.: B-0396 Suranyi P.: B-0452, B-0456
Soylu A.R.: B-0274 Stoffels I.: B-0908 Surekha B.: B-0009
Soylu E.: B-0190 Stojakovic T.: B-1079 Šurlan Popovič K.: B-0317, B-1106
Sozzi C.: B-1103 Stojanov D.: B-1109, B-1302 Susani M.: B-0944
Spasic N.: B-0419 Stojanovic I.: B-1109 Sutela A.: B-1118
Spearman J.V.: B-1203 Stojanovic S.: A-576, B-1378 Sutter R.: B-0915
Sperga M.: B-1018 Stoker J.: B-0444, B-0451, B-0792, B-1091 Sutton E.J.: B-1274
Spezia L.: B-1103 Stork A.: B-1132 Suzuki S.: B-0872
Spezzacatene A.: B-0476 Stoupis C.: A-724, K-20 Suzuki T.: B-0495
Spiga S.: B-0299, B-0662, B-0770 Stowe J.G.: B-0146 Svensson A.: B-0749
Spijkerboer A.: B-0451 Sträter A.: B-1158 Sverzellati N.: A-238
Spiliopoulos S.: B-0330, B-0618 Stray-Pedersen A.: B-0105 Swerdlow A.: B-1117
Spiliopoulos S.C.: A-192 Strecker R.: B-0486, B-0635 Swift S.: A-381
Spinelli L.: B-0453 Streekstra G.J.: B-0954 Sworczak K.: B-1027
Spinicci G.: B-1108 Streitparth F.: B-0621, B-0690, B-1174 Sydo N.: B-0248
Spink C.: B-0622, B-1353 Štrekelj U.: B-1380 Syha R.: B-0297
Spira D.: A-018 Streuber A.: B-0230, B-0235 Symersky P.: B-1078, B-1082
Spitzweg C.: B-0296 Strobbe L.J.A.: B-0925 Syrgiamiotis V.: A-350
Splendiani A.: B-0326 Stroebel M.: B-1072 Szapiro D.: B-0442
Spliethoff J.W.: B-0225 Stroeder J.: B-0619, B-1230 Szczepura K.: B-1008, B-1243
Sponza M.: B-1101 Stroszczynski C.: B-0475, B-1026, B-1300 Szczerbo-Trojanowska M.: A-698
Sporea I.: B-1086, B-1087 Struikmans H.: B-0420 Szilveszter B.: B-0787, B-0788
Sportoletti C.: B-0139 Štrumfa I.: B-1018, B-1022 Szima Mármarosi E.: B-0457
Spronk P.E.: B-0114 Struthers A.D.: B-0748 Szucs-Farkas Z.: B-0570
Stäb D.: B-0314 Stubenrauch A.: B-0263 Szurowska E.: B-0183
Stabile Ianora A.A.: B-0421, B-0468, B-0631, Stumpp P.: B-0074, B-0902, B-0906
B-1067, B-1256 Suaris T.: B-0018, B-0759 T
Stadlbauer A.: B-0281, B-0283, B-0284 Subasic I.: B-0575 Tabacco G.: B-0054
Staebler A.: B-1068 Succio G.: B-0760 Taberner Bonastre M.T.: B-1260
Staffa R.: B-0260 Sucha D.: B-0765, B-1078, B-1082 Taberner López E.: B-1260
Ståhlbrandt H.: A-384 Sudah M.: B-1118 Tacchetti C.: B-1145
Stajgis M.: A-552 Sudarski S.: B-1161 Tack D.: A-794, B-0347
Stalder A.F.: B-0257 Südmeyer M.: B-1341, B-1342 Tadros D.: B-0934
Stancombe K.: B-0345 Sudoł-Szopińska I.: A-154 Taeymans Y.: B-0675

Tagliabue E.: B-0705, B-0950 Terpstra A.: B-1179 Toledo L.S.: B-0243
Tagliaferri B.: B-0881 Terraz S.: A-539 Tolonen A.: A-601
Tagliafico A.: B-0016, B-0760, B-1069 Tervonen O.: B-0585 Tomà P.: B-0369, B-0890
Tagliafico G.: B-1069 Tesche C.: B-0174, B-0783, B-0785, B-1072 Tomás Cucarella J.: B-1112
Taha H.: B-0083 Tessa C.: A-187 Tomiyama N.: A-575, B-0979
Tahir E.: B-0049, B-0382, B-1156 Tetsuka R.: B-0223, B-0531, B-1277 Toms A.: B-0487, B-0980
Tahon F.: B-0500 Tezgah E.: B-1150 Tondelli G.: B-1062
Taibbi A.: B-0533 Tezza M.: B-0054 Tonetti L.: B-0679
Taina M.: B-0786 Thaher F.: B-0401 Tonkopi E.: B-1206
Tajikawa T.: B-1377 Thalhammer A.: B-1222 Tontini G.: B-0447
Takács T.: B-1373 Thali M.J.: B-0438 Tootell A.: B-0307
Takagi H.: B-0110 Thanaratnam P.: B-0267 Tootle A.: B-1243
Takahashi K.: B-0431 Thapar S.: B-0009 Topilsky Y.: B-0115, B-0116
Takahashi S.: B-0731 Thawait G.K.: B-1188 Topopolsky R.: B-0827
Takase K.: B-0055, B-0110 the German National Cohort.: B-0667 Torén K.: CTiR 1
Takx R.A.P.: B-0787 Theilig D.: B-1212 Torii M.: B-0216
Tal S.: B-0360 Thenint M.-A.: B-0323 Tornvall P.: B-0749
Talakic E.: B-0417 Theodosiadou V.: B-0618 Törnwall O.: A-327
Talei Franzesi C.: B-0092, B-0096, B-0299, Theruvath A.: B-0455 Torre G.: B-0890
B-0441, B-0448, B-0662, B-0774, Thevenin F.: B-0071 Torres C.: B-1192
B-0775, B-0805, B-0835, B-1030, B-1084 Theysohn J.: B-1201 Torresin A.: A-169, A-784
Talei Franzesi C.R.G.L.: B-0767, B-0770, Theysohn J.M.: B-0909 Tosetti M.: A-712, B-1345
B-1173 Thian Y.: B-1325 Tosto S.: B-0016, B-1069
Tali E.T.: A-057, A-176 Thiéfin G.: B-0094 Tot T.: A-092
Talwar A.: B-0436 Thiel C.: B-0039 Toth A.: B-0248, B-0457, B-0471
Tam H.: B-0185 Thierens H.: B-0920 Tóth K.: B-0613
Tamborino C.: B-0813 Thierfelder K.: B-0820 Touraine S.: B-0809
Tamura M.: B-1171 Thierfelder K.M.: B-0793, B-0965, B-0968, Touska P.: B-0365
Tan C.H.: B-0489, B-1241 B-1203 Tramontini C.: B-0202
Tan T.: B-0527 Thiesse P.: B-0329 Tran Dong K.: B-0162
Tanabe Y.: B-0382 Thijssen J.M.: B-0022 Trattenero C.: B-0441
Tanboga I.H.: B-1081 Thoeny H.C.: A-087, A-606, A-806 Trattnig S.: A-150, A-270, B-0491
Tanenbaum L.N.: B-1197 Thomas C.: B-0044, B-0099, B-0394, Trauth M.: B-1211
Tang K.Y.K.: B-0799 B-0545 Tredan O.: B-0123
Tang L.: B-1031 Thomassin-Naggara I.: A-038 Treece G.M.: B-0912, B-1147
Tanis W.: B-1078 Thomsen C.: B-1212 Treitl K.M.: B-0058
Tanoue S.: B-0405, B-1372 Thomsen F.: B-0493 Trenti R.: B-1170
Tantawy H.I.: B-1135 Thorborg K.: B-0639 Treutlein M.: B-0048
Tanyildizi Y.: B-0769 Thorelius L.: B-0714 Trezzi M.: B-0369
Taoka T.: A-574, B-1051 Thorenz A.: B-0939 Trianni A.: A-393, A-651
Tarantino L.: B-0843, B-0844, B-0845 Thorwarth W.T.: A-289 Tribunella A.: B-0566, B-0829
Tarantino P.: B-0844 Thunberg P.: B-1013 Trilla E.: B-0124
Tardáguila G.: B-0443 Thurnher M.M.: A-567, A-594 Trillaud H.: B-1223
Tardivon A.: A-058 Thway K.: B-1335 Trimboli R.M.: B-0923, CTiR 2
Tarella C.: B-0659 Tian J.: B-0970 Trinci M.: A-121, B-0522
Tarnoki A.D.: B-0061, B-0179 Tielbeek J.A.W.: B-0444 Tripathi M.: B-0084
Tarnoki D.L.: B-0061, B-0766 Till V.: B-1378 Trojanowska A.: A-590
Taron J.: B-0593 Tilli M.: B-0834, B-1238 Truong J.: B-0235
Tartaro A.: B-0389 Timmermans L.: B-0920 Trzasko J.: B-0706
Tas S.: B-0274 Timmis A.: B-0741 Tsai K.: B-1319, B-1320
Tatsumi M.: B-0979 Timonen M.: B-1155 Tsai W.: B-0424
Taupitz M.: B-0159 Tinelli C.: B-1085 Tsapaki V.: A-097, K-10
Tavanti F.: B-1060 Tirāne M.: B-1018 Tse H.-F.: B-0784
Tavares A.: B-1218 Tirkes T.: B-0001, B-0003 Tseng C.-C.: B-0937
Tavares F.: B-0150 Tiryaki M.: B-1199 Tsetis D.K.: A-632
Tavera Bahillo I.: B-0520 Tissot V.: B-0949 Tsougos I.: A-715
Tawfik S.A.: B-1065 Titelbaum N.: B-1197 Tsoumakidou G.: B-0323
Tay L.: B-0489 Tjan-Heijnen V.: B-0420 Tsuboyama T.: B-0979
Taylor S.A.: A-006, A-160 Tjan-Heijnen V.C.G.: B-0925 Tsuchimochi H.: B-0216
Tecame M.: B-0620 Tkachev A.: B-1194 Tsuchiya K.: B-0429, B-0495
Tecl A.: B-0580 Todica A.: B-0933 Tsuruda K.: B-1125
Telegrafo M.: B-0421, B-0631, B-1067, B-1256 Toffart A.-C.: B-1358 Tsuruda K.M.: B-1120
Terada M.: B-0479 Toi M.: B-0216 Tuan A.S.: B-0801
Terceño M.: B-0502 Tok S.: B-0554 Tucker L.: B-1127, B-1136
Terhaard C.H.: B-0568 Tol J.L.: B-0639 Tufman A.: B-0990

Tuhamy Y.M.: B-1065 Valentino M.: B-0137 van Laarhoven K.: B-0188
Tumanova U.N.: B-0898 Valeri A.: B-0949 van Loveren M.: B-0225
Tunay Bayrakcı V.: B-0270 Valero L.: B-0201 van Mieghem N.M.: B-0400
Tuncel S.A.: B-0140 Valette P.-J.: B-1088, B-1169 van Nijnatten T.J.A.: B-1276, B-1281
Tung Y.: B-0359 van Aerde M.: B-0789 Van Ongeval C.: B-0920, B-1357
Tuñón M.: B-0355 van Beek E.J.H.: B-0118 van Ooij P.: B-1148
Turini F.M.: B-0093 van Beek E.J.R.: A-095, A-465, A-678, van Ooijen P.M.A.: B-0789
Turkeli M.: B-0598 B-0741, B-1213, B-1218 van Oostenbrugge R.: B-0056
Turmezei T.D.: B-0912, B-1147 van Beers B.: B-0977 van Osch J.A.C.: B-0954
Turowski B.: B-0402, B-1341, B-1342 Van Beers B.E.: A-542 van Raamt F.: B-0114
Turtulici G.: B-0271 Van Binnebeek S.: B-1323 van Rein I.L.: B-0345
Tutein Nolthenius C.J.: B-0451 van Bommel R.M.G.: B-0925 Van Steen A.: B-0920, B-1357
Tuthill E.: B-1170 Van Cutsem E.: B-1323 Van Tuijl S.: B-0376
Tutton S.: B-0127 van Dalen T.: B-0420 Van Veluw S.J.: B-1105
Tveit K.: B-0008 van Dam L.: B-0408 Van Westen D.: B-0397, B-0969
Tyurin I.E.: A-027 van de Pol D.: B-1179 van Wissen M.S.O.: B-0930
Tzedakis A.: B-1205 van den Berg J.W.K.: B-0589 van Zanten M.: B-0188
van den Berg R.: B-0071 van Zelst J.: B-0527, B-0535, B-1137, B-1138
U Van den Bosch F.: B-0069 van Zelst J.C.M.: B-0022
Uberoi R.: A-191, A-370, A-634 van den Bosch H.: B-0244 van Zwam W.: A-716
Uder M.: B-0617, B-0879, B-0880 van den Bosch H.C.M.: B-0245 Vanags A.: B-1022
Udondo González del Tánago M.: B-0358 van den Bosch M.: B-0995 Vande Berg B.: K-03
Ueda K.: B-0841 van den Brink R.B.A.: B-1078 Vande Vyvere T.: B-0205
Uehara T.: B-0841 van den Hauwe L.: A-566, B-0205 Vandecaveye V.: A-342, B-1037, B-1038,
Ueno Y.: B-0106, B-0731 van den Heuvel A.F.M.: B-0400 B-1141, B-1323
Ugurluer G.: B-0469 van den Hoven A.: B-0995 Vandemeulebroucke J.: B-0212
Ukai T.: B-0872 Van Den Wyngaert T.: A-566 Vandenbroucke F.: B-0212
Ukkola L.: B-0585 van der Aalst C.M.: B-0789 Vanderschueren G.: A-313
Ulbrich E.J.: B-0640, B-1190 Van der Geest R.: B-0380 Vandulek C.: A-489
Ulcigrai V.: B-0778 van der Geest R.J.: B-0060, B-0768 Vanel D.: A-461
Ullrich T.: B-0335 van der Harst P.: CTiR 2 Vanhoenacker F.: A-076
Ulrich D.J.O.: B-1139 van der Heide U.: A-669 Vanhoenacker F.M.H.M.: A-313
Ulrich N.H.: B-0554 van der Heijde D.: B-0071 Vanhoenacker P.: B-0181
Ulusoy L.: B-1187 van der Hoorn A.: B-0290 Vanni E.: B-0053
Ulyte A.: B-0286 van der Laak J.: A-228 Vanninen R.: B-0786, B-1118
Umer A.: A-601 van der Lugt A.: A-125, A-326, B-0400 Vanovcanova L.: B-1255
Umetani K.: B-0216 van der Sande M.E.: B-1160 Vanslembrouck R.: B-1037
Umezawa R.: B-0055 van der Schaaf I.C.: B-0496 Vanwetswinkel S.: B-1064, B-1281
Umul A.: B-0002 van der Valk P.: B-0852 Várallyay C.: B-0285
Umutlu L.: A-044, A-757, B-0197, B-0656, van der Werf H.W.: B-0400 Varano G.M.: B-0125
B-0657, B-0901, B-0903, B-0905, van der Woude H.-J.: A-312 Várbíró S.: B-0471
B-1036, B-1058 van der Zaag-Loonen H.J.: B-0114 Varela C.: B-0443
Ünal Daphan B.: B-0161 van der Zijden T.: A-717, B-0403, B-0803 Varga Z.: B-1134
Ünlü M.E.: B-0140 van Dijken B.R.J.: B-0290 Varga-Szemes A.: B-0174, B-0175, B-0263,
Uno M.: B-1309 Van Eendenburg C.: B-0498 B-0264, B-0452, B-0456, B-0783,
Unterhumer G.: B-0147 van Engen R.E.: B-1355 B-0785, B-1072
Ünverdi H.: B-1328 van Geenen E.: B-0188 Vargha A.: A-687
Uprimny C.: B-0027 van Gent D.: B-0936 Varjonen E.A.: B-0691
Urbach H.: A-108 van Gerwen M.: B-0716 Varkas G.: B-0069
Urbani L.: B-0209 Van Gils C.: A-225 Varlet P.: B-0163
Ure C.: B-0924 van Gils L.: B-0400 Varma R.K.: B-0539
Urhemaa T.: A-601 van Gils M.: A-601 Varma S.: A-602
Uriza F.: A-781 van Ginneken B.: B-1362, B-1363 Varona-Porres D.: B-1046
Url C.: B-0564 Van Goethem J.: A-566, K-30, CTiR 2 Varoquaux D.-A.: A-569
Ussov W.: B-0461 van Goethem M.: B-1064 Varrassi M.: B-0326
Van Gompel G.: B-0107 Vasilevska Nikodinovska V.: A-260
V van Griethuysen J.: B-0776 Vasilyev S.: B-1164
Vacirca F.: B-1196 van Hamersvelt R.W.: B-0765, B-1365 Vasin D.: B-0214
Vacondio R.: B-0922, B-1062 van Hecke W.: B-0650 Vasudevan T.: B-0260
Vago H.: B-0248, B-0457 van Heeswijk M.M.: B-1160, B-1163, B-1166, Vatn M.: B-0008
Vakil P.: B-0822 B-1168 Vaudagna C.E.: B-0482
Valcseva É.: B-0471 Van Herck K.: B-0920 Vawda Z.: B-0173
Valdora F.: B-0016, B-1069 van Herwerden L.A.: B-1078, B-1082 Vaz G.: B-0329
Valentini V.: A-432, A-668, B-1361 van Kesteren F.: B-0792, B-1148 Vázquez E.: A-751
Valentino L.: B-0389 van Laar P.J.: B-0290 Vecchi M.: B-0447

Vecchio F.: B-0393 Vinnicombe S.J.: A-755, B-0427, B-0526 Wafaie A.M.: B-0663
Vecsey-Nagy M.: B-0788 Vinurel N.: B-0117 Wagenvoort A.M.: B-0036
Veekmans P.: B-0930 Virgilio M.: B-0354 Wahlund L.-O.: B-0390
Végh E.M.: B-0261 Virgolini I.J.: B-0027 Wakili R.: B-1315
Veillon F.: B-0720, B-0721, K-17 Virtanen J.: B-1207 Walecki J.: A-175, A-375, B-0911, B-0914
Veiss A.: B-0816 Vishnevskaya A.V.: B-0624 Walen S.: B-0589
Veit-Haibach P.: A-614 Visser J.J.: B-0237 Wallin E.: B-0814
Vejborg I.: A-385 Visser P.: B-0852 Walsh D.: A-532
Velarde Pedraza A.: B-0126 Vit A.: B-1101 Walsh S.: B-0587
Velardo D.: B-0638 Viteri Jusue A.: B-0358 Walsh S.L.F.: B-0112, B-0586
Veldhoen S.: B-0314, B-1045 Vivancos Costaleite K.: B-1096 Walther M.: CTiR 1
Veldkamp W.J.H.: B-1355 Vivoda Tomšič M.: B-0317 Wang D.-B.: B-1031
Velickaite V.: B-0388 Vlahos J.: A-214 Wang F.: B-0857
Veliou K.: B-1261 Vlassenbroek A.: B-0954 Wang H.: B-0240, B-0268, B-0269, B-0510
Vellucci V.: B-0045, B-0255, B-1311 Vliegenthart R.: A-322, A-545, B-0376, Wang J.: B-0634
Velthuis B.K.: B-0496 B-0380, B-0386, B-0789, B-0863, CTiR 2 Wang L.-J.: B-0523
Veltman J.: B-0217, CTiR 2 Vock P.: A-079 Wang M.: B-0599, B-0600
Veltri A.: B-0030, B-0829, B-0858 Voest E.E.: A-752 Wang P.: B-0736
Venderink W.: B-0727 Voevodin S.M.: B-0898 Wang Q.: B-0001, B-0003, B-0723, B-1093
Venkatasamy A.: B-0720, B-0721 Vogel-Claussen J.: A-168 Wang R.: B-0746
Venneri M.: B-0941 Vogl T.: B-0467, B-0725 Wang S.: B-0583, B-1274
Venstermans C.: A-566 Vogl T.J.: B-0129, B-0130, B-0186, B-0213, Wang W.: B-0095
Ventikos Y.: A-604 B-0264, B-0357, B-0432, B-0470, Wang W.-P.: B-1031, B-1228, B-1269
Venturini E.: B-1028 B-0483, B-0746, B-0860, B-0862, Wang X.: B-0577, B-0739, B-0836, B-1093,
Venturini M.: B-0160, B-1298 B-0877, B-0878, B-0967, B-0976, B-1177, B-1236, B-1265, B-1266, B-1268
Venuti G.: B-0254 B-0994, B-1003, B-1004, B-1077, B-1178, Wang Y.: B-0177, B-0628, B-0682, B-0857
Verbist B.: A-203, A-608 B-1222 Wang Y.L.: B-0289, B-0847, B-1052, B-1056
Verburg F.: B-0375 Vogl W.-D.: B-0428, B-1116 Wang Y.-N.: B-0177
Verdolotti T.: B-0164 Vogt L.: B-0984 Wang Z.: B-0134, B-0135, B-0391
Verdun F.R.: B-1286 Vojinovic S.: B-1109 Ward A.M.: B-0715
Vergote I.: B-0543, B-1037, B-1141 Völgyes D.: B-0105 Warin-Fresse K.: B-1151
Verhaar H.J.J.: B-0488 Volle G.: B-0363 Warmerdam N.C.: B-0345
Verheij J.: B-1091 Volterrani L.: B-1172 Warringa N.: B-0589
Verheyden J.: B-0204 vom Scheidt A.: B-0478, B-1224 Wasan R.: B-0928
Verhoef C.: B-0191 von Baumgarten L.: B-0820, B-0968 Wasserman M.: B-0693
Verkooijen H.: B-0995 von Below C.M.: B-0951 Watson M.: B-1185
Verón Sánchez A.: B-1282 von Falck C.: B-0978, B-1044, B-1094 Watson T.: B-1012
Verschakelen J.A.: A-147 von Fintel E.: B-0014, B-0218, B-0222 Wattjes M.P.: B-1105
Verslype C.: B-0543, B-1323 von Guggenberg E.: B-0027 Waugh S.: B-0427
Verstraete K.: A-076, A-563, B-0069, CTiR 1 Vonder M.: B-0789 Webber N.: B-1149
Vicennati V.: B-1242 Vonken E.-J.P.: B-1365 Weber C.: B-0492, B-0695, B-1219
Vicente Quílez M.: B-0683 Vöö S.: B-0224, B-1276 Weber M.: B-0070, B-0300, B-0660, B-1116
Videira A.R.R.: B-1384 Vöö S.A.: B-0056 Weber M.-A.: A-372
Vieira I.F.: B-1141 Voogd A.: B-0420 Weber R.J.P.: B-0925
Vieira J.: B-1015 Voogd A.C.: B-0925 Weckbach S.: A-126
Vieira T.S.: B-1048 Voormolen M.: B-0403, B-0803 Wee S.H.: B-0215
Vierhapper M.: B-0278, B-0279 Vora M.P.: B-1346 Wegjan E.: B-1132
Viermetz M.: B-0547 Vorobiev S.: B-0063 Wei L.: B-0833
Vietti E.: B-0659 Vorobyov N.: B-0830 Wei W.: B-0556
Vignale D.: B-0256 Voropaev V.: B-1296 Weibrecht M.: B-1165, B-1166
Viguier A.: B-0818 Vörös E.: B-0613 Weijers G.: B-0022
Vikestad K.G.: B-0148 Voros S.: B-0766 Weinheimer O.: B-0433, B-0439, B-1211,
Viktil E.: B-0008 Vorster L.: B-0711 B-1216
Vilanova J.C.: A-694, B-0019, K-26 Vos A.: B-0650 Weinmann A.: B-0412
Vilar J.: A-434, A-436 Voss S.: B-0953 Weinrich J.: B-0049
Vilela P.: K-14 Vreemann S.: B-0426, B-0921, B-1071 Weir A.: B-0639
Vilgrain V.: A-272, A-397, A-542 Vriens I.: B-0420 Weirich G.: B-0341
Villalón M.: B-0019 Vriens M.R.: B-0364 Weir-McCall J.: B-0748
Villanueva A.: B-0443 Vujnovic S.: B-1302 Weis C.: B-0764
Villarejo T.: B-0311 Weis J.: B-0575
Villeirs G.M.: A-395, B-0942 W Weis M.: B-0373
Vimercati A.: B-1196 Waade G.G.: B-1119 Weishaupt D.: B-0306, B-0310, B-1250
Vinci V.: B-0168, B-0894, B-0896, B-1334 Waage J.E.R.: A-664 Weiss C.: A-282
Vindfeld S.: B-0075 Wacker F.: B-0939, B-0978, B-1003, B-1044, Weiß J.: B-0312, B-0593, B-0704, B-0861
Vink A.: B-0650 B-1094, B-1367 Welker L.: B-1219

Well L.: B-0049 Wilms G.: B-0205 Xue H.-D.: B-0571, B-0739, B-0836, B-1235,
Wellenberg R.H.H.: B-0954 Wilson D.J.: A-776, B-0280, B-1185 B-1265, B-1266, B-1268
Wells A.: B-0112, B-0586, B-0587, B-1368 Wilson I.: B-1370 Xydis V.: B-1059
Welsch G.H.: B-0642 Windhager R.: B-0491
Weng A.M.: B-0314, B-1045 Winklhofer S.: B-0554 Y
Wengert G.: B-1259 Winter-Warnars G.A.: B-0225 Yagami K.: B-0872
Wengert G.J.: B-0428, B-0758, B-1116 Winzer K.-J.: B-0926 Yagci R.: B-0155
Wenkel E.: CTiR 2 Wirth C.: B-0314 Yaguchi A.: B-1364
Wenter V.: B-0296 Wirth S.: A-553 Yamada A.: B-0841, B-1309
Wergeland C.: B-0345 Wirth W.: B-0555 Yamada Y.: B-1171
Werncke T.: B-1094, B-1367 Wiśniewska M.: B-0113 Yamagata H.: B-0655
Werner J.: A-265 Wissgott C.: B-0260, B-0616 Yamamoto S.: B-1039
Werring D.: B-0823 Wnuk E.: B-1374 Yamamura J.: B-0007, B-0382, B-0634
Wessalowski R.: B-0545 Wochner R.: B-0513 Yamashita M.: B-0495
Westbrook C.: B-0149 Wohlgemuth W.A.: B-0475 Yamazaki A.: B-0384, B-0385
Westenberg J.J.M.: B-0060 Woitek R.: B-0423, B-0757, B-0758, B-1116, Yamazoe S.: B-1189
Westenend P.J.: B-0012 B-1259 Yan J.: B-0992
Westhofen M.: B-0722 Wojcik D.: B-0952 Yan X.: B-0289, B-1052, B-1056
Westman E.: B-0388 Wojtaszek M.: B-1374 Yang D.H.: B-0250
Weston M.: A-236 Wolf F.: K-01 Yang Q.: B-0624
Wetscherek A.: B-0669 Wolfrum C.: B-0026 Yang Y.: B-0970
Wetter A.: B-0507, B-0560, B-0656, Wollersheim L.W.L.M.: B-1148 Yang Y.X.: B-0489
B-0900, B-1201, B-1351 Wolsztynski E.: B-0024 Yardimci A.H.: B-1280
Weyer H.: B-0483 Won J.Y.: B-1102 Yaroshenko A.: B-0671
White P.: B-0143, B-0672 Wong K.: B-1133 Yassin M.: B-0472, B-0680
Wichman J.L.: B-0746 Wong O.: B-0737 Yavaşi Ö.: B-0694
Wichmann J.: B-0175, B-0263 Wong P.C.: B-0359 Yavuz A.: B-0625
Wichmann J.L.: B-0174, B-0264, B-0380, Wong R.: B-0988 Yazar F.M.: B-0065
B-0386, B-0483, B-0783, B-0785, Wong S.C.: B-0973 Ye Y.: B-0628
B-0877, B-0878, B-0967, B-0976, B-1077, Wong Y.-C.: B-0523 Ye Z.: B-0089, B-0510, B-0773
B-1178, B-1222, B-1349 Woo E.K.: B-0227 Yeap P.M.: B-0427, B-0526, B-0916
Wick A.: B-0282 Woo S.M.: B-1234 Yegin G.: B-1356
Wick W.: B-0282 Woodley H.: A-318 Yehya M.A.M.: B-0567
Widmann G.: B-0564 Woods T.: B-0644 Yeniceri O.: B-1326
Wieben O.: B-1099 Wörtler K.: B-1184, K-24 Yeo A.: B-0489
Wiedenmann B.: B-0041 Wörz S.: B-0313, B-1043 Yeon E.: B-0636
Wiegerinck E.M.A.: B-0792 Wozniak M.: A-746 Yevich S.: B-0858
Wielema M.: B-0609, B-0610 Wray J.: B-0924 Yew S.: B-0489
Wielpütz M.: B-1211, B-1214 Wright C.L.: B-0029 Yi Y.: B-0177
Wielpütz M.O.: B-0433, B-0439, B-0513, Wu C.-H.: B-0523 Yilmaz E.: B-0140
B-1216 Wu H.: B-0584 Yilmaz E.U.T.A.A.K.C.T.: B-0318
Vienna J.: B-1156 Wu J.: B-0628 Yilmaz K.: B-0155
Wienbeck S.: B-0014, B-0218, B-0222 Wu L.: B-0051 Yılmaz O.: B-0002
Wieners G.: B-0621, B-0690 Wu L.M.: B-0253 Yilmaz S.: B-0085, B-0274, B-0591
Wiersma J.: B-0589 Wu Y.-W.: B-1241 Yim Y.: B-0464, B-1331
Wierts R.: B-0056 Wuest W.: B-0879 Yin B.: B-0288
Wiesinger B.: B-1068 Wulff A.: B-0953 Yin L.: B-0970
Wiesinger I.: B-0475, B-1026 Würstlin S.: B-1348 Yinn R.: B-0185
Wieske V.: CTiR 1 Wüst W.: B-0880 Yiu K.-H.: B-0784
Wietek B.M.: B-1068 Wuthrick E.: B-0029 Yoneyama Y.: B-0479
Wijesuriya S.: B-0928 Wyse G.: B-0795 Yong Q.: B-0059
Wikström J.: B-0203 Yonggao Z.: B-0992
Wildberger J.E.: B-0224, B-0473, B-0791, X Yoo J.L.: B-0975
B-1040, B-1064, B-1276 Xia Y.: B-0847 Yoo R.-E.: B-1363
Wildgruber M.: B-0547 Xiao L.: B-0359 Yoon J.: B-0546
Wildner S.: B-0534 Xiao Y.: B-0505, B-0511 Yoon J.H.: B-0410, B-0842, B-1297
Wilkmann C.: B-0864 Xiao Y.-D.: B-0974 Yoon K.H.: B-0215
Willaime J.M.Y.: B-0436 Xu C.: B-0584 Yoon K.-H.: B-1092
Willemink M.J.: B-1365 Xu H.: B-0676, B-0681, B-1360 Yoon Y.C.: B-0812
Willems S.M.: B-0568 Xu J.: B-0051, B-0584, B-1093 Yoshikawa T.: B-0106, B-0316, B-0319,
Willemssen F.E.J.A.: B-0408 Xu J.-M.: B-0268, B-0269 B-0684, B-0685, B-1364
Willer K.: B-0671 Xu J.R.: B-0253 You C.: B-1070
Williams M.C.: B-0118, B-0741 Xu Y.: B-0098 You S.H.: B-0573
Willinek W.: B-1003 Xue H.: B-1177, B-1327 You Y.: B-1093
Willner M.: B-1149 Xue H.D.: B-1093 Youn I.: B-0754

Yousry T.A.: A-106, A-337, A-655 Zhao Q.: B-1274

Youssef A.: B-0567 Zheng D.: B-0511
Youssef A.: B-0356 Zheng L.: B-0193, B-0938
Youssef A.A.Y.: B-1066 Zheng X.: B-0511
Youssif O.Z.: B-1065 Zhou D.-J.: B-0268, B-0269
Yperzeele L.: B-0403, B-0803 Zhou J.: B-0963
Yu B.: B-1029 Zhou Y.: B-0733, B-0734, B-0735
Yu C.: B-1330 Zhu B.: B-0962
Yu J.I.: B-0839 Zhu L.: B-1265, B-1266, B-1268
Yu M.: B-0584 Žibert J.: B-1380, B-1381
Yu M.H.: B-0464, B-1331 Zidan D.Z.: B-0294
Yu S.: B-0265 Zidi A.: B-0046, B-1308
Yuan H.: B-0391 Ziegeler K.: B-0067
Yuan J.: B-0059 Ziemlewicz T.: B-0206
Yuen C.T.: B-0321 Zijlstra I.A.J.: B-0407
Yuen M.K.: B-0359 Zikou A.: B-1059
Yui M.: B-0316, B-0319 Zimlichman E.: B-0686
Yun B.L.: B-0530 Zimmer C.: B-1193
Yurttutan N.: B-0065, B-0066, B-0171, Zimmermann E.: B-0460
B-0637 Zimmermann M.: B-0281, B-0283, B-0284
Yutaka N.: B-0134 Zini C.: B-0537, B-0941
Zins M.: B-0037
Z Zinsser D.: B-0292
Zabala Landa R.M.: B-0358 Ziv-Baran T.: B-0115, B-0116
Zackrisson S.: A-351, A-387, A-702 Złotorowicz M.: B-0911, B-0914
Zagoria R.J.: A-194, A-196 Zmuda M.: B-0157
Zakharova M.: B-1111 Zoga A.C.: B-1180
Zamboni G.: A-661, B-0819 Zolda P.: A-455
Zanca F.: A-653, B-1287 Zompatori M.: B-0111, B-0139
Zanetti G.: A-066 Zonnenberg B.: B-0995
Zanetti M.: A-371, A-562, A-720, B-1186 Zou W.: B-0847
Zangos S.: B-0130, B-0467, B-0470, Zuber N.: B-0306, B-0310, B-1250
B-0862, B-0976, B-1004, B-1222 Zugaro L.: B-0324, B-0331, B-0332
Zantedeschi L.: B-0832 Zuiani C.: B-0220, B-0605, CTiR 2
Zarb F.: B-0718 Zulina T.: B-1305
Zarnowski J.: B-0549 Zurera L.J.: B-0536
Zauner Jakubik M.: B-0328 Zvěřina E.: B-0728
Zdešar U.: A-766, B-1381 Zykov O.: B-0154
Zeccolini F.: B-1057 Zynger D.: B-0825, B-0833
Zech C.J.: A-315
Zechlinski J.: B-0127
Zedan M.H.: B-0612, B-1279
Zefov V.N.: B-0888
Zeller T.: B-0260
Zeng X.: B-0391
Zerlauth J.-B.: B-0362
Zerolo A.: A-692
Zerunian M.: B-0780
Zhang C.: B-0628
Zhang D.: B-1177
Zhang F.: B-0584
Zhang G.: B-0938
Zhang G.F.: B-0132
Zhang G.-M.-Y.: B-0571, B-1235
Zhang H.: B-0134
Zhang J.: B-0028, B-0029, B-0374
Zhang K.: B-0089
Zhang L.: B-0059
Zhang M.: B-0504
Zhang X.: B-0970
Zhang X.-L.: B-0095
Zhang Y.: B-0265, B-0584, B-0628
Zhang Z.: B-0193, B-0445, B-0449, B-0938
Zhang Z.-L.: B-0991
Zhao J.: B-0289, B-1052, B-1056

LIST OF
M O D E R ATO R S
375
List of Moderators
A Camps Herrero J.: E3 24A, E3 24B, E3 24C, G

Abeyakoon O.: SS 1416 E3 24D, E3 24E Garðarsdóttir M.: EM 1
Adam E.J.: MIR 2 Carbonetti F.: SS 617 Garnon J.: SS 1009
Agadakos E.: SS 314 Carrafiello G.: SS 209 Geith T.: SS 1010b
Akata D.: SS 1001b Caseiro-Alves F.: SS 1501 Gibaud B.: SS 305
Akhan O.: SS 609 Cesar R.: SS 1904 Gillard J.H.: SS 1411b
Akchurina E.: SS 701c Chatziioannou S.: SS 206 Glaveckaite S.: SS 1415
Alberich-Bayarri A.: SS 1805 Choi B.I.: SS 201a Gogbashian A.: SS 1916
Albrecht T.: SS 1009 Ciet P.: SS 304 Gourtsoyianni S.: SS 601b
Alkadhi H.: E3 1226c Ciraj-Bjelac O.: SS 313 Gourtsoyiannis N.: ESOR
Allen, Jr. B.: ACR Claudon M.: ESR/EFSUMB/ESPR Gramer B.M.: SS 213
Allen S.: SS 202 Coche E.E.J.G.: SS 204 Gruszczynska K.: SS 703
Anderson S.E.: SS 1010b Coenegrachts K.: SS 1401 Guglielmi G.: SS 610a
Arenson R.: CTiR 1, CTiR 2 Conte G.: SS 308 Gulino P.: SS 212
Arkhipova I.: SS 1014 Contegiacomo A.: SS 1015
Artigas J.M.: SS 717 Cotten A.: RC 1210, SS 1410 H
Athanasiou A.: RC 102 Cowan N.C.: SS 707 Haage P.: SS 1015
Aviram G.: SS 704 Hagen G.: EM 1
Crocetti L.: SS 1001b
Ayuso C.: SS 216b Haider L.: SS 1911
Cunha T.M.: E3 922
Hamm B.: MIR 1
Curvo-Semedo L.: SS 1001a
B Hanelore H.: SS 211b
Czerny C.: SS 308
Balassy C.: SS 312 Heinz-Peer G.: SS 1807
Bali M.A.: SS 216a Helbich T.H.: RC 106
D Helmberger T.K.: E3 1518
Balleyguier C.S.: SS 302 Damilakis J.: EF 1
Bamberg F.: SS 203a Hemke R.: SS 210
Danielsen E.R.: ESR/ESMRMB
Henner A.: SS 1414
Bargalló N.: SS 211a de Bruijne M.: SS 605 Henzler T.: SS 1404
Bargellini I.: SS 1815 de Bucourt M.: SS 315 Hermans R.: RC 508
Basta-Nikolic M.: TF 1 de las Heras Gala H.: SS 1913 Herneth A.M.: SS 1006
Battisti S.: SS 1816 de Roos A.: SS 303a Herzog C.: SS 1903
Beardmore C.: SS 714 Dewey M.: CTiR 1, CTiR 2 Hirsch W.: RC 412
Beets-Tan R.G.H.: E3 1726b
Di Matteo M.: SS 1002 Hoeffel C.: SS 601b
Bell J.K.: MIR 3
Diamantopoulos A.: SS 309 Hogg P.H.: SS 214
Bellin M.-F.: SS 607b
Domingo A.: SS 602b Honda H.: EM 2
Bérczi V.: SS 1909
Dondelinger R.F.: SS 1409 Howarth N.: E3 25A, E3 25B, E3 25C, E3 25D,
Bernardi D.: RC 1602
Donoso L.: EM 1, EM 2, EM 3, ESOR E3 25E
Bernathova M.: SS 1402b
Dore R.: SS 203a Huzjan Korunić R.: SS 1807
Berritto D.: TF 1
Dormagen J.B.: SS 617
Beyer T.: EF 1
Dromain C.: SS 1902b I
Bharadwaz A.: SS 1809
Dudás I.: SS 1901b Issever A.S.: SS 610a
Bhatia K.S.S.: SS 1408
Due-Tønnessen P.: RC 111
Bick U.: SS 1805 J
Bickelhaupt S.: SS 605 Jahnen A.: SS 213
Bilbao J.I.: E3 1226a, SS 1515
E
Ekberg O.: SS 701b Jargiello T.: RC 815
Biondi A.: SS 311c Jon E.: SS 704
Esen G.: RC 1502
Blomqvist L.K.: E3 1218, SS 1816 Junker D.: SS 1407
Esposito A.: SS 1903
Bojanovic A.L.J.: SS 615
Bonekamp D.: SS 707 K
Borges A.: SS 608
F
Karabulut N.: ESR/ERS
Faggioni L.: SS 305
Bos D.: SS 1411a Karantanas A.H.: SS 1810
Bouchareb Y.: SS 713 Falini A.: SS 311a
Karnabatidis D.: RC 415
Boudabbous S.: SS 1010a Fallenberg E.M.: SS 1902a
Kasatkina E.: SS 301a
Bougias B.: SS 1914 Fanelli F.: SS 715
Kasprian G.: SS 1012
Brandão S.: SS 1014 Feuchtner G.: SS 203b
Kau T.: SS 1011a
Bremerich J.: E3 1520, ESR/ESMRMB Fischbach R.: SS 303b
Kauczor H.-U.: ACR
Brisbois D.: SS 1003 Fohlen A.: SS 216a Kelekis A.D.: SS 1809
Brkljačić B.: SS 602b Forrai G.: SS 1902a Kerl J.M.: SS 1003
Broncano J.: SS 303a Fournier L.S.: SS 1916 Kienzl-Palma D.: SS 1804
Brountzos E.: SS 1815 Franchi-Abella S.: E3 1226b Kirova-Nedialkova G.I.: E3 1220
Buls N.: SS 313 Francone M.: SS 303b Klumpp B.: SS 1416
Buruian M.: SS 1011b Freling N.J.M.: RC 808 Knogler T.: SS 1802
Frija G.: EuroSafe 2 Koerte I.: SS 211a
C Frühwald-Pallamar J.: RC 1308 Koff D.A.: MIR 2
Cademartiri F.: SS 203b Fuchsjäger M.H.: SS 302 Koh D.-M.: E3 1618
Calli C.: SS 1411a Fütterer J.J.: E3 1022 Kösling S.: SS 708

List of Moderators
Koutalonis M.: SS 1813 P T

Krokidis M.: SS 1909 Pagonidis K.: SS 1803 Tack D.: SS 1404
Kuhelj D.: SS 609 Palkó A.: MC 528, MC 628, MC 728, MC 828 Tali E.T.: RC 1511
Kucheruk O.V.: SS 216b Panebianco V.: SS 616 Taylor A.M.: RC 512
Kuhn F.P.: SS 311a Panizza P.: SS 1902b Taylor Z.A.: EIBIR 4
Papaioannou G.: SS 1012 Thibault F.: SS 702
L Parkar A.P.: RC 904 Thierfelder K.M.: SS 611
Lambregts D.M.: SS 316 Pasterk M.: PC 9a Thoeny H.C.: E3 622
Lammers T.: SS 206 Pediconi F.: SS 702 Thomassin-Naggara I.: SS 602a
Lamot U.: SS 711 Tomà P.: RC 1312
Peetrons P.: SS 310
Lang K.: SS 714 Trattnig S.: SS 610b
Perez Rodrigo S.: SS 1402a
Leander P.: SS 701a Traykova N.I.: SS 1008
Pershina E.: SS 1503
Lee J.M.: SS 1901a Trojanowska A.: E3 1726a
Persson A.: RC 1504
Lefere P.: E3 1318 Tsalafoutas I.A.: SS 1913
Pijnappel R.: RC 1302, SS 1402a
Lehéricy S.: SS 1911 Tsapaki V.: EF 2
Pina Insausti L.J.: SS 1402b
Leidecker C.: RC 1614 Tsetis D.K.: SS 715
Plumb A.: SS 1001a
Ley S.: ESR/ERS Tsitskari M.: SS 209
Politi L.S.: SS 208
Linsenmaier U.: RC 417 Turkay R.: SS 207
Prayer D.: SS 212
Loewe C.: E3 920
Puzakov K.B.: SS 1907
Logager V.: E3 822 V
Pyatigorskaya N.: SS 311b
Looby S.: SS 1411b Van Beers B.E.: SS 201b
Pyra K.: SS 607a
Loose R.W.R.: SS 1813 van Buchem M.A.: SS 311b
Lopes Dias J.: SS 607b Van der Lugt A.: SS 215
R
Løvblad K.-O.: SS 1511 van der Molen A.J.: SS 1401
Rainford L.: EuroSafe 1
Lubinus F.G.: EM 3 Van Goethem J.: SS 1811
Raissaki M.: RC 912
Rand T.: SS 615 van Ooijen P.M.A.: SS 1905
M Van Westen D.: E3 1726d
Raupach R.: SS 713
Madureira A.J.B.S.: SS 603 Vanninen R.L.: EM 1
Regier M.: E3 1626, SS 1904
Maintz D.: SS 1503 Varoquaux D.-A.: RC 408
Reiter M.: SS 215
Maksimović R.: SS 301b Venancio J.: E3 522
Riddell A.M.: SS 301a
Malagari K.: SS 1804 Venkatesh S.K.: SS 1501
Riklund K.: EM 1, EM 2, EM 3, ESR/ESHI
Malone D.E.: SS 601a Vernooij M.: RC 1211
Ringl H.: SS 701c
Mang T.: SS 301b Vilanova J.C.: SS 1407
Roditi G.: RC 403
Mann R.M.: E3 1726c Vilela P.: SS 611
Rodríguez P.: SS 601a
Marcia S.: SS 309 Vorwerk D.: SS 1901b
Markiet K.: SS 708 Rodt T.: SS 208
Rohde S.: RC 1611
Masselli G.: SS 1907
Rørvik J.: SS 1016
W
Mayer J.: SS 1004 Walker-Samuel S.: SS 1406
Mazzei M.A.: SS 701b Rostovtseva T.: SS 1011b
Wängler B.: SS 1406
Meissnitzer M.: SS 307 Weber M.-A.: RC 410
Merhemic Z.: SS 711 S
Weckbach S.: PS 427
Meyer M.: SS 603 Sachs A.: SS 1810
Westwood T.D.: SS 716
Mildenberger P.: MIR 3 Salvador R.: SS 1905
Wibmer A.: SS 701a
Miletić D.: SS 1414 Santos J.: RC 1614
Widmann G.: SS 1008
Molinari F.: SS 604 Schaarschmidt B.M.: SS 616
Wilson D.J.: SS 710
Morgan R.: RC 915 Schemuth H.P.: SS 311c
Wirth S.: RC 117
Morozov S.: MIR 1 Schmid-Tannwald C.: SS 1409
Woitek R.: SS 1511
Morozova S.: SS 1811 Schulz-Wendtland R.: SS 1502
Wörtler K.: SS 1010a
Mousseaux E.: E3 1620 Sconfienza L.M.: SS 310
Mrakic Sposta F.: SS 717 Selim A.: SS 1802 Y
Mueller-Lisse U.G.: SS 207 Sellors J.: PS 427 Yazici Z.: SS 312
Sever A.: SS 602a
N Sharp P.: EF 2 Z
Neri E.: PC 9a Silva M.: SS 604 Zagoria R.J.: MC 528, MC 628, MC 728,
Nielsen K.R.: EM 1 Skrobisz-Balandowska K.: SS 201b MC 828
Nikolic O.: SS 607a Sohaib A.: SS 316 Zamboni G.: SS 201a
Noebauer-Huhmann I.-M.: SS 210 Sommer W.H.: SS 1016 Zarb F.: SS 1814
Sorantin E.: SS 314 Zlatareva D.: RC 1311
O Sosna J.: SS 716
Oei E.H.G.: SS 610b Spirovski M.: SS 1901a
Ortiz-Pérez J.T.: SS 315 Ståhlbrandt H.: EM 1, SS 1814
Otero-García M.M.: E3 722 Steens S.: SS 608
Oudeman J.: SS 710 Stern E.J.: SS 1004
Owens C.: ESR/EFSUMB/ESPR Szabó E.: SS 1914

vienna
march 1–5
the flower gardens
of radiology
the annual meeting of
myESR.org
The ECR is the annual meeting of the European Society of Radiology

ECR 2016 Final Programme PDF

Hochgeladen von

Dokumentinformationen

Originaltitel

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

ECR 2016 Final Programme PDF

Hochgeladen von

Copyright:

Verfügbare Formate

FINAL PROGRAMME

New Horizons Session E³ - ECR Academy E³ - The Beauty of Basic Knowledge

Special Focus Session MC 628 E³ - The Beauty of Basic Knowledge

E³ - ECR Academies Scientific Sessions (1000)

The Voice of EPOS • in the EPOS™ Arena

2 ECR 2016 | Final Programme www.myESR.org

Scientific Sessions (300) New Horizons Session Opening Ceremony

E³ - ECR Academies Professional Challenges Sessions

EFRS meets Sweden Professional Challenges Sessions

Special Focus Session Special Focus Session

E³ - European Diploma Prep Session

E³ - Rising Stars Programme

CONGRESS VENUE CONGRESS LANGUAGE

ONSITE OPENING HOURS

Press Office & Business Centre

SESSIONS IN JOINT SPONSORSHIP WITH

CIRSE Cardiovascular and Interventional Radiological Society of Europe

4 ECR 2016 | Final Programme www.myESR.org

INFORMATION FROM A–Z

Forewords Scientific Programme

Programme Overviews Industry Programme

www.myESR.org Final Programme | ECR 2016 5

FOREWORD BY THE ESR PRESIDENT

6 ECR 2016 | Final Programme www.myESR.org

FOREWORD BY THE ESR PRESIDENT

www.myESR.org Final Programme | ECR 2016 7

FOREWORD BY THE ECR PRESIDENT

during last year’s ECR. Even if we are in a transition period,

For ECR 2016, the new format introduced to the educational

8 ECR 2016 | Final Programme www.myESR.org

FOREWORD BY THE ECR PRESIDENT

I am also happy to announce that submission of Clinical

www.myESR.org Final Programme | ECR 2016 9

JUAN DIEGO FLÓREZ

INFORMATION FROM A–Z

ARTS & CULTURE BOOKSTORE

CASE-BASED DIAGNOSIS TRAINING

12 ECR 2016 | Final Programme www.myESR.org

INFORMATION FROM A–Z

CASES OF THE DAY CLINICAL TRIALS IN RADIOLOGY

Wednesday: CME ACCREDITATION SYSTEM

Friday: Please note that evaluation of the sessions is only possible

www.myESR.org Final Programme | ECR 2016 13

INFORMATION FROM A–Z

CONFIRMATION OF PAYMENT AND ATTENDANCE ECR 2016 SMARTPHONE APP

‘EFRS MEETS’ SESSION

ECR TODAY ber. A medical specialist trained in emergency medicine will

14 ECR 2016 | Final Programme www.myESR.org

INFORMATION FROM A–Z

EPOS™ – SCIENTIFIC EXHIBITION EUROPEAN EXCELLENCE IN EDUCATION (E3)

www.myESR.org Final Programme | ECR 2016 15

INFORMATION FROM A–Z

want to refresh their knowledge in basic topics of imaging EUROSAFE IMAGING

See page 35. ‘INSIGHTS INTO IMAGING’

16 ECR 2016 | Final Programme www.myESR.org

INFORMATION FROM A–Z

INDUSTRY WORKSHOPS MEETING ROOMS

The Image Interpretation Quizzes are two traditional high-

LIABILITY MINI COURSE

MEDITATION & PRAYER ZONE

www.myESR.org Final Programme | ECR 2016 17

INFORMATION FROM A–Z

MULTIDISCIPLINARY SESSIONS PREVIEW CENTRE